PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mangone, M; Manoharan, AP; Thierry-Mieg, D; Thierry-Mieg, J; Han, T; Mackowiak, SD; Mis, E; Zegar, C; Gutwein, MR; Khivansara, V; Attie, O; Chen, K; Salehi-Ashtiani, K; Vidal, M; Harkins, TT; Bouffard, P; Suzuki, Y; Sugano, S; Kohara, Y; Rajewsky, N; Piano, F; Gunsalus, KC; Kim, JK				Mangone, Marco; Manoharan, Arun Prasad; Thierry-Mieg, Danielle; Thierry-Mieg, Jean; Han, Ting; Mackowiak, Sebastian D.; Mis, Emily; Zegar, Charles; Gutwein, Michelle R.; Khivansara, Vishal; Attie, Oliver; Chen, Kevin; Salehi-Ashtiani, Kourosh; Vidal, Marc; Harkins, Timothy T.; Bouffard, Pascal; Suzuki, Yutaka; Sugano, Sumio; Kohara, Yuji; Rajewsky, Nikolaus; Piano, Fabio; Gunsalus, Kristin C.; Kim, John K.			The Landscape of C. elegans 3 ' UTRs	SCIENCE			English	Article							HISTONE MESSENGER-RNA; CAENORHABDITIS-ELEGANS; GENOME; TRANSCRIPTOME; MECHANISMS; EXPRESSION; WORMBASE; RESOURCE; BIOLOGY; PROTEIN	Three-prime untranslated regions (3'UTRs) of metazoan messenger RNAs (mRNAs) contain numerous regulatory elements, yet remain largely uncharacterized. Using polyA capture, 3' rapid amplification of complementary DNA (cDNA) ends, full-length cDNAs, and RNA-seq, we defined similar to 26,000 distinct 3'UTRs in Caenorhabditis elegans for similar to 85% of the 18,328 experimentally supported protein-coding genes and revised similar to 40% of gene models. Alternative 3'UTR isoforms are frequent, often differentially expressed during development. Average 3'UTR length decreases with animal age. Surprisingly, no polyadenylation signal (PAS) was detected for 13% of polyadenylation sites, predominantly among shorter alternative isoforms. Trans-spliced (versus non-trans-spliced) mRNAs possess longer 3'UTRs and frequently contain no PAS or variant PAS. We identified conserved 3'UTR motifs, isoform-specific predicted microRNA target sites, and polyadenylation of most histone genes. Our data reveal a rich complexity of 3'UTRs, both genome-wide and throughout development.	[Mangone, Marco; Mis, Emily; Zegar, Charles; Gutwein, Michelle R.; Attie, Oliver; Chen, Kevin; Piano, Fabio; Gunsalus, Kristin C.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Manoharan, Arun Prasad; Han, Ting; Khivansara, Vishal; Kim, John K.] Univ Michigan, Dept Human Genet, Inst Life Sci, Ann Arbor, MI 48109 USA; [Thierry-Mieg, Danielle; Thierry-Mieg, Jean] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Mackowiak, Sebastian D.; Chen, Kevin; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Salehi-Ashtiani, Kourosh; Vidal, Marc] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Salehi-Ashtiani, Kourosh; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Salehi-Ashtiani, Kourosh; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Harkins, Timothy T.] Roche Appl Sci, Indianapolis, IN 46250 USA; [Bouffard, Pascal] Roche Appl Sci, Life Sci 454, Branford, CT 06405 USA; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Kohara, Yuji] Natl Inst Genet, Ctr Genet Resource Informat, Genome Biol Lab, Mishima, Shizuoka 4118540, Japan; [Piano, Fabio; Gunsalus, Kristin C.] NYU, Abu Dhabi, U Arab Emirates	New York University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Roche Holding; Roche Holding; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Piano, F (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, 1009 Silver Ctr, New York, NY 10003 USA.	fp1@nyu.edu; kcg1@nyu.edu; jnkim@umich.edu	Chen, Kevin/GYU-8963-2022; KHIVANSARA, VISHAL/P-7702-2019; Mackowiak, Sebastian D/S-3266-2017; THIERRY-MIEG, Jean/F-1975-2017; Mangone, Marco/H-2462-2016	KHIVANSARA, VISHAL/0000-0003-2574-5298; Mackowiak, Sebastian D/0000-0003-1673-5389; THIERRY-MIEG, Jean/0000-0002-0396-6789; Thierry-Mieg, Danielle/0000-0001-9568-4211; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243; Mangone, Marco/0000-0001-7551-8793; manoharan, arun prasad/0000-0002-7030-7353; Rajewsky, Nikolaus/0000-0002-4785-4332	NIH [U01-HG004276, R00HG004515, R01GM088565]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Muscular Dystrophy Association; Pew Charitable Trusts; DFCI Strategic Initiative; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); NIH; National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004276, R00HG004515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; DFCI Strategic Initiative; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from NIH (U01-HG004276) to F. P., K. C. G., J.K.K., and N.R.; NIH grant (R00HG004515) to K. C.; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Y.K., S.S., and Y.S.; NIH (R01GM088565), Muscular Dystrophy Association and the Pew Charitable Trusts to J.K.K.; a gift from the Ellison Foundation to M. V. and Institute Sponsored Research funds from the DFCI Strategic Initiative in support of the CCSB; the Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network) to S. D. M.; and the Intramural Research Program of NIH, National Library of Medicine to J.T.-M. and D. T.-M. We thank J. V. Moran, T. Blumenthal, A. Billi, D. Mecenas, and B. Bargmann for discussions; T. Shin'I and Exelixis for C. elegans cDNA traces; and, for technical assistance, T. Nawy and B. Brown (statistical analysis); R. Sachidanandam, R. Lyons, and S. Genik (deep sequencing); P. MacMenamin and D. Schaub (3'UTRome database); M. Morris (data submission); and L. Huang (stage analysis). 3'UTRome data sets are available from NCBI Trace Archive, dbEST, Sequence Read Archive, Gene Expression Omnibus, and modENCODE (8). See supporting online materials and methods for details. Annotations are displayed at NCBI AceView (www.aceview.org) (9) and www.UTRome.org (12).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Keall R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-51; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Liu YM, 2001, RNA, V7, P176, DOI 10.1017/S1355838201002333; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Mangone M, 2008, NUCLEIC ACIDS RES, V36, pD57, DOI 10.1093/nar/gkm946; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; THIEMANN V, 2006, APPL MICROBIOL BIOT, V12, P1; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	23	196	200	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					432	435		10.1126/science.1191244	http://dx.doi.org/10.1126/science.1191244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20522740	Green Accepted			2022-12-28	WOS:000280196500035
J	Mallet, V; Nicand, E; Sultanik, P; Chakvetadze, C; Tesse, S; Thervet, E; Mouthon, L; Sogni, P; Pol, S				Mallet, Vincent; Nicand, Elisabeth; Sultanik, Philippe; Chakvetadze, Catherine; Tesse, Sophie; Thervet, Eric; Mouthon, Luc; Sogni, Philippe; Pol, Stanislas			Brief Communication: Case Reports of Ribavirin Treatment for Chronic Hepatitis E	ANNALS OF INTERNAL MEDICINE			English	Article							E VIRUS-INFECTION; LIVER-TRANSPLANT RECIPIENTS; THERAPY; PATIENT	Background: There is currently no accepted treatment of chronic hepatitis E virus (HEV) infection. Objective: To report 2 patients in whom ribavirin therapy seemed to alter the natural history of chronic HEV infection. Design: Case reports. Setting: Hepatology unit of a tertiary care center in France. Patients: A kidney and pancreas transplant recipient and a patient with idiopathic CD4(+) T lymphocytopenia, both with biopsy-proven chronic HEV infection. Intervention: Patients received oral ribavirin, 12 mg/kg of body weight daily for 12 weeks. Measurements: Liver function tests, detection of HEV RNA (viremia and stool shedding) by reverse transcriptase polymerase chain reaction, and anti-HEV IgM and IgG antibodies. Results: Both patients had normalized liver function test results after 2 weeks of treatment and cleared HEV after 4 weeks of treatment. Hepatitis E virus RNA remained undetectable in the serum and stools throughout follow-up (3 months and 2 months for the first and second patient, respectively). Side effects were considered mild. Limitation: Given the relatively short follow-up, the achievement of HEV eradication could not be claimed. Conclusion: Ribavirin is a potentially effective treatment of HEV infection and should be evaluated in patients with chronic HEV infection.	[Mallet, Vincent] Univ Paris 05, Assistance Publ Hop Paris,Inst Cochin,UMR S1016, Unite Hepatol,CNRS,UMR 8104,Hop Necker Enfants Ma, Ctr Univ St Peres,UMR 775,Grp Hosp Cochin St Vinc, F-75014 Paris, France; Hop Instruct Armees Val de Grace, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Val-de-Grace Hospital	Mallet, V (corresponding author), Univ Paris 05, Assistance Publ Hop Paris,Inst Cochin,UMR S1016, Unite Hepatol,CNRS,UMR 8104,Hop Necker Enfants Ma, Ctr Univ St Peres,UMR 775,Grp Hosp Cochin St Vinc, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	vincent.mallet@cch.aphp.fr	Mallet, Vincent/G-4623-2011	Mallet, Vincent/0000-0003-2219-9201				Briggs GG, 2008, DRUGS PREGNANCY LACT; Dalton HR, 2008, EUR J CLIN MICROBIOL, V27, P579, DOI 10.1007/s10096-008-0480-z; Dalton HR, 2007, LANCET, V369, P1260, DOI 10.1016/S0140-6736(07)60595-9; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Enouf V, 2006, J MED VIROL, V78, P1076, DOI 10.1002/jmv.20665; Fontaine H, 2004, TRANSPLANTATION, V78, P853, DOI 10.1097/01.TP.0000128911.87538.AA; *FRENCH NAT REF LA, ANN REP 2008 FRENCH; Garnier JL, 1997, TRANSPL P, V29, P783, DOI 10.1016/S0041-1345(96)00100-5; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Haagsma EB, 2010, LIVER TRANSPLANT, V16, P474, DOI 10.1002/lt.22014; Haagsma EB, 2009, LIVER TRANSPLANT, V15, P1225, DOI 10.1002/lt.21819; Jacobson IM, 2007, HEPATOLOGY, V46, P982, DOI 10.1002/hep.21670; Kamar N, 2003, AM J KIDNEY DIS, V42, P184, DOI 10.1016/S0272-6386(03)00422-0; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2010, TRANSPLANTATION, V89, P353, DOI 10.1097/TP.0b013e3181c4096c; Kamar N, 2010, CLIN INFECT DIS, V50, pE30, DOI 10.1086/650488; Mast EE, 1996, ANNU REV MED, V47, P257; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Peron JM, 2006, J GASTROEN HEPATOL, V21, P1223, DOI 10.1111/j.1440-1746.2006.04209.x; Pischke S, 2010, LIVER TRANSPLANT, V16, P74, DOI 10.1002/lt.21958; REICHARD O, 1991, LANCET, V337, P1058, DOI 10.1016/0140-6736(91)91707-2; Tamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0	25	131	135	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2					85	W31		10.7326/0003-4819-153-2-201007200-00257	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00257			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20547886				2022-12-28	WOS:000280095400003
J	Serruys, PW; Silber, S; Garg, S; van Geuns, RJ; Richardt, G; Buszman, PE; Kelbaek, H; van Boven, AJ; Hofma, SH; Linke, A; Klauss, V; Wijns, W; Macaya, C; Garot, P; DiMario, C; Manoharan, G; Kornowski, R; Ischinger, T; Bartorelli, A; Ronden, J; Bressers, M; Gobbens, P; Negoita, M; van Leeuwen, F; Windecker, S				Serruys, Patrick W.; Silber, Sigmund; Garg, Scot; van Geuns, Robert Jan; Richardt, Gert; Buszman, Pawel E.; Kelbaek, Henning; van Boven, Adrianus Johannes; Hofma, Sjoerd H.; Linke, Axel; Klauss, Volker; Wijns, William; Macaya, Carlos; Garot, Philippe; DiMario, Carlo; Manoharan, Ganesh; Kornowski, Ran; Ischinger, Thomas; Bartorelli, Antonio; Ronden, Jacintha; Bressers, Marco; Gobbens, Pierre; Negoita, Manuela; van Leeuwen, Frank; Windecker, Stephan			Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; THROMBOSIS; INTERVENTION; THERAPY; SYSTEM	BACKGROUND New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration. METHODS In this multicenter, noninferiority trial with minimal exclusion criteria, we randomly assigned 2292 patients to undergo treatment with coronary stents releasing either zotarolimus or everolimus. Twenty percent of patients were randomly selected for repeat angiography at 13 months. The primary end point was target-lesion failure, defined as a composite of death from cardiac causes, any myocardial infarction (not clearly attributable to a nontarget vessel), or clinically indicated target-lesion revascularization within 12 months. The secondary angiographic end point was the extent of in-stent stenosis at 13 months. RESULTS At least one off-label criterion for stent placement was present in 66% of patients. The zotarolimus-eluting stent was noninferior to the everolimus-eluting stent with respect to the primary end point, which occurred in 8.2% and 8.3% of patients, respectively (P<0.001 for noninferiority). There were no significant between-group differences in the rate of death from cardiac causes, any myocardial infarction, or revascularization. The rate of stent thrombosis was 2.3% in the zotarolimus-stent group and 1.5% in the everolimus-stent group (P=0.17). The zotarolimus-eluting stent was also noninferior regarding the degree (+/- SD) of in-stent stenosis (21.65 +/- 14.42% for zotarolimus vs. 19.76 +/- 14.64% for everolimus, P=0.04 for noninferiority). In-stent late lumen loss was 0.27 +/- 0.43 mm in the zotarolimus-stent group versus 0.19 +/- 0.40 mm in the everolimus-stent group (P=0.08). There were no significant between-group differences in the rate of adverse events. CONCLUSIONS At 13 months, the new-generation zotarolimus-eluting stent was found to be noninferior to the everolimus-eluting stent in a population of patients who had minimal exclusion criteria. (ClinicalTrials.gov number, NCT00617084.)	[Serruys, Patrick W.] Erasmus MC, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands; [van Boven, Adrianus Johannes; Hofma, Sjoerd H.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Klauss, Volker] Univ Hosp Munich Innenstadt, Munich, Germany; [Silber, Sigmund] Kardiol Praxis & Praxisklin, Munich, Germany; [Ischinger, Thomas] Hosp Bogenhausen, Munich, Germany; [Richardt, Gert] Segeberger Kliniken, Herz Kreislauf Zentrum, Bad Segeberg, Germany; [Linke, Axel] Herzzentrum Leipzig, Leipzig, Germany; [Buszman, Pawel E.] Med Univ Silesia, Katowice, Poland; [Kelbaek, Henning] Rigshosp, DK-2100 Copenhagen, Denmark; [Wijns, William] Onze Lieve Vrouw Hosp, Aalst, Belgium; [Macaya, Carlos] Univ Hosp, Madrid, Spain; [Garot, Philippe] Inst Cardiovasc Paris Sud, Quincy, France; [DiMario, Carlo] Royal Brompton Hosp, London SW3 6LY, England; [Manoharan, Ganesh] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland; [Kornowski, Ran] Tel Aviv Univ, Rabin Med Ctr, IL-69978 Tel Aviv, Israel; [Bartorelli, Antonio] Ctr Cardiol Monzino, Milan, Italy; [Negoita, Manuela; van Leeuwen, Frank] Medtronic, Santa Rosa, CA USA; [Windecker, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland	Erasmus University Rotterdam; Erasmus MC; Medical Center Leeuwarden; University of Munich; Munchen Klinik; Segeberger Kliniken Group; Heart Center Leipzig GMBH; Medical University Silesia; Rigshospitalet; University of Copenhagen; UDICE-French Research Universities; Universite Paris Saclay; Royal Brompton Hospital; Rabin Medical Center; Tel Aviv University; IRCCS Centro Cardiologico Monzino; Medtronic; University of Bern; University Hospital of Bern	Serruys, PW (corresponding author), Erasmus MC, Dept Cardiol, Molewaterpl 40,BA 583, NL-3015 GD Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	van Geuns, Robert/AAR-6386-2021; van Geuns, Robert-Jan M/N-7976-2017; Bartorelli, Antonio/K-3955-2018; Buszman, Pawel/AAX-9336-2020; Bartorelli, Antonio Luca/ABG-9593-2020	van Geuns, Robert-Jan M/0000-0003-2943-5932; Wijns, William/0000-0002-7267-4376; Garg, Scot/0000-0002-8911-0278; Buszman, Pawel/0000-0002-2511-4077	Medtronic CardioVascular	Medtronic CardioVascular	Supported by Medtronic CardioVascular.	Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Farb A, 2007, NEW ENGL J MED, V356, P984, DOI 10.1056/NEJMp068304; GARG S, EUROINTERVE IN PRESS; GARG S, J AM COLL C IN PRESS; Hezi-Yamit A, 2009, COMB CHEM HIGH T SCR, V12, P664, DOI 10.2174/138620709788923674; Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Meredith IT, 2010, EUROINTERVENTION, V5, P692, DOI 10.4244/EIJV5I6A114; Meredith IT, 2009, JACC-CARDIOVASC INTE, V2, P977, DOI 10.1016/j.jcin.2009.07.007; Meredith Ian T, 2007, EuroIntervention, V3, P50; Serruys P.W., 1994, QUANTITATIVE CORONAR; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys Patrick W, 2007, EuroIntervention, V2, P405; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; Sianos Georgios, 2005, EuroIntervention, V1, P219; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Udipi K, 2008, J BIOMED MATER RES A, V85A, P1064, DOI 10.1002/jbm.a.31664; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; WYKRZYKOWSKA J, J AM COLL C IN PRESS	25	528	542	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					136	146		10.1056/NEJMoa1004130	http://dx.doi.org/10.1056/NEJMoa1004130			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20554978	Green Published			2022-12-28	WOS:000279574100006
J	Koster, JB				Koster, Jelle B.			Neuralgic Amyotrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Koster, JB (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	j.koster@aios.umcn.nl							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2304	2304		10.1056/NEJMicm0908009	http://dx.doi.org/10.1056/NEJMicm0908009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554985				2022-12-28	WOS:000278816300009
J	Walport, M				Walport, Mark			Do summary care records have the potential to do more harm than good? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Wellcome Trust Res Labs, London NW1 2BE, England		Walport, M (corresponding author), Wellcome Trust Res Labs, London NW1 2BE, England.	m.walport@wellcome.ac.uk		Walport, Mark/0000-0001-7220-5273				Butt S., 2010, WELLCOME TRUST MONIT; Draper G, 2005, BRIT MED J, V330, P1290, DOI 10.1136/bmj.330.7503.1290; WALPORT MJ, 2008, DATA SHARING REV	3	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c3022	10.1136/bmj.c3022	http://dx.doi.org/10.1136/bmj.c3022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554686				2022-12-28	WOS:000279051900007
J	Morris, SR; Little, SJ; Cunningham, T; Garfein, RS; Richman, DD; Smith, DM				Morris, Sheldon R.; Little, Susan J.; Cunningham, Terry; Garfein, Richard S.; Richman, Douglas D.; Smith, Davey M.			Evaluation of an HIV Nucleic Acid Testing Program With Automated Internet and Voicemail Systems to Deliver Results	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-PROMOTION; NATIONAL-SURVEY; UNITED-STATES; BISEXUAL MEN; REAL-TIME; INFECTION; RISK; ANTIBODY; POPULATION; SEX	Background: Nucleic acid testing (NAT) in routine HIV testing programs can increase the detection of infected individuals, but the most effective implementation of NAT remains unclear. Objective: To determine how many HIV cases can be identified with NAT and how many persons can be contacted, to identify predictors of acute and early HIV infection cases, and to test reporting of negative results by automated Internet and voicemail systems. Design: Prospective study. Setting: San Diego County, California. Participants: Persons seeking HIV testing. Measurements: Rates and predictors of HIV infection by stage, notification of positive NAT results, use of automated Internet or voicemail systems to access negative NAT results, and estimated HIV infections prevented. Results: Of 3151 persons tested, 79 had newly diagnosed cases of HIV: 64 had positive results from rapid HIV test, and 15 had positive results only by NAT (that is, NAT increased the HIV detection yield by 23%). Of all HIV infections, 44% (in 35 persons) were in the acute and early stages. Most participants (56%) and persons with HIV (91%) were men who have sex with men (MSM). All persons with NAT-positive results were notified within 1 week. Of all 3070 uninfected patients, 2105 (69%) retrieved their negative NAT results, with 1358 using the Internet system. After adjustment for covariates, persons reporting MSM behavior, higher incomes, younger ages, no testing at substance abuse rehabilitation centers, no recent syphilis, and no methamphetamine use were more likely to access negative NAT results by either Internet or voicemail systems. Limitation: Findings may not be generalizable to other populations and testing programs. Conclusion: Nucleic acid testing programs that include automated systems for result reporting can increase case yield, especially in settings that cater to MSM.	[Morris, Sheldon R.] Univ Calif San Diego, Antiviral Res Ctr, San Diego Hlth & Human Serv, San Diego, CA 92103 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Morris, SR (corresponding author), Univ Calif San Diego, Antiviral Res Ctr, San Diego Hlth & Human Serv, 200 Arbor Dr,Mail Code 8208, San Diego, CA 92103 USA.	shmorris@ucsd.edu	Little, Susan/AAA-6116-2019	Smith, Davey/0000-0003-3603-1733	National Institutes of Health [MH083552, AI077304, AI69432, MH62512, AI27670, AI38858, AI43638, AI43752, AI047745, NS51132, DA026306, AI29164, AI47745, AI57167, AI074621]; UCSD Centers for AIDS Research [AI36214]; California HIV/AIDS Research Program [RN07-SD-702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI047745, U01AI038858, R21AI077304, R01AI029164, U01AI027670, U01AI069432, R01AI057167, U01AI043638, R01AI047745, P30AI036214, UM1AI069432, P01AI074621, R01AI043752, R24AI106039, R56AI047745, R37AI029164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH083552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA026306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Centers for AIDS Research; California HIV/AIDS Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By National Institutes of Health grants MH083552, AI077304, AI69432, MH62512, AI27670, AI38858, AI43638, AI43752, AI047745, NS51132, DA026306, AI29164, AI47745, AI57167, AI074621; UCSD Centers for AIDS Research grant AI36214; and California HIV/AIDS Research Program grant RN07-SD-702.	[Anonymous], 2006, MMWR RECOMM REP; Baker L, 2003, JAMA-J AM MED ASSOC, V289, P2400, DOI 10.1001/jama.289.18.2400; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bull SS, 2004, AIDS CARE, V16, P1012, DOI 10.1080/09540120412331292426; Calvert SL, 2005, AM BEHAV SCI, V48, P590, DOI 10.1177/0002764204271508; *CDCP, 2006, HIV AIDS SURV REP; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fiscus SA, 2007, J INFECT DIS, V195, P416, DOI 10.1086/510755; Grov C, 2007, AIDS BEHAV, V11, P527, DOI 10.1007/s10461-007-9234-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hightow LB, 2003, AIDS EDUC PREV, V15, P282, DOI 10.1521/aeap.15.4.282.23826; Hogben M, 2008, SEX TRANSM DIS, V35, P117, DOI 10.1097/OLQ.0b013e31816408dd; Kalichman SC, 2005, AIDS PATIENT CARE ST, V19, P439, DOI 10.1089/apc.2005.19.439; Kendrick SR, 2005, JAIDS-J ACQ IMM DEF, V38, P142, DOI 10.1097/00126334-200502010-00004; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; McFarlane M, 2005, SEX TRANSM DIS, V32, pS60, DOI 10.1097/01.olq.0000180464.77968.e2; Miller EA, 2007, J TELEMED TELECARE, V13, P298, DOI 10.1258/135763307781644852; Morin SF, 2005, JAIDS-J ACQ IMM DEF, V40, P226, DOI 10.1097/01.qai.0000166375.16222.eb; Niederhauser C, 2009, J CLIN VIROL, V45, P367, DOI 10.1016/j.jcv.2009.05.027; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Reback CJ, 2003, AIDS CARE, V15, P775, DOI 10.1080/09540120310001618621; Rietmeijer CA, 2008, SEX TRANSM DIS, V35, P770, DOI 10.1097/OLQ.0b013e318180280d; Roberts KJ, 2007, AIDS PATIENT CARE ST, V21, P621, DOI 10.1089/apc.2006.0196; Robinson L, 2006, J ASSOC NURSE AIDS C, V17, P7, DOI 10.1016/j.jana.2006.07.003; Sherlock M, 2007, SEX TRANSM DIS, V34, P314, DOI 10.1097/01.olq.0000263262.00273.9c; Stekler J, 2005, AIDS, V19, P1323, DOI 10.1097/01.aids.0000180105.73264.81; Stekler JD, 2009, CLIN INFECT DIS, V49, P444, DOI 10.1086/600043; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Welz T, 2008, SEX TRANSM DIS, V35, P372, DOI 10.1097/OLQ.0b013e31815fd3fc; Wurcel A, 2005, AIDS PATIENT CARE ST, V19, P499, DOI 10.1089/apc.2005.19.499; Xia Q, 2006, JAIDS-J ACQ IMM DEF, V41, P238, DOI 10.1097/01.qai.0000185574.98472.36	39	44	44	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					778	+		10.7326/0003-4819-152-12-201006150-00005	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611OP	20547906	Green Accepted			2022-12-28	WOS:000278827700003
J	Todesco, M; Balasubramanian, S; Hu, TT; Traw, MB; Horton, M; Epple, P; Kuhns, C; Sureshkumar, S; Schwartz, C; Lanz, C; Laitinen, RAE; Huang, Y; Chory, J; Lipka, V; Borevitz, JO; Dangl, JL; Bergelson, J; Nordborg, M; Weigel, D				Todesco, Marco; Balasubramanian, Sureshkumar; Hu, Tina T.; Traw, M. Brian; Horton, Matthew; Epple, Petra; Kuhns, Christine; Sureshkumar, Sridevi; Schwartz, Christopher; Lanz, Christa; Laitinen, Roosa A. E.; Huang, Yu; Chory, Joanne; Lipka, Volker; Borevitz, Justin O.; Dangl, Jeffery L.; Bergelson, Joy; Nordborg, Magnus; Weigel, Detlef			Natural allelic variation underlying a major fitness trade-off in Arabidopsis thaliana	NATURE			English	Article							SALICYLIC-ACID; CELL-DEATH; DISEASE RESISTANCE; ARTIFICIAL MICRORNAS; DEFENSE; COSTS; MUTANTS; INDUCTION; REVEALS; PROTEIN	Plants can defend themselves against a wide array of enemies, from microbes to large animals, yet there is great variability in the effectiveness of such defences, both within and between species. Some of this variation can be explained by conflicting pressures from pathogens with different modes of attack(1). A second explanation comes from an evolutionary 'tug of war', in which pathogens adapt to evade detection, until the plant has evolved new recognition capabilities for pathogen invasion(2-5). If selection is, however, sufficiently strong, susceptible hosts should remain rare. That this is not the case is best explained by costs incurred from constitutive defences in a pest-free environment(6-11). Using a combination of forward genetics and genome-wide association analyses, we demonstrate that allelic diversity at a single locus, ACCELERATED CELL DEATH 6 (ACD6)(12,13), underpins marked pleiotropic differences in both vegetative growth and resistance to microbial infection and herbivory among natural Arabidopsis thaliana strains. A hyperactive ACD6 allele, compared to the reference allele, strongly enhances resistance to a broad range of pathogens from different phyla, but at the same time slows the production of new leaves and greatly reduces the biomass of mature leaves. This allele segregates at intermediate frequency both throughout the worldwide range of A. thaliana and within local populations, consistent with this allele providing substantial fitness benefits despite its marked impact on growth.	[Todesco, Marco; Balasubramanian, Sureshkumar; Sureshkumar, Sridevi; Lanz, Christa; Laitinen, Roosa A. E.; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Hu, Tina T.; Huang, Yu; Nordborg, Magnus] Univ So Calif, Los Angeles, CA 90089 USA; [Traw, M. Brian] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15238 USA; [Horton, Matthew; Borevitz, Justin O.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Epple, Petra; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Kuhns, Christine; Lipka, Volker] John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Kuhns, Christine; Lipka, Volker] Univ Gottingen, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [Schwartz, Christopher; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schwartz, Christopher] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Curriculum Genet & Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Nordborg, Magnus] Gregor Mendel Inst, A-1030 Vienna, Austria	Max Planck Society; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Gottingen; Salk Institute; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Salk Institute; University of North Carolina; University of North Carolina Chapel Hill; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Todesco, Marco/HCH-3494-2022; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Traw, Milton Brian/ABD-3275-2020; Huang, Yu/C-2789-2011; Balasubramanian, Sureshkumar/AAS-6919-2020; Borevitz, Justin/B-5423-2012; Weigel, Detlef/C-1418-2008	Weigel, Detlef/0000-0002-2114-7963; Traw, Milton Brian/0000-0002-3148-2108; Balasubramanian, Sureshkumar/0000-0002-1057-2606; Borevitz, Justin/0000-0001-8408-3699; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748; Todesco, Marco/0000-0002-6227-4096; Schwartz, CJ/0000-0001-9295-8504; Bergelson, Joy/0000-0001-7893-7387; Horton, Matthew/0000-0002-7537-0730	NSF [DEB-0519961, MCB0603515]; European Arabidopsis Stock Centre (NASC); NIH NRSA [F23-GM65032-1]; EMBO; NIH [GM62932, GM057171, GM057994, GM073822]; HFSPO [RGP0057/2007-C]; DFG [LI 1317/2-1]; Gatsby Foundation; Dropkin Foundation; Howard Hughes Medical Institute; Marie Curie RTN SY-STEM; ERA-PG (BMBF); IP AGRON-OMICS [LSHG-CT-2006-037704]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073822, F32GM065032, R01GM062932, R01GM057171, R01GM057994] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); European Arabidopsis Stock Centre (NASC); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSPO(Human Frontier Science Program); DFG(German Research Foundation (DFG)); Gatsby Foundation; Dropkin Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Marie Curie RTN SY-STEM; ERA-PG (BMBF)(Federal Ministry of Education & Research (BMBF)); IP AGRON-OMICS; Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.-W. Park and D. Klessig for the nahG clone; J. Greenberg, the NSF-supported Arabidopsis Biological Resource Centre (ABRC) and the European Arabidopsis Stock Centre (NASC) for seeds; and S. Atwell, K. Broman and Y.-L. Guo for advice. We are grateful to K. Bomblies and L. Yant for establishing the Tubingen A. thaliana collection. This work was supported by NIH NRSA fellowship F23-GM65032-1 (C. S.), an EMBO Long-Term Fellowship (S. B.), NIH grants GM62932 (J. C. and D. W.), GM057171 (J. L. D.), GM057994 (J. B.) and GM073822 (J.O.B.), NSF grants DEB-0519961 (J. B. and M. N.) and NSF MCB0603515 (J. B.), HFSPO grant RGP0057/2007-C (J. L. D. and D. W.), DFG grant LI 1317/2-1 (V. L.), the Gatsby Foundation (V. L.), the Dropkin Foundation (J. B.), the Howard Hughes Medical Institute (J. C.), Marie Curie RTN SY-STEM (D. W.), ERA-PG (BMBF) grant ARABRAS (D. W.), FP6 IP AGRON-OMICS (contract LSHG-CT-2006-037704, D. W.), a Gottfried Wilhelm Leibniz Award of the DFG (D. W.), and the Max Planck Society (D. W.).	Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ATWELL S, 2010, NATURE          0324, DOI DOI 10.1038/NATURE08800; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hirata Tetsuya, 1996, Mycoscience, V37, P283, DOI 10.1007/BF02461299; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Holub EB, 2007, CURR OPIN PLANT BIOL, V10, P415, DOI 10.1016/j.pbi.2007.05.003; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; KING EO, 1954, J LAB CLIN MED, V44, P301; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Korves T, 2004, AM NAT, V163, P489, DOI 10.1086/382552; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Lu H, 2005, PLANT J, V44, P798, DOI 10.1111/j.1365-313X.2005.02567.x; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Lu H, 2009, PLANT J, V58, P401, DOI 10.1111/j.1365-313X.2009.03791.x; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rate DN, 1999, PLANT CELL, V11, P1695, DOI 10.1105/tpc.11.9.1695; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Segarra G, 2006, PHYTOCHEMISTRY, V67, P395, DOI 10.1016/j.phytochem.2005.11.017; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Traw MB, 2007, EVOLUTION, V61, P2444, DOI 10.1111/j.1558-5646.2007.00211.x; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Weigel D., 2002, ARABIDOPSIS LAB MANU; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zavala Jorge A., 2004, BMC Ecology, V4, P11, DOI 10.1186/1472-6785-4-11	53	249	254	2	164	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					632	U129		10.1038/nature09083	http://dx.doi.org/10.1038/nature09083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520716	Green Accepted, Green Submitted			2022-12-28	WOS:000278249000045
J	Kilgannon, JH; Jones, AE; Shapiro, NI; Angelos, MG; Milcarek, B; Hunter, K; Parrillo, JE; Trzeciak, S				Kilgannon, J. Hope; Jones, Alan E.; Shapiro, Nathan I.; Angelos, Mark G.; Milcarek, Barry; Hunter, Krystal; Parrillo, Joseph E.; Trzeciak, Stephen		Emergency Med Shock Res Network E	Association Between Arterial Hyperoxia Following Resuscitation From Cardiac Arrest and In-Hospital Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL LIAISON COMMITTEE; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; NORMOXIC VENTILATION; 100-PERCENT OXYGEN; STROKE FOUNDATION; CRITICAL-CARE; REPERFUSION; DYSFUNCTION; STATEMENT	Context Laboratory investigations suggest that exposure to hyperoxia after resuscitation from cardiac arrest may worsen anoxic brain injury; however, clinical data are lacking. Objective To test the hypothesis that postresuscitation hyperoxia is associated with increased mortality. Design, Setting, and Patients Multicenter cohort study using the Project IMPACT critical care database of intensive care units (ICUs) at 120 US hospitals between 2001 and 2005. Patient inclusion criteria were age older than 17 years, nontraumatic cardiac arrest, cardiopulmonary resuscitation within 24 hours prior to ICU arrival, and arterial blood gas analysis performed within 24 hours following ICU arrival. Patients were divided into 3 groups defined a priori based on PaO2 on the first arterial blood gas values obtained in the ICU. Hyperoxia was defined as PaO2 of 300 mm Hg or greater; hypoxia, PaO2 of less than 60 mm Hg (or ratio of PaO2 to fraction of inspired oxygen <300); and normoxia, not classified as hyperoxia or hypoxia. Main Outcome Measure In-hospital mortality. Results Of 6326 patients, 1156 had hyperoxia (18%), 3999 had hypoxia (63%), and 1171 had normoxia (19%). The hyperoxia group had significantly higher in-hospital mortality (732/1156 [63%; 95% confidence interval {CI}, 60%-66%]) compared with the normoxia group (532/1171 [45%; 95% CI, 43%-48%]; proportion difference, 18% [95% CI, 14%-22%]) and the hypoxia group (2297/3999 [57%; 95% CI, 56%-59%]; proportion difference, 6% [95% CI, 3%-9%]). In a model controlling for potential confounders (eg, age, preadmission functional status, comorbid conditions, vital signs, and other physiological indices), hyperoxia exposure had an odds ratio for death of 1.8 (95% CI, 1.5-2.2). Conclusion Among patients admitted to the ICU following resuscitation from cardiac arrest, arterial hyperoxia was independently associated with increased in-hospital mortality compared with either hypoxia or normoxia. JAMA. 2010; 303(21): 2165-2171	[Kilgannon, J. Hope; Trzeciak, Stephen] Cooper Univ Hosp, Dept Emergency Med, Camden, NJ 08103 USA; [Parrillo, Joseph E.; Trzeciak, Stephen] Cooper Univ Hosp, Dept Med, Div Crit Care Med, Camden, NJ 08103 USA; [Milcarek, Barry; Hunter, Krystal] Cooper Univ Hosp, Biostat Grp, Camden, NJ 08103 USA; [Jones, Alan E.] Carolinas Med Ctr, Dept Emergency Med, Charlotte, NC 28203 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Angelos, Mark G.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA	Cooper University Hospital; Cooper University Hospital; Cooper University Hospital; Carolinas Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University System of Ohio; Ohio State University	Trzeciak, S (corresponding author), Cooper Univ Hosp, Dept Emergency Med, 1 Cooper Plaza,D363, Camden, NJ 08103 USA.	trzeciak-stephen@cooperhealth.edu	Shapiro, Nathan/F-1718-2016		Emergency Medicine Foundation; National Institutes of Health [GM76652, HL091757, GM83211]; National Institute of General Medical Sciences [GM076659]; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076659, K23GM083211, K23GM076652] Funding Source: NIH RePORTER	Emergency Medicine Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Kilgannon was supported by a career development grant from the Emergency Medicine Foundation. Dr Jones was supported by grant GM76652 from the National Institutes of Health and the National Institute of General Medical Sciences. Dr Shapiro was supported in part by grant HL091757 from the National Institutes of Health and the National Heart, Lung, and Blood Institute and grant GM076659 from the National Institute of General Medical Sciences. Dr Trzeciak was supported by grant GM83211 from the National Institutes of Health and the National Institute of General Medical Sciences.	Abraham E, 2000, CRIT CARE MED, V28, P232, DOI 10.1097/00003246-200001000-00039; Ambrosio G, 1999, AM HEART J, V138, pS69, DOI 10.1016/S0002-8703(99)70323-6; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Balan IS, 2006, STROKE, V37, P3008, DOI 10.1161/01.STR.0000248455.73785.b1; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Douzinas EE, 2001, INTENS CARE MED, V27, P905, DOI 10.1007/s001340100932; Halpern NA, 2006, CRIT CARE MED, V34, P2105, DOI 10.1097/01.CCM.0000227174.30337.3E; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; KILGORE KS, 1993, CLIN BIOCHEM, V26, P359, DOI 10.1016/0009-9120(93)90112-J; Lipinski CA, 1999, RESUSCITATION, V42, P221, DOI 10.1016/S0300-9572(99)00083-0; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; Negovsky V A, 1972, Resuscitation, V1, P1, DOI 10.1016/0300-9572(72)90058-5; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Richards EM, 2007, STROKE, V38, P1578, DOI 10.1161/STROKEAHA.106.473967; Rosenthal RE, 2003, STROKE, V34, P1311, DOI 10.1161/01.STR.0000066868.95807.91; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; ZWEMER CF, 1994, RESUSCITATION, V27, P159, DOI 10.1016/0300-9572(94)90009-4	26	571	594	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2165	2171		10.1001/jama.2010.707	http://dx.doi.org/10.1001/jama.2010.707			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516417				2022-12-28	WOS:000278182100025
J	Chen, SK; Tvrdik, P; Peden, E; Cho, S; Wu, S; Spangrude, G; Capecchi, MR				Chen, Shau-Kwaun; Tvrdik, Petr; Peden, Erik; Cho, Scott; Wu, Sen; Spangrude, Gerald; Capecchi, Mario R.			Hematopoietic Origin of Pathological Grooming in Hoxb8 Mutant Mice	CELL			English	Article							OBSESSIVE-COMPULSIVE DISORDER; HOX-2.4 HOMEOBOX GENE; COMMON VARIANTS; SERIAL ORDER; MICROGLIA; SCHIZOPHRENIA; EXPRESSION; MOUSE; DIFFERENTIATION; PROGENITORS	Mouse Hoxb8 mutants show unexpected behavior manifested by compulsive grooming and hair removal, similar to behavior in humans with the obsessive-compulsive disorder spectrum disorder trichotillomania. As Hox gene disruption often has pleiotropic effects, the root cause of this behavioral deficit was unclear. Here we report that, in the brain, Hoxb8 cell lineage exclusively labels bone marrow-derived microglia. Furthermore, transplantation of wild-type bone marrow into Hoxb8 mutant mice rescues their pathological phenotype. It has been suggested that the grooming dysfunction results from a nociceptive defect, also exhibited by Hoxb8 mutant mice. However, bone marrow transplant experiments and cell type-specific disruption of Hoxb8 reveal that these two phenotypes are separable, with the grooming phenotype derived from the hematopoietic lineage and the sensory defect derived from the spinal cord cells. Immunological dysfunctions have been associated with neuropsychiatric disorders, but the causative relationships are unclear. In this mouse, a distinct compulsive behavioral disorder is associated with mutant microglia.	[Chen, Shau-Kwaun; Tvrdik, Petr; Peden, Erik; Wu, Sen; Capecchi, Mario R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA; [Cho, Scott; Spangrude, Gerald] Univ Utah, Dept Pathol & Med, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu	Tvrdik, Petr/AAK-4398-2021	Tvrdik, Petr/0000-0002-8750-9672; CHEN, SHAU-KWAUN/0000-0002-0701-6799; Peden, Erik/0000-0002-8436-3217; Cho, Scott/0000-0002-7909-4702	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R37 HD030701] Funding Source: Medline; NIGMS NIH HHS [R01 GM021168, R01 GM021168-36] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD030701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021168] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE JW, 1993, PSYCHOL SCI, V4, P391, DOI 10.1111/j.1467-9280.1993.tb00587.x; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; Brash HM, 2005, J NEUROSCI METH, V142, P107, DOI 10.1016/j.jneumeth.2004.08.001; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; da Rocha FF, 2008, PROG NEURO-PSYCHOPH, V32, P1139, DOI 10.1016/j.pnpbp.2007.12.026; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Holstege JC, 2008, P NATL ACAD SCI USA, V105, P6338, DOI 10.1073/pnas.0802176105; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; Hounie AG, 2008, NEUROSCI LETT, V442, P86, DOI 10.1016/j.neulet.2008.07.022; Huey ED, 2008, J NEUROPSYCH CLIN N, V20, P390, DOI 10.1176/appi.neuropsych.20.4.390; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kaur C, 2001, MICROSC RES TECHNIQ, V54, P2, DOI 10.1002/jemt.1114; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; Krishnaraju K, 1997, BLOOD, V90, P1840, DOI 10.1182/blood.V90.5.1840; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; PERKINS AC, 1993, EMBO J, V12, P3835, DOI 10.1002/j.1460-2075.1993.tb06062.x; PETRINI M, 1992, BLOOD, V80, P185; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spangrude GJ, 2006, STEM CELLS, V24, P2045, DOI 10.1634/stemcells.2006-0013; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Strous RD, 2006, J AUTOIMMUN, V27, P71, DOI 10.1016/j.jaut.2006.07.006; Taylor JL, 2010, BRAIN RES, V1322, P92, DOI 10.1016/j.brainres.2010.01.052; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang HF, 2006, EXP HEMATOL, V34, P1730, DOI 10.1016/j.exphem.2006.08.001; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104	36	285	294	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					775	785		10.1016/j.cell.2010.03.055	http://dx.doi.org/10.1016/j.cell.2010.03.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510925	Green Accepted, Bronze			2022-12-28	WOS:000278132900013
J	Holm, EA; Foiles, SM				Holm, Elizabeth A.; Foiles, Stephen M.			How Grain Growth Stops: A Mechanism for Grain-Growth Stagnation in Pure Materials	SCIENCE			English	Article							BOUNDARY MOTION; COMPUTER-SIMULATION; ROUGHENING TRANSITION; MOBILITY; METALS; KINETICS; MIGRATION; EVOLUTION; IRON	The thermodynamic equilibrium state of crystalline materials is a single crystal; however, polycrystalline grain growth almost always stops before this state is reached. Although typically attributed to solute drag, grain-growth stagnation occurs, even in high-purity materials. Recent studies indicate that grain boundaries undergo thermal roughening associated with an abrupt mobility change, so that at typical annealing temperatures, polycrystals will contain both smooth (slow) and rough (fast) boundaries. Mesoscale grain-growth models, validated by large-scale polycrystalline molecular dynamics simulations, show that even small fractions of smooth, slow boundaries can stop grain growth. We conclude that grain-boundary roughening provides an alternate stagnation mechanism that applies even to high-purity materials.	[Holm, Elizabeth A.; Foiles, Stephen M.] Sandia Natl Labs, Computat Mat Sci & Engn Dept, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Holm, EA (corresponding author), Sandia Natl Labs, Computat Mat Sci & Engn Dept, POB 5800, Albuquerque, NM 87185 USA.	eaholm@sandia.gov	Holm, Elizabeth/S-2612-2016	Holm, Elizabeth/0000-0003-3064-5769; Foiles, Stephen/0000-0002-1907-454X	U.S. Department of Energy (DOE), Office of Basic Energy Sciences; Sandia National Laboratories; DOE's National Nuclear Security Administration [DE-AC04-94AL85000]	U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); Sandia National Laboratories(United States Department of Energy (DOE)); DOE's National Nuclear Security Administration(National Nuclear Security Administration)	Our initial work on grain growth with frozen boundaries, which informed this study, was performed in collaboration with G. Hassold. Support for this work was provided by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, and by the Laboratory Directed Research and Development program at Sandia National Laboratories. Sandia National Laboratories is a multiprogram laboratory operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin company, for the DOE's National Nuclear Security Administration under contract DE-AC04-94AL85000.	ANDERSON MP, 1989, PHILOS MAG B, V59, P293, DOI 10.1080/13642818908220181; ANDERSON MP, 1984, ACTA METALL MATER, V32, P783, DOI 10.1016/0001-6160(84)90151-2; BOLLING GF, 1958, ACTA METALL MATER, V6, P283, DOI 10.1016/0001-6160(58)90148-2; BURKE JE, 1949, T AM I MIN MET ENG, V180, P73; BURKE JE, 1952, PROG MET PHYS, V3, P220, DOI 10.1016/0502-8205(52)90009-9; CAHN JW, 1962, ACTA METALL MATER, V10, P789, DOI 10.1016/0001-6160(62)90092-5; Dillon SJ, 2008, ACTA MATER, V56, P1374, DOI 10.1016/j.actamat.2007.11.042; Dillon SJ, 2007, J AM CERAM SOC, V90, P2291, DOI 10.1111/j.1551-2916.2007.01655.x; Farkas D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.165502; Foiles SM, 2006, ACTA MATER, V54, P3351, DOI 10.1016/j.actamat.2006.03.037; GALINA AV, 1987, FIZ MET METALLOVED+, V63, P1220; Gottstein G, 1998, INTERFACE SCI, V6, P7, DOI 10.1023/A:1008641617937; Hassold G. N., 1993, Computers in Physics, V7, P97, DOI 10.1063/1.168481; HAZZLEDINE PM, 1990, PHILOS MAG A, V61, P579, DOI 10.1080/01418619008231936; HILLERT M, 1988, ACTA METALL MATER, V36, P3177, DOI 10.1016/0001-6160(88)90053-3; HU H, 1974, CAN METALL QUART, V13, P275; Janssens KGF, 2006, NAT MATER, V5, P124, DOI 10.1038/nmat1559; Kizuka T, 1997, J MATER SCI, V32, P1501, DOI 10.1023/A:1018566303784; Liu F, 2006, THERMOCHIM ACTA, V443, P212, DOI 10.1016/j.tca.2006.01.028; LUCKE K, 1957, ACTA METALL MATER, V5, P628, DOI 10.1016/0001-6160(57)90109-8; LUCKE K, 1963, RECOVERY RECRYSTALLI, P131; Malow TR, 1997, ACTA MATER, V45, P2177, DOI 10.1016/S1359-6454(96)00300-X; MULLINS WW, 1958, ACTA METALL MATER, V6, P414, DOI 10.1016/0001-6160(58)90020-8; Olmsted DL, 2007, SCRIPTA MATER, V57, P1161, DOI 10.1016/j.scriptamat.2007.07.045; Olmsted DL, 2009, ACTA MATER, V57, P3704, DOI 10.1016/j.actamat.2009.04.015; PLIMPTON SJ, 2007, LAMMPS MOL DYNAMICS; Rabkin E, 2005, J MATER SCI, V40, P875, DOI 10.1007/s10853-005-6504-5; ROTTMAN C, 1989, SCRIPTA METALL MATER, V23, P1037, DOI 10.1016/0036-9748(89)90295-0; Smith C.S., 1948, AIME T, V175, P15; Sursaeva VG, 2008, ACTA MATER, V56, P2728, DOI 10.1016/j.actamat.2008.02.014; Wu ZX, 2009, ACTA MATER, V57, P4278, DOI 10.1016/j.actamat.2009.05.026; Yoon DY, 2005, J MATER SCI, V40, P861, DOI 10.1007/s10853-005-6502-7	32	180	185	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1138	1141		10.1126/science.1187833	http://dx.doi.org/10.1126/science.1187833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508126				2022-12-28	WOS:000278104700038
J	Schneps, MH; Griswold, A; Finkelstein, N; McLeod, M; Schrag, DP				Schneps, Matthew H.; Griswold, Alex; Finkelstein, Nancy; McLeod, Michele; Schrag, Daniel P.			Using Video to Build Learning Contexts Online	SCIENCE			English	Editorial Material									[Schneps, Matthew H.; Griswold, Alex; Finkelstein, Nancy] Harvard Smithsonian Ctr Astrophys, Lab Visual Learning, Cambridge, MA 02138 USA; [McLeod, Michele] Annenberg Media, Washington, DC 20004 USA; [Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Ctr Environm, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Harvard University	Schneps, MH (corresponding author), Harvard Smithsonian Ctr Astrophys, Lab Visual Learning, 60 Garden St, Cambridge, MA 02138 USA.	mschneps@cfa.harvard.edu						Driver R., 1985, CHILDRENS IDEAS SCI; Galvin SJ, 1997, VISION RES, V37, P2035, DOI 10.1016/S0042-6989(97)00016-3; INTRAUB H, 1989, J EXP PSYCHOL LEARN, V15, P179, DOI 10.1037/0278-7393.15.2.179; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Oliva Aude, 2005, P251, DOI 10.1016/B978-012375731-9/50045-8; SCHNEPS MH, 1995, PRIVATE UNIVERSE PRO; SCHNEPS MH, 2000, PRIVATE UNIVERSE PRO; Schneps MH, 1987, PRIVATE UNIVERSE	8	8	8	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1119	1120		10.1126/science.1186934	http://dx.doi.org/10.1126/science.1186934			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601YR	20508122				2022-12-28	WOS:000278104700033
J	Geraghty, LN				Geraghty, Laurel Naversen			The Denver II	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												laurel.geraghty@med.nyu.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2012	2012		10.1001/jama.2010.623	http://dx.doi.org/10.1001/jama.2010.623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501916				2022-12-28	WOS:000278018200001
J	Jones, R; Barraclough, K; Dowrick, C				Jones, Roger; Barraclough, Kevin; Dowrick, Christopher			Diagnosis in General Practice When no diagnostic label is applied	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; PRIMARY-CARE CONSULTATIONS; PATIENT		[Jones, Roger] Kings Coll London, London SE1 3QD, England; [Dowrick, Christopher] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of London; King's College London; University of Liverpool	Jones, R (corresponding author), Kings Coll London, London SE1 3QD, England.	roger.jones@kcl.ac.uk						Dowrick C, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-46; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fleming DM, 2005, BRIT J GEN PRACT, V55, P589; Groopman J, 2007, DOCTORS THINK; HARMDEN A, 2009, BMJ-BRIT MED J, V338, pB491; Hatcher S, 2008, BRIT MED J, V336, P1124, DOI 10.1136/bmj.39554.592014.BE; Heneghan C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b946; Howie J G, 1972, J R Coll Gen Pract, V22, P310; Jones R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3094; Kostopoulou O, 2008, FAM PRACT, V25, P400, DOI 10.1093/fampra/cmn071; Kostopoulou O, 2009, MED DECIS MAKING, V29, P282, DOI 10.1177/0272989X08327493; Norman G, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3490; Peters S, 2009, J GEN INTERN MED, V24, P443, DOI 10.1007/s11606-008-0872-x; Rosendal M, 2003, BRIT J GEN PRACT, V53, P917; Salmon P, 2005, J PSYCHOSOM RES, V59, P255, DOI 10.1016/j.jpsychores.2005.03.004; Salmon P, 2004, BRIT J GEN PRACT, V54, P171; Salmon P, 2007, PSYCHOSOM MED, V69, P571, DOI 10.1097/PSY.0b013e3180cabc85; Salmon P, 2009, J GEN INTERN MED, V24, P450, DOI 10.1007/s11606-008-0898-0; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; THOMAS KB, 1978, BRIT MED J, V1, P1327, DOI 10.1136/bmj.1.6123.1327; THOMAS KB, 1974, BRIT MED J, V1, P625, DOI 10.1136/bmj.1.5908.625; WILLIAMSON P, 1981, J FAM PRACTICE, V13, P999	22	10	11	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2010	340								c2683	10.1136/bmj.c2683	http://dx.doi.org/10.1136/bmj.c2683			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604LB	20501578				2022-12-28	WOS:000278279400004
J	Meyers, TM; Ndung'u, T				Meyers, Tammy M.; Ndung'u, Thumbi			Case 18-2010: A 7-Year-Old Boy with Elevated HIV RNA Levels despite Antiretroviral Medications HIV infection with drug-resistance mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECONSTITUTION INFLAMMATORY SYNDROME; REVERSE-TRANSCRIPTASE; INHIBITOR RESISTANCE; IN-VIVO; THERAPY; CHILDREN; FAILURE; PHARMACOKINETICS; TUBERCULOSIS		[Meyers, Tammy M.] Univ Witwatersrand, Dept Pediat, Johannesburg, South Africa; [Ndung'u, Thumbi] Nelson R Mandela Sch Med, HIV Pathogenesis Program Lab, Durban, South Africa	University of Witwatersrand; University of Kwazulu Natal	Meyers, TM (corresponding author), Univ Witwatersrand, Dept Pediat, Johannesburg, South Africa.			Ndung'u, Thumbi/0000-0003-2962-3992				Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Bonora S, 2008, CURR OPIN HIV AIDS, V3, P306, DOI 10.1097/COH.0b013e3282fbaad0; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cozzi-Lepri A, 2009, J INFECT DIS, V200, P687, DOI 10.1086/604731; DAVIES MA, 2009, 5 INT AIDS SOC C HIV; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Delaugerre C, 2001, AIDS, V15, P2189, DOI 10.1097/00002030-200111090-00016; Gianotti N, 2008, J MED VIROL, V80, P201, DOI 10.1002/jmv.21085; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; HICKS CB, 2009, CONSEQUENCES FAILURE; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Hsu A, 1998, CLIN PHARMACOKINET, V35, P275, DOI 10.2165/00003088-199835040-00002; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; National Department of Health South Africa, 2010, GUID MAN HIV CHILDR; Neely Michael, 2009, Ther Clin Risk Manag, V5, P595; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; PETERSEN M, 2008, 15 C RETR OPP INF BO; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Purdy JB, 2008, J PEDIATR, V152, P582, DOI 10.1016/j.jpeds.2007.12.020; Puthanakit T, 2005, CLIN INFECT DIS, V41, P1049, DOI 10.1086/433177; Ramirez BC, 2008, VIRUS RES, V134, P64, DOI 10.1016/j.virusres.2008.01.007; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Ren Y, 2009, JAIDS-J ACQ IMM DEF, V50, P439, DOI 10.1097/QAI.0b013e31819c33a3; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sharland M, 2002, HIV Med, V3, P215, DOI 10.1046/j.1468-1293.2002.00120.x; Smith K, 2009, AIDS, V23, P1097, DOI 10.1097/QAD.0b013e32832afefc; van Zyl GU, 2009, PEDIATR INFECT DIS J, V28, P1125, DOI 10.1097/INF.0b013e3181af829d; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2009, GUID US ANT AG PED H; World Health Organization, 2006, ANT THER HIV INF AD	36	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2305	2312		10.1056/NEJMcpc1002113	http://dx.doi.org/10.1056/NEJMcpc1002113			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554986				2022-12-28	WOS:000278816300011
J	Greenhalgh, T; Stramer, K; Bratan, T; Byrne, E; Russell, J; Potts, HWW				Greenhalgh, Trisha; Stramer, Katja; Bratan, Tanja; Byrne, Emma; Russell, Jill; Potts, Henry W. W.			Adoption and non-adoption of a shared electronic summary record in England: a mixed-method case study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; FIELD	Objective To evaluate a national programme to develop and implement centrally stored electronic summaries of patients' medical records. Design Mixed-method, multilevel case study. Setting English National Health Service 2007-10. The summary care record (SCR) was introduced as part of the National Programme for Information Technology. This evaluation of the SCR considered it in the context of national policy and its frontline implementation and use in three districts. Participants and methods Quantitative data (cumulative records created nationally plus a dataset of 416 325 encounters in participating primary care out-of-hours and walk-in centres) were analysed statistically. Qualitative data (140 interviews including policy makers, managers, clinicians, and software suppliers; 2000 pages of ethnographic field notes including observation of 214 clinical consultations; and 3000 pages of documents) were analysed thematically and interpretively. Results Creating individual SCRs and supporting their adoption and use was a complex, technically challenging, and labour intensive process that occurred more slowly than planned. By early 2010, 1.5 million such records had been created. In participating primary care out-of-hours and walk-in centres, an SCR was accessed in 4% of all encounters and in 21% of encounters where one was available; these figures were rising in some but not all sites. The main determinant of SCR access was the identity of the clinician: individual clinicians accessed available SCRs between 0 and 84% of the time. When accessed, an SCR seemed to support better quality care and increase clinician confidence in some encounters. There was no direct evidence of improved safety, but findings were consistent with a rare but important positive impact on preventing medication errors. SCRs sometimes contained incomplete or inaccurate data, but clinicians drew judiciously on these data along with other sources. SCR use was not associated with shorter consultations or reduction in onward referral. Successful introduction of SCRs depended on interaction between multiple stakeholders from different worlds (clinical, political, technical, commercial) with different values, priorities, and ways of working. The programme's fortunes seemed to turn on the ability of change agents to bridge these different institutional worlds, align their conflicting logics, and mobilise implementation effort. Conclusions Benefits of centrally stored electronic summary records seem more subtle and contingent than many stakeholders anticipated, and clinicians may not access them. Complex interdependencies, inherent tensions, and high implementation workload should be expected when they are introduced on a national scale.	[Greenhalgh, Trisha] Barts & London Queen Marys Sch Med & Dent, Ctr Hlth Sci, Healthcare Innovat & Policy Unit, London E1 2AD, England; [Stramer, Katja; Bratan, Tanja; Russell, Jill] UCL, Div Med Educ, London WC1E 6BT, England; [Byrne, Emma; Potts, Henry W. W.] UCL, Ctr Hlth Informat & Multiprofess Educ, London WC1E 6BT, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Hlth Sci, Healthcare Innovat & Policy Unit, London E1 2AD, England.	p.greenhalgh@qmul.ac.uk	Potts, Henry WW/B-9597-2008; Greenhalgh, Trisha/B-1825-2015	Potts, Henry WW/0000-0002-6200-8804; Greenhalgh, Trisha/0000-0003-2369-8088	UK National Institute of Health Research [CFHEP002, 007]; Medical Research Council [07/133]; University College London (UCL); Queen Mary University of London (QMUL); Medical Research Council [G0600654] Funding Source: researchfish	UK National Institute of Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London (UCL); Queen Mary University of London (QMUL); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The independent evaluation of the summary care record programme was funded by a research grant from the UK National Institute of Health Research (ref CFHEP002 and 007). The Medical Research Council funded a parallel research study ("healthcare electronic records in organisations," ref 07/133) by our team in which the SCR formed one case example. The analysis presented in this paper draws on both those studies. University College London (UCL) held the research grants; the empirical work was undertaken while all authors were employed at UCL. Queen Mary University of London (QMUL) funded the salary of TG during the writing-up phase.	Anderson Ross, 2009, DATABASE STATE; BEALE P, 2007, NHS SUMMARY CARE REC; BLOMMAERT J., 2005, DISCOURSE CRITICAL I; Boje D.M., 2001, NARRATIVE METHODS OR; BRATAN T, HLTH EXPECT IN PRESS; CAR J, 2008, IMPACT EHEALTH QUALI; CLAY R, 2009, SUMMARY CARE RECORD; Coiera E, 2009, J AM MED INFORM ASSN, V16, P271, DOI 10.1197/jamia.M3183; Currie WL, 2007, J INF TECHNOL, V22, P235, DOI 10.1057/palgrave.jit.2000102; DARLING A, 1998, COMPREHENSIVE SPENDI; DARLING A, 1998, MODERN PUBLIC SERVIC; DARZI A, 2008, HIGH QUALITY HLTH AL; DARZI A, 2007, OUR NHS OUR FUTURE; *DEP HLTH, 2000, BUILD INF COR; *DEP HLTH, 2005, CONN HLTH GUID NAT P; *DEP HLTH, 2006, DIR TRAV URG CAR DIS; *DEP HLTH, 2004, BETT INF BETT CHOIC; Department of Health, 2008, NHS INF REV REP; Department of Health, 2002, DEL 21 CENT IT SUPP; Department of Health, 1998, INF HLTH INF STRAT M; EDWARDS J, 2006, DENMARKS ACHIEVEMENT; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; GOLDENBIDDLE K, 1993, ORGAN SCI, V4, P595, DOI 10.1287/orsc.4.4.595; Greenhalgh T, 2010, DEVILS DETAIL FINAL; Greenhalgh T, 2008, BMJ-BRIT MED J, V336, P1290, DOI 10.1136/bmj.a114; Greenhalgh T, 2010, SOC SCI MED, V70, P1285, DOI 10.1016/j.socscimed.2009.12.034; Greenhalgh T, 2009, MILBANK Q, V87, P729, DOI 10.1111/j.1468-0009.2009.00578.x; Greenhalgh T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1786; Hanseth O, 2007, RISK, COMPLEXITY AND ICT, P1; Klein HK, 1999, MIS QUART, V23, P67, DOI 10.2307/249410; Lilford RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000186; Ling T, 2002, PUBLIC ADMIN, V80, P615, DOI 10.1111/1467-9299.00321; Ludwick DA, 2009, INT J MED INFORM, V78, P22, DOI 10.1016/j.ijmedinf.2008.06.005; Michel Callon, 1986, POWER ACTION BELIEF, P196, DOI DOI 10.1111/J.1467-954X.1984.TB00113.X; Newman J, 2006, J SOC POLICY, V35, P193, DOI 10.1017/S0047279405009487; Pagliari Claudia, 2005, Inform Prim Care, V13, P97; Patton MQ., 1997, UTILIZATION FOCUSED; Prasad P, 1997, INFORMATION SYSTEMS AND QUALITATIVE RESEARCH, P101; Protti D., 2007, HEALTHC Q, V10, P107; Protti Denis, 2009, Inform Prim Care, V17, P17; Protti Denis, 2008, Inform Prim Care, V16, P291; Protti Denis, 2008, Inform Prim Care, V16, P285; Protti Denis, 2008, Inform Prim Care, V16, P189; Protti Denis, 2008, Inform Prim Care, V16, P183; Ramiller NC, 2009, J ASSOC INF SYST, V10, P474; Raymond Eric S., CATHEDRAL BAZAAR; Scambler G., 2001, HABERMAS CRITICAL TH, P45; Smith J., 2004, BUILDING SAFER NHS P; St John of God Health Care, 2019, OUR VIS; Strauss, 1967, DISCOVERY GROUNDED T; VIDLER E, 2005, PUBLIC POLICY ADMIN, V20, P19, DOI DOI 10.1177/095207670502000202; Wanless, 2002, SECURING OUR FUTURE; 2005, APROS 11 AS PAC RES	53	112	112	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2010	340								c3111	10.1136/bmj.c3111	http://dx.doi.org/10.1136/bmj.c3111			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554687	Green Submitted, hybrid			2022-12-28	WOS:000279051900008
J	Johansson, M; Relton, C; Ueland, PM; Vollset, SE; Midttun, O; Nygard, O; Slimani, N; Boffetta, P; Jenab, M; Clavel-Chapelon, F; Boutron-Ruault, MC; Fagherazzi, G; Kaaks, R; Rohrmann, S; Boeing, H; Weikert, C; Bueno-de-Mesquita, HB; Ros, MM; van Gils, CH; Peeters, PHM; Agudo, A; Barricarte, A; Navarro, C; Rodriguez, L; Sanchez, MJ; Larranaga, N; Khaw, KT; Wareham, N; Allen, NE; Crowe, F; Gallo, V; Norat, T; Krogh, V; Masala, G; Panico, S; Sacerdote, C; Tumino, R; Trichopoulou, A; Lagiou, P; Trichopoulos, D; Rasmuson, T; Hallmans, G; Riboli, E; Vineis, P; Brennan, P				Johansson, Mattias; Relton, Caroline; Ueland, Per Magne; Vollset, Stein Emil; Midttun, Oivind; Nygard, Ottar; Slimani, Nadia; Boffetta, Paolo; Jenab, Mazda; Clavel-Chapelon, Francoise; Boutron-Ruault, Marie-Christine; Fagherazzi, Guy; Kaaks, Rudolf; Rohrmann, Sabine; Boeing, Heiner; Weikert, Cornelia; Bueno-de-Mesquita, H. Bas; Ros, Martine M.; van Gils, Carla H.; Peeters, Petra H. M.; Agudo, Antonio; Barricarte, Aurelio; Navarro, Carmen; Rodriguez, Laudina; Sanchez, Maria-Jose; Larranaga, Nerea; Khaw, Kay-Tee; Wareham, Nick; Allen, Naomi E.; Crowe, Francesca; Gallo, Valentina; Norat, Teresa; Krogh, Vittorio; Masala, Giovanna; Panico, Salvatore; Sacerdote, Carlotta; Tumino, Rosario; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Rasmuson, Torgny; Hallmans, Goeran; Riboli, Elio; Vineis, Paolo; Brennan, Paul			Serum B Vitamin Levels and Risk of Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ONE-CARBON METABOLISM; GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; PLASMA FOLATE; FOLIC-ACID; MICROBIOLOGICAL ASSAY; BREAST-CANCER; NEVER SMOKERS; HOMOCYSTEINE; PREVENTION	Context B vitamins and factors related to 1-carbonmetabolism help to maintain DNA integrity and regulate gene expression and may affect cancer risk. Objective To investigate if 1-carbon metabolism factors are associated with onset of lung cancer. Design, Setting, and Participants The European Prospective Investigation into Cancer and Nutrition (EPIC) recruited 519 978 participants from 10 countries between 1992 and 2000, of whom 385 747 donated blood. By 2006, 899 lung cancer cases were identified and 1770 control participants were individually matched by country, sex, date of birth, and date of blood collection. Serum levels were measured for 6 factors of 1-carbon metabolism and cotinine. Main Outcome Measure Odds ratios (ORs) of lung cancer by serum levels of 4 B vitamins (B-2, B-6, folate [B-9], and B-12), methionine, and homocysteine. Results Within the entire EPIC cohort, the age-standardized incidence rates of lung cancer (standardized to the world population, aged 35-79 years) were 6.6, 44.9, and 156.1 per 100 000 person-years among never, former, and current smokers for men, respectively. The corresponding incidence rates for women were 7.1, 23.9, and 100.9 per 100 000 person-years, respectively. After accounting for smoking, a lower risk for lung cancer was seen for elevated serum levels of B6 (fourth vs first quartile OR, 0.44; 95% confidence interval [CI], 0.33-0.60; P for trend<.000001), as well as for serum methionine (fourth vs first quartile OR, 0.52; 95% CI, 0.39-0.69; P for trend<.000001). Similar and consistent decreases in risk were observed in never, former, and current smokers, indicating that results were not due to confounding by smoking. The magnitude of risk was also constant with increasing length of follow-up, indicating that the associations were not explained by preclinical disease. A lower risk was also seen for serum folate (fourth vs first quartile OR, 0.68; 95% CI, 0.51-0.90; P for trend=.001), although this was apparent only for former and current smokers. When participants were classified by median levels of serum methionine and B6, having above-median levels of both was associated with a lower lung cancer risk overall (OR, 0.41; 95% CI, 0.31-0.54), as well as separately among never (OR, 0.36; 95% CI, 0.18-0.72), former(OR, 0.51; 95% CI, 0.34-0.76), and current smokers(OR, 0.42; 95% CI, 0.27-0.65). Conclusion Serum levels of vitamin B6 and methionine were inversely associated with risk of lung cancer. JAMA. 2010; 303(23): 2377-2385	[Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Brennan, P (corresponding author), Int Agcy Res Canc, Genet Epidemiol Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	Brennan@iarc.fr	Ueland, Per M/C-7340-2013; Fagherazzi, Guy/ABB-2555-2020; Khaw, Kay-Tee/AAZ-3209-2021; Krogh, Vittorio/K-2628-2016; Rohrmann, Sabine/D-2113-2012; Gallo, Valentina/X-1139-2018; Boutron-Ruault, Marie-Christine/H-3936-2014; Clavel-Chapelon, Francoise/G-6733-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Agudo, Antonio/J-1805-2016; Boffetta, Paolo/AAI-7767-2021; Sánchez, Maria-José/D-1087-2011; Johansson, Mattias/ABF-3365-2020; Masala, Giovanna/AAC-5474-2022; Panico, Salvatore/K-6506-2016; Gallo, Valentina/J-3089-2012; Relton, Caroline/AAC-5904-2019; Krogh, Vittorio/AAA-9171-2019; Fagherazzi, Guy/P-3534-2017	Fagherazzi, Guy/0000-0001-5033-5966; Krogh, Vittorio/0000-0003-0122-8624; Rohrmann, Sabine/0000-0002-2215-1200; Gallo, Valentina/0000-0002-1268-8629; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Agudo, Antonio/0000-0001-9900-5677; Boffetta, Paolo/0000-0002-3811-2791; Sánchez, Maria-José/0000-0003-4817-0757; Masala, Giovanna/0000-0002-5758-9069; Panico, Salvatore/0000-0002-5498-8312; Krogh, Vittorio/0000-0003-0122-8624; Fagherazzi, Guy/0000-0001-5033-5966; Navarro, Carmen/0000-0001-8896-7483; Riboli, Elio/0000-0001-6795-6080; Sacerdote, Carlotta/0000-0002-8008-5096; Johansson, Mattias/0000-0002-3116-5081; Ueland, Per Magne/0000-0002-1903-0571; Larranaga, Nerea/0000-0002-9993-9880; Crowe, Francesca/0000-0003-4026-1726; tumino, rosario/0000-0003-2666-414X; Jenab, Mazda/0000-0002-0573-1852; Relton, Caroline/0000-0003-2052-4840	World Cancer Research Fund (United Kingdom); European Commission (SANCO); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research; Danish Cancer Society; Spanish Ministry of Health, Spanish Regional Government of Andalucia; Spanish Ministry of Health, Spanish Regional Government of Asturias; Spanish Ministry of Health, Spanish Regional Government of Basque Country; Spanish Ministry of Health, Spanish Regional Government of Murcia; Spanish Ministry of Health, Spanish Regional Government of Navarra; ISCIII Network RCESP, Spain [C03/09]; ISCIII of the Spanish Ministry of Health [RETICC DR06/0020]; Cancer Research UK; Medical Research Council, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy; Compagnia di San Paolo; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France; Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France; Gustave Roussy Institute (IGR), France; General Councils of France; Medical Research Council [MC_U106179471, G0401527] Funding Source: researchfish	World Cancer Research Fund (United Kingdom); European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research(Deutsche KrebshilfeFederal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Spanish Ministry of Health, Spanish Regional Government of Andalucia; Spanish Ministry of Health, Spanish Regional Government of Asturias; Spanish Ministry of Health, Spanish Regional Government of Basque Country; Spanish Ministry of Health, Spanish Regional Government of Murcia; Spanish Ministry of Health, Spanish Regional Government of Navarra; ISCIII Network RCESP, Spain; ISCIII of the Spanish Ministry of Health(Spanish Government); Cancer Research UK(Cancer Research UK); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Greek Ministry of Health(Greek Ministry of Development-GSRT); Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy(Consiglio Nazionale delle Ricerche (CNR)); Compagnia di San Paolo(Compagnia di San Paolo); Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France(3M); Gustave Roussy Institute (IGR), France; General Councils of France; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	World Cancer Research Fund (United Kingdom) funded the biochemical analyses for the study. The EPIC study has been supported by the Europe Against Cancer Program of the European Commission (SANCO); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health, Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; the ISCIII Network RCESP (C03/09), Spain; the ISCIII of the Spanish Ministry of Health (RETICC DR06/0020); Cancer Research UK; Medical Research Council, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy; Compagnia di San Paolo; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France; Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France; Gustave Roussy Institute (IGR), France; and General Councils of France.	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bray F., 2002, CANC INCIDENCE 5 CON, VVIII; Chou YC, 2007, BREAST CANCER RES TR, V101, P199, DOI 10.1007/s10549-006-9278-9; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Dahlin AM, 2008, INT J CANCER, V122, P2057, DOI 10.1002/ijc.23299; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Dierkes J, 2007, AM J CLIN NUTR, V86, P214; Drake BF, 2009, JAMA-J AM MED ASSOC, V302, P2152, DOI 10.1001/jama.2009.1691; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Figueiredo JC, 2008, CANCER EPIDEM BIOMAR, V17, P2136, DOI 10.1158/1055-9965.EPI-07-2895; Gibson A, 2008, QJM-INT J MED, V101, P881, DOI 10.1093/qjmed/hcn112; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Johansson M, 2008, CANCER EPIDEM BIOMAR, V17, P279, DOI 10.1158/1055-9965.EPI-07-0657; Johansson M, 2009, CANCER EPIDEM BIOMAR, V18, P1538, DOI 10.1158/1055-9965.EPI-08-1193; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Laufer EM, 2004, EUR J CLIN NUTR, V58, P1518, DOI 10.1038/sj.ejcn.1602002; Le Marchand L, 2009, CANCER EPIDEM BIOMAR, V18, P2195, DOI 10.1158/1055-9965.EPI-09-0141; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1197, DOI 10.1158/1055-9965.EPI-08-1001; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; National Institution of Health Office of Dietary Supplements, DIET SUPPL FACT SHEE; Olsen A, 2009, EUR J CLIN NUTR, V63, pS122, DOI 10.1038/ejcn.2009.78; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rudin CM, 2009, CLIN CANCER RES, V15, P5622, DOI 10.1158/1078-0432.CCR-09-0373; Schernhammer E, 2007, CANCER RES, V67, P5553, DOI 10.1158/0008-5472.CAN-06-4463; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Ueland P., FOLATE SERUM; Ueland PM, 2007, CLIN CHEM LAB MED, V45, P1737, DOI 10.1515/CCLM.2007.339; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Vollset SE, 2007, CANCER EPIDEM BIOMAR, V16, P2416, DOI 10.1158/1055-9965.EPI-07-0256; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Weinstein SJ, 2008, CANCER EPIDEM BIOMAR, V17, P3233, DOI 10.1158/1055-9965.EPI-08-0459; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; WILLET W, 1998, NUTR EPIDEMIOLOGY, P124; Yoshino K, 2010, INT J FOOD SCI NUTR, V61, P61, DOI 10.3109/09637480903286363; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373	47	118	120	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2377	2385		10.1001/jama.2010.808	http://dx.doi.org/10.1001/jama.2010.808			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551408	Bronze, Green Accepted			2022-12-28	WOS:000278759200027
J	Krogh, C; Fischer, TK; Skotte, L; Biggar, RJ; Oyen, N; Skytthe, A; Goertz, S; Christensen, K; Wohlfahrt, J; Melbye, M				Krogh, Camilla; Fischer, Thea K.; Skotte, Line; Biggar, Robert J.; Oyen, Nina; Skytthe, Axel; Goertz, Sanne; Christensen, Kaare; Wohlfahrt, Jan; Melbye, Mads			Familial Aggregation and Heritability of Pyloric Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPIDEMIOLOGY; POPULATION; ERYTHROMYCIN; GENES	Context Pyloric stenosis is the most common condition requiring surgery in the first months of life. Case reports have suggested familial aggregation, but to what extent this is caused by common environment or inheritance is unknown. Objectives To investigate familial aggregation of pyloric stenosis from monozygotic twins to fourth-generation relatives according to sex and maternal and paternal contributions and to estimate disease heritability. Design, Setting, and Patients Population-based cohort study of 1 999 738 children born in Denmark between 1977 and 2008 and followed up for the first year of life, during which 3362 children had surgery for pyloric stenosis. Main Outcome Measure Familial aggregation of pyloric stenosis, evaluated by rate ratios. Results The incidence rate (per 1000 person-years) of pyloric stenosis in the first year of life was 1.8 for singletons and 3.1 for twins. The rate ratios of pyloric stenosis were 182 (95% confidence interval [CI], 70.7-467) for monozygotic twins, 29.4 (95% CI, 9.45-91.5) for dizygotic twins, 18.5 (95% CI, 13.7-25.1) for siblings, 4.99 (95% CI, 2.59-9.65) for half-siblings, 3.06 (95% CI, 2.10-4.44) for cousins, and 1.60 (95% CI, 0.51-4.99) for half-cousins. We found no difference in rate ratios for maternal and paternal relatives of children with pyloric stenosis and no difference according to sex of cohort member or sex of relative. The heritability of pyloric stenosis was 87%. Conclusion Pyloric stenosis in Danish children shows strong familial aggregation and heritability. JAMA. 2010; 303(23): 2393-2399	[Krogh, Camilla; Fischer, Thea K.; Skotte, Line; Biggar, Robert J.; Oyen, Nina; Goertz, Sanne; Wohlfahrt, Jan; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Fischer, Thea K.] Danish Natl Board Hlth, Copenhagen, Denmark; [Oyen, Nina] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Skytthe, Axel; Christensen, Kaare] Univ So Denmark, Inst Publ Hlth, Odense, Denmark	Statens Serum Institut; University of Bergen; Haukeland University Hospital; University of Southern Denmark	Krogh, C (corresponding author), Statens Serum Inst, Dept Epidemiol Res, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.	ckr@ssi.dk	Fischer, Thea K/AAH-9892-2019; Christensen, Kaare/C-2360-2009; Skotte, Line/F-7359-2014; Skytthe, Axel/G-4820-2019	Fischer, Thea K/0000-0003-4812-980X; Christensen, Kaare/0000-0002-5429-5292; Skotte, Line/0000-0002-7398-1271; Skytthe, Axel/0000-0002-8629-4913; melbye, mads/0000-0001-8264-6785	Lundbeck Foundation [27/06]; Faculty of Health Sciences, University of Copenhagen; Danish Agency for Science, Technology, and Innovation	Lundbeck Foundation(Lundbeckfonden); Faculty of Health Sciences, University of Copenhagen; Danish Agency for Science, Technology, and Innovation	The study was funded by grants from the Lundbeck Foundation (27/06), the Faculty of Health Sciences, University of Copenhagen, and the Danish Agency for Science, Technology, and Innovation.	ADELSTEIN P, 1976, J MED GENET, V13, P439, DOI 10.1136/jmg.13.6.439; Andersen TF, 1999, DAN MED BULL, V46, P263; APPLEGATE MS, 1995, ARCH PEDIAT ADOL MED, V149, P1123, DOI 10.1001/archpedi.1995.02170230077011; ARMITAGE P, 2005, ENCY BIOSTATISTICS, V1, P147; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; CARTER C O, 1969, Journal of Medical Genetics, V6, P233, DOI 10.1136/jmg.6.3.233; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; CARTER CO, 1980, J MED GENET, V17, P411, DOI 10.1136/jmg.17.6.411; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/twin.6.4.275; Chung E, 1996, AM J HUM GENET, V58, P363; Chung E, 2008, ARCH DIS CHILD, V93, P1003, DOI 10.1136/adc.2008.141499; Cockayne E. A., 1943, OHIO JOUR SCI, V43, P1; Cooper WO, 2002, ARCH PEDIAT ADOL MED, V156, P647, DOI 10.1001/archpedi.156.7.647; CZEIZEL A, 1972, ARCH DIS CHILD, V47, P977, DOI 10.1136/adc.47.256.978; Haahr P, 2000, Ugeskr Laeger, V162, P3456; Hedback G, 2001, ARCH DIS CHILD, V85, P379, DOI 10.1136/adc.85.5.379; Hernanz-Schulman M, 2003, RADIOLOGY, V227, P319, DOI 10.1148/radiol.2272011329; Honein MA, 1999, LANCET, V354, P2101, DOI 10.1016/S0140-6736(99)10073-4; JEDD MB, 1988, AM J DIS CHILD, V142, P334, DOI 10.1001/archpedi.1988.02150030108033; KIDD KK, 1976, J MED GENET, V13, P290, DOI 10.1136/jmg.13.4.290; MacMahon B, 2006, EPIDEMIOLOGY, V17, P195, DOI 10.1097/01.ede.0000192032.83843.c9; MACMAHON B, 1955, Acta Genet Med Gemellol (Roma), V4, P320; MCKEOWN T, 1951, ANN EUGENIC, V16, P249, DOI 10.1111/j.1469-1809.1951.tb02478.x; MCKEOWN T, 1955, ARCH DIS CHILD, V30, P497, DOI 10.1136/adc.30.154.497; MCKEOWN T, 1951, ANN EUGENIC, V16, P260, DOI 10.1111/j.1469-1809.1951.tb02479.x; METRAKOS JD, 1953, ARCH DIS CHILD, V28, P351, DOI 10.1136/adc.28.141.351; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nielsen JP, 2000, DAN MED BULL, V47, P223; Pedersen CB, 2006, DAN MED BULL, V53, P441; Persson S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e70; Pisacane A, 1996, BRIT MED J, V312, P745, DOI 10.1136/bmj.312.7033.745; RAMSTEDT C, 1912, MED KLIN, V8, P1702; RASMUSSEN L, 1989, INT J EPIDEMIOL, V18, P413, DOI 10.1093/ije/18.2.413; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schechter R, 1997, PAEDIATR PERINAT EP, V11, P407, DOI 10.1046/j.1365-3016.1997.d01-32.x; Skytthe A, 2002, TWIN RES, V5, P352; Sorensen HT, 2002, BMJ-BRIT MED J, V325, P1011, DOI 10.1136/bmj.325.7371.1011; SPICER RD, 1982, BRIT J SURG, V69, P128, DOI 10.1002/bjs.1800690304; Szmytkowska K, 2000, Med Sci Monit, V6, P1179; Velaoras K, 2005, PEDIATR SURG INT, V21, P669, DOI 10.1007/s00383-005-1435-4; Yang G, 2008, PAED CHILD HEALT-CAN, V13, P383, DOI 10.1093/pch/13.5.383; Yen Ju-Bei, 2003, Chang Gung Med J, V26, P933	45	60	63	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2393	2399		10.1001/jama.2010.784	http://dx.doi.org/10.1001/jama.2010.784			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551410	Bronze			2022-12-28	WOS:000278759200029
J	Spence, D				Spence, Des			From The Frontline Bad medicine: chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2000, LANCET, V355, P253; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Ku E, 2009, ARCH INTERN MED, V169, P1015, DOI 10.1001/archinternmed.2009.128; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE	4	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c3188	10.1136/bmj.c3188	http://dx.doi.org/10.1136/bmj.c3188			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554677				2022-12-28	WOS:000279051900022
J	Palmer, SM; Limaye, AP; Banks, M; Gallup, D; Chapman, J; Lawrence, EC; Dunitz, J; Milstone, A; Reynolds, J; Yung, GL; Chan, KM; Aris, R; Garrity, E; Valentine, V; McCall, J; Chow, SC; Davis, RD; Avery, R				Palmer, Scott M.; Limaye, Ajit P.; Banks, Missy; Gallup, Dianne; Chapman, Jeffrey; Lawrence, E. Clinton; Dunitz, Jordan; Milstone, Aaron; Reynolds, John; Yung, Gordon L.; Chan, Kevin M.; Aris, Robert; Garrity, Edward; Valentine, Vincent; McCall, Jonathan; Chow, Shein-Chung; Davis, Robert Duane; Avery, Robin			Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							GANCICLOVIR RESISTANCE; ORAL GANCICLOVIR; UL97 MUTATIONS; BRONCHIOLITIS OBLITERANS; CMV INFECTION; RECIPIENTS; DISEASE; EMERGENCE; REJECTION; TRIAL	Background: Cytomegalovirus (CMV) is the most prevalent opportunistic infection after lung transplantation. Current strategies do not prevent CMV in most at-risk patients. Objective: To determine whether extending prophylaxis with oral valganciclovir from the standard 3 months to 12 months after lung transplantation is efficacious. Design: Randomized, clinical trial. Patients were randomly assigned by a central automated system to treatment or placebo. Patients and investigators were blinded to treatment status. (ClinicalTrials. gov registration number: NCT00227370) Setting: Multicenter trial involving 11 U. S. lung transplant centers. Patients: 136 lung transplant recipients who completed 3 months of valganciclovir prophylaxis. Intervention: 9 additional months of oral valganciclovir (n = 70) or placebo (n = 66). Measurements: The primary end point was freedom from CMV disease (syndrome or tissue-invasive) on an intention-to-treat basis 300 days after randomization. Secondary end points were CMV disease severity, CMV infection, acute rejection, opportunistic infections, ganciclovir resistance, and safety. Results: CMV disease occurred in 32% of the short-course group versus 4% of the extended-course group (P < 0.001). Significant reductions were observed with CMV infection (64% vs. 10%; P < 0.001) and disease severity (110 000 vs. 3200 copies/mL, P = 0.009) with extended treatment. Rates of acute rejection, opportunistic infections, adverse events, CMV UL97 ganciclovir-resistance mutations, and laboratory abnormalities were similar between groups. During the 6 months after study completion, a low incidence of CMV disease was observed in both groups. Limitation: Longer-term effects of extended prophylaxis were not assessed. Conclusion: In adult lung transplant recipients who have received 3 months of valganciclovir, extending prophylaxis by an additional 9 months significantly reduces CMV infection, disease, and disease severity without increased ganciclovir resistance or toxicity. A beneficial effect with regard to prevention of CMV disease seems to extend at least through 18 months after transplantation.	[Palmer, Scott M.] Duke Univ, Med Ctr, Dept Med, Lung Transplant Program, Durham, NC 27710 USA; Duke Clin Res Inst, Durham, NC USA; Univ Washington, Med Ctr, Seattle, WA 98195 USA; Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; Emory Univ, Atlanta, GA 30322 USA; Univ Minnesota, Minneapolis, MN USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Resp & Crit Care Consultants, Indianapolis, IN USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ N Carolina, Univ N Carolina Hosp, Chapel Hill, NC USA; Univ Chicago, Med Ctr, Chicago, IL 60637 USA; Texas Transplant Ctr, Galveston, TX USA; Univ Texas Med Branch, Galveston, TX USA	Duke University; Duke University; University of Washington; University of Washington Seattle; Case Western Reserve University; Cleveland Clinic Foundation; Emory University; University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University; University of California System; University of California San Diego; University of Michigan System; University of Michigan; University North Carolina Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; University of Chicago Medical Center; University of Texas System; University of Texas Medical Branch Galveston	Palmer, SM (corresponding author), Duke Univ, Med Ctr, Dept Med, Lung Transplant Program, Suite 2073,Med Sci Res Bldg 2,106 Res Dr, Durham, NC 27710 USA.	palme002@mc.duke.edu	Yung, Gordon/GVS-9985-2022	Reynolds, John/0000-0003-4766-8852; Palmer, Scott/0000-0002-1370-3771				Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Boivin G, 2004, J INFECT DIS, V189, P1615, DOI 10.1086/382753; Cainelli F, 2002, LANCET INFECT DIS, V2, P539, DOI 10.1016/S1473-3099(02)00370-5; Castor J, 2007, J CLIN MICROBIOL, V45, P2681, DOI 10.1128/JCM.00526-07; Chmiel C, 2008, CLIN INFECT DIS, V46, P831, DOI 10.1086/528689; Chou SW, 2008, REV MED VIROL, V18, P233, DOI 10.1002/rmv.574; Chow SC, 2007, J BIOPHARM STAT, V17, P1163, DOI 10.1080/10543400701645249; Christie JD, 2008, J HEART LUNG TRANSPL, V27, P957, DOI 10.1016/j.healun.2008.07.018; Drew WL, 2000, LANCET, V356, P609, DOI 10.1016/S0140-6736(00)02597-6; Drew WL, 2001, AM J TRANSPLANT, V1, P307, DOI 10.1034/j.1600-6143.2001.10403.x; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Gilbert C, 1998, AIDS, V12, P125, DOI 10.1097/00002030-199802000-00001; Hertz MI, 1998, J HEART LUNG TRANSPL, V17, P913; Humar A, 2005, AM J TRANSPLANT, V5, P1462, DOI 10.1111/j.1600-6143.2005.00866.x; HUMAR A, 2009, AM TRANSPL C 1 JUN B; Jaksch P, 2009, J HEART LUNG TRANSPL, V28, P670, DOI 10.1016/j.healun.2009.03.012; Kruger RM, 2003, J HEART LUNG TRANSPL, V22, P754, DOI 10.1016/S1053-2498(02)00648-4; Limaye AP, 2000, LANCET, V356, P645, DOI 10.1016/S0140-6736(00)02607-6; Palmer SM, 2004, CLIN TRANSPLANT, V18, P179, DOI 10.1046/j.1399-0012.2003.00152.x; Paya C, 2004, AM J TRANSPLANT, V4, P611, DOI 10.1111/j.1600-6143.2004.00382.x; Perreas KG, 2005, J HEART LUNG TRANSPL, V24, P583, DOI 10.1016/j.healun.2004.02.005; Razonable RR, 2003, J INFECT DIS, V187, P1801, DOI 10.1086/375194; *ROCH PHARM, VALC VALG HYDR TABL; RUBIN RH, 1989, JAMA-J AM MED ASSOC, V261, P3607; Sharples LD, 2002, J HEART LUNG TRANSPL, V21, P271, DOI 10.1016/S1053-2498(01)00360-6; Singh N, 2005, CLIN INFECT DIS, V40, P704, DOI 10.1086/427506; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; US Department of Health and Human Services Food and Drug Administration, 1996, GUID IND E6 GOOD CLI; Valentine VG, 2008, J HEART LUNG TRANSPL, V27, P875, DOI 10.1016/j.healun.2008.05.009; Weigt SS, 2008, AM J TRANSPLANT, V8, P1512, DOI 10.1111/j.1600-6143.2008.02280.x; Westall GP, 2008, AM J TRANSPLANT, V8, P1749, DOI 10.1111/j.1600-6143.2008.02294.x; Zamora MR, 2004, AM J TRANSPLANT, V4, P1635, DOI 10.1111/j.1600-6143.2004.00571.x	32	167	169	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					761	+		10.7326/0003-4819-152-12-201006150-00003	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547904				2022-12-28	WOS:000278827700001
J	Doucet, CM; Talamas, JA; Hetzer, MW				Doucet, Christine M.; Talamas, Jessica A.; Hetzer, Martin W.			Cell Cycle-Dependent Differences in Nuclear Pore Complex Assembly in Metazoa	CELL			English	Article							MEMBRANE-PROTEINS; DE-NOVO; ENVELOPE; NUCLEOPORIN; CHROMATIN; NDC1; ARCHITECTURE; RECRUITMENT; CONTAINS; DYNAMICS	In metazoa, nuclear pore complexes (NPCs) assemble from disassembled precursors into a reforming nuclear envelope (NE) at the end of mitosis and into growing intact NEs during interphase. Here, we show via RNAi-mediated knockdown that ELYS, a nucleoporin critical for the recruitment of the essential Nup107/160 complex to chromatin, is required for NPC assembly at the end of mitosis but not during interphase. Conversely, the transmembrane nucleoporin POM121 is critical for the incorporation of the Nup107/160 complex into new assembly sites specifically during interphase. Strikingly, recruitment of the Nup107/160 complex to an intact NE involves a membrane curvature-sensing domain of its constituent Nup133, which is not required for postmitotic NPC formation. Our results suggest that in organisms with open mitosis, NPCs assemble via two distinct mechanisms to accommodate cell cycle-dependent differences in NE topology.	[Doucet, Christine M.; Talamas, Jessica A.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Doucet, Christine/0000-0002-1611-8279	National Institute of General Medical Sciences [R01GM057438];  [CA14195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Hunter lab for antibodies and the H2B-tdTomato reporter construct; and the Hetzer lab for critical discussion and reading of the manuscript, in particular Roberta Schulte for help with the Xenopus egg extract depletion experiments. J.T. performed experiments regarding Pom121 and Elys. C.D. performed live imaging assays and experiments describing the ALPS domain of Nup133. M.H performed Xenopus in vitro experiments. Paper was written by all authors. We also thank Stephane Richard for help with design of the EGFP-ALPS fusion protein. This work was supported by Award Number R01GM057438 from the National Institute of General Medical Sciences and a Core Cancer Grant (CA14195).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2008, CURR OPIN CELL BIOL, V20, P386, DOI 10.1016/j.ceb.2008.03.016; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Antonin W, 2009, CURR BIOL, V19, pR410, DOI 10.1016/j.cub.2009.03.053; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Chial HJ, 1998, J CELL BIOL, V143, P1789, DOI 10.1083/jcb.143.7.1789; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Eriksson C, 2004, FEBS LETT, V572, P261, DOI 10.1016/j.febslet.2004.07.044; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HALLBERG E, 1993, J CELL BIOL, V122, P513, DOI 10.1083/jcb.122.3.513; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; MAUL GG, 1971, J CELL BIOL, V51, P558, DOI 10.1083/jcb.51.2.558; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Schulte R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002061; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	49	175	177	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1030	1041		10.1016/j.cell.2010.04.036	http://dx.doi.org/10.1016/j.cell.2010.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550937	Bronze, Green Accepted			2022-12-28	WOS:000278618800017
J	Le Picard, SD; Tizniti, M; Canosa, A; Sims, IR; Smith, IWM				Le Picard, Sebastien D.; Tizniti, Meryem; Canosa, Andre; Sims, Ian R.; Smith, Ian W. M.			The Thermodynamics of the Elusive HO3 Radical	SCIENCE			English	Article							INFRARED ACTION SPECTROSCOPY; DYNAMICS; HOOO; STABILITY; OH	The role of HO3 as a temporary reservoir of atmospheric OH radicals remains an open question largely because of the considerable uncertainty in the value of the dissociation energy of the HO-O-2 bond (D-0) or, equivalently, the standard enthalpy of formation of HO3 (Delta H-f(-)). Using a supersonic flow apparatus, we have observed by means of laser-induced fluorescence the decay of OH radicals in the presence of O-2 at temperatures between 55.7 and 110.8 kelvin (K). Between 87.4 and 99.8 K, the OH concentration approached a nonzero value at long times, allowing equilibrium constants for the reaction with O-2 to be calculated. Using expressions for the equilibrium constant from classical and statistical thermodynamics, and values of partition functions and standard entropies calculated from spectroscopic data, we derived values of D-0 = (12.3 +/- 0.3) kilojoules per mole and Delta H-f(sic) (298 K) = (19.3 +/- 0.5) kilojoules per mole. The atmospheric implications of HO3 formation are therefore very slight.	[Le Picard, Sebastien D.; Tizniti, Meryem; Canosa, Andre; Sims, Ian R.] Univ Rennes 1, CNRS, UMR 6251, Inst Phys Rennes,Equipe Astrochim Expt, F-35042 Rennes, France; [Smith, Ian W. M.] Univ Cambridge, Univ Chem Lab, Cambridge CB2 1EW, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes; University of Cambridge	Le Picard, SD (corresponding author), Univ Rennes 1, CNRS, UMR 6251, Inst Phys Rennes,Equipe Astrochim Expt, Batiment 11C,Campus Beaulieu, F-35042 Rennes, France.	sebastien.le-picard@univ-rennes1.fr; ian.sims@univ-rennes1.fr; iwms2@cam.ac.uk	LE PICARD, Sebastien D/N-1668-2014; Canosa, Andre/ABD-1646-2020; Canosa, André/N-1709-2014; Sims, Ian R/F-8989-2014	Canosa, André/0000-0001-5719-9899; Sims, Ian R/0000-0001-7870-1585	Centre National de la Recherche Scientifique; Universite de Rennes 1	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Rennes 1	We are grateful to the Centre National de la Recherche Scientifique and the Universite de Rennes 1 for funding.	Braams BJ, 2008, PHYS CHEM CHEM PHYS, V10, P3150, DOI 10.1039/b801928b; Cacace F, 1999, SCIENCE, V285, P81, DOI 10.1126/science.285.5424.81; Denis PA, 2002, CHEM PHYS LETT, V365, P440, DOI 10.1016/S0009-2614(02)01432-X; Denis PA, 2009, J PHYS CHEM A, V113, P499, DOI 10.1021/jp808795e; Derro EL, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2945872; Derro EL, 2008, J PHYS CHEM A, V112, P9269, DOI 10.1021/jp801232a; Derro EL, 2007, J PHYS CHEM A, V111, P11592, DOI 10.1021/jp0760915; KLENERMAN D, 1987, J CHEM SOC FARAD T 2, V83, P229, DOI 10.1039/f29878300229; McCabe DC, 2006, CHEM PHYS LETT, V421, P111, DOI 10.1016/j.cplett.2006.01.037; Murray C, 2007, J PHYS CHEM A, V111, P4727, DOI 10.1021/jp071473w; Murray C, 2009, ACCOUNTS CHEM RES, V42, P419, DOI 10.1021/ar8001987; PILLING MJ, 1995, J CHEM SOC FARADAY T, V91, P4179, DOI 10.1039/ft9959104179; PILLING MJ, 1995, REACTION KINETICS, P195; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; POLANYI JC, 1975, INT J CHEM KINET, V1, P51; ROWE BR, 1984, J CHEM PHYS, V80, P4915, DOI 10.1063/1.446513; Speranza M, 1996, INORG CHEM, V35, P6140, DOI 10.1021/ic960549s; SRIDHARAN UC, 1985, J CHEM PHYS, V82, P592, DOI 10.1063/1.448973; Suma K, 2005, SCIENCE, V308, P1885, DOI 10.1126/science.1112233; Varner ME, 2009, J PHYS CHEM A, V113, P11238, DOI 10.1021/jp907262s; Wayne, 2000, CHEM ATMOSPHERES	21	69	69	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1258	1262		10.1126/science.1184459	http://dx.doi.org/10.1126/science.1184459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522771				2022-12-28	WOS:000278318600029
J	Savile, CK; Janey, JM; Mundorff, EC; Moore, JC; Tam, S; Jarvis, WR; Colbeck, JC; Krebber, A; Fleitz, FJ; Brands, J; Devine, PN; Huisman, GW; Hughes, GJ				Savile, Christopher K.; Janey, Jacob M.; Mundorff, Emily C.; Moore, Jeffrey C.; Tam, Sarena; Jarvis, William R.; Colbeck, Jeffrey C.; Krebber, Anke; Fleitz, Fred J.; Brands, Jos; Devine, Paul N.; Huisman, Gjalt W.; Hughes, Gregory J.			Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture	SCIENCE			English	Article							SUBSTRATE-SPECIFICITY; AMINOTRANSFERASE; TRANSAMINASE; CHEMISTRY; EVOLUTION	Pharmaceutical synthesis can benefit greatly from the selectivity gains associated with enzymatic catalysis. Here, we report an efficient biocatalytic process to replace a recently implemented rhodium-catalyzed asymmetric enamine hydrogenation for the large-scale manufacture of the antidiabetic compound sitagliptin. Starting from an enzyme that had the catalytic machinery to perform the desired chemistry but lacked any activity toward the prositagliptin ketone, we applied a substrate walking, modeling, and mutation approach to create a transaminase with marginal activity for the synthesis of the chiral amine; this variant was then further engineered via directed evolution for practical application in a manufacturing setting. The resultant biocatalysts showed broad applicability toward the synthesis of chiral amines that previously were accessible only via resolution. This work underscores the maturation of biocatalysis to enable efficient, economical, and environmentally benign processes for the manufacture of pharmaceuticals.	[Savile, Christopher K.; Mundorff, Emily C.; Tam, Sarena; Jarvis, William R.; Colbeck, Jeffrey C.; Krebber, Anke; Huisman, Gjalt W.] Codexis Inc, Redwood City, CA 94063 USA; [Janey, Jacob M.; Moore, Jeffrey C.; Fleitz, Fred J.; Brands, Jos; Devine, Paul N.; Hughes, Gregory J.] Merck & Co Inc, Merck Res Labs, Dept Proc Res, Rahway, NJ 07065 USA	Merck & Company	Savile, CK (corresponding author), Codexis Inc, 200 Penobscot Dr, Redwood City, CA 94063 USA.	christopher.savile@codexis.com; jacob_janey@merck.com		Huisman, Gjalt/0000-0003-1955-1120; Janey, Jacob/0000-0001-7697-1709				Chen ZL, 2005, J MOL BIOL, V348, P1273, DOI 10.1016/j.jmb.2005.02.070; Cho BK, 2008, BIOTECHNOL BIOENG, V99, P275, DOI 10.1002/bit.21591; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Crump S. P., 1992, BIOCATALYTIC PRODUCT, P43; Davies IW, 2009, SCIENCE, V325, P701, DOI 10.1126/science.1174501; De Wildeman SMA, 2007, ACCOUNTS CHEM RES, V40, P1260, DOI 10.1021/ar7001073; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Hansen KB, 2009, J AM CHEM SOC, V131, P8798, DOI 10.1021/ja902462q; Hohne M, 2008, CHEMBIOCHEM, V9, P363, DOI 10.1002/cbic.200700601; Huisman G.W., 2006, BIOCATALYSIS PHARM B, P717; Huisman GW, 2010, CURR OPIN CHEM BIOL, V14, P122, DOI 10.1016/j.cbpa.2009.12.003; Iwasaki A, 2006, APPL MICROBIOL BIOT, V69, P499, DOI 10.1007/s00253-005-0002-1; Johnson NB, 2007, ACCOUNTS CHEM RES, V40, P1291, DOI 10.1021/ar700114k; Kendall DM, 2009, EUR J INTERN MED, V20, pS329, DOI 10.1016/j.ejim.2009.05.009; Koszeleivski D, 2008, ANGEW CHEM INT EDIT, V47, P9337, DOI 10.1002/anie.200803763; Koszelewski D, 2009, EUR J ORG CHEM, V2009, P2289, DOI 10.1002/ejoc.200801265; Koszelewski D, 2008, ADV SYNTH CATAL, V350, P2761, DOI 10.1002/adsc.200800496; Liao J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-16; Moore JC, 2007, ACCOUNTS CHEM RES, V40, P1412, DOI 10.1021/ar700167a; Shin JS, 2002, J ORG CHEM, V67, P2848, DOI 10.1021/jo016115i; Stutzman-Engwall K, 2005, METAB ENG, V7, P27, DOI 10.1016/j.ymben.2004.07.003; Truppo MD, 2009, CHEM COMMUN, P2127, DOI 10.1039/b902995h; Truppo MD, 2009, ORG BIOMOL CHEM, V7, P395, DOI 10.1039/b817730a; Williams-Herman Debora, 2008, BMC Endocr Disord, V8, P14, DOI 10.1186/1472-6823-8-14; Zhang JH, 1997, P NATL ACAD SCI USA, V94, P4504, DOI 10.1073/pnas.94.9.4504	26	1063	1122	33	794	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					305	309		10.1126/science.1188934	http://dx.doi.org/10.1126/science.1188934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	625VW	20558668				2022-12-28	WOS:000279925900036
J	Sanne, I; Orrell, C; Fox, MP; Conradie, F; Ive, P; Zeinecker, J; Cornell, M; Heiberg, C; Ingram, C; Panchia, R; Rassool, M; Gonin, R; Stevens, W; Truter, H; Dehlinger, M; van der Horst, C; McIntyre, J; Wood, R				Sanne, Ian; Orrell, Catherine; Fox, Matthew P.; Conradie, Francesca; Ive, Prudence; Zeinecker, Jennifer; Cornell, Morna; Heiberg, Christie; Ingram, Charlotte; Panchia, Ravindre; Rassool, Mohammed; Gonin, Rene; Stevens, Wendy; Truter, Handre; Dehlinger, Marjorie; van der Horst, Charles; McIntyre, James; Wood, Robin		CIPRA-SA Study Team	Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PRIMARY-CARE; EXPERIENCE; RESOURCES; PROGRAM	Background Expanded access to combination antiretroviral therapy (ART) in resource-poor settings is dependent on task shifting from doctors to other health-care providers. We compared outcomes of nurse versus doctor management of ART care for HIV-infected patients. Methods This randomised non-inferiority trial was undertaken at two South African primary-care clinics. HIV-positive individuals with a CD4 cell count of less than 350 cells per mu L or WHO stage 3 or 4 disease were randomly assigned to nurse-monitored or doctor-monitored ART care. Patients were randomly assigned by stratified permuted block randomisation, and neither the patients nor those analysing the data were masked to assignment. The primary objective was a composite endpoint of treatment-limiting events, incorporating mortality, viral failure, treatment-limiting toxic effects, and adherence to visit schedule. Analysis was by intention to treat. Non-inferiority of the nurse versus doctor group for cumulative treatment failure was prespecified as an upper 95% CI for the hazard ratio that was less than 1.40. This study is registered with ClinicalTrials.gov, number NCT00255840. Findings 408 patients were assigned to doctor-monitored ART care and 404 to nurse-monitored ART care; all participants were analysed. 371 (46%) patients reached an endpoint of treatment failure: 192 (48%) in the nurse group and 179 (44%) in the doctor group. The hazard ratio for composite failure was 1.09 (95% CI 0.89-1.33), which was within the limits for non-inferiority. After a median follow-up of 120 weeks (IQR 60-144), deaths (ten vs 11), virological failures (44 vs 39), toxicity failures (68 vs 66), and programme losses (70 vs 63) were similar in nurse and doctor groups, respectively. Interpretation Nurse-monitored ART is non-inferior to doctor-monitored therapy. Findings from this study lend support to task shifting to appropriately trained nurses for monitoring of ART.	[Sanne, Ian; Conradie, Francesca; Ive, Prudence; Ingram, Charlotte; Panchia, Ravindre; Rassool, Mohammed; Stevens, Wendy; Truter, Handre] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Orrell, Catherine] Univ Cape Town, Desmond Tutu HIV Ctr, IIDMM, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Fox, Matthew P.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Gonin, Rene] Westat Corp, Rockville, IN USA; [Dehlinger, Marjorie] NIAID, Bethesda, MD 20892 USA; [van der Horst, Charles] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [McIntyre, James] Anova Hlth Inst, Johannesburg, South Africa	University of Witwatersrand; University of Cape Town; Boston University; Westat; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Orrell, C (corresponding author), Univ Cape Town, Desmond Tutu HIV Ctr, IIDMM, Fac Hlth Sci, Werner Beit Bldg N,Anzio Rd, ZA-7925 Cape Town, South Africa.	catherine.orrell@hiv-research.org.za	Fox, Matthew/K-2004-2019; Wood, Robin/G-8509-2011; Sanne, Ian/ABH-2231-2020; Orrell, Catherine/AAF-3405-2019; McIntyre, James/V-7115-2019	Orrell, Catherine/0000-0003-1134-7475; Fox, Matthew/0000-0001-9887-0634; Cornell, Morna/0000-0001-7149-8799	National Institutes of Allergy and Infectious Diseases, the National Institutes of Health [1U19A153217-01]; US Agency for International Development (USAID) [674-A-00-08-00007-00]; National Institute of Allergy And Infectious Diseases [K01AI083097, P30-AI50410]; Gauteng and Western Cape Provincial Health Authorities; CIPRA-SA Study Team; Endpoint Review Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217, P30AI050410, K01AI083097] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases, the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gauteng and Western Cape Provincial Health Authorities; CIPRA-SA Study Team; Endpoint Review Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the CIPRA-SA trial was provided by the Division of AIDS (DAIDS) of the National Institutes of Allergy and Infectious Diseases, the National Institutes of Health, through grant number 1U19A153217-01. Funding was also provided by the US Agency for International Development (USAID) under the terms of agreement 674-A-00-08-00007-00 with Right to Care (RTC). The project was also supported by Awards K01AI083097 and P30-AI50410 from the National Institute of Allergy And Infectious Diseases. We would like to acknowledge the support of the Gauteng and Western Cape Provincial Health Authorities, the work of the CIPRA-SA Study Team, the Endpoint Review Committee (Gary Maartens and David Spencer), and especially the contribution of our patients. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Division of AIDS, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, USAID, or other parties.	[Anonymous], 2004, DIVISION AIDS TABLE; Assefa Yibeltal, 2008, Ethiop Med J, V46, P401; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Boulle A, 2007, ANTIVIR THER, V12, P753; CASTEN U, 1993, GEOPHYS PROSPECT, V41, P1, DOI 10.1111/j.1365-2478.1993.tb00562.x; Charalambous S, 2007, AIDS CARE, V19, P34, DOI 10.1080/09500340600677872; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Department of Health, 2006, GUID GOOD PRACT COND; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Keitz SA, 2001, J GEN INTERN MED, V16, P573, DOI 10.1046/j.1525-1497.2001.016009573.x; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Laine C, 1998, AIDS, V12, P417, DOI 10.1097/00002030-199804000-00011; Landon BE, 2005, ARCH INTERN MED, V165, P1133, DOI 10.1001/archinte.165.10.1133; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lehmann U., 2008, S AFRICAN HLTH REV 2, P163; LOGAN AG, 1979, LANCET, V2, P1175; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Muula AS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-208; *NAT DEP HLTH S AF, 2004, S AFR NAT ANT TREATM; *NAT I HLTH, 2000, REQ ED PROT HUM RES; National Department of Health South Africa, 2010, CLIN GUID MAN HIV AI; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Romanelli F, 2009, AM FAM PHYSICIAN, V80, P946; *S AFR NAT DEP HLT, 2007, HIV AIDS STI STRAT P; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Smith S, 1996, BRIT MED J, V312, P416, DOI 10.1136/bmj.312.7028.416; *UNAIDS, 2009, AIDS EP UPD; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; WHO, 2002, SCAL ANT THER RES LI; *WHO, 2006, ADD 2006 WHO GUID AN; World Health Organization, 2006, UN ACC 2010 WHO IS W; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; NATL HUMAN RESOURCES	39	183	184	2	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					33	40		10.1016/S0140-6736(10)60894-X	http://dx.doi.org/10.1016/S0140-6736(10)60894-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624SR	20557927	Green Published, Green Accepted			2022-12-28	WOS:000279841600022
J	Doney, SC				Doney, Scott C.			The Growing Human Footprint on Coastal and Open-Ocean Biogeochemistry	SCIENCE			English	Review							ACIDIFICATION; NITROGEN; IMPACT; SINK; EUTROPHICATION; 21ST-CENTURY; TRENDS; DRIVEN	Climate change, rising atmospheric carbon dioxide, excess nutrient inputs, and pollution in its many forms are fundamentally altering the chemistry of the ocean, often on a global scale and, in some cases, at rates greatly exceeding those in the historical and recent geological record. Major observed trends include a shift in the acid-base chemistry of seawater, reduced subsurface oxygen both in near-shore coastal water and in the open ocean, rising coastal nitrogen levels, and widespread increase in mercury and persistent organic pollutants. Most of these perturbations, tied either directly or indirectly to human fossil fuel combustion, fertilizer use, and industrial activity, are projected to grow in coming decades, resulting in increasing negative impacts on ocean biota and marine resources.	Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Doney, SC (corresponding author), Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA.	sdoney@whoi.edu	Doney, Scott C/F-9247-2010	Doney, Scott C/0000-0002-3683-2437	Center for Microbial Oceanography, Research and Education (C-MORE) (NSF) [EF-0424599]; Woods Hole Oceanographic Institution	Center for Microbial Oceanography, Research and Education (C-MORE) (NSF)(National Science Foundation (NSF)); Woods Hole Oceanographic Institution	This work was supported by the Center for Microbial Oceanography, Research and Education (C-MORE) (NSF grant EF-0424599) and the W. Van Alan Clark, Sr. Chair for Excellence in Oceanography from the Woods Hole Oceanographic Institution. I thank J. Dore for Fig. 2, I. Lima for Fig. 3, S. Mecking for Fig. 4, and C. Reddy and C. Lamborg for discussions on ocean pollutants.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Byrne RH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040999; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doney SC, 2004, FRONT ECOL ENVIRON, V2, P457, DOI 10.2307/3868334; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2009, DEEP-SEA RES PT II, V56, P504, DOI 10.1016/j.dsr2.2008.12.016; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Fasham, 2003, OCEAN BIOGEOCHEMISTR; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; Flores-Cervantes DX, 2009, MAR CHEM, V113, P172, DOI 10.1016/j.marchem.2009.01.012; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Frolicher TL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003316; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Howard PH, 2010, ENVIRON SCI TECHNOL, V44, P2277, DOI 10.1021/es903383a; Johnson KS, 2009, OCEANOGRAPHY, V22, P216, DOI 10.5670/oceanog.2009.81; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kelly AE, 2009, EARTH PLANET SC LETT, V283, P93, DOI 10.1016/j.epsl.2009.03.045; Krishnamurthy A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003440; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Lima ALC, 2005, ENVIRON FORENSICS, V6, P109, DOI 10.1080/15275920590952739; Lovenduski NS, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003139; Luo C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002964; MacDonald RW, 2000, SCI TOTAL ENVIRON, V254, P93, DOI 10.1016/S0048-9697(00)00434-4; Mecking S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003101; *NAT RES COUNC, 2003, OIL SEA INP FAT EFF; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; REDDY CM, 2008, OCEANS HUMAN HLTH RI, P121; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sabine CL, 2010, ANNU REV MAR SCI, V2, P175, DOI 10.1146/annurev-marine-120308-080947; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Schroth AW, 2009, NAT GEOSCI, V2, P337, DOI 10.1038/NGEO501; Seitzinger SP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002606; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinacher M, 2010, BIOGEOSCIENCES, V7, P979, DOI 10.5194/bg-7-979-2010; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; von Waldow H, 2010, ENVIRON SCI TECHNOL, V44, P2791, DOI 10.1021/es9030694; Watson AJ, 2009, SCIENCE, V326, P1391, DOI 10.1126/science.1177394; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007	58	524	542	20	689	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1512	1516		10.1126/science.1185198	http://dx.doi.org/10.1126/science.1185198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558706				2022-12-28	WOS:000278859200034
J	Martinez-Garcia, A; Rosell-Mele, A; McClymont, EL; Gersonde, R; Haug, GH				Martinez-Garcia, Alfredo; Rosell-Mele, Antoni; McClymont, Erin L.; Gersonde, Rainer; Haug, Gerald H.			Subpolar Link to the Emergence of the Modern Equatorial Pacific Cold Tongue	SCIENCE			English	Article							PERMANENT EL-NINO; SOUTHERN-OCEAN; HIGH-LATITUDE; PLIOCENE; CLIMATE; ATLANTIC; OSCILLATION; TEMPERATURE; CIRCULATION; TROPICS	The cold upwelling "tongue" of the eastern equatorial Pacific is a central energetic feature of the ocean, dominating both the mean state and temporal variability of climate in the tropics and beyond. Recent evidence for the development of the modern cold tongue during the Pliocene-Pleistocene transition has been explained as the result of extratropical cooling that drove a shoaling of the thermocline. We have found that the sub-Antarctic and sub-Arctic regions underwent substantial cooling nearly synchronous to the cold tongue development, thereby providing support for this hypothesis. In addition, we show that sub-Antarctic climate changed in its response to Earth's orbital variations, from a subtropical to a subpolar pattern, as expected if cooling shrank the warm-water sphere of the ocean and thus contracted the subtropical gyres.	[Martinez-Garcia, Alfredo; Haug, Gerald H.] ETH, Inst Geol, CH-8092 Zurich, Switzerland; [Martinez-Garcia, Alfredo; Haug, Gerald H.] Univ Potsdam, Inst Geosci, DFG Leibniz Ctr Surface Proc & Climate Studies, D-14476 Potsdam, Germany; [Martinez-Garcia, Alfredo; Rosell-Mele, Antoni] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, Bellaterra 08193, Catalonia, Spain; [Rosell-Mele, Antoni] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Catalonia, Spain; [McClymont, Erin L.] Newcastle Univ, Sch Geog Polit & Sociol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gersonde, Rainer] Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam; Autonomous University of Barcelona; ICREA; Newcastle University - UK; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Martinez-Garcia, A (corresponding author), ETH, Inst Geol, CH-8092 Zurich, Switzerland.	alfredo.martinez-garcia@erdw.ethz.ch	McClymont, Erin/AAX-3657-2020; Martínez-García, Alfredo/A-6244-2010; McClymont, Erin/AAX-3567-2020; McClymont, Erin L/K-2153-2012; Rosell-Melé, Antoni/B-3433-2013	McClymont, Erin/0000-0003-1562-8768; Martínez-García, Alfredo/0000-0002-7206-5079; McClymont, Erin/0000-0003-1562-8768; McClymont, Erin L/0000-0003-1562-8768; Rosell-Melé, Antoni/0000-0002-5513-2647	Ministerio de Ciencia e Innovacion, Spain; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	We thank the Integrated Ocean Drilling Program (IODP) for providing the samples used in this study, and two anonymous reviewers for providing valuable comments that improved the final version of the paper. Supported by a FPU grant awarded by the Ministerio de Ciencia e Innovacion, Spain (A. M.-G.).	Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; BRASSELL SC, 1986, NATURE, V320, P129, DOI 10.1038/320129a0; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; CANE MA, 1985, SCIENCE, V228, P1085, DOI 10.1126/science.228.4703.1085; Cortese G, 2008, MAR GEOL, V252, P100, DOI 10.1016/j.margeo.2008.03.015; Cortese G, 2004, EARTH PLANET SC LETT, V224, P509, DOI 10.1016/j.epsl.2004.05.035; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Hopley PJ, 2007, EARTH PLANET SC LETT, V256, P419, DOI 10.1016/j.epsl.2007.01.031; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; McClymont EL, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001622; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; PHILANDER SGH, 1983, NATURE, V302, P295, DOI 10.1038/302295a0; PRAHL FG, 1987, NATURE, V330, P367, DOI 10.1038/330367a0; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Rosell-Mele A, 1998, PALEOCEANOGRAPHY, V13, P694, DOI 10.1029/98PA02355; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Venz KA, 2002, PALAEOGEOGR PALAEOCL, V182, P197, DOI 10.1016/S0031-0182(01)00496-5; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596	28	142	149	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1550	1553		10.1126/science.1184480	http://dx.doi.org/10.1126/science.1184480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558716				2022-12-28	WOS:000278859200044
J	Cykert, S; Dilworth-Anderson, P; Monroe, MH; Walker, P; McGuire, FR; Corbie-Smith, G; Edwards, LJ; Bunton, AJ				Cykert, Samuel; Dilworth-Anderson, Peggye; Monroe, Michael H.; Walker, Paul; McGuire, Franklin R.; Corbie-Smith, Giselle; Edwards, Lloyd J.; Bunton, Audrina Jones			Factors Associated With Decisions to Undergo Surgery Among Patients With Newly Diagnosed Early-Stage Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN COMMUNICATION; RACIAL DISPARITIES; SURGICAL RESECTION; AFRICAN-AMERICANS; CARE; SURVIVAL; RACE; PREDICTION; EDUCATION; QUALITY	Context Lung cancer is the leading cause of cancer death in the United States. Surgical resection for stage I or II non-small cell cancer remains the only reliable treatment for cure. Patients who do not undergo surgery have a median survival of less than 1 year. Despite the survival disadvantage, many patients with early-stage disease do not receive surgical care and rates are even lower for black patients. Objectives To identify potentially modifiable factors regarding surgery in patients newly diagnosed with early-stage lung cancer and to explore why blacks undergo surgery less often than whites. Design, Setting, and Patients Prospective cohort study with patients identified by pulmonary, oncology, thoracic surgery, and generalist practices in 5 communities through study referral or computerized tomography review protocol. A total of 437 patients with biopsy-proven or probable early-stage lung cancer were enrolled between December 2005 and December 2008. Before establishment of treatment plans, patients were administered a survey including questions about trust, patient-physician communication, attitudes toward cancer, and functional status. Information about comorbid illnesses was obtained through chart audits. Main Outcome Measure Lung cancer surgery within 4 months of diagnosis. Results A total of 386 patients met full eligibility criteria for lung resection surgery. The median age was 66 years (range, 26-90 years) and 29% of patients were black. The surgical rate was 66% for white patients (n=179/273) compared with 55% for black patients (n=62/113; P=.05). Negative perceptions of patient-physician communication manifested by a 5-point decrement on a 25-point communication scale (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.32-0.74) and negative perception of 1-year prognosis postsurgery (OR, 0.27; 95% CI, 0.14-0.50; absolute risk, 34%) were associated with decisions against surgery. Surgical rates for blacks were particularly low when they had 2 or more comorbid illnesses (13% vs 62% for <2 comorbidities; OR, 0.04 [95% CI, 0.01-0.25]; absolute risk, 49%) and when blacks lacked a regular source of care (42% with no regular care vs 57% with regular care; OR, 0.20 [95% CI, 0.10-0.43]; absolute risk, 15%). Conclusions A decision not to undergo surgery by patients with newly diagnosed lung cancer was independently associated with perceptions of communication and prognosis, older age, multiple comorbidities, and black race. Interventions to optimize surgery should consider these factors. JAMA. 2010; 303(23): 2368-2376	[Cykert, Samuel; Corbie-Smith, Giselle; Edwards, Lloyd J.; Bunton, Audrina Jones] Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Cykert, Samuel; Corbie-Smith, Giselle] Univ N Carolina, Sch Med, Div Gen Internal Med & Clin Epidemiol, Chapel Hill, NC USA; [Dilworth-Anderson, Peggye] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Dilworth-Anderson, Peggye] Univ N Carolina, UNC Inst Aging, Chapel Hill, NC USA; [Edwards, Lloyd J.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cykert, Samuel] Greensboro Area Hlth Educ Ctr, Moses Cone Hlth Syst, Internal Med Program, Greensboro, NC USA; [Monroe, Michael H.] Carolinas Med Ctr, Dept Internal Med, Charlotte, NC 28203 USA; [Walker, Paul] E Carolina Univ, Leo Jenkins Canc Ctr, Brody Sch Med, Greenville, NC USA; [McGuire, Franklin R.] Univ S Carolina, Sch Med, Div Pulm & Crit Care Med, Columbia, SC 29208 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Carolinas Medical Center; University of North Carolina; East Carolina University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Cykert, S (corresponding author), Moses Cone Hosp, Internal Med Teaching Program, 1200 N Elm St, Greensboro, NC 27401 USA.	samuel_cykert@med.unc.edu	Edwards, Lloyd/N-2759-2019	Edwards, Lloyd/0000-0002-7788-4575; Cykert, Samuel/0000-0003-2037-6809; Corbie, Giselle/0000-0003-0737-6775	American Cancer Society [RSGPB-05-217-01-CPPB]; NATIONAL CANCER INSTITUTE [R01CA150980] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the American Cancer Society via grant RSGPB-05-217-01-CPPB.	Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Baile WF, 2005, CURR OPIN ONCOL, V17, P331, DOI 10.1097/01.cco.0000167738.49325.2c; Battafarano RJ, 2002, J THORAC CARDIOV SUR, V123, P280, DOI 10.1067/mtc.2002.119338; Bickell NA, 2008, JNCI-J NATL CANCER I, V100, P1717, DOI 10.1093/jnci/djn387; Clever SL, 2006, MED CARE, V44, P398, DOI 10.1097/01.mlr.0000208117.15531.da; Cykert S, 2003, MED DECIS MAKING, V23, P167, DOI 10.1177/0272989X03251244; Dewan NA, 1997, CHEST, V112, P416, DOI 10.1378/chest.112.2.416; Diggle PJ, 1994, ANAL LONGITUDINAL DA; EDWARDS FH, 1987, CHEST, V92, P888, DOI 10.1378/chest.92.5.888; Esnaola NF, 2008, ANN THORAC SURG, V86, P220, DOI 10.1016/j.athoracsur.2008.02.072; Farjah F, 2009, ARCH SURG-CHICAGO, V144, P14, DOI 10.1001/archsurg.2008.519; Gordon HS, 2006, CANCER-AM CANCER SOC, V107, P1313, DOI 10.1002/cncr.22122; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald HP, 1998, AM J PUBLIC HEALTH, V88, P1681, DOI 10.2105/AJPH.88.11.1681; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; King WD, 2004, J GEN INTERN MED, V19, P1146, DOI 10.1111/j.1525-1497.2004.30443.x; Kraetschmer N, 2004, HEALTH EXPECT, V7, P317, DOI 10.1111/j.1369-7625.2004.00296.x; Lathan CS, 2006, J CLIN ONCOL, V24, P413, DOI 10.1200/JCO.2005.02.1758; LIN AY, 1992, JAMA-J AM MED ASSOC, V267, P1661, DOI 10.1001/jama.267.12.1661; McCann J, 2005, CHEST, V128, P3440, DOI 10.1378/chest.128.5.3440; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mulligan CR, 2006, CANCER EPIDEM BIOMAR, V15, P25, DOI 10.1158/1055-9965.EPI-05-0537; National Cancer Institute, SEER CANC STAT REV 1; Osborne RH, 1999, PSYCHOL MED, V29, P1335, DOI 10.1017/S0033291799001142; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Salkeld G, 2004, HEALTH EXPECT, V7, P104, DOI 10.1111/j.1369-7625.2004.00257.x; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Strand TE, 2007, THORAX, V62, P991, DOI 10.1136/thx.2007.079145; Torke AM, 2004, ARCH INTERN MED, V164, P525, DOI 10.1001/archinte.164.5.525; VRDOLJAK E, 1994, CHEST, V106, P1797, DOI 10.1378/chest.106.6.1797; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams SW, 2008, J PALLIAT MED, V11, P1221, DOI 10.1089/jpm.2008.0057; Wilson FL, 2008, COMPR CHILD ADOLES N, V31, P7, DOI 10.1080/01460860701877142; Yin HS, 2008, ARCH PEDIAT ADOL MED, V162, P814, DOI 10.1001/archpedi.162.9.814; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	39	181	181	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2368	2376		10.1001/jama.2010.793	http://dx.doi.org/10.1001/jama.2010.793			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	610TE	20551407	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000278759200026
J	Yakubovskaya, E; Mejia, E; Byrnes, J; Hambardjieva, E; Garcia-Diaz, M				Yakubovskaya, Elena; Mejia, Edison; Byrnes, James; Hambardjieva, Elena; Garcia-Diaz, Miguel			Helix Unwinding and Base Flipping Enable Human MTERF1 to Terminate Mitochondrial Transcription	CELL			English	Article							MAMMALIAN MITOCHONDRIA; MTDNA TRANSCRIPTION; CRYSTAL-STRUCTURE; POINT MUTATION; NUCLEIC-ACIDS; RIBOSOMAL-RNA; DNA; PROTEIN; BIOGENESIS; FAMILY	Defects in mitochondrial gene expression are associated with aging and disease. Mterf proteins have been implicated in modulating transcription, replication and protein synthesis. We have solved the structure of a member of this family, the human mitochondrial transcriptional terminator MTERF1, bound to dsDNA containing the termination sequence. The structure indicates that upon sequence recognition MTERF1 unwinds the DNA molecule, promoting eversion of three nucleotides. Base flipping is critical for stable binding and transcriptional termination. Additional structural and biochemical results provide insight into the DNA binding mechanism and explain how MTERF1 recognizes its target sequence. Finally, we have demonstrated that the mitochondrial pathogenic G3249A and G3244A mutations interfere with key interactions for sequence recognition, eliminating termination. Our results provide insight into the role of mterf proteins and suggest a link between mitochondrial disease and the regulation of mitochondrial transcription.	[Yakubovskaya, Elena; Mejia, Edison; Byrnes, James; Hambardjieva, Elena; Garcia-Diaz, Miguel] SUNY Stony Brook, Dept Pharmacol Sci, BST 7-169, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Garcia-Diaz, M (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, BST 7-169, Stony Brook, NY 11794 USA.	mgd@pharm.stonybrook.edu			Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health;  [R00 ES015421]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518] Funding Source: NIH RePORTER	Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Drs. Bebenek, Bogenhagen, De los Santos, Demple, Garcia-Segura, and Kunkel for critical reading of the manuscript; and the NSLS Protein Crystallography group. NSLS beamlines 325 and 329 are mainly supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and the National Center for Research Resources of the National Institutes of Health. This work was supported by R00 ES015421 to M.G.-D.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; FORTELLE EDL, 1997, METHODS ENZYMOLOGY, V276; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; HENDRICKSON WA, 1997, METHODS ENZYMOLOGY, V276; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Lu G, 2009, CURR OPIN STRUC BIOL, V19, P110, DOI 10.1016/j.sbi.2008.12.009; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005; Nam SC, 2005, J BIOCHEM MOL BIOL, V38, P690; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010	40	75	79	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					982	993		10.1016/j.cell.2010.05.018	http://dx.doi.org/10.1016/j.cell.2010.05.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550934	Bronze, Green Accepted			2022-12-28	WOS:000278618800013
J	Tufail, A; Patel, PJ; Egan, C; Hykin, P; da Cruz, L; Gregor, Z; Dowler, J; Majid, MA; Bailey, C; Mohamed, Q; Johnston, R; Bunce, C; Xing, W				Tufail, Adnan; Patel, Praveen J.; Egan, Catherine; Hykin, Philip; da Cruz, Lyndon; Gregor, Zdenek; Dowler, Jonathan; Majid, Mohammed A.; Bailey, Clare; Mohamed, Quresh; Johnston, Robert; Bunce, Catey; Xing, Wen		ABC Trial Investigators	Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VERTEPORFIN PHOTODYNAMIC THERAPY; INTRAVITREAL BEVACIZUMAB; CHOROIDAL NEOVASCULARIZATION; AVASTIN; RANIBIZUMAB; SECONDARY; EFFICACY; SAFETY	Objectives To evaluate the efficacy and safety of intravitreous bevacizumab injections for the treatment of neovascular age related macular degeneration. Design Prospective, double masked, multicentre, randomised controlled trial. Setting Three ophthalmology centres in the United Kingdom. Participants 131 patients (mean age 81) with wet age related macular degeneration randomised 1: 1 to intervention or control. Interventions Intravitreous bevacizumab (1.25 mg, three loading injections at six week intervals followed by further treatment if required at six week intervals) or standard treatment available at the start of the trial (photodynamic treatment with verteporfin for predominantly classic type neovascular age related macular degeneration, or intravitreal pegaptanib or sham treatment for occult or minimally classic type neovascular age related macular degeneration). Main outcome measures Primary outcome: proportion of patients gaining >= 15 letters of visual acuity at one year (54 weeks). Secondary outcomes: proportion of patients with stable vision and mean change in visual acuity. Results Of the 131 patients enrolled in the trial, five patients did not complete the study because of adverse events, loss to follow-up, or death. In the bevacizumab group, 21 (32%) patients gained 15 or more letters from baseline visual acuity compared with two (3%) in the standard care group (P<0.001); the estimated adjusted odds ratio was 18.1 (95% confidence interval 3.6 to 91.2) and the number needed to treat was 4 (3 to 6). In addition, the proportion of patients who lost fewer than 15 letters of visual acuity from baseline was significantly greater among those receiving bevacizumab treatment (91% (59) v 67% (44) in standard care group; P<0.001). Mean visual acuity increased by 7.0 letters in the bevacizumab group with a median of seven injections compared with a decrease of 9.4 letters in the standard care group (P<0.001), and the initial improvement at week 18 (plus 6.6 letters) was sustained to week 54. Among 65 patients treated with bevacizumab, there were no cases of endophthalmitis or serious uveitis related to the intervention. All end points with respect to visual acuity in the study eye at 54 weeks favoured bevacizumab treatment over standard care. Conclusions Bevacizumab 1.25 mg intavitreous injections given as part of a six weekly variable retreatment regimen is superior to standard care (pegaptanib sodium, verteporfin, sham), with low rates of serious ocular adverse events. Treatment improved visual acuity on average at 54 weeks.	[Tufail, Adnan] Moorfields Eye Hosp NHS Fdn Trust, Med Retina Dept, London EC1V 2PD, England; [Majid, Mohammed A.; Bailey, Clare] Bristol Eye Hosp, Bristol BSL 2LX, Avon, England; [Bunce, Catey; Xing, Wen] Moorfields Eye Hosp NHS Fdn Trust, Dept Res & Dev, London EC1V 2PD, England; [Mohamed, Quresh; Johnston, Robert] Cheltenham Gen Hosp, Gloucestershire Eye Dept, Cheltenham GL53 7AN, Glos, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Bristol Eye Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Tufail, A (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, Med Retina Dept, London EC1V 2PD, England.	adnan.tufail@moorfields.nhs.uk	, Fred/B-8158-2013; Aslam, Tariq/A-8532-2016	, Fred/0000-0003-2809-9930; Sivaprasad, Sobha/0000-0001-8952-0659; Aslam, Tariq/0000-0002-9739-7280; Tufail, Adnan/0000-0001-6131-7640; Richardson, Matthew/0000-0002-7390-9480; Bunce, Catey/0000-0002-0935-3713; Fraser-Bell, Samantha/0000-0001-5646-9359	Moorfields Eye Hospital; Department of Health through National Institute for Health Research; UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; National Eye Research Centre, Bristol	Moorfields Eye Hospital; Department of Health through National Institute for Health Research; UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; National Eye Research Centre, Bristol	This study was funded by the special trustees of Moorfields Eye Hospital. We also received financial support from the Department of Health through an award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Additional local support was obtained from the National Eye Research Centre, Bristol.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Azad Rajvardhan, 2007, Indian Journal of Ophthalmology, V55, P441; Bashshur ZF, 2007, ARCH OPHTHALMOL-CHIC, V125, P1357, DOI 10.1001/archopht.125.10.1357; Bashshur ZF, 2006, AM J OPHTHALMOL, V142, P1, DOI 10.1016/j.ajo.2006.02.037; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Costa RA, 2007, GRAEF ARCH CLIN EXP, V245, P1273, DOI 10.1007/s00417-007-0557-x; *CTR PREV OPTH BIO, 2009, COMP AG REL MAC DEG; Dafer Rima M, 2007, Semin Ophthalmol, V22, P201, DOI 10.1080/08820530701543024; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Giansanti F, 2007, EUR J OPHTHALMOL, V17, P230, DOI 10.1177/112067210701700213; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; *IVAN TRIAL, 2009, CTEU BRIST; Klein R, 1999, OPHTHALMOLOGY, V106, P1056, DOI 10.1016/S0161-6420(99)90255-5; Lazic R, 2007, GRAEF ARCH CLIN EXP, V245, P68, DOI 10.1007/s00417-006-0466-4; Patel PJ, 2008, INVEST OPHTH VIS SCI, V49, P4347, DOI 10.1167/iovs.08-1935; Patel PJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-56; PEDERSEN KB, 2008, ACTA OPHTHALMOL 1216; Raftery J, 2007, BRIT J OPHTHALMOL, V91, P1244, DOI 10.1136/bjo.2007.116616; Rich RM, 2006, RETINA-J RET VIT DIS, V26, P495, DOI 10.1097/01.iae.0000225766.75009.3a; Rosenfeld PJ, 2007, LANCET, V370, P1479, DOI 10.1016/S0140-6736(07)61624-9; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P331, DOI 10.3928/1542-8877-20050701-14; Schouten JSAG, 2009, GRAEF ARCH CLIN EXP, V247, P1, DOI 10.1007/s00417-008-0952-y; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001; Steinbrook R, 2006, NEW ENGL J MED, V355, P1409, DOI 10.1056/NEJMp068185; Taylor HR, 2007, LANCET, V370, P1481, DOI 10.1016/S0140-6736(07)61628-6; Wagle AM, 2007, LANCET, V370, P1481, DOI 10.1016/S0140-6736(07)61629-8; Wong TY, 2007, LANCET, V370, P204, DOI 10.1016/S0140-6736(07)61104-0; Ziemssen F, 2009, DRUG AGING, V26, P295, DOI 10.2165/00002512-200926040-00002	34	153	155	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2010	340								c2459	10.1136/bmj.c2459	http://dx.doi.org/10.1136/bmj.c2459			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611MF	20538634	hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000278818700002
J	Martyn, C				Martyn, Christopher			Out of Hours Why medicine is overweight	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Martyn, C (corresponding author), BMJ, London, England.	cmartyn@bmj.com							0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 2	2010	340								c2800	10.1136/bmj.c2800	http://dx.doi.org/10.1136/bmj.c2800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BL	20519269				2022-12-28	WOS:000278556400004
J	Jouvenet, N; Simon, SM				Jouvenet, Nolwenn; Simon, Sanford M.			Viral Houseguests Undertake Interior Redesign	CELL			English	Editorial Material							VIRUS-REPLICATION		[Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA; [Jouvenet, Nolwenn] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Simon, SM (corresponding author), Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA.	simon@mail.rockefeller.edu	jouvenet, nolwenn/K-2067-2019	jouvenet, nolwenn/0000-0001-6103-6048; Simon, Sanford/0000-0002-8615-4224	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089844] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI089844] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005	4	1	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					754	756		10.1016/j.cell.2010.05.012	http://dx.doi.org/10.1016/j.cell.2010.05.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510923	Bronze			2022-12-28	WOS:000278132900011
J	Kitajiri, S; Sakamoto, T; Belyantseva, IA; Goodyear, RJ; Stepanyan, R; Fujiwara, I; Bird, JE; Riazuddin, S; Riazuddin, S; Ahmed, ZM; Hinshaw, JE; Sellers, J; Bartles, JR; Hammer, JA; Richardson, GP; Griffith, AJ; Frolenkov, GI; Friedman, TB				Kitajiri, Shin-ichiro; Sakamoto, Takeshi; Belyantseva, Inna A.; Goodyear, Richard J.; Stepanyan, Ruben; Fujiwara, Ikuko; Bird, Jonathan E.; Riazuddin, Saima; Riazuddin, Sheikh; Ahmed, Zubair M.; Hinshaw, Jenny E.; Sellers, James; Bartles, James R.; Hammer, John A., III; Richardson, Guy P.; Griffith, Andrew J.; Frolenkov, Gregory I.; Friedman, Thomas B.			Actin-Bundling Protein TRIOBP Forms Resilient Rootlets of Hair Cell Stereocilia Essential for Hearing	CELL			English	Article							F-ACTIN; BINDING-PROTEIN; CUTICULAR PLATE; BIRD COCHLEA; MYOSIN-XVA; FILAMENTS; INNER; ELONGATION; MOUSE; ESPIN	Inner ear hair cells detect sound through deflection of mechanosensory stereocilia. Each stereocilium is supported by a paracrystalline array of parallel actin filaments that are packed more densely at the base, forming a rootlet extending into the cell body. The function of rootlets and the molecules responsible for their formation are unknown. We found that TRIOBP, a cytoskeleton-associated protein mutated in human hereditary deafness DFNB28, is localized to rootlets. In vitro, purified TRIOBP isoform 4 protein organizes actin filaments into uniquely dense bundles reminiscent of rootlets but distinct from bundles formed by espin, an actin crosslinker in stereocilia. We generated mutant Triobp mice (Triobp(Delta ex8/Delta ex8)) that are profoundly deaf. Stereocilia of Triobp(Delta ex8/Delta ex8) mice develop normally but fail to form rootlets and are easier to deflect and damage. Thus, F-actin bundling by TRIOBP provides durability and rigidity for normal mechanosensitivity of stereocilia and may contribute to resilient cytoskeletal structures elsewhere.	[Kitajiri, Shin-ichiro; Belyantseva, Inna A.; Bird, Jonathan E.; Riazuddin, Saima; Ahmed, Zubair M.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Mol Biol & Genet Sect, NIH, Rockville, MD 20850 USA; [Sakamoto, Takeshi; Sellers, James] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Fujiwara, Ikuko; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Goodyear, Richard J.; Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Stepanyan, Ruben; Frolenkov, Gregory I.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 54700, Pakistan; [Hinshaw, Jenny E.] NIDDKD, Struct Cell Biol Sect, NIH, Bethesda, MD 20892 USA; [Bartles, James R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Sussex; University of Kentucky; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Northwestern University; Feinberg School of Medicine	Friedman, TB (corresponding author), Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X; Bird, Jonathan/0000-0001-5531-8794; Frolenkov, Gregory/0000-0002-9810-5024; Bartles, James/0000-0002-7056-3875	NIDCD/NIH [R01DC008861, R01DC009434, R01 DC004314]; Wellcome Trust [071394/Z/03/Z]; HEC; MoST, Islamabad; NIDDK; NHLBI; NIDCD [Z01 DK060100, Z01 HL004232-08, Z01 DC 000064, Z01 DC000048]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006120, ZIAHL004232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039, ZIADC000048, ZIADC000060] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Wellcome Trust(Wellcome TrustEuropean Commission); HEC; MoST, Islamabad; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank M. Ikeya for advice and vectors, M. Streuli for mononclonal antiserum to TRIOBP-1/5, P. Belyantsev for drawings, and N. Gavara, M. Barzik, R. Chadwick, J. Schultz, and D. Drayna for discussions. This work was supported by NIDCD/NIH R01DC008861 and R01DC009434 to G.I.F., R01 DC004314 to J.R.B., the Wellcome Trust grant 071394/Z/03/Z to G.P.R., the HEC and MoST, Islamabad to S.R., intramural programs of NIDDK, NHLBI, and NIDCD Z01 DK060100 to J.E.H., Z01 DK060100 to J.A.H., Z01 HL004232-08 to J.S., Z01 DC 000064 to A.J.G., and Z01 DC000048 to T.B.	Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chen B, 1999, MOL BIOL CELL, V10, P4327, DOI 10.1091/mbc.10.12.4327; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339; Frolenkov GI, 1997, BIOPHYS J, V73, P1665, DOI 10.1016/S0006-3495(97)78198-0; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; ITOH M, 1982, HEARING RES, V6, P277, DOI 10.1016/0378-5955(82)90060-0; Karavitaki KD, 2006, Auditory Mechanisms: Processes and Models, P286, DOI 10.1142/9789812773456_0048; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Matsudaira P T, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 2, P845; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; Purdy KR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058105; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Seipel K, 2001, J CELL SCI, V114, P389; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stepanyan R, 2009, J NEUROSCI, V29, P4023, DOI 10.1523/JNEUROSCI.4566-08.2009; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; TILNEY LG, 1986, DEV BIOL, V116, P119, DOI 10.1016/0012-1606(86)90048-5; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	37	137	141	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					786	798		10.1016/j.cell.2010.03.049	http://dx.doi.org/10.1016/j.cell.2010.03.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510926	Bronze, Green Accepted			2022-12-28	WOS:000278132900014
J	Tielrooij, KJ; Garcia-Araez, N; Bonn, M; Bakker, HJ				Tielrooij, K. J.; Garcia-Araez, N.; Bonn, M.; Bakker, H. J.			Cooperativity in Ion Hydration	SCIENCE			English	Article							AQUEOUS-SOLUTIONS; LIQUID WATER; DIELECTRIC-SPECTROSCOPY; DYNAMICS; REORIENTATION; RELAXATION; MECHANISM; NABR	Despite prolonged scientific efforts to unravel the effects of ions on the structure and dynamics of water, many open questions remain, in particular concerning the spatial extent of this effect (i.e., the number of water molecules affected) and the origin of ion-specific effects. A combined terahertz and femtosecond infrared spectroscopic study of water dynamics around different ions (specifically magnesium, lithium, sodium, and cesium cations, as well as sulfate, chloride, iodide, and perchlorate anions) reveals that the effect of ions and counterions on water can be strongly interdependent and nonadditive, and in certain cases extends well beyond the first solvation shell of water molecules directly surrounding the ion.	[Tielrooij, K. J.; Garcia-Araez, N.; Bonn, M.; Bakker, H. J.] FOM Inst Atom & Mol Phys AMOLF, NL-1098 XG Amsterdam, Netherlands	AMOLF	Bakker, HJ (corresponding author), FOM Inst Atom & Mol Phys AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	bakker@amolf.nl	Garcia-Araez, Nuria/A-5194-2013; Bonn, Mischa/H-7446-2012; Tielrooij, Klaas-Jan/R-7133-2019	Garcia-Araez, Nuria/0000-0001-9095-2379; Bonn, Mischa/0000-0001-6851-8453; Tielrooij, Klaas-Jan/0000-0002-0055-6231	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO). We thank H. Schoenmaker for technical support, R. L. A. Timmer and E. H. G. Backus for useful discussions, and D. Frenkel and E. W. Meijer for helpful comments on the manuscript.	Buchner R, 2004, J PHYS CHEM B, V108, P2365, DOI 10.1021/jp034870p; Buchner R, 1999, J PHYS CHEM B, V103, P1185, DOI 10.1021/jp983706c; Buchner R, 1999, J PHYS CHEM A, V103, P1, DOI 10.1021/jp982977k; Cappa CD, 2006, J PHYS CHEM B, V110, P5301, DOI 10.1021/jp054699c; Chen T, 2003, J PHYS CHEM A, V107, P4025, DOI 10.1021/jp026429p; Collins KD, 2007, BIOPHYS CHEM, V128, P95, DOI 10.1016/j.bpc.2007.03.009; Franks F., 1973, WATER COMPREHENSIVE; Jungwirth P, 2006, CHEM REV, V106, P1259, DOI 10.1021/cr0403741; Kaatze U, 1997, J SOLUTION CHEM, V26, P1049, DOI 10.1007/BF02768829; Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g; Koneshan S, 1998, J PHYS CHEM B, V102, P4193, DOI 10.1021/jp980642x; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P19, DOI 10.1016/j.cocis.2004.05.005; Laage D, 2006, SCIENCE, V311, P832, DOI 10.1126/science.1122154; Laage D, 2008, J PHYS CHEM B, V112, P14230, DOI 10.1021/jp805217u; Laage D, 2007, P NATL ACAD SCI USA, V104, P11167, DOI 10.1073/pnas.0701699104; Lin YS, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3242083; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; Marcus Y, 2009, CHEM REV, V109, P1346, DOI 10.1021/cr8003828; Moilanen DE, 2009, P NATL ACAD SCI USA, V106, P375, DOI 10.1073/pnas.0811489106; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Omta AW, 2003, SCIENCE, V301, P347, DOI 10.1126/science.1084801; Park S, 2007, P NATL ACAD SCI USA, V104, P16731, DOI 10.1073/pnas.0707824104; Rezus YLA, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2009729; Ronne C, 1997, J CHEM PHYS, V107, P5319, DOI 10.1063/1.474242; Smith JD, 2007, J AM CHEM SOC, V129, P13847, DOI 10.1021/ja071933z; Tielrooij KJ, 2009, CHEM PHYS LETT, V471, P71, DOI 10.1016/j.cplett.2009.02.003; Tobias DJ, 2008, SCIENCE, V319, P1197, DOI 10.1126/science.1152799; Turton DA, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2906132; Wachter W, 2005, J PHYS CHEM A, V109, P8675, DOI 10.1021/jp053299m; Wachter W, 2007, J PHYS CHEM B, V111, P9010, DOI 10.1021/jp072425e	30	501	509	16	481	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1006	1009		10.1126/science.1183512	http://dx.doi.org/10.1126/science.1183512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489020				2022-12-28	WOS:000277877100035
J	Zhang, CL; Frias, MA; Mele, A; Ruggiu, M; Eom, T; Marney, CB; Wang, HD; Licatalosi, DD; Fak, JJ; Darnell, RB				Zhang, Chaolin; Frias, Maria A.; Mele, Aldo; Ruggiu, Matteo; Eom, Taesun; Marney, Christina B.; Wang, Huidong; Licatalosi, Donny D.; Fak, John J.; Darnell, Robert B.			Integrative Modeling Defines the Nova Splicing-Regulatory Network and Its Combinatorial Controls	SCIENCE			English	Article							PROTEIN INTERACTIONS; INSIGHTS; INCLUSION; SWITCH; MOTIF	The control of RNA alternative splicing is critical for generating biological diversity. Despite emerging genome-wide technologies to study RNA complexity, reliable and comprehensive RNA-regulatory networks have not been defined. Here, we used Bayesian networks to probabilistically model diverse data sets and predict the target networks of specific regulators. We applied this strategy to identify similar to 700 alternative splicing events directly regulated by the neuron-specific factor Nova in the mouse brain, integrating RNA-binding data, splicing microarray data, Nova-binding motifs, and evolutionary signatures. The resulting integrative network revealed combinatorial regulation by Nova and the neuronal splicing factor Fox, interplay between phosphorylation and splicing, and potential links to neurologic disease. Thus, we have developed a general approach to understanding mammalian RNA regulation at the systems level.	[Zhang, Chaolin; Frias, Maria A.; Mele, Aldo; Ruggiu, Matteo; Eom, Taesun; Marney, Christina B.; Wang, Huidong; Licatalosi, Donny D.; Fak, John J.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Zhang, CL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	czhang@rockefeller.edu; darnelr@rockefeller.edu	Marney, Christina Beate/AAK-2494-2021; Darnell, Robert B/B-9022-2008	Marney, Christina Beate/0000-0001-5475-9811; Darnell, Robert B/0000-0002-5134-8088; Ruggiu, Matteo/0000-0002-6404-1210; Frias, Maria A/0000-0001-7753-6290	NIH [NS34389]; Rockefeller University Hospital CTSA [UL1 RR024143]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM095713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034389, R01NS034389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Hospital CTSA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. R. Krainer for Fox1/2 expression constructs, S. Dewell for Illumina sequencing, and all Darnell lab members for helpful discussions. This work was supported by grants from the NIH to R. B. D. (NS34389) and the Rockefeller University Hospital CTSA (UL1 RR024143). R. B. D. is an Investigator of the Howard Hughes Medical Institute. The HITS-CLIP and microarray data have been deposited to the National Center for Biotechnology Information Sequence Read Archive (SRA019982) and Gene Expression Omnibus (GSE22115) databases, respectively.	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P5943, DOI 10.1093/nar/gkp625; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	27	206	211	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					439	443		10.1126/science.1191150	http://dx.doi.org/10.1126/science.1191150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558669	Green Accepted			2022-12-28	WOS:000280196500037
J	Sund, J; Ander, M; Aqvist, J				Sund, Johan; Ander, Martin; Aqvist, Johan			Principles of stop-codon reading on the ribosome	NATURE			English	Article							POLYPEPTIDE RELEASE FACTORS; DIFFERENT GROWTH-RATES; TRANSFER-RNA; ESCHERICHIA-COLI; TRANSLATION TERMINATION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FACTOR RF2; GGQ MOTIF; COMPLEX	In termination of protein synthesis, the bacterial release factors RF1 and RF2 bind to the ribosome through specific recognition of messenger RNA stop codons and trigger hydrolysis of the bond between the nascent polypeptide and the transfer RNA at the peptidyl-tRNA site, thereby releasing the newly synthesized protein. The release factors are highly specific for a U in the first stop-codon position 1 and recognize different combinations of purines in the second and third positions, with RF1 reading UAA and UAG and RF2 reading UAA and UGA. With recently determined crystal structures of termination complexes(2-4), it has become possible to decipher the energetics of stop-codon reading by computational analysis and to clarify the origin of the high release-factor binding accuracy. Here we report molecular dynamics free-energy calculations on different cognate and non-cognate termination complexes. The simulations quantitatively explain the basic principles of decoding in all three codon positions and reveal the key elements responsible for specificity of the release factors. The overall reading mechanism involves hitherto unidentified interactions and recognition switches that cannot be described in terms of a tripeptide anticodon model. Further simulations of complexes with tRNA(Trp), the tRNA recognizing the triplet codon for Trp, explain the observation of a 'leaky' stop codon 5 and highlight the fundamentally different third position reading by RF2, which leads to a high stop-codon specificity with strong discrimination against the Trp codon. The simulations clearly illustrate the versatility of codon reading by protein, which goes far beyond tRNA mimicry.	[Sund, Johan; Ander, Martin; Aqvist, Johan] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Uppsala University	Aqvist, J (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.	aqvist@xray.bmc.uu.se	Aqvist, Johan/A-4360-2012		Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Support from the Swedish Research Council is gratefully acknowledged. We thank M. Ehrenberg for discussions and M. Laurberg, H. Noller, A. Weixlbaumer and V. Ramakrishnan for sending us their atomic coordinates before release and for providing electron density maps.	ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; Almlof M, 2007, BIOCHEMISTRY-US, V46, P200, DOI 10.1021/bi061713i; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; HIRSH D, 1971, J MOL BIOL, V58, P459, DOI 10.1016/0022-2836(71)90363-9; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; KING G, 1989, J CHEM PHYS, V91, P3647, DOI 10.1063/1.456845; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Kristensen O, 2002, CURR PROTEIN PEPT SC, V3, P133, DOI 10.2174/1389203023380837; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; LEE FS, 1992, J CHEM PHYS, V97, P3100, DOI 10.1063/1.462997; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; Trobro S, 2005, P NATL ACAD SCI USA, V102, P12395, DOI 10.1073/pnas.0504043102; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Trobro S, 2009, BIOCHEMISTRY-US, V48, P11296, DOI 10.1021/bi9017297; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	33	44	45	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					947	U12		10.1038/nature09082	http://dx.doi.org/10.1038/nature09082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20512119				2022-12-28	WOS:000278804500042
J	Zhang, Y; Zhu, XL; Torelli, AT; Lee, M; Dzikovski, B; Koralewski, RM; Wang, E; Freed, J; Krebs, C; Ealick, SE; Lin, HN				Zhang, Yang; Zhu, Xuling; Torelli, Andrew T.; Lee, Michael; Dzikovski, Boris; Koralewski, Rachel M.; Wang, Eileen; Freed, Jack; Krebs, Carsten; Ealick, Steven E.; Lin, Hening			Diphthamide biosynthesis requires an organic radical generated by an iron-sulphur enzyme	NATURE			English	Article							TOXIN-RESISTANT MUTANTS; S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; DIPHTHERIA-TOXIN; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SAM; PROTEINS; SYNTHASE; LOCALIZATION	Archaeal and eukaryotic translation elongation factor 2 contain a unique post-translationally modified histidine residue called diphthamide, which is the target of diphtheria toxin. The biosynthesis of diphthamide was proposed to involve three steps, with the first being the formation of a C-C bond between the histidine residue and the 3-amino-3-carboxypropyl group of S-adenosyl-L-methionine (SAM). However, further details of the biosynthesis remain unknown. Here we present structural and biochemical evidence showing that the first step of diphthamide biosynthesis in the archaeon Pyrococcus horikoshii uses a novel iron-sulphur-cluster enzyme, Dph2. Dph2 is a homodimer and each of its monomers can bind a [4Fe-4S] cluster. Biochemical data suggest that unlike the enzymes in the radical SAM superfamily, Dph2 does not form the canonical 59-deoxyadenosyl radical. Instead, it breaks the Cc, Met-S bond of SAM and generates a 3-amino-3-carboxypropyl radical. Our results suggest that P. horikoshii Dph2 represents a previously unknown, SAM-dependent, [4Fe-4S]-containing enzyme that catalyses unprecedented chemistry.	[Zhang, Yang; Zhu, Xuling; Torelli, Andrew T.; Dzikovski, Boris; Koralewski, Rachel M.; Wang, Eileen; Freed, Jack; Ealick, Steven E.; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Lee, Michael; Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lin, HN (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	see3@cornell.edu; hl379@cornell.edu	Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	Dreyfus Foundation; NIH/NIGMS [R01GM088276]; NIH/NCRR [P41-RR016292]; US National Center for Research Resources at the US National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR016292, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088276] Funding Source: NIH RePORTER	Dreyfus Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Center for Research Resources at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Kinsland for assistance with manuscript preparation, the Dreyfus Foundation for a New Faculty Award to H. L., NIH/NIGMS R01GM088276 to H. L. and S. E. E., and NIH/NCRR P41-RR016292 for the ACERT Center Grant to J.F. This work is based upon research conducted at the Advanced Photon Source (APS), Argonne National Laboratory, on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the US National Center for Research Resources at the US National Institutes of Health. Use of the APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CDCP, 2005, DIPHTH DIS LIST DIPH; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; Cicchillo RM, 2005, J AM CHEM SOC, V127, P7310, DOI 10.1021/ja051369x; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; MAKINEN GB, 1987, ENDOR EPR ELECT SPIN, P129; Marinoni I, 2008, FEBS J, V275, P5090, DOI 10.1111/j.1742-4658.2008.06641.x; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MATTHEAKIS LC, 1993, GENE, V132, P149, DOI 10.1016/0378-1119(93)90528-B; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; MOEHRING TJ, 1984, MOL CELL BIOL, V4, P642, DOI 10.1128/MCB.4.4.642; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips NJ, 1996, CANCER LETT, V102, P85, DOI 10.1016/0304-3835(96)04169-9; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Rekittke I, 2008, J AM CHEM SOC, V130, P17206, DOI 10.1021/ja806668q; Sakuraba H, 2005, J BIOL CHEM, V280, P26645, DOI 10.1074/jbc.C500192200; Saunders AH, 2008, BIOCHEMISTRY-US, V47, P10999, DOI 10.1021/bi801268f; Schultz DC, 1998, GENOMICS, V52, P186, DOI 10.1006/geno.1998.5420; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; WALSH CT, 2006, POSTTRANSLATIONAL MO, P321	47	142	146	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					891	U4		10.1038/nature09138	http://dx.doi.org/10.1038/nature09138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559380	Green Accepted			2022-12-28	WOS:000278804500030
J	Bongaarts, J; Over, M				Bongaarts, John; Over, Mead			Global HIV/AIDS Policy in Transition	SCIENCE			English	Editorial Material							HEALTH; AID		[Bongaarts, John] Populat Council, New York, NY 10017 USA; [Over, Mead] Ctr Global Dev, Washington, DC 20036 USA	Population Council	Bongaarts, J (corresponding author), Populat Council, New York, NY 10017 USA.	jbongaarts@popcouncil.org						[Anonymous], AIDS EP UPD DEC 2007; Bongaarts J, 2010, LANCET, V375, P103, DOI 10.1016/S0140-6736(09)61756-6; Clinton Hillary, 2010, COMMUNICATION   0106; Denny CC, 2008, JAMA-J AM MED ASSOC, V300, P2048, DOI 10.1001/jama.2008.556; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; *I MED, 2007, PEPFAR IMPL PROGR PR; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; *OFF US GLOB AIDS, 2008, US PRES EM PLAN AIDS; Over M, 2004, MACROECONOMICS OF HIV/AIDS, P311; Over M., 2010, USING INCENTIVES PRE; OVER M, 2009, REV EC DEV, V23, P107; Over M., 2010, GLOBAL AIDS TRANSITI; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; UNAIDS, 2009, AIDS EP UPD NOV 2009; WHO, 2009, UN ACC; World Bank, 2009, IMPROVING EFFECTIVENESS AND OUTCOMES FOR THE POOR IN HEALTH, NUTRITION, AND POPULATION: AN EVALUATION OF WORLD BANK GROUP SUPPORT SINCE 1997, P1, DOI 10.1596/978-0-8213-7542-6; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2009, RAP ADV ANT THER HIV	20	33	33	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1359	1360		10.1126/science.1191804	http://dx.doi.org/10.1126/science.1191804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608PO	20538936				2022-12-28	WOS:000278598400023
J	McPhee, CK; Baehrecke, EH				McPhee, Christina K.; Baehrecke, Eric H.			Autophagy Shows Its Animal Side	CELL			English	Editorial Material									[McPhee, Christina K.; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	eric.baehrecke@umassmed.edu		Kary, Christina/0000-0002-2586-4185	NIGMS NIH HHS [R01 GM079431] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	7	2	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					922	924		10.1016/j.cell.2010.05.036	http://dx.doi.org/10.1016/j.cell.2010.05.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550928	Bronze, Green Accepted			2022-12-28	WOS:000278618800007
J	Oreskes, N; Conway, EM				Oreskes, Naomi; Conway, Erik M.			Defeating the merchants of doubt	NATURE			English	Editorial Material									[Oreskes, Naomi] Univ Calif San Diego, La Jolla, CA 92093 USA; [Conway, Erik M.] CALTECH, Pasadena, CA 91109 USA	University of California System; University of California San Diego; California Institute of Technology	Oreskes, N (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	naoreskes@ucsd.edu						Gleick PH, 2010, SCIENCE, V328, P689, DOI 10.1126/science.328.5979.689; GWYNNE P, 1975, NEWSWEEK        0428, V64; HANSEN J, 1981, SCIENCE, V213, P957, DOI 10.1126/science.213.4511.957; Leiserowitz A., 2003, THESIS; Michaels D, 2008, DOUBT IS THEIR PRODU, V1st; *NAT AC SCI ARCH, 1979, EV EV CO2 IND CLIM C; Nisbet MC, 2007, PUBLIC OPIN QUART, V71, P444, DOI 10.1093/poq/nfm031; Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030; Oreskes N., 2010, MERCHANTS DOUBT; Peterson TC, 2008, B AM METEOROL SOC, V89, P1325, DOI 10.1175/2008BAMS2370.1	10	92	93	7	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					686	687		10.1038/465686a	http://dx.doi.org/10.1038/465686a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535183				2022-12-28	WOS:000278551800017
J	Terauchi, A; Johnson-Venkatesh, EM; Toth, AB; Javed, D; Sutton, MA; Umemori, H				Terauchi, Akiko; Johnson-Venkatesh, Erin M.; Toth, Anna B.; Javed, Danish; Sutton, Michael A.; Umemori, Hisashi			Distinct FGFs promote differentiation of excitatory and inhibitory synapses	NATURE			English	Article							PRESYNAPTIC ORGANIZING MOLECULES; SYNAPTIC-TRANSMISSION; GROWTH-FACTOR; BRAIN; INTERNEURONS; LOCALIZATION; EPILEPSY; FAMILY	The differential formation of excitatory (glutamate-mediated) and inhibitory(GABA-mediated) synapses is a critical step for the proper functioning of the brain. An imbalance in these synapses may lead to various neurological disorders such as autism, schizophrenia, Tourette's syndrome and epilepsy(1-4). Synapses are formed through communication between the appropriate synaptic partners(5-8). However, the molecular mechanisms that mediate the formation of specific synaptic types are not known. Here we show that two members of the fibroblast growth factor (FGF) family, FGF22 and FGF7, promote the organization of excitatory and inhibitory presynaptic terminals, respectively, as target-derived presynaptic organizers. FGF22 and FGF7 are expressed by CA3 pyramidal neurons in the hippocampus. The differentiation of excitatory or inhibitory nerve terminals on dendrites of CA3 pyramidal neurons is specifically impaired in mutants lacking FGF22 or FGF7. These presynaptic defects are rescued by postsynaptic expression of the appropriate FGF. FGF22-deficientmice are resistant to epileptic seizures, and FGF7-deficient mice are prone to them, as expected from the alterations in excitatory/inhibitory balance. Differential effects of FGF22 and FGF7 involve both their distinct synaptic localizations and their use of different signalling pathways. These results demonstrate that specific FGFs act as target-derived presynaptic organizers and help to organize specific presynaptic terminals in the mammalian brain.	[Terauchi, Akiko; Johnson-Venkatesh, Erin M.; Toth, Anna B.; Javed, Danish; Sutton, Michael A.; Umemori, Hisashi] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Sutton, Michael A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Umemori, Hisashi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Umemori, H (corresponding author), Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	umemoh@umich.edu	Sutton, Michael/C-6264-2011	Sutton, Michael/0000-0002-0692-6459; Umemori, Hisashi/0000-0001-7198-2062	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr Foundation; March of Dimes Foundation; Whitehall Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070005] Funding Source: NIH RePORTER	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr Foundation; March of Dimes Foundation(March of Dimes); Whitehall Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Sanes and M. Hortsch for critical comments on the manuscript; M. Webb and P. Woodhams for the antibody Py; D. Sorenson for help with electron microscopy; A. Murayama for plasmid construction; M. De Freitas for help with histology; and M. Zhang for technical assistance. This work was supported by the Ester A. & Joseph Klingenstein Fund, the Edward Mallinckrodt Jr Foundation, the March of Dimes Foundation and the Whitehall Foundation (H. U.).	Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Goslin K., 1998, CULTURING NERVE CELL, P339; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	25	139	144	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					783	U8		10.1038/nature09041	http://dx.doi.org/10.1038/nature09041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20505669	Green Accepted			2022-12-28	WOS:000278551800046
J	Gustafson, JL; Lim, D; Miller, SJ				Gustafson, Jeffrey L.; Lim, Daniel; Miller, Scott J.			Dynamic Kinetic Resolution of Biaryl Atropisomers via Peptide-Catalyzed Asymmetric Bromination	SCIENCE			English	Article							ORGANIC-SYNTHESIS; N-BROMOSUCCINIMIDE; METAL-COMPLEXES; DIMETHYLFORMAMIDE; STEREOCHEMISTRY; RACEMIZATION; DERIVATIVES; CONVERSION; DIPHENYLS; MILD	Despite the widespread use of axially chiral, or atropisomeric, biaryl ligands in modern synthesis and the occurrence of numerous natural products exhibiting axial chirality, few catalytic methods have emerged for the direct asymmetric preparation of this compound class. Here, we present a tripeptide-derived small-molecule catalyst for the dynamic kinetic resolution of racemic biaryl substrates. The reaction proceeds via an atropisomer-selective electrophilic aromatic substitution reaction using simple bromination reagents. The result is an enantioselective synthesis that delivers chiral nonracemic biaryl compounds with excellent optical purity and good isolated chemical yields (in most cases a >95:5 enantiomer ratio and isolated yields of 65 to 87%). A mechanistic model is advanced that accounts for the basis of selectivity observed.	[Gustafson, Jeffrey L.; Lim, Daniel; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Miller, SJ (corresponding author), Yale Univ, Dept Chem, 225 Prospect St,POB 208107, New Haven, CT 06520 USA.	scott.miller@yale.edu	Miller, Scott/N-7761-2017	Miller, Scott/0000-0001-7817-1318	National Institute of General Medical Sciences of the NIH [GM068649]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068649, R37GM068649] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the National Institute of General Medical Sciences of the NIH for support (GM068649). Metrical parameters for the solid state structure of compound 3d are available free of charge from the Cambridge Crystallographic Data Centre under CCDC-773872.	Adams R, 1933, CHEM REV, V12, P261, DOI 10.1021/cr60042a003; Ahmad SM, 2007, TETRAHEDRON LETT, V48, P915, DOI 10.1016/j.tetlet.2006.12.042; BOTT G, 1980, J AM CHEM SOC, V102, P5618, DOI 10.1021/ja00537a036; Bringmann G, 2001, ACCOUNTS CHEM RES, V34, P615, DOI 10.1021/ar000106z; Bringmann G, 2005, ANGEW CHEM INT EDIT, V44, P5384, DOI 10.1002/anie.200462661; Clayden J, 2009, ANGEW CHEM INT EDIT, V48, P6398, DOI 10.1002/anie.200901719; Clayden J, 2009, J AM CHEM SOC, V131, P5331, DOI 10.1021/ja900722q; Davie EAC, 2007, CHEM REV, V107, P5759, DOI 10.1021/cr068377w; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Eliel E. N., 1994, STEREOCHEMISTRY ORGA; France S, 2005, EUR J ORG CHEM, V2005, P475, DOI 10.1002/ejoc.200400517; Haque TS, 1996, J AM CHEM SOC, V118, P6975, DOI 10.1021/ja960429j; HAYASHI T, 1988, J AM CHEM SOC, V110, P8153, DOI 10.1021/ja00232a030; JOHNSON F, 1968, CHEM REV, V68, P375, DOI 10.1021/cr60254a001; Kakiuchi F, 2000, TETRAHEDRON-ASYMMETR, V11, P2647, DOI 10.1016/S0957-4166(00)00244-5; KENDE AS, 1976, J AM CHEM SOC, V98, P267, DOI 10.1021/ja00417a060; Kenner J, 1921, J CHEM SOC, V119, P593, DOI 10.1039/ct9211900593; Lewis CA, 2008, J AM CHEM SOC, V130, P16358, DOI 10.1021/ja807120z; Li XL, 2003, J ORG CHEM, V68, P5500, DOI 10.1021/jo0340206; Littke AF, 2000, J AM CHEM SOC, V122, P4020, DOI 10.1021/ja0002058; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; MEYERS AI, 1985, J AM CHEM SOC, V107, P682, DOI 10.1021/ja00289a023; Miller SJ, 2004, ACCOUNTS CHEM RES, V37, P601, DOI 10.1021/ar030061c; MITCHELL RH, 1979, J ORG CHEM, V44, P4733, DOI 10.1021/jo00393a066; NOYORI R, 1995, B CHEM SOC JPN, V68, P36, DOI 10.1246/bcsj.68.36; NOYORI R, 1990, ACCOUNTS CHEM RES, V23, P345, DOI 10.1021/ar00178a005; Sakakura A, 2007, NATURE, V445, P900, DOI 10.1038/nature05553; Seebach D, 1997, TETRAHEDRON, V53, P7539, DOI 10.1016/S0040-4020(97)00456-0; SHINDO M, 1992, J AM CHEM SOC, V114, P8732, DOI 10.1021/ja00048a074; Steinreiber J, 2008, CHEM-EUR J, V14, P8060, DOI 10.1002/chem.200701643; Stoughton RW, 1932, J AM CHEM SOC, V54, P4426, DOI 10.1021/ja01350a046; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Yin JJ, 2000, J AM CHEM SOC, V122, P12051, DOI 10.1021/ja005622z; Zhang W, 2009, J AM CHEM SOC, V131, P3832, DOI 10.1021/ja8099008	34	314	314	5	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1251	1255		10.1126/science.1188403	http://dx.doi.org/10.1126/science.1188403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	605AC	20522769	Green Accepted			2022-12-28	WOS:000278318600027
J	Nisbet, E; Weiss, R				Nisbet, Euan; Weiss, Ray			Top-Down Versus Bottom-Up	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2 MEASUREMENTS; QUANTIFY REGIONAL FLUXES; EMISSIONS; INVENTORIES; SENSITIVITY; INVERSION; MODELS; LEARN; CH4		[Nisbet, Euan] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Weiss, Ray] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of London; Royal Holloway University London; University of California System; University of California San Diego; Scripps Institution of Oceanography	Nisbet, E (corresponding author), Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England.	e.nisbet@es.rhul.ac.uk; rfweiss@ucsd.edu			Natural Environment Research Council [NE/F006160/1] Funding Source: researchfish; NERC [NE/F006160/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bergamaschi P, 2005, ATMOS CHEM PHYS, V5, P2431, DOI 10.5194/acp-5-2431-2005; Carouge C, 2010, ATMOS CHEM PHYS, V10, P3119, DOI 10.5194/acp-10-3119-2010; Carouge C, 2010, ATMOS CHEM PHYS, V10, P3107, DOI 10.5194/acp-10-3107-2010; Chen YH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006058; Committee on Methods for Estimating Greenhouse Gas Emissions, 2010, VER GREENH GAS EM ME; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; Levin I, 2010, ATMOS CHEM PHYS, V10, P2655, DOI 10.5194/acp-10-2655-2010; Levin I, 2008, NATURWISSENSCHAFTEN, V95, P203, DOI 10.1007/s00114-007-0313-4; Lowry D, 2001, J GEOPHYS RES-ATMOS, V106, P7427, DOI 10.1029/2000JD900601; Marquis M, 2008, SCIENCE, V320, P460, DOI 10.1126/science.1156451; Muhle J., 2010, ATMOS CHEM PHYS DISC, V10, P6485, DOI DOI 10.5194/ACPD-10-6485-2010; Pison I, 2009, ATMOS CHEM PHYS, V9, P5281, DOI 10.5194/acp-9-5281-2009; Rodenbeck C, 2009, ATMOS CHEM PHYS, V9, P5331; *ROYAL ASTR SOC, ROYAL ASTR SOC WORKS; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Stohl A, 2009, ATMOS CHEM PHYS, V9, P1597, DOI 10.5194/acp-9-1597-2009; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; Vetter M, 2008, BIOGEOSCIENCES, V5, P561, DOI 10.5194/bg-5-561-2008; Weiss RF, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035913	19	98	99	12	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1241	1243		10.1126/science.1189936	http://dx.doi.org/10.1126/science.1189936			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522765				2022-12-28	WOS:000278318600022
J	Lauer, MS; Collins, FS				Lauer, Michael S.; Collins, Francis S.			Using Science to Improve the Nation's Health System NIH's Commitment to Comparative Effectiveness Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIAL		[Collins, Francis S.] NIH, Off Director, Bethesda, MD 20892 USA; [Lauer, Michael S.] NHLBI, Off Director, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Collins, FS (corresponding author), NIH, Off Director, Bldg 10, Bethesda, MD 20892 USA.	collinsf@mail.nih.gov	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				Althabe F, 2008, NEW ENGL J MED, V358, P1929, DOI 10.1056/NEJMsa071456; [Anonymous], 2020, RES C DE LIST OFF PA; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Collins FS, 2010, SCIENCE, V327, P36, DOI 10.1126/science.1185055; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Institute of Medicine, 2009, IN PRIOR COMP EFF RE; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Peterson ED, 2005, JAMA-J AM MED ASSOC, V294, P369, DOI 10.1001/jama.294.3.369; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	10	78	80	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2182	2183		10.1001/jama.2010.726	http://dx.doi.org/10.1001/jama.2010.726			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516419				2022-12-28	WOS:000278182100027
J	de Monvel, JB; Petit, C				de Monvel, Jacques Boutet; Petit, Christine			Wrapping up Stereocilia Rootlets	CELL			English	Editorial Material							COCHLEAR HAIR-CELLS; MUTATIONS; MEMBRANE; PROTEIN; ENCODES; TRIOBP		[de Monvel, Jacques Boutet; Petit, Christine] Inst Pasteur, Dept Neurosci, Unite Genet & Physiol Audit, F-75724 Paris 15, France; [de Monvel, Jacques Boutet; Petit, Christine] INSERM, UMRS 587, Paris, France; [Petit, Christine] Univ Paris 06, Paris, France; [Petit, Christine] Coll France, F-75231 Paris 05, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; College de France	Petit, C (corresponding author), Inst Pasteur, Dept Neurosci, Unite Genet & Physiol Audit, F-75724 Paris 15, France.	christine.petit@pasteur.fr		Boutet de Monvel, Jacques/0000-0001-6182-3527; Petit, Christine/0000-0002-9069-002X				Etournay R, 2010, DEVELOPMENT, V137, P1373, DOI 10.1242/dev.045138; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; HOWARD J, 1986, HEARING RES, V23, P93, DOI 10.1016/0378-5955(86)90178-4; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; LIBERMAN MC, 1987, HEARING RES, V26, P45, DOI 10.1016/0378-5955(87)90035-9; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380	9	8	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					748	750		10.1016/j.cell.2010.05.022	http://dx.doi.org/10.1016/j.cell.2010.05.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510920	Bronze			2022-12-28	WOS:000278132900008
J	Marti, K; Kerridge, J				Marti, Kurt; Kerridge, John			Nitrogen in the Solar System	SCIENCE			English	Editorial Material							RATIO		[Marti, Kurt; Kerridge, John] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Marti, K (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	jkerridg@ucsd.edu						Abbas MM, 2004, ASTROPHYS J, V602, P1063, DOI 10.1086/381084; Bizzocchi L, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913835; Briani G, 2009, P NATL ACAD SCI USA, V106, P10522, DOI 10.1073/pnas.0901546106; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; Gerin M, 2009, ASTRON ASTROPHYS, V498, pL9, DOI 10.1051/0004-6361/200911759; KALLIO APA, 2010, 41 LUN PLAN SCI C WO; KERRIDGE JF, 1993, REV GEOPHYS, V31, P423, DOI 10.1029/93RG01953; KIM JS, 1995, NATURE, V375, P383, DOI 10.1038/375383a0; Marty B, 2010, GEOCHIM COSMOCHIM AC, V74, P340, DOI 10.1016/j.gca.2009.09.007; Mathew KJ, 1998, GEOPHYS RES LETT, V25, P4293, DOI 10.1029/1998GL900181; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; Wieler R, 1999, EARTH PLANET SC LETT, V167, P47, DOI 10.1016/S0012-821X(99)00012-6	12	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1112	1113		10.1126/science.1189836	http://dx.doi.org/10.1126/science.1189836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508118				2022-12-28	WOS:000278104700028
J	Sarmiento, EE				Sarmiento, Esteban E.			Comment on the Paleobiology and Classification of Ardipithecus ramidus	SCIENCE			English	Editorial Material							TIME-SCALE; HUMANS; SPECIATION	White and colleagues (Research Articles, 2 October 2009, pp. 64-106 and www.sciencemag.org/ardipithecus) reported Ardipithecus ramidus as an exclusive member of the human lineage post-African ape divergence. However, their analysis of shared-derived characters provides insufficient evidence of an ancestor-descendant relationship and exclusivity to the hominid lineage. Molecular and anatomical studies rather suggest that Ar. ramidus predates the human/African ape divergence.	Human Evolut Fdn, E Brunswick, NJ 08816 USA		Sarmiento, EE (corresponding author), Human Evolut Fdn, E Brunswick, NJ 08816 USA.	este444@yahoo.com						Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Louchart A, 2009, SCIENCE, V326, DOI 10.1126/science.1175823; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; Sarmiento E.E., 1995, Human Evolution, V10, P289, DOI 10.1007/BF02438967; SARMIENTO EE, 2002, NEW ANATOMIST, V269, P50; SARMIENTO EE, 1987, AM MUS NOVIT, P1; Sarmiento Esteban E., 1998, American Museum Novitates, V3250, P1; Sarmiento Esteban E., 1994, American Museum Novitates, V3091, P1; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; Tattersall Ian, 1993, P163; Wheeler QD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P55; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WILSON AC, 1969, P NATL ACAD SCI USA, V63, P1088, DOI 10.1073/pnas.63.4.1088; WoldeGabriel G, 2009, SCIENCE, V326, DOI 10.1126/science.1175817; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389	27	25	26	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982								10.1126/science.1184148	http://dx.doi.org/10.1126/science.1184148			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508113				2022-12-28	WOS:000278104700020
J	Grasko, JM; Nguyen, HH; Glendenning, P				Grasko, Jonathan M.; Nguyen, Hieu H.; Glendenning, Paul			Lesson of the Week Delayed diagnosis of primary hyperaldosteronism	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY ALDOSTERONISM; RENIN RATIO; HYPERTENSION		[Grasko, Jonathan M.; Glendenning, Paul] Royal Perth Hosp, Dept Core Clin Pathol & Biochem, PathWest Lab Med WA, Perth, WA 6847, Australia; [Nguyen, Hieu H.] Sir Charles Gairdner Hosp, Dept Gen Surg, Perth, WA, Australia; [Glendenning, Paul] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia	Glendenning, P (corresponding author), Royal Perth Hosp, Dept Core Clin Pathol & Biochem, PathWest Lab Med WA, Perth, WA 6847, Australia.	paul.glendenning@health.wa.gov.au						Brown MJ, 1999, POSTGRAD MED J, V75, P235, DOI 10.1136/pgmj.75.882.235; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fiad TM, 1997, J CLIN ENDOCR METAB, V82, P457, DOI 10.1210/jc.82.2.457; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Glendenning P, 2002, PATHOLOGY, V34, P297, DOI 10.1080/00313020212464; Gordon RD, 2004, J HYPERTENS, V22, P251, DOI 10.1097/00004872-200402000-00006; Handrock R, 1999, J PHYSIOL-LONDON, V521, P31, DOI 10.1111/j.1469-7793.1999.00031.x; Lezoche E, 2008, SURG ENDOSC, V22, P522, DOI 10.1007/s00464-007-9555-7; Lim PO, 2003, CLIN ENDOCRINOL, V59, P427, DOI 10.1046/j.1365-2265.2003.01841.x; Mosso L, 2003, HYPERTENSION, V42, P161, DOI 10.1161/01.HYP.0000079505.25750.11; Mulatero P, 2002, HYPERTENSION, V40, P897, DOI 10.1161/01.HYP.0000038478.59760.41; Nadar S, 2003, ANN CLIN BIOCHEM, V40, P439, DOI 10.1258/000456303322326362; National Heart Foundation of Australia, GUID MAN HYP 2008; Stowasser M, 2009, J CLIN ENDOCR METAB, V94, P3623, DOI 10.1210/jc.2009-1399; Tiu SC, 2005, J CLIN ENDOCR METAB, V90, P72, DOI 10.1210/jc.2004-1149; Torre Joseph J, 2006, Endocr Pract, V12, P193; Williams JS, 2006, J HUM HYPERTENS, V20, P129, DOI 10.1038/sj.jhh.1001948; Yokoyama T, 1995, Nihon Naibunpi Gakkai Zasshi, V71, P1059; Young WF, 2007, CLIN ENDOCRINOL, V66, P607, DOI 10.1111/j.1365-2265.2007.02775.x	20	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2010	340								c2461	10.1136/bmj.c2461	http://dx.doi.org/10.1136/bmj.c2461			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604LB	20501556				2022-12-28	WOS:000278279400003
J	Levison, HF; Duncan, MJ; Brasser, R; Kaufmann, DE				Levison, Harold F.; Duncan, Martin J.; Brasser, Ramon; Kaufmann, David E.			Capture of the Sun's Oort Cloud from Stars in Its Birth Cluster	SCIENCE			English	Article							SOLAR-SYSTEM; ORIGIN; EVOLUTION; OBJECTS; COMETS	Oort cloud comets are currently believed to have formed in the Sun's protoplanetary disk and to have been ejected to large heliocentric orbits by the giant planets. Detailed models of this process fail to reproduce all of the available observational constraints, however. In particular, the Oort cloud appears to be substantially more populous than the models predict. Here we present numerical simulations that show that the Sun captured comets from other stars while it was in its birth cluster. Our results imply that a substantial fraction of the Oort cloud comets, perhaps exceeding 90%, are from the protoplanetary disks of other stars.	[Levison, Harold F.; Kaufmann, David E.] SW Res Inst, Boulder, CO 80302 USA; [Duncan, Martin J.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Brasser, Ramon] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Dept Cassiope, Nice, France	Queens University - Canada; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Levison, HF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	hal@boulder.swri.edu	Levison, Harold F/C-6061-2013	Levison, Harold F/0000-0001-5847-8099	NASA's Astrobiology Institute; NASA; Isaac Newton Institute at Cambridge University; Natural Sciences and Engineering Research Council, Canada; Germany's Helmholz Alliance	NASA's Astrobiology Institute; NASA(National Aeronautics & Space Administration (NASA)); Isaac Newton Institute at Cambridge University; Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Germany's Helmholz Alliance	We thank A. Morbidelli and L. Dones for useful discussions. This work was supported by NASA's Astrobiology Institute through a grant to the Goddard Center for Astrobiology. H. F. L. is grateful to NASA for funding through its Operational Support Services and Outer Planets Research programs. M.J.D. is grateful for the hospitality and financial support of the Isaac Newton Institute at Cambridge University, where some of this work was performed. M.J.D. acknowledges the continuing financial support of the Natural Sciences and Engineering Research Council, Canada. R. B. thanks Germany's Helmholz Alliance for financial support.	Adams FC, 2006, ASTROPHYS J, V641, P504, DOI 10.1086/500393; CLARKE CJ, 1993, MON NOT R ASTRON SOC, V261, P190, DOI 10.1093/mnras/261.1.190; Dones L, 2004, SPACE SCI S, P153; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; Eggers S, 1997, PLANET SPACE SCI, V45, P1099, DOI 10.1016/S0032-0633(97)00065-2; Kaib NA, 2009, SCIENCE, V325, P1234, DOI 10.1126/science.1172676; Kenyon SJ, 2004, NATURE, V432, P598, DOI 10.1038/nature03136; Kouwenhoven MBN, 2010, MON NOT R ASTRON SOC, V404, P1835, DOI 10.1111/j.1365-2966.2010.16399.x; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Levison HF, 2010, ASTRON J, V139, P1297, DOI 10.1088/0004-6256/139/4/1297; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; Paulech T, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200912712; Thommes EW, 1999, NATURE, V402, P635, DOI 10.1038/45185; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; WEISSMAN PR, 1996, ASTRONOMICAL SOC PAC, V265, P106; Zheng JQ, 1990, CELEST MECH DYN ASTR, V49, P265, DOI 10.1007/BF00049417	17	122	124	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					187	190		10.1126/science.1187535	http://dx.doi.org/10.1126/science.1187535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20538912				2022-12-28	WOS:000279635200040
J	D'Anastasio, R; Di Silvestro, G; Versacci, P; Capasso, L; Marino, B				D'Anastasio, Ruggero; Di Silvestro, Gianpaolo; Versacci, Paolo; Capasso, Luigi; Marino, Bruno			The Heart of Santa Rosa	LANCET			English	Editorial Material									[D'Anastasio, Ruggero; Capasso, Luigi] State Univ G dAnnunzio, Sect Anthropol, Dept Human Movement Sci, I-66100 Chieti, Italy; [Di Silvestro, Gianpaolo] State Univ Modena, Sch Doctorate, Modena, Italy; [Versacci, Paolo; Marino, Bruno] Univ Roma La Sapienza, Dept Paediat, Rome, Italy	G d'Annunzio University of Chieti-Pescara; Sapienza University Rome	D'Anastasio, R (corresponding author), State Univ G dAnnunzio, Sect Anthropol, Dept Human Movement Sci, Piazza Trento & Trieste 1, I-66100 Chieti, Italy.	r.danastasio@unich.it		VERSACCI, PAOLO/0000-0002-4484-4729				Capasso L, 1999, LANCET, V353, P504, DOI 10.1016/S0140-6736(05)75184-9	1	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2168	2168		10.1016/S0140-6736(09)60729-7	http://dx.doi.org/10.1016/S0140-6736(09)60729-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20541795	Bronze			2022-12-28	WOS:000279255100027
J	Langston, RF; Ainge, JA; Couey, JJ; Canto, CB; Bjerknes, TL; Witter, MP; Moser, EI; Moser, MB				Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Development of the Spatial Representation System in the Rat	SCIENCE			English	Article							ENTORHINAL CORTEX; PLACE CELLS; GRID CELLS; PATH-INTEGRATION; MAP; MODEL; HIPPOCAMPUS; DIRECTION	In the adult brain, space and orientation are represented by an elaborate hippocampal-parahippocampal circuit consisting of head-direction cells, place cells, and grid cells. We report that a rudimentary map of space is already present when 21/2-week-old rat pups explore an open environment outside the nest for the first time. Head-direction cells in the pre- and parasubiculum have adultlike properties from the beginning. Place and grid cells are also present but evolve more gradually. Grid cells show the slowest development. The gradual refinement of the spatial representation is accompanied by an increase in network synchrony among entorhinal stellate cells. The presence of adultlike directional signals at the onset of navigation raises the possibility that such signals are instrumental in setting up networks for place and grid representation.	[Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, Med Tech Res Ctr, N-7489 Trondheim, Norway; [Ainge, James A.] Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of St Andrews	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Ainge, James A/D-5831-2012; Couey, Jonathan/GXG-6340-2022	Ainge, James A/0000-0002-0007-1533; Langston, Rosamund/0000-0002-4668-3105; Bjerknes, Tale Litlere/0000-0001-7518-5132; Couey, Jonathan/0000-0003-2658-692X	European Commission; Kavli Foundation; Research Council of Norway	European Commission(European CommissionEuropean Commission Joint Research Centre); Kavli Foundation; Research Council of Norway(Research Council of Norway)	We thank R. Skjerpeng for programming; C. N. Boccara for sharing adult pre- and parasubiculum data; and A. M. Amundsgard, K. Haugen, K. Jenssen, H. Waade, and T. Asmul for technical assistance. Supported by Fondation Bettencourt-Schueller, Seventh Framework Programme of the European Commission (SPACEBRAIN), Kavli Foundation, and a Centre of Excellence grant from the Research Council of Norway.	BOCCARA CN, 2008, SOC NEUROSCI ABSTR, V34; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Kant I., 1781, KRITIK REINEN VERNUN; Martin PD, 2002, HIPPOCAMPUS, V12, P465, DOI 10.1002/hipo.10021; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420	20	390	396	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1576	1580		10.1126/science.1188210	http://dx.doi.org/10.1126/science.1188210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558721				2022-12-28	WOS:000278859200052
J	Nicholls, RJ; Cazenave, A				Nicholls, Robert J.; Cazenave, Anny			Sea-Level Rise and Its Impact on Coastal Zones	SCIENCE			English	Review							CLIMATE-CHANGE; MASS-BALANCE; ICE; FUTURE	Global sea levels have risen through the 20th century. These rises will almost certainly accelerate through the 21st century and beyond because of global warming, but their magnitude remains uncertain. Key uncertainties include the possible role of the Greenland and West Antarctic ice sheets and the amplitude of regional changes in sea level. In many areas, nonclimatic components of relative sea-level change (mainly subsidence) can also be locally appreciable. Although the impacts of sea-level rise are potentially large, the application and success of adaptation are large uncertainties that require more assessment and consideration.	[Nicholls, Robert J.] Univ Southampton, Sch Civil Engn & Environm, Southampton SO17 1BJ, Hants, England; [Nicholls, Robert J.] Univ Southampton, Tyndall Ctr Climate Change Res, Southampton SO17 1BJ, Hants, England; [Cazenave, Anny] Observ Midi Pyrenees, LEGOS CNES, F-31401 Toulouse 9, France	University of Southampton; University of Southampton	Nicholls, RJ (corresponding author), Univ Southampton, Sch Civil Engn & Environm, Southampton SO17 1BJ, Hants, England.	r.j.nicholls@soton.ac.uk; anny.cazenave@legos.obs-mip.fr	Nicholls, Robert James/G-3898-2010; Nicholls, Robert James/ABD-1481-2020	Nicholls, Robert James/0000-0002-9715-1109; Nicholls, Robert James/0000-0002-9715-1109				Ablain M, 2009, OCEAN SCI, V5, P193, DOI 10.5194/os-5-193-2009; Allison I, 2009, ANTARCT SCI, V21, P413, DOI 10.1017/S0954102009990137; Cazenave A, 2010, ANNU REV MAR SCI, V2, P145, DOI 10.1146/annurev-marine-120308-081105; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; Chen JL, 2009, NAT GEOSCI, V2, P859, DOI 10.1038/ngeo694; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Ericson JP, 2006, GLOBAL PLANET CHANGE, V50, P63, DOI 10.1016/j.gloplacha.2005.07.004; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; Leuliette EW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036010; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Lowe J., 2009, UK CLIMATE PROJECTIO; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Milly P. C. D., 2010, UNDERSTANDING SEA LE, DOI 10. 1002/9781444323276; Milne GA, 2009, NAT GEOSCI, V2, P471, DOI 10.1038/ngeo544; MIMURA N, 2007, CLIMATE CHANGE 2007; Nicholls R.J., 2007, CLIMATE CHANGE 2007; NICHOLLS RJ, 2008, ENV WORKING PAPERS O, V1; Nicholls RJ, 2008, CLIMATIC CHANGE, V91, P171, DOI 10.1007/s10584-008-9424-y; Nicholls RJ, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, P409, DOI 10.1016/B978-0-444-53301-2.00024-5; Nicholls RJ, 2008, SUSTAIN SCI, V3, P89, DOI 10.1007/s11625-008-0050-4; Notz D, 2009, P NATL ACAD SCI USA, V106, P20590, DOI 10.1073/pnas.0902356106; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035417; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Rignot E, 2010, NAT GEOSCI, V3, P187, DOI 10.1038/NGEO765; Solomon S., 2007, PHYS SCI BASIS WORKI; Stammer D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004079; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; SUGIYAMA M, 2008, MIT GLOBAL CHANGE JO; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Van Koningsveld M, 2008, J COASTAL RES, V24, P367, DOI 10.2112/07A-0010.1; Vaughan DG, 2008, CLIMATIC CHANGE, V91, P65, DOI 10.1007/s10584-008-9448-3; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; *WORLD BANK, 2009, EC AD CLIM IN PRESS; Wunsch C, 2007, J CLIMATE, V20, P5889, DOI 10.1175/2007JCLI1840.1	46	1457	1524	35	911	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1517	1520		10.1126/science.1185782	http://dx.doi.org/10.1126/science.1185782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558707				2022-12-28	WOS:000278859200035
J	Zheng, JM; Jia, ZC				Zheng, Jimin; Jia, Zongchao			Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; X-RAY ANALYSIS; PHOSPHORYLATION CYCLE; CRYSTAL-STRUCTURE; PHOSPHATASE; SUBSTRATE; PURIFICATION; ENZYME; CRYSTALLIZATION; RECOGNITION	The Escherichia coli isocitrate dehydrogenase kinase/phosphatase (AceK) is a unique bifunctional enzyme that phosphorylates or dephosphorylates isocitrate dehydrogenase (ICDH) in response to environmental changes, resulting in the inactivation or, respectively, activation of ICDH1. ICDH inactivation short-circuits the Krebs cycle by enabling the glyoxlate bypass(2,3). It was the discovery of AceK and ICDH that established the existence of protein phosphorylation regulation in prokaryotes(1,4). As a 65-kDa protein, AceK is significantly larger than typical eukaryotic protein kinases. Apart from the ATP-binding motif, AceK does not share sequence homology with any eukaryotic protein kinase or phosphatase(5,6). Most intriguingly, AceK possesses the two opposing activities of protein kinase and phosphatase within one protein, and specifically recognizes only intact ICDH7,8. Additionally, AceK has strong ATPase activity(9). It has been shown that AceK kinase, phosphatase and ATPase activities reside at the same site(6,10), although the molecular basis of such multifunctionality and its regulation remains completely unknown. Here we report the structures of AceK and its complex with ICDH. The AceK structure reveals a eukaryotic protein-kinase-like domain containing ATP and a regulatory domain with a novel fold. As an AceK phosphatase activator and kinase inhibitor, AMP is found to bind in an allosteric site between the two AceK domains. An AMP-mediated conformational change exposes and shields ATP, acting as a switch between AceK kinase and phosphatase activities, and ICDH-binding induces further conformational change for AceK activation. The substrate recognition loop of AceK binds to the ICDH dimer, allowing higher-order substrate recognition and interaction, and inducing critical conformational change at the phosphorylation site of ICDH.	[Zheng, Jimin; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Zheng, Jimin] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China	Queens University - Canada; Beijing Normal University	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors would like to thank M. Cygler and A. Matte for help in cloning, L. Li and R. Theiss for help in mutagenesis and activity measurements, and J. Allingham and G. Cote for critical reading of the manuscript. We would also like to thank the staff of the Cornell High Energy Synchrotron Source for helping with the collection of synchrotron X-ray data. This work was supported by the Canadian Institutes of Health Research (Z.J.). Z.J. is a Canada Research Chair in Structural Biology.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNETT PM, 1975, J GEN MICROBIOL, V87, P37, DOI 10.1099/00221287-87-1-37; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HB, 2008, P NATL ACAD SCI USA, V105, P19660, DOI 10.1073/pnas.0807752105; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FinerMoore J, 1997, BIOCHEMISTRY-US, V36, P13890, DOI 10.1021/bi9711691; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; GARNAK M, 1979, J BIOL CHEM, V254, P7915; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOYT JC, 1988, BIOCHEM BIOPH RES CO, V153, P875, DOI 10.1016/S0006-291X(88)81177-X; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; IKEDA T, 1991, J BACTERIOL, V173, P1801, DOI 10.1128/jb.173.5.1801-1806.1991; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KLUMPP DJ, 1988, J BACTERIOL, V170, P2763, DOI 10.1128/jb.170.6.2763-2769.1988; KORNBERG HL, 1966, BIOCHEM J, V99, P1; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; LAPORTE DC, 1989, BIOCHIMIE, V71, P1051, DOI 10.1016/0300-9084(89)90110-7; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; MCKEE JS, 1989, BIOCHIMIE, V71, P1059, DOI 10.1016/0300-9084(89)90111-9; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller SP, 1996, J BIOL CHEM, V271, P19124, DOI 10.1074/jbc.271.32.19124; Miller SP, 2000, J BIOL CHEM, V275, P833, DOI 10.1074/jbc.275.2.833; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STUELAND CS, 1988, J BIOL CHEM, V263, P19475; STUELAND CS, 1987, J BIOL CHEM, V262, P16095; STUELAND CS, 1989, J BIOL CHEM, V264, P13775; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P1153, DOI 10.1107/S1744309109038718; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	39	54	57	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					961	U16		10.1038/nature09088	http://dx.doi.org/10.1038/nature09088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20505668				2022-12-28	WOS:000278804500045
J	Fletcher, RH				Fletcher, Robert H.			Immunochemical FOBT had higher participation and detection rates than guaiac-based FOBT for colorectal cancer screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COLONOSCOPY		Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.							Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-2	10.7326/0003-4819-152-12-201006150-02002	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547896				2022-12-28	WOS:000278827700023
J	Moist, L				Moist, Louise			Stent grafts were more effective than balloon angioplasty alone for revision of stenosis in failing dialysis-access grafts	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Western Ontario, London, ON, Canada	Western University (University of Western Ontario)	Moist, L (corresponding author), Univ Western Ontario, London, ON, Canada.							Lumsden AB, 1997, J VASC SURG, V26, P382, DOI 10.1016/S0741-5214(97)70031-4; Tonelli M, 2008, AM J KIDNEY DIS, V51, P630, DOI 10.1053/j.ajkd.2007.11.025; *VASC ACC WORK GRO, 2006, AM J KIDNEY DIS S, V48, pS248, DOI DOI 10.1053/J.AJKD.2006.04.040.MEDLINE	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-8	10.7326/0003-4819-152-12-201006150-02008	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547902				2022-12-28	WOS:000278827700029
J	Uyanik, M; Okamoto, H; Yasui, T; Ishihara, K				Uyanik, Muhammet; Okamoto, Hiroaki; Yasui, Takeshi; Ishihara, Kazuaki			Quaternary Ammonium (Hypo)iodite Catalysis for Enantioselective Oxidative Cycloetherification	SCIENCE			English	Article							ABSOLUTE-CONFIGURATIONS; CHEMICAL-CONSTITUENTS; TREMETONE; DEAROMATIZATION; CYCLIZATION; IODOARENES; COMPLEXES; AGONISTS; IODINE; POTENT	It is desirable to minimize the use of rare or toxic metals for oxidative reactions in the synthesis of pharmaceutical products. Hypervalent iodine compounds are environmentally benign alternatives, but their catalytic use, particularly for asymmetric transformations, has been quite limited. We report here an enantioselective oxidative cycloetherification of ketophenols to 2-acyl-2,3-dihydrobenzofuran derivatives, catalyzed by in situ-generated chiral quaternary ammonium (hypo)iodite salts, with hydrogen peroxide as an environmentally benign oxidant. The optically active 2-acyl 2,3-dihydrobenzofuran skeleton is a key structure in several biologically active compounds.	[Uyanik, Muhammet; Okamoto, Hiroaki; Yasui, Takeshi; Ishihara, Kazuaki] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishihara, Kazuaki] Japan Sci & Technol Agcy, Chikusa Ku, Nagoya, Aichi 4638603, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Ishihara, K (corresponding author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	ishihara@cc.nagoya-u.ac.jp	Uyanik, Muhammet/E-1533-2011; Yasui, Takeshi/M-7378-2019	Uyanik, Muhammet/0000-0002-9751-1952; Yasui, Takeshi/0000-0002-7630-8736	Japan Society for the Promotion of Science [20245022]; New Energy and Industrial Technology Development Organization; Shionogi Award in Synthetic Organic Chemistry, Japan; Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Shionogi Award in Synthetic Organic Chemistry, Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this project was partially provided by a Grant-in-Aid for Scientific Research (#20245022) from the Japan Society for the Promotion of Science, the New Energy and Industrial Technology Development Organization, the Shionogi Award in Synthetic Organic Chemistry, Japan, and the Global Centers of Excellence Program in Chemistry of Nagoya University from the Ministry of Education, Culture, Sports, Science and Technology.	Altermann SM, 2008, EUR J ORG CHEM, V2008, P5315, DOI 10.1002/ejoc.200800741; Banskota AH, 1998, J NAT PROD, V61, P896, DOI 10.1021/np980028c; BONNER WA, 1964, TETRAHEDRON, V20, P1419, DOI 10.1016/S0040-4020(01)99135-5; BOWEN DM, 1963, J MED CHEM, V6, P315, DOI 10.1021/jm00339a023; Cespedes CL, 2002, J AGR FOOD CHEM, V50, P2283, DOI 10.1021/jf011108g; Chu GH, 2005, BIOORG MED CHEM LETT, V15, P5114, DOI 10.1016/j.bmcl.2005.08.094; Cohen JL, 2006, BIOORG MED CHEM LETT, V16, P2189, DOI 10.1016/j.bmcl.2006.01.047; Dohi T, 2008, ANGEW CHEM INT EDIT, V47, P3787, DOI 10.1002/anie.200800464; Dohi T, 2009, CHEM COMMUN, P2073, DOI 10.1039/b821747e; Duan JA, 2008, ARCH PHARM RES, V31, P965, DOI 10.1007/s12272-001-1252-z; Evans DA, 2007, J AM CHEM SOC, V129, P10029, DOI 10.1021/ja072976i; Ito C, 2006, J NAT PROD, V69, P138, DOI 10.1021/np050341w; KAWASE Y, 1980, CHEM LETT, P1581, DOI 10.1246/cl.1980.1581; MATSUZAKI I, 1974, CHEM LETT, P1463, DOI 10.1246/cl.1974.1463; Ochiai M, 2008, EUR J ORG CHEM, V2008, P4229, DOI 10.1002/ejoc.200800416; Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737; Pelly SC, 2007, J ORG CHEM, V72, P2857, DOI 10.1021/jo062447h; Quideau S, 2009, ANGEW CHEM INT EDIT, V48, P4605, DOI 10.1002/anie.200901039; Shi GQ, 2005, J MED CHEM, V48, P5589, DOI 10.1021/jm050373g; Tanaka S, 2009, ANGEW CHEM INT EDIT, V48, P8948, DOI 10.1002/anie.200904671; Trend RM, 2003, ANGEW CHEM INT EDIT, V42, P2892, DOI 10.1002/anie.200351196; Uozumi Y, 1997, J AM CHEM SOC, V119, P5063, DOI 10.1021/ja9701366; Uyanik M, 2010, ANGEW CHEM INT EDIT, V49, P2175, DOI 10.1002/anie.200907352; Wirth T., 2003, TOPICS CURRENT CHEM, V224; YAMADA S, 1992, TETRAHEDRON LETT, V33, P4329, DOI 10.1016/S0040-4039(00)74252-3; Yamaguchi S, 2003, J ORG CHEM, V68, P6274, DOI 10.1021/jo034396j; Zhdankin VV, 2008, CHEM REV, V108, P5299, DOI 10.1021/cr800332c	27	361	362	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1376	1379		10.1126/science.1188217	http://dx.doi.org/10.1126/science.1188217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	608PO	20538945				2022-12-28	WOS:000278598400032
J	Zhou, W; Jan, L				Zhou, Wei; Jan, Lily			A Twist on Potassium Channel Gating	CELL			English	Editorial Material							K+ CHANNELS; RECTIFICATION; SELECTIVITY		[Zhou, Wei; Jan, Lily] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, L (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498				Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859	8	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					920	922		10.1016/j.cell.2010.05.038	http://dx.doi.org/10.1016/j.cell.2010.05.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550927	Bronze			2022-12-28	WOS:000278618800006
J	Brown, JR; O'Connor, GT				Brown, Jeremiah R.; O'Connor, Gerald T.			Focus on Research: Coronary Heart Disease and Prevention in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material															AHRQ HHS [K01 HS018443] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018443] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Centers for Disease Control and Prevention, 2005, MOV ACT PROM HEART H; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; van Dam RM, 2009, CIRCULATION, V120, P1171, DOI 10.1161/CIRCULATIONAHA.109.891507	4	51	52	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2150	2153		10.1056/NEJMp1003880	http://dx.doi.org/10.1056/NEJMp1003880			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608AL	20558365				2022-12-28	WOS:000278551500003
J	Dulac, C				Dulac, Catherine			Brain function and chromatin plasticity	NATURE			English	Review							DNA METHYLATION; GENE-EXPRESSION; HISTONE ACETYLATION; IMPRINTED GENES; NEURONAL-ACTIVITY; MEMORY FORMATION; RETT-SYNDROME; MECP2; DISEASE; STRESS	The characteristics of epigenetic control, including the potential for long-lasting, stable effects on gene expression that outlive an initial transient signal, could be of singular importance for post-mitotic neurons, which are subject to changes with short-to long-lasting influence on their activity and connectivity. Persistent changes in chromatin structure are thought to contribute to mechanisms of epigenetic inheritance. Recent advances in chromatin biology offer new avenues to investigate regulatory mechanisms underlying long-lasting changes in neurons, with direct implications for the study of brain function, behaviour and diseases.	Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, 16 Divin Ave, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu		Dulac, Catherine/0000-0001-5024-5418	Howard Hughes Medical Institute; Klarman Family Foundation; National Institutes of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903, R01DC009019] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	I thank R. Hellmiss for the original illustrations, F. Meale for help with the manuscript, and N. Francis, M. Ptashne, D. Schubeler and members of the laboratory for insights and discussions. My research is supported by the Howard Hughes Medical Institute, the Klarman Family Foundation and the National Institutes of Health.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DENENBERG VH, 1967, ENDOCRINOLOGY, V81, P1047, DOI 10.1210/endo-81-5-1047; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Keverne EB, 2007, ADV GENET, V59, P217, DOI 10.1016/S0065-2660(07)59008-5; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Kramer JM, 2009, INT J BIOCHEM CELL B, V41, P96, DOI 10.1016/j.biocel.2008.08.009; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; LEVINE S, 1957, SCIENCE, V126, P405, DOI 10.1126/science.126.3270.405; Lim AL, 2010, SEMIN CELL DEV BIOL, V21, P201, DOI 10.1016/j.semcdb.2009.10.008; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Matzke M, 2006, COLD SPRING HARB SYM, V71, P449, DOI 10.1101/sqb.2006.71.028; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Patisaul HB, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.010.2009; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ptak C, 2008, ANNU REV PHARMACOL, V48, P257, DOI 10.1146/annurev.pharmtox.48.113006.094731; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Radman-Livaja M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000837; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Squire L. R., 1987, MEMORY BRAIN; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tamashiro KLK, 2003, EXP BIOL MED, V228, P1193, DOI 10.1177/153537020322801015; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	100	184	189	5	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					728	735		10.1038/nature09231	http://dx.doi.org/10.1038/nature09231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535202	Green Submitted, Green Accepted			2022-12-28	WOS:000278551800035
J	Mayeux, R				Mayeux, Richard			Early Alzheimer's Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; QUALITY STANDARDS SUBCOMMITTEE; GENOME-WIDE ASSOCIATION; CSF BIOMARKERS; IDENTIFIES VARIANTS; MEMANTINE TREATMENT; PRACTICE PARAMETER; AMERICAN-ACADEMY; DOUBLE-BLIND; DEMENTIA		[Mayeux, Richard] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Mayeux, Richard] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA	Columbia University; Columbia University	Mayeux, R (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.	rpm2@columbia.edu	Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696	Quintiles	Quintiles	Dr. Mayeux reports receiving an honorarium from Quintiles for serving on a data and safety monitoring board for a trial of a product manufactured by Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Aggarwal NT, 2005, J NEUROL NEUROSUR PS, V76, P1479, DOI 10.1136/jnnp.2004.053561; Aisen PS, 2008, CURR ALZHEIMER RES, V5, P73, DOI 10.2174/156720508783884602; Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Bakchine S, 2008, J ALZHEIMERS DIS, V13, P97; Clare L., 2003, COCHRANE DB SYST REV, V4, P1, DOI [https://doi.org/10.1002/14651858.CD003260, DOI 10.1002/14651858.CD003260]; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; Dickerson BC, 2007, ARCH GEN PSYCHIAT, V64, P1443, DOI 10.1001/archpsyc.64.12.1443; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Farlow MR, 2007, AM J MED, V120, P388, DOI 10.1016/j.amjmed.2006.08.036; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fripp J, 2008, NEUROIMAGE, V43, P430, DOI 10.1016/j.neuroimage.2008.07.053; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hansen RA, 2008, CLIN INTERV AGING, V3, P211; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hogervorst E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003799.pub2; Hsiung GYR, 2008, DEMENT GERIATR COGN, V25, P483, DOI 10.1159/000126499; Isaac MGEKN, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002854.pub2; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; Kelley BJ, 2008, NEUROLOGIST, V14, P299, DOI 10.1097/NRL.0b013e318172cf4d; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lopez OL, 2003, J NEUROPSYCH CLIN N, V15, P346, DOI 10.1176/appi.neuropsych.15.3.346; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Petersen, 1999, ARCH NEUROL-CHICAGO, V56, P760; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rogaeva E, 2006, J ALZHEIMERS DIS, V9, P381; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Rountree SD, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt7; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Seltzer B, 2004, ARCH NEUROL-CHICAGO, V61, P1852, DOI 10.1001/archneur.61.12.1852; Smach MA, 2009, EUR NEUROL, V62, P349, DOI 10.1159/000241881; Starkstein SE, 2008, INT REV PSYCHIATR, V20, P382, DOI 10.1080/09540260802094480; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Winblad B, 2006, DEMENT GERIATR COGN, V21, P353, DOI 10.1159/000091790; Yuan Y, 2009, AM J NEURORADIOL, V30, P404, DOI 10.3174/ajnr.A1357; Ziegler-Graham K, 2008, ALZHEIMERS DEMENT, V4, P316, DOI 10.1016/j.jalz.2008.05.2479	56	112	120	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2194	2201		10.1056/NEJMcp0910236	http://dx.doi.org/10.1056/NEJMcp0910236			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558370				2022-12-28	WOS:000278551500008
J	Pera, MF; Tam, PPL				Pera, Martin F.; Tam, Patrick P. L.			Extrinsic regulation of pluripotent stem cells	NATURE			English	Review							FIBROBLAST-GROWTH-FACTOR; SELF-RENEWAL; MAINTAINS PLURIPOTENCY; LINEAGE COMMITMENT; BMP INHIBITOR; GROUND-STATE; GERM-LINE; ES CELLS; DIFFERENTIATION; EXPRESSION	During early mammalian development, as the pluripotent cells that give rise to all of the tissues of the body proliferate and expand in number, they pass through transition states marked by a stepwise restriction in developmental potential and by changes in the expression of key regulatory genes. Recent findings show that cultured stem-cell lines derived from different stages of mouse development can mimic these transition states. They further reveal that there is a high degree of heterogeneity and plasticity in pluripotent populations in vitro and that these properties are modulated by extrinsic signalling. Understanding the extrinsic control of plasticity will guide efforts to use human pluripotent stem cells in research and therapy.	[Pera, Martin F.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Tam, Patrick P. L.] Childrens Med Res Inst, Embryol Unit, Westmead, NSW 2145, Australia; [Tam, Patrick P. L.] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia	University of Southern California; Children's Medical Research Institute - Australia; University of Sydney	Pera, MF (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	pera@usc.edu; ptam@cmri.org.au	PERA, MARTIN/A-9812-2012	PERA, MARTIN/0000-0001-6239-0428				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chase LG, 2007, CURR OPIN CHEM BIOL, V11, P367, DOI 10.1016/j.cbpa.2007.06.421; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eakin GS, 2004, SEMIN CELL DEV BIOL, V15, P619, DOI 10.1016/j.semcdb.2004.04.008; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hannan NRF, 2009, CLONING STEM CELLS, V11, P427, DOI 10.1089/clo.2009.0024; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Huntriss J, 2004, MOL REPROD DEV, V67, P323, DOI 10.1002/mrd.20030; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kolle G, 2009, STEM CELLS, V27, P2446, DOI 10.1002/stem.182; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lander Arthur D., 2009, Journal of Biology (London), V8, P70, DOI 10.1186/jbiol177; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Levine AJ, 2009, DEV BIOL, V325, P43, DOI 10.1016/j.ydbio.2008.09.006; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pera MF, 2000, J CELL SCI, V113, P5; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; PERA MF, 1989, DIFFERENTIATION, V42, P10, DOI 10.1111/j.1432-0436.1989.tb00602.x; Rathjen J, 1999, J CELL SCI, V112, P601; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	97	216	225	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					713	720		10.1038/nature09228	http://dx.doi.org/10.1038/nature09228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535200				2022-12-28	WOS:000278551800033
J	Annas, GJ				Annas, George J.			Standard of Care - In Sickness and in Health and in Emergencies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PUBLIC-HEALTH		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				*AG HEALTHC RES QU, 2005, AHRQ PUBL; American Nurses Association, 2008, AD STAND CAR EXTR CO; Annas G J, 1979, Medicoleg News, V7, P4; ANNAS GJ, 1994, AM J LAW MED, V20, P357; Annas GJ, 2002, NEW ENGL J MED, V346, P1337, DOI 10.1056/NEJM200204253461722; Annas GJ., 2010, WORST CASE BIOETHICS; CHAYET NL, 1969, LEGAL IMPLICATIONS E; FINK S, 2009, NY TIMES MAGAZI 0830, P29; Hodge JG, 2010, JAMA-J AM MED ASSOC, V303, P361, DOI 10.1001/jama.2010.31; Hodge Jr James G., 2008, N Y U ANN SURV AM L, V64, P249; Hoffman S, 2008, GEORGETOWN LAW J, V96, P1913; Institute of Medicine, 2010, CRISIS STANDARDS CAR, P69; LACEY M, 2010, NY TIMES        1203, pA1; Okie S, 2008, NEW ENGL J MED, V358, P1, DOI 10.1056/NEJMp0707917; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAK HLTH CAR DEC; RONAN LJ, 2010, BOSTON GLOBE    0209, pA15; SALZARULO H, SENECA DOCTORS LEAVE; Smith S., 2010, BOSTON GLOBE    0121, pA1; Sontag Deborah, 2010, NY TIMES, pA1; WECHT CH, 2008, QUESTION MURDER	20	24	25	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2126	2131		10.1056/NEJMhle1002260	http://dx.doi.org/10.1056/NEJMhle1002260			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603XU	20519685				2022-12-28	WOS:000278242200015
J	Feero, WG; Guttmacher, AE; Collins, FS				Feero, W. Gregory; Guttmacher, Alan E.; Collins, Francis S.			Genomic Medicine: Genomic Medicine -- An Updated Primer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MOLECULAR-ORIGINS; SEQUENCE; EPIGENETICS; SIGNATURES; CANCER; WILL		[Feero, W. Gregory] NHGRI, NIH, Bethesda, MD 20892 USA; [Guttmacher, Alan E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Collins, Francis S.] NIH, Off Director, Bethesda, MD 20892 USA; [Feero, W. Gregory] Maine Dartmouth Family Med Residency Program, Augusta, GA USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA	Feero, WG (corresponding author), NHGRI, NIH, Bldg 31,Rm 4B09,31 Ctr Dr, Bethesda, MD 20892 USA.	feerow@mail.nih.gov						Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Khoury MJ, 2007, AM J PREV MED, V33, P310, DOI 10.1016/j.amepre.2007.05.010; Khoury MJ, 2009, GENET MED, V11, P488, DOI 10.1097/GIM.0b013e3181a551cc; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; NAT'L HUMAN GENOME RES. INST, CAT PUBL GEN WID ASS; National Library of Medicine, GEN HOM REF GEN; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Varmus H, 2002, NEW ENGL J MED, V347, P1526, DOI 10.1056/NEJMe020119; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	49	296	304	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					2001	2011		10.1056/NEJMra0907175	http://dx.doi.org/10.1056/NEJMra0907175			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601JI	20505179				2022-12-28	WOS:000278054000008
J	Ji, MB; Odelius, M; Gaffney, KJ				Ji, Minbiao; Odelius, Michael; Gaffney, K. J.			Large Angular Jump Mechanism Observed for Hydrogen Bond Exchange in Aqueous Perchlorate Solution	SCIENCE			English	Article							INFRARED-SPECTROSCOPY; ULTRAFAST DYNAMICS; MOLECULAR-DYNAMICS; LIQUID WATER; 2D IR; REORIENTATION; 3RD-ORDER; 2D-IR; TIME	The mechanism for hydrogen bond (H-bond) switching in solution has remained subject to debate despite extensive experimental and theoretical studies. We have applied polarization-selective multidimensional vibrational spectroscopy to investigate the H-bond exchange mechanism in aqueous NaClO(4) solution. The results show that a water molecule shifts its donated H-bonds between water and perchlorate acceptors by means of large, prompt angular rotation. Using a jump-exchange kinetic model, we extracted an average jump angle of 49 +/- 4 degrees, in qualitative agreement with the jump angle observed in molecular dynamics simulations of the same aqueous NaClO(4) solution.	[Ji, Minbiao; Gaffney, K. J.] Stanford Univ, SLAC Natl Accelerator Lab, PULSE Inst Ultrafast Energy Sci, Stanford, CA 94305 USA; [Ji, Minbiao] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Odelius, Michael] Stockholm Univ, AlbaNova Univ Ctr, SE-10691 Stockholm, Sweden	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stockholm University	Gaffney, KJ (corresponding author), Stanford Univ, SLAC Natl Accelerator Lab, PULSE Inst Ultrafast Energy Sci, Stanford, CA 94305 USA.	kgaffney@slac.stanford.edu	Gaffney, Kelly J/N-1597-2017; Ji, Minbiao/AAV-8331-2021; Odelius, Michael/A-7628-2014; Ji, Minbiao/C-7793-2011; Gaffney, Kelly/AAG-7136-2020; Odelius, Michael/J-6142-2019	Gaffney, Kelly J/0000-0002-0525-6465; Odelius, Michael/0000-0002-7023-2486; Ji, Minbiao/0000-0002-9066-4008; 	U.S. Department of Energy Office of Basic Energy Sciences; Carl Tryggers foundation; Magnus Bergwall foundation; Swedish Research Council	U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Carl Tryggers foundation; Magnus Bergwall foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	M.J. and K.J.G. were supported through the PULSE Institute at the SLAC National Accelerator Laboratory by the U.S. Department of Energy Office of Basic Energy Sciences. M.O. acknowledges support from the Carl Tryggers and Magnus Bergwall foundations and the Swedish Research Council, and computer time allocations at the Swedish National Supercomputer Center and Center for Parallel Computing (PDC).	Asbury JB, 2004, J PHYS CHEM A, V108, P1107, DOI 10.1021/jp036266k; Bakker HJ, 2008, CHEM REV, V108, P1456, DOI 10.1021/cr0206622; Cahoon JF, 2008, SCIENCE, V319, P1820, DOI 10.1126/science.1154041; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Eaves JD, 2005, P NATL ACAD SCI USA, V102, P13019, DOI 10.1073/pnas.0505125102; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Golonzka O, 2001, J CHEM PHYS, V115, P297, DOI 10.1063/1.1376144; Kim YS, 2005, P NATL ACAD SCI USA, V102, P11185, DOI 10.1073/pnas.0504865102; Kwak K, 2006, J PHYS CHEM B, V110, P19998, DOI 10.1021/jp0624808; Laage D, 2006, SCIENCE, V311, P832, DOI 10.1126/science.1122154; Laage D, 2007, P NATL ACAD SCI USA, V104, P11167, DOI 10.1073/pnas.0701699104; Lawrence CP, 2003, J CHEM PHYS, V118, P264, DOI 10.1063/1.1525802; Ludwig R, 2007, CHEMPHYSCHEM, V8, P44, DOI 10.1002/cphc.200600497; Luzar A, 1996, PHYS REV LETT, V76, P928, DOI 10.1103/PhysRevLett.76.928; Moilanen DE, 2009, P NATL ACAD SCI USA, V106, P375, DOI 10.1073/pnas.0811489106; Nigro B, 2006, J PHYS CHEM A, V110, P11237, DOI 10.1021/jp064846m; Park S, 2009, J PHYS CHEM B, V113, P7825, DOI 10.1021/jp9016739; Rezus YLA, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2009729; Tokmakoff A, 1996, J CHEM PHYS, V105, P1, DOI 10.1063/1.471856; Woutersen S, 2001, CHEM PHYS, V266, P137, DOI 10.1016/S0301-0104(01)00224-5; Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998; Zheng JR, 2005, SCIENCE, V309, P1338, DOI 10.1126/science.1116213; Zheng JR, 2006, SCIENCE, V313, P1951, DOI 10.1126/science.1132178	24	178	178	6	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1003	1005		10.1126/science.1187707	http://dx.doi.org/10.1126/science.1187707			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489019	Green Submitted			2022-12-28	WOS:000277877100034
J	Robinson, JWA; Witt, JDS; Blamire, MG				Robinson, J. W. A.; Witt, J. D. S.; Blamire, M. G.			Controlled Injection of Spin-Triplet Supercurrents into a Strong Ferromagnet	SCIENCE			English	Article							SUPERCONDUCTIVITY	The superconductor-ferromagnet proximity effect describes the fast decay of a spin-singlet supercurrent originating from the superconductor upon entering the neighboring ferromagnet. After placing a conical magnet (holmium) at the interface between the two, we detected a long-ranged supercurrent in the ferromagnetic layer. The long-range effect required particular thicknesses of the spiral magnetically ordered holmium, consistent with spin-triplet proximity theory. This enabled control of the electron pairing symmetry by tuning the degree of magnetic inhomogeneity through the thicknesses of the holmium injectors.	[Robinson, J. W. A.; Witt, J. D. S.; Blamire, M. G.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Robinson, JWA (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	jjr33@cam.ac.uk		Blamire, Mark/0000-0002-3888-4476	St. John's College, Cambridge; UK Engineering and Physical Sciences Research Council [EP/E026206, EP/E026532/1, EP/D001536/1]; Engineering and Physical Sciences Research Council [EP/E026206/1, EP/F016611/1] Funding Source: researchfish; EPSRC [EP/F016611/1, EP/E026206/1] Funding Source: UKRI	St. John's College, Cambridge; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	J.W.A.R. acknowledges support from St. John's College, Cambridge, through a Research Fellowship. We thank G. Halasz for valuable discussions. This work was funded by the UK Engineering and Physical Sciences Research Council (EP/E026206; EP/E026532/1; EP/D001536/1).	Bannykh AA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054501; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1957, PHYS REV, V106, P162, DOI 10.1103/PhysRev.106.162; Bell C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.180501; Bergeret FS, 2005, REV MOD PHYS, V77, P1321, DOI 10.1103/RevModPhys.77.1321; Blum Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.187004; Born F, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.140501; Braude V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.207001; Buzdin AI, 2005, REV MOD PHYS, V77, P935, DOI 10.1103/RevModPhys.77.935; Chikazumi S., 1997, PHYS FERROMAGNETISM; Eschrig M, 2008, NAT PHYS, V4, P138, DOI 10.1038/nphys831; Fominov YV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104509; Houzet M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.060504; Keizer RS, 2006, NATURE, V439, P825, DOI 10.1038/nature04499; Khaire TS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137002; KOEHLER WC, 1966, PHYS REV, V151, P414, DOI 10.1103/PhysRev.151.414; Kontos T, 2001, PHYS REV LETT, V86, P304, DOI 10.1103/PhysRevLett.86.304; Linder J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107008; Lofwander T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.187003; Robinson JWA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.177003; Robinson JWA, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3262969; Ryazanov VV, 2001, PHYS REV LETT, V86, P2427, DOI 10.1103/PhysRevLett.86.2427; Schussler-Langeheine C, 2001, J ELECTRON SPECTROSC, V114, P953, DOI 10.1016/S0368-2048(00)00318-2; Sosnin I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.157002; Volkov AF, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024519	25	406	411	7	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					59	61		10.1126/science.1189246	http://dx.doi.org/10.1126/science.1189246			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20538913				2022-12-28	WOS:000279402700030
J	Saglio, G; Kim, DW; Issaragrisil, S; le Coutre, P; Etienne, G; Lobo, C; Pasquini, R; Clark, RE; Hochhaus, A; Hughes, TP; Gallagher, N; Hoenekopp, A; Dong, M; Haque, A; Larson, RA; Kantarjian, HM				Saglio, Giuseppe; Kim, Dong-Wook; Issaragrisil, Surapol; le Coutre, Philipp; Etienne, Gabriel; Lobo, Clarisse; Pasquini, Ricardo; Clark, Richard E.; Hochhaus, Andreas; Hughes, Timothy P.; Gallagher, Neil; Hoenekopp, Albert; Dong, Mei; Haque, Ariful; Larson, Richard A.; Kantarjian, Hagop M.		ENESTnd Investigators	Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE CML-CP; HARMONIZING CURRENT METHODOLOGY; CHRONIC MYELOGENOUS LEUKEMIA; PATIENTS RECEIVING IMATINIB; UP SUSTAINED SURVIVAL; BCR-ABL TRANSCRIPTS; FOLLOW-UP; PATIENTS PTS; 800 MG; MOLECULAR RESPONSES	Background Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib. We evaluated the efficacy and safety of nilotinib, as compared with imatinib, in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in the chronic phase. Methods In this phase 3, randomized, open-label, multicenter study, we assigned 846 patients with chronic-phase Philadelphia chromosome-positive CML in a 1: 1: 1 ratio to receive nilotinib (at a dose of either 300 mg or 400 mg twice daily) or imatinib (at a dose of 400 mg once daily). The primary end point was the rate of major molecular response at 12 months. Results At 12 months, the rates of major molecular response for nilotinib (44% for the 300-mg dose and 43% for the 400-mg dose) were nearly twice that for imatinib (22%) (P<0.001 for both comparisons). The rates of complete cytogenetic response by 12 months were significantly higher for nilotinib (80% for the 300-mg dose and 78% for the 400-mg dose) than for imatinib (65%) (P<0.001 for both comparisons). Patients receiving either the 300-mg dose or the 400-mg dose of nilotinib twice daily had a significant improvement in the time to progression to the accelerated phase or blast crisis, as compared with those receiving imatinib (P = 0.01 and P = 0.004, respectively). No patient with progression to the accelerated phase or blast crisis had a major molecular response. Gastrointestinal and fluid-retention events were more frequent among patients receiving imatinib, whereas dermatologic events and headache were more frequent in those receiving nilotinib. Discontinuations due to aminotransferase and bilirubin elevations were low in all three study groups. Conclusions Nilotinib at a dose of either 300 mg or 400 mg twice daily was superior to imatinib in patients with newly diagnosed chronic-phase Philadelphia chromosome-positive CML. (ClinicalTrials.gov number, NCT00471497.)	[Saglio, Giuseppe] Univ Turin, Div Med Interna & Ematol, Osped San Luigi Gonzaga, I-10043 Turin, Italy; [Kim, Dong-Wook] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea; [Issaragrisil, Surapol] Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; [le Coutre, Philipp] Univ Med Berlin, Charite, Berlin, Germany; [Etienne, Gabriel] Inst Bergonie, Bordeaux, France; [Lobo, Clarisse] Inst Estadual Hematol Arthur de Siqueira Cavalcan, Rio De Janeiro, Brazil; [Pasquini, Ricardo] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil; [Clark, Richard E.] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Hochhaus, Andreas] Univ Klinikum Jena, Jena, Germany; [Hughes, Timothy P.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Gallagher, Neil; Hoenekopp, Albert] Novartis Pharmaceut, Basel, Switzerland; [Dong, Mei; Haque, Ariful] Novartis Pharmaceut, E Hanover, NJ USA; [Larson, Richard A.] Univ Chicago, Chicago, IL 60637 USA; [Kantarjian, Hagop M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; Catholic University of Korea; Seoul St. Mary's Hospital; Mahidol University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UNICANCER; Institut Bergonie; Universidade Federal do Parana; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Friedrich Schiller University of Jena; Royal Adelaide Hospital; Novartis; Novartis; University of Chicago; University of Texas System; UTMD Anderson Cancer Center	Saglio, G (corresponding author), Univ Turin, Div Med Interna & Ematol, Osped San Luigi Gonzaga, I-10043 Turin, Italy.	giuseppe.saglio@unito.it	Test, Test/Y-7921-2019; Larson, Richard A./AAE-7223-2019; Greil, Richard F/C-7673-2017; Louw, Vernon/ABA-1753-2020; Hughes, Tim/AAO-9975-2021; Ottmann, Oliver/D-5007-2016; Sanz, Miguel/F-7485-2018; holyoake, tessa/M-3668-2015; Porkka, Kimmo/O-2323-2016; abruzzese, elisabetta/D-4408-2019	Larson, Richard A./0000-0001-9168-3203; Greil, Richard F/0000-0002-4462-3694; Louw, Vernon/0000-0002-2885-3342; Kuliczkowski, Kazimierz/0000-0001-6812-1421; Ottmann, Oliver/0000-0001-9559-1330; Sanz, Miguel/0000-0003-1489-1177; Hughes, Timothy/0000-0002-0910-3730; holyoake, tessa/0000-0002-0608-6066; Masszi, Tamas/0000-0002-9038-302X; Porkka, Kimmo/0000-0003-4112-5902; abruzzese, elisabetta/0000-0001-5228-6491; Hochhaus, Andreas/0000-0003-0626-0834; Rea, Delphine/0000-0001-5379-7461; BATLLE, JAVIER/0000-0002-7931-2546; Saglio, Giuseppe/0000-0002-1046-3514; Issaragrisil, Surapol/0000-0002-8924-0646; Guilhot, Francois/0000-0001-7222-487X	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	Supported by Novartis Pharmaceuticals.	Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2009, BLOOD, V114, P142; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Branford S, 2006, LEUKEMIA, V20, P1925, DOI 10.1038/sj.leu.2404388; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Cortes J, 2005, CLIN CANCER RES, V11, P3425, DOI 10.1158/1078-0432.CCR-04-2139; Cortes J, 2009, BLOOD, V114, P144; Cortes JE, 2010, J CLIN ONCOL, V28, P424, DOI 10.1200/JCO.2009.25.3724; Cortes JE, 2010, J CLIN ONCOL, V28, P392, DOI 10.1200/JCO.2009.25.4896; Davies A, 2009, LEUKEMIA, V23, P1999, DOI 10.1038/leu.2009.166; Deininger M, 2009, BLOOD, V114, P462; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Hehlmann R, 2009, BLOOD, V114, P143, DOI 10.1182/blood.V114.22.339.339; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Muller MC, 2008, LEUKEMIA, V22, P96, DOI 10.1038/sj.leu.2404983; Muller MC, 2009, LEUKEMIA, V23, P1957, DOI 10.1038/leu.2009.168; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Brien SG, 2008, BLOOD, V112, P76; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Rosti G, 2009, BLOOD, V114, P868; Rosti G, 2009, BLOOD, V114, P4933, DOI 10.1182/blood-2009-07-232595; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007	25	1219	1264	1	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2251	2259		10.1056/NEJMoa0912614	http://dx.doi.org/10.1056/NEJMoa0912614			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20525993	Green Published			2022-12-28	WOS:000278816300004
J	Yu, XZ; Onose, Y; Kanazawa, N; Park, JH; Han, JH; Matsui, Y; Nagaosa, N; Tokura, Y				Yu, X. Z.; Onose, Y.; Kanazawa, N.; Park, J. H.; Han, J. H.; Matsui, Y.; Nagaosa, N.; Tokura, Y.			Real-space observation of a two-dimensional skyrmion crystal	NATURE			English	Article							MAGNETIC PHASE-DIAGRAM; STATE	Crystal order is not restricted to the periodic atomic array, but can also be found in electronic systems such as the Wigner crystal(1) or in the form of orbital order(2), stripe order(3) and magnetic order. In the case of magnetic order, spins align parallel to each other in ferromagnets and antiparallel in antiferromagnets. In other, less conventional, cases, spins can sometimes form highly nontrivial structures called spin textures(4-23). Among them is the unusual, topologically stable skyrmion spin texture, in which the spins point in all the directions wrapping a sphere(4-7). The skyrmion configuration in a magnetic solid is anticipated to produce unconventional spin-electronic phenomena such as the topological Hall effect(24-26). The crystallization of skyrmions as driven by thermal fluctuations has recently been confirmed in a narrow region of the temperature/magnetic field (T-B) phase diagram in neutron scattering studies of the three-dimensional helical magnets MnSi (ref. 17) and Fe1-xCoxSi (ref. 22). Here we report real-space imaging of a two-dimensional skyrmion lattice in a thin film of Fe0.5Co0.5Si using Lorentz transmission electron microscopy. With a magnetic field of 50-70 mT applied normal to the film, we observe skyrmions in the form of a hexagonal arrangement of swirling spin textures, with a lattice spacing of 90 nm. The related T-B phase diagram is found to be in good agreement with Monte Carlo simulations. In this two-dimensional case, the skyrmion crystal seems very stable and appears over a wide range of the phase diagram, including near zero temperature. Such a controlled nanometre-scale spin topology in a thin film may be useful in observing unconventional magneto-transport effects.	[Yu, X. Z.; Matsui, Y.] Natl Inst Mat Sci, Adv Elect Microscopy Grp, Tsukuba, Ibaraki 3050044, Japan; [Yu, X. Z.; Matsui, Y.] Natl Inst Mat Sci, High Voltage Elect Microscopy Stn, Tsukuba, Ibaraki 3050044, Japan; [Yu, X. Z.; Onose, Y.; Tokura, Y.] Japan Sci & Technol Agcy, Multiferro Project, Tokyo 1138656, Japan; [Onose, Y.; Kanazawa, N.; Nagaosa, N.; Tokura, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Park, J. H.; Han, J. H.] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Nagaosa, N.; Tokura, Y.] RIKEN ASI, Cross Correlated Mat Res Grp, Wako, Saitama 3510198, Japan; [Nagaosa, N.; Tokura, Y.] RIKEN ASI, Correlated Elect Res Grp, Wako, Saitama 3510198, Japan	National Institute for Materials Science; National Institute for Materials Science; Japan Science & Technology Agency (JST); University of Tokyo; Sungkyunkwan University (SKKU); RIKEN; RIKEN	Yu, XZ (corresponding author), Natl Inst Mat Sci, Adv Elect Microscopy Grp, Tsukuba, Ibaraki 3050044, Japan.	yu.xiuzhen@nims.go.jp; tokura@ap.t.u-tokyo.ac.jp	Kanazawa, Naoya/D-6260-2017; Nagaosa, Naoto/G-7057-2012; MATSUI, Yoshio/H-2685-2011; Park, Jin-Hong/O-4480-2016; Yu, Xiuzhen/B-3634-2013; Park, Jin-Hong/F-1829-2014; Onose, Yoshinori/F-1977-2010; Tokura, Yoshinori/C-7352-2009	Kanazawa, Naoya/0000-0003-3270-2915; MATSUI, Yoshio/0000-0003-2044-3450; Yu, Xiuzhen/0000-0003-3136-7289; Park, Jin-Hong/0000-0001-8084-071X; Onose, Yoshinori/0000-0002-8398-2956; Tokura, Yoshinori/0000-0002-2732-4983; Park, Jin-Hong/0000-0003-4408-7171	Ministry of Education, Culture, Sports, Science and Technology of Japan [ADE21005, 16076205, 17105002, 19019004, 19048008, 19048015, 20046004, 20340086, 21244053, 22014003]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Korea Research Foundation [KRF-2008-521-C00085, KRF-2008-314-C00101]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Korea Research Foundation(National Research Foundation of Korea)	We would like to thank K. Ishizuka, K. Kimoto, T. Asaka, T. Hara and W. Z. Zhang for discussions. This work was partly supported by the Nanotechnology Network Project (no. ADE21005) and Grants-in-Aid for Scientific Research (numbers 16076205, 17105002, 19019004, 19048008, 19048015, 20046004, 20340086, 21244053 and 22014003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and also by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). J.H.H. is supported by grants from the Korea Research Foundation (KRF-2008-521-C00085 and KRF-2008-314-C00101).	Binz B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207202; BOGDANOV AN, 1989, ZH EKSP TEOR FIZ+, V95, P178; Grigoriev SV, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224424; Grigoriev SV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037204; GRUNDY PJ, 1968, ADV PHYS, V17, P153, DOI 10.1080/00018736800101286; Ho TL, 1998, PHYS REV LETT, V81, P742, DOI 10.1103/PhysRevLett.81.742; ISHIKAWA Y, 1976, SOLID STATE COMMUN, V19, P525, DOI 10.1016/0038-1098(76)90057-0; ISHIKAWA Y, 1984, J PHYS SOC JPN, V53, P2726, DOI 10.1143/JPSJ.53.2726; ISHIMOTO K, 1995, PHYSICA B, V213, P381, DOI 10.1016/0921-4526(95)00163-4; Landau L. D., 2008, ELECTRODYNAMICS CONT, V8, P178; LEBECH B, 1995, J MAGN MAGN MATER, V140, P119, DOI 10.1016/0304-8853(94)01115-X; Lee M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186601; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; Onose Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174421; Pfleiderer C, 2004, NATURE, V427, P227, DOI 10.1038/nature02232; Rajaraman R., 1987, SOLITONS INSTANTONS, P115; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; SKYRME THR, 1962, NUCL PHYS, V31, P556, DOI 10.1016/0029-5582(62)90775-7; Takeda M, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.093704; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tonomura A, 2001, NATURE, V412, P620, DOI 10.1038/35088021; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Uchida M, 2006, SCIENCE, V311, P359, DOI 10.1126/science.1120639; Wigner E, 1934, PHYS REV, V46, P1002, DOI 10.1103/PhysRev.46.1002; Yi SD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.054416	29	2150	2166	43	1138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					901	904		10.1038/nature09124	http://dx.doi.org/10.1038/nature09124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559382				2022-12-28	WOS:000278804500032
J	Kautz, T; Bendavid, E; Bhattacharya, J; Miller, G				Kautz, Tim; Bendavid, Eran; Bhattacharya, Jay; Miller, Grant			AIDS and declining support for dependent elderly people in Africa: retrospective analysis using demographic and health surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPACT; HIV/AIDS	Objectives To determine the relation between the HIV/AIDS epidemic and support for dependent elderly people in Africa. Design Retrospective analysis using data from Demographic and Health Surveys. Setting 22 African countries between 1991 and 2006. Participants 123 176 individuals over the age of 60. Main outcome measures We investigated how three measures of the living arrangements of older people have been affected by the HIV/AIDS epidemic: the number of older individuals living alone (that is, the number of unattended elderly people); the number of older individuals living with only dependent children under the age of 10 (that is, in missing generation households); and the number of adults age 18-59 (that is, prime age adults) per household where an older person lives. Results An increase in annual AIDS mortality of one death per 1000 people was associated with a 1.5% increase in the proportion of older individuals living alone (95% CI 1.2% to 1.9%) and a 0.4% increase in the number of older individuals living in missing generation households (95% CI 0.3% to 0.6%). Increases in AIDS mortality were also associated with fewer prime age adults in households with at least one older person and at least one prime age adult (P<0.001). These findings suggest that in our study countries, which encompass 70% of the sub-Saharan population, the HIV/AIDS epidemic could be responsible for 582 200-917 000 older individuals living alone without prime age adults and 141 000-323 100 older individuals being the sole caregivers for young children. Conclusions Africa's HIV/AIDS epidemic might be responsible for a large number of older people losing their support and having to care for young children. This population has previously been under-recognised. Efforts to reduce HIV/AIDS deaths could have large "spillover" benefits for elderly people in Africa.	[Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, CHP, Stanford, CA 94305 USA; [Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, Ctr Primary Care & Outcomes Res PCOR, Stanford, CA 94305 USA; [Kautz, Tim] Univ Chicago, Dept Econ, Chicago, IL 60637 USA	Stanford University; Stanford University; University of Chicago	Miller, G (corresponding author), Stanford Univ, CHP, Stanford, CA 94305 USA.	ngmiller@stanford.edu			National Institute on Aging [K02-AG024237]; National Institute of Child Health and Human Development [K01-HD053504]; Agency for Healthcare Research and Quality [T32-HS000028]; National Institute of Allergy and Infectious Diseases [K01-AI084582]; Stanford Center for Demography and Economics of Aging [P30-AG017253]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD053504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024237, P30AG017253] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Center for Demography and Economics of Aging; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging (K02-AG024237), the National Institute of Child Health and Human Development (K01-HD053504), the Agency for Healthcare Research and Quality (T32-HS000028), the National Institute of Allergy and Infectious Diseases (K01-AI084582), and the Stanford Center for Demography and Economics of Aging (P30-AG017253). The supporting agencies had no part in formulating, analysing, or writing this work.	Aboderin I, 2004, J GERONTOL B-PSYCHOL, V59, pS128, DOI 10.1093/geronb/59.3.S128; Agesa R.U, 2004, REV ECON HOUSEHOLD, V2, P161, DOI DOI 10.1023/B:REHO.0000031612.77882.29; [Anonymous], WORLD URB PROSP 2005; Barrientos A, 2003, WORLD DEV, V31, P555, DOI 10.1016/S0305-750X(02)00211-5; CATTELL M G, 1990, Journal of Cross-Cultural Gerontology, V5, P375, DOI 10.1007/BF00057646; DAYTON J, 2002, POLICY RES DIVISION, V160; GHYS PD, 2004, SEX TRANSM INFECT S1, V80, P5; Gregson S, 2007, P NATL ACAD SCI USA, V104, P14586, DOI 10.1073/pnas.0611540104; Knodel J, 2001, SOC SCI MED, V52, P1313, DOI 10.1016/S0277-9536(00)00233-1; KNODEL J, 2002, AIDS S3, V16, P77; Merli M. G, 2006, AGING SUBSAHARAN AFR, P117; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Ntozi James P. M., 1999, CONTINUING AFRICAN H, P193; Nyambedha EO, 2003, SOC SCI MED, V57, P301, DOI 10.1016/S0277-9536(02)00359-3; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; SMITH J, 2007, AIDS S6, V21, P81; Ssengonzi R, 2007, J CROSS-CULT GERONTO, V22, P339, DOI 10.1007/s10823-007-9043-5; UNAIDS, 2008, REP GLOB AIDS EP; Unanka GO, 2002, J SOC ISSUES, V58, P681, DOI 10.1111/1540-4560.00040; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; *US BUR CENS, 2008, INT DAT; Wachter KW, 2003, J ECONOMETRICS, V112, P193, DOI 10.1016/S0304-4076(02)00160-4; Wachter KW, 2002, DEMOGRAPHY, V39, P25, DOI 10.1353/dem.2002.0012; WILLIAMS A, 1996, ASIAN STUDIES REV, V20, P98; ZIMMER Z, 2000, POPUL STUD CAMB, V59, P295	26	46	46	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2010	340								c2841	10.1136/bmj.c2841	http://dx.doi.org/10.1136/bmj.c2841			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554660	Green Published, hybrid			2022-12-28	WOS:000279051900002
J	Mullan, F; Chen, C; Petterson, S; Kolsky, G; Spagnola, M				Mullan, Fitzhugh; Chen, Candice; Petterson, Stephen; Kolsky, Gretchen; Spagnola, Michael			The Social Mission of Medical Education: Ranking the Schools	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN MASTERFILE; U.S. NEWS; HEALTH; CARE; POPULATIONS; WORKFORCE; AMERICA	Background: The basic purpose of medical schools is to educate physicians to care for the national population. Fulfilling this goal requires an adequate number of primary care physicians, adequate distribution of physicians to underserved areas, and a sufficient number of minority physicians in the workforce. Objective: To develop a metric called the social mission score to evaluate medical school output in these 3 dimensions. Design: Secondary analysis of data from the American Medical Association (AMA) Physician Masterfile and of data on race and ethnicity in medical schools from the Association of American Medical Colleges and the Association of American Colleges of Osteopathic Medicine. Setting: U. S. medical schools. Participants: 60 043 physicians in active practice who graduated from medical school between 1999 and 2001. Measurements: The percentage of graduates who practice primary care, work in health professional shortage areas, and are underrepresented minorities, combined into a composite social mission score. Results: The contribution of medical schools to the social mission of medical education varied substantially. Three historically black colleges had the highest social mission rankings. Public and community-based medical schools had higher social mission scores than private and non-community-based schools. National Institutes of Health funding was inversely associated with social mission scores. Medical schools in the northeastern United States and in more urban areas were less likely to produce primary care physicians and physicians who practice in underserved areas. Limitations: The AMA Physician Masterfile has limitations, including specialty self-designation by physicians, inconsistencies in reporting work addresses, and delays in information updates. The public good provided by medical schools may include contributions not reflected in the social mission score. The study was not designed to evaluate quality of care provided by medical school graduates. Conclusion: Medical schools vary substantially in their contribution to the social mission of medical education. School rankings based on the social mission score differ from those that use research funding and subjective assessments of school reputation. These findings suggest that initiatives at the medical school level could increase the proportion of physicians who practice primary care, work in underserved areas, and are underrepresented minorities.	[Mullan, Fitzhugh] George Washington Univ, Dept Hlth Policy, Childrens Natl Med Ctr, Washington, DC 20037 USA; Robert Graham Ctr, Washington, DC USA	Children's National Health System; George Washington University	Mullan, F (corresponding author), George Washington Univ, Dept Hlth Policy, Childrens Natl Med Ctr, 2121 K St NW,Suite 210, Washington, DC 20037 USA.	fmullan@gwu.edu			Josiah Macy, Jr. Foundation	Josiah Macy, Jr. Foundation	By the Josiah Macy, Jr. Foundation.	*AM MED ASS, TOT PHYS RAC ETHN 20; American Osteopathic Association, OST MED; *ASS AM MED COLL, 2002, MIN STUD MED ED; Boelen C, 1995, DEFINING MEASURING S; *CARN FDN ADV TEAC, 1970, HIGH ED NAT HLTH POL; Coggeshall LT., 1965, PLANNING MED PROGR E; *COUNC GRAD MED ED, 2005, 17 COUNC GRAD MED ED; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Freed GL, 2006, ACAD MED, V81, P847, DOI 10.1097/00001888-200609000-00017; Freeman J, 2007, ACAD MED, V82, P133, DOI 10.1097/ACM.0b013e31802d8d242; GRUMBACH K, 1995, AM J PUBLIC HEALTH, V85, P1402, DOI 10.2105/AJPH.85.10.1402; Kaufman A, 1996, ACAD MED, V71, P432, DOI 10.1097/00001888-199605000-00010; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Konrad TR, 2000, J RURAL HEALTH, V16, P162, DOI 10.1111/j.1748-0361.2000.tb00450.x; McGaghie WC, 2001, ACAD MED, V76, P985, DOI 10.1097/00001888-200110000-00005; Mitka M, 2009, JAMA-J AM MED ASSOC, V301, P1114, DOI 10.1001/jama.2009.321; MORSE R, 2009, US NEWS WORLD R 0415; National Association of Community Health Centers Robert Graham Center & The George Washington University School of Public Health and Health Services, 2008, ACC TRANSF BUILD PRI; OBAMA BH, 2009, CNN             0224; *PC HLTH NEEDS NAT, 1952, BUILD AM HLTH FIND R; RICKETTS T, 2007, IMPACT TESTING PROPO; Ricketts TC, 2008, HEALTH AFFAIR, V27, P1409, DOI 10.1377/hlthaff.27.5.1409; Rosenblatt RA, 2006, JAMA-J AM MED ASSOC, V295, P1042, DOI 10.1001/jama.295.9.1042; SACK K, 2008, NY TIMES        0405; Saha S, 2000, HEALTH AFFAIR, V19, P76, DOI 10.1377/hlthaff.19.4.76; Schofield J.R, 1984, NEW EXPANDED MED SCH; SCHROEDER SA, 1989, JAMA-J AM MED ASSOC, V262, P803, DOI 10.1001/jama.262.6.803; Sehgal AR, 2010, ANN INTERN MED, V152, P521, DOI 10.7326/0003-4819-152-8-201004200-00009; Simpson C, 1994, J Am Osteopath Assoc, V94, P502; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Tooke-Rawlins D, 2000, J RURAL HEALTH, V16, P299, DOI 10.1111/j.1748-0361.2000.tb00478.x; U.S.) C on GME, DHHSPUBL 1998 HRSA, V97, P53; United States Census Bureau, 2008, ANN EST RES POP SEX; US Census Bureau, CENS REG DIV US; USDA, MEAS RUR RUR URB CON; WHITE KL, 1991, ANN INTERN MED, V115, P968, DOI 10.7326/0003-4819-115-12-968; Woollard RF, 2006, MED EDUC, V40, P301, DOI 10.1111/j.1365-2929.2006.02416.x	37	208	211	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					804	+		10.7326/0003-4819-152-12-201006150-00009	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611OP	20547907				2022-12-28	WOS:000278827700007
J	Gulati, D; Mullen, K; Magrey, M				Gulati, Dhiraj; Mullen, Kevin; Magrey, Marina			Unilateral pleural effusion-but where from?	LANCET			English	Editorial Material							HEPATIC HYDROTHORAX; CIRRHOSIS		[Gulati, Dhiraj; Mullen, Kevin; Magrey, Marina] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Internal Med, Cleveland, OH 44130 USA	Case Western Reserve University; MetroHealth System	Gulati, D (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Dept Internal Med, 2500 MetroHlth Dr, Cleveland, OH 44130 USA.	dgulati@metrohealth.org	Magrey, Marina/AAX-4067-2020					Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Dhanasekaran R, 2010, AM J GASTROENTEROL, V105, P635, DOI 10.1038/ajg.2009.634; MORROW CS, 1958, ANN INTERN MED, V49, P193, DOI 10.7326/0003-4819-49-1-193; Roussos A, 2007, J GASTROEN HEPATOL, V22, P1388, DOI 10.1111/j.1440-1746.2007.05069.x; Singh C, 2009, MED CLIN N AM, V93, P871, DOI 10.1016/j.mcna.2009.03.006	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 12	2010	375	9731					2120	2120		10.1016/S0140-6736(10)60631-9	http://dx.doi.org/10.1016/S0140-6736(10)60631-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20542164				2022-12-28	WOS:000279069300025
J	Davies, AA; Neiss, A; Ulrich, HD				Davies, Adelina A.; Neiss, Andrea; Ulrich, Helle D.			Ubiquitylation of the 9-1-1 Checkpoint Clamp Is Independent of Rad6-Rad18 and DNA Damage	CELL			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; RAD6 PATHWAY; SOS RESPONSE; UBIQUITIN; REPAIR; PCNA; POLYMERASE; CELLS; SUMO	A recent report proposed a function of the ubiquitin conjugation factors Rad6 and Rad18 comparable to the bacterial SOS response, controlling damage-induced transcriptional activation and contributing to checkpoint signaling. The relevant ubiquitylation target was identified as budding yeast Rad17, a subunit of the PCNA-like 9-1-1 checkpoint clamp. We report here that in fact all three subunits of the 9-1-1 complex are ubiquitylated. However, in contrast to previous results, we found modification of Rad17 to be independent of DNA damage, the Rad6-Rad18 complex, the putative acceptor site (lysine 197), and loading of the complex onto DNA. Consistently, we were unable to observe enhanced damage sensitivity or defects in checkpoint signaling in a rad17(K197R) mutant. Instead, our findings suggest that ubiquitylation of the 9-1-1 complex may be a background reaction that in some cases can mediate proteasomal degradation.	[Davies, Adelina A.; Ulrich, Helle D.] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, S Mimms EN6 3LD, Herts, England; [Neiss, Andrea] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Cancer Research UK; Max Planck Society	Ulrich, HD (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, Blanche Lane, S Mimms EN6 3LD, Herts, England.	helle.ulrich@cancer.org.uk		Ulrich, Helle D./0000-0003-0431-2223	Cancer Research UK; Deutsche Forschungsgemeinschaft	Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Susan Gasser and Wolfram Siede for yeast strains. This work was supported by Cancer Research UK and a grant from the Deutsche Forschungsgemeinschaft.	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Frei C, 2000, GENE DEV, V14, P81; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Zhang H, 2001, J BIOL CHEM, V276, P26715, DOI 10.1074/jbc.M103682200; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	32	10	10	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1080	1087		10.1016/j.cell.2010.04.039	http://dx.doi.org/10.1016/j.cell.2010.04.039			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550940	Bronze			2022-12-28	WOS:000278618800021
J	Singh, R; Cresswell, P				Singh, Reshma; Cresswell, Peter			Defective Cross-Presentation of Viral Antigens in GILT-Free Mice	SCIENCE			English	Article							MHC CLASS-I; HERPES-SIMPLEX-VIRUS; THIOL REDUCTASE GILT; DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; DISULFIDE BONDS; INFLUENZA-VIRUS; GLYCOPROTEIN-B; CROSSPRESENTATION; LYSOSOMES	Gamma-interferon-inducible lysosomal thiolreductase (GILT) promotes major histocompatibility complex (MHC) class II-restricted presentation of exogenous antigens containing disulfide bonds. Here, we show that GILT also facilitates MHC class I-restricted recognition of such antigens by CD8(+) T cells, or cross-presentation. GILT is essential for cross-presentation of a CD8(+) T cell epitope of glycoprotein B (gB) from herpes simplex virus 1 (HSV-1) but not for its presentation by infected cells. Initiation of the gB-specific CD8(+) T cell response during HSV-1 infection, or cross-priming, is highly GILT-dependent, as is initiation of the response to the envelope glycoproteins of influenza A virus. Efficient cross-presentation of disulfide-rich antigens requires a complex pathway involving GILT-mediated reduction, unfolding, and partial proteolysis, followed by translocation into the cytosol for proteasomal processing.	[Singh, Reshma; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06250 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, 300 Cedar St,POB 208011, New Haven, CT 06250 USA.	peter.cresswell@yale.edu			Howard Hughes Medical Institute; NIH [R37AI23081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute and NIH grant R37AI23081 (P.C.).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MCCOY KL, 1989, J IMMUNOL, V143, P29; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	29	108	113	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1394	1398		10.1126/science.1189176	http://dx.doi.org/10.1126/science.1189176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538950	Green Accepted			2022-12-28	WOS:000278598400038
J	Singhal, N; Graumann, J; Wu, GM; Arauzo-Bravo, MJ; Han, DW; Greber, B; Gentile, L; Mann, M; Scholer, HR				Singhal, Nishant; Graumann, Johannes; Wu, Guangming; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Greber, Boris; Gentile, Luca; Mann, Matthias; Schoeler, Hans R.			Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming	CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; SWI/SNF COMPLEX; GENE-EXPRESSION; SELF-RENEWAL; AMINO-ACIDS; FIBROBLASTS; INDUCTION; REQUIRES; EXTRACT	Reprogramming of somatic cells achieved by combination of the four transcription factors Oct4, Sox2, Klf4, and c-Myc has very low efficiency. To increase the reprogramming efficiency and better understand the process, we sought to identify factors that mediate reprogramming with higher efficiency. We established an assay to screen nuclear fractions from extracts of pluripotent mouse cells based on Oct4 reactivation. Using proteomics, we identified components of the ATP-dependent BAF chromatin-remodeling complex, which significantly increases reprogramming efficiency when used together with the four factors. The reprogrammed cells could transmit to the germline and exhibited pluripotency. Reprogramming remained highly efficient when c-Myc was not present but BAF components were overexpressed. BAF complex components mediate this effect by facilitating enhanced Oct4 binding to target promoters during reprogramming. Thus, somatic cell reprogramming using chromatin-remodeling molecules represents an efficient method of generating reprogrammed cells.	[Singhal, Nishant; Wu, Guangming; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Greber, Boris; Gentile, Luca; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Graumann, Johannes; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Max Planck Society; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Gentile, Luca/E-4908-2019; Gentile, Luca/L-4473-2014; Graumann, Johannes/C-5241-2008; , HS/AAB-4434-2019; Han, Dong Wook/D-6041-2011; Marcos, Arauzo-Bravo/A-1706-2011; Mann, Matthias/A-3454-2013	Gentile, Luca/0000-0002-7393-7502; Graumann, Johannes/0000-0002-3015-5850; , HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Mann, Matthias/0000-0003-1292-4799; Greber, Boris/0000-0002-9404-7293; Wu, Guangming/0000-0003-1923-7609; Singhal, Nishant/0000-0002-7988-5125	Max Planck Society; Deutsche Forschungsgemeinschaft DFG [SPP 1356, SCHO 340/5-1]; Federal Ministry of Education and Research BMBF [01GN0934]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	editing the manuscript. The project was partly funded by the Max Planck Society for the advancement of Sciences, by the Deutsche Forschungsgemeinschaft DFG within the Priority Programme SPP 1356 "Pluripotency and Cellular Reprogramming" (grant SCHO 340/5-1), and by the Federal Ministry of Education and Research BMBF "Cell-based regenerative medicine-Pluripotent cells for heart therapies" (grant 01GN0934).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datta J, 2005, CANCER RES, V65, P10891, DOI 10.1158/0008-5472.CAN-05-1455; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Miyamoto K, 2007, MOL REPROD DEV, V74, P1268, DOI 10.1002/mrd.20691; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neri T, 2007, CLONING STEM CELLS, V9, P394, DOI 10.1089/clo.2006.0011; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	45	284	303	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					943	955		10.1016/j.cell.2010.04.037	http://dx.doi.org/10.1016/j.cell.2010.04.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550931	Bronze			2022-12-28	WOS:000278618800010
J	Yao, NY; O'Donnell, M				Yao, Nina Y.; O'Donnell, Mike			SnapShot: The Replisome	CELL			English	Editorial Material							REPLICATION FORK		[Yao, Nina Y.] Rockefeller Univ, New York, NY 10065 USA; HHMI, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	Yao, NY (corresponding author), Rockefeller Univ, New York, NY 10065 USA.			O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [R01 GM038839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; SINHA NK, 1980, J BIOL CHEM, V255, P4290; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; Yao NY, 2009, CURR OPIN CELL BIOL, V21, P336, DOI 10.1016/j.ceb.2009.02.008	6	39	40	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 11	2010	141	6					1088	U181	1088.e1	10.1016/j.cell.2010.05.042	http://dx.doi.org/10.1016/j.cell.2010.05.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550941	Bronze, Green Accepted			2022-12-28	WOS:000278618800022
J	Chyba, CF				Chyba, Christopher F.			Countering the Early Faint Sun	SCIENCE			English	Editorial Material							ORGANIC HAZES; EARLY EARTH		Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Chyba, CF (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	cchyba@princeton.edu						BADA JL, 1994, P NATL ACAD SCI USA, V91, P1248, DOI 10.1073/pnas.91.4.1248; Catling D., 2007, PLANETS LIFE EMERGIN, P91; Chyba CF, 2006, ADV ASTROBIO BIOGEOP, P169; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; McKay CP, 1999, ICARUS, V137, P56, DOI 10.1006/icar.1998.6039; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; SHAPIRO R, 2007, PLANETS LIFE; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Wolf ET, 2010, SCIENCE, V328, P1266, DOI 10.1126/science.1183260	13	4	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1238	1239		10.1126/science.1189196	http://dx.doi.org/10.1126/science.1189196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522763				2022-12-28	WOS:000278318600020
J	Rodriguez-Munoz, R; Bretman, A; Slate, J; Walling, CA; Tregenza, T				Rodriguez-Munoz, R.; Bretman, A.; Slate, J.; Walling, C. A.; Tregenza, T.			Natural and Sexual Selection in a Wild Insect Population	SCIENCE			English	Article							FEMALES; DOMINANCE	The understanding of natural and sexual selection requires both field and laboratory studies to exploit the advantages and avoid the disadvantages of each approach. However, studies have tended to be polarized among the types of organisms studied, with vertebrates studied in the field and invertebrates in the lab. We used video monitoring combined with DNA profiling of all of the members of a wild population of field crickets across two generations to capture the factors predicting the reproductive success of males and females. The factors that predict a male's success in gaining mates differ from those that predict how many offspring he has. We confirm the fundamental prediction that males vary more in their reproductive success than females, and we find that females as well as males leave more offspring when they mate with more partners.	[Rodriguez-Munoz, R.; Bretman, A.; Tregenza, T.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 EZ, England; [Bretman, A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Slate, J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Walling, C. A.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Exeter; University of East Anglia; University of Sheffield; University of Edinburgh	Tregenza, T (corresponding author), Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Cornwall Campus, Penryn TR10 EZ, England.	t.tregenza@exeter.ac.uk	Slate, Jon/D-2925-2012; Walling, Craig/HGT-8539-2022; Tregenza, Tom/B-1078-2014	Slate, Jon/0000-0003-3356-5123; Tregenza, Tom/0000-0003-4182-2222; Bretman, Amanda/0000-0002-4421-3337	Natural Environment Research Council (NERC) [NE/E005403/1]; NERC Sheffield Biomolecular Analysis Facility; Leverhulme Trust; Royal Society; Natural Environment Research Council [NE/H02364X/1, NE/E005403/1, NBAF010001] Funding Source: researchfish; NERC [NE/H02364X/1, NBAF010001] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC Sheffield Biomolecular Analysis Facility; Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC) (grant NE/E005403/1), the NERC Sheffield Biomolecular Analysis Facility, the Leverhulme Trust, and a Royal Society Fellowship to T. T. We thank L. Rodriguez and M. C. Munoz for providing access and facilities at the study site; J. M. Lopez, C. Lopez, E. Gonzalez, C. R. del Valle, and F. Gonzalez for assistance with the field work; and D. J. Hodgson and A. Wetherelt for assistance with data analysis and surveying.	Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bilde T, 2009, SCIENCE, V324, P1705, DOI 10.1126/science.1171675; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2006, BIOL LETT-UK, V2, P409, DOI 10.1098/rsbl.2006.0493; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clutton-Brock T. H., 1988, REPROD SUCCESS; Darwin C., 1871, P475; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; FINCKE OM, 1986, EVOLUTION, V40, P791, DOI 10.1111/j.1558-5646.1986.tb00539.x; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 1999, AM NAT, V154, P358, DOI 10.1086/303235; Kortet R, 2005, BEHAV ECOL SOCIOBIOL, V59, P77, DOI 10.1007/s00265-005-0011-1; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Schwarzenbach GA, 2005, J EVOLUTION BIOL, V18, P455, DOI 10.1111/j.1420-9101.2004.00820.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Snyder BF, 2007, EVOLUTION, V61, P2457, DOI 10.1111/j.1558-5646.2007.00212.x; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; ZUK M, 1993, BEHAV ECOL SOCIOBIOL, V33, P339; Zuk Marlene, 1997, P89, DOI 10.1017/CBO9780511721946.006	25	158	158	0	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1269	1272		10.1126/science.1188102	http://dx.doi.org/10.1126/science.1188102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522773				2022-12-28	WOS:000278318600032
J	Manfredi, AA; Rovere-Querini, P				Manfredi, Angelo A.; Rovere-Querini, Patrizia			The Mitochondrion - A Trojan Horse That Kicks Off Inflammation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DAMPS		[Manfredi, Angelo A.] Ist Sci San Raffaele, Milan, Italy; Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Manfredi, AA (corresponding author), Ist Sci San Raffaele, Milan, Italy.		Manfredi, Angelo A./C-7018-2014; Rovere-Querini, Patrizia/J-2340-2012	Manfredi, Angelo A./0000-0001-8370-6970; 				Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Davidov Y, 2009, BIOESSAYS, V31, P748, DOI 10.1002/bies.200900018; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	5	58	59	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2132	2134		10.1056/NEJMcibr1003521	http://dx.doi.org/10.1056/NEJMcibr1003521			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20519686				2022-12-28	WOS:000278242200016
J	Lucas, GM; Chaudhry, A; Hsu, J; Woodson, T; Lau, B; Olsen, Y; Keruly, JC; Fiellin, DA; Finkelstein, R; Barditch-Crovo, P; Cook, K; Moore, RD				Lucas, Gregory M.; Chaudhry, Amina; Hsu, Jeffrey; Woodson, Tanita; Lau, Bryan; Olsen, Yngvild; Keruly, Jeanne C.; Fiellin, David A.; Finkelstein, Ruth; Barditch-Crovo, Patricia; Cook, Katie; Moore, Richard D.			Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PATTERN-MIXTURE MODELS; PRIMARY-CARE; DRUG-USE; ANTIRETROVIRAL THERAPY; METHADONE-MAINTENANCE; OUTPATIENT TREATMENT; MEDICAL-CARE; BUPRENORPHINE; ABUSE; USERS	Background: Opioid dependence is common in HIV clinics. Buprenorphine-naloxone (BUP) is an effective treatment of opioid dependence that may be used in routine medical settings. Objective: To compare clinic-based treatment with BUP (clinic-based BUP) with case management and referral to an opioid treatment program (referred treatment). Design: Single-center, 12-month randomized trial. Participants and investigators were aware of treatment assignments. (ClinicalTrials.gov registration number: NCT00130819) Setting: HIV clinic in Baltimore, Maryland. Patients: 93 HIV-infected, opioid-dependent participants who were not receiving opioid agonist therapy and were not dependent on alcohol or benzodiazepines. Intervention: Clinic-based BUP included BUP induction and dose titration, urine drug testing, and individual counseling. Referred treatment included case management and referral to an opioid-treatment program. Measurements: Initiation and long-term receipt of opioid agonist therapy, urine drug test results, visit attendance with primary HIV care providers, use of antiretroviral therapy, and changes in HIV RNA levels and CD4 cell counts. Results: The average estimated participation in opioid agonist therapy was 74% (95% CI, 61% to 84%) for clinic-based BUP and 41% (CI, 29% to 53%) for referred treatment (P < 0.001). Positive test results for opioids and cocaine were significantly less frequent in clinic-based BUP than in referred treatment, and study participants receiving clinic-based BUP attended significantly more HIV primary care visits than those receiving referred treatment. Use of antiretroviral therapy and changes in HIV RNA levels and CD4 cell counts did not differ between the 2 groups. Limitation: This was a small single-center study, follow-up was only moderate, and the study groups were unbalanced in terms of recent drug injections at baseline. Conclusion: Management of HIV-infected, opioid-dependent patients with a clinic-based BUP strategy facilitates access to opioid agonist therapy and improves outcomes of substance abuse treatment.	Johns Hopkins Univ, Sch Med, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Baltimore Subst Abuse Syst, Baltimore, MD 21201 USA; Yale Univ, Sch Med, New Haven, CT USA; New York Acad Med, New York, NY 10029 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; New York Academy of Medicine	Lucas, GM (corresponding author), 1830 E Monument St,Room 435A, Baltimore, MD 21287 USA.	glucas@jhmi.edu		Fiellin, David/0000-0002-4006-010X	Health Resources and Services Administration Special Projects of National Significance program [H97HA03794]; National Center for Research Resources [UL1 RR 025005]; National Institutes of Health [K23DA015616, R01DA018577, K01AI071754, R01DA019511, R01DA025991, R01DA020576, K24DA000432, R01DA011602, R01AA016893]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI071754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020576, K24DA000432, R01DA019511, R01DA025991, R01DA018577, R01DA011602, K23DA015616] Funding Source: NIH RePORTER	Health Resources and Services Administration Special Projects of National Significance program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: By the Health Resources and Services Administration Special Projects of National Significance program (H97HA03794) and the National Center for Research Resources (UL1 RR 025005), a component of the National Institutes of Health and NIH Roadmap for Medical Research. Drs. Lucas, Lau, Fiellin, and Moore were also supported by the National Institutes of Health (K23DA015616, R01DA018577, K01AI071754, R01DA019511, R01DA025991, R01DA020576, K24DA000432, R01DA011602, and R01AA016893). Reckitt Benckiser Pharmaceuticals provided buprenorphine-naloxone for uninsured study participants.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Center for Substance Abuse Treatment, 2004, TREATM IMPR PROT TIP, V40; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; Fiellin DA, 2001, JAMA-J AM MED ASSOC, V286, P1724, DOI 10.1001/jama.286.14.1724; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; Hogan JW, 1997, STAT MED, V16, P239; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Lucas GM, 2006, AM J EPIDEMIOL, V163, P412, DOI 10.1093/aje/kwj059; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; Moore BA, 2007, J GEN INTERN MED, V22, P527, DOI 10.1007/s11606-007-0129-0; O'Connor PG, 1998, AM J MED, V105, P100, DOI 10.1016/S0002-9343(98)00194-6; O'Toole TP, 2002, J GEN INTERN MED, V17, P334, DOI 10.1007/s11606-002-0036-3; PEACHEY JE, 1988, BRIT J ADDICT, V83, P193; Rabe-Hesketh S, 2004, PSYCHOMETRIKA, V69, P167, DOI 10.1007/BF02295939; Schottenfeld RS, 1997, ARCH GEN PSYCHIAT, V54, P713; Sullivan LE, 2005, CLIN INFECT DIS, V41, P891, DOI 10.1086/432888; Sullivan LE, 2008, ANN INTERN MED, V148, P662, DOI 10.7326/0003-4819-148-9-200805060-00006; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; UMBRICHTSCHNEITER A, 1994, AM J PUBLIC HEALTH, V84, P207, DOI 10.2105/AJPH.84.2.207; Vlopp KG, 2009, NEW ENGL J MED, V361, P331, DOI 10.1056/NEJMp0903496; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715; Willenbring ML, 1999, ARCH INTERN MED, V159, P1946, DOI 10.1001/archinte.159.16.1946	27	83	84	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					704	W289		10.7326/0003-4819-152-11-201006010-00003	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20513828	Green Accepted			2022-12-28	WOS:000278560000003
J	St Johnston, D; Ahringer, J				St Johnston, Daniel; Ahringer, Julie			Cell Polarity in Eggs and Epithelia: Parallels and Diversity	CELL			English	Review							C-ELEGANS EMBRYOS; TIGHT JUNCTION FORMATION; ANTERIOR-POSTERIOR AXIS; CANINE KIDNEY-CELLS; ACTIVATED PROTEIN-KINASE; PLASMA-MEMBRANE DOMAINS; ADHESION MOLECULE JAM; OSKAR MESSENGER-RNA; LETHAL-GIANT-LARVAE; CAENORHABDITIS-ELEGANS	Cell polarity, the generation of cellular asymmetries, is necessary for diverse processes in animal cells, such as cell migration, asymmetric cell division, epithelial barrier function, and morphogenesis. Common mechanisms generate and transduce cell polarity in different cells, but cell type-specific processes are equally important. In this review, we highlight the similarities and differences between the polarity mechanisms in eggs and epithelia. We also highlight the prospects for future studies on how cortical polarity interfaces with other cellular processes, such as morphogenesis, exocytosis, and lipid signaling, and how defects in polarity contribute to tumor formation.	[St Johnston, Daniel; Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [St Johnston, Daniel; Ahringer, Julie] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	d.stjohnston@gurdon.cam.ac.uk; j.ahringer@gurdon.cam.ac.uk	St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301; Ahringer, Julie/0000-0002-7074-4051	Wellcome Trust; Cancer Research UK	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	D. StJ. and J. A. are supported by fellowships from the Wellcome Trust and core funding from the Wellcome Trust and Cancer Research UK.	Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Baumann O, 2001, EXP CELL RES, V270, P176, DOI 10.1006/excr.2001.5343; Bayraktar J, 2006, J CELL SCI, V119, P711, DOI 10.1242/jcs.02789; Becalska AN, 2010, DEV BIOL, V340, P528, DOI 10.1016/j.ydbio.2010.02.006; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Beronja S, 2005, J CELL BIOL, V169, P635, DOI 10.1083/jcb.200410081; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bohl J, 2007, J BIOL CHEM, V282, P9392, DOI 10.1074/jbc.M610002200; Bossinger O, 2004, DEV BIOL, V268, P448, DOI 10.1016/j.ydbio.2004.01.003; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Cowan CR, 2007, DEVELOPMENT, V134, P1035, DOI 10.1242/dev.000513; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Daniels BR, 2009, J CELL BIOL, V184, P473, DOI 10.1083/jcb.200809077; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Doerflinger H, 2003, DEVELOPMENT, V130, P3965, DOI 10.1242/dev.00616; Doerflinger H, 2006, CURR BIOL, V16, P1090, DOI 10.1016/j.cub.2006.04.001; Doerflinger H, 2010, DEVELOPMENT, V137, P1765, DOI 10.1242/dev.045807; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Eisen R, 2006, AM J PHYSIOL-CELL PH, V290, pC1297, DOI 10.1152/ajpcell.00287.2005; Fan SL, 2007, J CELL BIOL, V178, P387, DOI 10.1083/jcb.200609096; Feng W, 2007, EMBO J, V26, P2786, DOI 10.1038/sj.emboj.7601702; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Kumfer KT, 2010, MOL BIOL CELL, V21, P266, DOI 10.1091/mbc.E09-01-0060; Laprise P, 2004, J BIOL CHEM, V279, P10157, DOI 10.1074/jbc.M309843200; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Li Q, 2008, CELL RES, V18, P372, DOI 10.1038/cr.2008.25; Li ZH, 2008, J CELL BIOL, V180, P31, DOI 10.1083/jcb.200707007; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Michel D, 2005, J CELL SCI, V118, P4049, DOI 10.1242/jcs.02528; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Mizuno K, 2003, J BIOL CHEM, V278, P31240, DOI 10.1074/jbc.M303593200; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; MORTON DG, 1992, GENETICS, V130, P771; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Satohisa S, 2005, EXP CELL RES, V310, P66, DOI 10.1016/j.yexcr.2005.06.025; Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Sonneville R, 2004, DEVELOPMENT, V131, P3527, DOI 10.1242/dev.01244; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tian AG, 2008, DEVELOPMENT, V135, P463, DOI 10.1242/dev.016253; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Vanzo N, 2007, DEV CELL, V12, P543, DOI 10.1016/j.devcel.2007.03.002; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; WANG AZ, 1990, J CELL SCI, V95, P137; WANG AZ, 1990, J CELL SCI, V95, P153; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; YARNITZKY T, 1995, DEV BIOL, V169, P609, DOI 10.1006/dbio.1995.1173; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zimyanin V, 2007, CURR BIOL, V17, P353, DOI 10.1016/j.cub.2006.12.044; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	165	352	352	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					757	774		10.1016/j.cell.2010.05.011	http://dx.doi.org/10.1016/j.cell.2010.05.011			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510924	Bronze			2022-12-28	WOS:000278132900012
J	George, A; Chopra, M; Seymour, D; Marchi, P				George, Asha; Chopra, Mickey; Seymour, Daniel; Marchi, Paolo			Making rights more relevant for health professionals	LANCET			English	Editorial Material									[George, Asha; Chopra, Mickey] UNICEF, Hlth Sect, New York, NY 10017 USA; [Seymour, Daniel; Marchi, Paolo] UNICEF, Gender & Rights Unit, New York, NY 10017 USA	UNICEF; UNICEF	George, A (corresponding author), UNICEF, Hlth Sect, New York, NY 10017 USA.	ageorge@unicef.org		George, Asha/0000-0002-5968-1424				Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; George A, 2008, Glob Public Health, V3 Suppl 1, P75, DOI 10.1080/17441690801892240; Gruskin S, 2008, AM J PUBLIC HEALTH, V98, P1573, DOI 10.2105/AJPH.2007.123182; *INT IN MAT MORT H, 2009, MISS LINK APPL BUDG; Kar K, 2008, HDB COMMUNITY LED TO; *MOTHERS2MOTHERS, HIV POS WOM MENT OTH; Narsee A., 2021, EUOBSERVER; NUNEZURQUIZA RM, 2009, STATE WORLDS CHILDRE, P73; Office of the United Nations High Commissioner for Human Rights, 1989, CONV RIGHTS CHILD CR; Office of the United Nations High Commissioner for Human Rights, 1979, CONV EL ALL FORMS DI; *OHCHR, 2008, WHO EL FEM GEN MULT; Sen A., 2010, IDEA JUSTICE, DOI DOI 10.2307/J.CTVJNRV7N; Solomon Robert C., 1995, PASSION JUSTICE EMOT; unicef, 2009, STATE WORLDS CHILDRE; *UNICEF, 2008, STAT WORLDS CHILDR 2, P70; UNICEF, 2002, AD TIM MATT; UNICEF DIFID, 2008, MAT PER DEATH ENQ RE; United Nations Committee on Economic Social and Cultural Rights, 2000, RIGHT HIGH ATT STAND; Yamin Alicia Ely, 2009, Health Hum Rights, V11, P5	19	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 22	2010	375	9728					1764	1765		10.1016/S0140-6736(09)62102-4	http://dx.doi.org/10.1016/S0140-6736(09)62102-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20494714				2022-12-28	WOS:000278216500009
J	Kerr, T; Montaner, JSG; Wood, E				Kerr, Thomas; Montaner, Julio S. G.; Wood, Evan			Science and politics of heroin prescription	LANCET			English	Editorial Material							ASSISTED TREATMENT; METHADONE		[Kerr, Thomas; Wood, Evan] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, Vancouver, BC V6Z 1Y6, Canada; [Kerr, Thomas; Montaner, Julio S. G.; Wood, Evan] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Kerr, T (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, Vancouver, BC V6Z 1Y6, Canada.	uhri@cfenet.ubc.ca	Montaner, Julio/K-7621-2012		NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER; NIDA NIH HHS [DP1 DA026182] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Berridge V, 2009, NEW ENGL J MED, V361, P820, DOI 10.1056/NEJMe0904243; FERRI M, 2003, COCHRANE DB SYST REV, V3; Fischer B, 2002, EUR J PUBLIC HEALTH, V12, P228, DOI 10.1093/eurpub/12.3.228; Fischer B, 2007, J URBAN HEALTH, V84, P552, DOI 10.1007/s11524-007-9198-y; Gartry CC, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-2; Haasen C, 2007, BRIT J PSYCHIAT, V191, P55, DOI 10.1192/bjp.bp.106.026112; KAHAN M, 2008, NAOMI TRIAL CRITICAL; March JC, 2006, J SUBST ABUSE TREAT, V31, P203, DOI 10.1016/j.jsat.2006.04.007; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P2195; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; SCHECHTER M, 2008, PROVINCE VANCOU 0526; Sneader W, 1998, LANCET, V352, P1697, DOI 10.1016/S0140-6736(98)07115-3; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; Wodak AD, 2002, MED J AUSTRALIA, V176, P449, DOI 10.5694/j.1326-5377.2002.tb04510.x	15	9	9	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1849	1850		10.1016/S0140-6736(10)60544-2	http://dx.doi.org/10.1016/S0140-6736(10)60544-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609BC	20511000				2022-12-28	WOS:000278628800005
J	Zhang, YT; Baicker, K; Newhouse, JP				Zhang, Yuting; Baicker, Katherine; Newhouse, Joseph P.			Geographic Variation in Medicare Drug Spending.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhang, Yuting] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA; [Baicker, Katherine; Newhouse, Joseph P.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University	Zhang, YT (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA.		Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019	Zhang, Yuting/0000-0002-6460-6779	NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088510] Funding Source: NIH RePORTER; NIMH NIH HHS [RC1 MH088510-01, RC1 MH088510] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1999, DARTMOUTH ATLAS HLTH; *CTR MED MED SERV, 2010, HIER COND CAT CMS HC; MaCurdy T., 2009, GEOGRAPHIC VARIATION; Medicare Payment Advisory Committee, 2009, REP C MEAS REG VAR S; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881	5	78	78	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2010	363	5					405	409		10.1056/NEJMp1004872	http://dx.doi.org/10.1056/NEJMp1004872			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GS	20538621	Green Accepted			2022-12-28	WOS:000280411300003
J	Woodward, JJ; Iavarone, AT; Portnoy, DA				Woodward, Joshua J.; Iavarone, Anthony T.; Portnoy, Daniel A.			c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response	SCIENCE			English	Article							CHECKPOINT PROTEIN; ESSENTIAL GENES; RECOGNITION; FLAGELLIN; TRANSPORTERS; INFECTION; BACTERIA; REQUIRES	Intracellular bacterial pathogens, such as Listeria monocytogenes, are detected in the cytosol of host immune cells. Induction of this host response is often dependent on microbial secretion systems and, in L. monocytogenes, is dependent on multidrug efflux pumps (MDRs). Using L. monocytogenes mutants that overexpressed MDRs, we identified cyclic diadenosine monophosphate (c-di-AMP) as a secreted molecule able to trigger the cytosolic host response. Overexpression of the di-adenylate cyclase, dacA (lmo2120), resulted in elevated levels of the host response during infection. c-di-AMP thus represents a putative bacterial secondary signaling molecule that triggers a cytosolic pathway of innate immunity and is predicted to be present in a wide variety of bacteria and archea.	[Woodward, Joshua J.; Portnoy, Daniel A.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; [Portnoy, Daniel A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Portnoy, DA (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	portnoy@berkeley.edu			NIH [P01 AI063302, T32 CA 009179]; NATIONAL CANCER INSTITUTE [T32CA009179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank K. Monroe and R. Vance for MAVS<SUP>-/-</SUP> BMDMs and Portnoy laboratory members J. D. Sauer and C. Rae for BMDMs. This work was supported by NIH grant P01 AI063302 (D. A. P.) and NIH training grant T32 CA 009179 (J. J. W.). D. A. Portnoy has a consulting relationship with and a financial interest in Aduro BioTech, which stands to benefit from commercialization of the results of this research. A patent covering the use of Listeria monocytogenes strains that express enhanced or diminished levels of c-di-AMP for use as vaccine vectors has been applied for.	Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Crimmins GT, 2008, P NATL ACAD SCI USA, V105, P10191, DOI 10.1073/pnas.0804170105; de Avalos SV, 2002, J BIOL CHEM, V277, P639, DOI 10.1074/jbc.M109037200; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Neyfakh AA, 1997, TRENDS MICROBIOL, V5, P309, DOI 10.1016/S0966-842X(97)01064-0; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Song JH, 2005, MOL CELLS, V19, P365; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Yang S, 2006, P NATL ACAD SCI USA, V103, P2386, DOI 10.1073/pnas.0502890102	26	546	584	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1703	1705		10.1126/science.1189801	http://dx.doi.org/10.1126/science.1189801			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20508090	Green Accepted			2022-12-28	WOS:000279107400046
J	Palmer, L; Lynch, G				Palmer, Linda; Lynch, Gary			A Kantian View of Space	SCIENCE			English	Editorial Material							SPATIAL MAP		[Palmer, Linda; Lynch, Gary] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Palmer, L (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	lcpalmer@uci.edu						[Anonymous], 1983, KANTS TRANSCENDENTAL; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Kant I., 1781, KRITIK REINEN VERNUN; Kramar EA, 2003, NEUROSCIENCE, V118, P387, DOI 10.1016/S0306-4522(02)00916-8; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Palmer L, 2008, REV GEN PSYCHOL, V12, P105, DOI 10.1037/1089-2680.12.2.105; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224	9	8	9	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1487	1488		10.1126/science.1191527	http://dx.doi.org/10.1126/science.1191527			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	611XW	20558692				2022-12-28	WOS:000278859200020
J	Dasenbrook, EC; Checkley, W; Merlo, CA; Konstan, MW; Lechtzin, N; Boyle, MP				Dasenbrook, Elliott C.; Checkley, William; Merlo, Christian A.; Konstan, Michael W.; Lechtzin, Noah; Boyle, Michael P.			Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; PULMONARY-FUNCTION; CHOICE	Context The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the respiratory tract of individuals with cystic fibrosis (CF) has increased dramatically; however, its impact on outcomes in CF is unclear. Because the time between infection with bacteria in CF and death can be decades, observational studies with long periods of follow-up are well suited to address the current gap in knowledge. Objective To determine whether isolation of MRSA from the respiratory tract of CF patients is associated with worse survival compared with patients who never have a culture positive for MRSA. Design, Setting, and Participants Cohort study of 19 833 CF patients aged 6 to 45 years seen at centers accredited by the Cystic Fibrosis Foundation in the United States. Patients entered between January 1996 and December 2006 and were followed up through December 2008. Cox regression models with time-varying covariates were used to compare survival between CF patients with and without respiratory tract MRSA. Main Outcome Measure Time from age at entry until age at death from any cause. Results In 137 819 patient-years of observation (median, 7.3 years/patient), 2537 CF patients died and 5759 patients had MRSA detected. The mortality rate was 18.3 deaths (95% confidence interval [CI], 17.5-19.1) per 1000 patient-years in patients without MRSA and 27.7 deaths (95% CI, 25.3-30.4) per 1000 patient-years in those with MRSA. Among those with MRSA, the attributable risk percentage of death associated with MRSA was 34.0% (95% CI, 26.7%-40.4%). The unadjusted hazard ratio associated with MRSA was 1.47 (95% CI, 1.32-1.62). After adjustment for time-varying covariates associated with severity of illness, MRSA remained associated with a higher risk of death (1.27; 95% CI, 1.11-1.45). Conclusion Detection of MRSA in the respiratory tract of CF patients was associated with worse survival. JAMA. 2010; 303(23): 2386-2392	[Dasenbrook, Elliott C.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.] Case Western Reserve Univ, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Konstan, Michael W.] Case Western Reserve Univ, Sch Med, Dept Pediat, Div Pediat Pulmonol & Allergy Immunol, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Konstan, Michael W.] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Checkley, William; Merlo, Christian A.; Lechtzin, Noah; Boyle, Michael P.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Checkley, William] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dasenbrook, EC (corresponding author), Univ Hosp Case Med Ctr, 11100 Euclid Ave,Mailstop WRN 5067, Cleveland, OH 44106 USA.	ecd28@case.edu		Checkley, William/0000-0003-1106-8812; Konstan, Michael/0000-0002-0557-7277; Boyle, Michael/0000-0002-9740-1630; Dasenbrook, Elliott/0000-0001-9811-8004	Cystic Fibrosis Foundation [DASENB08D0]; Johns Hopkins University; National Heart, Lung, and Blood Institute [K99HL096955]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Johns Hopkins University(Johns Hopkins University); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant DASENB08D0 from the Cystic Fibrosis Foundation and a Research Development Program grant to Case Western Reserve University from the Cystic Fibrosis Foundation. Dr Checkley is supported by a Clinician Scientist Award from Johns Hopkins University and a Pathway to Independence Award (K99HL096955) from the National Heart, Lung, and Blood Institute.	Boyle MP, 2007, JAMA-J AM MED ASSOC, V298, P1787, DOI 10.1001/jama.298.15.1787; Collett D., 1994, MODELING SURVIVAL DA; *CYST FIBR FDN PAT, 2009, 2008 ANN DAT REP; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Elizur A, 2007, CHEST, V131, P1718, DOI 10.1378/chest.06-2756; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Moran A., 1999, Diabetes Research and Clinical Practice, V45, P61, DOI 10.1016/S0168-8227(99)00058-3; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sawicki GS, 2008, PEDIATR PULM, V43, P1117, DOI 10.1002/ppul.20914; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Therneau TM, 2000, MODELING SURVIVAL DA; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; VANDENBRANDEN SL, 2007, PEDIAT PULMONOL S30, V42, pS365; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S	21	251	253	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2386	2392		10.1001/jama.2010.791	http://dx.doi.org/10.1001/jama.2010.791			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551409	Bronze			2022-12-28	WOS:000278759200028
J	Sox, HC; Greenfield, S				Sox, Harold C.; Greenfield, Sheldon			Quality of Care-How Good Is Good Enough?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sox, Harold C.] Dartmouth Med Sch, Hanover, NH USA; [Sox, Harold C.] Dartmouth Inst, Hanover, NH USA; [Greenfield, Sheldon] Univ Calif Irvine, Irvine, CA 92717 USA	Dartmouth College; Dartmouth College; University of California System; University of California Irvine	Sox, HC (corresponding author), 31 Faraway Ln, Hanover, NH 03784 USA.	hsox@comcast.net		Greenfield, Sheldon/0000-0003-4628-1998				Kaplan S. H., 1995, PROVIDING QUALITY CA; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Sepucha K, 2007, PATIENT EDUC COUNS, V65, P261, DOI 10.1016/j.pec.2006.08.007; Sepucha KR, 2008, PATIENT EDUC COUNS, V73, P504, DOI 10.1016/j.pec.2008.07.009	5	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2403	2404		10.1001/jama.2010.810	http://dx.doi.org/10.1001/jama.2010.810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	610TE	20551411				2022-12-28	WOS:000278759200031
J	Arie, S				Arie, Sophie			Disaster Relief What next for Haiti's healthcare?	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk							0	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2010	340								c3078	10.1136/bmj.c3078	http://dx.doi.org/10.1136/bmj.c3078			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551124				2022-12-28	WOS:000279051800007
J	Levine, M; Ruha, A				Levine, Michael; Ruha, Anne-Michelle			Rattlesnake Envenomation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												michael.levine@bannerhealth.com							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2212	2212		10.1056/NEJMicm0904484	http://dx.doi.org/10.1056/NEJMicm0904484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558372				2022-12-28	WOS:000278551500010
J	Ship, AN				Ship, Amy N.			The Most Primary of Care -- Talking about Driving and Distraction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ship, Amy N.] Harvard Univ, Sch Med, Boston, MA 02163 USA; [Ship, Amy N.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Ship, AN (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.							*NAT MUT INS, NAT DWD 98 PERC AM B; National Safety Council, 2010, NAT SAF COUNC EST LE; Strayer DL, 2006, HUM FACTORS, V48, P381, DOI 10.1518/001872006777724471; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; *VIRGINIATECH TRAN, 2009, NEW DAT VTTI PROV IN	5	12	12	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2145	2147		10.1056/NEJMp0910137	http://dx.doi.org/10.1056/NEJMp0910137			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608AL	20558364				2022-12-28	WOS:000278551500001
J	Brook, RH				Brook, Robert H.			Rights and Responsibilities in Health Care Striking a Balance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									RAND Corp, Santa Monica, CA 90407 USA	RAND Corporation	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA.	robert_brook@rand.org						Cohen DA, 2008, DIABETES, V57, P1768, DOI 10.2337/db08-0163; Comarow Avery, 2009, US News World Rep, V146, P91; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Institute of Medicine, 2010, POP BAS POL SYST CHA; Linnan L, 2008, AM J PUBLIC HEALTH, V98, P1503, DOI 10.2105/AJPH.2006.100313; Marmot M, 2010, FAIR SOC HLTH LIVES; Steinbrook R, 2006, NEW ENGL J MED, V355, P753, DOI 10.1056/NEJMp068141	7	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2289	2290		10.1001/jama.2010.787	http://dx.doi.org/10.1001/jama.2010.787			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	607IY	20530783				2022-12-28	WOS:000278496800029
J	Spence, D				Spence, Des			From the Frontline Compulsive doing: sport in childhood	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2010	340								c3071	10.1136/bmj.c3071	http://dx.doi.org/10.1136/bmj.c3071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534680				2022-12-28	WOS:000278818500008
J	Aragao, LEOC; Shimabukuro, YE				Aragao, Luiz E. O. C.; Shimabukuro, Yosio E.			The Incidence of Fire in Amazonian Forests with Implications for REDD	SCIENCE			English	Article							CLIMATE-CHANGE; DEFORESTATION; EMISSIONS; REGROWTH; BIOMASS; DIEBACK; CARBON	Reducing emissions from deforestation and degradation (REDD) may curb carbon emissions, but the consequences for fire hazard are poorly understood. By analyzing satellite-derived deforestation and fire data from the Brazilian Amazon, we show that fire occurrence has increased in 59% of the area that has experienced reduced deforestation rates. Differences in fire frequencies across two land-use gradients reveal that fire-free land-management can substantially reduce fire incidence by as much as 69%. If sustainable fire-free land-management of deforested areas is not adopted in the REDD mechanism, then the carbon savings achieved by avoiding deforestation may be partially negated by increased emissions from fires.	[Aragao, Luiz E. O. C.] Univ Exeter, Sch Geog, Landscape & Ecosyst Dynam Grp, Exeter EX4 4RJ, Devon, England; [Shimabukuro, Yosio E.] Natl Inst Space Res, Remote Sensing Div, BR-12227010 Sao Paulo, Brazil	University of Exeter; Instituto Nacional de Pesquisas Espaciais (INPE)	Aragao, LEOC (corresponding author), Univ Exeter, Sch Geog, Landscape & Ecosyst Dynam Grp, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England.	l.aragao@exeter.ac.uk	Shimabukuro, Yosio E/F-2956-2012; aragao, luiz eoc/G-8387-2012	Shimabukuro, Yosio E/0000-0002-1469-8433; aragao, luiz eoc/0000-0002-4134-6708	U.K. Natural Environment Research Council [NE/F015356/2]; NERC [NE/F015356/2] Funding Source: UKRI; Natural Environment Research Council [NE/F015356/2] Funding Source: researchfish	U.K. Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the U.K. Natural Environment Research Council for providing funds to L.E.O.C.A. (NE/F015356/2). We acknowledge the valuable discussions with L. Anderson, T. Quine, and P. Cox during elaboration of this manuscript and thank A. Lima for providing the MODIS fire data set for the supporting analysis. We thank the Brazilian Institute for Space Research for making available their deforestation and fire data sets and the European Commission's Joint Research Centre for making available their land cover map.	Alves DS, 2002, INT J REMOTE SENS, V23, P2903, DOI 10.1080/01431160110096791; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Carvalho GO, 2002, ENVIRONMENT, V44, P34, DOI 10.1080/00139150209605606; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Denich M, 2005, AGR ECOSYST ENVIRON, V110, P43, DOI 10.1016/j.agee.2005.05.005; Eva H, 2000, J BIOGEOGR, V27, P765, DOI 10.1046/j.1365-2699.2000.00441.x; Eva HD, 2004, GLOBAL CHANGE BIOL, V10, P731, DOI 10.1111/j.1529-8817.2003.00774.x; Ewers RM, 2008, ENVIRON CONSERV, V35, P303, DOI 10.1017/S0376892908005122; Fearnside PM, 2007, FOREST ECOL MANAG, V242, P678, DOI 10.1016/j.foreco.2007.02.002; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; *INPE, PRODES PROGR DEF ASS; *INPE, 2006, QUEIM PROJ; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Nepstad D, 2004, GLOBAL CHANGE BIOL, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671	29	200	205	8	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1275	1278		10.1126/science.1186925	http://dx.doi.org/10.1126/science.1186925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522775				2022-12-28	WOS:000278318600034
J	Puneet, P; Yap, CT; Wong, LK; Yulin, L; Koh, DR; Moochhala, S; Pfeilschifter, J; Huwiler, A; Melendez, AJ				Puneet, Padmam; Yap, Celestial T.; Wong, Lingkai; Yulin, Lam; Koh, Dow Rhoon; Moochhala, Shabbir; Pfeilschifter, Josef; Huwiler, Andrea; Melendez, Alirio J.			SphK1 Regulates Proinflammatory Responses Associated with Endotoxin and Polymicrobial Sepsis	SCIENCE			English	Article							SPHINGOSINE KINASE 1; FC-GAMMA-RI; INFLAMMATORY RESPONSES; CECAL LIGATION; CA2+ SIGNALS; MODULATION; ACTIVATION; RECEPTOR; THERAPY; EPSILON	During sepsis, activation of phagocytes leads to the overproduction of proinflammatory cytokines, causing systemic inflammation. Despite substantial information regarding the underlying molecular mechanisms that lead to sepsis, several elements in the pathway remain to be elucidated. We found that the enzyme sphingosine kinase 1 (SphK1) is up-regulated in stimulated human phagocytes and in peritoneal phagocytes of patients with severe sepsis. Blockade of SphK1 inhibited phagocyte production of endotoxin-induced proinflammatory cytokines. We observed protection against sepsis in mice treated with a specific SphK1 inhibitor that was enhanced by treatment with a broad-spectrum antibiotic. These results demonstrated a critical role for SphK1 in endotoxin signaling and sepsis-induced inflammatory responses and suggest that inhibition of SphK1 is a potential therapy for septic shock.	[Puneet, Padmam; Yap, Celestial T.; Koh, Dow Rhoon; Melendez, Alirio J.] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Wong, Lingkai; Yulin, Lam] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Moochhala, Shabbir] Def Med & Environm Res Inst, DSO Natl Labs, Singapore 117510, Singapore; [Pfeilschifter, Josef] Univ Hosp, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany; [Huwiler, Andrea] Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland; [Melendez, Alirio J.] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland	National University of Singapore; National University of Singapore; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Bern; University of Glasgow	Melendez, AJ (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore.	a.melendez-romero@clinmed.gla.ac.uk		MOOCHHALA, SHABBIR/0000-0003-4521-3192	Medical Research Council UK; Biomedical Research Council of Singapore; Swiss National Foundation; German Research Foundation; Medical Research Council [G0700794] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German Research Foundation(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A.-K. Melendez-Fraser for proofreading the manuscript. We thank M. M. Harnett for advice during the preparation of the manuscript. This work was supported by grants from the Medical Research Council UK, the Biomedical Research Council of Singapore, the Swiss National Foundation (to A.H.) and the German Research Foundation ( to A. H. and J.P.). A patent application has been filed for compound 5c (U.S. Provisional Patent Application 61/217,334) by A.J.M., Y.L., X.H., and L.W. A material transfer agreement is required for use of SphK1<SUP>-/-</SUP> and SphK2<SUP>-/-</SUP> mice and compound 5c.	BEAL AL, 1994, JAMA-J AM MED ASSOC, V271, P226, DOI 10.1001/jama.271.3.226; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Dellinger RP, 2004, CRIT CARE MED, V32, P282, DOI 10.1097/01.CCM.0000105423.06091.8E; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Gu X, 2003, TRENDS GENET, V19, P354, DOI 10.1016/S0168-9525(03)00139-2; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Marik PE, 2001, DM-DIS MON, V47, P465, DOI 10.1067/mda.2001.119745; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Melendez A, 1998, CURR BIOL, V8, P210, DOI 10.1016/S0960-9822(98)70085-5; Melendez AJ, 2008, BBA-PROTEINS PROTEOM, V1784, P66, DOI 10.1016/j.bbapap.2007.07.013; Melendez AJ, 2004, J IMMUNOL, V173, P1596, DOI 10.4049/jimmunol.173.3.1596; Melendez AJ, 2002, J BIOL CHEM, V277, P17255, DOI 10.1074/jbc.M110944200; Melendez AJ, 2001, BLOOD, V98, P3421, DOI 10.1182/blood.V98.12.3421; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; PUSHPARAJ PN, 2008, INT J BIOCHEM CELL B, V40, P1167; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Weighardt H, 2007, IMMUNOBIOLOGY, V212, P715, DOI 10.1016/j.imbio.2007.09.010; Wong LK, 2009, J MED CHEM, V52, P3618, DOI 10.1021/jm900121d; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646	26	111	115	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1290	1294		10.1126/science.1188635	http://dx.doi.org/10.1126/science.1188635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522778				2022-12-28	WOS:000278318600039
J	Swain, SM; Jeong, JH; Geyer, CE; Costantino, JP; Pajon, ER; Fehrenbacher, L; Atkins, JN; Polikoff, J; Vogel, VG; Erban, JK; Rastogi, P; Livingston, RB; Perez, EA; Mamounas, EP; Land, SR; Ganz, PA; Wolmark, N				Swain, Sandra M.; Jeong, Jong-Hyeon; Geyer, Charles E., Jr.; Costantino, Joseph P.; Pajon, Eduardo R.; Fehrenbacher, Louis; Atkins, James N.; Polikoff, Jonathan; Vogel, Victor G.; Erban, John K.; Rastogi, Priya; Livingston, Robert B.; Perez, Edith A.; Mamounas, Eleftherios P.; Land, Stephanie R.; Ganz, Patricia A.; Wolmark, Norman			Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADJUVANT CHEMOTHERAPY; PREMENOPAUSAL WOMEN; DOXORUBICIN; DOCETAXEL; CYCLOPHOSPHAMIDE; OUTCOMES	BACKGROUND Chemotherapy regimens that combine anthracyclines and taxanes result in improved disease-free and overall survival among women with operable lymph-node-positive breast cancer. The effectiveness of concurrent versus sequential regimens is not known. METHODS We randomly assigned 5351 patients with operable, node-positive, early-stage breast cancer to receive four cycles of doxorubicin and cyclophosphamide followed by four cycles of docetaxel (sequential ACT); four cycles of doxorubicin and docetaxel (doxorubicin-docetaxel); or four cycles of doxorubicin, cyclophosphamide, and docetaxel (con-current ACT). The primary aims were to examine whether concurrent ACT was more effective than sequential ACT and whether the doxorubicin-docetaxel regimen would be as effective as the concurrent-ACT regimen. The secondary aims were to assess toxic effects and to correlate amenorrhea with outcomes in premenopausal women. RESULTS At a median follow-up of 73 months, overall survival was improved in the sequential-ACT group (8-year overall survival, 83%) as compared with the doxorubicin-docetaxel group (overall survival, 79%; hazard ratio for death, 0.83; P=0.03) and the concurrent-ACT group (overall survival, 79%; hazard ratio, 0.86; P=0.09). Disease-free survival was improved in the sequential-ACT group (8-year disease-free survival, 74%) as compared with the doxorubicin-docetaxel group (disease-free survival, 69%; hazard ratio for recurrence, a second malignant condition, or death, 0.80; P=0.001) and the concurrent-ACT group (disease-free survival, 69%; hazard ratio, 0.83; P=0.01). The doxorubicin-docetaxel regimen showed noninferiority to the concurrent-ACT regimen for overall survival (hazard ratio, 0.96; 95% confidence interval, 0.82 to 1.14). Overall survival was improved in patients with amenorrhea for 6 months or more across all treatment groups, independently of estrogen-receptor status. CONCLUSIONS Sequential ACT improved disease-free survival as compared with doxorubicin-docetaxel or concurrent ACT, and it improved overall survival as compared with doxorubicin-docetaxel. Amenorrhea was associated with improved survival regardless of the treatment and estrogen-receptor status. (ClinicalTrials.gov number, NCT00003782.)	[Swain, Sandra M.] Washington Hosp Ctr, Washington Canc Inst, Washington, DC 20010 USA; [Jeong, Jong-Hyeon; Costantino, Joseph P.; Land, Stephanie R.] Univ Pittsburgh, NSABP Biostat Ctr, Pittsburgh, PA USA; [Jeong, Jong-Hyeon; Costantino, Joseph P.; Land, Stephanie R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Geyer, Charles E., Jr.; Wolmark, Norman] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; [Vogel, Victor G.; Rastogi, Priya] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Pajon, Eduardo R.] Colorado Canc Res Program, Denver, CO USA; [Fehrenbacher, Louis] Kaiser Permanente No Calif, Vallejo, CA USA; [Atkins, James N.] SE Canc Control Consortium, Clin Canc Oncol Program, Goldsboro, NC USA; [Polikoff, Jonathan] So Calif Kaiser Permanente, San Diego, CA USA; [Vogel, Victor G.] Amer Canc Soc, Atlanta, GA 30329 USA; [Erban, John K.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Erban, John K.] Harvard Univ, Sch Med, Boston, MA USA; [Erban, John K.] Eastern Cooperat Oncol Grp, Philadelphia, PA USA; [Livingston, Robert B.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Livingston, Robert B.] SW Oncol Grp, Ann Arbor, MI USA; [Perez, Edith A.] Mayo Clin, Jacksonville, FL USA; [Perez, Edith A.] N Cent Canc Treatment Grp, Rochester, MN USA; [Mamounas, Eleftherios P.] Aultman Hlth Fdn, Canton, OH USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Med & Publ Hlth, Los Angeles, CA 90024 USA	MedStar Washington Hospital Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; Kaiser Permanente; American Cancer Society; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Arizona Center Cancer Care; University of Arizona; Southwest Oncology Group; Mayo Clinic; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Swain, SM (corresponding author), Washington Hosp Ctr, Washington Canc Inst, 110 Irving St NW, Washington, DC 20010 USA.	sandra.m.swain@medstar.net	Geyer, Charles/AGY-0119-2022	Geyer, Charles/0000-0002-2379-5702; Swain, Sandra/0000-0002-1320-3830; Jeong, Jong/0000-0003-0596-2201	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [U10-CA-37377, U10-CA-69974, U10-CA-12027, U10-CA-69651, CA07190, CA2115, CA-25224, CA-32102, CA-13612, CA-58348, CA-45808]; Sanofi-Aventis; Rhone-Poulenc-Rhorer; Genentech; Bristol-Myers Squibb; Susan G. Komen for the Cure Foundation, Living in Pink, and Safeway; Eisai; GlaxoSmithKline; Pfizer; Onyx; Novartis; Roche; Abraxis; BiPar; Wyeth; NSABP; Kaiser Permanente; Eastern Cooperative Oncology Group; Lance Armstrong Foundation; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [U10CA069974, U10CA058348, U10CA032102, U10CA012027, U10CA007190, U10CA045808, U10CA013612, U10CA025224, U10CA069651, U10CA037377] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sanofi-Aventis(Sanofi-Aventis); Rhone-Poulenc-Rhorer; Genentech(Roche HoldingGenentech); Bristol-Myers Squibb(Bristol-Myers Squibb); Susan G. Komen for the Cure Foundation, Living in Pink, and Safeway(Susan G. Komen Breast Cancer Foundation); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Onyx; Novartis(Novartis); Roche(Roche Holding); Abraxis; BiPar; Wyeth(Wyeth); NSABP; Kaiser Permanente; Eastern Cooperative Oncology Group; Lance Armstrong Foundation; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Public Health Service grants (U10-CA-37377, U10-CA-69974, U10-CA-12027, and U10-CA-69651 to the National Surgical Adjuvant Breast and Bowel Project; CA07190 to Dr. Erban; CA2115 to the Eastern Cooperative Oncology Group; CA-25224 to the North Central Cancer Treatment Group; and CA-32102, CA-13612, CA-58348, and CA-45808 to the Southwest Oncology Group) from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services; and by Sanofi-Aventis.; Dr. Swain reports receiving consulting fees from Rhone-Poulenc-Rhorer, grant support from Genentech, Sanofi-Aventis, Bristol-Myers Squibb, the Susan G. Komen for the Cure Foundation, Living in Pink, and Safeway, donations to the Washington Hospital Center Foundation from Genentech, Sanofi-Aventis, and Eisai, in-kind travel fees from Sanofi-Aventis, and grants to her institution (Medstar Research Institute) from Genentech, GlaxoSmithKline, Pfizer, Onyx, Novartis, Roche, Abraxis, BiPar, and Wyeth. Dr. Pajon reports receiving travel fees from the NSABP, which also provided fees to cover the clinical research associates and data managers; and owning stocks with his spouse in Gilead, Abbott, and Bristol-Myers Squibb. Dr. Fehrenbacher reports receiving grants and travel fees from Kaiser Permanente. Dr. Vogel reports receiving grants to the University of Pittsburgh from Sanofi-Aventis. Dr. Erban reports receiving grants from the Eastern Cooperative Oncology Group. Dr. Mamounas reports receiving consulting and lecture fees and serving on an advisory board for Sanofi-Aventis. Dr. Ganz reports receiving research support from the Lance Armstrong Foundation and the Breast Cancer Research Foundation. Drs. Geyer and Wolmark report receiving funding from Sanofi-Aventis for work performed by the NSABP to cover costs for non-standard of care procedures required by the study. No other potential conflict of interest relevant to this article was reported.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; *AM JOINT COMM CAN, 1997, AJCC CANC STAG MAN; [Anonymous], SEER CANC STAT REV 1; Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; Castiglione-Gertsch M, 2003, JNCI-J NATL CANCER I, V95, P1833, DOI 10.1093/jnci/djg119; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzick J, 2007, LANCET, V369, P1711; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; EIERMANN W, 2009, 32 ANN SAN ANT BREAS; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; Ganz P, 2008, 31 ANN SAN ANT BREAS; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Harvey V, 2006, J CLIN ONCOL, V24, P4963, DOI 10.1200/JCO.2005.05.0294; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Knobf MT, 2006, ONCOLOGIST, V11, P96, DOI 10.1634/theoncologist.11-2-96; Nabholtz JM, 2003, J CLIN ONCOL, V21, P968, DOI 10.1200/JCO.2003.04.040; Paterson A, 2002, P AN M AM SOC CLIN, V21, p35a; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Swain SM, 2009, BREAST CANCER RES TR, V113, P315, DOI 10.1007/s10549-008-9937-0; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	23	243	249	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2053	2065		10.1056/NEJMoa0909638	http://dx.doi.org/10.1056/NEJMoa0909638			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20519679	Green Accepted, Bronze			2022-12-28	WOS:000278242200005
J	Boeglin, C; Beaurepaire, E; Halte, V; Lopez-Flores, V; Stamm, C; Pontius, N; Durr, HA; Bigot, JY				Boeglin, C.; Beaurepaire, E.; Halte, V.; Lopez-Flores, V.; Stamm, C.; Pontius, N.; Duerr, H. A.; Bigot, J. -Y.			Distinguishing the ultrafast dynamics of spin and orbital moments in solids	NATURE			English	Article							MAGNETIC CIRCULAR-DICHROISM; X-RAY DICHROISM; THIN-FILMS; ANISOTROPY; NICKEL; DEMAGNETIZATION; MULTILAYERS; TRANSITION	For an isolated quantum particle, such as an electron, the orbital (L) and spin (S) magnetic moments can change provided that the total angular momentum of the particle is conserved. In condensed matter, an efficient transfer between L and S can occur owing to the spin-orbit interaction, which originates in the relativistic motion of electrons(1). Disentangling the absolute contributions of the orbital and spin angular momenta is challenging, however, as any transfer between the two occurs on femtosecond timescales. Here we investigate such phenomena by using ultrashort optical laser pulses to change the magnetization of a ferromagnetic film(2-7) and then probe its dynamics with circularly polarized femtosecond X-ray pulses(8). Our measurements enable us to disentangle the spin and orbital components of the magnetic moment, revealing different dynamics for L and S. We highlight the important role played by the spin-orbit interaction in the ultrafast laser-induced demagnetization of ferromagnetic films, and show also that the magneto-crystalline anisotropy energy is an important quantity to consider in such processes. Our study provides insights into the dynamics in magnetic systems(9) as well as perspectives for the ultrafast control of information in magnetic recording media(10).	[Boeglin, C.; Beaurepaire, E.; Halte, V.; Lopez-Flores, V.; Bigot, J. -Y.] CNRS, UMR7504, Inst Phys & Chim Mat Strasbourg, F-67034 Strasbourg, France; [Boeglin, C.; Beaurepaire, E.; Halte, V.; Lopez-Flores, V.; Bigot, J. -Y.] Univ Strasbourg, F-67034 Strasbourg, France; [Stamm, C.; Pontius, N.; Duerr, H. A.] Helmholtz Zentrum Berlin Mat & Energie GmbH, BESSY 2, D-12489 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Boeglin, C (corresponding author), CNRS, UMR7504, Inst Phys & Chim Mat Strasbourg, 23 Rue Loess, F-67034 Strasbourg, France.	christine.boeglin@ipcms.u-strasbg.fr	Durr, Hermann A/F-6205-2012; Lopez-Flores, Victor/A-5570-2010; Pontius, Niko/I-1804-2013; Stamm, Christian/G-4814-2013	Lopez-Flores, Victor/0000-0002-6319-5971; Stamm, Christian/0000-0001-5611-9084; Pontius, Niko/0000-0002-5658-1751; Durr, Hermann/0000-0001-9680-8730	CNRS-PICS; Universite de Strasbourg; EU [R II 3 CT-2004-5060008]; European Research Council [ERC-2009-AdG-20090325, 247452]; US Department of Energy, Office of Basic Energy Sciences	CNRS-PICS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; EU(European Commission); European Research Council(European Research Council (ERC)European Commission); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank T. Quast, T. Kachel, K. Holldack and R. Mitzner for help and support during the femtoslicing experiments and J. Arabski, M. Acosta, M. Albrecht and V. Da Costa for sample elaboration and characterization. This work was supported by the CNRS-PICS, by Universite de Strasbourg and by the EU Contract Integrated Infrastructure Initiative I3 in FP6-Project No. R II 3 CT-2004-5060008, BESSY IA-SFS Access Program. J.-Y.B. acknowledges a grant from the European Research Council in the final stage of this work (ERC-2009-AdG-20090325 # 247452). H. A. D. acknowledges support through the PULSE Institute at SLAC by the US Department of Energy, Office of Basic Energy Sciences.	Anisimov AN, 1999, PHYS REV LETT, V82, P2390, DOI 10.1103/PhysRevLett.82.2390; BARTEL AF, 2004, APPL PHYS LETT, V90; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; Bigot JY, 2009, NAT PHYS, V5, P515, DOI 10.1038/NPHYS1285; BJORKEN JD, 1964, RELATIVISTIC QUANTUM, V1; Bovensiepen U, 2009, NAT PHYS, V5, P461, DOI 10.1038/nphys1322; CARRA P, 1993, PHYS REV LETT, V70, P694, DOI 10.1103/PhysRevLett.70.694; Carva K, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/57002; Chikazumi S, 1978, PHYS MAGNETISM; DAALDEROP GHO, 1990, PHYS REV B, V42, P7270, DOI 10.1103/PhysRevB.42.7270; Durr HA, 1996, PHYS REV B, V54, pR760, DOI 10.1103/PhysRevB.54.R760; Durr HA, 1997, SCIENCE, V277, P213, DOI 10.1126/science.277.5323.213; Garreau G, 1997, EUROPHYS LETT, V39, P557, DOI 10.1209/epl/i1997-00393-0; Grange W, 1998, PHYS REV B, V58, P6298, DOI 10.1103/PhysRevB.58.6298; Guidoni L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.017401; Hohlfeld J, 1997, PHYS REV LETT, V78, P4861, DOI 10.1103/PhysRevLett.78.4861; Kamp P, 1999, PHYS REV B, V59, P1105, DOI 10.1103/PhysRevB.59.1105; Khan S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.074801; Koopmans B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.267207; Rhie HS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.247201; Scholl A, 1997, PHYS REV LETT, V79, P5146, DOI 10.1103/PhysRevLett.79.5146; Stamm C, 2007, NAT MATER, V6, P740, DOI 10.1038/nmat1985; STOHR J, 1995, PHYS REV LETT, V75, P3748, DOI 10.1103/PhysRevLett.75.3748; Stohr J., 2006, MAGNETISM FUNDAMENTA; THOLE BT, 1992, PHYS REV LETT, V68, P1943, DOI 10.1103/PhysRevLett.68.1943; Walowski J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.237401; WELLER D, 1994, PHYS REV B, V49, P12888, DOI 10.1103/PhysRevB.49.12888; WELLER D, 1995, PHYS REV LETT, V75, P3752, DOI 10.1103/PhysRevLett.75.3752; Zhang GP, 2002, TOP APPL PHYS, V83, P245; PERPENDICULAR MAGNET	30	295	296	5	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					458	U78		10.1038/nature09070	http://dx.doi.org/10.1038/nature09070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505724				2022-12-28	WOS:000278043700030
J	Valentine, DL				Valentine, David L.			Measure methane to quantify the oil spill	NATURE			English	Editorial Material									[Valentine, David L.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Valentine, DL (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	valentine@geol.ucsb.edu	Valentine, David/E-5594-2012	Valentine, David/0000-0001-5914-9107	Directorate For Geosciences [0950600] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))			0	5	5	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					421	421		10.1038/465421a	http://dx.doi.org/10.1038/465421a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601FM	20495546	Bronze			2022-12-28	WOS:000278043700015
J	Berkley, JA; Munywoki, P; Ngama, M; Kazungu, S; Abwao, J; Bett, A; Lassauniere, R; Kresfelder, T; Cane, PA; Venter, M; Scott, JAG; Nokes, DJ				Berkley, James A.; Munywoki, Patrick; Ngama, Mwanajuma; Kazungu, Sidi; Abwao, John; Bett, Anne; Lassauniere, Ria; Kresfelder, Tina; Cane, Patricia A.; Venter, Marietjie; Scott, J. Anthony G.; Nokes, D. James			Viral Etiology of Severe Pneumonia Among Kenyan Infants and Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFLUENZAE TYPE-B; GAMBIAN CHILDREN; VACCINE CANDIDATE; CONJUGATE VACCINE; TRACT INFECTIONS; KILIFI DISTRICT; IMMUNIZATION; DISEASE; LIVE	Context Pneumonia is the leading cause of childhood death in sub-Saharan Africa. Comparative estimates of the contribution of causative pathogens to the burden of disease are essential for targeted vaccine development. Objective To determine the viral etiology of severe pneumonia among infants and children at a rural Kenyan hospital using comprehensive and sensitive molecular diagnostic techniques. Design, Setting, and Participants Prospective observational and case-control study during 2007 in a rural Kenyan district hospital. Participants were children aged 1 day to 12 years, residing in a systematically enumerated catchment area, and who either were admitted to Kilifi District Hospital meeting World Health Organization clinical criteria for severe pneumonia or very severe pneumonia; (2) presented with mild upper respiratory tract infection but were not admitted; or (3) were well infants and children attending for immunization. Main Outcome Measures The presence of respiratory viruses and the odds ratio for admission with severe disease. Results Of 922 eligible admitted patients, 759 were sampled (82% [median age, 9 months]). One or more respiratory viruses were detected in 425 of the 759 sampled (56% [95% confidence interval {CI}, 52%-60%]). Respiratory syncytial virus (RSV) was detected in 260 participants (34% [95% CI, 31%-38%]) and other respiratory viruses were detected in 219 participants (29%; 95% CI, 26%-32%), the most common being Human coronavirus 229E (n=51 [6.7%]), influenza type A (n=44 [5.8%]), Parainfluenza type 3 (n=29 [3.8%]), Human adenovirus (n=29 [3.8%]), and Human metapneumovirus (n=23 [3.0%]). Compared with well control participants, detection of RSV was associated with severe disease (5% in control participants; adjusted odds ratio, 6.11 [95% CI, 1.65-22.6]) while collectively, other respiratory viruses were not associated with severe disease (23% in control participants; adjusted odds ratio, 1.27 [95% CI, 0.64-2.52]). Conclusion In a sample of Kenyan infants and children admitted with severe pneumonia to a rural hospital, RSV was the predominant viral pathogen. JAMA. 2010;303(20):2051-2057 www.jama.com	[Berkley, James A.; Munywoki, Patrick; Ngama, Mwanajuma; Kazungu, Sidi; Abwao, John; Bett, Anne; Scott, J. Anthony G.; Nokes, D. James] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya; [Berkley, James A.; Scott, J. Anthony G.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Lassauniere, Ria; Kresfelder, Tina; Venter, Marietjie] Univ Pretoria, Dept Med Virol, Fac Hlth Sci, Resp & Zoonot Virus Programme, ZA-0001 Pretoria, South Africa; [Cane, Patricia A.] Hlth Protect Agcy, Ctr Infect, London, England; [Venter, Marietjie] Natl Inst Communicable Dis, Resp Virus Unit, Johannesburg, South Africa; [Nokes, D. James] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Kenya Medical Research Institute; University of Oxford; University of Pretoria; Health Protection Agency; National Institute for Communicable Diseases (NICD); University of Warwick	Berkley, JA (corresponding author), POB 230, Kilifi 80108, Kenya.	jberkley@kilifi.kemri-wellcome.org	Venter, Marietjie/H-3032-2011; Munywoki, Patrick K./GQP-4775-2022; Lassaunière, Ria/AAM-2324-2021; Venter, Marietjie/P-9604-2016	Munywoki, Patrick K./0000-0001-9419-7155; Lassaunière, Ria/0000-0002-3910-7185; Venter, Marietjie/0000-0003-2696-824X; Berkley, James/0000-0002-1236-849X	Wellcome Trust (Great Britain) [081186]	Wellcome Trust (Great Britain)(Wellcome Trust)	The study was funded by a project grant (081186) from the Wellcome Trust (Great Britain). Drs Berkley, Scott, and Nokes report receipt of support by fellowships from the Wellcome Trust (Great Britain).	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Albargish K A, 1999, East Mediterr Health J, V5, P941; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DAGAN R, 1993, PEDIATR INFECT DIS J, V12, P381, DOI 10.1097/00006454-199305000-00006; FLIESS JL, 1981, STAT METHODS RATES P; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Johnson B R, 1993, West Afr J Med, V12, P11; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Kuypers J, 2004, J CLIN VIROL, V31, P123, DOI 10.1016/j.jcv.2004.03.018; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1997, LANCET, V350, P524; *NAT I HLTH CLIN T, STUD EV SAF TOL IMM; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Nokes JD, 2008, CURR OPIN INFECT DIS, V21, P639, DOI 10.1097/QCO.0b013e3283184245; PHILLIPS P A, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P373; Schmidt AC, 2001, J VIROL, V75, P4594, DOI 10.1128/JVI.75.10.4594-4603.2001; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; SOBESLAVSKY O, 1977, B WORLD HEALTH ORGAN, V55, P625; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; Vieira Sandra E., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P125, DOI 10.1590/S0036-46652001000300002; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859	33	221	238	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2051	2057		10.1001/jama.2010.675	http://dx.doi.org/10.1001/jama.2010.675			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501927	Bronze, Green Accepted			2022-12-28	WOS:000278018200029
J	Potts, M; Prata, N; Sahin-Hodoglugil, NN				Potts, Malcolm; Prata, Ndola; Sahin-Hodoglugil, Nuriye Nalan			Maternal mortality: one death every 7 min	LANCET			English	Editorial Material							3RD STAGE; MISOPROSTOL; MANAGEMENT; LABOR		[Potts, Malcolm; Prata, Ndola] Univ Calif Berkeley, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA; [Sahin-Hodoglugil, Nuriye Nalan] Venture Strategies Innovat, Anaheim, CA USA	University of California System; University of California Berkeley	Potts, M (corresponding author), Univ Calif Berkeley, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA.	potts@berkeley.edu						Blum J, 2010, LANCET, V375, P217, DOI 10.1016/S0140-6736(09)61923-1; *DEP MAK PREGN SAF, 2007, WHO REC PREV POSTP H; *DEP REPR HLTH RES, 2009, WHO STAT REG US MIS; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; International Confederation of Midwives International Federation of Gynaecology and Obstetrics, 2006, PREV TREATM POSTP HA; Prata N, 2006, INT J GYNECOL OBSTET, V94, P149, DOI 10.1016/j.ijgo.2006.05.027; Prata N, 2005, INT J GYNECOL OBSTET, V90, P51, DOI 10.1016/j.ijgo.2005.03.007; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Rajbhandari S, 2010, INT J GYNECOL OBSTET, V108, P282, DOI 10.1016/j.ijgo.2009.11.006; Sanghvi H, 2010, INT J GYNECOL OBSTET, V108, P276, DOI 10.1016/j.ijgo.2009.12.003; Widmer M, 2010, LANCET, V375, P1808, DOI 10.1016/S0140-6736(10)60348-0; Winikoff B, 2010, LANCET, V375, P210, DOI 10.1016/S0140-6736(09)61924-3	12	29	31	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 22	2010	375	9728					1762	1763		10.1016/S0140-6736(10)60750-7	http://dx.doi.org/10.1016/S0140-6736(10)60750-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20494713				2022-12-28	WOS:000278216500008
J	Jensen, V; Rappaport, BA				Jensen, Valerie; Rappaport, Bob A.			The Reality of Drug Shortages - The Case of the Injectable Agent Propofol	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jensen, Valerie] Ctr Drug Evaluat & Res, Drug Shortage Program, FDA, Silver Spring, MD USA; [Rappaport, Bob A.] Ctr Drug Evaluat & Res, Div Anesthesia & Analgesia Prod, FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Jensen, V (corresponding author), Ctr Drug Evaluat & Res, Drug Shortage Program, FDA, Silver Spring, MD USA.							Food and Drug Administration, CURR DRUG SHORT; Hampton T, 2007, JAMA-J AM MED ASSOC, V298, P727, DOI 10.1001/jama.298.7.727; *NAT LIB MED, PROP DRUG LAB; Steinbrook R, 2009, NEW ENGL J MED, V361, P1525, DOI 10.1056/NEJMp0906922; 2008, MMWR MORB MORTAL WKL, V57, P513	5	64	65	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					806	807		10.1056/NEJMp1005849	http://dx.doi.org/10.1056/NEJMp1005849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20554977				2022-12-28	WOS:000281196600003
J	Ouchi, N; Higuchi, A; Ohashi, K; Oshima, Y; Gokce, N; Shibata, R; Akasaki, Y; Shimono, A; Walsh, K				Ouchi, Noriyuki; Higuchi, Akiko; Ohashi, Koji; Oshima, Yuichi; Gokce, Noyan; Shibata, Rei; Akasaki, Yuichi; Shimono, Akihiko; Walsh, Kenneth			Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity	SCIENCE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; SIGNALING PATHWAY; INFLAMMATION; JNK; ADIPOGENESIS; ADIPONECTIN; INHIBITION; MECHANISMS; DISEASE	Adipose tissue secretes proteins referred to as adipokines, many of which promote inflammation and disrupt glucose homeostasis. Here we show that secreted frizzled-related protein 5 (Sfrp5), a protein previously linked to the Wnt signaling pathway, is an anti-inflammatory adipokine whose expression is perturbed inmodels of obesity and type 2 diabetes. Sfrp5-deficient mice fed a high-calorie diet developed severe glucose intolerance and hepatic steatosis, and their adipose tissue showed an accumulation of activated macrophages that was associated with activation of the c-Jun N-terminal kinase signaling pathway. Adenovirus-mediated delivery of Sfrp5 to mouse models of obesity ameliorated glucose intolerance and hepatic steatosis. Thus, in the setting of obesity, Sfrp5 secretion by adipocytes exerts salutary effects on metabolic dysfunction by controlling inflammatory cells within adipose tissue.	[Ouchi, Noriyuki; Higuchi, Akiko; Ohashi, Koji; Oshima, Yuichi; Gokce, Noyan; Akasaki, Yuichi; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Gokce, Noyan] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Shibata, Rei] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Shimono, Akihiko] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117456, Singapore	Boston University; Boston University; Nagoya University; National University of Singapore	Ouchi, N (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	nouchi@bu.edu; kxwalsh@bu.edu	OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Walsh, Kenneth/0000-0001-7580-2276; Gokce, Noyan/0000-0003-2920-3445	National Institutes of Health [AG34972, HL86785, AG15052, HL81587]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587, R01HL086785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG015052, R01AG015052, R01AG034972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Sono-Romanelli for technical assistance. Funded by National Institutes of Health grants (AG34972, HL86785, AG15052, and HL81587) to K.W.	Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	21	336	376	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					454	457		10.1126/science.1188280	http://dx.doi.org/10.1126/science.1188280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558665	Green Accepted			2022-12-28	WOS:000280196500041
J	Li, P; Burke, S; Wang, JX; Chen, XF; Ortiz, M; Lee, SC; Lu, D; Campos, L; Goulding, D; Ng, BL; Dougan, G; Huntly, B; Gottgens, B; Jenkins, NA; Copeland, NG; Colucci, F; Liu, PT				Li, Peng; Burke, Shannon; Wang, Juexuan; Chen, Xiongfeng; Ortiz, Mariaestela; Lee, Song-Choon; Lu, Dong; Campos, Lia; Goulding, David; Ng, Bee Ling; Dougan, Gordon; Huntly, Brian; Gottgens, Bertie; Jenkins, Nancy A.; Copeland, Neal G.; Colucci, Francesco; Liu, Pentao			Reprogramming of T Cells to Natural Killer-Like Cells upon Bcl11b Deletion	SCIENCE			English	Article							H-2-DEFICIENT LYMPHOMA VARIANTS; IN-VITRO; NK CELLS; DIFFERENTIATION; RECOGNITION; EXPRESSION; SURVIVAL; PATHWAY; VIVO	T cells develop in the thymus and are critical for adaptive immunity. Natural killer (NK) lymphocytes constitute an essential component of the innate immune system in tumor surveillance, reproduction, and defense against microbes and viruses. Here, we show that the transcription factor Bcl11b was expressed in all T cell compartments and was indispensable for T lineage development. When Bcl11b was deleted, T cells from all developmental stages acquired NK cell properties and concomitantly lost or decreased T cell-associated gene expression. These induced T-to-natural killer (ITNK) cells, which were morphologically and genetically similar to conventional NK cells, killed tumor cells in vitro, and effectively prevented tumor metastasis in vivo. Therefore, ITNKs may represent a new cell source for cell-based therapies.	[Li, Peng; Burke, Shannon; Wang, Juexuan; Ortiz, Mariaestela; Lee, Song-Choon; Lu, Dong; Campos, Lia; Goulding, David; Ng, Bee Ling; Dougan, Gordon; Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Burke, Shannon; Colucci, Francesco] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Colucci, Francesco] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Chen, Xiongfeng] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Huntly, Brian; Gottgens, Bertie] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Jenkins, Nancy A.; Copeland, Neal G.] Inst Mol & Cell Biol, Proteos 138673, Singapore	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Liu, PT (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England.	pl2@sanger.ac.uk	Colucci, Francesco/F-2844-2010; huntly, brian JP/E-6725-2014; Li, Peng/AER-7520-2022	Colucci, Francesco/0000-0001-5193-6376; huntly, brian JP/0000-0003-0312-161X; Li, Peng/0000-0003-4530-2400; Gottgens, Berthold/0000-0001-6302-5705	Wellcome Trust; MRC; BBSRC; Medical Research Council [G116/187, G0800784, G0501150, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; MRC [G0501150, G0800784, G116/187] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the Wellcome Trust to P. Liu, from MRC and BBSRC to F. Colucci, and by MRC to B. Huntly. We thank core facilities at Sanger Institute (RSF and microarray), Babraham Institute and CIMR for technical support. Microarray data have been submitted to GEO (Gene Expression Ominibus). Accession number: GSE21016. A patent application has been filed by the Wellcome Trust for production and application of ITNKs (U. K. patent application No. 0912287. U. S. Provisional Application No. 61/225779), and P. L. and P. L. are listed as authors on this application. A Mouse/Tissue Transfer Agreement is required for the use of PLBD mice.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Boos MD, 2008, IMMUNOL RES, V40, P193, DOI 10.1007/s12026-007-8006-9; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Colucci F, 1999, J IMMUNOL, V162, P2761; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KAWANO YI, 1986, J IMMUNOL, V136, P4729; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104	26	236	243	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					85	89		10.1126/science.1188063	http://dx.doi.org/10.1126/science.1188063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20538915	Green Accepted			2022-12-28	WOS:000279402700038
J	Ramsey, CB; Dee, MW; Rowland, JM; Higham, TFG; Harris, SA; Brock, F; Quiles, A; Wild, EM; Marcus, ES; Shortland, AJ				Ramsey, Christopher Bronk; Dee, Michael W.; Rowland, Joanne M.; Higham, Thomas F. G.; Harris, Stephen A.; Brock, Fiona; Quiles, Anita; Wild, Eva M.; Marcus, Ezra S.; Shortland, Andrew J.			Radiocarbon-Based Chronology for Dynastic Egypt	SCIENCE			English	Article							ASTRONOMICAL ORIENTATION; AMS; OFFSETS	The historical chronologies for dynastic Egypt are based on reign lengths inferred from written and archaeological evidence. These floating chronologies are linked to the absolute calendar by a few ancient astronomical observations, which remain a source of debate. We used 211 radiocarbon measurements made on samples from short-lived plants, together with a Bayesian model incorporating historical information on reign lengths, to produce a chronology for dynastic Egypt. A small offset (19 radiocarbon years older) in radiocarbon levels in the Nile Valley is probably a growing-season effect. Our radiocarbon data indicate that the New Kingdom started between 1570 and 1544 B. C. E., and the reign of Djoser in the Old Kingdom started between 2691 and 2625 B. C. E.; both cases are earlier than some previous historical estimates.	[Ramsey, Christopher Bronk; Dee, Michael W.; Rowland, Joanne M.; Higham, Thomas F. G.; Brock, Fiona] Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QY, England; [Harris, Stephen A.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Quiles, Anita] France Univ Paris VII Diderot, CEA Saclay, Lab Mesure Carbone 14, F-91191 Gif Sur Yvette, France; [Wild, Eva M.] Univ Vienna, Vienna Environm Res Accelerator Lab, Fak Phys, A-1090 Vienna, Austria; [Marcus, Ezra S.] Univ Haifa, Recanati Inst Maritime Studies, IL-31905 Haifa, Israel; [Shortland, Andrew J.] Cranfield Univ, Ctr Archaeol & Forens Anal, Dept Appl Sci Secur & Resilience, Swindon SN6 8LA, Wilts, England	University of Oxford; University of Oxford; CEA; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of Vienna; University of Haifa; Cranfield University	Ramsey, CB (corresponding author), Univ Oxford, Archaeol & Hist Art Res Lab, Dyson Perrins Bldg,S Parks Rd, Oxford OX1 3QY, England.	christopher.ramsey@rlaha.ox.ac.uk	Dee, M.W./AAU-3258-2020; Brock, Fiona/I-4970-2016; Ramsey, Christopher Bronk/A-3277-2012; Higham, Tom/Y-2707-2019; Dee, Michael/ABA-4786-2020; Ramsey, Christopher Bronk/AAQ-2227-2021	Brock, Fiona/0000-0003-0728-6091; Ramsey, Christopher Bronk/0000-0002-8641-9309; Higham, Tom/0000-0002-5949-598X; Dee, Michael/0000-0002-3116-453X; Ramsey, Christopher Bronk/0000-0002-8641-9309; Shortland, Andrew/0000-0003-2460-9358; Quiles, Anita/0000-0002-2933-4472	Leverhulme Trust [F/08 622/A]; Natural Environment Research Council; German-Israeli Foundation for Scientific Research and Development [I-2069-1230.4/2004]; CNRS; CEA; Institut de Radioprotection et de Surete Nucleaire; Institut de Recherche pour le Developpement; Ministere de La Culture; NERC [NRCF010002] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); Institut de Radioprotection et de Surete Nucleaire; Institut de Recherche pour le Developpement; Ministere de La Culture; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Leverhulme Trust (grant no. F/08 622/A). The botanical specimens were from the Oxford University Herbaria and the Natural History Museum, London. Archaeological samples were from Agyptisches Museum und Papyrussammlung, Berlin; Ashmolean Museum, Oxford; Bolton Museum and Art Gallery; British Museum, London; City Museum and Art Gallery, Bristol, UK; Cornell University, New York; Desert Research Institute, Las Vegas, Nevada; Kunsthistorisches Museum, Vienna; The Manchester Museum; Medelhavsmuseet, Stockholm; Metropolitan Museum of Art, New York; Musee du Louvre, Paris; Musees royaux d'art et d'histoire, Brussels; National Museums, Liverpool, UK; The Petrie Museum of Egyptian Archeology, London; The Pitt Rivers Museum, Oxford; Royal Botanic Gardens, Kew, UK; Staatliches Museum Agyptischer Kunst, Munich; and the Victoria Museum of Egyptian Antiquities, Uppsala University, Sweden. The Oxford laboratory infrastructure was funded by the Natural Environment Research Council and software development by English Heritage. The Illahun, Heqanakht, and Hatshepsut measurements and research were funded by the German-Israeli Foundation for Scientific Research and Development (grant no. I-2069-1230.4/2004); preliminary background research was aided by the SCIEM2000 project. The dating at Saclay was performed at the LMC14 (funded by CNRS, CEA, Institut de Radioprotection et de Surete Nucleaire, Institut de Recherche pour le Developpement, and Ministere de La Culture).	BIETAK M, 2007, SYNCHRONISATION CIVI, V3, P13; BIETAK M, 2001, SYNCHRONISATION CIVI; BIETAK M, 2007, SYNCHRONISATION CIVI, V3; BIETAK M, 2003, SYNCHRONISATION CIVI, V2; Bonani G, 2001, RADIOCARBON, V43, P1297; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Bruhn F, 2001, RADIOCARBON, V43, P229; Cottereau E, 2007, RADIOCARBON, V49, P291, DOI 10.1017/S0033822200042211; Dee M, 2000, NUCL INSTRUM METH B, V172, P449, DOI 10.1016/S0168-583X(00)00337-2; Dee MW, 2010, J ARCHAEOL SCI, V37, P687, DOI 10.1016/j.jas.2009.09.003; FRANKE D, 1988, ORIENTALIA, V57, P113; Friedrich WL, 2006, SCIENCE, V312, P548, DOI 10.1126/science.1125087; Hornung E., 2006, ANCIENT EGYPTIAN CHR; Hua Q, 2004, NUCL INSTRUM METH B, V223, P489, DOI 10.1016/j.nimb.2004.04.092; KITCHEN KA, 1991, WORLD ARCHAEOL, V23, P201, DOI 10.1080/00438243.1991.9980172; KITCHEN KA, 2007, SYNCHRONISATION CIVI, V3, P163; KRAUSS R, 1985, SOTHIS MONDDATEN STU; Kromer B, 2001, SCIENCE, V294, P2529, DOI 10.1126/science.1066114; Manning SW, 2006, SCIENCE, V312, P565, DOI 10.1126/science.1125682; Ramsey CB, 2004, RADIOCARBON, V46, P17, DOI 10.1017/S0033822200039308; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rawlins D, 2001, NATURE, V412, P699, DOI 10.1038/35089138; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; SHAW I, 2000, OXFORD HIST ANCIENT; Spence K, 2000, NATURE, V408, P320, DOI 10.1038/35042510; Steier P, 2004, RADIOCARBON, V46, P5, DOI 10.1017/S0033822200039291; WARD WA, 1992, B AM SCH ORIENTAL RE, P53, DOI 10.2307/1357231; Wild EM, 2008, RADIOCARBON, V50, P1, DOI 10.1017/S0033822200043332	29	154	156	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1554	1557		10.1126/science.1189395	http://dx.doi.org/10.1126/science.1189395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	611XW	20558717				2022-12-28	WOS:000278859200045
J	Vijaykrishna, D; Poon, LLM; Zhu, HC; Ma, SK; Li, OTW; Cheung, CL; Smith, GJD; Peiris, JSM; Guan, Y				Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.			Reassortment of Pandemic H1N1/2009 Influenza A Virus in Swine	SCIENCE			English	Article									[Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Vijaykrishna, D.; Zhu, H. C.; Smith, G. J. D.; Guan, Y.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou 515031, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Shantou University	Peiris, JSM (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	malik@hkucc.hku.hk; yguan@hkucc.hku.hk	Dhanasekaran, Vijaykrishna/D-1011-2010; Zhu, Huachen/A-8252-2017; Poon, Leo Lit Man/C-4382-2009; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Poon, Leo/AAP-6887-2020; Cheung, Yiu Man/T-2708-2019	Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Zhu, Huachen/0000-0003-2711-0501; Poon, Leo Lit Man/0000-0002-9101-7953; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Smith, Gavin JD/0000-0001-5031-468X; Guan, Yi/0000-0001-6057-9243	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN266200700005C]; University Grants Committee of the Hong Kong SAR Government [AoE/M-12/06]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University Grants Committee of the Hong Kong SAR Government	This work was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN266200700005C and the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/06) of the Hong Kong SAR Government. We acknowledge the Food and Environmental Hygiene Department of Hong Kong for facilitating this study. Authors declare no conflict of interest. Sequence data generated from this study were deposited in GenBank with accession nos. CY061626 to CY061881.	Bastien N, 2010, J INFECT DIS, V201, P1178, DOI 10.1086/651507; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; WHO website, PAND H1N1 2009 UPD 8	7	304	325	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1529	1529		10.1126/science.1189132	http://dx.doi.org/10.1126/science.1189132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558710	Green Accepted			2022-12-28	WOS:000278859200038
J	Aarabi, S; Smithers, CJ; Mukharjee, J				Aarabi, Shahram; Smithers, Charles Jason; Mukharjee, Joia			Disaster Medicine Don't ignore home grown medical systems	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aarabi, Shahram] Univ Washington, Washington, DC USA; [Smithers, Charles Jason] Childrens Hosp Boston, Boston, MA USA; [Mukharjee, Joia] Partners Hlth, Boston, MA USA	University of Washington; Harvard University; Boston Children's Hospital; Partners Healthcare System	Aarabi, S (corresponding author), Univ Washington, Washington, DC USA.	saarabi@hsph.harvard.edu							0	1	1	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 17	2010	340								c3187	10.1136/bmj.c3187	http://dx.doi.org/10.1136/bmj.c3187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JC	20558517	Green Published			2022-12-28	WOS:000279052000002
J	Sun, YJ; Wu, GK; Liu, BH; Li, P; Zhou, M; Xiao, Z; Tao, HW; Zhang, LI				Sun, Yujiao J.; Wu, Guangying K.; Liu, Bao-hua; Li, Pingyang; Zhou, Mu; Xiao, Zhongju; Tao, Huizhong W.; Zhang, Li I.			Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development	NATURE			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELDS; NEURONS; CIRCUITS; RAT; REPRESENTATION; SELECTIVITY; INPUTS; MAPS	Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development(1-4). Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency-intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation-inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.	[Sun, Yujiao J.; Wu, Guangying K.; Liu, Bao-hua; Li, Pingyang; Zhou, Mu; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Xiao, Zhongju] So Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou 510515, Guangdong, Peoples R China	University of Southern California; University of Southern California; University of Southern California; Southern Medical University - China	Zhang, LI (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	htao@usc.edu; liizhang@usc.edu	Tao, Huizhong W/HDM-9767-2022; Zhou, Mu/K-8137-2016; Sun, Yujiao/E-5668-2015; Wu, Guangying/E-8117-2010	Zhou, Mu/0000-0001-5326-4884; Wu, Guangying/0000-0002-7243-5412; Sun, Yujiao Jennifer/0000-0003-2437-2936	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01DC008983, R21DC008588]; Searle Scholar Program; Klingenstein Foundation; David and Lucile Packard Foundation; US National Institutes of Health [EY018718, EY019049]; Karl Kirchgessner Foundation; National Natural Science Foundation of China [30730039, 30970982, 30670665]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019049, R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008588, R03DC006814, R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Searle Scholar Program; Klingenstein Foundation(Klingenstein Philanthropies); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karl Kirchgessner Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J.R. Chan for suggestions. This work was supported by grants to L.I.Z. from the US National Institutes of Health/National Institute on Deafness and Other Communication Disorders (R01DC008983, R21DC008588), the Searle Scholar Program, the Klingenstein Foundation and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). H. W. T. is supported by the US National Institutes of Health (EY018718 and EY019049) and the Karl Kirchgessner Foundation. Z.X. is supported by the National Natural Science Foundation of China (grant numbers 30730039, 30970982 and 30670665).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chapman B, 1996, J NEUROSCI, V16, P6443; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; GEALDOR M, 1993, HEARING RES, V69, P236, DOI 10.1016/0378-5955(93)90113-F; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Romand R, 1997, PROG NEUROBIOL, V51, P1, DOI 10.1016/S0301-0082(96)00043-3; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	30	134	135	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					927	U8		10.1038/nature09079	http://dx.doi.org/10.1038/nature09079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559386	Green Accepted			2022-12-28	WOS:000278804500038
J	Joly, CA; Rodrigues, RR; Metzger, JP; Haddad, CFB; Verdade, LM; Oliveira, MC; Bolzani, VS				Joly, Carlos A.; Rodrigues, Ricardo R.; Metzger, Jean Paul; Haddad, Celio F. B.; Verdade, Luciano M.; Oliveira, Mariana C.; Bolzani, Vanderlan S.			Biodiversity Conservation Research, Training, and Policy in Sao Paulo	SCIENCE			English	Editorial Material									[Joly, Carlos A.] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, BR-13083970 Campinas, SP, Brazil; [Rodrigues, Ricardo R.; Verdade, Luciano M.] State Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Biol Sci, Piracicaba, SP, Brazil; [Metzger, Jean Paul] Univ Sao Paulo, Inst Biol Sci, Dept Ecol, Sao Paulo, Brazil; [Haddad, Celio F. B.] Univ Estadual Paulista, Inst Biosci, Dept Zool, Rio Claro, SP, Brazil; [Oliveira, Mariana C.] Univ Sao Paulo, Inst Biosci, Dept Bot, Sao Paulo, Brazil; [Bolzani, Vanderlan S.] Univ Estadual Paulista, Dept Organ Chem, Araraquara, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Joly, CA (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Plant Biol, BR-13083970 Campinas, SP, Brazil.	cjoly@unicamp.br	Verdade, Luciano M./H-5549-2012; Rodrigues, Ricardo Ribeiro/D-5557-2012; JOLY, Carlos A./C-4523-2012; Haddad, Célio F. B./C-4267-2012; Metzger, Jean Paul/C-2514-2012; Bolzani, Vanderlan S/C-2111-2012; JOLY, Carlos A/H-7925-2012; de Oliveira, Mariana Cabral/G-2512-2012; Bolzani, Vanderlan/C-2111-2012	Verdade, Luciano M./0000-0002-1326-0886; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; JOLY, Carlos A./0000-0002-7945-2805; Haddad, Célio F. B./0000-0002-7044-5764; Metzger, Jean Paul/0000-0002-0087-5240; Bolzani, Vanderlan S/0000-0003-0615-8776; de Oliveira, Mariana Cabral/0000-0001-8495-2962; Bolzani, Vanderlan/0000-0001-7019-5825				Durigan G., 2006, Edinburgh Journal of Botany, V63, P119, DOI 10.1017/S0960428606000357; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RODRIGUES RR, 2008, DIRETRIZES CONSERVAC; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x	5	66	71	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1358	1359		10.1126/science.1188639	http://dx.doi.org/10.1126/science.1188639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608PO	20538935				2022-12-28	WOS:000278598400022
J	Zucker, I; Beery, AK				Zucker, Irving; Beery, Annaliese K.			Males still dominate animal studies	NATURE			English	Editorial Material									[Zucker, Irving] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Beery, Annaliese K.] Univ Calif San Francisco, Ctr Hlth & Community, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Zucker, I (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	irvzuck@berkeley.edu		Beery, Annaliese/0000-0002-1249-9182				BEERY AK, NEUROSCI BI IN PRESS; Gold SM, 2009, J NEUROL SCI, V286, P99, DOI 10.1016/j.jns.2009.05.028; Hughes RN, 2007, BEHAV PHARMACOL, V18, P583, DOI 10.1097/FBP.0b013e3282eff0e8; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Veliskova J, 2007, NEUROSCIENTIST, V13, P77, DOI 10.1177/1073858406295827; Wang CH, 1923, COMP PSYCHOL MONOGR, V6, P1	6	278	280	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					690	690		10.1038/465690a	http://dx.doi.org/10.1038/465690a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535186	Bronze			2022-12-28	WOS:000278551800020
J	Yamashita, M; Nakata, N; Senshu, Y; Nagata, M; Yamamoto, HM; Kato, R; Shibauchi, T; Matsuda, Y				Yamashita, Minoru; Nakata, Norihito; Senshu, Yoshinori; Nagata, Masaki; Yamamoto, Hiroshi M.; Kato, Reizo; Shibauchi, Takasada; Matsuda, Yuji			Highly Mobile Gapless Excitations in a Two-Dimensional Candidate Quantum Spin Liquid	SCIENCE			English	Article							RESONATING-VALENCE-BOND; TRIANGULAR LATTICE; STATE; MODEL; ANTIFERROMAGNETS; FRUSTRATION; PHASE; WAVE	The nature of quantum spin liquids, a novel state of matter where strong quantum fluctuations destroy the long-range magnetic order even at zero temperature, is a long-standing issue in physics. We measured the low-temperature thermal conductivity of the recently discovered quantum spin liquid candidate, the organic insulator EtMe(3)Sb[Pd(dmit)(2)](2). A sizable linear temperature dependence term is clearly resolved in the zero-temperature limit, indicating the presence of gapless excitations with an extremely long mean free path, analogous to excitations near the Fermi surface in pure metals. Its magnetic field dependence suggests a concomitant appearance of spin-gap-like excitations at low temperatures. These findings expose a highly unusual dichotomy that characterizes the low-energy physics of this quantum system.	[Yamashita, Minoru; Nakata, Norihito; Senshu, Yoshinori; Nagata, Masaki; Shibauchi, Takasada; Matsuda, Yuji] Kyoto Univ, Grad Sch Sci, Dept Phys, Kyoto 6068502, Japan; [Yamamoto, Hiroshi M.; Kato, Reizo] RIKEN, Wako, Saitama 3510198, Japan; [Yamamoto, Hiroshi M.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; RIKEN; Japan Science & Technology Agency (JST)	Yamashita, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Phys, Kyoto 6068502, Japan.	yamashitaminoru@scphys.kyoto-u.ac.jp; matsuda@scphys.kyoto-u.ac.jp	Kato, Reizo/I-1073-2014; YAMASHITA, MINORU/D-6556-2011; Yamamoto, Hiroshi/F-3839-2012; Shibauchi, Takasada/B-9349-2008; Yamamoto, Hiroshi/T-5955-2019; Matsuda, Yuji/ABH-7166-2020	Kato, Reizo/0000-0002-2606-4657; YAMASHITA, MINORU/0000-0002-3616-6606; Yamamoto, Hiroshi/0000-0002-5686-5156; Shibauchi, Takasada/0000-0001-5831-4924; Yamamoto, Hiroshi/0000-0002-5686-5156; Matsuda, Yuji/0000-0001-9947-9418	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MEXT, Japan [20102006]; Grants-in-Aid for Scientific Research [23654118] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. P. A. Fisher, S. Fujimoto, T. Itou, H. Katsura, N. Kawakami, H. Kawamura, P. A. Lee, G. Misguich, Y. Nakazawa, and A. Tanaka for valuable discussion. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), a Grant-in-Aid for the Global Centers of Excellence Program "The Next Generation of Physics, Spun from Universality and Emergence," and a Grant-in-Aid for Scientific Research on Innovative Areas "Heavy Electrons" (No. 20102006) from MEXT, Japan.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; FADDEEV LD, 1981, PHYS LETT A, V85, P375, DOI 10.1016/0375-9601(81)90335-2; GROVER T, 2009, WEAK MOTT INSULATORS; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; Hayashi Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.053705; HUSE DA, 1988, PHYS REV LETT, V60, P2531, DOI 10.1103/PhysRevLett.60.2531; Itou T, 2009, J PHYS CONF SER, V145, DOI 10.1088/1742-6596/145/1/012039; Itou T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104413; KALMEYER V, 1987, PHYS REV LETT, V59, P2095, DOI 10.1103/PhysRevLett.59.2095; Katsura H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066403; Lee PA, 2008, SCIENCE, V321, P1306, DOI 10.1126/science.1163196; Lee SS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.036403; Manna RS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016403; Misguich G, 1999, PHYS REV B, V60, P1064, DOI 10.1103/PhysRevB.60.1064; Moessner R, 2001, PHYS REV LETT, V86, P1881, DOI 10.1103/PhysRevLett.86.1881; Morita H, 2002, J PHYS SOC JPN, V71, P2109, DOI 10.1143/JPSJ.71.2109; Motrunich OI, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045105; Qi Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176401; Sheng DN, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205112; Shimizu Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.140407; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Sologubenko AV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054412; Tamura M, 2005, POLYHEDRON, V24, P2817, DOI 10.1016/j.poly.2005.03.170; Waldtmann C, 1998, EUR PHYS J B, V2, P501, DOI 10.1007/s100510050274; Wen XG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165113; Yamashita M, 2009, NAT PHYS, V5, P44, DOI 10.1038/NPHYS1134; Yamashita S, 2008, NAT PHYS, V4, P459, DOI 10.1038/nphys942; Yoshioka T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.036401; Yunoki S, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.014408	29	319	323	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1246	1248		10.1126/science.1188200	http://dx.doi.org/10.1126/science.1188200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522768				2022-12-28	WOS:000278318600025
J	Halevy, I; Johnston, DT; Schrag, DP				Halevy, Itay; Johnston, David T.; Schrag, Daniel P.			Explaining the Structure of the Archean Mass-Independent Sulfur Isotope Record	SCIENCE			English	Article							FRACTIONATION; ATMOSPHERE; GREENHOUSE; VOLCANISM; CYCLE	Sulfur isotopes in ancient sediments provide a record of past environmental conditions. The long-time-scale variability and apparent asymmetry in the magnitude of minor sulfur isotope fractionation in Archean sediments remain unexplained. Using an integrated biogeochemical model of the Archean sulfur cycle, we find that the preservation of mass-independent sulfur is influenced by a variety of extra-atmospheric mechanisms, including biological activity and continental crust formation. Preservation of atmospherically produced mass-independent sulfur implies limited metabolic sulfur cycling before similar to 2500 million years ago; the asymmetry in the record indicates that bacterial sulfate reduction was geochemically unimportant at this time. Our results suggest that the large-scale structure of the record reflects variability in the oxidation state of volcanic sulfur volatiles.	[Halevy, Itay; Johnston, David T.; Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Halevy, I (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	itay.halevy@gmail.com	Halevy, Itay/W-9850-2019; HALEVY, ITAY/K-1364-2012	Halevy, Itay/0000-0002-7325-8139; HALEVY, ITAY/0000-0002-7325-8139; Johnston, David/0000-0002-2487-1084	Harvard University Origins of Life Initiative; NASA	Harvard University Origins of Life Initiative; NASA(National Aeronautics & Space Administration (NASA))	I.H. was supported by the Harvard University Origins of Life Initiative, and D.T.J. was supported by NASA Exobiology. D. P. S. thanks H. Breck and W. Breck for support. We also thank three anonymous reviewers.	Bao HM, 2007, GEOCHIM COSMOCHIM AC, V71, P4868, DOI 10.1016/j.gca.2007.05.032; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; Cleaves HJ, 2008, PRECAMBRIAN RES, V164, P111, DOI 10.1016/j.precamres.2008.04.002; Danielache SO, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009695; Domagal-Goldman SD, 2008, EARTH PLANET SC LETT, V269, P29, DOI 10.1016/j.epsl.2008.01.040; Emmanuel S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030532; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Halmer MM, 2002, J VOLCANOL GEOTH RES, V115, P511, DOI 10.1016/S0377-0273(01)00318-3; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; Holland HD., 2004, TREATISE GEOCHEMISTR, VVol. 6, P583; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Lyons JR, 2009, CHEM GEOL, V267, P164, DOI 10.1016/j.chemgeo.2009.03.027; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Ran H, 2007, CHEM PHYS LETT, V439, P280, DOI 10.1016/j.cplett.2007.03.103; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Van Ark E, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002949; von Paris P, 2008, PLANET SPACE SCI, V56, P1244, DOI 10.1016/j.pss.2008.04.008; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	27	109	110	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					204	207		10.1126/science.1190298	http://dx.doi.org/10.1126/science.1190298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20508089				2022-12-28	WOS:000279635200045
J	Lee, JH; Yu, WH; Kumar, A; Lee, S; Mohan, PS; Peterhoff, CM; Wolfe, DM; Martinez-Vicente, M; Massey, AC; Sovak, G; Uchiyama, Y; Westaway, D; Cuervo, AM; Nixon, RA				Lee, Ju-Hyun; Yu, W. Haung; Kumar, Asok; Lee, Sooyeon; Mohan, Panaiyur S.; Peterhoff, Corrinne M.; Wolfe, Devin M.; Martinez-Vicente, Marta; Massey, Ashish C.; Sovak, Guy; Uchiyama, Yasuo; Westaway, David; Cuervo, Ana Maria; Nixon, Ralph A.			Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations	CELL			English	Article							POSTTRANSLATIONAL N-GLYCOSYLATION; INTRACELLULAR PROTEIN-DEGRADATION; CATHEPSIN-D; MOUSE MODELS; ACIDIC ORGANELLES; DISEASE; ATPASE; ACIDIFICATION; NEURONS; CELLS	Macroautophagy is a lysosomal degradative pathway essential for neuron survival. Here, we show that macroautophagy requires the Alzheimer's disease (AD)-related protein presenilin-1 (PS1). In PS1 null blastocysts, neurons from mice hypomorphic for PS1 or conditionally depleted of PS1, substrate proteolysis and autophagosome clearance during macroautophagy are prevented as a result of a selective impairment of autolysosome acidification and cathepsin activation. These deficits are caused by failed PS1-dependent targeting of the v-ATPase V0a1 subunit to lysosomes. N-glycosylation of the V0a1 subunit, essential for its efficient ER-to-lysosome delivery, requires the selective binding of PS1 holoprotein to the unglycosylated subunit and the Sec61alpha/oligosaccharyltransferase complex. PS1 mutations causing early-onset AD produce a similar lysosomal/autophagy phenotype in fibroblasts from AD patients. PS1 is therefore essential for v-ATPase targeting to lysosomes, lysosome acidification, and proteolysis during autophagy. Defective lysosomal proteolysis represents a basis for pathogenic protein accumulations and neuronal cell death in AD and suggests previously unidentified therapeutic targets.	[Lee, Ju-Hyun; Yu, W. Haung; Kumar, Asok; Lee, Sooyeon; Mohan, Panaiyur S.; Peterhoff, Corrinne M.; Wolfe, Devin M.; Nixon, Ralph A.] Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Lee, Ju-Hyun; Yu, W. Haung; Mohan, Panaiyur S.; Nixon, Ralph A.] NYU, Langone Med Ctr, Dept Psychiat, New York, NY 10016 USA; [Kumar, Asok] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Lee, Sooyeon] NYU, Langone Med Ctr, Dept Neurosci, New York, NY 10016 USA; [Nixon, Ralph A.] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Martinez-Vicente, Marta; Massey, Ashish C.; Sovak, Guy; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Res, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan; [Westaway, David] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Yeshiva University; Albert Einstein College of Medicine; Juntendo University; University of Alberta	Nixon, RA (corresponding author), Nathan S Kline Inst, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	nixon@nki.rfmh.org	Martinez-Vicente, Marta/K-4312-2014	Martinez-Vicente, Marta/0000-0001-7053-2625; Yu, Wai Haung/0000-0001-7186-6731; Lee, Ju-hyun/0000-0002-0280-8375; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [P01AG017617]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are very grateful to Alan Bernstein (Global HIV Vaccine Enterprise, Seattle) for blastocysts, Tamotsu Yoshimori (Osaka University) for the tandem-tagged LC3 construct, Samuel E. Gandy (Mount Sinai Medical Center) for PS1 antibody, Satoshi Sato (Kyoto University) for the rabbit pAb against 116 kDa subunit of the v-ATPase, Jean Gruenberg (Universite de Geneve) for anti-LBPA antibody, and Richard Cowburn (Karolinska Institute), Ralph Martins (Cornell University), Sandro Sorbi (Universita degli studi di Firenze) for PS1-FAD human fibroblasts, and Sangram S. Sisodia (University of Chicago) for PS cKO mice. We also thank Gert Kreibich (New York University Langone Medical Center) and members of the Nixon laboratory for valuable discussions and Nicole Piorkowski for assistance with manuscript preparation. This work was supported by National Institutes of Health grant number P01AG017617 (R.A.N) and the Alzheimer's Association (R.A.N).	ANDERSON RGW, 1984, P NATL ACAD SCI-BIOL, V81, P4838, DOI 10.1073/pnas.81.15.4838; AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Diwu ZJ, 1999, CHEM BIOL, V6, P411, DOI 10.1016/S1074-5521(99)80059-3; DOTTAVIOMARTIN D, 1978, ANAL BIOCHEM, V87, P562, DOI 10.1016/0003-2697(78)90706-6; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; GILLESPIE J, 1991, FEBS LETT, V282, P69, DOI 10.1016/0014-5793(91)80446-A; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim TW, 1997, CURR OPIN NEUROBIOL, V7, P683, DOI 10.1016/S0959-4388(97)80089-X; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; NAKANISHI H, 1994, EXP NEUROL, V126, P119, DOI 10.1006/exnr.1994.1048; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rozmahel R, 2002, NEUROBIOL AGING, V23, P187, DOI 10.1016/S0197-4580(01)00267-6; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shioi J, 2007, J NEUROCHEM, V101, P674, DOI 10.1111/j.1471-4159.2006.04391.x; U.S. Office of Science and Technology Policy, 1985, Fed Regist, V50, P20864; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	53	806	827	7	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1146	U91		10.1016/j.cell.2010.05.008	http://dx.doi.org/10.1016/j.cell.2010.05.008			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20541250	Green Accepted, Bronze			2022-12-28	WOS:000279148100012
J	Dang, L; White, DW; Gross, S; Bennett, BD; Bittinger, MA; Driggers, EM; Fantin, VR; Jang, HG; Jin, SF; Keenan, MC; Marks, KM; Prins, RM; Ward, PS; Yen, KE; Liau, LM; Rabinowitz, JD; Cantley, LC; Thompson, CB; Vander Heiden, MG; Su, SM				Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.			Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)	NATURE			English	Correction													Prins, Robert/AAX-1155-2021; Cantley, Lewis C/D-1800-2014; Ward, Patrick/H-2361-2014	Cantley, Lewis C/0000-0002-1298-7653; Ward, Patrick/0000-0001-6437-8174; Dang, Lenny/0000-0002-2073-6109; Liau, Linda/0000-0002-4053-0052; Prins, Robert/0000-0002-6282-6583	NATIONAL CANCER INSTITUTE [R01CA105463] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA105463] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890	2	311	322	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					966	966		10.1038/nature09132	http://dx.doi.org/10.1038/nature09132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559394	Green Accepted, Bronze			2022-12-28	WOS:000278804500046
J	Hayes, KS; Bancroft, AJ; Goldrick, M; Portsmouth, C; Roberts, IS; Grencis, RK				Hayes, K. S.; Bancroft, A. J.; Goldrick, M.; Portsmouth, C.; Roberts, I. S.; Grencis, R. K.			Exploitation of the Intestinal Microflora by the Parasitic Nematode Trichuris muris	SCIENCE			English	Article							ESCHERICHIA-COLI; HYGIENE HYPOTHESIS; IMMUNE-SYSTEM; MATURATION; CELLS; GUT; ADHERENCE; RESPONSES; BACTERIA	The inhabitants of the mammalian gut are not always relatively benign commensal bacteria but may also include larger and more parasitic organisms, such as worms and protozoa. At some level, all these organisms are capable of interacting with each other. We found that successful establishment of the chronically infecting parasitic nematode Trichuris muris in the large intestine of mice is dependent on microflora and coincident with modulation of the host immune response. By reducing the number of bacteria in the host animal, we significantly reduced the number of hatched T. muris eggs. Critical interactions between bacteria (microflora) and parasites (macrofauna) introduced a new dynamic to the intestinal niche, which has fundamental implications for our current concepts of intestinal homeostasis and regulation of immunity.	[Hayes, K. S.; Bancroft, A. J.; Goldrick, M.; Portsmouth, C.; Roberts, I. S.; Grencis, R. K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Roberts, IS (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	ian.s.roberts@manchester.ac.uk; richard.k.grencis@manchester.ac.uk	hayes, kelly/GVT-8455-2022		UK Biotechnology and Biological Sciences Research Council; Wellcome Trust [083620Z]; University of Manchester; UK Medical Research Council [G0601205]; MRC [G0601205] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Cliffe for numerous helpful discussions; J. Kott and R. Fernandez for help with microscopy; the staff in the Faculty of Life Sciences EM Facility for their assistance, particularly A. Mironov and the Wellcome Trust for equipment grant support to the EM Facility; the Faculty of Life Sciences Mass Spectrometry Unit and E. Keevill for help with protein identification; and P. Klemm for bacterial strains and plasmids. The Bioimaging Facility microscopes used in this study were purchased with grants from the UK Biotechnology and Biological Sciences Research Council, Wellcome, and the University of Manchester Strategic Fund. Accession numbers for proteins identified by mass spectrometry are Q9N5A6 CAEEL, TMP00496_1, TMP00827_1, TMP00007_1, and TMP00821_1 and can be found at www.nematodes.org/nembase4. Supported by Wellcome Trust grant 083620Z and UK Medical Research Council grant G0601205.	[Anonymous], [No title captured]; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; BREINES DM, 1994, J ANTIMICROB CHEMOTH, V34, P205, DOI 10.1093/jac/34.2.205; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Edelman SM, 2008, CURR OPIN GASTROEN, V24, P720, DOI 10.1097/MOG.0b013e32830c4355; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Yazdanbakhsh M, 2004, CLIN REV ALLERG IMMU, V26, P15, DOI 10.1385/CRIAI:26:1:15	22	203	209	0	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1391	1394		10.1126/science.1187703	http://dx.doi.org/10.1126/science.1187703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538949	Green Accepted			2022-12-28	WOS:000278598400037
J	Smith, AJ; Schwappach, B				Smith, Andrew J.; Schwappach, Blanche			Think Vesicular Chloride	SCIENCE			English	Editorial Material							CHANNELS		[Smith, Andrew J.; Schwappach, Blanche] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Smith, AJ (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	blanche.schwappach@manchester.ac.uk		Schwappach, Blanche/0000-0003-0225-6432				Berg J.S., J CELL SCI, V113, P3439, DOI [10.1242/jcs.113.19.3439, DOI 10.1242/JCS.113.19.3439]; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Planells-Cases R, 2009, BBA-MOL BASIS DIS, V1792, P173, DOI 10.1016/j.bbadis.2009.02.002; Smith AJ, 2010, J PHYSIOL-LONDON, V588, P2033, DOI 10.1113/jphysiol.2010.188540; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072	10	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1364	1365		10.1126/science.1191529	http://dx.doi.org/10.1126/science.1191529			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538939				2022-12-28	WOS:000278598400026
J	Bardisa-Ezcurra, L; Ullman, R; Gordon, J				Bardisa-Ezcurra, Lauren; Ullman, Roz; Gordon, Jenny		Guideline Dev Grp	Guidelines Diagnosis and management of idiopathic childhood constipation: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bardisa-Ezcurra, Lauren; Ullman, Roz] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Gordon, Jenny] Royal Coll Nursing Inst, Oxford OX4 2JY, England		Bardisa-Ezcurra, L (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	lbardisa-ezcurra@ncc-wch.org.uk	; Tinelli, Michela/C-3008-2016	Cave, James/0000-0003-0721-9534; Tinelli, Michela/0000-0002-8816-4389	National Collaborating Centre for Women's and Children's Health; National Institute for Health and Clinical Excellence	National Collaborating Centre for Women's and Children's Health; National Institute for Health and Clinical Excellence	Funding: The National Collaborating Centre for Women's and Children's Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Borowitz SM, 2003, J AM BOARD FAM PRACT, V16, P213, DOI 10.3122/jabfm.16.3.213; Candelli M, 2001, HEPATO-GASTROENTEROL, V48, P1050; CROFFIE JM, 2000, PEDIAT GASTROINTESTI, P830; Farrell M, 2003, J ADV NURS, V44, P479, DOI 10.1046/j.0309-2402.2003.02831.x; National Institute for Health and Clinical Excellence, 2010, CONST DIAGN MAN ID C; van den Berg MM, 2006, AM J GASTROENTEROL, V101, P2401, DOI 10.1111/j.1572-0241.2006.00771.x; Youssef NN, 2001, J CLIN GASTROENTEROL, V33, P199, DOI 10.1097/00004836-200109000-00006	7	47	49	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2010	340								c2585	10.1136/bmj.c2585	http://dx.doi.org/10.1136/bmj.c2585			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BK	20516006				2022-12-28	WOS:000278556300003
J	Smith, IB; Holt, JW				Smith, Isaac B.; Holt, John W.			Onset and migration of spiral troughs on Mars revealed by orbital radar	NATURE			English	Article							POLAR LAYERED DEPOSITS; GEOLOGIC HISTORY; REGION; FLOW; STRATIGRAPHY; EVOLUTION; SURFACE; ORIGIN; CAP	The landscape of the north polar layered deposits of Mars (NPLD) is dominated by a pinwheel array of enigmatic spiral troughs(1). The troughs have intrigued planetary scientists since the Mariner 9 spacecraft returned the first close-up image in 1972, but conclusive evidence of their origin has remained elusive. Debate continues regarding all aspects of the troughs, including the possibility that they have migrated(2-5), their age in relation to the current NPLD surface(6), and whether they are fundamentally erosional(6,7) or constructional(2,4) features. The troughs are probably related to climatic processes(2,8), yet the nature of this relationship has remained a mystery. Previous data characterizing only the exposed NLPD surface were insufficient to test these hypotheses. Here we show that the central spiral troughs initiated after deposition of three-quarters of the NPLD, quickly reached a stable morphology and migrated approximately 65 kilometres poleward and 600 metres in altitude over the past two million years or so. Our radar stratigraphy rules out hypotheses of erosional incision post-dating deposition(6,7,9,10), and instead largely validates an early hypothesis for constructional trough migration(2-5) with wind transport and atmospheric deposition as dominant processes. These results provide hard constraints for palaeo-climate models and a new context for evaluating imagery, spectral data, and now radar sounding data, the better to understand the link between orbital parameters and climate, the role of climate in shaping the polar ice of Mars, and eventually, the age of the polar deposits themselves(8,11-13).	[Smith, Isaac B.; Holt, John W.] Univ Texas Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA		Smith, IB (corresponding author), Univ Texas Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	isaac@ig.utexas.edu	Holt, John/C-4896-2009	Smith, Isaac/0000-0002-4331-913X	NASA [NAG5-12693]; Gayle White Fellowship at the University of Texas Institute for Geophysics	NASA(National Aeronautics & Space Administration (NASA)); Gayle White Fellowship at the University of Texas Institute for Geophysics	This work was supported by NASA grant NAG5-12693 to J.H. and by the Gayle White Fellowship at the University of Texas Institute for Geophysics. We especially thank D. Young, S. Kempf, C. Brothers and S. Christian for listening to ideas and for help preparing the data and images. We thank A. Howard for insight and comments, and the SHARAD Operations Center for their continuous support in data acquisition. We dedicate this paper to the memory of SHARAD team member Ali Safaenili, who provided the focused radargrams we use. This is UTIG contribution 2187.	Christensen P.R., THEMIS PUBLIC DATA R; CUTTS JA, 1973, J GEOPHYS RES, V78, P4211, DOI 10.1029/JB078i020p04211; CUTTS JA, 1979, J GEOPHYS RES, V84, P2975, DOI 10.1029/JB084iB06p02975; CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; Fishbaugh KE, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002571; Fishbaugh KE, 2005, ICARUS, V174, P444, DOI 10.1016/j.icarus.2004.06.021; FISHER DA, 1993, ICARUS, V105, P501, DOI 10.1006/icar.1993.1144; Fisher DA, 2000, ICARUS, V144, P289, DOI 10.1006/icar.1999.6293; Grima C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036326; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; HOWARD AD, 1978, ICARUS, V34, P581, DOI 10.1016/0019-1035(78)90047-7; Howard AD, 2000, ICARUS, V144, P267, DOI 10.1006/icar.1999.6305; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; Milkovich SM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002987; Milkovich SM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002349; Ng FSL, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002533; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Pelletier JD, 2004, GEOLOGY, V32, P365, DOI 10.1130/G20228.2; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; SODERBLOM LA, 1973, J GEOPHYS RES, V78, P4197, DOI 10.1029/JB078i020p04197; SQUYRES SW, 1979, ICARUS, V40, P244, DOI 10.1016/0019-1035(79)90070-8; Tanaka KL, 2008, ICARUS, V196, P318, DOI 10.1016/j.icarus.2008.01.021; WEIJERMARS R, 1986, EARTH PLANET SC LETT, V76, P227, DOI 10.1016/0012-821X(86)90075-0; Winebrenner DP, 2008, ICARUS, V195, P90, DOI 10.1016/j.icarus.2007.11.030; ZENG Z, 2008, 39 LUN PLAN SCI C LU	29	48	48	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					450	453		10.1038/nature09049	http://dx.doi.org/10.1038/nature09049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505722				2022-12-28	WOS:000278043700028
J	Sahakian, BJ; Malloch, G; Kennard, C				Sahakian, Barbara J.; Malloch, Gavin; Kennard, Christopher		Mental Hlth Review Grp	A UK strategy for mental health and wellbeing	LANCET			English	Editorial Material									[Malloch, Gavin] MRC, London W1B 1AL, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, MRC, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England; [Kennard, Christopher] Univ Oxford, Dept Clin Neurol, Oxford, England	University of Cambridge; University of Cambridge; University of Oxford	Malloch, G (corresponding author), MRC, London W1B 1AL, England.	gavin.malloch@headoffice.mrc.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745				Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Green H., 2005, J RES SPEC EDUC NEED; Insel TR, 2009, ARCH GEN PSYCHIAT, V66, P128, DOI 10.1001/archgenpsychiatry.2008.540; *MRC, REV MENT HLTH RES RE; Sainsbury Centre for Mental Health, 2003, EC SOC COSTS MENT IL; UK Clinical Research Collaboration, 2006, HLTH RES AN; Wellcome Trust, 2008, MED RES WHATS IT WOR; WHALEN J, 2010, WALL STREET J   0205; 2010, RPT UPDATE 1 ASTRAZE	9	36	36	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1854	1855		10.1016/S0140-6736(10)60817-3	http://dx.doi.org/10.1016/S0140-6736(10)60817-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609BC	20511002				2022-12-28	WOS:000278628800008
J	Surolia, I; Pirnie, SP; Chellappa, V; Taylor, KN; Cariappa, A; Moya, J; Liu, H; Bell, DW; Driscoll, DR; Diederichs, S; Haider, K; Netravali, I; Le, S; Elia, R; Dow, E; Lee, A; Freudenberg, J; De Jager, PL; Chretien, Y; Varki, A; MacDonald, ME; Gillis, T; Behrens, TW; Bloch, D; Collier, D; Korzenik, J; Podolsky, DK; Hafler, D; Murali, M; Sands, B; Stone, JH; Gregersen, PK; Pillai, S				Surolia, Ira; Pirnie, Stephan P.; Chellappa, Vasant; Taylor, Kendra N.; Cariappa, Annaiah; Moya, Jesse; Liu, Haoyuan; Bell, Daphne W.; Driscoll, David R.; Diederichs, Sven; Haider, Khaleda; Netravali, Ilka; Le, Sheila; Elia, Roberto; Dow, Ethan; Lee, Annette; Freudenberg, Jan; De Jager, Philip L.; Chretien, Yves; Varki, Ajit; MacDonald, Marcy E.; Gillis, Tammy; Behrens, Timothy W.; Bloch, Donald; Collier, Deborah; Korzenik, Joshua; Podolsky, Daniel K.; Hafler, David; Murali, Mandakolathur; Sands, Bruce; Stone, John H.; Gregersen, Peter K.; Pillai, Shiv			Functionally defective germline variants of sialic acid acetylesterase in autoimmunity	NATURE			English	Article							MUTATIONS; DISEASE; MARKER	Sialic acid acetylesterase (SIAE) is an enzyme that negatively regulates B lymphocyte antigen receptor signalling and is required for the maintenance of immunological tolerance in mice(1,2). Heterozygous loss-of-function germline rare variants and a homozygous defective polymorphic variant of SIAE were identified in 24/923 subjects of European origin with relatively common autoimmune disorders and in 2/648 controls of European origin. All heterozygous loss-of-function SIAE mutations tested were capable of functioning in a dominant negative manner. Ahomozygous secretion-defective polymorphic variant of SIAE was catalytically active, lacked the ability to function in a dominant negative manner, and was seen in eight autoimmune subjects but in no control subjects. The odds ratio for inheriting defective SIAE alleles was 8.6 in all autoimmune subjects, 8.3 in subjects with rheumatoid arthritis, and 7.9 in subjects with type I diabetes. Functionally defective SIAE rare and polymorphic variants represent a strong genetic link to susceptibility in relatively common human autoimmune disorders.	[Surolia, Ira; Pirnie, Stephan P.; Chellappa, Vasant; Taylor, Kendra N.; Cariappa, Annaiah; Moya, Jesse; Liu, Haoyuan; Bell, Daphne W.; Driscoll, David R.; Diederichs, Sven; Haider, Khaleda; Netravali, Ilka; Le, Sheila; Elia, Roberto; Dow, Ethan; Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Lee, Annette; Freudenberg, Jan; Gregersen, Peter K.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [De Jager, Philip L.; Hafler, David] Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [De Jager, Philip L.; Hafler, David] MIT, Cambridge, MA 02142 USA; [Chretien, Yves] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [MacDonald, Marcy E.; Gillis, Tammy] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Bloch, Donald; Collier, Deborah; Stone, John H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Rheumatol, Boston, MA 02114 USA; [Korzenik, Joshua; Podolsky, Daniel K.; Sands, Bruce] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Murali, Mandakolathur] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Clin Immunol Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwell Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; Roche Holding; Genentech; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pillai, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	pillai@helix.mgh.harvard.edu	Sands, Bruce/R-7887-2019; Diederichs, Sven/J-6237-2012	Sands, Bruce/0000-0001-5762-5042; Diederichs, Sven/0000-0001-7901-4752; Bloch, Donald/0000-0002-6828-4754	Alliance for Lupus Research; Center for the Study of Inflammatory Bowel Disease at MGH; NIH [AI 064930, AI 076505, AR 058481, NS 32765]; NIH for NARAC [AR 044422, AR 022263]; MADGC [AI 068759]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338] Funding Source: NIH RePORTER	Alliance for Lupus Research; Center for the Study of Inflammatory Bowel Disease at MGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH for NARAC; MADGC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Cohen for coordinating the recall of inflammatory bowel disease patients, and K. Pedrick and E. Chung for their contributions. These studies were supported by grants from the Alliance for Lupus Research, the Center for the Study of Inflammatory Bowel Disease at MGH, and the NIH (AI 064930, AI 076505, and AR 058481) to S. P. and a grant to M.E.M. (NS 32765). P.K.G. acknowledges NIH support for NARAC (AR 044422 and AR 022263) and MADGC (AI 068759). The NIDDK is acknowledged for making samples available from the EDIC collection of its DNA repository. D. W. B. acknowledges the Intramural program of the National Human Genome Research Institute at NIH.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bell DW, 1999, CANCER RES, V59, P3883; Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Jessani N, 2005, ANGEW CHEM INT EDIT, V44, P2400, DOI 10.1002/anie.200463098; Krishna M, 1997, J EXP MED, V185, P1997, DOI 10.1084/jem.185.11.1997; Kwak EL, 2006, CLIN CANCER RES, V12, P4283, DOI 10.1158/1078-0432.CCR-06-0189; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pillai S, 2009, TRENDS IMMUNOL, V30, P488, DOI 10.1016/j.it.2009.07.006; SHUKLA AK, 1982, H-S Z PHYSIOL CHEM, V363, P255, DOI 10.1515/bchm2.1982.363.1.255; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	16	129	134	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					243	U118		10.1038/nature09115	http://dx.doi.org/10.1038/nature09115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20555325	Green Accepted			2022-12-28	WOS:000279580800038
J	Bruins, HJ				Bruins, Hendrik J.			Dating Pharaonic Egypt	SCIENCE			English	Editorial Material							SANTORINI ERUPTION; ANCIENT-EGYPT; CHRONOLOGY; BC		[Bruins, Hendrik J.] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-84990 Sede Boqer, Israel; [Bruins, Hendrik J.] Ben Gurion Univ Negev, Dept Bible Archaeol & Ancient Near Eastern Studie, IL-84990 Sede Boqer, Israel	Ben Gurion University; Ben Gurion University	Bruins, HJ (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-84990 Sede Boqer, Israel.	hjbruins@bgu.ac.il						BIETAK M, 2003, SYNCHRONISATION CIVI, P23; Bietak M., 2007, SYNCHRONISATION CIVI, P13; Bruins HJ, 2009, RADIOCARBON, V51, P397, DOI 10.1017/S003382220005579X; Doumas C., 1983, THERA POMPEII ANCIEN; Friedrich WL, 2006, SCIENCE, V312, P548, DOI 10.1126/science.1125087; HASSAN FA, 1987, ANTIQUITY, V61, P119, DOI 10.1017/S0003598X00072641; Hornung E., 2006, ANCIENT EGYPTIAN CHR; KITCHEN KA, 1991, WORLD ARCHAEOL, V23, P201, DOI 10.1080/00438243.1991.9980172; KRAUSS R, 1985, SOTHIS MONDDATEN STU; MacGillivray J. A., 2009, MONOGRAPHS DANISH I, V10, P154; Manning SW, 2006, SCIENCE, V312, P565, DOI 10.1126/science.1125682; Ramsey CB, 2004, RADIOCARBON, V46, P325, DOI 10.1017/S0033822200039631; Ramsey CB, 2010, SCIENCE, V328, P1554, DOI 10.1126/science.1189395; SHAW I, 2000, OXFORD HIST ANCIENT; SIGURDSSON H, 2006, AGU, V87, P337; von Beckerath J, 1997, CHRONOLOGIE PHARAONI	16	12	12	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1489	1490		10.1126/science.1191410	http://dx.doi.org/10.1126/science.1191410			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	611XW	20558694				2022-12-28	WOS:000278859200022
J	Watson, P				Watson, Peggy			Health Reform Poland's painful market reforms	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Dept Sociol, Cambridge CB2 1TN, England	University of Cambridge	Watson, P (corresponding author), Univ Cambridge, Dept Sociol, Cambridge CB2 1TN, England.	pw125@cam.ac.uk			British Academy	British Academy	The author acknowledges the support of the British Academy.	BURKE J, 2009, OBSERVER        0118; Czapinski J., 2009, DIAGNOZA SPOLECZNA; European Commission, 2010, SPEC EUR 327 PAT SAF; *MIN HLTH, 2009, B STAT MIN ZDROW; *MIN HLTH, 2008, RAP FIN OCHR ZDROW P; *NAT SEC BUR, 2010, WYN KEWST BBN DOT ZA; SIKORA D, 2010, DZIENNIK        0408	7	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2010	340								c2837	10.1136/bmj.c2837	http://dx.doi.org/10.1136/bmj.c2837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551121				2022-12-28	WOS:000279051800004
J	Shelly, DR				Shelly, David R.			Periodic, Chaotic, and Doubled Earthquake Recurrence Intervals on the Deep San Andreas Fault	SCIENCE			English	Article							SLIP; TREMOR; MODEL; PARKFIELD; SEISMICITY; CALIFORNIA; BENEATH; HAZARD	Earthquake recurrence histories may provide clues to the timing of future events, but long intervals between large events obscure full recurrence variability. In contrast, small earthquakes occur frequently, and recurrence intervals are quantifiable on a much shorter time scale. In this work, I examine an 8.5-year sequence of more than 900 recurring low-frequency earthquake bursts composing tremor beneath the San Andreas fault near Parkfield, California. These events exhibit tightly clustered recurrence intervals that, at times, oscillate between similar to 3 and similar to 6 days, but the patterns sometimes change abruptly. Although the environments of large and low-frequency earthquakes are different, these observations suggest that similar complexity might underlie sequences of large earthquakes.	US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Shelly, DR (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	dshelly@usgs.gov		Shelly, David/0000-0003-2783-5158				Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; BECKER TW, 2001, GEOPHYS MONOGR, V120, P5; Beeler NM, 2001, B SEISMOL SOC AM, V91, P1797, DOI 10.1785/0120000096; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; Chen T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005749; Ellsworth WL, 1999, 99522 US GEOL SURV; Erickson B, 2008, NONLINEAR PROC GEOPH, V15, P1, DOI 10.5194/npg-15-1-2008; Field EH, 2009, B SEISMOL SOC AM, V99, P2053, DOI 10.1785/0120080049; Gu Y., 1994, GEOPHYS MONOGR SER, V83, P15; HUANG J, 1990, GEOPHYS RES LETT, V17, P223, DOI 10.1029/GL017i003p00223; HUANG J, 1990, NATURE, V348, P234, DOI 10.1038/348234a0; ITO K, 1980, J GEOPHYS RES, V85, P1399, DOI 10.1029/JB085iB03p01399; Julian BR, 2000, J VOLCANOL GEOTH RES, V101, P19, DOI 10.1016/S0377-0273(00)00165-7; Ma SL, 2001, TECTONOPHYSICS, V337, P135, DOI 10.1016/S0040-1951(01)00114-7; Murray J, 2006, B SEISMOL SOC AM, V96, pS283, DOI 10.1785/0120050820; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; RICE JR, 1993, J GEOPHYS RES-SOL EA, V98, P9885, DOI 10.1029/93JB00191; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Scharer KM, 2010, GEOLOGY, V38, P555, DOI 10.1130/G30746.1; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2010, NATURE, V463, P648, DOI 10.1038/nature08755; Shelly DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039589; Shelly DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036367; SHIMAZAKI K, 1980, GEOPHYS RES LETT, V7, P279, DOI 10.1029/GL007i004p00279; Thomas AM, 2009, NATURE, V462, P1048, DOI 10.1038/nature08654; Waldhauser F, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005479; WEEKS JD, 1985, J GEOPHYS RES-SOLID, V90, P7821, DOI 10.1029/JB090iB09p07821; Weldon R., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)014%3C4:watecw%3E2.0.co;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2,2004]	29	55	56	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1385	1388		10.1126/science.1189741	http://dx.doi.org/10.1126/science.1189741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538948				2022-12-28	WOS:000278598400035
J	Dempsey, OJ; Kerr, KM; Remmen, H; Denison, AR				Dempsey, Owen J.; Kerr, Keith M.; Remmen, Hardy; Denison, Alan R.			How to investigate a patient with suspected interstitial lung disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IDIOPATHIC PULMONARY-FIBROSIS; EXTRINSIC ALLERGIC ALVEOLITIS; BRAIN NATRIURETIC PEPTIDE; HYPERSENSITIVITY PNEUMONITIS; GASTROESOPHAGEAL-REFLUX; ARTERIAL-HYPERTENSION; PROGNOSTIC VALUE; SYSTEMIC-SCLEROSIS; SARCOIDOSIS; CT		[Dempsey, Owen J.] Aberdeen Royal Infirm, Dept Resp Med, Aberdeen AB25 2ZN, Scotland; [Kerr, Keith M.] Aberdeen Univ Med Sch, Aberdeen AB25 2ZN, Scotland; [Remmen, Hardy] Aberdeen Royal Infirm, Dept Cardiothorac Surg, Aberdeen AB25 2ZN, Scotland; [Denison, Alan R.] Aberdeen Royal Infirm, Aberdeen Biomed Imaging Ctr, Aberdeen AB25 2ZN, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen	Dempsey, OJ (corresponding author), Aberdeen Royal Infirm, Dept Resp Med, Foresterhill, Aberdeen AB25 2ZN, Scotland.	owen.dempsey@nhs.net						*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Atis S, 2005, EUR RESPIR J, V25, P110, DOI 10.1183/09031936.04.00138403; Attili AK, 2008, RADIOGRAPHICS, V28, P1383, DOI 10.1148/rg.285075223; Barton R, 2008, THORAX, V63, P1, DOI 10.1136/thx.2007.086215; BAUGHMAN RP, 2003, OXFORD TXB MED, P1464; Behr J, 2008, EUR RESPIR J, V31, P1357, DOI 10.1183/09031936.00171307; Behr J, 2009, EUR RESPIR MONOGR, P67; Cameron SEH, 2010, CYTOPATHOLOGY, V21, P6, DOI 10.1111/j.1365-2303.2009.00722.x; Camus P, 2004, BRIT J CANCER, V91, pS18, DOI 10.1038/sj.bjc.6602063; CAMUS P, 2007, DIFFUSE PARENCHYMAL, P212; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; Cohen RAC, 2008, SEMIN RESP CRIT CARE, V29, P651, DOI 10.1055/s-0028-1101275; Copley SJ, 2009, RADIOLOGY, V251, P566, DOI 10.1148/radiol.2512081242; Corte TJ, 2009, SARCOIDOSIS VASC DIF, V26, P7; CORTE TJ, 2010, EUR RESP J; Cottin V, 2009, EUR RESPIR MONOGR, P287; Currie GP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3209; Dempsey OJ, 2006, QJM-INT J MED, V99, P643, DOI 10.1093/qjmed/hcl098; Dempsey OJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3206; Denton CP, 1997, BRIT J RHEUMATOL, V36, P239; Diego C, 2009, EUR RESPIR MONOGR, P112; Doherty MJ, 1997, THORAX, V52, P998, DOI 10.1136/thx.52.11.998; DOUGLAS JG, 1986, THORAX, V41, P787, DOI 10.1136/thx.41.10.787; Enriquez-Matas A, 2007, J INVEST ALLERG CLIN, V17, P126; EPLER GR, 1978, NEW ENGL J MED, V298, P934, DOI 10.1056/NEJM197804272981703; Flaherty KR, 2007, AM J RESP CRIT CARE, V175, P1054, DOI 10.1164/rccm.200606-833OC; Flaherty KR, 2006, AM J RESP CRIT CARE, V174, P803, DOI 10.1164/rccm.200604-488OC; Flaherty KR, 2004, AM J RESP CRIT CARE, V170, P904, DOI 10.1164/rccm.200402-147OC; Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P1722, DOI 10.1164/ajrccm.164.9.2103074; Fox J, 1999, AM J IND MED, V35, P58, DOI 10.1002/(SICI)1097-0274(199901)35:1<58::AID-AJIM8>3.0.CO;2-5; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Gay SE, 1998, AM J RESP CRIT CARE, V157, P1063, DOI 10.1164/ajrccm.157.4.9703022; Girard M, 2009, ALLERGY, V64, P322, DOI 10.1111/j.1398-9995.2009.01949.x; Glazer CS, 2009, EUR RESPIR MONOGR, P265; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; HAITJEMA T, 1992, THORAX, V47, P990, DOI 10.1136/thx.47.11.990; HALPIN DMG, 1994, OCCUP ENVIRON MED, V51, P165, DOI 10.1136/oem.51.3.165; Han MK, 2009, EUR RESPIR MONOGR, P7; Huang SK, 2009, EUR RESPIR MONOGR, P24; Hunninghake GW, 2001, AM J RESP CRIT CARE, V164, P193, DOI 10.1164/ajrccm.164.2.2101090; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Inase N, 2006, ANN ALLERG ASTHMA IM, V96, P98, DOI 10.1016/S1081-1206(10)61047-2; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; Kreider ME, 2007, ANN THORAC SURG, V83, P1140, DOI 10.1016/j.athoracsur.2006.10.002; Lama VN, 2003, AM J RESP CRIT CARE, V168, P1084, DOI 10.1164/rccm.200302-219OC; Latsi PI, 2003, AM J RESP CRIT CARE, V168, P531, DOI 10.1164/rccm.200210-1245OC; LEBACQ E, 1970, POSTGRAD MED J, V46, P526, DOI 10.1136/pgmj.46.538.526; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Leuchte HH, 2006, AM J RESP CRIT CARE, V173, P744, DOI 10.1164/rccm.200510-1545OC; Leuchte HH, 2004, AM J RESP CRIT CARE, V170, P360, DOI 10.1164/rccm.200308-1142OC; Lok SS, 1999, J HEART LUNG TRANSPL, V18, P884, DOI 10.1016/S1053-2498(99)00050-9; Lynch JP, 2006, SEMIN RESP CRIT CARE, V27, P634, DOI 10.1055/s-2006-957335; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Marshall BG, 1998, THORAX, V53, P439, DOI 10.1136/thx.53.6.439; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; McGrath DS, 2000, THORAX, V55, P751, DOI 10.1136/thorax.55.9.751; McLaughlin V, 2009, RHEUMATOLOGY, V48, P25, DOI 10.1093/rheumatology/kep107; Medford ARL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3962; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mogulkoc N, 2001, AM J RESP CRIT CARE, V164, P103, DOI 10.1164/ajrccm.164.1.2007077; Mukerjee D, 2003, ANN RHEUM DIS, V62, P1088, DOI 10.1136/ard.62.11.1088; Munson JC, 2010, EUR RESPIR J, V35, P9, DOI 10.1183/09031936.00156909; Nadrous HF, 2005, CHEST, V128, p616S, DOI 10.1378/chest.128.6_suppl.616S-a; Nannini C, 2008, CURR OPIN RHEUMATOL, V20, P340, DOI 10.1097/BOR.0b013e3282f798ed; Nicholson AG, 2001, SEM RESP CRIT CARE M, V22, P409, DOI 10.1055/s-2001-17384; Nukiwa T, 2009, EUR RESPIR MONOGR, P47; Padley S P, 1993, J Thorac Imaging, V8, P189, DOI 10.1097/00005382-199322000-00004; Patel NM, 2007, CHEST, V132, P998, DOI 10.1378/chest.06-3087; Raghu G, 2008, EUR RESPIR REV, V17, P108, DOI 10.1183/09059180.00010902; Remy-Jardin M, 2002, RADIOLOGY, V222, P261, DOI 10.1148/radiol.2221001154; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Savarino E, 2009, AM J RESP CRIT CARE, V179, P408, DOI 10.1164/rccm.200808-1359OC; SHARMA OP, 1967, SARCOIDOSE, P627; SHARMA OP, 2005, EUR RESP MON, V32, P220; Shorr AF, 2001, CHEST, V120, P881, DOI 10.1378/chest.120.3.881; Silva CIS, 2008, RADIOLOGY, V247, P251, DOI 10.1148/radiol.2471070369; Silva CIS, 2009, J THORAC IMAG, V24, P260, DOI 10.1097/RTI.0b013e3181c1a9eb; Song JW, 2009, RESP MED, V103, P180, DOI 10.1016/j.rmed.2008.11.012; SOVIJARVI ARA, 1977, SCAND J RESPIR DIS, V58, P41; Specks U, 2009, EUR RESPIR MONOGR, P251; Sumikawa H, 2006, RADIOLOGY, V241, P258, DOI 10.1148/radiol.2411050928; Sweet MP, 2009, THORAX, V64, P167, DOI 10.1136/thx.2007.082719; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Tobin RW, 1998, AM J RESP CRIT CARE, V158, P1804, DOI 10.1164/ajrccm.158.6.9804105; Tomas LHS, 2009, CURR OPIN PULM MED, V15, P165, DOI 10.1097/MCP.0b013e3283218341; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-78; WARREN CPW, 1977, THORAX, V32, P567, DOI 10.1136/thx.32.5.567; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691; Wells AU, 2009, RHEUMATOLOGY, V48, P40, DOI 10.1093/rheumatology/kep109; Wells AU, 2007, THORAX, V62, P904, DOI 10.1136/thx.2004.031021; WELLS AU, 1993, AM J ROENTGENOL, V161, P1159, DOI 10.2214/ajr.161.6.8249719; WIGGINS J, 1990, RESP MED, V84, P365, DOI 10.1016/S0954-6111(08)80070-4; Woodhead F, 2008, CLIN CHEST MED, V29, P149, DOI 10.1016/j.ccm.2007.11.009	99	7	9	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2010	340								c2843	10.1136/bmj.c2843	http://dx.doi.org/10.1136/bmj.c2843			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611MD	20534676				2022-12-28	WOS:000278818500012
J	Emery, CA; Kang, J; Shrier, I; Goulet, C; Hagel, BE; Benson, BW; Nettel-Aguirre, A; McAllister, JR; Hamilton, GM; Meeuwisse, WH				Emery, Carolyn A.; Kang, Jian; Shrier, Ian; Goulet, Claude; Hagel, Brent E.; Benson, Brian W.; Nettel-Aguirre, Alberto; McAllister, Jenelle R.; Hamilton, Gavin M.; Meeuwisse, Willem H.			Risk of Injury Associated With Body Checking Among Youth Ice Hockey Players	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPORT INJURY; CONCUSSION; RATES; PARTICIPATION; STATEMENT; RECOVERY; CALGARY	Context Ice hockey has one of the highest sport participation and injury rates in youth in Canada. Body checking is the predominant mechanism of injury in leagues in which it is permitted. Objective To determine if risk of injury and concussion differ for Pee Wee (ages 11-12 years) ice hockey players in a league in which body checking is permitted (Alberta, Canada) vs a league in which body checking is not permitted (Quebec, Canada). Design, Setting, and Participants Prospective cohort study conducted in Alberta and Quebec during the 2007-2008 Pee Wee ice hockey season. Participants (N=2154) were players from teams in the top 60% of divisions of play. Main Outcome Measures Incidence rate ratios adjusted for cluster based on Poisson regression for game-and practice-related injury and concussion. Results Seventy-four Pee Wee teams from Alberta (n=1108 players) and 76 Pee Wee teams from Quebec (n=1046 players) completed the study. In total, there were 241 injuries (78 concussions) reported in Alberta (85 077 exposure-hours) and 91 injuries (23 concussions) reported in Quebec (82 099 exposure-hours). For game-related injuries, the Alberta vs Quebec incidence rate ratio was 3.26 (95% confidence interval [CI], 2.31-4.60 [n=209 and n=70 for Alberta and Quebec, respectively]) for all injuries, 3.88 (95% CI, 1.91-7.89 [n=73 and n=20]) for concussion, 3.30 (95% CI, 1.77-6.17 [n=51 and n=16]) for severe injury (time loss, >7 days), and 3.61 (95% CI, 1.16-11.23 [n=14 and n=4]) for severe concussion (time loss, >10 days). The estimated absolute risk reduction (injuries per 1000 player-hours) that would be achieved if body checking were not permitted in Alberta was 2.84 (95% CI, 2.18-3.49) for all game-related injuries, 0.72 (95% CI, 0.40-1.04) for severe injuries, 1.08 (95% CI, 0.70-1.46) for concussion, and 0.20 (95% CI, 0.04-0.37) for severe concussion. There was no difference between provinces for practice-related injuries. Conclusion Among 11- to 12-year-old ice hockey players, playing in a league in which body checking is permitted compared with playing in a league in which body checking is not permitted was associated with a 3-fold increased risk of all game-related injuries and the categories of concussion, severe injury, and severe concussion. JAMA. 2010; 303(22): 2265-2272	[Emery, Carolyn A.; Kang, Jian; Benson, Brian W.; McAllister, Jenelle R.; Hamilton, Gavin M.; Meeuwisse, Willem H.] Univ Calgary, Sport Med Ctr, Roger Jackson Ctr Hlth & Wellness Res, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.; Hagel, Brent E.; Nettel-Aguirre, Alberto] Univ Calgary, Alberta Childrens Hosp, Fac Med, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.; Hagel, Brent E.; Nettel-Aguirre, Alberto; Meeuwisse, Willem H.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Shrier, Ian] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2, Canada; [Goulet, Claude] Univ Laval, Fac Educ, Dept Phys Educ, Quebec City, PQ, Canada	University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; Lady Davis Institute; McGill University; Laval University	Emery, CA (corresponding author), Univ Calgary, Sport Med Ctr, Roger Jackson Ctr Hlth & Wellness Res, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca	Emery, Carolyn/AAI-2761-2020; Nettel-Aguirre, Alberto/ABB-9412-2021; Hagel, Brent/AAK-3319-2020; Shrier, Ian/AAI-6502-2020	Shrier, Ian/0000-0001-9914-3498; Nettel-Aguirre, Alberto/0000-0001-6604-0652; Emery, Carolyn Ann/0000-0002-9499-6691	Canadian Institutes of Health Research; Max Bell Foundation; Hockey Calgary; Hockey Edmonton; Hockey Quebec; Hockey Alberta; Hockey Canada; Quebec Ministry of Education, Leisure and Sport; Alberta Heritage Foundation; Canadian National Railway Company; Alberta Heritage Foundation for Medical Research Population Health Investigator; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Max Bell Foundation; Hockey Calgary; Hockey Edmonton; Hockey Quebec; Hockey Alberta; Hockey Canada; Quebec Ministry of Education, Leisure and Sport; Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Canadian National Railway Company; Alberta Heritage Foundation for Medical Research Population Health Investigator; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was funded by the Canadian Institutes of Health Research and the Max Bell Foundation. This research also received support from Hockey Calgary, Hockey Edmonton, Hockey Quebec, Hockey Alberta, Hockey Canada, and the Quebec Ministry of Education, Leisure and Sport. Dr Emery is supported by a Population Health Investigator Award from the Alberta Heritage Foundation, a New Investigator Award from the Canadian Institutes of Health Research, and a Professorship in Pediatric Rehabilitation in the Faculty of Medicine, University of Calgary (Alberta Children's Hospital Foundation). Dr Hagel holds the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness, funded through the support of an anonymous donor and the Canadian National Railway Company, as well as the Alberta Heritage Foundation for Medical Research Population Health Investigator and Canadian Institutes of Health Research New Investigator Awards. Dr Shrier is supported by the Senior Clinician Scientist program of the Fonds de la Recherche en Sante du Quebec.	Benson B., 2005, CLIN J SPORT MED, V15, P395; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; *HOCK CAN, BACKGR CHECK; *HOCK CAN, HOCK CAN ANN REP 200; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meeuwisse WH, 1998, CLIN J SPORT MED, V8, P164, DOI 10.1097/00042752-199807000-00003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; ROY MA, 1989, PHYSICIAN SPORTSMED, V17, P119, DOI 10.1080/00913847.1989.11709735; *STATACORP, 2005, STAT STAT SOFTW COMP; *US HOCK, HOCK ANN REP US 2007; *US HOCK, 2007, 2007 09 OFF RUL IC H; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wiggins W., 1999, THESIS LAKEHEAD U TH; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	29	157	158	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2265	2272		10.1001/jama.2010.755	http://dx.doi.org/10.1001/jama.2010.755			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530780	Green Published			2022-12-28	WOS:000278496800025
J	Christen, M; Kulasekara, HD; Christen, B; Kulasekara, BR; Hoffman, LR; Miller, SI				Christen, Matthias; Kulasekara, Hemantha D.; Christen, Beat; Kulasekara, Bridget R.; Hoffman, Lucas R.; Miller, Samuel I.			Asymmetrical Distribution of the Second Messenger c-di-GMP upon Bacterial Cell Division	SCIENCE			English	Article							CAULOBACTER-CRESCENTUS; ALLOSTERIC CONTROL; STRUCTURAL BASIS; PROTEINS	The bacterial second messenger cyclic diguanosine monophosphate (c-di-GMP) regulates cellular motility and the synthesis of organelles and molecules that promote adhesion to a variety of biological and nonbiological surfaces. These properties likely require tight spatial and temporal regulation of c-di-GMP concentration. We have developed genetically encoded fluorescence resonance energy transfer (FRET)-based biosensors to monitor c-di-GMP concentrations within single bacterial cells by microscopy. Fluctuations of c-di-GMP were visualized in diverse Gram-negative bacterial species and observed to be cell cycle dependent. Asymmetrical distribution of c-di-GMP in the progeny correlated with the time of cell division and polarization for Caulobacter crescentus and Pseudomonas aeruginosa. Thus, asymmetrical distribution of c-di-GMP was observed as part of cell division, which may indicate an important regulatory step in extracellular organelle biosynthesis or function.	[Christen, Matthias; Kulasekara, Hemantha D.; Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Christen, Beat] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kulasekara, Bridget R.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Hoffman, Lucas R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, SI (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	millersi@uw.edu	Christen, Beat/AAC-2974-2021; Hoffman, Lucas/AAX-1853-2021	Christen, Matthias/0000-0001-7724-4562; Christen, Beat/0000-0002-9528-3685	National Institute of Allergy and Infectious Diseases, NIH [1R21NS067579-01, U54AI057141, KO8AI066251]; NSF; Swiss National Foundation [PA00P3-124140, PBBSA-120489, PA00P3-126243]; Novartis Foundation; Cystic Fibrosis Foundation [HOFFMA04L0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL105543, R01HL098084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, K08AI066251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067579] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF(National Science Foundation (NSF)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Jones from Rutgers University, Piscataway, NJ, for c-di-GMP and T. Ohashi from Duke University, Durham, NC, for the pET15b::mCYPet_12AA_mYPet plasmids. This research was supported by the National Institute of Allergy and Infectious Diseases, NIH (1R21NS067579-01 and U54AI057141 to S.I.M; KO8AI066251 to L.R.H and 1R21NS067579-01 to H. D. K), NSF (Graduate Research Fellowship to B.R.K), Swiss National Foundation (PA00P3-124140 and PBBSA-120489 to M.C. and PA00P3-126243 to B.C), Novartis Foundation to M.C., and Cystic Fibrosis Foundation (HOFFMA04L0 to L.R.H).	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2	16	194	197	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1295	1297		10.1126/science.1188658	http://dx.doi.org/10.1126/science.1188658			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522779	Green Accepted			2022-12-28	WOS:000278318600040
J	Sarewitz, D				Sarewitz, Daniel			World view: Defending democracy	NATURE			English	Editorial Material									Arizona State Univ, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Washington, DC USA.	dsarewitz@gmail.com						2010, NATURE, V465, P412	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					546	546		10.1038/465546a	http://dx.doi.org/10.1038/465546a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	604AF	20520686	Bronze			2022-12-28	WOS:000278249000012
J	Sendoel, A; Kohler, I; Fellmann, C; Lowe, SW; Hengartner, MO				Sendoel, Ataman; Kohler, Ines; Fellmann, Christof; Lowe, Scott W.; Hengartner, Michael O.			HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase	NATURE			English	Article							HYPOXIA-INDUCIBLE FACTOR; DAMAGE-INDUCED APOPTOSIS; CAENORHABDITIS-ELEGANS; C-ELEGANS; CELL-LINES; PROTEIN; P53; PATHWAY; CANCER; GENE	Hypoxia-inducible factor (HIF) is a transcription factor that regulates fundamental cellular processes in response to changes in oxygen concentration. HIF alpha protein levels are increased in most solid tumours and correlate with patient prognosis. The link between HIF and apoptosis, a major determinant of cancer progression and treatment outcome, is poorly understood. Here we show that Caenorhabditis elegans HIF-1 protects against DNA-damage-induced germ cell apoptosis by antagonizing the function of CEP-1, the homologue of the tumour suppressor p53. The antiapoptotic property of HIF-1 is mediated by means of transcriptional upregulation of the tyrosinase family member TYR-2 in the ASJ sensory neurons. TYR-2 is secreted by ASJ sensory neurons to antagonize CEP-1-dependent germline apoptosis. Knock down of the TYR-2 homologue TRP2 (also called DCT) in human melanoma cells similarly increases apoptosis, indicating an evolutionarily conserved function. Our findings identify a novel link between hypoxia and programmed cell death, and provide a paradigm for HIF-1 dictating apoptotic cell fate at a distance.	[Sendoel, Ataman; Kohler, Ines; Fellmann, Christof; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Sendoel, Ataman] Univ Zurich, PhD Program Canc Biol, CH-8057 Zurich, Switzerland; [Sendoel, Ataman] Univ Zurich, MD PhD Program, CH-8057 Zurich, Switzerland; [Lowe, Scott W.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Fellmann, Christof] Univ Zurich, PhD Program Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Zurich	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Hengartner, Michael O/E-6235-2011	Sendoel, Ataman/0000-0002-0381-9965; Fellmann, Christof/0000-0002-9545-5723; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation; Kanton of Zurich; Josef-Steiner Foundation; Oncosuisse; NIH National Center for Research Resources (NCRR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton of Zurich; Josef-Steiner Foundation; Oncosuisse; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Y. Lazebnik, A. Gartner, A. Hajnal, J. Jiricny, R. Wenger and C. Mosimann for critical reading of the manuscript. We are grateful to S. Schrimpf, L. Stergiou, E. Bogan, S. Egger, O. Georgiev, M. Moser and Hengartner, Hajnal and Lowe laboratory members for help and discussions. We thank Y. Auchli and P. Hunziker from the Functional Genomics Center Zurich for protein analysis. We are grateful to V. Hearing and J. Valencia for the TRP2 antibody and help. This work was supported by the Swiss National Science Foundation, the Kanton of Zurich and the Josef-Steiner Foundation. M.O.H. is Ernst Hadorn endowed Professor of Molecular Biology. A.S. was supported by Oncosuisse and the Swiss National Science Foundation. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; BRENNER S, 1974, GENETICS, V77, P71; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; ITO S, 1984, BIOCHEM J, V222, P407, DOI 10.1042/bj2220407; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MONTANO X, 1994, ONCOGENE, V9, P1455; PALUMBO A, 1987, BIOCHIM BIOPHYS ACTA, V925, P203, DOI 10.1016/0304-4165(87)90110-3; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Xu YQ, 1997, J INVEST DERMATOL, V109, P788, DOI 10.1111/1523-1747.ep12340971; Ying-Tao Z, 2005, EUR J GASTROEN HEPAT, V17, P725, DOI 10.1097/00042737-200507000-00006; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhong H, 1999, CANCER RES, V59, P5830; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	46	138	159	4	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					577	U69		10.1038/nature09141	http://dx.doi.org/10.1038/nature09141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520707	Green Accepted			2022-12-28	WOS:000278249000033
J	Beltrao, P; Cagney, G; Krogan, NJ				Beltrao, Pedro; Cagney, Gerard; Krogan, Nevan J.			Quantitative Genetic Interactions Reveal Biological Modularity	CELL			English	Article							PROTEIN COMPLEXES; HIGH-THROUGHPUT; NETWORKS; CELL; EPISTASIS; CONSERVATION; PERTURBATION; ORGANIZATION; METHYLATION; STRATEGY		[Beltrao, Pedro; Cagney, Gerard; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Cagney, Gerard] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Belfield, Ireland	University of California System; University of California San Francisco; University College Dublin	Krogan, NJ (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA.	krogan@cmp.ucsf.edu		Cagney, Gerard/0000-0001-7189-9496; Beltrao, Pedro/0000-0002-2724-7703	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM084448-02, R01 GM084448] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	57	112	113	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					739	745		10.1016/j.cell.2010.05.019	http://dx.doi.org/10.1016/j.cell.2010.05.019			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510918	Green Accepted, Bronze			2022-12-28	WOS:000278132900006
J	Coffman, RL				Coffman, Robert L.			The Origin of T(H)2 Responses	SCIENCE			English	Editorial Material							IMMUNE-RESPONSES; CYTOKINES; INNATE		Dynavax Technol Corp, Berkeley, CA 94710 USA		Coffman, RL (corresponding author), Dynavax Technol Corp, 2929 7th St,Suite 100, Berkeley, CA 94710 USA.	RCoffman@dynavax.com						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015	10	22	23	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1116	1117		10.1126/science.1192009	http://dx.doi.org/10.1126/science.1192009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508120				2022-12-28	WOS:000278104700031
J	Dowling, RJO; Topisirovic, I; Alain, T; Bidinosti, M; Fonseca, BD; Petroulakis, E; Wang, XS; Larsson, O; Selvaraj, A; Liu, Y; Kozma, SC; Thomas, G; Sonenberg, N				Dowling, Ryan J. O.; Topisirovic, Ivan; Alain, Tommy; Bidinosti, Michael; Fonseca, Bruno D.; Petroulakis, Emmanuel; Wang, Xiaoshan; Larsson, Ola; Selvaraj, Anand; Liu, Yi; Kozma, Sara C.; Thomas, George; Sonenberg, Nahum			mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs	SCIENCE			English	Article							INSULIN-RESISTANCE; CANCER-THERAPY; MTOR; INHIBITOR; PHOSPHORYLATION; DOWNSTREAM; DROSOPHILA; REGULATOR; PROTEINS; KINASE	The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size. Hence, mTORC1 is implicated in a large number of human diseases-including diabetes, obesity, heart disease, and cancer-that are characterized by aberrant cell growth and proliferation. Although eukaryotic translation initiation factor 4E-binding proteins (4E-BPs) are critical mediators of mTORC1 function, their precise contribution to mTORC1 signaling and the mechanisms by which they mediate mTORC1 function have remained unclear. We inhibited the mTORC1 pathway in cells lacking 4E-BPs and analyzed the effects on cell size, cell proliferation, and cell cycle progression. Although the 4E-BPs had no effect on cell size, they inhibited cell proliferation by selectively inhibiting the translation of messenger RNAs that encode proliferation-promoting proteins and proteins involved in cell cycle progression. Thus, control of cell size and cell cycle progression appear to be independent in mammalian cells, whereas in lower eukaryotes, 4E-BPs influence both cell growth and proliferation.	[Dowling, Ryan J. O.; Topisirovic, Ivan; Alain, Tommy; Bidinosti, Michael; Fonseca, Bruno D.; Petroulakis, Emmanuel; Wang, Xiaoshan; Larsson, Ola; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Dowling, Ryan J. O.; Topisirovic, Ivan; Alain, Tommy; Bidinosti, Michael; Fonseca, Bruno D.; Petroulakis, Emmanuel; Wang, Xiaoshan; Larsson, Ola; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Selvaraj, Anand; Kozma, Sara C.; Thomas, George] Univ Cincinnati, Dept Canc & Cell Biol, Metab Dis Inst, Cincinnati, OH 45237 USA; [Liu, Yi] Intellikine, La Jolla, CA 92037 USA	McGill University; McGill University; University System of Ohio; University of Cincinnati	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca	Larsson, Ola/F-8151-2013; Topisirovic, Ivan/A-9426-2008; Thomas, George/K-9235-2014; Dowling, Ryan/Q-8912-2018	Topisirovic, Ivan/0000-0002-5510-9762; Thomas, George/0000-0003-3518-8149; Larsson, Ola/0000-0003-1412-1308; Dowling, Ryan/0000-0002-5381-8805	Canadian Cancer Society; Howard Hughes Medical Institute; Terry Fox Foundation; NIH Mouse Models for Human Cancer Consortium [U01 CA84292-06]; Leukemia and Lymphoma Society; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Natural Sciences and Engineering Research Council of Canada; Air Force Research Laboratory, Human Effectiveness Directorate, Bioscience and Protection, Wright-Patterson AFB; NIH [R01 DK73802, P50 NS057531]; John and Gladys Strauss Chair in Cancer Research; NATIONAL CANCER INSTITUTE [U01CA084292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073802, R01DK078019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS057531] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Terry Fox Foundation; NIH Mouse Models for Human Cancer Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Air Force Research Laboratory, Human Effectiveness Directorate, Bioscience and Protection, Wright-Patterson AFB(United States Department of DefenseUS Air Force Research Laboratory); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John and Gladys Strauss Chair in Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Rapamycin was from LC laboratories and Calbiochem, PP242 was from Intellikine, and Torin1 was from N. Gray D. Sabatini. Experimental procedures are described in the supplementary material. We thank M. Pende for S6K1CA construct; M. Holcik and N. Colburn for antibody to PDCD4; K. Shokat, C. Rommel, L. W. Ler, S. Fumagalli, and M. Livingstone for advice; C. Lister and P. Kirk for assistance; and M. Daston for editing. Supported by a grant from the Canadian Cancer Society and a Howard Hughes Medical Institute international research scholarship (N. S.); a Terry Fox Foundation research studentship (R.J.O.D.); NIH Mouse Models for Human Cancer Consortium grant U01 CA84292-06 (N. S., G. T., and S. C. K.); a Leukemia and Lymphoma Society special fellowship (I. T.); Canadian Institutes of Health Research and Alberta Heritage Foundation for Medical Research postdoctoral fellowships (T. A.); a Natural Sciences and Engineering Research Council of Canada predoctoral fellowship (M. B.); a CIHR consortium training fellowship award (B. D. F.); the Research Participation Program at the Air Force Research Laboratory, Human Effectiveness Directorate, Bioscience and Protection, Wright-Patterson AFB, administered by the Oak Ridge Institute for Science and Education (A. S.); NIH grants R01 DK73802 and P50 NS057531 (G. T. and S. C. K.); and the John and Gladys Strauss Chair in Cancer Research (G. T.). G. T. is a paid consultant for Novartis Oncology. There are MTAs or patents restricting use of materials listed, described as: PP242 and Torin1.	Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kim YY, 2009, CANCER RES, V69, P8455, DOI 10.1158/0008-5472.CAN-09-1923; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	26	509	528	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1172	1176		10.1126/science.1187532	http://dx.doi.org/10.1126/science.1187532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508131	Green Accepted, Green Published			2022-12-28	WOS:000278104700048
J	Percec, V; Wilson, DA; Leowanawat, P; Wilson, CJ; Hughes, AD; Kaucher, MS; Hammer, DA; Levine, DH; Kim, AJ; Bates, FS; Davis, KP; Lodge, TP; Klein, ML; DeVane, RH; Aqad, E; Rosen, BM; Argintaru, AO; Sienkowska, MJ; Rissanen, K; Nummelin, S; Ropponen, J				Percec, Virgil; Wilson, Daniela A.; Leowanawat, Pawaret; Wilson, Christopher J.; Hughes, Andrew D.; Kaucher, Mark S.; Hammer, Daniel A.; Levine, Dalia H.; Kim, Anthony J.; Bates, Frank S.; Davis, Kevin P.; Lodge, Timothy P.; Klein, Michael L.; DeVane, Russell H.; Aqad, Emad; Rosen, Brad M.; Argintaru, Andreea O.; Sienkowska, Monika J.; Rissanen, Kari; Nummelin, Sami; Ropponen, Jarmo			Self-Assembly of Janus Dendrimers into Uniform Dendrimersomes and Other Complex Architectures	SCIENCE			English	Article							BLOCK-COPOLYMER VESICLES; DRUG-DELIVERY; LIPOSOMES; TRANSITION; MEMBRANES; DYNAMICS; ORIGINS; SYSTEMS; MODELS; PORES	Self-assembled nanostructures obtained from natural and synthetic amphiphiles serve as mimics of biological membranes and enable the delivery of drugs, proteins, genes, and imaging agents. Yet the precise molecular arrangements demanded by these functions are difficult to achieve. Libraries of amphiphilic Janus dendrimers, prepared by facile coupling of tailored hydrophilic and hydrophobic branched segments, have been screened by cryogenic transmission electron microscopy, revealing a rich palette of morphologies in water, including vesicles, denoted dendrimersomes, cubosomes, disks, tubular vesicles, and helical ribbons. Dendrimersomes marry the stability and mechanical strength obtainable from polymersomes with the biological function of stabilized phospholipid liposomes, plus superior uniformity of size, ease of formation, and chemical functionalization. This modular synthesis strategy provides access to systematic tuning of molecular structure and of self-assembled architecture.	[Percec, Virgil; Wilson, Daniela A.; Leowanawat, Pawaret; Wilson, Christopher J.; Hughes, Andrew D.; Kaucher, Mark S.; Aqad, Emad; Rosen, Brad M.; Argintaru, Andreea O.; Sienkowska, Monika J.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; [Hammer, Daniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Hammer, Daniel A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Hammer, Daniel A.; Levine, Dalia H.; Kim, Anthony J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Bates, Frank S.; Davis, Kevin P.; Lodge, Timothy P.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Lodge, Timothy P.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Klein, Michael L.; DeVane, Russell H.] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Rissanen, Kari; Nummelin, Sami; Ropponen, Jarmo] Univ Jyvaskyla, Dept Chem, Nanosci Ctr, Jyu 40014, Finland; [Nummelin, Sami] Aalto Univ, Dept Appl Phys, Sch Sci & Technol, FI-02150 Espoo, Finland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Jyvaskyla; Aalto University	Percec, V (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	percec@sas.upenn.edu	Sienkowska, Monika/GLR-1518-2022; Wilson, Christopher J/C-9390-2009; Percec, Virgil/H-6316-2014; Wilson, Christopher/ABC-5819-2020; Nummelin, Sami J/O-5741-2015; Wilson, Christopher/T-5925-2019; Wilson, Daniela A./A-8119-2010; Kim, Anthony/A-1681-2012; Rissanen, Kari T/B-5688-2008; Nummelin, Sami/P-4185-2019; Rosen, Brad/A-5174-2008	Wilson, Christopher J/0000-0003-0760-3421; Percec, Virgil/0000-0001-5926-0489; Wilson, Christopher/0000-0003-0760-3421; Nummelin, Sami J/0000-0003-2195-4818; Wilson, Christopher/0000-0003-0760-3421; Wilson, Daniela A./0000-0002-8796-2274; Rissanen, Kari T/0000-0002-7282-8419; Nummelin, Sami/0000-0003-2195-4818; Aqad, Emad/0000-0002-8907-7391; Lodge, Timothy/0000-0001-5916-8834; Bates, Frank/0000-0003-3977-1278	NSF [DMR-0548559]; Academy of Finland; P. Roy Vagelos Chair at the University of Pennsylvania; Finnish Cultural Foundation	NSF(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); P. Roy Vagelos Chair at the University of Pennsylvania; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	We thank the NSF (grant DMR-0548559), NSF-funded Materials Research Science and Engineering Centers at the University of Pennsylvania and at the University of Minnesota, the Academy of Finland, and the P. Roy Vagelos Chair at the University of Pennsylvania for financial support. We also thank T. Tuttila, N. Kuuloja, and M. Lahtinen from the University of Jyvaskyla for contributions on the synthesis and analysis of some Janus dendrimers from library 1. Additional funding was provided by the Finnish Cultural Foundation.	Almgren M, 2000, COLLOID SURFACE A, V174, P3, DOI 10.1016/S0927-7757(00)00516-1; [Anonymous], 1992, INTERMOLECULAR SURFA; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; Bridson RH, 2006, J PHARM PHARMACOL, V58, P775, DOI 10.1211/jpp.58.6.0008; CHIRUVOLU S, 1994, SCIENCE, V266, P1222, DOI 10.1126/science.7973704; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Dobereiner HG, 2000, CURR OPIN COLLOID IN, V5, P256, DOI 10.1016/S1359-0294(00)00064-9; Dubois M, 2001, NATURE, V411, P672, DOI 10.1038/35079541; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; Guo X, 2003, ACCOUNTS CHEM RES, V36, P335, DOI 10.1021/ar9703241; Haluska CK, 2006, P NATL ACAD SCI USA, V103, P15841, DOI 10.1073/pnas.0602766103; Hanczyc MM, 2004, CURR OPIN CHEM BIOL, V8, P660, DOI 10.1016/j.cbpa.2004.10.002; Jung HT, 2001, P NATL ACAD SCI USA, V98, P1353, DOI 10.1073/pnas.041420998; Kita-Tokarczyk K, 2008, CHIMIA, V62, P820, DOI 10.2533/chimia.2008.820; Klein ML, 2008, SCIENCE, V321, P798, DOI 10.1126/science.1157834; Krafft MP, 2001, ADV DRUG DELIVER REV, V47, P209, DOI 10.1016/S0169-409X(01)00107-7; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Matsen MW, 1996, MACROMOLECULES, V29, P7641, DOI 10.1021/ma960744q; Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770; Rank A, 2009, LANGMUIR, V25, P1337, DOI 10.1021/la802709v; RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131; Rosen BM, 2009, J AM CHEM SOC, V131, P17500, DOI 10.1021/ja907882n; Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Thiele J, 2010, LANGMUIR, V26, P6860, DOI 10.1021/la904163v; THOMAS JL, 1992, ACCOUNTS CHEM RES, V25, P336, DOI 10.1021/ar00020a003; van Dongen SFM, 2009, CHEM REV, V109, P6212, DOI 10.1021/cr900072y; WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zhu TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005009	35	556	565	17	853	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1009	1014		10.1126/science.1185547	http://dx.doi.org/10.1126/science.1185547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	598YW	20489021				2022-12-28	WOS:000277877100036
J	Geisbert, TW; Lee, ACH; Robbins, M; Geisbert, JB; Honko, AN; Sood, V; Johnson, JC; de Jong, S; Tavakoli, I; Judge, A; Hensley, LE; MacLachlan, I				Geisbert, Thomas W.; Lee, Amy C. H.; Robbins, Marjorie; Geisbert, Joan B.; Honko, Anna N.; Sood, Vandana; Johnson, Joshua C.; de Jong, Susan; Tavakoli, Iran; Judge, Adam; Hensley, Lisa E.; MacLachlan, Ian			Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study	LANCET			English	Article							SYNTHETIC SIRNA; GUINEA-PIGS; INFECTION; STIMULATION; MODEL; MICE	Background We previously showed that small interfering RNAs (siRNAs) targeting the Zaire Ebola virus (ZEBOV) RNA polymerase L protein formulated in stable nucleic acid-lipid particles (SNALPs) completely protected guineapigs when administered shortly after a lethal ZEBOV challenge. Although rodent models of ZEBOV infection are useful for screening prospective countermeasures, they are frequently not useful for prediction of efficacy in the more stringent non-human primate models. We therefore assessed the efficacy of modified non-immunostimulatory siRNAs in a uniformly lethal non-human primate model of ZEBOV haemorrhagic fever. Methods A combination of modified siRNAs targeting the ZEBOV L polymerase (EK-1 mod), viral protein (VP) 24 (VP24-1160 mod), and VP35 (VP35-855 mod) were formulated in SNALPs. A group of macaques (n=3) was given these pooled anti-ZEBOV siRNAs (2 mg/kg per dose, bolus intravenous infusion) after 30 min, and on days 1, 3, and 5 after challenge with ZEBOV. A second group of macaques (n=4) was given the pooled anti-ZEBOV siRNAs after 30 min, and on days 1, 2, 3, 4, 5, and 6 after challenge with ZEBOV. Findings Two (66%) of three rhesus monkeys given four postexposure treatments of the pooled anti-ZEBOV siRNAs were protected from lethal ZEBOV infection, whereas all macaques given seven postexposure treatments were protected. The treatment regimen in the second study was well tolerated with minor changes in liver enzymes that might have been related to viral infection. Interpretation This complete postexposure protection against ZEBOV in non-human primates provides a model for the treatment of ZEBOV-induced haemorrhagic fever. These data show the potential of RNA interference as an effective postexposure treatment strategy for people infected with Ebola virus, and suggest that this strategy might also be useful for treatment of other emerging viral infections.	[Geisbert, Thomas W.; Geisbert, Joan B.] Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, Boston, MA 02118 USA; [Geisbert, Thomas W.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Geisbert, Thomas W.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Honko, Anna N.; Johnson, Joshua C.; Hensley, Lisa E.] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Lee, Amy C. H.; Robbins, Marjorie; Sood, Vandana; de Jong, Susan; Tavakoli, Iran; Judge, Adam; MacLachlan, Ian] Tekmira Pharmaceut, Burnaby, BC, Canada	Boston University; Boston University; Boston University	Geisbert, TW (corresponding author), Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, 620 Albany St,Room 401B, Boston, MA 02118 USA.	geisbert@bu.edu	Honko, Anna/H-9539-2019	Honko, Anna/0000-0001-9165-148X; Hensley, Lisa/0000-0003-1188-4342; Robbins, Marjorie/0000-0002-4123-7106; Johnson, Joshua/0000-0002-5677-3841	Defense Threat Reduction Agency [04-4-7J-012]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Work on filoviruses at US Army Medical Research Institute of Infectious Diseases was funded by the Defense Threat Reduction Agency (project number 04-4-7J-012). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by Boston University or the US Army.	Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Enterlein S, 2006, ANTIMICROB AGENTS CH, V50, P984, DOI 10.1128/AAC.50.3.984-993.2006; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2006, J INFECT DIS, V193, P1650, DOI 10.1086/504267; Geisbert TW, 2004, EBOLA AND MARBURG VIRUSES: MOLECULAR AND CELLULAR BIOLOGY, P203; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Grimm D, 2007, MOL THER, V15, P878, DOI 10.1038/sj.mt.6300116; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Heyes J, 2005, J CONTROL RELEASE, V107, P276, DOI 10.1016/j.jconrel.2005.06.014; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; *INT SOC INF DIS, EB LAB ACC DEATH RUS; *INT SOC INF DIS, EB NEEDL INJ GERM HA; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Kortepeter MG, 2008, EMERG INFECT DIS, V14, P881, DOI 10.3201/eid1406.071489; Prins KC, 2010, J VIROL, V84, P3004, DOI 10.1128/JVI.02459-09; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Robbins M, 2008, HUM GENE THER, V19, P991, DOI 10.1089/hum.2008.131; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Sanchez A, 2006, FIELDS VIROLOGY, P1409; Tang Qingquan, 2008, V442, P139, DOI 10.1007/978-1-59745-191-8_11; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; Warfield Kelly L., 2006, PLoS Pathogens, V2, P5; Yokota T, 2007, BIOCHEM BIOPH RES CO, V361, P294, DOI 10.1016/j.bbrc.2007.06.182	30	341	424	1	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1896	1905		10.1016/S0140-6736(10)60357-1	http://dx.doi.org/10.1016/S0140-6736(10)60357-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20511019	Bronze, Green Published			2022-12-28	WOS:000278628800031
J	Daviglus, ML; Bell, CC; Berrettini, W; Bowen, PE; Connolly, ES; Cox, NJ; Dunbar-Jacob, JM; Granieri, EC; Hunt, G; McGarry, K; Patel, D; Potosky, AL; Sanders-Bush, E; Silberberg, D; Trevisan, M				Daviglus, Martha L.; Bell, Carl C.; Berrettini, Wade; Bowen, Phyllis E.; Connolly, E. Sander, Jr.; Cox, Nancy Jean; Dunbar-Jacob, Jacqueline M.; Granieri, Evelyn C.; Hunt, Gail; McGarry, Kathleen; Patel, Dinesh; Potosky, Arnold L.; Sanders-Bush, Elaine; Silberberg, Donald; Trevisan, Maurizio			National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease and Cognitive Decline	ANNALS OF INTERNAL MEDICINE			English	Article								National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality, 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session, 3) questions and statements from conference attendees during open discussion periods that are part of the public session, and 4) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of NIH or the U. S. government. The following statement is an abridged version of the panel's report, which is available in full at http://consensus.nih.gov/2010/alzstatement.htm.	[Daviglus, Martha L.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Univ Illinois, Inst Juvenile Res, Chicago, IL USA; Community Mental Hlth Council, Chicago, IL USA; Univ Chicago, Chicago, IL 60637 USA; Univ Penn, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Philadelphia, PA 19104 USA; Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; Natl Alliance Caregiving, Bethesda, MD USA; Univ Calif Los Angeles, Los Angeles, CA USA; George Washington Univ, Sch Med, Rockville, MD USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Lombardi Comprehens Canc Ctr, Washington, DC USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Nevada Syst Higher Educ, Las Vegas, NV USA; Univ Nevada, Sch Med, Las Vegas, NV 89154 USA	Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Columbia University; NewYork-Presbyterian Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; George Washington University; Georgetown University; Vanderbilt University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Daviglus, ML (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1400, Chicago, IL 60611 USA.			trevisan, maurizio/0000-0001-5479-0050; Bowen, Phyllis/0000-0002-2950-3694					0	239	251	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					176	U72		10.7326/0003-4819-153-3-201008030-00260	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00260			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20547888				2022-12-28	WOS:000280557600006
J	Gomez, JM; Verdu, M; Perfectti, F				Gomez, Jose M.; Verdu, Miguel; Perfectti, Francisco			Ecological interactions are evolutionarily conserved across the entire tree of life	NATURE			English	Article							PHYLOGENETIC SIGNAL; PATTERNS	Ecological interactions are crucial to understanding both the ecology and the evolution of organisms(1,2). Because the phenotypic traits regulating species interactions are largely a legacy of their ancestors, it is widely assumed that ecological interactions are phylogenetically conserved, with closely related species interacting with similar partners(2). However, the existing empirical evidence is inadequate to appropriately evaluate the hypothesis of phylogenetic conservatism in ecological interactions, because it is both ecologically and taxonomically biased. In fact, most studies on the evolution of ecological interactions have focused on specialized organisms, such as some parasites or insect herbivores(3-7), belonging to a limited subset of the overall tree of life. Here we study the evolution of host use in a large and diverse group of interactions comprising both specialist and generalist acellular, unicellular and multicellular organisms. We show that, as previously found for specialized interactions, generalized interactions can be evolutionarily conserved. Significant phylogenetic conservatism of interaction patterns was equally likely to occur in symbiotic and non-symbiotic interactions, as well as in mutualistic and antagonistic interactions. Host-use differentiation among species was higher in phylogenetically conserved clades, irrespective of their generalization degree and taxonomic position within the tree of life. Our findings strongly suggest a shared pattern in the organization of biological systems through evolutionary time, mediated by marked conservatism of ecological interactions among taxa.	[Gomez, Jose M.] Univ Granada, Dept Ecol, E-18071 Granada, Spain; [Verdu, Miguel] Univ Valencia Generalitat Valenciana, CSIC, Ctr Invest Desertificac, E-46470 Valencia, Spain; [Perfectti, Francisco] Univ Granada, Dept Genet, E-18071 Granada, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); University of Granada	Gomez, JM (corresponding author), Univ Granada, Dept Ecol, E-18071 Granada, Spain.	jmgreyes@ugr.es	Verdu, Miguel/C-4461-2008; Perfectti, Francisco/C-5087-2008; Gómez, José M/K-8061-2017	Verdu, Miguel/0000-0002-9778-7692; Perfectti, Francisco/0000-0002-5551-213X; Gómez, José M/0000-0002-2487-4664	Spanish Ministry of Science; Junta de Andalucia	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	We thank J. Bascompte, J. Bosch, A. Gonzalez-Megias, P. Jordano, M. Lineham, M. Mendez, I. Reche, E. W. Schupp and S. Strauss for comments on a previous draft, R. Guimera for kindly providing NETCARTO software, and B. Krasnov, C. Mitter, L. Navarro, J. Ollerton and J. M. Pleguezuelos for providing access to their data set. This work was funded by the Spanish Ministry of Science (J. M. G., M. V. and F. P.) and by the Junta de Andalucia (J. M. G. and F. P.)	Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; CHASE JM, 2003, ECOLOGICAL NICHES LI, P19; DARWIN C, 1859, ORIGIN SPECIES, P78; De Nooy W., 2005, EXPLORATORY SOCIAL N; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Holmes E., 2009, EVOLUTION EMERGENCE; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; Maddison WP., 2019, MESQUITE MODULAR SYS; OKSANEN J, 2008, MULTIVARIATE ANAL EC; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Price P.W., 2003, MACROEVOLUTIONARY TH; Price PW, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P174; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Refregier G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-100; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Sasal P, 1998, ECOGRAPHY, V21, P639, DOI 10.1111/j.1600-0587.1998.tb00557.x; Thompson J.N., 2005, INTERSPEC INTERACT; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240	29	157	157	1	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					918	U6		10.1038/nature09113	http://dx.doi.org/10.1038/nature09113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20520609	Green Submitted			2022-12-28	WOS:000278804500036
J	Tan, ZS				Tan, Zaldy S.			The "Right" to Fall	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ztan@hms.harvard.edu						Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2333	2334		10.1001/jama.2010.792	http://dx.doi.org/10.1001/jama.2010.792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551398				2022-12-28	WOS:000278759200001
J	Kmech, J				Kmech, Jonn			A blow to the fight against snakebite	LANCET			English	Editorial Material									Univ Alberta, Edmonton, AB T6G 2J7, Canada	University of Alberta	Kmech, J (corresponding author), Univ Alberta, Edmonton, AB T6G 2J7, Canada.							Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organization, VEN SNAK DISTR SPEC; World Health Organization, 2016, WHO GUID PROD CONTR; 2010, FIRE DESTROYS WORLDS	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 12	2010	375	9731					2061	2061		10.1016/S0140-6736(10)60941-5	http://dx.doi.org/10.1016/S0140-6736(10)60941-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20542157				2022-12-28	WOS:000279069300009
J	De Dreu, CKW; Greer, LL; Handgraaf, MJJ; Shalvi, S; Van Kleef, GA; Baas, M; Ten Velden, FS; Van Dijk, E; Feith, SWW				De Dreu, Carsten K. W.; Greer, Lindred L.; Handgraaf, Michel J. J.; Shalvi, Shaul; Van Kleef, Gerben A.; Baas, Matthijs; Ten Velden, Femke S.; Van Dijk, Eric; Feith, Sander W. W.			The Neuropeptide Oxytocin Regulates Parochial Altruism in Intergroup Conflict Among Humans	SCIENCE			English	Article							SOCIAL-BEHAVIOR; AGGRESSION; AFFILIATION; HYPOTHESIS; WARFARE; TRUST; LOVE; HATE; GAME; WAR	Humans regulate intergroup conflict through parochial altruism; they self-sacrifice to contribute to in-group welfare and to aggress against competing out-groups. Parochial altruism has distinct survival functions, and the brain may have evolved to sustain and promote in-group cohesion and effectiveness and to ward off threatening out-groups. Here, we have linked oxytocin, a neuropeptide produced in the hypothalamus, to the regulation of intergroup conflict. In three experiments using double-blind placebo-controlled designs, male participants self-administered oxytocin or placebo and made decisions with financial consequences to themselves, their in-group, and a competing out-group. Results showed that oxytocin drives a "tend and defend" response in that it promoted in-group trust and cooperation, and defensive, but not offensive, aggression toward competing out-groups.	[De Dreu, Carsten K. W.; Greer, Lindred L.; Handgraaf, Michel J. J.; Shalvi, Shaul; Van Kleef, Gerben A.; Baas, Matthijs; Ten Velden, Femke S.] Univ Amsterdam, Dept Psychol, NL-1018 WB Amsterdam, Netherlands; [Van Dijk, Eric] Leiden Univ, Dept Psychol, NL-2300 RB Leiden, Netherlands; [Feith, Sander W. W.] Stichting AllesKits, NL-3059 XA Rotterdam, Netherlands	University of Amsterdam; Leiden University; Leiden University - Excl LUMC	De Dreu, CKW (corresponding author), Univ Amsterdam, Dept Psychol, Roetersstr 15, NL-1018 WB Amsterdam, Netherlands.	c.k.w.dedreu@uva.nl	Greer, Lindred/J-7832-2019; Handgraaf, Michel J.J./H-3462-2012; Shalvi, Shaul/D-6728-2011; De Dreu, Carsten/G-4215-2010; De Dreu, Carsten K.W./X-7762-2019	Greer, Lindred/0000-0002-8302-538X; De Dreu, Carsten/0000-0003-3692-4611; De Dreu, Carsten K.W./0000-0003-3692-4611; Shalvi, Shaul/0000-0003-2225-7352; Baas, Matthijs/0000-0003-4001-9657; Van Kleef, Gerben/0000-0003-0823-7654	Netherlands Science Foundation [NWO 400-06-098]	Netherlands Science Foundation(Netherlands Organization for Scientific Research (NWO))	The authors thank H. Aaldering, H. Ter Kuijlen, N. Halevy, and M. Kemper for their support at various stages of the project. This research was supported by grant NWO 400-06-098 of the Netherlands Science Foundation to Carsten K. W. De Dreu. The authors declare no competing interests.	Ahn TK, 2001, PUBLIC CHOICE, V106, P137, DOI 10.1023/A:1005219123532; ALBERT DJ, 1993, NEUROSCI BIOBEHAV R, V17, P405, DOI 10.1016/S0149-7634(05)80117-4; Arrow H, 2007, SCIENCE, V318, P581, DOI 10.1126/science.1150316; Bartz JA, 2006, HORM BEHAV, V50, P518, DOI 10.1016/j.yhbeh.2006.06.018; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59; Bornstein G, 2003, PERS SOC PSYCHOL REV, V7, P129, DOI 10.1207/S15327957PSPR0702_129-145; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Cohen TR, 2008, PERSPECT PSYCHOL SCI, V3, P87, DOI 10.1111/j.1745-6916.2008.00066.x; DARWIN C, 1873, DESCENT MAN APPLETON; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Fiske ST, 2002, CURR DIR PSYCHOL SCI, V11, P123, DOI 10.1111/1467-8721.00183; Halevy N, 2008, PSYCHOL SCI, V19, P405, DOI 10.1111/j.1467-9280.2008.02100.x; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; KOMORITA SS, 1995, ANNU REV PSYCHOL, V46, P183, DOI 10.1146/annurev.ps.46.020195.001151; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Pedersen CA, 2004, ANN NY ACAD SCI, V1036, P106, DOI 10.1196/annals.1330.006; Rapoport A., 1965, PRISONERS DILEMMA ST; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Van Vugt M, 2009, ANN NY ACAD SCI, V1167, P124, DOI 10.1111/j.1749-6632.2009.04539.x; Wildschut T, 2003, PSYCHOL BULL, V129, P698, DOI 10.1037/0033-2909.129.5.698; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009	30	681	685	7	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1408	1411		10.1126/science.1189047	http://dx.doi.org/10.1126/science.1189047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608PO	20538951				2022-12-28	WOS:000278598400042
J	Baylis, F				Baylis, Francoise			Pregnant women deserve better	NATURE			English	Editorial Material									[Baylis, Francoise] Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 3P7, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Philosophy, Halifax, NS B3H 3P7, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS B3H 3P7, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Baylis, F (corresponding author), Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 3P7, Canada.	francoise.baylis@dal.ca	Baylis, Francoise/AAP-4565-2021	Baylis, Francoise/0000-0003-2961-5802				Baylis F, 2010, J OBSTET GYNAECOL CA, V32, P473, DOI 10.1016/S1701-2163(16)34502-9; Council for International Organizations of Medical Sciences (CIOMS), INT ETH GUID BIOM RE; Lyerly Anne Drapkin, 2008, Int J Fem Approaches Bioeth, V1, P5, DOI 10.2979/FAB.2008.1.2.5	3	62	62	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					689	690		10.1038/465689a	http://dx.doi.org/10.1038/465689a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535185				2022-12-28	WOS:000278551800019
J	Jentink, J; Loane, MA; Dolk, H; Barisic, I; Garne, E; Morris, JK; de Jong-van den Berg, LTW				Jentink, Janneke; Loane, Maria A.; Dolk, Helen; Barisic, Ingeborg; Garne, Ester; Morris, Joan K.; de Jong-van den Berg, Lolkje T. W.		EUROCAT Antiepileptic Study Workin	Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEURAL-TUBE DEFECTS; ANTIEPILEPTIC DRUGS; SODIUM VALPROATE; PRENATAL EXPOSURE; BIRTH-DEFECTS; IN-UTERO; EPILEPSY; TERATOGENICITY; REGISTER; FETAL	Background: The use of valproic acid in the first trimester of pregnancy is associated with an increased risk of spina bifida, but data on the risks of other congenital malformations are limited. Methods: We first combined data from eight published cohort studies (1565 pregnancies in which the women were exposed to valproic acid, among which 118 major malformations were observed) and identified 14 malformations that were significantly more common among the offspring of women who had received valproic acid during the first trimester. We then assessed the associations between use of valproic acid during the first trimester and these 14 malformations by performing a case-control study with the use of the European Surveillance of Congenital Anomalies (EUROCAT) antiepileptic-study database, which is derived from population-based congenital-anomaly registries. Registrations (i.e., pregnancy outcomes with malformations included in EUROCAT) with any of these 14 malformations were compared with two control groups, one consisting of infants with malformations not previously linked to valproic acid use (control group 1), and one consisting of infants with chromosomal abnormalities (control group 2). The data set included 98,075 live births, stillbirths, or terminations with malformations among 3.8 million births in 14 European countries from 1995 through 2005. Results: Exposure to valproic acid monotherapy was recorded for a total of 180 registrations, with 122 registrations in the case group, 45 in control group 1, and 13 in control group 2. As compared with no use of an antiepileptic drug during the first trimester (control group 1), use of valproic acid monotherapy was associated with significantly increased risks for 6 of the 14 malformations under consideration; the adjusted odds ratios were as follows: spina bifida, 12.7 (95% confidence interval [CI], 7.7 to 20.7); atrial septal defect, 2.5 (95% CI, 1.4 to 4.4); cleft palate, 5.2 (95% CI, 2.8 to 9.9); hypospadias, 4.8 (95% CI, 2.9 to 8.1); polydactyly, 2.2 (95% CI, 1.0 to 4.5); and craniosynostosis, 6.8 (95% CI, 1.8 to 18.8). Results for exposure to valproic acid were similar to results for exposure to other antiepileptic drugs. Conclusions: The use of valproic acid monotherapy in the first trimester was associated with significantly increased risks of several congenital malformations, as compared with no use of antiepileptic drugs or with use of other antiepileptic drugs. N Engl J Med 2010;362:2185-93.	[Jentink, Janneke; de Jong-van den Berg, Lolkje T. W.] Univ Groningen, Dept Pharmacoepidemiol & Pharmacoecon, Div Pharm, NL-9713 AV Groningen, Netherlands; [Loane, Maria A.; Dolk, Helen] Univ Ulster, Inst Nursing Res, EUROCAT Cent Registry, Coleraine BT52 1SA, Londonderry, North Ireland; [Loane, Maria A.; Dolk, Helen] Univ Ulster, Sch Nursing, Coleraine BT52 1SA, Londonderry, North Ireland; [Barisic, Ingeborg] Childrens Univ Hosp Zagreb, Zagreb, Croatia; [Garne, Ester] Lillebaelt Hosp, Kolding, Denmark; [Morris, Joan K.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	University of Groningen; Ulster University; Ulster University; University of Zagreb; University of London; Queen Mary University London	de Jong-van den Berg, LTW (corresponding author), Univ Groningen, Dept Pharmacoepidemiol & Pharmacoecon, Div Pharm, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	l.t.w.de.jong-van.den.berg@rug.nl	Morris, Joan/AAT-9211-2020; Barisic, Ingeborg/A-7314-2016; Barisic, Ingeborg/HDN-8784-2022; Khoshnood, Babak/N-9096-2017; Pierini, Anna/A-9622-2013	Morris, Joan/0000-0002-7164-612X; Pierini, Anna/0000-0003-3321-9343; Portillo, Isabel/0000-0002-3871-3423; Loane, Maria/0000-0002-1206-3637	European Union; GlaxoSmithKline	European Union(European Commission); GlaxoSmithKline(GlaxoSmithKline)	The EUROCAT Central Database is supported in part by the European Union Public Health Programme, with a variety of sources of public funding for individual registries. Additional funding was obtained from GlaxoSmithKline for a study of lamotrigine, during which the antiepileptic-study database was constructed. GlaxoSmithKline was not involved in the present study. Drs. Garne and Barisic report that their registry received funding from GlaxoSmithKline for the data submitted to the lamotrigine study.; Dr. Jentink reports receiving travel reimbursements from GlaxoSmithKline through the University of Ulster. No other potential conflict of interest relevant to this article was reported.	Arpino C, 2000, EPILEPSIA, V41, P1436, DOI 10.1111/j.1528-1157.2000.tb00119.x; Dolk H, 2008, NEUROLOGY, V71, P714, DOI 10.1212/01.wnl.0000316194.98475.d8; Duncan S, 2007, CURR OPIN NEUROL, V20, P175, DOI 10.1097/WCO.0b013e32805866fb; *EUR SURV CONG AN, EUROCAT MEMB REG; European Surveillance of Congenital Anomalies, EUROCAT GUID 1 3 REF; Genton P, 2006, DRUG SAFETY, V29, P1, DOI 10.2165/00002018-200629010-00001; GOMEZ MR, 1981, J PEDIATR-US, V98, P508, DOI 10.1016/S0022-3476(81)80743-3; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; HIILESMAA VK, 1980, LANCET, V1, P883; Kaaja E, 2003, NEUROLOGY, V60, P575, DOI 10.1212/01.WNL.0000044157.28073.DC; LINDHOUT D, 1992, NEUROLOGY, V42, P111; LOSCHER W, 1984, EUR J PHARMACOL, V99, P211, DOI 10.1016/0014-2999(84)90243-7; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531; Mitchell AA, 2003, NEW ENGL J MED, V349, P2556, DOI 10.1056/NEJMsb031395; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; OMTZIGT JGC, 1992, NEUROLOGY, V42, P119; Ornoy A, 2006, REPROD TOXICOL, V22, P214, DOI 10.1016/j.reprotox.2006.03.014; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; PINDER RM, 1977, DRUGS, V13, P81, DOI 10.2165/00003495-197713020-00001; ROBERT E, 1982, LANCET, V2, P937, DOI 10.1016/s0140-6736(82)90908-4; Rodriguez-Pinilla E, 2000, AM J MED GENET, V90, P376, DOI 10.1002/(SICI)1096-8628(20000228)90:5<376::AID-AJMG6>3.3.CO;2-M; Sabers A, 2004, ACTA NEUROL SCAND, V109, P9, DOI 10.1034/j.1600-0404.2003.00200.x; Samren EB, 1997, EPILEPSIA, V38, P981, DOI 10.1111/j.1528-1157.1997.tb01480.x; Tomson T, 2004, EPILEPSIA, V45, P1171, DOI 10.1111/j.0013-9580.2004.15104.x; Vajda FJ, 2004, J CLIN NEUROSCI, V11, P854, DOI 10.1016/j.jocn.2004.05.003; WHO Collaborating Centre for Drug Statistics Methodology, 2003, AN THER CHEM CLASS S; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Wyszynski DF, 2005, NEUROLOGY, V64, P961, DOI 10.1212/01.WNL.0000154516.43630.C5	29	308	316	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2185	2193		10.1056/NEJMoa0907328	http://dx.doi.org/10.1056/NEJMoa0907328			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558369				2022-12-28	WOS:000278551500007
J	Sims, M; Maxwell, R; Bauld, L; Gilmore, A				Sims, Michelle; Maxwell, Roy; Bauld, Linda; Gilmore, Anna			Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PARTICULATE AIR-POLLUTION; PASSIVE SMOKING; SECONDHAND SMOKE; YOUNG-ADULTS; SEASONAL-VARIATION; EUROPEAN-SOCIETY; WORKING GROUP; BAN; MORTALITY	Objective To measure the short term impact on hospital admissions for myocardial infarction of the introduction of smoke-free legislation in England on 1 July 2007. Design An interrupted time series design with routinely collected hospital episode statistics data. Analysis of admissions from July 2002 to September 2008 (providing five years' data from before the legislation and 15 months' data from after) using segmented Poisson regression. Setting England. Population All patients aged 18 or older living in England with an emergency admission coded with a primary diagnosis of myocardial infarction. Main outcome measures Weekly number of completed hospital admissions. Results After adjustment for secular and seasonal trends and variation in population size, there was a small but significant reduction in the number of emergency admissions for myocardial infarction after the implementation of smoke-free legislation (-2.4%, 95% confidence interval -4.06% to -0.66%, P=0.007). This equates to 1200 fewer emergency admissions for myocardial infarction (1600 including readmissions) in the first year after legislation. The reduction in admissions was significant in men (3.1%, P=0.001) and women (3.8%, P=0.007) aged 60 and over, and men (3.5%, P<0.01) but not women (2.5% P=0.38) aged under 60. Conclusion This study adds to a growing body of evidence that smoke-free legislation leads to reductions in myocardial infarctions. It builds on previous work by showing that such declines are observed even when underlying reductions in admissions and potential confounders are controlled for. The considerably smaller decline in admissions observed in England compared with many other jurisdictions probably reflects aspects of the study design and the relatively low levels of exposure to secondhand smoke in England before the legislation.	[Sims, Michelle; Gilmore, Anna] Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England; [Sims, Michelle; Bauld, Linda; Gilmore, Anna] Univ Bath, UK Ctr Tobacco Control Studies, Bath BA2 7AY, Avon, England; [Maxwell, Roy] SW Publ Hlth Observ, Bristol BS8 2RA, Avon, England; [Bauld, Linda] Univ Bath, Dept Social & Policy Sci, Bath BA2 7AY, Avon, England; [Gilmore, Anna] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Bath; University of Bath; University of Bath; University of London; London School of Hygiene & Tropical Medicine	Gilmore, A (corresponding author), Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England.	a.gilmore@bath.ac.uk	gilmore, anna B/I-7130-2012	gilmore, anna B/0000-0003-0281-1248	Department of Health; Health Foundation; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish	Department of Health; Health Foundation; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was undertaken by the University of Bath, which received funding from the Department of Health's Policy Research Programme. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. AG is supported by a Health Foundation Clinician Scientist Fellowship. MS, LB, and AG are members of the UK Centre for Tobacco Control, a UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council and the Department of Health, under the auspices of the UK Clinical Research Collaboration is gratefully acknowledged. The funders played no role in the study design, analysis, and interpretation of data nor in the writing of the report or the decision to submit the article for publication.	Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Bartecchi C, 2006, CIRCULATION, V114, P1490, DOI 10.1161/CIRCULATIONAHA.106.615245; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Crawford VLS, 2003, QJM-INT J MED, V96, P45, DOI 10.1093/qjmed/hcg005; Croxton PJ, 2006, INT J CLIMATOL, V26, P2287, DOI 10.1002/joc.1378; *DEP HLTH, 2009, SMOK ENGL ON YEAR; Dinno A, 2007, PREV MED, V45, P9, DOI 10.1016/j.ypmed.2007.03.013; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Edwards E, 2006, SMOKE HAS CLEARED EV; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Fox KAA, 2004, HEART, V90, P603, DOI 10.1136/hrt.2004.038679; Gemmell I, 2000, INT J EPIDEMIOL, V29, P274, DOI 10.1093/ije/29.2.274; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; *IARC, 2009, IARC HDB CANC PREV T; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; Khuder SA, 2007, PREV MED, V45, P3, DOI 10.1016/j.ypmed.2007.03.011; Kloner RA, 2004, CIRCULATION, V110, P3744, DOI 10.1161/01.CIR.0000151786.03797.18; Koek HL, 2006, HEART, V92, P162, DOI 10.1136/hrt.2004.054486; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P62, DOI 10.1007/BF03403743; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MacIntyre K, 2006, HEART, V92, P691, DOI 10.1136/hrt.2005.068742; Marques-Vidal P, 2000, HEART, V84, P171, DOI 10.1136/heart.84.2.171; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Murphy NF, 2004, BMJ-BRIT MED J, V328, P1413, DOI 10.1136/bmj.38111.650741.F7; *NHS INF CTR HLTH, 2010, HOSP EP STAT ONL; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; OFARRELL AM, 2004, HOSP DISCHARGE RATES; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Pell JP, 1999, QJM-INT J MED, V92, P689, DOI 10.1093/qjmed/92.12.689; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; Richiardi L, 2009, PREV MED, V48, P167, DOI 10.1016/j.ypmed.2008.11.013; Royal College of Physicians, 2005, GOING SMOK FREE MED; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; SEMPLE S, 2010, ANN OCCUP HYG   0219; Seo DC, 2007, J DRUG EDUC, V37, P217, DOI 10.2190/DE.37.3.a; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; *UK MET OFF, 2009, HIST CENTR ENGL TEMP; Vasselli S, 2008, Minerva Cardioangiol, V56, P197; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WARDIE H, 2008, HLTH SURVEY ENGLAND, V1; WARDLE H, 2009, IMPACT SMOKEFREE LEG; WELLS AJ, 1994, J AM COLL CARDIOL, V24, P546, DOI 10.1016/0735-1097(94)90315-8; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	63	110	114	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2010	340								c2161	10.1136/bmj.c2161	http://dx.doi.org/10.1136/bmj.c2161			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MB	20530563	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000278818300002
J	Panman, MR; Bodis, P; Shaw, DJ; Bakker, BH; Newton, AC; Kay, ER; Brouwer, AM; Buma, WJ; Leigh, DA; Woutersen, S				Panman, Matthijs R.; Bodis, Pavol; Shaw, Daniel J.; Bakker, Bert H.; Newton, Arthur C.; Kay, Euan R.; Brouwer, Albert M.; Buma, Wybren Jan; Leigh, David A.; Woutersen, Sander			Operation Mechanism of a Molecular Machine Revealed Using Time-Resolved Vibrational Spectroscopy	SCIENCE			English	Article							DYNAMICS; MOTION; POLYMER; DRIVEN; ROTOR; MOTOR	Rotaxanes comprise macrocycles that can shuttle between docking stations along an axle. We explored the nanosecond shuttling mechanism by reversing the relative binding affinities of two stations through ultraviolet-induced transient reduction. We monitored the ensuing changes in the CO-stretching bands of the two stations and the shuttling macrocycle by means of an infrared probing pulse. Because hydrogen-bond scission and formation at the initial and final stations led to well-resolved changes in the respective CO-stretch frequencies, the departure and arrival of the macrocycle could be observed separately. We found that the shuttling involves two steps: thermally driven escape from the initial station, followed by rapid motion along the track ending either at the initial or final station. By varying the track's length, we found that the rapid motion approximates a biased one-dimensional random walk. However, surprisingly, the direction of the overall motion is opposite that of the bias.	[Panman, Matthijs R.; Bodis, Pavol; Shaw, Daniel J.; Bakker, Bert H.; Newton, Arthur C.; Brouwer, Albert M.; Buma, Wybren Jan; Woutersen, Sander] Univ Amsterdam, Vant Hoff Inst Mol Sci, NL-1018 WV Amsterdam, Netherlands; [Kay, Euan R.; Leigh, David A.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Amsterdam; University of Edinburgh	Brouwer, AM (corresponding author), Univ Amsterdam, Vant Hoff Inst Mol Sci, Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	a.m.brouwer@uva.nl; w.j.buma@uva.nl; david.leigh@ed.ac.uk; s.woutersen@uva.nl	Buma, Wybren Jan/F-6691-2011; Panman, Matthijs/N-3455-2019; Brouwer, Albert/A-2366-2010; Leigh, David/K-5965-2015; Kay, Euan R/G-4473-2011; Shaw, Daniel/R-3603-2017; Panman, Matthijs/D-4873-2011; Shaw, Daniel John/N-5692-2019	Buma, Wybren Jan/0000-0002-1265-8016; Panman, Matthijs/0000-0003-3853-123X; Brouwer, Albert/0000-0002-1731-3869; Leigh, David/0000-0002-1202-4507; Kay, Euan R/0000-0001-8177-6393; Shaw, Daniel/0000-0003-0090-2947; Panman, Matthijs/0000-0003-3853-123X; Shaw, Daniel John/0000-0003-0090-2947; Newton, Arthur/0000-0003-2140-121X	European Community [HPRN-CT-2002-00168, NMP4-CT-2004-013525]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Engineering and Physical Sciences Research Council [EP/C545001/1, EP/H021620/1] Funding Source: researchfish; EPSRC [EP/H021620/1] Funding Source: UKRI	European Community(European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank P. Reinders, S. Kettelarij, D. Bebelaar, M. Groeneveld, H. Luiten, H. Beukers, and C. van den Biggelaar for technical support, and G. Rothenberg for valuable discussions. Supported by the European Community (EMMMA IHP Research Training Network, contract HPRN-CT-2002-00168, and Hy3M STREP, contract NMP4-CT-2004-013525) and by the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO).	AKIYAMA M, 1994, SPECTROCHIM ACTA A, V50, P317, DOI 10.1016/0584-8539(94)80060-X; Astumian RD, 2007, P NATL ACAD SCI USA, V104, P19715, DOI 10.1073/pnas.0708040104; Astumian RD, 2005, P NATL ACAD SCI USA, V102, P1843, DOI 10.1073/pnas.0409341102; Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; Balzani V, 2006, P NATL ACAD SCI USA, V103, P1178, DOI 10.1073/pnas.0509011103; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Collin D, 2005, NATURE, V437, P231, DOI 10.1038/nature04061; Deutman ABC, 2008, SCIENCE, V322, P1668, DOI 10.1126/science.1164647; Feng EH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090602; Fletcher SP, 2005, SCIENCE, V310, P80, DOI 10.1126/science.1117090; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; GRIMMETT G, 1986, PROBABILITY INTRO; Hernandez JV, 2004, SCIENCE, V306, P1532, DOI 10.1126/science.1103949; Hiraoka S, 2008, J AM CHEM SOC, V130, P9089, DOI 10.1021/ja8014583; JAGESAR DC, 1935, CHEM-EUR J, V14, P2008; Jagesar DC, 2009, ADV FUNCT MATER, V19, P3440, DOI 10.1002/adfm.200900668; Jarzynski C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046105; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Kolano C, 2006, NATURE, V444, P469, DOI 10.1038/nature05352; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; Serreli V, 2007, NATURE, V445, P523, DOI 10.1038/nature05452; Stolow A, 2004, SCIENCE, V305, P1575, DOI 10.1126/science.1103195; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; von Delius M, 2010, NAT CHEM, V2, P96, DOI [10.1038/NCHEM.481, 10.1038/nchem.481]	26	81	81	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1255	1258		10.1126/science.1187967	http://dx.doi.org/10.1126/science.1187967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522770				2022-12-28	WOS:000278318600028
J	Pace, P; Mosedale, G; Hodskinson, MR; Rosado, IV; Sivasubramaniam, M; Patel, KJ				Pace, Paul; Mosedale, Georgina; Hodskinson, Michael R.; Rosado, Ivan V.; Sivasubramaniam, Meera; Patel, Ketan J.			Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway	SCIENCE			English	Article							STRAND BREAK REPAIR; PROTEIN; GENE; PROMOTES; RECOMBINATION; FIDELITY; REVEALS	A conserved DNA repair response is defective in the human genetic illness Fanconi anemia (FA). Mutation of some FA genes impairs homologous recombination and error-prone DNA repair, rendering FA cells sensitive to DNA cross-linking agents. We found a genetic interaction between the FA gene FANCC and the nonhomologous end joining (NHEJ) factor Ku70. Disruption of both FANCC and Ku70 suppresses sensitivity to cross-linking agents, diminishes chromosome breaks, and reverses defective homologous recombination. Ku70 binds directly to free DNA ends, committing them to NHEJ repair. We show that purified FANCD2, a downstream effector of the FA pathway, might antagonize Ku70 activity by modifying such DNA substrates. These results reveal a function for the FA pathway in processing DNA ends, thereby diverting double-strand break repair away from abortive NHEJ and toward homologous recombination.	[Pace, Paul; Hodskinson, Michael R.; Rosado, Ivan V.; Sivasubramaniam, Meera; Patel, Ketan J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Mosedale, Georgina] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	MRC Laboratory Molecular Biology; University of Oxford	Patel, KJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	kjp@mrc-lmb.cam.ac.uk	Rosado, Ivan/AAZ-9068-2020; Pace, Paul E/A-3104-2012	Rosado, Ivan/0000-0001-7409-7341; Pace, Paul E/0000-0003-1855-5760	Children's Leukaemia Trust; Leukaemia and Lymphoma Research Fund; FEBS; MRC [MC_U105178811] Funding Source: UKRI; Medical Research Council [MC_U105178811] Funding Source: researchfish	Children's Leukaemia Trust; Leukaemia and Lymphoma Research Fund; FEBS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Takata for the anti-Ku70 antibody and the Ku70 cDNA expression vector; H. Koyama and S. Takeda for Delta Lig4, Delta Ku70, and Delta DNA-PKcs DT40 cell lines; H. Joenje and J. DeWinter for human FANCC cell lines; and W. Niedzwiedz and J. Sale for help with IgM sequence analysis. Supported by the Children's Leukaemia Trust (G. M.), the Leukaemia and Lymphoma Research Fund (M. R. H.), and a FEBS fellowship (I.V.R.).	Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Escarceller M, 1997, SOMAT CELL MOLEC GEN, V23, P401, DOI 10.1007/BF02673750; Escarceller M, 1998, J MOL BIOL, V279, P375, DOI 10.1006/jmbi.1998.1784; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Houghtaling S, 2005, HUM MOL GENET, V14, P3027, DOI 10.1093/hmg/ddi334; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Mazloum N, 2009, MOL CELL, V36, P620, DOI 10.1016/j.molcel.2009.09.033; Mazloum N, 2009, MOL CELL, V33, P160, DOI 10.1016/j.molcel.2008.12.023; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Sale JE, 2001, PHILOS T R SOC B, V356, P21, DOI 10.1098/rstb.2000.0744; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhang ZM, 2001, J BIOL CHEM, V276, P38231	18	191	197	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					219	223		10.1126/science.1192277	http://dx.doi.org/10.1126/science.1192277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20538911				2022-12-28	WOS:000279635200050
J	Cazalla, D; Yario, T; Steitz, J				Cazalla, Demian; Yario, Therese; Steitz, Joan			Down-Regulation of a Host MicroRNA by a Herpesvirus saimiri Noncoding RNA	SCIENCE			English	Article							SMALL NUCLEAR RNAS; TRANSFORMED T-CELLS; GENES; EXPRESSION; DEGRADATION; MIR-27A	T cells transformed by Herpesvirus saimiri express seven viral U-rich noncoding RNAs of unknown function called HSURs. We noted that conserved sequences in HSURs 1 and 2 constitute potential binding sites for three host-cell microRNAs (miRNAs). Coimmunoprecipitation experiments confirmed that HSURs 1 and 2 interact with the predicted miRNAs in virally transformed T cells. The abundance of one of these miRNAs, miR-27, is dramatically lowered in transformed cells, with consequent effects on the expression of miR-27 target genes. Transient knockdown and ectopic expression of HSUR 1 demonstrate that it directs degradation of mature miR-27 in a sequence-specific and binding-dependent manner. This viral strategy illustrates use of a ncRNA to manipulate host-cell gene expression via the miRNA pathway.	[Cazalla, Demian; Yario, Therese; Steitz, Joan] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, J (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Cazalla, Demian/0000-0002-9076-3655	NIH [CA16038]; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Giraldez for initial bioinformatic searches, R. C. Desrosiers for plasmids and cell lines, R. Jobava for technical assistance, K. Tycowski and K. Riley for critical commentary, and A. Miccinello for editorial assistance. This work was supported by grant CA16038 from the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. J.S. is an investigator at the Howard Hughes Medical Institute.	Albrecht JC, 2000, J VIROL, V74, P1033, DOI 10.1128/JVI.74.2.1033-1037.2000; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; BIESINGER B, 1990, VIROLOGY, V176, P505, DOI 10.1016/0042-6822(90)90020-R; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cook HL, 2005, CURR BIOL, V15, P974, DOI 10.1016/j.cub.2005.04.034; Cook HL, 2004, MOL CELL BIOL, V24, P4522, DOI 10.1128/MCB.24.10.4522-4533.2004; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ensser A, 1999, J VIROL, V73, P10551, DOI 10.1128/JVI.73.12.10551-10555.1999; Ensser A, 2005, ADV CANCER RES, V93, P91, DOI 10.1016/S0065-230X(05)93003-0; Fan XHC, 1997, GENE DEV, V11, P2557, DOI 10.1101/gad.11.19.2557; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE SI, 1988, CELL, V54, P599, DOI 10.1016/S0092-8674(88)80004-7; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; MURTHY SCS, 1989, J VIROL, V63, P3307, DOI 10.1128/JVI.63.8.3307-3314.1989; MYER VE, 1992, P NATL ACAD SCI USA, V89, P1296, DOI 10.1073/pnas.89.4.1296; WASSARMAN DA, 1989, NUCLEIC ACIDS RES, V17, P1258, DOI 10.1093/nar/17.3.1258	24	348	367	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1563	1566		10.1126/science.1187197	http://dx.doi.org/10.1126/science.1187197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558719	Green Accepted			2022-12-28	WOS:000278859200048
J	Herbert, TD; Peterson, LC; Lawrence, KT; Liu, ZH				Herbert, Timothy D.; Peterson, Laura Cleaveland; Lawrence, Kira T.; Liu, Zhonghui			Tropical Ocean Temperatures Over the Past 3.5 Million Years	SCIENCE			English	Article							CARBON-DIOXIDE CONCENTRATION; LATE PLEISTOCENE; ATMOSPHERIC CO2; CLIMATE-CHANGE; ICE; CYCLE; GLACIATION; ONSET; CORE; PALEOTEMPERATURE	Determining the timing and amplitude of tropical sea surface temperature (SST) change is an important part of solving the puzzle of the Plio-Pleistocene ice ages. Alkenone-based tropical SST records from the major ocean basins show coherent glacial-interglacial temperature changes of 1 degrees to 3 degrees C that align with (but slightly lead) global changes in ice volume and deep ocean temperature over the past 3.5 million years. Tropical temperatures became tightly coupled with benthic delta O-18 and orbital forcing after 2.7 million years. We interpret the similarity of tropical SST changes, in dynamically dissimilar regions, to reflect "top-down" forcing through the atmosphere. The inception of a strong carbon dioxide-greenhouse gas feedback and amplification of orbital forcing at similar to 2.7 million years ago connected the fate of Northern Hemisphere ice sheets with global ocean temperatures since that time.	[Herbert, Timothy D.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Peterson, Laura Cleaveland] Luther Coll, Decorah, IA 52101 USA; [Lawrence, Kira T.] Lafayette Coll, Dept Geol & Environm Geosci, Easton, PA 18042 USA; [Liu, Zhonghui] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China	Brown University; Lafayette College; University of Hong Kong	Herbert, TD (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Liu, Zhonghui/D-3163-2009; Peterson, A. Townsend/I-5697-2013	Liu, Zhonghui/0000-0002-2168-8305; Peterson, A. Townsend/0000-0003-0243-2379	National Science Foundation (NSF) [OCE9986760, OCE-0351599, OCE0623487, OCE0623310]; Evolving Earth Foundation; Japan's Ministry of Education, Culture, Sports, Science and Technology; European Consortium for Ocean Drilling Research; People's Republic of China, Ministry of Science and Technology	National Science Foundation (NSF)(National Science Foundation (NSF)); Evolving Earth Foundation; Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Consortium for Ocean Drilling Research; People's Republic of China, Ministry of Science and Technology	This research was supported by National Science Foundation (NSF) grants OCE9986760 and OCE-0351599 to T. D. H. and OCE0623487 and OCE0623310 to T. D. H. and K. T. L. and by grants from the Evolving Earth Foundation to K. T. L. This research used samples provided by ODP and the Integrated Ocean Drilling Program (IODP). ODP was sponsored by NSF and participating countries under the management of Joint Oceanographic Institutions. IODP is supported by NSF; Japan's Ministry of Education, Culture, Sports, Science and Technology; the European Consortium for Ocean Drilling Research; and the People's Republic of China, Ministry of Science and Technology.	Andreasen DH, 2001, J GEOPHYS RES-OCEANS, V106, P879, DOI 10.1029/1999JC000087; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; BLOEMENDAL J, 1989, NATURE, V342, P897, DOI 10.1038/342897a0; BROCCOLI AJ, 1987, CLIM DYNAM, V1, P87; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; Clemens SC, 1997, NATURE, V385, P801, DOI 10.1038/385801a0; Clement AC, 2004, CLIM DYNAM, V22, P327, DOI 10.1007/s00382-003-0375-8; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Huybers P, 2007, CLIM PAST, V3, P549, DOI 10.5194/cp-3-549-2007; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Jackson CS, 2003, CLIM DYNAM, V21, P539, DOI 10.1007/s00382-003-0351-3; Karas C, 2009, NAT GEOSCI, V2, P433, DOI 10.1038/NGEO520; Kienast M, 2001, SCIENCE, V291, P2132, DOI 10.1126/science.1057131; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; Lee SY, 2006, EARTH PLANET SC LETT, V248, P253, DOI 10.1016/j.epsl.2006.05.030; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lisiecki LE, 2007, QUATERNARY SCI REV, V26, P56, DOI 10.1016/j.quascirev.2006.09.005; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Maslin MA, 1996, GEOL RUNDSCH, V85, P452, DOI 10.1007/BF02369002; McIntyre A., 1976, Science, V191, P1131, DOI 10.1126/science.191.4232.1131; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Pagani M, 2002, PHILOS T ROY SOC A, V360, P609, DOI 10.1098/rsta.2001.0959; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Pierrehumbert RT, 1999, GEOPH MONOG SERIES, V112, P339; Rosell- Mele A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018151; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Schmidt MW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC000957; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; SHACKLETON NJ, 2000, J SCI, V217, P1897; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Tripati AK, 2009, SCIENCE, V326, P1394, DOI 10.1126/science.1178296; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596	48	223	238	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1530	1534		10.1126/science.1185435	http://dx.doi.org/10.1126/science.1185435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558711				2022-12-28	WOS:000278859200039
J	Lozier, MS				Lozier, M. Susan			Deconstructing the Conveyor Belt	SCIENCE			English	Review							WESTERN BOUNDARY CURRENT; MERIDIONAL OVERTURNING CIRCULATION; AGULHAS LEAKAGE; ATLANTIC; LABRADOR; VARIABILITY; TRANSPORT; TRACERS; EDDIES; IMPACT	For the past several decades, oceanographers have embraced the dominant paradigm that the ocean's meridional overturning circulation operates like a conveyor belt, transporting cold waters equatorward at depth and warm waters poleward at the surface. Within this paradigm, the conveyor, driven by changes in deepwater production at high latitudes, moves deep waters and their attendant properties continuously along western boundary currents and returns surface waters unimpeded to deepwater formation sites. A number of studies conducted over the past few years have challenged this paradigm by revealing the vital role of the ocean's eddy and wind fields in establishing the structure and variability of the ocean's overturning. Here, we review those studies and discuss how they have collectively changed our view of the simple conveyor-belt model.	Duke Univ, Nicholas Sch Environm, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University	Lozier, MS (corresponding author), Duke Univ, Nicholas Sch Environm, Div Earth & Ocean Sci, Durham, NC 27708 USA.	mslozier@duke.edu	Kushnir, Yochanan/B-4472-2013		NSF	NSF(National Science Foundation (NSF))	I would like to acknowledge S. Gary's aid in the construction of Fig. 2, helpful comments on the manuscipt from B. Corliss and P. Baker, and insightful discussions with A. Bower and R. Williams. Support from the NSF is also gratefully acknowledged.	Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Biastoch A, 2009, NATURE, V462, P495, DOI 10.1038/nature08519; Biastoch A, 2008, J CLIMATE, V21, P6599, DOI 10.1175/2008JCLI2404.1; Bingham RJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031731; Bower AS, 2009, NATURE, V459, P243, DOI 10.1038/nature07979; Bower AS, 2000, J PHYS OCEANOGR, V30, P784, DOI 10.1175/1520-0485(2000)030<0784:LOOTDW>2.0.CO;2; Brambilla E, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003146; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Broecker W.S., 1982, TRACERS SEA; BROECKER WS, 1987, NAT HIST, V96, P74; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; Delworth TL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035166; Dengler M, 2004, NATURE, V432, P1018, DOI 10.1038/nature03134; Fischer J, 2004, J PHYS OCEANOGR, V34, P1548, DOI 10.1175/1520-0485(2004)034<1548:BCATEO>2.0.CO;2; Fischer J, 2002, J PHYS OCEANOGR, V32, P573, DOI 10.1175/1520-0485(2002)032<0573:LSWTBP>2.0.CO;2; Getzlaff K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026470; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Hakkinen S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004883; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; HOGG N, 1995, COLLECTED WORKS HM S, V2, P307; HOLLAND WR, 1975, J PHYS OCEANOGR, V5, P642, DOI 10.1175/1520-0485(1975)005<0642:OTGOME>2.0.CO;2; Lavender KL, 2000, NATURE, V407, P66, DOI 10.1038/35024048; Lozier MS, 1997, SCIENCE, V277, P361, DOI 10.1126/science.277.5324.361; Lozier MS, 1999, GEOPHYS RES LETT, V26, P219, DOI 10.1029/1998GL900264; Pickart RS, 2007, J PHYS OCEANOGR, V37, P2207, DOI 10.1175/JPO3178.1; PICKART RS, 1992, DEEP-SEA RES, V39, P1553, DOI 10.1016/0198-0149(92)90047-W; RHEIN M, 1994, DEEP-SEA RES PT I, V41, P263, DOI 10.1016/0967-0637(94)90003-5; RHINES PB, 1982, J FLUID MECH, V122, P347, DOI 10.1017/S0022112082002250; Richardson PL, 2008, PROG OCEANOGR, V76, P466, DOI 10.1016/j.pocean.2008.01.005; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Smethie WM, 2000, J GEOPHYS RES-OCEANS, V105, P14297, DOI 10.1029/1999JC900274; STOMMEL H, 1958, DEEP-SEA RES, V5, P80, DOI 10.1016/S0146-6291(58)80014-4; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; Straneo F, 2006, J PHYS OCEANOGR, V36, P1822, DOI 10.1175/JPO2932.1; Visbeck M, 2007, NATURE, V447, P383, DOI 10.1038/447383a; Warren BA., 1981, EVOLUTION PHYSICAL O, P6; WATTS DR, 1991, EQUATORWARD CURRENTS, P183, DOI DOI 10.1016/S0422-9894(08)70067-9; Willis JK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042372; Wunsch C, 2002, SCIENCE, V298, P1179, DOI 10.1126/science.1079329; Wunsch C, 2008, NAT GEOSCI, V1, P165, DOI 10.1038/ngeo126	40	109	119	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1507	1511		10.1126/science.1189250	http://dx.doi.org/10.1126/science.1189250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558705				2022-12-28	WOS:000278859200033
J	Philander, SG				Philander, S. George			Tilting at Connections, from Pole to Equator	SCIENCE			English	Editorial Material							PERMANENT EL-NINO; EARLY PLIOCENE		[Philander, S. George] Princeton Univ, Princeton, NJ 08540 USA; [Philander, S. George] Univ Cape Town, ZA-7700 Rondebosch, South Africa	Princeton University; University of Cape Town	Philander, SG (corresponding author), Princeton Univ, Princeton, NJ 08540 USA.	gphlder@princeton.edu						Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2010, NATURE, V463, P1066, DOI 10.1038/nature08831; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Horikawa K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025948; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	8	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1488	1489		10.1126/science.1189748	http://dx.doi.org/10.1126/science.1189748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558693				2022-12-28	WOS:000278859200021
J	Vura-Weis, J; Abdelwahed, SH; Shukla, R; Rathore, R; Ratner, MA; Wasielewski, MR				Vura-Weis, Josh; Abdelwahed, Sameh H.; Shukla, Ruchi; Rathore, Rajendra; Ratner, Mark A.; Wasielewski, Michael R.			Crossover from Single-Step Tunneling to Multistep Hopping for Molecular Triplet Energy Transfer	SCIENCE			English	Article							PHOTOSYNTHETIC REACTION CENTERS; ELECTRON-TRANSFER; DISTANCE-DEPENDENCE; SEQUENTIAL ELECTRON; CHARGE; WIRE; SUPEREXCHANGE; TRANSPORT	Triplet energy transfer (TT), a key process in molecular and organic electronics, generally occurs by either strongly distance-dependent single-step tunneling or weakly distance-dependent multistep hopping. We have synthesized a series of pi-stacked molecules consisting of a benzophenone donor, one to three fluorene bridges, and a naphthalene acceptor, and studied the rate of TT from benzophenone to naphthalene across the fluorene bridge using femtosecond transient absorption spectroscopy. We show that the dominant TT mechanism switches from tunneling to wire-like hopping between bridge lengths 1 and 2. The crossover observed for TT can be determined by direct observation of the bridge-occupied state.	[Abdelwahed, Sameh H.; Shukla, Ruchi; Rathore, Rajendra] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA; [Vura-Weis, Josh; Ratner, Mark A.; Wasielewski, Michael R.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Vura-Weis, Josh; Ratner, Mark A.; Wasielewski, Michael R.] Northwestern Univ, ANSER Ctr, Evanston, IL 60208 USA	Marquette University; Northwestern University; Northwestern University	Rathore, R (corresponding author), Marquette Univ, Dept Chem, POB 1881, Milwaukee, WI 53201 USA.	rajendra.rathore@marquette.edu; ratner@chem.northwestern.edu; m-wasielewski@northwestern.edu		Abdelwahed, Sameh/0000-0002-3445-4065	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Department of Energy [DE-FG02-99ER14999]; NSF; Office of Naval Research; Division Of Chemistry [0848871] Funding Source: National Science Foundation	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J.V.W. thanks R. H. Goldsmith for assistance with Matlab and helpful discussions. This work was supported by the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Department of Energy, under grant DE-FG02-99ER14999 (M. R. W.), NSF Chemistry (R. R. and M. A. R.), and Office of Naval Research (M. A. R.). The crystal structure of Bp-F<INF>3</INF>-Nap has been deposited at CCDC with accession number 772735.	Albinsson B, 2008, J PHOTOCH PHOTOBIO C, V9, P138, DOI 10.1016/j.jphotochemrev.2008.01.002; Andreasson J, 2000, J AM CHEM SOC, V122, P9844, DOI 10.1021/ja001409r; Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663; BENNISTON AC, 1994, ANGEW CHEM INT EDIT, V33, P1884, DOI 10.1002/anie.199418841; Cleave V, 1999, ADV MATER, V11, P285, DOI 10.1002/(SICI)1521-4095(199903)11:4<285::AID-ADMA285>3.0.CO;2-N; Davis WB, 1998, NATURE, V396, P60, DOI 10.1038/23912; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; Goldsmith RH, 2005, P NATL ACAD SCI USA, V102, P3540, DOI 10.1073/pnas.0408940102; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gust D, 1998, J PHOTOCH PHOTOBIO B, V43, P209, DOI 10.1016/S1011-1344(98)00110-9; Harriman A, 2000, ANGEW CHEM INT EDIT, V39, P4287, DOI 10.1002/1521-3773(20001201)39:23<4287::AID-ANIE4287>3.0.CO;2-0; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P3640, DOI 10.1073/pnas.71.9.3640; Kang YK, 2002, J AM CHEM SOC, V124, P8275, DOI 10.1021/ja012504i; Lewis FD, 2006, J AM CHEM SOC, V128, P791, DOI 10.1021/ja0540831; Liao HH, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245211; MARCUS RA, 1964, ANNU REV PHYS CHEM, V15, P155, DOI 10.1146/annurev.pc.15.100164.001103; Montalti M., 2006, HDB PHOTOCHEMISTRY; Palacios RE, 2005, CHEMPHYSCHEM, V6, P2359, DOI 10.1002/cphc.200500177; Rathore R, 2003, J AM CHEM SOC, V125, P8712, DOI 10.1021/ja035518s; SIGMAN ME, 1991, J PHYS CHEM-US, V95, P5012, DOI 10.1021/j100166a022; TAKIFF L, 1988, J AM CHEM SOC, V110, P4425, DOI 10.1021/ja00221a059; Wasserberg D, 2005, CHEM PHYS LETT, V411, P273, DOI 10.1016/j.cplett.2005.06.039; Weiss EA, 2004, J AM CHEM SOC, V126, P5577, DOI 10.1021/ja0398215; Winters MU, 2005, CHEM-EUR J, V11, P562, DOI 10.1002/chem.200400755; Wohlgenannt M, 2003, J PHYS-CONDENS MAT, V15, pR83, DOI 10.1088/0953-8984/15/3/202	26	88	89	5	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1547	1550		10.1126/science.1189354	http://dx.doi.org/10.1126/science.1189354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558715				2022-12-28	WOS:000278859200043
J	Hawkes, N				Hawkes, Nigel			Body Politic The biggest change in health care for a generation?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c3128	10.1136/bmj.c3128	http://dx.doi.org/10.1136/bmj.c3128			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554675				2022-12-28	WOS:000279051900010
J	de Palma, O; Cruz, L; Ramos, H; de Baires, A; Villatoro, N; Pastor, D; de Oliveira, LH; Kerin, T; Bowen, M; Gentsch, J; Esposito, DH; Parashar, U; Tate, J; Patel, M				de Palma, Orbelina; Cruz, Lilian; Ramos, Hector; de Baires, Amada; Villatoro, Nora; Pastor, Desiree; de Oliveira, Lucia Helena; Kerin, Tara; Bowen, Michael; Gentsch, Jon; Esposito, Douglas H.; Parashar, Umesh; Tate, Jacqueline; Patel, Manish			Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							1ST 2 YEARS; RHESUS-HUMAN; DOUBLE-BLIND; EFFICACY; REASSORTANT; SAFETY; CHILDREN; VACCINES; STRAINS; INFANTS	Objective To evaluate the effectiveness of a monovalent rotavirus vaccine against severe rotavirus disease and to assess its impact on diarrhoea in children aged less than 2 years after national introduction in El Salvador, a low-middle income country in Central America. Design Matched case-control study. Setting Seven hospitals in cities across El Salvador, January 2007 to June 2009. Participants 323 children aged less than 2 years admitted with laboratory confirmed rotavirus diarrhoea and 969 healthy controls matched for age and neighbourhood. Main outcome measure Effectiveness of rotavirus vaccination ((1-adjusted odds ratio of vaccination) x 100) against rotavirus diarrhoea requiring hospital admission. Results Cases and controls were similar for breast feeding, premature birth, maternal education, and socioeconomic variables. G1P[8] strains were identified in 92% of rotavirus cases. Effectiveness of two doses of vaccination against diarrhoea requiring hospital admission was 76% (95% confidence interval 64% to 84%). Protection was significantly lower (P=0.046) among children aged 12 months or more (59%, 27% to 77%) compared with children aged 6-11 months (83%, 68% to 91%). One dose of vaccine was 51% (26% to 67%) effective. At the sentinel hospitals, all admissions for diarrhoea among children under 5 declined by 40% in 2008 and by 51% in 2009 from the prevaccine year 2006. Conclusions A monovalent rotavirus vaccine was highly effective against admissions for rotavirus diarrhoea in children aged less than 2 years in El Salvador and substantially reduced the number of such admissions in this low-middle income setting. The impact on disease epidemiology after vaccination, particularly among older children, warrants future attention.	[Kerin, Tara; Bowen, Michael; Gentsch, Jon; Esposito, Douglas H.; Parashar, Umesh; Tate, Jacqueline; Patel, Manish] Ctr Dis Control & Prevent, Viral Gastroenteritis Team, Epidemiol Branch, DVD NCIRD, Atlanta, GA 30333 USA; [de Palma, Orbelina; Cruz, Lilian; Ramos, Hector; de Baires, Amada; Villatoro, Nora] Minist Salud, San Salvador, El Salvador; [Pastor, Desiree] PanAmer Hlth Org, San Salvador, El Salvador; [de Oliveira, Lucia Helena] PanAmer Hlth Org, Washington, DC USA	Centers for Disease Control & Prevention - USA	Patel, M (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Team, Epidemiol Branch, DVD NCIRD, MS-A47, Atlanta, GA 30333 USA.	aul3@cdc.gov			GAVI Alliance; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	GAVI Alliance; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was carried out under a collaborative arrangement with Program for Appropriate Technology in Health and was funded in part by the GAVI Alliance. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; BERNSTEIN DI, 1995, JAMA-J AM MED ASSOC, V273, P1191, DOI 10.1001/jama.273.15.1191; Bresee JS, 2005, PEDIATR INFECT DIS J, V24, P947, DOI 10.1097/01.inf.0000186295.18969.e6; CHIBA S, 1986, LANCET, V2, P417; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Griffin DD, 2002, VIROLOGY, V294, P256, DOI 10.1006/viro.2001.1333; GUARDADO JA, 2004, PEDIAT INFECT DI S10, V23, P156; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; John TJ, 2004, B WORLD HEALTH ORGAN, V82, P53; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; Linhares AC, 1996, B WORLD HEALTH ORGAN, V74, P491; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Moulton LH, 1998, J INFECT DIS, V178, P1562, DOI 10.1086/314504; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2008, EMERG INFECT DIS, V14, P863, DOI 10.3201/eid1405.071440; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Sanchez-Padilla E, 2009, LANCET INFECT DIS, V9, P567, DOI 10.1016/S1473-3099(09)70179-3; Santosham M, 1997, J PEDIATR-US, V131, P632, DOI 10.1016/S0022-3476(97)70076-3; SATTEN GA, 1990, J CLIN EPIDEMIOL, V43, P55, DOI 10.1016/0895-4356(90)90056-U; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; *UN DAT, 2010, WORLD INF; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; World Health Organization, 2008, GEN PROT MON IMP ROT	37	128	129	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2010	340								c2825	10.1136/bmj.c2825	http://dx.doi.org/10.1136/bmj.c2825			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551120	hybrid, Green Published			2022-12-28	WOS:000279051800002
J	Levy, C; Khaled, M; Robinson, KC; Veguilla, RA; Chen, PH; Yokoyama, S; Makino, E; Lu, J; Larue, L; Beermann, F; Chin, L; Bosenberg, M; Song, JS; Fisher, DE				Levy, Carmit; Khaled, Mehdi; Robinson, Kathleen C.; Veguilla, Rosa A.; Chen, Po-Hao; Yokoyama, Satoru; Makino, Eiichi; Lu, Jun; Larue, Lionel; Beermann, Friedrich; Chin, Lynda; Bosenberg, Marcus; Song, Jun. S.; Fisher, David E.			Lineage-Specific Transcriptional Regulation of DICER by MITF in Melanocytes	CELL			English	Article							POSTTRANSCRIPTIONAL REGULATION; MICRORNA BIOGENESIS; BCL-2 DEFICIENCY; MASTER REGULATOR; EXPRESSION; MICROPHTHALMIA; MELANOMA; GENE; SURVIVAL; FAMILY	DICER is a central regulator of microRNA maturation. However, little is known about mechanisms regulating its expression in development or disease. While profiling miRNA expression in differentiating melanocytes, two populations were observed: some upregulated at the pre-miRNA stage, and others upregulated as mature miRNAs (with stable pre-miRNA levels). Conversion of pre-miRNAs to fully processed miRNAs appeared to be dependent upon stimulation of DICER expression-an event found to occur via direct transcriptional targeting of DICER by the melanocyte master transcriptional regulator MITF. MITF binds and activates a conserved regulatory element upstream of DICER's transcriptional start site upon melanocyte differentiation. Targeted KO of DICER is lethal to melanocytes, at least partly via DICER-dependent processing of the pre-miRNA-17 similar to 92 cluster thus targeting BIM, a known proapoptotic regulator of melanocyte survival. These observations highlight a central mechanism underlying lineage-specific miRNA regulation which could exist for other cell types during development.	[Levy, Carmit; Khaled, Mehdi; Robinson, Kathleen C.; Veguilla, Rosa A.; Yokoyama, Satoru; Makino, Eiichi; Fisher, David E.] Harvard Univ, Sch Med, Dept Dermatol, Cutaneous Biol Res Ctr,Mass Gen Hosp, Boston, MA 02115 USA; [Chen, Po-Hao] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lu, Jun] Broad Inst, Cambridge, MA 02141 USA; [Lu, Jun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Lu, Jun] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Larue, Lionel] UMR CNRS 146, Inst Curie, F-91405 Orsay, France; [Beermann, Friedrich] Swiss Inst Expt Canc Res, EPFL SV ISREC, CH-1015 Lausanne, Switzerland; [Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Song, Jun. S.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Dana-Farber Cancer Institute; Yale University; Institute for Advanced Study - USA	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Cutaneous Biol Res Ctr,Mass Gen Hosp, Boston, MA 02115 USA.	dfisher3@partners.org	Song, Jun S/E-2526-2016; Fisher, David/AAH-2878-2019; Yokoyama, Satoru/AAT-3254-2021; khaled, mehdi/C-4854-2012; Larue, Lionel/F-7355-2013; Larue, Lionel/I-6532-2016	Song, Jun S/0000-0002-0422-2175; khaled, mehdi/0000-0002-9880-858X; Yokoyama, Satoru/0000-0001-8336-486X	Martin A. and Helen Chooljian Membership; NIH; Melanoma Research Alliance; Doris Duke Charitable Foundation; Adelson Medical Research Foundation; Israel-US Binational Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Martin A. and Helen Chooljian Membership; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Adelson Medical Research Foundation; Israel-US Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors gratefully acknowledge help from Dr. Rod Bronson with mouse pathology; Dr. Carl Novina for useful discussions; Dr. Ian Jackson for Dct-LacZ transgenic mice; Dr. T. Kunisada for K14-SCF transgenic mice; Dr. Clifford J. Tabin for Dicer Floxed mice; Dr. Ruth Halaban for 501mel melanoma cells; Maja Janas, Ana Hernandez, Dr. Jacob Hanna, and members of the Fisher lab for help with numerous aspects of this work. JSS was supported in part by the Martin A. and Helen Chooljian Membership. D.E.F. gratefully acknowledges grant support from NIH, The Melanoma Research Alliance, The Doris Duke Charitable Foundation, The Adelson Medical Research Foundation, and the Israel-US Binational Science Foundation.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Barbato C, 2007, BRAIN RES, V1175, P17, DOI 10.1016/j.brainres.2007.07.088; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; KAMADA S, 1995, CANCER RES, V55, P354; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Maroney PA, 2006, COLD SPRING HARB SYM, V71, P531, DOI 10.1101/sqb.2006.71.043; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Neilson JR, 2008, CELL, V134, P899, DOI 10.1016/j.cell.2008.09.006; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schier AF, 2006, COLD SPRING HARB SYM, V71, P195, DOI 10.1101/sqb.2006.71.055; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; STEINGRIMSSON E, 2004, ANNU REV GENET, V365, P411; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamamura K, 1996, CANCER RES, V56, P3546; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeng Yan, 2006, V342, P49, DOI 10.1385/1-59745-123-1:49; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	79	92	97	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					994	1005		10.1016/j.cell.2010.05.004	http://dx.doi.org/10.1016/j.cell.2010.05.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550935	Green Accepted, Bronze			2022-12-28	WOS:000278618800014
J	Baldridge, MT; King, KY; Boles, NC; Weksberg, DC; Goodell, MA				Baldridge, Megan T.; King, Katherine Y.; Boles, Nathan C.; Weksberg, David C.; Goodell, Margaret A.			Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection	NATURE			English	Article							PROGENITOR CELLS; IDENTIFICATION; HOMEOSTASIS; DEFICIENT; ALPHA	Lymphocytes and neutrophils are rapidly depleted by systemic infection(1). Progenitor cells of the haematopoietic system, such as common myeloid progenitors and common lymphoid progenitors, increase the production of immune cells to restore and maintain homeostasis during chronic infection, but the contribution of haematopoietic stem cells (HSCs) to this process is largely unknown(2). Here we show, using an in vivo mouse model of Mycobacterium avium infection, that an increased proportion of long-term repopulating HSCs proliferate during M. avium infection, and that this response requires interferon-gamma (IFN-gamma) but not interferon-alpha (IFN-alpha) signalling. Thus, the haematopoietic response to chronic bacterial infection involves the activation not only of intermediate blood progenitors but of long-term repopulating HSCs as well. IFN-gamma is sufficient to promote long-term repopulating HSC proliferation in vivo; furthermore, HSCs from IFN-gamma-deficient mice have a lower proliferative rate, indicating that baseline IFN-gamma tone regulates HSC activity. These findings implicate IFN-gamma both as a regulator of HSCs during homeostasis and under conditions of infectious stress. Our studies contribute to a deeper understanding of haematological responses in patients with chronic infections such as HIV/AIDS or tuberculosis(3-5).	[Baldridge, Megan T.; Weksberg, David C.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [King, Katherine Y.; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Boles, Nathan C.; Goodell, Margaret A.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	goodell@bcm.edu	Baldridge, Megan/T-7274-2019; King, Katherine/AAI-2436-2021	Baldridge, Megan/0000-0002-7030-6131; Goodell, Margaret A./0000-0003-1111-2932; King, Katherine/0000-0002-5093-6005	NIDDK institute of the National Institutes of Health (NIH); Texas Children's Hospital Auxiliary; Simmons Foundation; NHLBI institute of the NIH; NCI institute of the NIH; NIBIB institute of the NIH; NATIONAL CANCER INSTITUTE [P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332, U54HL081007, R01HL096360, K08HL098898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192, F30DK082107] Funding Source: NIH RePORTER	NIDDK institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Children's Hospital Auxiliary; Simmons Foundation; NHLBI institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Feng and A. Sher for providing Mycobacterium avium. We also thank D. Levy and C. Schindler for providing us with Stat1 and Ifnar1 knockout mice. We are grateful to G. Challen for providing information about Ifngr1, to Y. Zheng and S. Wu for technical assistance, and to J. Gilbert for critical reading of the manuscript. M. T. B. is supported by the NIDDK institute of the National Institutes of Health (NIH), and K. Y. K. was supported by the Adeline B. Landa Fellowship of the Texas Children's Hospital Auxiliary and the Simmons Foundation Collaborative Research Fund. This work was supported by the NIDDK, NHLBI, NCI and NIBIB institutes of the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ezoe S, 2004, CELL CYCLE, V3, P314; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Florido M, 2005, INFECT IMMUN, V73, P3577, DOI 10.1128/IAI.73.6.3577-3586.2005; Hawkins CA, 2006, INTERN MED J, V36, P385, DOI 10.1111/j.1445-5994.2006.01076.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klautau Giselle Burlamaqui, 2005, Braz J Infect Dis, V9, P464, DOI 10.1590/S1413-86702005000600004; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murray PJ, 1998, BLOOD, V91, P2914, DOI 10.1182/blood.V91.8.2914.2914_2914_2924; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saunders BM, 2002, IMMUNOL CELL BIOL, V80, P544, DOI 10.1046/j.1440-1711.2002.01121.x; Shahbazian LM, 2004, CRIT CARE MED, V32, P1740, DOI 10.1097/01.CCM.0000132900.84627.90; Singh K J, 2001, J Assoc Physicians India, V49, P790; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Sundell I Birgitta, 2006, J Stem Cells, V1, P283; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang P, 2008, STEM CELLS, V26, P1778, DOI 10.1634/stemcells.2007-1027	32	580	586	5	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					793	U9		10.1038/nature09135	http://dx.doi.org/10.1038/nature09135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535209	Green Accepted			2022-12-28	WOS:000278551800048
J	Spiller, DG; Wood, CD; Rand, DA; White, MRH				Spiller, David G.; Wood, Christopher D.; Rand, David A.; White, Michael R. H.			Measurement of single-cell dynamics	NATURE			English	Review							PROTEIN-PROTEIN INTERACTIONS; RAMAN-SCATTERING MICROSCOPY; STOCHASTIC GENE-EXPRESSION; GREEN FLUORESCENT PROTEINS; RESONANCE ENERGY-TRANSFER; REAL-TIME ANALYSIS; LIVING CELLS; IN-VIVO; INDIVIDUAL CELLS; NETWORK DYNAMICS	Populations of cells are almost always heterogeneous in function and fate. To understand the plasticity of cells, it is vital to measure quantitatively and dynamically the molecular processes that underlie cell-fate decisions in single cells. Early events in cell signalling often occur within seconds of the stimulus, whereas intracellular signalling processes and transcriptional changes can take minutes or hours. By contrast, cell-fate decisions, such as whether a cell divides, differentiates or dies, can take many hours or days. Multiparameter experimental and computational methods that integrate quantitative measurement and mathematical simulation of these noisy and complex processes are required to understand the highly dynamic mechanisms that control cell plasticity and fate.	[Spiller, David G.; White, Michael R. H.] Ctr Cell Imaging, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Wood, Christopher D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico; [Rand, David A.] Univ Warwick, Warwick Syst Biol & Math Inst, Coventry CV4 7AL, W Midlands, England	University of Liverpool; Universidad Nacional Autonoma de Mexico; University of Warwick	White, MRH (corresponding author), Ctr Cell Imaging, Sch Biol Sci, Biosci Res Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	mwhite@liverpool.ac.uk	Wood, Christopher D/H-5606-2012; Rand, David A/J-9085-2012; Spiller, David G/I-3645-2012	Wood, Christopher D/0000-0001-7175-7121; Rand, David A/0000-0002-2217-3274; White, Michael/0000-0002-3617-3232; Spiller, David Geoffrey/0000-0003-2502-6787	Biotechnology and Biological Sciences Research Council [BBD0107481, BBF0059381, BBE0136001, BBE0042101, BBE0129651, BBF0052611, BBF0053181, BBF0058061]; Medical Research Council [G0500346]; Wellcome Trust [67252]; Engineering and Physical Sciences Research Council; BioSim Network of Excellence, European Union [005137]; PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Mexico) [IN223810]; BBSRC [BB/F005938/1, BB/D010748/1, BB/H013725/2, BB/H013725/1, BB/F005814/1, BB/E012965/1, BB/E004210/1, BB/G530276/1, BB/F005938/2, BB/E013600/1] Funding Source: UKRI; MRC [G0500346] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D010748/1, BB/H013725/2, BB/E012965/1, BB/H013725/1, BB/F005938/2, BB/E013600/1, BB/G530276/1, BB/F005814/1, BB/F005938/1, BB/E004210/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BioSim Network of Excellence, European Union; PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Mexico)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Z. Seymour, C. Harper, A. Adamson, R. Awais, J. Ankers, S. Semprini and J. Cooper for providing data for the figures, as well as the many colleagues who provided suggestions, comments and assistance with the manuscript. Work in our laboratories has been funded by the Biotechnology and Biological Sciences Research Council (grants BBD0107481, BBF0059381, BBE0136001, BBE0042101, BBE0129651, BBF0052611, BBF0053181 and BBF0058061), the Medical Research Council (grant G0500346), the Wellcome Trust (grant 67252), the Engineering and Physical Sciences Research Council, the BioSim Network of Excellence (part of the European Union's Sixth Framework Programme; grant 005137) and PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Mexico; grant IN223810). We apologize to the authors of the many excellent papers that were omitted because of space limitations.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bontoux N, 2008, LAB CHIP, V8, P443, DOI 10.1039/b716543a; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Bray D., 2000, CELL MOVEMENTS MOL M; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Castano JP, 1996, MOL ENDOCRINOL, V10, P599, DOI 10.1210/me.10.5.599; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiang MK, 2003, DEV CELL, V4, P383, DOI 10.1016/S1534-5807(03)00035-2; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Davis I, 2009, BIOCHEM SOC T, V37, P1042, DOI 10.1042/BST0371042; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Fertig N, 2002, BIOPHYS J, V82, P3056, DOI 10.1016/S0006-3495(02)75646-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Finkenstadt B, 2008, BIOINFORMATICS, V24, P2901, DOI 10.1093/bioinformatics/btn562; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARLOW E, 1998, USING ANTIBODIES LAB; Harper CV, 2010, J CELL SCI, V123, P424, DOI 10.1242/jcs.060434; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hida N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005868; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Kumaresan P, 2008, ANAL CHEM, V80, P3522, DOI 10.1021/ac800327d; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu P, 2009, TRENDS BIOTECHNOL, V27, P572, DOI 10.1016/j.tibtech.2009.07.002; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MADDOX J, 1992, NATURE, V355, P201, DOI 10.1038/355201a0; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; McFerran DW, 2001, ENDOCRINOLOGY, V142, P3255, DOI 10.1210/en.142.7.3255; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Merrill GF, 1998, METHOD CELL BIOL, V57, P229; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Newlands S, 1998, GENE DEV, V12, P2748, DOI 10.1101/gad.12.17.2748; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rand DA, 2008, J R SOC INTERFACE, V5, pS59, DOI 10.1098/rsif.2008.0084.focus; Reid G, 2009, INT J BIOCHEM CELL B, V41, P155, DOI 10.1016/j.biocel.2008.08.028; Roenneberg T, 2008, CURR BIOL, V18, pR826, DOI 10.1016/j.cub.2008.07.017; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakon JJ, 2010, NAT METHODS, V7, P203, DOI [10.1038/nmeth.1421, 10.1038/NMETH.1421]; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schubert W, 2009, J PROTEOME RES, V8, P2696, DOI 10.1021/pr800944f; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Semprini S, 2009, MOL ENDOCRINOL, V23, P529, DOI 10.1210/me.2008-0399; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Swedlow JR, 2003, SCIENCE, V300, P100, DOI 10.1126/science.1082602; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takasuka N, 1998, ENDOCRINOLOGY, V139, P1361, DOI 10.1210/en.139.3.1361; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tyson JJ, 2008, CURR BIOL, V18, pR759, DOI 10.1016/j.cub.2008.07.001; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; White MRH, 2009, CELL CYCLE, V8, P2677; WHITE MRH, 1995, J CELL SCI, V108, P441; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Wlodkowic D, 2009, ANAL CHEM, V81, P5517, DOI 10.1021/ac9008463; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	122	304	313	5	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					736	745		10.1038/nature09232	http://dx.doi.org/10.1038/nature09232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535203				2022-12-28	WOS:000278551800036
J	Schaefer, MK; Jhung, M; Dahl, M; Schillie, S; Simpson, C; Llata, E; Link-Gelles, R; Sinkowitz-Cochran, R; Patel, P; Bolyard, E; Sehulster, L; Srinivasan, A; Perz, JF				Schaefer, Melissa K.; Jhung, Michael; Dahl, Marilyn; Schillie, Sarah; Simpson, Crystal; Llata, Eloisa; Link-Gelles, Ruth; Sinkowitz-Cochran, Ronda; Patel, Priti; Bolyard, Elizabeth; Sehulster, Lynne; Srinivasan, Arjun; Perz, Joseph F.			Infection Control Assessment of Ambulatory Surgical Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-STREAM INFECTIONS; HEPATITIS-C VIRUS; B-VIRUS; OUTBREAK; CONTAMINATION; TRANSMISSION	Context More than 5000 ambulatory surgical centers (ASCs) in the United States participate in the Medicare program. Little is known about infection control practices in ASCs. The Centers for Medicare & Medicaid Services (CMS) piloted an infection control audit tool in a sample of ASC inspections to assess facility adherence to recommended practices. Objective To describe infection control practices in a sample of ASCs. Design, Setting, and Participants All State Survey Agencies were invited to participate. Seven states volunteered; 3 were selected based on geographic dispersion, number of ASCs each state committed to inspect, and relative cost per inspection. A stratified random sample of ASCs was selected from each state. Sample size was based on the number of inspections each state estimated it could complete between June and October 2008. Sixty-eight ASCs were assessed; 32 in Maryland, 16 in North Carolina, and 20 in Oklahoma. Surveyors from CMS, trained in use of the audit tool, assessed compliance with specific infection control practices. Assessments focused on 5 areas of infection control: hand hygiene, injection safety and medication handling, equipment reprocessing, environmental cleaning, and handling of blood glucose monitoring equipment. Main Outcome Measures Proportion of facilities with lapses in each infection control category. Results Overall, 46 of 68 ASCs (67.6%; 95% confidence interval [CI], 55.9%-77.9%) had at least 1 lapse in infection control; 12 of 68 ASCs (17.6%; 95% CI, 9.9%-28.1%) had lapses identified in 3 or more of the 5 infection control categories. Common lapses included using single-dose medication vials for more than 1 patient (18/64; 28.1%; 95% CI, 18.2%-40.0%), failing to adhere to recommended practices regarding reprocessing of equipment (19/67; 28.4%; 95% CI, 18.6%-40.0%), and lapses in handling of blood glucose monitoring equipment (25/54; 46.3%; 95% CI, 33.4%-59.6%). Conclusion Among a sample of US ASCs in 3 states, lapses in infection control were common. JAMA. 2010; 303(22): 2273-2279	[Schaefer, Melissa K.; Jhung, Michael; Schillie, Sarah; Llata, Eloisa; Link-Gelles, Ruth; Sinkowitz-Cochran, Ronda; Patel, Priti; Bolyard, Elizabeth; Sehulster, Lynne; Srinivasan, Arjun; Perz, Joseph F.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis Proposed, Atlanta, GA 30333 USA; [Schaefer, Melissa K.; Schillie, Sarah; Llata, Eloisa] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce Career Dev, Atlanta, GA 30333 USA; [Dahl, Marilyn; Simpson, Crystal] Ctr Medicare & Medicaid Serv, Ctr Medicaid & State Operat, Survey & Certificat Grp, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Medicare & Medicaid Services	Schaefer, MK (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis Proposed, 1600 Clifton Rd NE,Mailstop A-31, Atlanta, GA 30333 USA.	mschaefer@cdc.gov			Centers for Medicare & Medicaid Services	Centers for Medicare & Medicaid Services	Funding for the pilot ASC inspections was provided by the Centers for Medicare & Medicaid Services.	[Anonymous], 2009, GAO09213; ARCHER WR, 2009, 47 ANN M INF DIS SOC; BENNETT SN, 1995, NEW ENGL J MED, V333, P147, DOI 10.1056/NEJM199507203330303; BOND WW, 1981, LANCET, V1, P550; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P217; Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HIPAC), 2007, 2007 GUID IS PREC PR; Cohen AL, 2008, CLIN J PAIN, V24, P374, DOI 10.1097/AJP.0b013e31816157db; *CTR MED MED SERV, STAT OP MAN SOM APP; de Oliveira AM, 2005, ANN INTERN MED, V142, P898, DOI 10.7326/0003-4819-142-11-200506070-00007; *FOOD DRUG ADM, REPR SINGL US DEV; GREELEY RZ, 2009, ANN M COUNC STAT TER; Grohskopf LA, 2001, NEW ENGL J MED, V344, P1491, DOI 10.1056/NEJM200105173442001; Kamili S, 2007, INFECT CONT HOSP EP, V28, P519, DOI 10.1086/513727; Kirschke DL, 2003, CLIN INFECT DIS, V36, P1369, DOI 10.1086/375064; Labus B., 2008, Morbidity and Mortality Weekly Report, V57, P513; Louie RF, 2005, POINT CARE, V4, P158, DOI 10.1097/01.poc.0000189933.35225.77; *MEDPAC, 2009, DAT BOOK HEALTHC SPE; MOORE ZS, 2009, ANN SCI M SOC HEALTH; Perz Joseph F, 2010, Clin Liver Dis, V14, P137, DOI 10.1016/j.cld.2009.11.004; POLISH LB, 1992, NEW ENGL J MED, V326, P721, DOI 10.1056/NEJM199203123261101; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P283; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; Watson JT, 2005, ARCH INTERN MED, V165, P2639, DOI 10.1001/archinte.165.22.2639; Webb R., 2005, Morbidity and Mortality Weekly Report, V54, P220; 2008, FED REG         1118, V73, P68714	25	82	86	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2273	2279		10.1001/jama.2010.744	http://dx.doi.org/10.1001/jama.2010.744			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530781	Bronze			2022-12-28	WOS:000278496800026
J	Faccenna, C; Becker, TW				Faccenna, Claudio; Becker, Thorsten W.			Shaping mobile belts by small-scale convection	NATURE			English	Article							DYNAMIC TOPOGRAPHY; SUBDUCTION; KINEMATICS; TECTONICS; EAST; SLAB	Mobile belts are long-lived deformation zones composed of an ensemble of crustal fragments, distributed over hundreds of kilometres inside continental convergent margins(1,2). The Mediterranean represents a remarkable example of this tectonic setting(3): the region hosts a diffuse boundary between the Nubia and Eurasia plates comprised of a mosaic of microplates that move and deform independently from the overall plate convergence(4). Surface expressions of Mediterranean tectonics include deep, subsiding backarc basins, intraplate plateaux and uplifting orogenic belts. Although the kinematics of the area are now fairly well defined, the dynamical origins of many of these active features are controversial and usually attributed to crustal and lithospheric interactions. However, the effects of mantle convection, well established for continental interiors(5-7), should be particularly relevant in a mobile belt, and modelling may constrain important parameters such as slab coherence and lithospheric strength. Here we compute global mantle flow on the basis of recent, high-resolution seismic tomography to investigate the role of buoyancy-driven and plate-motion-induced mantle circulation for the Mediterranean. We show that mantle flow provides an explanation for much of the observed dynamic topography and microplate motion in the region. More generally, vigorous small-scale convection in the uppermost mantle may also underpin other complex mobile belts such as the North American Cordillera or the Himalayan-Tibetan collision zone.	[Faccenna, Claudio] Univ Roma TRE, Dipartimento Sci Geol, I-00146 Rome, Italy; [Faccenna, Claudio] CNR IGAG, I-00016 Monterotondo, Italy; [Becker, Thorsten W.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geologia Ambientale e Geoingegneria (IGAG-CNR); University of Southern California	Faccenna, C (corresponding author), Univ Roma TRE, Dipartimento Sci Geol, I-00146 Rome, Italy.	faccenna@uniroma3.it	Becker, Thorsten W/ABF-7643-2021	Becker, Thorsten W/0000-0002-5656-4564; Faccenna, Claudio/0000-0003-0765-4165	University of Southern California (USC); Consiglio Nazionale Ricerche; TOPOEUROPE; MEDUSA [NSF-EAR 0451952]; Directorate For Geosciences [0809023] Funding Source: National Science Foundation	University of Southern California (USC); Consiglio Nazionale Ricerche; TOPOEUROPE; MEDUSA; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	C. F. thanks the University of Southern California (USC) and the Consiglio Nazionale Ricerche for supporting his visit at USC. This work has been financially supported by TOPOEUROPE and MEDUSA (NSF-EAR 0451952), computations were performed on USC's High Performance Computing Center, and we thank the Computational Infrastructure for Geodynamics and the seismologists who shared their tomographic models in electronic form. C. F. thanks R. Funiciello for his support and suggestions.	Bassin C., 2000, EOS T AM GEOPHYS UN, V81, pF897; Casas-Sainz AM, 2009, TECTONOPHYSICS, V474, P214, DOI 10.1016/j.tecto.2009.01.030; D'Agostino N, 1999, TERRA NOVA, V11, P234; D'Agostino N, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005860; Daradich A, 2003, GEOLOGY, V31, P901, DOI 10.1130/G19661.1; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; DOGLIONI C, 1991, TERRA NOVA, V3, P423, DOI 10.1111/j.1365-3121.1991.tb00172.x; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; Ferranti L, 2006, QUATERN INT, V145, P30, DOI 10.1016/j.quaint.2005.07.009; GARFUNKEL Z, 1986, J GEOPHYS RES-SOLID, V91, P7205, DOI 10.1029/JB091iB07p07205; Gautier P, 1999, TECTONOPHYSICS, V315, P31, DOI 10.1016/S0040-1951(99)00281-4; Gurnis M, 2001, SCI AM, V284, P40, DOI 10.1038/scientificamerican0301-40; Husson L, 2006, GEOLOGY, V34, P741, DOI 10.1130/G22436.1; Hyndman R. D., 2005, GSA TODAY, V15; Li C., 2008, GEOCHEM GEOPHY GEOSY, V9, P5, DOI [10.1029/2007GC001806, DOI 10.1029/2007GC001806]; Lithgow-Bertelloni C, 1998, NATURE, V395, P269, DOI 10.1038/26212; Lucente FP, 2006, EARTH PLANET SC LETT, V241, P517, DOI 10.1016/j.epsl.2005.10.041; Lustrino M, 2007, EARTH-SCI REV, V81, P1, DOI 10.1016/j.earscirev.2006.09.002; MCKENZIE D, 1972, GEOPHYS J ROY ASTR S, V30, P109, DOI 10.1111/j.1365-246X.1972.tb02351.x; MOLNAR P, 1988, NATURE, V335, P131, DOI 10.1038/335131a0; Piromallo C, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001757; Reilinger R, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004051; ROYDEN LH, 1993, TECTONICS, V12, P629, DOI 10.1029/92TC02641; Seber D, 2001, GEOPHYS J INT, V147, P630, DOI 10.1046/j.0956-540x.2001.01572.x; Sengor AMC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017858; Serpelloni E, 2007, GEOPHYS J INT, V169, P1180, DOI 10.1111/j.1365-246X.2007.03367.x; Shaw M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028337; Simmons NA, 2009, GEOPHYS J INT, V177, P1284, DOI 10.1111/j.1365-246X.2009.04133.x; Wortel MJR, 2000, SCIENCE, V290, P1910, DOI 10.1126/science.290.5498.1910; Zhong SJ, 2000, J GEOPHYS RES-SOL EA, V105, P11063, DOI 10.1029/2000JB900003	30	179	186	1	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					602	605		10.1038/nature09064	http://dx.doi.org/10.1038/nature09064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520711				2022-12-28	WOS:000278249000038
J	Barrett, MA; Brown, JL; Morikawa, MK; Labat, JN; Yoder, AD				Barrett, Meredith A.; Brown, Jason L.; Morikawa, Megan K.; Labat, Jean-Noel; Yoder, Anne D.			CITES Designation for Endangered Rosewood in Madagascar	SCIENCE			English	Editorial Material							FOREST; FRAGMENTATION; CONSERVATION; DIVERSITY		[Barrett, Meredith A.] Duke Univ, Univ Program Ecol, Durham, NC 27708 USA; [Brown, Jason L.; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Morikawa, Megan K.] Duke Univ, Trinity Coll Arts & Sci, Durham, NC 27708 USA; [Labat, Jean-Noel] Museum Natl Hist Nat, UMR 7205, Dept Systemat & Evolut, F-75005 Paris, France; [Yoder, Anne D.] Duke Univ, Duke Lemur Ctr, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Duke University	Barrett, MA (corresponding author), Duke Univ, Univ Program Ecol, Durham, NC 27708 USA.	meredith.barrett@duke.edu						Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Blundell AG, 2007, ECOL APPL, V17, P323, DOI 10.1890/06-0127; Bohannon J, 2010, SCIENCE, V328, P23, DOI 10.1126/science.328.5974.23; Brown KA, 2004, P NATL ACAD SCI USA, V101, P6045, DOI 10.1073/pnas.0401456101; Cochrane MA, 1998, CONSERV BIOL, V12, P948, DOI 10.1046/j.1523-1739.1998.012005948.x; Favreau B, 2007, MOL ECOL NOTES, V7, P774, DOI 10.1111/j.1471-8286.2007.01692.x; Gillespie TR, 2008, AM J PRIMATOL, V70, P222, DOI 10.1002/ajp.20475; Gillies ACM, 1999, HEREDITY, V83, P722, DOI 10.1038/sj.hdy.6886260; Global Witness and The Environmental Investigation Agency, 2009, INV ILL FELL TRANSP; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; IUCN, 2014, IUCN RED LIST THREAT; Keong CH, 2007, INT FOREST REV, V9, P805, DOI 10.1505/ifor.9.3.805; Labat J-N., 2003, NATURAL HIST MADAGAS, P346; Laurance WF, 2008, SCIENCE, V319, P1184, DOI 10.1126/science.319.5867.1184b; Louppe D., 2008, PLANT RESOURCES TROP, V7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEVILLE K, 2010, EARTH NEGOT B, V21, P1; Patel E. R., 2007, MADAG CONSERV DEV, V2, P11, DOI DOI 10.4314/MCD.V2I1.44124; Rapport DJ, 1999, BIOSCIENCE, V49, P193, DOI 10.2307/1313509; Rasolomampianina R, 2005, MOL ECOL, V14, P4135, DOI 10.1111/j.1365-294X.2005.02730.x; Schuurman D., 2009, Madagascar Conservation and Development, V4, P98; SCHUURMAN D, 2009, TRAFFIC B, V22, P49; WILME L, PRECIOUS TREES PAY O; *WWF, 2009, COMM; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	26	47	47	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1109	1110		10.1126/science.1187740	http://dx.doi.org/10.1126/science.1187740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508116				2022-12-28	WOS:000278104700026
J	Fan, JA; Wu, CH; Bao, K; Bao, JM; Bardhan, R; Halas, NJ; Manoharan, VN; Nordlander, P; Shvets, G; Capasso, F				Fan, Jonathan A.; Wu, Chihhui; Bao, Kui; Bao, Jiming; Bardhan, Rizia; Halas, Naomi J.; Manoharan, Vinothan N.; Nordlander, Peter; Shvets, Gennady; Capasso, Federico			Self-Assembled Plasmonic Nanoparticle Clusters	SCIENCE			English	Article							NEGATIVE-INDEX; FANO RESONANCES; METAMATERIALS; REFRACTION; MAGNETISM; ROUTE	The self-assembly of colloids is an alternative to top-down processing that enables the fabrication of nanostructures. We show that self-assembled clusters of metal-dielectric spheres are the basis for nanophotonic structures. By tailoring the number and position of spheres in close-packed clusters, plasmon modes exhibiting strong magnetic and Fano-like resonances emerge. The use of identical spheres simplifies cluster assembly and facilitates the fabrication of highly symmetric structures. Dielectric spacers are used to tailor the interparticle spacing in these clusters to be approximately 2 nanometers. These types of chemically synthesized nanoparticle clusters can be generalized to other two- and three-dimensional structures and can serve as building blocks for new metamaterials.	[Fan, Jonathan A.; Manoharan, Vinothan N.; Capasso, Federico] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wu, Chihhui; Shvets, Gennady] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Bao, Kui; Nordlander, Peter] Rice Univ, Dept Phys, Houston, TX 77005 USA; [Bao, Jiming] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77204 USA; [Bardhan, Rizia; Halas, Naomi J.] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA; [Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; University of Texas System; University of Texas Austin; Rice University; University of Houston System; University of Houston; Rice University; Harvard University	Capasso, F (corresponding author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St, Cambridge, MA 02138 USA.	capasso@seas.harvard.edu	Bardhan, Rizia/B-4674-2014; bardhan, rizia/A-9393-2010; Manoharan, Vinothan/C-1292-2008; Halas, Naomi/D-2935-2011; Nordlander, Peter/A-2560-2008	Manoharan, Vinothan/0000-0003-0370-6095; Halas, Naomi/0000-0002-8461-8494; Nordlander, Peter/0000-0002-1633-2937	NSF Nanoscale Interdisciplinary Research Team [ECCS-0709323]; Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative [FA9550-06-1-0279, FA9550-08-1-0394]; U.S. Department of Defense National Security Science and Engineering Faculty; Robert A. Welch Foundation [C-1220, C-1222]; AFOSR [F49620-03-C-0068]; SUG@R (Shared University Grid at Rice) team; Center for Advanced Solar Photophysics, U.S. Department of Energy Energy Frontier Research Center	NSF Nanoscale Interdisciplinary Research Team(National Science Foundation (NSF)); Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); U.S. Department of Defense National Security Science and Engineering Faculty; Robert A. Welch Foundation(The Welch Foundation); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); SUG@R (Shared University Grid at Rice) team; Center for Advanced Solar Photophysics, U.S. Department of Energy Energy Frontier Research Center	J.A.F., F. C., C. W., and G. S. acknowledge funding by the NSF Nanoscale Interdisciplinary Research Team under grant no. ECCS-0709323; G. S. and C. W. acknowledge funding by Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative grants FA9550-06-1-0279 and FA9550-08-1-0394; R. B, N.J.H., and P.N. acknowledge support from the U.S. Department of Defense National Security Science and Engineering Faculty Fellowship program, the Robert A. Welch Foundation (C-1220 and C-1222), AFOSR grant F49620-03-C-0068, the SUG@R (Shared University Grid at Rice) team, and the Center for Advanced Solar Photophysics, a U.S. Department of Energy Energy Frontier Research Center. Electron microscopy was performed at the Center for Nanoscale Science at Harvard University, a member of the National Nanotechnology Infrastructure Network. J.A.F. acknowledges R. Guerra for helpful discussions and D. Bell for EM support.	Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; Brandl DW, 2006, J PHYS CHEM B, V110, P12302, DOI 10.1021/jp0613485; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Enkrich C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.203901; Klein MW, 2006, SCIENCE, V313, P502, DOI 10.1126/science.1129198; Lee JH, 2009, OPT LETT, V34, P443, DOI 10.1364/OL.34.000443; Liu N, 2009, NAT MATER, V8, P758, DOI [10.1038/NMAT2495, 10.1038/nmat2495]; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Ming T, 2008, ANGEW CHEM INT EDIT, V47, P9685, DOI 10.1002/anie.200803642; Mirin NA, 2009, J PHYS CHEM A, V113, P4028, DOI [10.1021/jp810411q, 10.1021/jp81041]; Mock JJ, 2002, J CHEM PHYS, V116, P6755, DOI 10.1063/1.1462610; Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Plum E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.113902; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Sherry LJ, 2005, NANO LETT, V5, P2034, DOI 10.1021/nl0515753; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Urzhumov YA, 2008, SOLID STATE COMMUN, V146, P208, DOI 10.1016/j.ssc.2007.08.047; Urzhumov YA, 2007, OPT EXPRESS, V15, P14129, DOI 10.1364/OE.15.014129; Verellen N, 2009, NANO LETT, V9, P1663, DOI 10.1021/nl9001876; Wheeler MS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.073103; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v	30	1246	1259	32	1333	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1135	1138		10.1126/science.1187949	http://dx.doi.org/10.1126/science.1187949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508125				2022-12-28	WOS:000278104700037
J	Stefankiewicz, AR; Sanders, JKM				Stefankiewicz, Artur R.; Sanders, Jeremy K. M.			Harmony of the Self-Assembled Spheres	SCIENCE			English	Editorial Material							COMPLEX		[Stefankiewicz, Artur R.; Sanders, Jeremy K. M.] Univ Chem Lab, Cambridge CB2 1EW, England	University of Cambridge	Stefankiewicz, AR (corresponding author), Univ Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	as2044@cam.ac.uk; jkms@cam.ac.uk		Sanders, Jeremy Keith Morris/0000-0002-5143-5210; Stefankiewicz, Artur/0000-0002-6177-358X				Alcaraz G, 2009, ACCOUNTS CHEM RES, V42, P1640, DOI 10.1021/ar900091a; Fyfe MCT, 1997, ACCOUNTS CHEM RES, V30, P393, DOI 10.1021/ar950199y; Hasenknopf B, 1997, J AM CHEM SOC, V119, P10956, DOI 10.1021/ja971204r; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063; Murase T, 2007, ANGEW CHEM INT EDIT, V46, P5133, DOI 10.1002/anie.200700793; Reinhoudt DN, 2002, SCIENCE, V295, P2403, DOI 10.1126/science.1069197; Stulz E, 2003, CHEM-EUR J, V9, P6039, DOI 10.1002/chem.200305265; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Swiegers GF, 2000, CHEM REV, V100, P3483, DOI 10.1021/cr990110s; Tominaga M, 2004, ANGEW CHEM INT EDIT, V43, P5621, DOI 10.1002/anie.200461422	11	2	2	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1115	1116		10.1126/science.1190821	http://dx.doi.org/10.1126/science.1190821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508119				2022-12-28	WOS:000278104700030
J	Boutron, I; Dutton, S; Ravaud, P; Altman, DG				Boutron, Isabelle; Dutton, Susan; Ravaud, Philippe; Altman, Douglas G.			Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMPIRICAL-EVIDENCE; CLINICAL-TRIALS; DRUG TRIALS; BIAS; PUBLICATION; CONCLUSIONS; METAANALYSES; EXPLANATION; ABSTRACTS; PROTOCOLS	Context Previous studies indicate that the interpretation of trial results can be distorted by authors of published reports. Objective To identify the nature and frequency of distorted presentation or "spin" (ie, specific reporting strategies, whatever their motive, to highlight that the experimental treatment is beneficial, despite a statistically nonsignificant difference for the primary outcome, or to distract the reader from statistically nonsignificant results) in published reports of randomized controlled trials (RCTs) with statistically nonsignificant results for primary outcomes. Data Sources March 2007 search of MEDLINE via PubMed using the Cochrane Highly Sensitive Search Strategy to identify reports of RCTs published in December 2006. Study Selection Articles were included if they were parallel-group RCTs with a clearly identified primary outcome showing statistically nonsignificant results (ie, P >= .05). Data Extraction Two readers appraised each selected article using a pretested, standardized data abstraction form developed in a pilot test. Results From the 616 published reports of RCTs examined, 72 were eligible and appraised. The title was reported with spin in 13 articles (18.0%; 95% confidence interval [CI], 10.0%-28.9%). Spin was identified in the Results and Conclusions sections of the abstracts of 27 (37.5%; 95% CI, 26.4%-49.7%) and 42 (58.3%; 95% CI, 46.1%-69.8%) reports, respectively, with the conclusions of 17 (23.6%; 95% CI, 14.4%-35.1%) focusing only on treatment effectiveness. Spin was identified in the main-text Results, Discussion, and Conclusions sections of 21 (29.2%; 95% CI, 19.0%-41.1%), 31 (43.1%; 95% CI, 31.4%-55.3%), and 36 (50.0%; 95% CI, 38.0%-62.0%) reports, respectively. More than 40% of the reports had spin in at least 2 of these sections in the main text. Conclusion In this representative sample of RCTs published in 2006 with statistically nonsignificant primary outcomes, the reporting and interpretation of findings was frequently inconsistent with the results. JAMA. 2010;303(20):2058-2064 www.jama.com	[Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, Ctr Epidemiol Clin, Assistance Publ Hop Paris, F-75181 Paris 4, France; [Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, Fac Med, Paris, France; [Dutton, Susan; Ravaud, Philippe] INSERM, U738, Paris, France; [Boutron, Isabelle; Dutton, Susan; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford	Boutron, I (corresponding author), Hop Hotel Dieu, Ctr Epidemiol Clin, Assistance Publ Hop Paris, 1 Pl Parvis Notre Dame, F-75181 Paris 4, France.	isabelle.boutron@htd.aphp.fr	ravaud, philippe/C-1694-2009; Altman, Douglas G/A-9714-2012	Ravaud, Philippe/0000-0001-8264-9206; Dutton, Susan/0000-0003-4573-5257; Boutron, Isabelle/0000-0002-5263-6241	Societe Francaise de Rhumatologie (SFR); Ministere des Affaires etrangeres et europeennes	Societe Francaise de Rhumatologie (SFR); Ministere des Affaires etrangeres et europeennes	Dr Boutron was supported by a grant from the Societe Francaise de Rhumatologie (SFR) and that Lavoisier Program (Ministere des Affaires etrangeres et europeennes).	Al-Marzouki S, 2005, CONTEMP CLIN TRIALS, V26, P331, DOI 10.1016/j.cct.2005.01.011; Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BAILAR JC, 2006, EUR J ONCOL, V11, P217; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Blader JC, 2005, CONTEMP CLIN TRIALS, V26, P290, DOI 10.1016/j.cct.2005.01.003; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; BUCHER HC, 1994, BRIT MED J, V309, P761, DOI 10.1136/bmj.309.6957.761; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fletcher RH, 2007, MED LAW, V26, P511; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Hewitt C, 2008, BMJ-BRIT MED J, V336, P23, DOI 10.1136/bmj.39379.359560.AD; Hoekstra R, 2006, PSYCHON B REV, V13, P1033, DOI 10.3758/BF03213921; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; HORTON R, 1995, BRIT MED J, V310, P985, DOI 10.1136/bmj.310.6985.985; Horton R, 2002, JAMA-J AM MED ASSOC, V287, P2775, DOI 10.1001/jama.287.21.2775; Hrobjartsson A, 2007, J CLIN PSYCHOL, V63, P373, DOI 10.1002/jclp.20357; Ioannidis JPA, 2007, J CLIN EPIDEMIOL, V60, P324, DOI 10.1016/j.jclinepi.2006.09.011; Jefferson T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b354; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Jorgensen KJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-3; JUNGER D, 1995, BRIT MED J, V311, P61, DOI 10.1136/bmj.311.6996.61b; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Marco CA, 2000, ACAD EMERG MED, V7, P691, DOI 10.1111/j.1553-2712.2000.tb02049.x; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Matthews JNS, 1996, BRIT MED J, V313, P808; McGettigan P, 1999, J GEN INTERN MED, V14, P633, DOI 10.1046/j.1525-1497.1999.09038.x; Moyer CA, 2009, EVID-BASED COMPL ALT, V6, P49, DOI 10.1093/ecam/nem164; Pocock SJ, 2009, LANCET, V373, P1926, DOI 10.1016/S0140-6736(09)60499-2; Rattinger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005826; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Zinsmeister AR, 2008, AM J GASTROENTEROL, V103, P262, DOI 10.1111/j.1572-0241.2007.01590.x	46	473	477	4	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2058	2064		10.1001/jama.2010.651	http://dx.doi.org/10.1001/jama.2010.651			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501928	Bronze			2022-12-28	WOS:000278018200030
J	Egan, BM; Zhao, YM; Axon, RN				Egan, Brent M.; Zhao, Yumin; Axon, R. Neal			US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES ADULTS; BLOOD-PRESSURE; HEALTH	Context Hypertension is a major risk factor for cardiovascular disease and treatment and control of hypertension reduces risk. The Healthy People 2010 goal was to achieve blood pressure (BP) control in 50% of the US population. Objective To assess progress in treating and controlling hypertension in the United States from 1988-2008. Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2008 in five 2-year blocks included 42 856 adults aged older than 18 years, representing a probability sample of the US civilian population. Main Outcome Measures Hypertension was defined as systolic BP of at least 140 mm Hg and diastolic BP of at least 90 mm Hg, self-reported use of antihypertensive medications, or both. Hypertension control was defined as systolic BP values of less than 140 mm Hg and diastolic BP values of less than 90 mm Hg. All survey periods were age-adjusted to the year 2000 US population. Results Rates of hypertension increased from 23.9% (95% confidence interval [CI], 22.7%-25.2%) in 1988-1994 to 28.5% (95% CI, 25.9%-31.3%; P<.001) in 1999-2000, but did not change between 1999-2000 and 2007-2008 (29.0%; 95% CI, 27.6%-30.5%; P=.24). Hypertension control increased from 27.3% (95% CI, 25.6%-29.1%) in 19881994 to 50.1%(95% CI, 46.8%-53.5%; P=.006) in 2007-2008, and BP among patients with hypertension decreased from 143.0/80.4 mm Hg (95% CI, 141.9-144.2/79.6-81.1 mm Hg) to 135.2/74.1 mm Hg (95% CI, 134.2-136.2/73.2-75.0 mm Hg; P=.02/P<.001). Blood pressure control improved significantly more in absolute percentages between 1999-2000 and 2007-2008 vs 1988-1994 and 1999-2000 (18.6%; 95% CI, 13.3%-23.9%; vs 4.1%; 95% CI, -0.5% to 8.8%; P<.001). Better BP control reflected improvements in awareness (69.1%; 95% CI, 67.1%-71.1%; vs 80.7%; 95% CI, 78.1%-83.0%; P for trend=.03), treatment (54.0%; 95% CI, 52.0%-56.1%; vs 72.5%; 95% CI, 70.1%-74.8%; P=.004), and proportion of patients who were treated and had controlled hypertension (50.6%; 95% CI, 48.0%-53.2%; vs 69.1%; 95% CI, 65.7%-72.3%; P=.006). Hypertension control improved significantly between 1988-1994 and 2007-2008, across age, race, and sex groups, but was lower among individuals aged 18 to 39 years vs 40 to 59 years(P<.001) and 60 years or older(P<.001), and in Hispanic vs white individuals (P=.004). Conclusions Blood pressure was controlled in an estimated 50.1% of all patients with hypertension in NHANES 2007-2008, with most of the improvement since 1988 occurring after 1999-2000. Hypertension control was significantly lower among younger than middle-aged individuals and older adults, and Hispanic vs white individuals. JAMA. 2010;303(20):2043-2050 www.jama.com	[Egan, Brent M.; Zhao, Yumin; Axon, R. Neal] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina	Egan, BM (corresponding author), Med Univ S Carolina, Dept Med, 135 Rutledge Ave,1230 RT, Charleston, SC 29425 USA.	eganbm@musc.edu			NIH [NIH R0107080684, NIH R01DK067615, NIH R01NS058728]; State of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants NIH R0107080684, NIH R01DK067615, and NIH R01NS058728 and the State of South Carolina.	*ACC STUD GROUP, EFF INT BLOOD PRESS; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1988, ARCH INTERN MED, V148, P1023; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; [Anonymous], 2007, NATL HLTH NUTR EXAMI; [Anonymous], NATL HLTH NUTR EXAMI; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Egan BM, 2003, J INVEST MED, V51, P373, DOI 10.1136/jim-51-06-34; Ford ES, 2008, AM J HYPERTENS, V21, P1124, DOI 10.1038/ajh.2008.246; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; *HLTH PEOPL 2010, HEART DIS STROK; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kannel WB, 2009, MED CLIN N AM, V93, P541, DOI 10.1016/j.mcna.2009.02.006; Khosla N, 2009, MED CLIN N AM, V93, P697, DOI 10.1016/j.mcna.2009.02.001; MANCIA G, 1987, HYPERTENSION, V9, P209, DOI 10.1161/01.HYP.9.2.209; Mellen PB, 2008, ARCH INTERN MED, V168, P308, DOI 10.1001/archinternmed.2007.119; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Miller Nancy Houston, 2003, Manag Care, V12, P51; National Center for Health Statistics, 1988, 3 NAT HLTH NUTR EX S; National Center for Health Statistics, HLTH PEOPL 2000 FIN; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; OSTCHEGA Y, 2005, HYPERTENSION AWARENE; Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32; ROCCELLA EJ, 1985, PUBLIC HEALTH REP, V100, P652; United States Census Bureau, STAT COUNT QUICKF; Wong ND, 2003, AM HEART J, V145, P888, DOI 10.1016/S0002-8703(02)94787-3; 1997, ARCH INTERN MED, V157, P2413; 2003, NATL HLTH NUTR EXAMI	31	1395	1442	1	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2043	2050		10.1001/jama.2010.650	http://dx.doi.org/10.1001/jama.2010.650			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501926	Bronze			2022-12-28	WOS:000278018200028
J	Baker, MG; Thornley, CN; Mills, C; Roberts, S; Perera, S; Peters, J; Kelso, A; Barr, I; Wilson, N				Baker, Michael G.; Thornley, Craig N.; Mills, Clair; Roberts, Sally; Perera, Shanika; Peters, Julia; Kelso, Anne; Barr, Ian; Wilson, Nick			Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							A H1N1 VIRUS; OUTBREAK; INFECTIONS	Objectives To assess the risk of transmission of pandemic A/H1N1 2009 influenza (pandemic A/H1N1) from an infected high school group to other passengers on an airline flight and the effectiveness of screening and follow-up of exposed passengers. Design Retrospective cohort investigation using a questionnaire administered to passengers and laboratory investigation of those with symptoms. Setting Auckland, New Zealand, with national and international follow-up of passengers. Participants Passengers seated in the rear section of a Boeing 747-400 long haul flight that arrived on 25 April 2009, including a group of 24 students and teachers and 97 (out of 102) other passengers in the same section of the plane who agreed to be interviewed. Main outcome measures Laboratory confirmed pandemic A/H1N1 infection in susceptible passengers within 3. 2 days of arrival; sensitivity and specificity of influenza symptoms for confirmed infection; and completeness and timeliness of contact tracing. Results Nine members of the school group were laboratory confirmed cases of pandemic A/H1N1 infection and had symptoms during the flight. Two other passengers developed confirmed pandemic A/H1N1 infection, 12 and 48 hours after the flight. They reported no other potential sources of infection. Their seating was within two rows of infected passengers, implying a risk of infection of about 3.5% for the 57 passengers in those rows. All but one of the confirmed pandemic A/H1N1 infected travellers reported cough, but more complex definitions of influenza cases had relatively low sensitivity. Rigorous follow-up by public health workers located 93% of passengers, but only 52% were contacted within 72 hours of arrival. Conclusions A low but measurable risk of transmission of pandemic A/H1N1 exists during modern commercial air travel. This risk is concentrated close to infected passengers with symptoms. Follow-up and screening of exposed passengers is slow and difficult once they have left the airport.	[Baker, Michael G.; Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington 6242, New Zealand; [Thornley, Craig N.; Perera, Shanika; Peters, Julia] Auckland Dist Hlth Board, Auckland Reg Publ Hlth Serv, Auckland 1150, New Zealand; [Mills, Clair] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Roberts, Sally] Auckland Dist Hlth Board, Dept Microbiol, Auckland, New Zealand; [Kelso, Anne; Barr, Ian] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3051, Australia	University of Otago; Auckland District Health Board; University of Auckland; Auckland District Health Board; World Health Organization	Baker, MG (corresponding author), Univ Otago, Dept Publ Hlth, Box 7343, Wellington 6242, New Zealand.	michael.baker@otago.ac.nz		Barr, Ian/0000-0002-7351-418X; Kelso, Anne/0000-0002-3166-3267; Thornley, Craig/0000-0001-9280-6260	Centers for Disease Control and Prevention (USA) [1 U01 CI000445-01]; Australian Government Department of Health and Ageing; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000445] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (USA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This investigation was largely funded by the internal resources of the investigators' employing organisations as part of the public health response to the A/H1N1 pandemic. MGB was partly supported by a grant from the Centers for Disease Control and Prevention (USA) for research on pandemic influenza (1 U01 CI000445-01). The WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funding sources had no involvement with the decision to write this paper and submit it for publication.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; BAKER MG, 2009, EUROSURVEILLANCE, V14, pR2; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; KLONTZ KC, 1989, AM J EPIDEMIOL, V129, P341, DOI 10.1093/oxfordjournals.aje.a115137; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Malone JD, 2009, TRAVEL MED INFECT DI, V7, P181, DOI 10.1016/j.tmaid.2009.02.006; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Marsden AG, 2003, MED J AUSTRALIA, V179, P172, DOI 10.5694/j.1326-5377.2003.tb05483.x; McLeod M, 2008, NEW ZEAL MED J, V121, P62; Ministry of Health, 2006, NZ INFL PAND ACT PLA; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wagner BG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-81; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x	22	71	73	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2010	340								c2424	10.1136/bmj.c2424	http://dx.doi.org/10.1136/bmj.c2424			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LX	20495017	hybrid, Green Published			2022-12-28	WOS:000278062100002
J	Plassman, BL; Williams, JW; Burke, JR; Holsinger, T; Benjamin, S				Plassman, Brenda L.; Williams, John W., Jr.; Burke, James R.; Holsinger, Tracey; Benjamin, Sophiya			Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life	ANNALS OF INTERNAL MEDICINE			English	Review							BIRACIAL COMMUNITY POPULATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SOCIAL NETWORK CHARACTERISTICS; ISOLATED SYSTOLIC HYPERTENSION; INCIDENT ALZHEIMERS-DISEASE; RANDOMIZED CONTROLLED-TRIAL; APOLIPOPROTEIN-E GENOTYPE; OLDER MEXICAN-AMERICANS; ELDERLY MALE TWINS; LOW-DOSE ASPIRIN	Background: Many biological, behavioral, social, and environmental factors may contribute to the delay or prevention of cognitive decline. Purpose: To summarize evidence about putative risk and protective factors for cognitive decline in older adults and the effects of interventions for preserving cognition. Data Sources: English-language publications in MEDLINE, HuGE-pedia, AlzGene, and the Cochrane Database of Systematic Reviews from 1984 through 27 October 2009. Study Selection: Observational studies with 300 or more participants and randomized, controlled trials (RCTs) with 50 or more adult participants who were 50 years or older, drawn from general populations, and followed for at least 1 year were included. Relevant, good-quality systematic reviews were also eligible. Data Extraction: Information on study design, outcomes, and quality were extracted by one researcher and verified by another. An overall rating of the quality of evidence was assigned by using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) criteria. Data Synthesis: 127 observational studies, 22 RCTs, and 16 systematic reviews were reviewed in the areas of nutritional factors; medical factors and medications; social, economic, or behavioral factors; toxic environmental exposures; and genetics. Few of the factors had sufficient evidence to support an association with cognitive decline. On the basis of observational studies, evidence that supported the benefits of selected nutritional factors or cognitive, physical, or other leisure activities was limited. Current tobacco use, the apolipoprotein E epsilon 4 genotype, and certain medical conditions were associated with increased risk. One RCT found a small, sustained benefit from cognitive training (high quality of evidence) and a small RCT reported that physical exercise helps to maintain cognitive function. Limitations: The categorization and definition of exposures were heterogeneous. Few studies were designed a priori to assess associations between specific exposures and cognitive decline. The review included only English-language studies, prioritized categorical outcomes, and excluded small studies. Conclusion: Few potentially beneficial factors were identified from the evidence on risk or protective factors associated with cognitive decline, but the overall quality of the evidence was low.	[Plassman, Brenda L.] Duke Univ, Med Ctr, Durham, NC 27701 USA; Durham Vet Adm Med Ctr, Durham, NC USA; Duke Evidence Based Practice Ctr, Durham, NC USA	Duke University; Duke University	Plassman, BL (corresponding author), Duke Univ, Med Ctr, 905 W Main St,Suite 25-D,Box 41, Durham, NC 27701 USA.	brenda.plassman@duke.edu	Burke, James R/E-4245-2016; Plassman, Brenda L/K-2620-2015; Benjamin, Sophiya/AAA-6643-2021; Williams, John/AAM-4572-2020	Burke, James R/0000-0002-3408-7787; Williams, John/0000-0002-5267-5558	Agency for Healthcare Research and Quality [HHSA 290-2007-10066-I]; National Institute on Aging, through the Office of Medical Applications of Research, National Institutes of Health; U.S. Department of Veterans Affairs	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging, through the Office of Medical Applications of Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	By the Agency for Healthcare Research and Quality (contract HHSA 290-2007-10066-I) and the National Institute on Aging, through the Office of Medical Applications of Research, National Institutes of Health.; Drs. Plassman, Williams, Burke, Holsinger, and Benjamin have disclosed the following: Grants received (money to institution): Agency for Healthcare Research and Quality. Drs. Plassman, Williams, Burke, and Holsinger have also disclosed the following: Grants received/pending: U.S. Department of Veterans Affairs. Support for travel to meetings for the study or otherwise (to institution): Agency for Healthcare Research and Quality. Dr. Burke has further disclosed the following: Grants received/pending: National Institutes of Health, Toyama, Lilly, Novartis. Consultancy: Bristol-Myers Squibb. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms. do?msNum=M10-1107.	Aartsen MJ, 2005, PSYCHOL MED, V35, P217, DOI 10.1017/S0033291704002831; *AG HELATHC RES QU, 2007, METH REF GU IN PRESS; Agostini JV, 2007, J AM GERIATR SOC, V55, P420, DOI 10.1111/j.1532-5415.2007.01071.x; Akbaraly NT, 2007, EPIDEMIOLOGY, V18, P52, DOI 10.1097/01.ede.0000248202.83695.4e; Alvarado BE, 2002, AGING CLIN EXP RES, V14, P132, DOI 10.1007/BF03324426; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; APPLEGATE WB, 1994, ARCH INTERN MED, V154, P2154, DOI 10.1001/archinte.154.19.2154; Arvanitakis Z, 2008, NEUROLOGY, V70, P1795, DOI 10.1212/01.wnl.0000288181.00826.63; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Barnes DE, 2007, J AM GERIATR SOC, V55, P259, DOI 10.1111/j.1532-5415.2007.01040.x; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Berr C, 2000, J AM GERIATR SOC, V48, P1285, DOI 10.1111/j.1532-5415.2000.tb02603.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Beydoun MA, 2008, PUBLIC HEALTH NUTR, V11, P17, DOI 10.1017/S1368980007000080; Bierman EJM, 2008, AGING MENT HEALTH, V12, P517, DOI 10.1080/13607860802224276; Blair CK, 2005, NEUROLOGY, V64, P268, DOI 10.1212/01.WNL.0000149643.91367.8A; Bosma H, 2002, Z GERONTOL GERIATR, V35, P575, DOI 10.1007/s00391-002-0080-y; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Cherbuin N, 2009, DEMENT GERIATR COGN, V28, P47, DOI 10.1159/000229025; Christensen H, 1997, INT J GERIATR PSYCH, V12, P581, DOI 10.1002/(SICI)1099-1166(199705)12:5<581::AID-GPS571>3.0.CO;2-B; Christensen Helen, 2008, BMC Geriatr, V8, P14, DOI 10.1186/1471-2318-8-14; Clarke R, 2007, AM J CLIN NUTR, V86, P1384, DOI 10.1093/ajcn/86.5.1384; Comijs HC, 2009, ARCH GERONTOL GERIAT, V48, P191, DOI 10.1016/j.archger.2008.01.005; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; de Lau LML, 2009, J NEUROL NEUROSUR PS, V80, P149, DOI 10.1136/jnnp.2008.149286; de Moraes SA, 2002, PREV MED, V35, P258, DOI 10.1006/pmed.2002.1077; Devore EE, 2009, AM J EPIDEMIOL, V170, P1040, DOI 10.1093/aje/kwp224; Dik MG, 2000, NEUROLOGY, V54, P1492, DOI 10.1212/WNL.54.7.1492; Dodge HH, 2008, NEUROLOGY, V70, P1809, DOI 10.1212/01.wnl.0000303814.13509.db; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Dufouil C, 1996, AM J EPIDEMIOL, V144, P634; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; Dullemeijer C, 2007, AM J CLIN NUTR, V86, P1479, DOI 10.1093/ajcn/86.5.1479; Egger M, 1998, BRIT MED J, V316, P140; Evans JG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006221; Everson-Rose SA, 2003, AM J EPIDEMIOL, V158, P1083, DOI 10.1093/aje/kwg263; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Fotuhi M, 2008, ALZHEIMERS DEMENT, V4, P223, DOI 10.1016/j.jalz.2008.01.004; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Gallacher J, 2009, PSYCHOSOM MED, V71, P659, DOI 10.1097/PSY.0b013e3181a6177c; Ganguli M, 2005, NEUROLOGY, V65, P1210, DOI 10.1212/01.wnl.0000180520.35181.24; Geda YE, 2006, ARCH NEUROL-CHICAGO, V63, P435, DOI 10.1001/archneur.63.3.435; Geerlings MI, 2000, BRIT J PSYCHIAT, V176, P568, DOI 10.1192/bjp.176.6.568; Glynn RJ, 1999, JAMA-J AM MED ASSOC, V281, P438, DOI 10.1001/jama.281.5.438; Graves AB, 1999, J GERONTOL B-PSYCHOL, V54, pS154, DOI 10.1093/geronb/54B.3.S154; Green AF, 2008, INT J GERIATR PSYCH, V23, P972, DOI 10.1002/gps.2023; Grodstein F, 2008, NEUROEPIDEMIOLOGY, V30, P45, DOI 10.1159/000115749; GURLAND BJ, 1988, J AM GERIATR SOC, V36, P1015, DOI 10.1111/j.1532-5415.1988.tb04369.x; Guyatt G., 2008, USERS GUIDES MEDICAL; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hakansson K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2462; Hayden KM, 2007, NEUROLOGY, V69, P275, DOI 10.1212/01.wnl.0000265223.25679.2a; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; Ho RCM, 2008, AM J GERIAT PSYCHIAT, V16, P519, DOI 10.1097/JGP.0b013e31816b7841; Ho SC, 2001, INT J EPIDEMIOL, V30, P1389, DOI 10.1093/ije/30.6.1389; Holtzman RE, 2004, J GERONTOL B-PSYCHOL, V59, pP278, DOI 10.1093/geronb/59.6.P278; Insel KC, 2005, EXP AGING RES, V31, P35, DOI 10.1080/03610730590882837; Jonker C, 2003, NEUROBIOL AGING, V24, P583, DOI 10.1016/S0197-4580(02)00188-4; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kado DM, 2005, AM J MED, V118, P161, DOI 10.1016/j.amjmed.2004.08.019; Kalmijn S, 1999, AM J EPIDEMIOL, V150, P283, DOI 10.1093/oxfordjournals.aje.a010000; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029; Kalmijn S, 1997, BRIT MED J, V314, P34, DOI 10.1136/bmj.314.7073.34; Kang JH, 2008, NEUROBIOL AGING, V29, P1394, DOI 10.1016/j.neurobiolaging.2007.03.006; Kang JH, 2007, BMJ-BRIT MED J, V334, P987, DOI 10.1136/bmj.39166.597836.BE; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kang JH, 2008, AM J CLIN NUTR, V88, P1602, DOI 10.3945/ajcn.2008.26404; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kang JH, 2005, ANN NEUROL, V57, P713, DOI 10.1002/ana.20476; Kang JH, 2003, NEUROLOGY, V60, P1591; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Knopman DS, 2009, ALZHEIMERS DEMENT, V5, P207, DOI 10.1016/j.jalz.2009.01.027; Koster A, 2005, ANN EPIDEMIOL, V15, P564, DOI 10.1016/j.annepidem.2005.02.008; Kritz-Silverstein D, 2008, J AM GERIATR SOC, V56, P1292, DOI 10.1111/j.1532-5415.2008.01768.x; Kuo HK, 2005, J AM GERIATR SOC, V53, P1154, DOI 10.1111/j.1532-5415.2005.53368.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; Lee S, 2003, AM J EPIDEMIOL, V157, P712, DOI 10.1093/aje/kwg042; Lee SM, 2006, NEUROEPIDEMIOLOGY, V26, P93, DOI 10.1159/000090254; Lethaby A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003122.pub2; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Logroscino G, 2004, BMJ-BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Luchsinger JA, 2004, NEUROLOGY, V62, P1972, DOI 10.1212/01.WNL.0000129504.60409.88; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; Manly JJ, 2005, J GERIATR PSYCH NEUR, V18, P213, DOI 10.1177/0891988705281868; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Maxwell CJ, 2005, DEMENT GERIATR COGN, V20, P45, DOI 10.1159/000085074; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub2; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025; McNeill G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-10; Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8; Morris MC, 2006, ARCH NEUROL-CHICAGO, V63, P1085, DOI 10.1001/archneur.63.8.1085; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P641, DOI 10.1001/archneur.62.4.641; Morris MC, 2004, J NEUROL NEUROSUR PS, V75, P1093, DOI 10.1136/jnnp.2003.025858; Morris MC, 2004, NEUROLOGY, V62, P1573, DOI 10.1212/01.WNL.0000123250.82849.B6; Morris MC, 2005, AM J CLIN NUTR, V81, P508; Morris MC, 2002, ARCH NEUROL-CHICAGO, V59, P1125, DOI 10.1001/archneur.59.7.1125; Muniz-Terrera G, 2009, AGE AGEING, V38, P277, DOI 10.1093/ageing/afp004; Myers E., 2008, AHRQ PUBLICATION AHRQ PUBLICATION; Ng TP, 2009, J AM GERIATR SOC, V57, P1058, DOI 10.1111/j.1532-5415.2009.02262.x; Nguyen HT, 2002, J GERONTOL A-BIOL, V57, pM181, DOI 10.1093/gerona/57.3.M181; Nickelsen T, 1999, PSYCHONEUROENDOCRINO, V24, P115, DOI 10.1016/S0306-4530(98)00041-9; Niti M, 2008, INT PSYCHOGERIATR, V20, P237, DOI 10.1017/S1041610207006655; Packard CJ, 2007, J AM GERIATR SOC, V55, P1777, DOI 10.1111/j.1532-5415.2007.01415.x; Panza F, 2008, DEMENT GERIATR COGN, V25, P336, DOI 10.1159/000119522; Paterniti S, 2002, BRIT J PSYCHIAT, V181, P406, DOI 10.1192/bjp.181.5.406; Peila R, 2006, STROKE, V37, P1165, DOI 10.1161/01.STR.0000217653.01615.93; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Potter GG, 2006, NEUROLOGY, V67, P1377, DOI 10.1212/01.wnl.0000240061.51215.ed; Price JF, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1198; Prince MJ, 1996, BMJ-BRIT MED J, V312, P801; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Ravaglia G, 2008, AM J GERIAT PSYCHIAT, V16, P834, DOI 10.1097/JGP.0b013e318181f9b1; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Ryan J, 2009, PSYCHONEUROENDOCRINO, V34, P287, DOI 10.1016/j.psyneuen.2008.09.008; Saxby BK, 2008, NEUROLOGY, V70, P1858, DOI 10.1212/01.wnl.0000311447.85948.78; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Seeman TE, 2001, HEALTH PSYCHOL, V20, P243, DOI 10.1037//0278-6133.20.4.243; Shadlen MF, 2005, NEUROBIOL AGING, V26, P17, DOI 10.1016/j.neurobiolaging.2004.03.005; Shah RC, 2006, NEUROEPIDEMIOLOGY, V26, P30, DOI 10.1159/000089235; Skoog I, 2005, AM J HYPERTENS, V18, P1052, DOI 10.1016/j.amjhyper.2005.02.013; Smith A, 1999, HUM PSYCHOPHARM CLIN, V14, P459, DOI 10.1002/(SICI)1099-1077(199910)14:7&lt;459::AID-HUP128&gt;3.0.CO;2-0; Solfrizzi V, 2007, NEUROLOGY, V68, P1790, DOI 10.1212/01.wnl.0000262035.87304.89; Staehelin HB, 1999, ACTA NEUROL SCAND, V100, P53, DOI 10.1111/j.1600-0404.1999.tb00723.x; Stewart R, 2003, J AM GERIATR SOC, V51, P1547, DOI 10.1046/j.1532-5415.2003.51504.x; Stott DJ, 2008, J AM GERIATR SOC, V56, P2217, DOI 10.1111/j.1532-5415.2008.02007.x; Sturman MT, 2008, NEUROLOGY, V70, P360, DOI 10.1212/01.wnl.0000285081.04409.bb; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Szwast SJ, 2007, NEUROLOGY, V69, P1873, DOI 10.1212/01.wnl.0000279333.77404.d7; Tervo S, 2004, DEMENT GERIATR COGN, V17, P196, DOI 10.1159/000076356; Tierney MC, 2009, PSYCHONEUROENDOCRINO, V34, P1065, DOI 10.1016/j.psyneuen.2009.02.009; Tyas SL, 2007, AM J EPIDEMIOL, V165, P1231, DOI 10.1093/aje/kwm085; Tzourio C, 1999, NEUROLOGY, V53, P1948, DOI 10.1212/WNL.53.9.1948; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; van den Berg E, 2007, NEUROLOGY, V69, P979, DOI 10.1212/01.wnl.0000271381.30143.75; van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Virtanen M, 2009, AM J EPIDEMIOL, V169, P596, DOI 10.1093/aje/kwn382; Waldstein SR, 2005, HYPERTENSION, V45, P374, DOI 10.1161/01.HYP.0000156744.44218.74; Wang C, 2004, AHRQ PUBLICATION; Wengreen HJ, 2007, J NUTR HEALTH AGING, V11, P230; Wetherell JL, 2002, J GERONTOL B-PSYCHOL, V57, pP246, DOI 10.1093/geronb/57.3.P246; Williams JW, 2010, 193 AG HEALTHC RES Q; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson RS, 2007, NEUROLOGY, V68, P2085, DOI 10.1212/01.wnl.0000264930.97061.82; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wilson RS, 2005, NEUROEPIDEMIOLOGY, V25, P8, DOI 10.1159/000085307; Wilson RS, 2003, NEUROLOGY, V61, P812, DOI 10.1212/01.WNL.0000083989.44027.05; Wilson RS, 2002, J NEUROL NEUROSUR PS, V73, P672, DOI 10.1136/jnnp.73.6.672; Winnock M, 2002, J NEUROL NEUROSUR PS, V72, P794, DOI 10.1136/jnnp.72.6.794; Wright CB, 2006, NEUROEPIDEMIOLOGY, V27, P201, DOI 10.1159/000096300; Wu JH, 2003, J CLIN EPIDEMIOL, V56, P686, DOI 10.1016/S0895-4356(03)00077-5; Wu JH, 2003, ANN EPIDEMIOL, V13, P369, DOI 10.1016/S1047-2797(02)00464-7; Yaffe K, 1999, ARCH GEN PSYCHIAT, V56, P425, DOI 10.1001/archpsyc.56.5.425; Yaffe K, 1997, ARCH NEUROL-CHICAGO, V54, P1110, DOI 10.1001/archneur.1997.00550210044011; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yesavage JA, 2008, J GERONTOL B-PSYCHOL, V63, pP288, DOI 10.1093/geronb/63.5.P288; Yu F, 2009, RES NURS HEALTH, V32, P540, DOI 10.1002/nur.20340; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zunzunegui MV, 2003, J GERONTOL B-PSYCHOL, V58, pS93, DOI 10.1093/geronb/58.2.S93	176	428	434	4	120	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					182	U88		10.7326/0003-4819-153-3-201008030-00258	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00258			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634CR	20547887				2022-12-28	WOS:000280557600007
J	Bakr, WS; Peng, A; Tai, ME; Ma, R; Simon, J; Gillen, JI; Folling, S; Pollet, L; Greiner, M				Bakr, W. S.; Peng, A.; Tai, M. E.; Ma, R.; Simon, J.; Gillen, J. I.; Foelling, S.; Pollet, L.; Greiner, M.			Probing the Superfluid-to-Mott Insulator Transition at the Single-Atom Level	SCIENCE			English	Article							3D OPTICAL LATTICE; ULTRACOLD ATOMS	Quantum gases in optical lattices offer an opportunity to experimentally realize and explore condensed matter models in a clean, tunable system. We used single atom-single lattice site imaging to investigate the Bose-Hubbard model on a microscopic level. Our technique enables space-and time-resolved characterization of the number statistics across the superfluid-Mott insulator quantum phase transition. Site-resolved probing of fluctuations provides us with a sensitive local thermometer, allows us to identify microscopic heterostructures of low-entropy Mott domains, and enables us to measure local quantum dynamics, revealing surprisingly fast transition time scales. Our results may serve as a benchmark for theoretical studies of quantum dynamics, and may guide the engineering of low-entropy phases in a lattice.	[Bakr, W. S.; Peng, A.; Tai, M. E.; Ma, R.; Simon, J.; Gillen, J. I.; Foelling, S.; Pollet, L.; Greiner, M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Foelling, S.] Univ Munich, Inst Phys, D-80799 Munich, Germany	Harvard University; University of Munich	Greiner, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	greiner@physics.harvard.edu	Pollet, Lode C/F-6845-2010; Ma, Ruichao/P-3604-2014; Greiner, Markus/A-8502-2010; Greiner, Markus/E-9512-2017	Pollet, Lode C/0000-0002-7274-2842; Ma, Ruichao/0000-0003-4516-874X; Simon, Jonathan/0000-0001-7854-4647; Folling, Simon/0000-0002-6951-3651	Army Research Office with Defense Advanced Research Projects Agency; Air Force Office of Scientific Research Multidisciplinary University Research Initiative, NSF; Alfred P. Sloan Fellowship; Swiss National Science Foundation	Army Research Office with Defense Advanced Research Projects Agency; Air Force Office of Scientific Research Multidisciplinary University Research Initiative, NSF(MURI); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank G. Jotzu, E. Demler, D. Pekker, B. Wunsch, T. Kitagawa, E. Manousakis, W. Ketterle, and M. D. Lukin for stimulating discussions. Supported by a grant from the Army Research Office with funding from the Defense Advanced Research Projects Agency Optical Lattice Emulator program, and grants from Air Force Office of Scientific Research Multidisciplinary University Research Initiative, NSF, an Alfred P. Sloan Fellowship (M.G.), and the Swiss National Science Foundation. The simulations were run on the Brutus cluster at ETH Zurich.	Altman E, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/113; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Basche T., 1997, SINGLE MOL OPTICAL D; Campbell GK, 2006, SCIENCE, V313, P649, DOI 10.1126/science.1130365; Capogrosso-Sansone B, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.013619; Capogrosso-Sansone B, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.015602; DePue MT, 1999, PHYS REV LETT, V82, P2262, DOI 10.1103/PhysRevLett.82.2262; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Folling S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.060403; Gemelke N, 2009, NATURE, V460, P995, DOI 10.1038/nature08244; Gerbier F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090401; Gerbier F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120405; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; GREINER M, 2002, NATURE, V39, P415; Hung CL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160403; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Knap M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.024301; Kohl M, 2005, J LOW TEMP PHYS, V138, P635, DOI 10.1007/s10909-005-2273-4; Lang KM, 2002, NATURE, V415, P412, DOI 10.1038/415412a; POLLET L, 2008, J PHYS, V10; Pollet L, 2007, J COMPUT PHYS, V225, P2249, DOI 10.1016/j.jcp.2007.03.013; Popp M, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.013622; Prokof'ev NV, 1998, PHYS LETT A, V238, P253, DOI 10.1016/S0375-9601(97)00957-2; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Spielman IB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080404; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Weld DM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.245301; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	30	601	606	6	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					547	550		10.1126/science.1192368	http://dx.doi.org/10.1126/science.1192368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20558666	Green Submitted			2022-12-28	WOS:000280483500031
J	Frankel, N; Davis, GK; Vargas, D; Wang, S; Payre, F; Stern, DL				Frankel, Nicolas; Davis, Gregory K.; Vargas, Diego; Wang, Shu; Payre, Francois; Stern, David L.			Phenotypic robustness conferred by apparently redundant transcriptional enhancers	NATURE			English	Article							REGULATORY ELEMENTS; WINGLESS; ACTIVATION; EXPRESSION; MUTATIONS; EVOLUTION; EPIDERMIS; HEDGEHOG; DORSAL; ROLES	Genes include cis-regulatory regions that contain transcriptional enhancers. Recent reports have shown that developmental genes often possess multiple discrete enhancer modules that drive transcription in similar spatio-temporal patterns(1-4): primary enhancers located near the basal promoter and secondary, or 'shadow', enhancers located at more remote positions. It has been proposed that the seemingly redundant activity of primary and secondary enhancers contributes to phenotypic robustness(1,5). We tested this hypothesis by generating a deficiency that removes two newly discovered enhancers of shavenbaby (svb, a transcript of the ovo locus), a gene encoding a transcription factor that directs development of Drosophila larval trichomes(6). At optimal temperatures for embryonic development, this deficiency causes minor defects in trichome patterning. In embryos that develop at both low and high extreme temperatures, however, absence of these secondary enhancers leads to extensive loss of trichomes. These temperature-dependent defects can be rescued by a transgene carrying a secondary enhancer driving transcription of the svb cDNA. Finally, removal of one copy of wingless, a gene required for normal trichome patterning(7), causes a similar loss of trichomes only in flies lacking the secondary enhancers. These results support the hypothesis that secondary enhancers contribute to phenotypic robustness in the face of environmental and genetic variability.	[Frankel, Nicolas; Vargas, Diego; Wang, Shu; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Frankel, Nicolas; Vargas, Diego; Wang, Shu; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Davis, Gregory K.] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Payre, Francois] Univ Toulouse, F-31062 Toulouse, France; [Payre, Francois] CNRS, UMR5547, Ctr Dev Biol, F-31062 Toulouse, France	Howard Hughes Medical Institute; Princeton University; Princeton University; Bryn Mawr College; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Stern, DL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	dstern@princeton.edu		PAYRE, Francois/0000-0002-8144-6711; Stern, David/0000-0002-1847-6483	Pew Charitable Trusts; Agence Nationale de la Recherche; NIH [GM063622-06A1]; NSF [IOS-0640339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER	Pew Charitable Trusts; Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Chien and D. Erezyilmaz for assistance with early experiments, L. Kruglyak, S. Levin and S. Tavazoie for helpful comments on the manuscript, and E. Wieschaus for providing the wg mutant flies. This work was supported by The Pew Charitable Trusts Latin American Fellows Program in the Biomedical Sciences Fellowship to N.F., Agence Nationale de la Recherche (Blanc 2008, Netoshape) to F.P., and NIH (GM063622-06A1) and NSF (IOS-0640339) grants to D.L.S.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Bokor P, 1996, DEVELOPMENT, V122, P1083; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Crane-Robinson C, 2009, METHODS MOL BIOL, V543, P625, DOI 10.1007/978-1-60327-015-1_37; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; NIJHOUT HF, 2003, DEV INSTABILITY CAUS, pCH1; Overton PM, 2007, DEVELOPMENT, V134, P2807, DOI 10.1242/dev.02878; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Perry MW, 2009, COLD SH Q B, V74, P275, DOI 10.1101/sqb.2009.74.021; POWSNER LOUIS, 1935, PHYSIOL ZOOL, V8, P474; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	26	332	337	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					490	U8		10.1038/nature09158	http://dx.doi.org/10.1038/nature09158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20512118	Green Submitted, Green Accepted			2022-12-28	WOS:000280141200036
J	O'Donnell, MJ; Xavier, D; Liu, LS; Zhang, HY; Chin, SL; Rao-Melacini, P; Rangarajan, S; Islam, S; Pais, P; McQueen, MJ; Mondo, C; Damasceno, A; Lopez-Jaramillo, P; Hankey, GJ; Dans, AL; Yusoff, K; Truelsen, T; Diener, HC; Sacco, RL; Ryglewicz, D; Czlonkowska, A; Weimar, C; Wang, XY; Yusuf, S				O'Donnell, Martin J.; Xavier, Denis; Liu, Lisheng; Zhang, Hongye; Chin, Siu Lim; Rao-Melacini, Purnima; Rangarajan, Sumathy; Islam, Shofiqul; Pais, Prem; McQueen, Matthew J.; Mondo, Charles; Damasceno, Albertino; Lopez-Jaramillo, Patricio; Hankey, Graeme J.; Dans, Antonio L.; Yusoff, Khalid; Truelsen, Thomas; Diener, Hans-Christoph; Sacco, Ralph L.; Ryglewicz, Danuta; Czlonkowska, Anna; Weimar, Christian; Wang, Xingyu; Yusuf, Salim		INTERSTROKE Investigators	Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study	LANCET			English	Article							NORTHERN MANHATTAN STROKE; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; INTERHEART; MORTALITY; COHORT; APOLIPOPROTEINS; METAANALYSIS	Background The contribution of various risk factors to the burden of stroke worldwide is unknown, particularly in countries of low and middle income. We aimed to establish the association of known and emerging risk factors with stroke and its primary subtypes, assess the contribution of these risk factors to the burden of stroke, and explore the differences between risk factors for stroke and myocardial infarction. Methods We undertook a standardised case-control study in 22 countries worldwide between March 1, 2007, and April 23, 2010. Cases were patients with acute first stroke (within 5 days of symptoms onset and 72 h of hospital admission). Controls had no history of stroke, and were matched with cases for age and sex. All participants completed a structured questionnaire and a physical examination, and most provided blood and urine samples. We calculated odds ratios (ORs) and population-attributable risks (PARs) for the association of all stroke, ischaemic stroke, and intracerebral haemorrhagic stroke with selected risk factors. Findings In the first 3000 cases (n=2337, 78%, with ischaemic stroke; n=663, 22%, with intracerebral haemorrhagic stroke) and 3000 controls, significant risk factors for all stroke were: history of hypertension (OR 2.64, 99% CI 2.26-3.08; PAR 34.6%, 99% CI 30.4-39.1); current smoking (2.09, 1.75-2.51; 18.9%, 15.3-23.1); waist-to-hip ratio (1.65, 1.36-1.99 for highest vs lowest tertile; 26.5%, 18.8-36.0); diet risk score (1.35, 1.11-1.64 for highest vs lowest tertile; 18.8%, 11.2-29.7); regular physical activity (0.69, 0.53-0.90; 285%, 14 5-48.5); diabetes mellitus (1.36, 1.10-1.68; 5.0%, 2.6-9.5); alcohol intake (1.51, 1.18-1.92 for more than 30 drinks per month or binge drinking; 3 - 8%, 0.9-14.4); psychosocial stress (1.30, 1.06-1.60; 46%, 2.1-9.6) and depression (1.35, 1.10-1.66; 5.2%, 2.7-9.8); cardiac causes (2.38, 1.77-3.20; 6.7%, 4.8-9.1); and ratio of apolipoproteins B to A1 (1.89, 1.49-2.40 for highest vs lowest tertile; 24.9%, 15.7-37.1). Collectively, these risk factors accounted for 88.1% (99% CI 82.3-92.2) of the PAR for all stroke. When an alternate definition of hypertension was used (history of hypertension or blood pressure >160/90 mm Hg), the combined PAR was 90.3% (85.3-93.7) for all stroke. These risk factors were all significant for ischaemic stroke, whereas hypertension, smoking, waist-to-hip ratio, diet, and alcohol intake were significant risk factors for intracerebr-al haemorrhagic stroke. Interpretation Our findings suggest that ten risk factors are associated with 90% of the risk of stroke. Targeted interventions that reduce blood pressure and smoking, and promote physical activity and a healthy diet, could substantially reduce the burden of stroke.	[O'Donnell, Martin J.] McMaster Univ, Populat Hlth Res Inst, DBCVS Res Inst, Hamilton, ON L8L 2X2, Canada; [O'Donnell, Martin J.] NUI Galway, HRB Clin Res Facil, Galway, Ireland; [Xavier, Denis; Pais, Prem] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Liu, Lisheng] Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Zhang, Hongye; Wang, Xingyu] Beijing Hypertens League Inst, Beijing, Peoples R China; [Mondo, Charles] Mulago Hosp, Uganda Heart Inst, Kampala, Uganda; [Damasceno, Albertino] Eduardo Mondlane Univ, Maputo, Mozambique; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; [Dans, Antonio L.] Univ Philippines, Coll Med, Manila, Philippines; [Yusoff, Khalid] Univ Teknol MARA, Shah Alam, Malaysia; [Truelsen, Thomas] Univ Copenhagen, Herlev Hosp, Copenhagen, Denmark; [Diener, Hans-Christoph; Weimar, Christian] Univ Hosp, Dept Neurol, Essen, Germany; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Ryglewicz, Danuta; Czlonkowska, Anna] Inst Psychiat & Neurol, Warsaw, Poland	McMaster University; Population Health Research Institute; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; St. John's National Academy of Health Sciences; St. John's Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Hypertension League; Mulago National Referral Hospital; Eduardo Mondlane University; Royal Perth Hospital; University of Western Australia; University of the Philippines System; University of the Philippines Manila; Universiti Teknologi MARA; University of Copenhagen; Herlev & Gentofte Hospital; University of Duisburg Essen; University of Miami; Institute of Psychiatry & Neurology	O'Donnell, MJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, DBCVS Res Inst, 3rd Floor,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	odonnm@mcmaster.ca	Sacco, Ralph/Y-9278-2019; Yusoff, Khalid/I-7029-2019; Truelsen, Thomas/AAY-1549-2020; BEJOT, Yannick/E-6088-2010; Diener, Hans-Christoph/AAF-7275-2019; O'Donnell, Martin/ABE-7459-2020; Hankey, Graeme J/H-4968-2014; Kelishadi, Roya/E-6154-2012; Mohammadifard, Noushin/M-2244-2018	Yusoff, Khalid/0000-0001-5669-5188; O'Donnell, Martin/0000-0002-7347-7761; Hankey, Graeme J/0000-0002-6044-7328; Kelishadi, Roya/0000-0001-7455-1495; Mohammadifard, Noushin/0000-0003-1776-1060; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Czlonkowska, Anna/0000-0002-1956-1866; Iversen, Helle Klingenberg/0000-0002-5880-6352; Wuttig, Helge/0000-0003-1877-8905; Rao, Purnima/0000-0002-7537-9057; Lanas, Fernando/0000-0003-3595-9759; Yusuf, Salim/0000-0003-4776-5601	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canadian Stroke Network; Pfizer; Merck; AstraZeneca; Boehringer Ingelheim; Novartis; Janssen-Cilag; SanofiAventis; German Research Council (DFG); Gernam Ministry of Education and Research (BMBF); European Union; US National Institutes of Health; Bertelsmann Foundation; Heinz Nixdorf Foundation; National Institute of Neurological Disorders and Stroke	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Stroke Network; Pfizer(Pfizer); Merck(Merck & Company); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); SanofiAventis(Sanofi-Aventis); German Research Council (DFG)(German Research Foundation (DFG)); Gernam Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bertelsmann Foundation; Heinz Nixdorf Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Pfizer Cardiovascular Award, Merck, AstraZeneca, and Boehringer Ingelheim.; H-CD has received board membership fees, consulting fees, honoraria, payment for manuscript preparation, payment for development of educational presentations, or travel expenses, or a combination, from Abbott, AstraZeneca, Bayer Vital, Bristol Myers Squibb, Boehringer Ingelheim, CoAxia, D-Pharm, Fresenius, GlaxoSmithlaine, Janssen-Cilag, Knoll, Merck Sharpe and Dohme, Medtronic, MindFrame, Neurobiological Technologies, Novartis, Novo Nordisk, Paion, Parke-Davis, Pfizer, SanofiAyentis, Sankyo, Schering Plough, Servier, Solvay, Thrombogenics, Wyeth, and Yamaguchi; and his institution has received grants from AstraZeneca, GlaxoSmithlaine, Boehringer Ingelheim, Novartis, Janssen-Cilag, SanofiAventis, German Research Council (DFG), Gernam Ministry of Education and Research (BMBF), European Union, US National Institutes of Health, Bertelsmann Foundation, and Heinz Nixdorf Foundation. MJM has received honoraria from Merck and Pfizer for presentations. RLS has received consultancy fees from Boehringer Ingelheim (none in the past 16 months); is president-elect and serves on the board of the American Heart Association; and his institution has received consultancy fees from the National Institute of Neurological Disorders and Stroke, and committee membership fees from the Population Health Research Institute, Canada. All other authors declare that they have no conflicts of interest, apart from distribution of funds received from sources listed in the Acknowledgments to cover recruitment costs, research staff, study materials and equipment, funds for CT scans, and travel to investigator meetings for the INTERSTROKE study.; INTERSTROKE has received unrestricted grants from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Pfizer Cardiovascular Award, Merck, AstraZeneca, and Boehringer Ingelheim. The study was facilitated by CANNeCTIN network.	Appel LJ, 2010, NEW ENGL J MED, V362, P650, DOI 10.1056/NEJMe0910352; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Asplund K, 2005, LANCET NEUROL, V4, P64, DOI 10.1016/S1474-4422(04)00967-6; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Daniel Sajjan, 2004, Ideggyogy Sz, V57, P247; Dauchet L, 2005, NEUROLOGY, V65, P1193, DOI 10.1212/01.wnl.0000180600.09719.53; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Donnan GA, 2010, LANCET NEUROL, V9, P133, DOI 10.1016/S1474-4422(10)70001-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Hankey GJ, 2006, STROKE, V37, P2181, DOI 10.1161/01.STR.0000229883.72010.e4; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Heidrich J, 2007, EUR J NEUROL, V14, P255, DOI 10.1111/j.1468-1331.2006.01573.x; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Iso H, 2004, STROKE, V35, P1124, DOI 10.1161/01.STR.0000124459.33597.00; Jeng JS, 2002, ATHEROSCLEROSIS, V165, P317, DOI 10.1016/S0021-9150(02)00246-0; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kargman DE, 1998, ATHEROSCLEROSIS, V139, P391, DOI 10.1016/S0021-9150(98)00085-9; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; O'Donnell M, 2010, NEUROEPIDEMIOLOGY, V35, P36, DOI 10.1159/000306058; O'Donnell M, 2009, LANCET NEUROL, V8, P306, DOI 10.1016/S1474-4422(09)70024-9; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sacco RL, 2009, J AM COLL CARDIOL, V54, P2303, DOI 10.1016/j.jacc.2009.07.047; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P2729, DOI 10.1001/jama.285.21.2729; Song YM, 2008, STROKE, V39, P2432, DOI 10.1161/STROKEAHA.107.512632; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Truelsen T, 2003, STROKE, V34, P1346, DOI 10.1161/01.STR.0000069724.36173.4D; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	1926	2053	13	359	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					112	123		10.1016/S0140-6736(10)60834-3	http://dx.doi.org/10.1016/S0140-6736(10)60834-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20561675				2022-12-28	WOS:000279943200027
J	Ang, KK; Harris, J; Wheeler, R; Weber, R; Rosenthal, DI; Nguyen-Tan, PF; Westra, WH; Chung, CH; Jordan, RC; Lu, C; Kim, H; Axelrod, R; Silverman, CC; Redmond, KP; Gillison, ML				Ang, K. Kian; Harris, Jonathan; Wheeler, Richard; Weber, Randal; Rosenthal, David I.; Nguyen-Tan, Phuc Felix; Westra, William H.; Chung, Christine H.; Jordan, Richard C.; Lu, Charles; Kim, Harold; Axelrod, Rita; Silverman, C. Craig; Redmond, Kevin P.; Gillison, Maura L.			Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; ONCOLOGY GROUP RTOG; RADIATION-THERAPY; NECK CANCERS; HEAD; RADIOTHERAPY; P16; METAANALYSIS; EXPRESSION; INFECTION	BACKGROUND Oropharyngeal squamous-cell carcinomas caused by human papillomavirus (HPV) are associated with favorable survival, but the independent prognostic significance of tumor HPV status remains unknown. METHODS We performed a retrospective analysis of the association between tumor HPV status and survival among patients with stage III or IV oropharyngeal squamous-cell carcinoma who were enrolled in a randomized trial comparing accelerated-fractionation radiotherapy (with acceleration by means of concomitant boost radiotherapy) with standard-fractionation radiotherapy, each combined with cisplatin therapy, in patients with squamous-cell carcinoma of the head and neck. Proportional-hazards models were used to compare the risk of death among patients with HPV-positive cancer and those with HPV-negative cancer. RESULTS The median follow-up period was 4.8 years. The 3-year rate of overall survival was similar in the group receiving accelerated-fractionation radiotherapy and the group receiving standard-fractionation radiotherapy (70.3% vs. 64.3%; P = 0.18; hazard ratio for death with accelerated-fractionation radiotherapy, 0.90; 95% confidence interval [CI], 0.72 to 1.13), as were the rates of high-grade acute and late toxic events. A total of 63.8% of patients with oropharyngeal cancer (206 of 323) had HPV-positive tumors; these patients had better 3-year rates of overall survival (82.4%, vs. 57.1% among patients with HPV-negative tumors; P<0.001 by the log-rank test) and, after adjustment for age, race, tumor and nodal stage, tobacco exposure, and treatment assignment, had a 58% reduction in the risk of death (hazard ratio, 0.42; 95% CI, 0.27 to 0.66). The risk of death significantly increased with each additional packyear of tobacco smoking. Using recursive-partitioning analysis, we classified our patients as having a low, intermediate, or high risk of death on the basis of four factors: HPV status, pack-years of tobacco smoking, tumor stage, and nodal stage. CONCLUSIONS Tumor HPV status is a strong and independent prognostic factor for survival among patients with oropharyngeal cancer. (ClinicalTrials.gov number, NCT00047008.)	[Gillison, Maura L.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Ang, K. Kian; Weber, Randal; Rosenthal, David I.; Lu, Charles] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Harris, Jonathan] Radiat Therapy Oncol Grp Stat Ctr, Philadelphia, PA USA; [Axelrod, Rita] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Wheeler, Richard] Huntsman Canc Inst, Salt Lake City, UT USA; [Nguyen-Tan, Phuc Felix] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Westra, William H.] Johns Hopkins Univ, Baltimore, MD USA; [Chung, Christine H.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Silverman, C. Craig] Univ Louisville, Louisville, KY 40292 USA; [Jordan, Richard C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kim, Harold] Wayne State Univ, Med Ctr, Detroit, MI 48202 USA; [Redmond, Kevin P.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; Jefferson University; Huntsman Cancer Institute; Universite de Montreal; Johns Hopkins University; Vanderbilt University; University of Louisville; University of California System; University of California San Francisco; Detroit Medical Center; Wayne State University; University System of Ohio; University of Cincinnati	Gillison, ML (corresponding author), Ohio State Univ, Ctr Comprehens Canc, 420 W 12th Ave,Rm 690, Columbus, OH 43210 USA.	maura.gillison@osumc.edu		Rosenthal, David/0000-0001-7124-7447	National Cancer Institute (NCI) [RTOG U10 CA21661, CCOP U10 CA37422, P01 CA06294]; National Institute of Dental and Craniofacial Research (NIDCR) [DE016631]; Oral Cancer Foundation; NATIONAL CANCER INSTITUTE [U10CA021661, U10CA037422, P01CA006294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016631] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Oral Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by grants (RTOG U10 CA21661, CCOP U10 CA37422, and P01 CA06294) from the National Cancer Institute (NCI), a grant (DE016631) from the National Institute of Dental and Craniofacial Research (NIDCR), and the Oral Cancer Foundation.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; [Anonymous], 1997, AJCC CANC STAGING MA; Begum S, 2003, CLIN CANCER RES, V9, P6469; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Braakhuis BJM, 2004, JNCI-J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Fu KK, 2000, INT J RADIAT ONCOL, V48, P7, DOI 10.1016/S0360-3016(00)00663-5; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Huang CC, 1998, MODERN PATHOL, V11, P971; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Lassen P, 2009, J CLIN ONCOL, V27, P1992, DOI 10.1200/JCO.2008.20.2853; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lindquist D, 2007, MOL ONCOL, V1, P350, DOI 10.1016/j.molonc.2007.08.005; MARCIAL VA, 1990, CANCER-AM CANCER SOC, V66, P1861, DOI 10.1002/1097-0142(19901101)66:9<1861::AID-CNCR2820660902>3.0.CO;2-I; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Michiels S, 2009, LANCET ONCOL, V10, P341, DOI 10.1016/S1470-2045(09)70023-3; Nakao Y, 1997, BRIT J CANCER, V75, P1410, DOI 10.1038/bjc.1997.243; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Reed AL, 1996, CANCER RES, V56, P3630; Rubin DB, 1987, MULTIPLE IMPUTATIONS; Settle K, 2009, CANCER PREV RES, V2, P776, DOI 10.1158/1940-6207.CAPR-09-0149; Shi W, 2009, J CLIN ONCOL, V27, P6213, DOI 10.1200/JCO.2009.23.1670; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Smeets SJ, 2006, ONCOGENE, V25, P2558, DOI 10.1038/sj.onc.1209275; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402; Zhang H, 1999, RECURSIVE PARTITIONI, P93	33	4309	4374	16	344	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					24	35		10.1056/NEJMoa0912217	http://dx.doi.org/10.1056/NEJMoa0912217			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20530316	Green Accepted, Green Published			2022-12-28	WOS:000279343000005
J	Hoegh-Guldberg, O; Bruno, JF				Hoegh-Guldberg, Ove; Bruno, John F.			The Impact of Climate Change on the World's Marine Ecosystems	SCIENCE			English	Review							OCEAN ACIDIFICATION; HYDROGEN-SULFIDE; ERUPTIONS; RESPONSES	Marine ecosystems are centrally important to the biology of the planet, yet a comprehensive understanding of how anthropogenic climate change is affecting them has been poorly developed. Recent studies indicate that rapidly rising greenhouse gas concentrations are driving ocean systems toward conditions not seen for millions of years, with an associated risk of fundamental and irreversible ecological transformation. The impacts of anthropogenic climate change so far include decreased ocean productivity, altered food web dynamics, reduced abundance of habitat-forming species, shifting species distributions, and a greater incidence of disease. Although there is considerable uncertainty about the spatial and temporal details, climate change is clearly and fundamentally altering ocean ecosystems. Further change will continue to create enormous challenges and costs for societies worldwide, particularly those in developing countries.	[Hoegh-Guldberg, Ove; Bruno, John F.] Univ Queensland, Global Change Inst, Ocean & Coasts Program, St Lucia, Qld 4072, Australia; [Bruno, John F.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA	University of Queensland; University of North Carolina; University of North Carolina Chapel Hill	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Global Change Inst, Ocean & Coasts Program, St Lucia, Qld 4072, Australia.	oveh@uq.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713	Commonwealth Scientific and Industrial Research Organisation; University of North Carolina	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of North Carolina	We thank O. Pantos for important discussion and preparatory work undertaken for this review, the Coral Reef Ecosystems Laboratory at the University of Queensland's Global Change Institute (www.coralreefecosystems.org), and the ARC Centre for Excellence in Coral Reef Studies. J.F.B. was a sabbatical visitor at the Global Change Institute at the University of Queensland during the preparation of this review. O. H.-G. has not received any additional funds, paid consultancies, or patents pertaining to this work. J.F.B. has no paid consultancies and no other affiliations but was funded by a Commonwealth Scientific and Industrial Research Organisation Climate Adaptations Flagship and by the University of North Carolina for part of this work.	Alheit J, 2010, J MARINE SYST, V79, P267, DOI 10.1016/j.jmarsys.2008.11.029; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; Barbraud Christophe, 2008, Proceedings of the National Academy of Sciences of the United States of America, V105, pE38, DOI 10.1073/pnas.0802013105; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Bounama C, 2007, ASTROBIOLOGY, V7, P745, DOI 10.1089/ast.2006.0084; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cazenave A, 2010, ANNU REV MAR SCI, V2, P145, DOI 10.1146/annurev-marine-120308-081105; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Ford SE, 2007, MAR BIOL, V151, P119, DOI 10.1007/s00227-006-0454-6; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Gregory JM, 2004, NATURE, V428, P616, DOI 10.1038/428616a; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kump LR, 2005, GEOLOGY, V33, P397, DOI 10.1130/G21295.1; LANDSEA C, 2010, J CLIM, V34; Leuliette EW, 2004, MAR GEOD, V27, P79, DOI 10.1080/01490410490465193; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Moore JD, 2000, J AQUAT ANIM HEALTH, V12, P26, DOI [10.1577/1548-8667(2000)012<0026:WSIFRA>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0026:WSIFRA&gt;2.0.CO;2]; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Solomon S., 2007, PHYS SCI BASIS WORKI; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	57	1733	1789	87	1998	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1523	1528		10.1126/science.1189930	http://dx.doi.org/10.1126/science.1189930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558709				2022-12-28	WOS:000278859200037
J	Lindenauer, PK; Pekow, PS; Lahti, MC; Lee, Y; Benjamin, EM; Rothberg, MB				Lindenauer, Peter K.; Pekow, Penelope S.; Lahti, Maureen C.; Lee, Yoojin; Benjamin, Evan M.; Rothberg, Michael B.			Association of Corticosteroid Dose and Route of Administration With Risk of Treatment Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COPD; METHYLPREDNISOLONE; HOSPITALIZATION; PREDNISOLONE; MANAGEMENT; THERAPY; ASTHMA; TRIAL	Context Systemic corticosteroids are beneficial for patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (COPD); however, their optimal dose and route of administration are uncertain. Objective To compare the outcomes of patients treated with low doses of steroids administered orally to those treated with higher doses administered intravenously. Design, Setting, and Patients A pharmacoepidemiological cohort study conducted at 414 US hospitals involving patients admitted with acute exacerbation of COPD in 2006 and 2007 to a non-intensive care setting and who received systemic corticosteroids during the first 2 hospital days. Main Outcome Measures A composite measure of treatment failure, defined as the initiation of mechanical ventilation after the second hospital day, inpatient mortality, or readmission for acute exacerbation of COPD within 30 days of discharge. Length of stay and hospital costs. Results Of 79 985 patients, 73 765 (92%) were initially treated with intravenous steroids, whereas 6220 (8%) received oral treatment. We found that 1.4% (95% confidence interval [CI], 1.3%-1.5%) of the intravenously and 1.0% (95% CI, 0.7%-1.2%) of the orally treated patients died during hospitalization, whereas 10.9% (95% CI, 10.7%-11.1%) of the intravenously and 10.3% (95% CI, 9.5%-11.0%) of the orally treated patients experienced the composite outcome. After multivariable adjustment, including the propensity for oral treatment, the risk of treatment failure among patients treated orally was not worse than for those treated intravenously (odds ratio [OR], 0.93; 95% CI, 0.84-1.02). In a propensity-matched analysis, the risk of treatment failure was significantly lower among orally treated patients (OR, 0.84; 95% CI, 0.75-0.95), as was length of stay and cost. Using an adaptation of the instrumental variable approach, increased rate of treatment with oral steroids was not associated with a change in the risk of treatment failure (OR for each 10% increase in hospital use of oral steroids, 1.00; 95% CI, 0.97-1.03). A total of 1356 (22%) patients initially treated with oral steroids were switched to intravenous therapy later in the hospitalization. Conclusion Among patients hospitalized for acute exacerbation of COPD low-dose steroids administered orally are not associated with worse outcomes than high-dose intravenous therapy. JAMA. 0;0(23):2359-2367 www.jama.com	[Lindenauer, Peter K.; Pekow, Penelope S.; Benjamin, Evan M.; Rothberg, Michael B.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Benjamin, Evan M.; Rothberg, Michael B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Pekow, Penelope S.; Lahti, Maureen C.; Lee, Yoojin] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA	Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, 759 Chestnut St, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org			Premier Healthcare Informatics	Premier Healthcare Informatics	Role of the Sponsor: Premier Healthcare Informatics had no role in the design, conduct, analysis, interpretation of data, or the preparation, review, or approval of the manuscript.	ALBERT RK, 1980, ANN INTERN MED, V92, P753, DOI 10.7326/0003-4819-92-6-753; ALHABET S, 1980, BRIT J CLIN PHARMACO, V10, P503, DOI 10.1111/j.1365-2125.1980.tb01796.x; Brown CJ, 2007, J HOSP MED, V2, P305, DOI 10.1002/jhm.209; Bullard MJ, 1996, AM J EMERG MED, V14, P139, DOI 10.1016/S0735-6757(96)90120-5; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; de Jong YP, 2007, CHEST, V132, P1741, DOI 10.1378/chest.07-0208; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; *GLOB STRAT DIAGN, GLOB IN CHRON OBSTR; HARRISON BDW, 1986, LANCET, V1, P181; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Johnston SC, 2002, AM J EPIDEMIOL, V156, P753, DOI 10.1093/aje/kwf095; JONSSON S, 1988, CHEST, V94, P723, DOI 10.1378/chest.94.4.723; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; MAKI DG, 1991, ANN INTERN MED, V114, P845, DOI 10.7326/0003-4819-114-10-845; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McEvoy CE, 1997, CHEST, V111, P732, DOI 10.1378/chest.111.3.732; Moody A, 2004, THORAX, V59, P1; *NAT CTR HLTH STAT, NAT CTR HLTH STAT CH; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; *NIH NHLBI, 2009, MORB MORT CHATB CARD; Parsons, 2001, P 26 ANN SAS US GROU; RATTO D, 1988, JAMA-J AM MED ASSOC, V260, P527, DOI 10.1001/jama.260.4.527; Shortall Sean P, 2002, Respir Care, V47, P154; Singh JM, 2002, ARCH INTERN MED, V162, P2527, DOI 10.1001/archinte.162.22.2527; STEIN BD, 2009, AM J RESP CRIT CARE, V179, pA2159; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; TAGER IB, 1983, AM J EPIDEMIOL, V118, P839; Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814; Vondracek SF, 2006, AM J HEALTH-SYST PH, V63, P645, DOI 10.2146/ajhp050316; Walters JAE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub3	32	162	164	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2359	2367		10.1001/jama.2010.796	http://dx.doi.org/10.1001/jama.2010.796			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551406	Bronze			2022-12-28	WOS:000278759200025
J	Bartsch, T; Schonfeld, R; Muller, FJ; Alfke, K; Leplow, B; Aldenhoff, J; Deuschl, G; Koch, JM				Bartsch, T.; Schoenfeld, R.; Mueller, F. J.; Alfke, K.; Leplow, B.; Aldenhoff, J.; Deuschl, G.; Koch, J. M.			Focal Lesions of Human Hippocampal CA1 Neurons in Transient Global Amnesia Impair Place Memory	SCIENCE			English	Article							SPATIAL MEMORY; RECOGNITION MEMORY; DAMAGE; RATS; REPRESENTATIONS; CLASSIFICATION; NAVIGATION; DEFICITS; SYSTEM; SECTOR	A critical role in place learning has been attributed to place cells within the cornu ammonis 1 (CA1) sector of the hippocampus in rodents. The role of CA1 cells in the human hippocampus with regard to place learning remains elusive. Using a virtual Morris water maze, we investigated patients with acute transient global amnesia (TGA), a rare self-limiting dysfunction of the hippocampal system. Fourteen individuals with selective and focal lesions in the CA1 sector of the hippocampus showed a profound impairment in place learning. The size of the lesions and the duration of the TGA correlated with the deficit in the performance.	[Bartsch, T.; Deuschl, G.] Univ Kiel, Dept Neurol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Schoenfeld, R.; Leplow, B.] Univ Halle Wittenberg, Inst Psychol, Halle, Germany; [Mueller, F. J.; Aldenhoff, J.; Koch, J. M.] Univ Kiel, Dept Psychiat, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Alfke, K.] Univ Kiel, Inst Neuroradiol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; Martin Luther University Halle Wittenberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Bartsch, T (corresponding author), Univ Kiel, Dept Neurol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany.	t.bartsch@neurologie.uni-kiel.de	Bartsch, Thorsten/F-9950-2010; Aldenhoff, Josef/E-9469-2010; Müller, Franz-Josef/E-3336-2010; Bartsch, Thorsten/AAR-5564-2021; Deuschl, Gunther/A-7986-2010	Bartsch, Thorsten/0000-0001-8387-5731; Müller, Franz-Josef/0000-0001-9478-8430; Bartsch, Thorsten/0000-0001-8387-5731; Deuschl, Gunther/0000-0002-4176-9196	Deutsche Forschungsgemeinschaft [SFB 654, KO 2067/1-2]; Faculty of Medicine, University of Kiel, Germany; Else Kroner-Fresenius-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, University of Kiel, Germany; Else Kroner-Fresenius-Stiftung	We thank O. Jansen for helpful input and support and R. Rosentrager for technical assistance. This study has been supported by the Deutsche Forschungsgemeinschaft [to T.B., grant SFB 654 (TP A14); to J.M.K., grant KO 2067/1-2]; the Faculty of Medicine, University of Kiel, Germany (to T. B. and F.J.M.); and the Else Kroner-Fresenius-Stiftung (to F.J.M.). K.A. is currently affiliated with the Institute of Radiology and Neuroradiology, HELIOS Kliniken, Schwerin, Germany.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; AUER RN, 1989, J NEUROSCI, V9, P1641; BACHEVALIER J, 1989, NEUROPSYCHOLOGIA, V27, P83, DOI 10.1016/0028-3932(89)90092-4; Bartsch T, 2008, NEUROLOGY, V70, P1030, DOI 10.1212/01.wnl.0000306633.06027.33; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Bartsch T, 2007, ANN NEUROL, V62, P475, DOI 10.1002/ana.21189; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cianfoni A, 2005, ARCH NEUROL-CHICAGO, V62, P1468, DOI 10.1001/archneur.62.9.1468; Clark RE, 2000, J NEUROSCI, V20, P8853; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Lavenex PB, 2006, J NEUROSCI, V26, P4546, DOI 10.1523/JNEUROSCI.5412-05.2006; Lee HY, 2007, NEURORADIOLOGY, V49, P481, DOI 10.1007/s00234-007-0213-5; Maguire EA, 1997, PHILOS T R SOC B, V352, P1475, DOI 10.1098/rstb.1997.0134; McNaughton BL, 1996, J EXP BIOL, V199, P173; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Schoenfeld R, 2010, BEHAV BRAIN RES, V208, P169, DOI 10.1016/j.bbr.2009.11.022; Sedlaczek O, 2004, NEUROLOGY, V62, P2165, DOI 10.1212/01.WNL.0000130504.88404.C9; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Weon YC, 2008, AM J NEURORADIOL, V29, P1324, DOI 10.3174/ajnr.A1105; WHISHAW IQ, 1994, BRAIN RES BULL, V34, P283, DOI 10.1016/0361-9230(94)90065-5; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	33	118	122	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1412	1415		10.1126/science.1188160	http://dx.doi.org/10.1126/science.1188160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538952				2022-12-28	WOS:000278598400043
J	Parks, JJ; Champagne, AR; Costi, TA; Shum, WW; Pasupathy, AN; Neuscamman, E; Flores-Torres, S; Cornaglia, PS; Aligia, AA; Balseiro, CA; Chan, GKL; Abruna, HD; Ralph, DC				Parks, J. J.; Champagne, A. R.; Costi, T. A.; Shum, W. W.; Pasupathy, A. N.; Neuscamman, E.; Flores-Torres, S.; Cornaglia, P. S.; Aligia, A. A.; Balseiro, C. A.; Chan, G. K. -L.; Abruna, H. D.; Ralph, D. C.			Mechanical Control of Spin States in Spin-1 Molecules and the Underscreened Kondo Effect	SCIENCE			English	Article							SINGLE; TRANSISTORS; MAGNETS	The ability to make electrical contact to single molecules creates opportunities to examine fundamental processes governing electron flow on the smallest possible length scales. We report experiments in which we controllably stretched individual cobalt complexes having spin S = 1, while simultaneously measuring current flow through the molecule. The molecule's spin states and magnetic anisotropy were manipulated in the absence of a magnetic field by modification of the molecular symmetry. This control enabled quantitative studies of the underscreened Kondo effect, in which conduction electrons only partially compensate the molecular spin. Our findings demonstrate a mechanism of spin control in single-molecule devices and establish that they can serve as model systems for making precision tests of correlated-electron theories.	[Parks, J. J.; Champagne, A. R.; Pasupathy, A. N.; Ralph, D. C.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Ralph, D. C.] Cornell Univ, Kavli Inst Cornell, Ithaca, NY 14853 USA; [Parks, J. J.; Shum, W. W.; Neuscamman, E.; Flores-Torres, S.; Chan, G. K. -L.; Abruna, H. D.] Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; [Costi, T. A.] Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany; [Costi, T. A.] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Cornaglia, P. S.; Aligia, A. A.; Balseiro, C. A.] Consejo Nacl Invest Cient & Tecn, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Cornaglia, P. S.; Aligia, A. A.; Balseiro, C. A.] Consejo Nacl Invest Cient & Tecn, CNEA, Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Cornell University; Cornell University; Cornell University; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ralph, DC (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	ralph@ccmr.cornell.edu	Parks, Joshua/B-9889-2009; Costi, Theodoulos/AAY-1846-2021; Cornaglia, Pablo Sebastián/J-8009-2015; Costi, Theo A/C-5113-2011; Ralph, Daniel C/G-3251-2010; Champagne, Alexandre R/ABB-8080-2022	Parks, Joshua/0000-0003-4374-3317; Costi, Theodoulos/0000-0003-0815-5237; Cornaglia, Pablo Sebastián/0000-0003-4991-6573; Costi, Theo A/0000-0003-0815-5237; Champagne, Alexandre R/0000-0002-0669-4395; Shum, William/0000-0002-4281-5596; Aligia, Armando/0000-0001-9647-3926	NSF through the Cornell Center for Materials Research [DMR-0605742, CHE-0403806]; John von Neumann Institute for Computing (Julich); CONICET [11220080101821]	NSF through the Cornell Center for Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); John von Neumann Institute for Computing (Julich)(Helmholtz Association); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	We thank I. Cohen, M. Grobis, G. Hutchison, and P. McEuen for discussions and K. Bolotin, J. Grose, F. Kuemmeth, and E. Tam for technical help. Research at Cornell was supported by the NSF through the Cornell Center for Materials Research, DMR-0605742, CHE-0403806, and use of the Cornell Nanofabrication Facility/National Nanotechnology Infrastructure Network. T. A. C. acknowledges supercomputer support by the John von Neumann Institute for Computing (Julich). P. S. C., A. A. A., and C. A. B. were supported by Proyectos de Investigacion Plurianuales 11220080101821 of CONICET.	Abragam A., 1986, ELECT PARAMAGNETIC R; Agrait N, 2003, PHYS REP, V377, P81, DOI 10.1016/S0370-1573(02)00633-6; Boca R, 2004, COORDIN CHEM REV, V248, P757, DOI 10.1016/j.ccr.2004.03.001; Bogani L, 2008, NAT MATER, V7, P179, DOI 10.1038/nmat2133; Chae DH, 2006, NANO LETT, V6, P165, DOI 10.1021/nl0519027; Christou G, 2000, MRS BULL, V25, P66, DOI 10.1557/mrs2000.226; COSTI TA, 1994, J PHYS-CONDENS MAT, V6, P2519, DOI 10.1088/0953-8984/6/13/013; Goldhaber-Gordon D, 1998, PHYS REV LETT, V81, P5225, DOI 10.1103/PhysRevLett.81.5225; Grobis M., 2007, HDB MAGNETISM ADV MA; Heersche HB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.206801; Jo MH, 2006, NANO LETT, V6, P2014, DOI 10.1021/nl061212i; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Mallet F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.226804; Mehta P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014430; NOZIERES P, 1980, J PHYS-PARIS, V41, P193, DOI 10.1051/jphys:01980004103019300; Otte AF, 2008, NAT PHYS, V4, P847, DOI 10.1038/nphys1072; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Parks JJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.026601; PARKS JJ, 2009, THESIS CORNELL U ITH; Posazhennikova A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036802; Pustilnik M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.216601; Qiu XH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.206102; Roch N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.197202; Romeike C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206601; Yu LH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.266802; Zhao AD, 2005, SCIENCE, V309, P1542, DOI 10.1126/science.1113449	27	326	326	1	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1370	1373		10.1126/science.1186874	http://dx.doi.org/10.1126/science.1186874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538943	Green Submitted, Green Accepted			2022-12-28	WOS:000278598400030
J	Compston, A				Compston, Alastair			Commentary: Scheme has benefited patients	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England	University of Cambridge	Compston, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England.	alastair.compston@medschl.cam.ac.uk						Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; *HLTH SERV CIRC, 2002, COST EFF PROV DIS MO; MCCABE C, 2010, BRIT MED J, V339, pC1786; RAFTERY J, 2010, BRIT MED J, V339, pC1672	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c2707	10.1136/bmj.c2707	http://dx.doi.org/10.1136/bmj.c2707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BM	20522660				2022-12-28	WOS:000278556500009
J	Follett, KA; Weaver, FM; Stern, M; Hur, K; Harris, CL; Luo, P; Marks, WJ; Rothlind, J; Sagher, O; Moy, C; Pahwa, R; Burchiel, K; Hogarth, P; Lai, EC; Duda, JE; Holloway, K; Samii, A; Horn, S; Bronstein, JM; Stoner, G; Starr, PA; Simpson, R; Baltuch, G; De Salles, A; Huang, GD; Reda, DJ				Follett, Kenneth A.; Weaver, Frances M.; Stern, Matthew; Hur, Kwan; Harris, Crystal L.; Luo, Ping; Marks, William J., Jr.; Rothlind, Johannes; Sagher, Oren; Moy, Claudia; Pahwa, Rajesh; Burchiel, Kim; Hogarth, Penelope; Lai, Eugene C.; Duda, John E.; Holloway, Kathryn; Samii, Ali; Horn, Stacy; Bronstein, Jeff M.; Stoner, Gatana; Starr, Philip A.; Simpson, Richard; Baltuch, Gordon; De Salles, Antonio; Huang, Grant D.; Reda, Domenic J.		CSP 468 Study Grp	Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; GLOBUS-PALLIDUS; FOLLOW-UP; MOTOR FLUCTUATIONS; NUCLEUS; TRIAL; VALIDATION; EFFICACY	BACKGROUND Deep-brain stimulation is the surgical procedure of choice for patients with advanced Parkinson's disease. The globus pallidus interna and the subthalamic nucleus are accepted targets for this procedure. We compared 24-month outcomes for patients who had undergone bilateral stimulation of the globus pallidus interna (pallidal stimulation) or subthalamic nucleus (subthalamic stimulation). METHODS At seven Veterans Affairs and six university hospitals, we randomly assigned 299 patients with idiopathic Parkinson's disease to undergo either pallidal stimulation (152 patients) or subthalamic stimulation (147 patients). The primary outcome was the change in motor function, as blindly assessed on the Unified Parkinson's Disease Rating Scale, part III (UPDRS-III), while patients were receiving stimulation but not receiving antiparkinsonian medication. Secondary outcomes included self-reported function, quality of life, neurocognitive function, and adverse events. RESULTS Mean changes in the primary outcome did not differ significantly between the two study groups (P=0.50). There was also no significant difference in self-reported function. Patients undergoing subthalamic stimulation required a lower dose of dopaminergic agents than did those undergoing pallidal stimulation (P=0.02). One component of processing speed (visuomotor) declined more after subthalamic stimulation than after pallidal stimulation (P=0.03). The level of depression worsened after subthalamic stimulation and improved after pallidal stimulation (P=0.02). Serious adverse events occurred in 51% of patients undergoing pallidal stimulation and in 56% of those undergoing subthalamic stimulation, with no significant between-group differences at 24 months. CONCLUSIONS Patients with Parkinson's disease had similar improvement in motor function after either pallidal or subthalamic stimulation. Nonmotor factors may reasonably be included in the selection of surgical target for deep-brain stimulation. (ClinicalTrials.gov numbers, NCT00056563 and NCT01076452.)	[Weaver, Frances M.] Hines Vet Affairs Hosp, Ctr Management Complex Chron Care, Hines, IL 60141 USA; [Follett, Kenneth A.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA; [Stoner, Gatana] Univ Iowa Hlth Care, Iowa City, IA USA; [Follett, Kenneth A.] Univ Nebraska Med Ctr, Omaha, NE USA; [Hur, Kwan; Luo, Ping; Reda, Domenic J.] Hines Vet Affairs Hosp, Cooperat Studies Coordinating Ctr, Hines, IL 60141 USA; [Weaver, Frances M.] Loyola Univ, Stritch Sch Med, Maywood, IL 60153 USA; [Stern, Matthew; Horn, Stacy; Baltuch, Gordon] Univ Penn Hlth Syst, Philadelphia, PA USA; [Stern, Matthew; Duda, John E.; Baltuch, Gordon] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Harris, Crystal L.] VA Cooperat Studies Program, Clin Res Pharm, Albuquerque, NM USA; [Marks, William J., Jr.; Rothlind, Johannes; Starr, Philip A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Marks, William J., Jr.; Rothlind, Johannes; Starr, Philip A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Sagher, Oren] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Moy, Claudia] NINDS, Rockville, MD USA; [Pahwa, Rajesh] Univ Kansas, Med Ctr, Kansas City, MO USA; [Burchiel, Kim] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Burchiel, Kim; Hogarth, Penelope] Portland VA Med Ctr, Portland, OR USA; [Lai, Eugene C.; Simpson, Richard] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Lai, Eugene C.; Simpson, Richard] Baylor Coll Med, Houston, TX 77030 USA; [Hur, Kwan] Richmond VA Med Ctr, Richmond, VA USA; [Samii, Ali] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Bronstein, Jeff M.; De Salles, Antonio] Univ Calif Los Angeles, W Los Angeles VA Med Ctr, Los Angeles, CA USA; [Bronstein, Jeff M.; De Salles, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Huang, Grant D.] US Dept Vet Affairs, Cooperat Studies Program, Cent Off, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Kansas; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Baylor College of Medicine; Baylor College of Medicine; Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs	Weaver, FM (corresponding author), Hines Vet Affairs Hosp, Ctr Management Complex Chron Care, 5000 S 5th Ave,151H, Hines, IL 60141 USA.	frances.weaver@va.gov	Larson, Paul/AAT-9415-2020; Weaver, Frances/S-1540-2019	Holloway, Kathryn/0000-0003-3777-0060; , Domenic/0000-0003-1831-4270	Department of Veterans Affairs Office of Research and Development; National Institute of Neurological Disorders and Stroke; Medtronic; Novartis; Teva; Schering-Plough; Boehringer Ingelheim; Vernalis; Ipsen; Ceregene; Sofamor Danek; Schering-Plough Research Institute; Samueli Institute; Ipsen Pharmaceuticals; Teva Pharmaceuticals; Boston Scientific; SurgiVision	Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medtronic(Medtronic); Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Schering-Plough(Merck & CompanySchering Plough Corporation); Boehringer Ingelheim(Boehringer Ingelheim); Vernalis; Ipsen(Ipsen); Ceregene; Sofamor Danek; Schering-Plough Research Institute(Merck & Company); Samueli Institute; Ipsen Pharmaceuticals(Ipsen); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Boston Scientific(Boston Scientific); SurgiVision	Supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development, the National Institute of Neurological Disorders and Stroke, and Medtronic.; Dr. Stern reports receiving consulting fees from Novartis, Teva, Schering-Plough, Boehringer Ingelheim, Vernalis, and Ipsen and lecture fees from Novartis and having an equity interest in Adamis; Dr. Harris, having an equity interest in Johnson & Johnson; Dr. Marks, receiving consulting and lecture fees from Medtronic and grant support from Boehringer Ingelheim and Ceregene; Dr. Pahwa, receiving consulting and lecture fees from Medtronic; Dr. Burchiel, having an equity interest in Medtronic and receiving grant support from Medtronic and Sofamor Danek; Dr. Hogarth, receiving grant support from Schering-Plough Research Institute; Dr. Lai, receiving grant support from Medtronic; Dr. Duda, receiving consulting fees from Boehringer Ingelheim and grant support from the Samueli Institute; Dr. Holloway, receiving consulting fees and grant support from Medtronic; Dr. Samii, receiving lecture fees from Ipsen Pharmaceuticals, Boehringer Ingelheim, and Teva Pharmaceuticals; Dr. Starr, receiving consulting fees from Medtronic and Boston Scientific and grant support from SurgiVision; Dr. Simpson, receiving consulting and lecture fees from Medtronic; and Dr. De Salles, receiving fellowship support from Medtronic. No other potential conflict of interest relevant to this article was reported.	Anderson VC, 2005, ARCH NEUROL-CHICAGO, V62, P554, DOI 10.1001/archneur.62.4.554; Barcio-Salorio JL, 1999, STEREOT FUNCT NEUROS, V72, P202, DOI 10.1159/000029727; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Durif F, 2002, MOVEMENT DISORD, V17, P803, DOI 10.1002/mds.10128; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Ghika J, 1998, J NEUROSURG, V89, P713, DOI 10.3171/jns.1998.89.5.0713; Goetz CG, 1997, MOVEMENT DISORD, V12, P1039, DOI 10.1002/mds.870120631; Gross C, 1997, J NEUROSURG, V87, P491, DOI 10.3171/jns.1997.87.4.0491; Hauser RA, 2004, MOVEMENT DISORD, V19, P1409, DOI 10.1002/mds.20248; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Houeto JL, 2000, NEUROLOGY, V55, P728, DOI 10.1212/WNL.55.5.728; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Lyons KE, 2002, STEREOT FUNCT NEUROS, V79, P214, DOI 10.1159/000070834; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schrag A, 2006, MOVEMENT DISORD, V21, P1200, DOI 10.1002/mds.20914; Schwab J., 1968, 3 S PARK DIS, P152; Volkmann J, 2004, ANN NEUROL, V55, P871, DOI 10.1002/ana.20091; Volkmann J, 2004, J CLIN NEUROPHYSIOL, V21, P6, DOI 10.1097/00004691-200401000-00003; Weaver F, 2005, J NEUROSURG, V103, P956, DOI 10.3171/jns.2005.103.6.0956; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Zahodne LB, 2009, J NEUROL, V256, P1321, DOI 10.1007/s00415-009-5121-7	25	853	880	2	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2077	2091		10.1056/NEJMoa0907083	http://dx.doi.org/10.1056/NEJMoa0907083			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20519680				2022-12-28	WOS:000278242200007
J	Malmgren, RD; Ottino, JM; Amaral, LAN				Malmgren, R. Dean; Ottino, Julio M.; Amaral, Luis A. Nunes			The role of mentorship in protege performance	NATURE			English	Article							ORGANIZATIONAL COMMITMENT; LONGITUDINAL EXAMINATION; PERSPECTIVE; SELECTION	The role of mentorship in protege performance is a matter of importance to academic, business and governmental organizations. Although the benefits of mentorship for proteges, mentors and their organizations are apparent(1-9), the extent to which proteges mimic their mentors' career choices and acquire their mentorship skills is unclear(10-16). The importance of a science, technology, engineering and mathematics workforce to economic growth and the role of effective mentorship in maintaining a 'healthy' such workforce demand the study of the role of mentorship in academia. Here we investigate one aspect of mentor emulation by studying mentorship fecundity-the number of proteges a mentor trains-using data from the Mathematics Genealogy Project(17), which tracks the mentorship record of thousands of mathematicians over several centuries. We demonstrate that fecundity among academic mathematicians is correlated with other measures of academic success. We also find that the average fecundity of mentors remains stable over 60 years of recorded mentorship. We further discover three significant correlations in mentorship fecundity. First, mentors with low mentorship fecundities train proteges that go on to have mentorship fecundities 37% higher than expected. Second, in the first third of their careers, mentors with high fecundities train proteges that go on to have fecundities 29% higher than expected. Finally, in the last third of their careers, mentors with high fecundities train proteges that go on to have fecundities 31% lower than expected.	[Malmgren, R. Dean; Ottino, Julio M.; Amaral, Luis A. Nunes] Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; [Malmgren, R. Dean] Datascope Analyt, Evanston, IL 60201 USA; [Ottino, Julio M.; Amaral, Luis A. Nunes] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Howard Hughes Medical Institute; Northwestern University	Ottino, JM (corresponding author), Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.	jm-ottino@northwestern.edu; amaral@northwestern.edu	Amaral, LAN/A-4980-2008; Amaral, Luis N./C-5485-2009; Ottino, Julio/B-6682-2009	Amaral, LAN/0000-0002-3762-789X; 	US National Science Foundation [SBE 0830388, IIS 0838564]	US National Science Foundation(National Science Foundation (NSF))	We thank R. Guimera, P. McMullen, A. Pah, M. Sales-Pardo, E. N. Sawardecker, D. B. Stouffer and M. J. Stringer for comments and suggestions. L.A.N.A. gratefully acknowledges the support of US National Science Foundation awards SBE 0830388 and IIS 0838564. All figures were generated using PYGRACE (http://pygrace.sourceforge.net) with colour schemes from ColorBrewer 2.0 (http://colorbrewer.org).	Allen TD, 1997, J VOCAT BEHAV, V50, P1, DOI 10.1006/jvbe.1995.1525; Allen TD, 1997, J VOCAT BEHAV, V51, P70, DOI 10.1006/jvbe.1997.1596; Allen TD, 2004, J VOCAT BEHAV, V65, P469, DOI 10.1016/j.jvb.2003.07.003; Allen TD, 2000, J ORGAN BEHAV, V21, P271, DOI 10.1002/(SICI)1099-1379(200005)21:3<271::AID-JOB44>3.3.CO;2-B; [Anonymous], MATH GEN PROJ; Aryee S, 1996, GROUP ORGAN MANAGE, V21, P261, DOI 10.1177/1059601196213002; Athreya K.B., 2004, BRANCHING PROCESSES; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Bourne PE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000247; CHAO GT, 1992, PERS PSYCHOL, V45, P619, DOI 10.1111/j.1744-6570.1992.tb00863.x; CHAPMAN B, 2000, ACM SIGBIO NEWSLETTE, V20, P15; D'Agostino RB, 1986, GOODNESS OF FIT TECH; Donaldson SI, 2000, J CAREER DEV, V26, P233, DOI 10.1023/A:1022947322349; Enserink M, 2009, SCIENCE, V323, P1662, DOI 10.1126/science.323.5922.1662; GREEN SG, 1995, PERS PSYCHOL, V48, P537, DOI 10.1111/j.1744-6570.1995.tb01769.x; Hardy G.H, 1940, MATH APOLOGY; Higgins MC, 2001, ACAD MANAGE REV, V26, P264, DOI 10.5465/AMR.2001.4378023; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Itzkovitz S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.058102; KING J, 1987, J INFORM SCI, V13, P261, DOI 10.1177/016555158701300501; Kram K. E., 1985, MENTORING WORK DEV R; KRAM KE, 1985, ACAD MANAGE J, V28, P110, DOI 10.2307/256064; Milo R., 2004, UNIFORM GENERATION R; Moed HF., 2005, CITATION ANAL RES EV; Paglis LL, 2006, RES HIGH EDUC, V47, P451, DOI 10.1007/s11162-005-9003-2; Payne SC, 2005, ACAD MANAGE J, V48, P158, DOI 10.2307/20159647; Ragins BR, 1999, J ORGAN BEHAV, V20, P493, DOI 10.1002/(SICI)1099-1379(199907)20:4<493::AID-JOB894>3.0.CO;2-T; SCANDURA TA, 1992, J ORGAN BEHAV, V13, P169, DOI 10.1002/job.4030130206; Singh R, 2009, J VOCAT BEHAV, V74, P11, DOI 10.1016/j.jvb.2008.09.009; Stauffer D., 1992, INTRO PERCOLATION TH	30	95	96	5	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					622	U117		10.1038/nature09040	http://dx.doi.org/10.1038/nature09040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	604AF	20520715	Green Accepted, Green Submitted			2022-12-28	WOS:000278249000043
J	Peebles, PJE; Nusser, A				Peebles, P. J. E.; Nusser, Adi			Nearby galaxies as pointers to a better theory of cosmic evolution	NATURE			English	Review							DARK-MATTER; H I; ENVIRONMENTAL DEPENDENCE; ELLIPTIC GALAXIES; DWARF GALAXIES; STAR-FORMATION; DISK GALAXIES; CATALOG; VOIDS; LUMINOSITY	The great advances in the network of cosmological tests show that the relativistic Big Bang theory is a good description of our expanding Universe. However, the properties of nearby galaxies that can be observed in greatest detail suggest that a better theory would describe a mechanism by which matter is more rapidly gathered into galaxies and groups of galaxies. This more rapid growth occurs in some theoretical ideas now under discussion.	[Peebles, P. J. E.] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Nusser, Adi] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel	Princeton University; Technion Israel Institute of Technology	Peebles, PJE (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	pjep@princeton.edu			Israel Science Foundation [303/09]	Israel Science Foundation(Israel Science Foundation)	We are grateful to the Virgo Consortium for their cosmological simulations and to J. Wang, who produced Fig. 3 from these simulations. We have benefited from advice from F. Governato, A. Klypin, J. Kormendy, J. Silk, S. van den Bergh, J. van Gorkom, S. White and R. Wyse. This work was supported in part by The Israel Science Foundation (grant no. 303/09).	Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Bernardi M, 2006, ASTRON J, V131, P1288, DOI 10.1086/499522; Bezanson R, 2009, ASTROPHYS J, V697, P1290, DOI 10.1088/0004-637X/697/2/1290; Blanton MR, 2009, ANNU REV ASTRON ASTR, V47, P159, DOI 10.1146/annurev-astro-082708-101734; Bond JR, 1996, NATURE, V380, P603, DOI 10.1038/380603a0; Boomsma R, 2008, ASTRON ASTROPHYS, V490, P555, DOI 10.1051/0004-6361:200810120; Brax P, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.123518; DEVAUCOULEURS G, 1953, ASTRON J, V58, P30, DOI 10.1086/106805; Disney MJ, 2008, NATURE, V455, P1082, DOI 10.1038/nature07366; Dvali G, 2000, PHYS LETT B, V485, P208, DOI 10.1016/S0370-2693(00)00669-9; FABER SM, 1976, ASTROPHYS J, V204, P668, DOI 10.1086/154215; Falcon-Barroso J, 2006, MON NOT R ASTRON SOC, V369, P529, DOI 10.1111/j.1365-2966.2006.10261.x; Farrar GR, 2004, ASTROPHYS J, V604, P1, DOI 10.1086/381728; Gao L, 2004, ASTROPHYS J, V614, P17, DOI 10.1086/423444; Gottlober S, 2003, MON NOT R ASTRON SOC, V344, P715, DOI 10.1046/j.1365-8711.2003.06850.x; Governato F, 2010, NATURE, V463, P203, DOI 10.1038/nature08640; Grcevich J, 2009, ASTROPHYS J, V696, P385, DOI 10.1088/0004-637X/696/1/385; Hellwing WA, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.083522; HOGG DW, 2004, APJ, V601, P29; Hopkins PF, 2009, ASTROPHYS J, V691, P1168, DOI 10.1088/0004-637X/691/2/1168; Hui L, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.104002; Karachentsev ID, 2004, ASTRON J, V127, P2031, DOI 10.1086/382905; Keselman JA, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.063521; Keselman JA, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.063517; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Kormendy J, 2008, ASTR SOC P, V396, P297; KORMENDY J, 1977, ASTROPHYS J, V218, P333, DOI 10.1086/155687; Kravtsov A, 2010, ADV ASTRON, V2010, DOI 10.1155/2010/281913; LIN YT, 2009, ASTROPHYS J UNPUB; Martin AM, 2009, ASTROPHYS J SUPPL S, V183, P214, DOI 10.1088/0067-0049/183/2/214; MARTINO MC, 2009, DENSITY PROFILES VOI; Mathis H, 2002, MON NOT R ASTRON SOC, V337, P1193, DOI 10.1046/j.1365-8711.2002.06010.x; Naab T, 2009, ASTROPHYS J, V690, P1452, DOI 10.1088/0004-637X/690/2/1452; Nagamine K, 2006, ASTROPHYS J, V653, P881, DOI 10.1086/508765; Nair PB, 2010, ASTROPHYS J, V715, P606, DOI 10.1088/0004-637X/715/1/606; Nusser A, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.083505; OSTRIKER JP, 1975, ASTROPHYS J, V202, pL113, DOI 10.1086/181992; Park C, 2007, ASTROPHYS J, V658, P898, DOI 10.1086/511059; Parry OH, 2009, MON NOT R ASTRON SOC, V396, P1972, DOI 10.1111/j.1365-2966.2009.14921.x; Peebles PJE, 2007, NUOVO CIMENTO B, V122, P1035, DOI 10.1393/ncb/i2008-10440-y; Peebles PJE, 2009, FINDING THE BIG BANG, P1; POSTMAN M, 1984, ASTROPHYS J, V281, P95, DOI 10.1086/162078; Sage LJ, 1997, ASTRON J, V114, P1753, DOI 10.1086/118604; SCANNAPIECO C, 2010, MON NOT R ASTR UNPUB; Scannapieco C, 2009, MON NOT R ASTRON SOC, V396, P696, DOI 10.1111/j.1365-2966.2009.14764.x; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; SCHWEIZER F, 1982, ASTROPHYS J, V252, P455, DOI 10.1086/159573; Sheth RK, 2004, MON NOT R ASTRON SOC, V350, P517, DOI 10.1111/j.1365-2966.2004.07661.x; Silvestri A, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096901; Springel V, 2008, MON NOT R ASTRON SOC, V391, P1685, DOI 10.1111/j.1365-2966.2008.14066.x; Stanonik K, 2009, ASTROPHYS J LETT, V696, pL6, DOI 10.1088/0004-637X/696/1/L6; Steinmetz M, 2002, NEW ASTRON, V7, P155, DOI 10.1016/S1384-1076(02)00102-1; Szomoru A, 1996, ASTRON J, V111, P2150, DOI 10.1086/117951; Tal T, 2009, ASTRON J, V138, P1417, DOI 10.1088/0004-6256/138/5/1417; Tikhonov AV, 2009, MON NOT R ASTRON SOC, V395, P1915, DOI 10.1111/j.1365-2966.2009.14686.x; TOOMRE A, 1977, EVOLUTION GALAXIES S, P401; TREMAINE SD, 1977, ASTROPHYS J, V212, P311, DOI 10.1086/155049; TULLY RB, 1977, ASTRON ASTROPHYS, V54, P661; Vale A, 2006, MON NOT R ASTRON SOC, V371, P1173, DOI 10.1111/j.1365-2966.2006.10605.x; VANDENBERGH S, 1994, ASTRON J, V107, P1328, DOI 10.1086/116946; VISVANATHAN N, 1977, ASTROPHYS J, V216, P214, DOI 10.1086/155464; Wong OI, 2006, MON NOT R ASTRON SOC, V371, P1855, DOI 10.1111/j.1365-2966.2006.10846.x; WYSE RFG, 2008, P IAU, V4, P11; Zhang PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.141302; Zwaan MA, 2010, MON NOT R ASTRON SOC, V403, P1969, DOI 10.1111/j.1365-2966.2009.16188.x	66	134	136	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					565	569		10.1038/nature09101	http://dx.doi.org/10.1038/nature09101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520705	Green Submitted			2022-12-28	WOS:000278249000031
J	Goode, PS; Burgio, KL; Richter, HE; Markland, AD				Goode, Patricia S.; Burgio, Kathryn L.; Richter, Holly E.; Markland, Alayne D.			Incontinence in Older Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FLOOR ELECTRICAL-STIMULATION; QUALITY-OF-LIFE; URINARY STRESS-INCONTINENCE; NURSING-HOME ADMISSION; URGE INCONTINENCE; DOUBLE-BLIND; ETHNICALLY DIVERSE; FECAL INCONTINENCE; ESTROGEN THERAPY; ELDERLY-PEOPLE	Urinary incontinence is a common geriatric syndrome that affects at least 1 in 3 older women and can greatly diminish quality of life. Incontinence has been associated with increased social isolation, falls, fractures, and admission to long-term care facilities. Often unreported and thus untreated, it is important to include incontinence as part of the review of systems for all older women. Using the case of Mrs F, we highlight the chronicity of incontinence and discuss the evidence base for evaluation of incontinence in older women, with proper initial diagnosis of the type of incontinence stress, urgency, or mixed-in order to prescribe optimal treatment. We present an evidence-based discussion of available incontinence treatments including pelvic floor muscle exercises, stress strategies, urge-suppressions trategies, fluid management, medications, intravaginal pessaries, intravesical injection of botulinum toxin, percutaneous tibial nerve stimulation, sacral neuromodulation, and surgical procedures for stress incontinence. Special considerations in evaluation and treatment of patients with dementia are presented. Urinary incontinence treatments yield high levels of patient satisfaction and improvements in quality of life. JAMA. 2010; 303(21):2172-2181 www.jama.com	[Goode, Patricia S.; Burgio, Kathryn L.; Markland, Alayne D.] Univ Alabama Birmingham, Dept Vet Affairs Med Ctr, Birmingham Atlanta Geriatr Res Educ & Clin Ctr GR, Birmingham, AL USA; [Goode, Patricia S.; Burgio, Kathryn L.; Markland, Alayne D.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Richter, Holly E.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL USA	Geriatric Research Education & Clinical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Goode, PS (corresponding author), BVAMC GRECC 11G, 700 19th St S, Birmingham, AL 35233 USA.	pgoode@uab.edu		Richter, Holly E/0000-0001-7741-5771	Pfizer; SCAN Foundation	Pfizer(Pfizer); SCAN Foundation	Financial Disclosures: Dr Goode reports receipt of a research grant from Pfizer. Dr Burgio reports serving on an advisory board for Astellas, consulting for GlaxoSmithKline, Johnson & Johnson, and Pfizer, and receipt of research grants from Pfizer. Dr Richter reports receipt of a research grant from Pfizer and consulting for Uromedica, Xanodyne, and IDEO. Dr Markland reports no disclosures.; Funding/Support: The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Abrams P, 2006, J UROLOGY, V175, P1063, DOI 10.1016/S0022-5347(05)00348-4; Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; ABRAMS P, 2009, 4 INT CONS INC REC I; Altman D, 2009, INCONTINENCE, P35; Amundsen CL, 2002, AM J OBSTET GYNECOL, V187, P1462, DOI 10.1067/mob.2002.130004; ANDERSON KE, 1993, PHARMACOL REV, V45, P253; Arya LA, 2000, OBSTET GYNECOL, V96, P85, DOI 10.1016/S0029-7844(00)00808-5; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Azuma R, 2008, NURS HEALTH SCI, V10, P151, DOI 10.1111/j.1442-2018.2008.00390.x; Barry MJ, 2008, BJU INT, V101, P45, DOI 10.1111/j.1464-410X.2007.07191.x; Bemelmans BLH, 2003, CURR OPIN UROL, V13, P301, DOI 10.1097/00042307-200307000-00006; Bhattacharya S, 1996, BRIT J OBSTET GYNAEC, V103, P898, DOI 10.1111/j.1471-0528.1996.tb09909.x; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brown JS, 2006, ANN INTERN MED, V144, P715, DOI 10.7326/0003-4819-144-10-200605160-00005; Brown JS, 1996, OBSTET GYNECOL, V87, P715, DOI 10.1016/0029-7844(96)00013-0; Brown JS, 1999, OBSTET GYNECOL, V94, P66, DOI 10.1016/S0029-7844(99)00263-X; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Brubaker L, 2008, J UROLOGY, V180, P217, DOI 10.1016/j.juro.2008.03.028; Bryant Charmaine M, 2002, Br J Nurs, V11, P560; Burgio KL, 2010, INT UROGYNECOL J, V21, P711, DOI 10.1007/s00192-010-1100-x; Burgio KL, 2000, J AM GERIATR SOC, V48, P370, DOI 10.1111/j.1532-5415.2000.tb04692.x; Burgio KL, 2002, JAMA-J AM MED ASSOC, V288, P2293, DOI 10.1001/jama.288.18.2293; BURGIO KL, 1994, J AM GERIATR SOC, V42, P208, DOI 10.1111/j.1532-5415.1994.tb04954.x; BURGIO KL, 1986, AM J OBSTET GYNECOL, V154, P58; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Burgio KL, 1989, STAYING DRY PRACTICA; BURNS PA, 1993, J GERONTOL, V48, pM167; Cardozo L, 1998, OBSTET GYNECOL, V92, P722, DOI 10.1016/S0029-7844(98)00175-6; Chiarelli P, 1999, NEUROUROL URODYNAM, V18, P567, DOI 10.1002/(SICI)1520-6777(1999)18:6<567::AID-NAU7>3.0.CO;2-F; Chiarelli PE, 2009, AUST J PHYSIOTHER, V55, P89, DOI 10.1016/S0004-9514(09)70038-8; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Colombo M, 1995, INT UROGYNECOL J, V6, P63, DOI DOI 10.1007/BF01962573; CREIGHTON SM, 1990, BRIT J UROL, V66, P613, DOI 10.1111/j.1464-410X.1990.tb07192.x; Diokno AC, 2004, J UROLOGY, V171, P1165, DOI 10.1097/01.ju.0000111503.73803.c2; DIOKNO AC, 1988, J UROLOGY, V140, P567, DOI 10.1016/S0022-5347(17)41720-4; Dowd T T, 1996, J Community Health Nurs, V13, P179, DOI 10.1207/s15327655jchn1303_5; DuBeau C.E., 2009, 4 INT CONS INC REC I, P961; Fader M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001406.pub2; Fader M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007408; FALL M, 2008, GUIDELINES CHRONIC P, P62; Fantl JA, 1996, AM FAM PHYSICIAN, V54, P1661; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; FitzGerald MP, 2006, AM J OBSTET GYNECOL, V194, P1399, DOI 10.1016/j.ajog.2006.01.048; Flynn MK, 2009, J UROLOGY, V181, P2608, DOI 10.1016/j.juro.2009.01.117; FREWEN W, 1979, UROL CLIN N AM, V6, P273; Gibbs CF, 2007, AM J MED, V120, P211, DOI 10.1016/j.amjmed.2006.03.044; Gill SS, 2005, ARCH INTERN MED, V165, P808, DOI 10.1001/archinte.165.7.808; Goode PS, 2008, J UROLOGY, V179, P1449, DOI 10.1016/j.juro.2007.11.069; Goode PS, 2003, JAMA-J AM MED ASSOC, V290, P345, DOI 10.1001/jama.290.3.345; Goode PS, 2002, J AM GERIATR SOC, V50, P808, DOI 10.1046/j.1532-5415.2002.50204.x; GOODE PS, 2008, J UROLOGY, V179, P1453; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; GRIFFITHJONES MD, 1991, BRIT J UROL, V67, P295, DOI 10.1111/j.1464-410X.1991.tb15138.x; Grossfeld GD, 2001, UROLOGY, V57, P604, DOI 10.1016/S0090-4295(01)00920-7; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; HARTMANN KE, 2009, AHRQ PUBLICATION; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; Herbison GP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004202.pub2; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; Holroyd-Leduc JM, 2008, JAMA-J AM MED ASSOC, V299, P1446, DOI 10.1001/jama.299.12.1446; Holroyd-Leduc JM, 2004, J AM GERIATR SOC, V52, P712, DOI 10.1111/j.1532-5415.2004.52207.x; Holroyd-Leduc JM, 2004, JAMA-J AM MED ASSOC, V291, P986, DOI 10.1001/jama.291.8.986; Huang AJ, 2007, OBSTET GYNECOL, V109, P909, DOI 10.1097/01.AOG.0000258277.01497.4b; Huang AJ, 2006, ARCH INTERN MED, V166, P2000, DOI 10.1001/archinte.166.18.2000; Hunskaar S, 2004, BJU INT, V93, P324, DOI 10.1111/j.1464-410X.2003.04609.x; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; IOSIF CS, 1988, INT J GYNECOL OBSTET, V26, P255, DOI 10.1016/0020-7292(88)90270-6; Jackson RA, 2004, OBSTET GYNECOL, V104, P301, DOI 10.1097/01.AOG.0000133482.20685.d1; Johnson TM, 2005, J AM GERIATR SOC, V53, P846, DOI 10.1111/j.1532-5415.2005.53260.x; Johnson TM, 2000, J AGING HEALTH, V12, P25, DOI 10.1177/089826430001200102; Juthani-Mehta M, 2009, J AM GERIATR SOC, V57, P963, DOI 10.1111/j.1532-5415.2009.02227.x; Kincade JE, 2007, NEUROUROL URODYNAM, V26, P507, DOI 10.1002/nau.20413; Ko Y, 2005, AM J MANAG CARE, V11, pS103; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Lifford KL, 2005, J AM GERIATR SOC, V53, P1851, DOI 10.1111/j.1532-5415.2005.53565.x; MacDiarmid SA, 2010, J UROLOGY, V183, P234, DOI 10.1016/j.juro.2009.08.160; Miller JM, 1998, J AM GERIATR SOC, V46, P870, DOI 10.1111/j.1532-5415.1998.tb02721.x; Minassian VA, 2008, OBSTET GYNECOL, V111, P324, DOI 10.1097/01.AOG.0000267220.48987.17; Nakanishi N, 1999, AGE AGEING, V28, P301, DOI 10.1093/ageing/28.3.301; Newman Diane K, 2004, Urol Nurs, V24, P316; Novara G, 2007, EUR UROL, V52, P663, DOI 10.1016/j.eururo.2007.06.018; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Ostaszkiewicz J., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002802.pub2, DOI 10.1002/14651858.CD002802.PUB2]; Ostbye T, 2004, CAN J AGING, V23, P319, DOI 10.1353/cja.2005.0024; OUSLANDER JG, 1995, JAMA-J AM MED ASSOC, V273, P1366; Peters KM, 2009, J UROLOGY, V182, P1055, DOI 10.1016/j.juro.2009.05.045; Ponzone R, 2005, EUR J CANCER, V41, P2673, DOI 10.1016/j.ejca.2005.07.015; Press JZ, 2007, BIRTH-ISS PERINAT C, V34, P228, DOI 10.1111/j.1523-536X.2007.00175.x; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Reynard JM, 1998, BRIT J UROL, V81, P215; Richter HE, 2010, OBSTET GYNECOL, V115, P609, DOI 10.1097/AOG.0b013e3181d055d4; Roberts RO, 1998, J AM GERIATR SOC, V46, P467, DOI 10.1111/j.1532-5415.1998.tb02468.x; Rogers RG, 2008, NEW ENGL J MED, V358, P1029, DOI 10.1056/NEJMcp0707023; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Sahai A, 2007, J UROLOGY, V177, P2231, DOI 10.1016/j.juro.2007.01.130; SAND PK, 1995, AM J OBSTET GYNECOL, V173, P72, DOI 10.1016/0002-9378(95)90172-8; Semins MJ, 2004, NAT CLIN PRACT UROL, V1, P78, DOI 10.1038/ncpuro0054; SMITH JH, 2009, 4 INT CONS INC REC I, P1025; Staskin D R, 1986, Clin Geriatr Med, V2, P701; Steers William D, 2002, Rev Urol, V4 Suppl 4, pS7; Subak LL, 2009, NEW ENGL J MED, V360, P481, DOI 10.1056/NEJMoa0806375; Swithinbank L, 2005, J UROLOGY, V174, P187, DOI 10.1097/01.ju.0000162020.10447.31; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; *U MI HLTH SYST, UR TRACT INF; Waetjen LE, 2008, OBSTET GYNECOL, V111, P667, DOI 10.1097/AOG.0b013e31816386ce; Wyman JF, 1998, AM J OBSTET GYNECOL, V179, P999, DOI 10.1016/S0002-9378(98)70206-6; Yamanishi T, 1997, J UROLOGY, V158, P2127, DOI 10.1016/S0022-5347(01)68176-X	108	74	78	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2172	2181		10.1001/jama.2010.749	http://dx.doi.org/10.1001/jama.2010.749			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603BE	20516418				2022-12-28	WOS:000278182100026
J	Wagner, TH; Subak, LL				Wagner, Todd H.; Subak, Leslee L.			Talking About Incontinence The First Step Toward Prevention and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							URINARY-INCONTINENCE; WOMEN; LIFE		[Wagner, Todd H.] VA Hlth Econ Resource Ctr, Menlo Pk, CA 94025 USA; [Wagner, Todd H.] Stanford Univ, Dept Hlth Res & Policy, Menlo Pk, CA 94025 USA; [Subak, Leslee L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci Epidemiol & Urol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Wagner, TH (corresponding author), VA Hlth Econ Resource Ctr, 795 Willow Rd MPD-152, Menlo Pk, CA 94025 USA.	twagner@stanford.edu		Wagner, Todd/0000-0001-7625-3504	NIDDK NIH HHS [K24 DK080775] Funding Source: Medline; HSRD VA [I01 HX001056] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080775] Funding Source: NIH RePORTER; Veterans Affairs [I01HX001056] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HSRD VA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)		[Anonymous], 2007, NIH Consens State Sci Statements, V24, P1; Goode PS, 2010, JAMA-J AM MED ASSOC, V303, P2172, DOI 10.1001/jama.2010.749; Holroyd-Leduc JM, 2004, J AM GERIATR SOC, V52, P712, DOI 10.1111/j.1532-5415.2004.52207.x; Hu TW, 2004, UROLOGY, V63, P461, DOI 10.1016/j.urology.2003.10.037; Huang AJ, 2006, ARCH INTERN MED, V166, P2000, DOI 10.1001/archinte.166.18.2000; Milsom I, 2009, INCONTINENCE; MITTENESS LS, 1995, MED ANTHROPOL Q, V9, P188, DOI 10.1525/maq.1995.9.2.02a00050; Morrison A, 2006, VALUE HEALTH, V9, P272, DOI 10.1111/j.1524-4733.2006.00109.x; Subak LL, 2009, NEW ENGL J MED, V360, P481, DOI 10.1056/NEJMoa0806375	9	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2184	2185		10.1001/jama.2010.747	http://dx.doi.org/10.1001/jama.2010.747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603BE	20516420	Green Accepted			2022-12-28	WOS:000278182100028
J	Baudouin, S; Scheiffele, P				Baudouin, Stephane; Scheiffele, Peter			SnapShot: Neuroligin-Neurexin Complexes	CELL			English	Editorial Material									[Baudouin, Stephane; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Baudouin, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.			baudouin, stephane/0000-0001-6902-6071				BOURGERON T, 2009, NEURON, V19, P231, DOI DOI 10.1016/J.CONB.2009.06.003; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094	8	44	44	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					908	U187	908.e1	10.1016/j.cell.2010.05.024	http://dx.doi.org/10.1016/j.cell.2010.05.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510934	Bronze			2022-12-28	WOS:000278132900024
J	Collinge, J				Collinge, John			Prion Strain Mutation and Selection	SCIENCE			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; MOLECULAR-BASIS; VARIANT CJD; PROTEIN; ENCEPHALOPATHY; TRANSMISSION; HUMANS; GENE; MICE		UCL, Inst Neurol, MRC Prion Unit, London WC1N 3BG, England	University of London; University College London	Collinge, J (corresponding author), UCL, Inst Neurol, MRC Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk			MRC [MC_U123192748] Funding Source: UKRI; Medical Research Council [MC_U123192748] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Collinge J, 1997, NATURE, V389, P526, DOI 10.1038/39116; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wickner RB, 2004, ANNU REV GENET, V38, P681, DOI 10.1146/annurev.genet.38.072902.092200	18	54	55	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1111	1112		10.1126/science.1190815	http://dx.doi.org/10.1126/science.1190815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508117				2022-12-28	WOS:000278104700027
J	Schneider, T; Kruse, T; Wimmer, R; Wiedemann, I; Sass, V; Pag, U; Jansen, A; Nielsen, AK; Mygind, PH; Ravents, DS; Neve, S; Ravn, B; Bonvin, AMJJ; De Maria, L; Andersen, AS; Gammelgaard, LK; Sahl, HG; Kristensen, HH				Schneider, Tanja; Kruse, Thomas; Wimmer, Reinhard; Wiedemann, Imke; Sass, Vera; Pag, Ulrike; Jansen, Andrea; Nielsen, Allan K.; Mygind, Per H.; Ravents, Dorotea S.; Neve, Soren; Ravn, Birthe; Bonvin, Alexandre M. J. J.; De Maria, Leonardo; Andersen, Anders S.; Gammelgaard, Lora K.; Sahl, Hans-Georg; Kristensen, Hans-Henrik			Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II	SCIENCE			English	Article							BACILLUS-SUBTILIS; PEPTIDES; MECHANISM; BIOSYNTHESIS; EXPRESSION; NISIN	Host defense peptides such as defensins are components of innate immunity and have retained antibiotic activity throughout evolution. Their activity is thought to be due to amphipathic structures, which enable binding and disruption of microbial cytoplasmic membranes. Contrary to this, we show that plectasin, a fungal defensin, acts by directly binding the bacterial cell-wall precursor Lipid II. A wide range of genetic and biochemical approaches identify cell-wall biosynthesis as the pathway targeted by plectasin. In vitro assays for cell-wall synthesis identified Lipid II as the specific cellular target. Consistently, binding studies confirmed the formation of an equimolar stoichiometric complex between Lipid II and plectasin. Furthermore, key residues in plectasin involved in complex formation were identified using nuclear magnetic resonance spectroscopy and computational modeling.	[Nielsen, Allan K.; Mygind, Per H.; Ravents, Dorotea S.; Neve, Soren; Ravn, Birthe; De Maria, Leonardo; Andersen, Anders S.; Gammelgaard, Lora K.; Kristensen, Hans-Henrik] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Schneider, Tanja; Wiedemann, Imke; Sass, Vera; Pag, Ulrike; Jansen, Andrea; Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53115 Bonn, Germany; [Kruse, Thomas; Andersen, Anders S.] Statens Serum Inst, DK-2300 Copenhagen S, Denmark; [Wimmer, Reinhard] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Dept Chem, Fac Sci, NL-3584 CH Utrecht, Netherlands	Novozymes; University of Bonn; Statens Serum Institut; Aalborg University; Utrecht University	Kristensen, HH (corresponding author), Novozymes AS, DK-2880 Bagsvaerd, Denmark.	hahk@novozymes.com	Wimmer, Reinhard/M-2346-2019; Wimmer, Reinhard/A-7901-2012; Schneider, Tanja/L-8049-2013; De Maria, Leonardo/AAH-1026-2021; Bonvin, Alexandre M.J.J./A-5420-2009	Wimmer, Reinhard/0000-0001-6942-5056; De Maria, Leonardo/0000-0002-8061-4242; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Kruse, Thomas/0000-0002-2619-7388; Schneider, Tanja/0000-0001-7269-4716	Obel Foundation; European Union [PIAP-GA-2008-218191]; German Research Foundation [SA 292/10-2, SA 292/13-1]; Bundesministerium fur Bildung und Forschung (SkinStaph); Medical Faculty, University of Bonn; Netherlands Organization for Scientific Research [700.56.442]; Danish Research Council for Technology and Production [274-05-0435]	Obel Foundation; European Union(European Commission); German Research Foundation(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (SkinStaph)(Federal Ministry of Education & Research (BMBF)); Medical Faculty, University of Bonn; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Danish Research Council for Technology and Production	We thank M. Josten, A. Hansen, and M. R. Markvardsen for expert technical assistance and acknowledge the Carlsberg Research Center for use of the 800-MHz NMR spectrometer and the Obel Foundation for supporting the NMR laboratory at Aalborg University. H. G. S. acknowledges financial support by the European Union (PIAP-GA-2008-218191), the German Research Foundation (SA 292/10-2 and SA 292/13-1), the Bundesministerium fur Bildung und Forschung (SkinStaph), and by the BONFOR program of the Medical Faculty, University of Bonn. A.M.J.J.B. acknowledges financial support from the Netherlands Organization for Scientific Research (VICI grant 700.56.442). A. S. A. acknowledges financial support from the Danish Research Council for Technology and Production (274-05-0435). Novozymes AS holds a patent on plectasin (patent number WO2003/044049/044049) and has filed patent applications on improved variants of plectasin. L. D. M., A.K.N., and D. S. R. hold stock options in Novozymes AS. DNA microarray data can be accessed through ArrayExpress, accession number E-MTAB-60. NMR assignment of <SUP>1</SUP>H, <SUP>15</SUP>N, and <SUP>13</SUP>C atoms of plectasin have been deposited in the BioMagResBank (accession number 16739).	Allen NE, 2003, FEMS MICROBIOL REV, V26, P511, DOI 10.1111/j.1574-6976.2003.tb00628.x; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	19	382	397	2	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1168	1172		10.1126/science.1185723	http://dx.doi.org/10.1126/science.1185723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508130	Green Published			2022-12-28	WOS:000278104700047
J	Bedau, M; Church, G; Rasmussen, S; Caplan, A; Benner, S; Fussenegger, M; Collins, J; Deamer, D				Bedau, Mark; Church, George; Rasmussen, Steen; Caplan, Arthur; Benner, Steven; Fussenegger, Martin; Collins, Jim; Deamer, David			Life after the synthetic cell	NATURE			English	Editorial Material									[Bedau, Mark] Reed Coll, Portland, OR USA; [Church, George] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Rasmussen, Steen] Univ So Denmark, Odense, Denmark; [Caplan, Arthur] Univ Penn, Philadelphia, PA 19104 USA; [Benner, Steven] Fdn Appl Mol Evolut, Gainesville, FL USA; [Fussenegger, Martin] Swiss Fed Inst Technol, Basel, Switzerland; [Collins, Jim] Boston Univ, Boston, MA 02215 USA; [Deamer, David] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Reed College - Oregon; Harvard University; University of Southern Denmark; University of Pennsylvania; Swiss Federal Institutes of Technology Domain; ETH Zurich; Boston University; University of California System; University of California Santa Cruz	Bedau, M (corresponding author), Reed Coll, Portland, OR USA.			church, george/0000-0001-6232-9969					0	31	34	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					422	424		10.1038/465422a	http://dx.doi.org/10.1038/465422a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601FM	20495545				2022-12-28	WOS:000278043700016
J	Donahue, DA; Carmona, RH				Donahue, Donald A., Jr.; Carmona, Richard H.			Retooling the Uniformed US Public Health Service for the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Donahue, Donald A., Jr.] Potomac Inst Policy Studies, Ctr Hlth Policy & Preparedness, Arlington, VA 22203 USA; [Donahue, Donald A., Jr.] Univ Pittsburgh, Ctr Natl Preparedness, Pittsburgh, PA USA; [Carmona, Richard H.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Arizona	Donahue, DA (corresponding author), Potomac Inst Policy Studies, Ctr Hlth Policy & Preparedness, 901 N Stuart St,Ste 200, Arlington, VA 22203 USA.	ddonahue@potomacinstitute.org	Donahue, Donald/M-2116-2018	Donahue, Donald/0000-0001-8390-1303				Board on Health Promotion and Disease Prevention Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; de Kruif Paul, 1938, FIGHT LIFE; James Locher, 1996, TAKING STOCK GOLDWAT; Merrill Jacqueline, 2003, J Public Health Manag Pract, V9, P459; SHAW GB, 1919, HEARTBREAK HOUSE FAN; SIDEL VW, 2002, BIOL WARFARE DISARMA, P86; World Health Organization, 2007, WORLD HLTH REP 2007	7	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2080	2081		10.1001/jama.2010.673	http://dx.doi.org/10.1001/jama.2010.673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501931				2022-12-28	WOS:000278018200035
J	Tu, JV				Tu, Jack V.			Reducing the global burden of stroke: INTERSTROKE	LANCET			English	Editorial Material							RISK-FACTORS; MYOCARDIAL-INFARCTION; 52 COUNTRIES; SMOKING		Univ Toronto, Sunnybrook Schulich Heart Ctr, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Tu, JV (corresponding author), Univ Toronto, Sunnybrook Schulich Heart Ctr, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada.	tu@ices.on.ca		Tu, Jack/0000-0003-0111-722X				Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; O'Donnell M, 2010, NEUROEPIDEMIOLOGY, V35, P36, DOI 10.1159/000306058; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	12	30	30	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					74	75		10.1016/S0140-6736(10)60975-0	http://dx.doi.org/10.1016/S0140-6736(10)60975-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626CJ	20561674				2022-12-28	WOS:000279943200006
J	Silverman, JG				Silverman, Jay G.			Key to prevent HIV in women: reduce gender-based violence	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; SOUTH-AFRICA; INFECTION; RISK		Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Silverman, JG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	jsilverm@hsph.harvard.edu						Decker MR, 2008, INT J GYNECOL OBSTET, V100, P18, DOI 10.1016/j.ijgo.2007.06.045; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2007, SEX TRANSM INFECT, V83, P173, DOI 10.1136/sti.2007.024950; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI	12	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 3	2010	376	9734					6	7		10.1016/S0140-6736(10)60971-3	http://dx.doi.org/10.1016/S0140-6736(10)60971-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20557930				2022-12-28	WOS:000279841600006
J	Lagrange, AM; Bonnefoy, M; Chauvin, G; Apai, D; Ehrenreich, D; Boccaletti, A; Gratadour, D; Rouan, D; Mouillet, D; Lacour, S; Kasper, M				Lagrange, A. -M.; Bonnefoy, M.; Chauvin, G.; Apai, D.; Ehrenreich, D.; Boccaletti, A.; Gratadour, D.; Rouan, D.; Mouillet, D.; Lacour, S.; Kasper, M.			A Giant Planet Imaged in the Disk of the Young Star beta Pictoris	SCIENCE			English	Article							DEBRIS DISK; SYSTEM; ASYMMETRIES; NAOS; LINE; 1ST	Here, we show that the similar to 10-million-year-old beta Pictoris system hosts a massive giant planet, beta Pictoris b, located 8 to 15 astronomical units from the star. This result confirms that gas giant planets form rapidly within disks and validates the use of disk structures as fingerprints of embedded planets. Among the few planets already imaged, beta Pictoris b is the closest to its parent star. Its short period could allow for recording of the full orbit within 17 years.	[Lagrange, A. -M.; Bonnefoy, M.; Chauvin, G.; Ehrenreich, D.; Mouillet, D.] Univ Grenoble 1, CNRS, Astrophys Lab, Observ Grenoble, F-38041 Grenoble, France; [Apai, D.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Boccaletti, A.; Gratadour, D.; Rouan, D.; Lacour, S.] Univ Paris Diderot, Lab Etud Spatiales & Instrumentat Astrophys, CNRS, UMR 8109,Observ Paris,UPMC, F-92195 Meudon, France; [Kasper, M.] ESO, D-85748 Garching, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Space Telescope Science Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite	Lagrange, AM (corresponding author), Univ Grenoble 1, CNRS, Astrophys Lab, Observ Grenoble, BP 53, F-38041 Grenoble, France.	anne-marie.lagrange@obs.ujf-grenoble.fr	Gratadour, Damien/AAF-8236-2021	Gratadour, Damien/0000-0003-2080-7189	National de Planetologie Institut National des Sciences de l'Univers; Agence Nationale pour la Recherche [NT05-4_4463]; Centre National d'Etudes Spatiales	National de Planetologie Institut National des Sciences de l'Univers; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	We thank ESO staff, especially C. Melo, C. Dumas, and J. Girard for their help. We acknowledge financial support from the Programme National de Planetologie Institut National des Sciences de l'Univers, as well as from the Agence Nationale pour la Recherche (grant NT05-4_4463). D. E. acknowledges support from the Centre National d'Etudes Spatiales. We also thank H. Beust, P. Rubini, and D. Collardey.	Augereau JC, 2001, ASTRON ASTROPHYS, V370, P447, DOI 10.1051/0004-6361:20010199; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Beust H, 2000, ICARUS, V143, P170, DOI 10.1006/icar.1999.6238; Crifo F, 1997, ASTRON ASTROPHYS, V320, pL29; des Etangs AL, 2009, ASTRON ASTROPHYS, V497, P557, DOI 10.1051/0004-6361/200811528; Fitzgerald MP, 2009, ASTROPHYS J LETT, V706, pL41, DOI 10.1088/0004-637X/706/1/L41; Freistetter F, 2007, ASTRON ASTROPHYS, V466, P389, DOI 10.1051/0004-6361:20066746; Golimowski DA, 2006, ASTRON J, V131, P3109, DOI 10.1086/503801; Heap SR, 2000, ASTROPHYS J, V539, P435, DOI 10.1086/309188; Ida S, 2008, ASTROPHYS J, V685, P584, DOI 10.1086/590401; KALAS P, 1995, ASTRON J, V110, P794, DOI 10.1086/117565; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; Kalas P, 2008, SCIENCE, V322, P1345, DOI 10.1126/science.1166609; Kennedy GM, 2008, ASTROPHYS J, V673, P502, DOI 10.1086/524130; Lagrange A.-M., 2000, Protostars and planets 4, P639; Lagrange AM, 2009, ASTRON ASTROPHYS, V506, P927, DOI 10.1051/0004-6361/200912098; Lagrange AM, 2009, ASTRON ASTROPHYS, V493, pL21, DOI 10.1051/0004-6361:200811325; Lenzen R, 2003, P SOC PHOTO-OPT INS, V4841, P944, DOI 10.1117/12.460044; Mouillet D, 1997, MON NOT R ASTRON SOC, V292, P896, DOI 10.1093/mnras/292.4.896; Okamoto YK, 2004, NATURE, V431, P660, DOI 10.1038/nature02948; Olofsson G, 2001, ASTROPHYS J, V563, pL77, DOI 10.1086/338354; Pascucci I., 2010, PROTOPLANETARY DUST, P263; Rousset G, 2003, P SOC PHOTO-OPT INS, V4839, P140, DOI 10.1117/12.459332; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Su KYL, 2009, ASTROPHYS J, V705, P314, DOI 10.1088/0004-637X/705/1/314; Telesco CM, 2005, NATURE, V433, P133, DOI 10.1038/nature03255; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; Wahhaj Z, 2003, ASTROPHYS J, V584, pL27, DOI 10.1086/346123; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525; Zuckerman B, 2001, ASTROPHYS J, V562, pL87, DOI 10.1086/337968	32	608	611	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					57	59		10.1126/science.1187187	http://dx.doi.org/10.1126/science.1187187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20538914	Green Submitted			2022-12-28	WOS:000279402700029
J	Antony, R; Dargie, HJ				Antony, Renjith; Dargie, Henry J.			Allopurinol for chronic stable angina: old drug, new tricks?	LANCET			English	Editorial Material							CHRONIC HEART-FAILURE; DISEASE		[Antony, Renjith; Dargie, Henry J.] Golden Jubilee Natl Hosp, Scottish Adv Heart Failure Serv, Clydebank G81 4HX, W Dunbartonshir, Scotland; [Dargie, Henry J.] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland	Golden Jubilee Hospital; University of Glasgow	Antony, R (corresponding author), Golden Jubilee Natl Hosp, Scottish Adv Heart Failure Serv, Clydebank G81 4HX, W Dunbartonshir, Scotland.	h.dargie@clinmed.gla.ac.uk						Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Chaitman BR, 2006, CIRCULATION, V113, P2462, DOI 10.1161/CIRCULATIONAHA.105.597500; Ciapponi A, 2005, COCHRANE DB SYST REV, V4; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Gavin AD, 2005, HEART, V91, P749, DOI 10.1136/hrt.2004.040477; HEMINGWAY H, 2006, JAMA-J AM MED ASSOC, V295, P404; Hemingway H, 2008, CIRCULATION, V117, P1526, DOI 10.1161/CIRCULATIONAHA.107.720953; Khatib SY, 2001, BIOCHEMISTRY-MOSCOW+, V66, P328, DOI 10.1023/A:1010264216357; Lee L, 2004, EUR HEART J, V25, P634, DOI 10.1016/j.ehj.2004.02.018; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Rose G, 1982, CARDIOVASCULAR SURVE; Timmis AD, 2007, HEART, V93, P786, DOI 10.1136/hrt.2006.103119; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771	13	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2126	2127		10.1016/S0140-6736(10)60578-8	http://dx.doi.org/10.1016/S0140-6736(10)60578-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	617BF	20542555				2022-12-28	WOS:000279255100006
J	Budd, AF; Pandolfi, JM				Budd, Ann F.; Pandolfi, John M.			Evolutionary Novelty Is Concentrated at the Edge of Coral Species Distributions	SCIENCE			English	Article							MONTASTRAEA-ANNULARIS; REEF CORAL; CLIMATE-CHANGE; BIODIVERSITY HOTSPOTS; HYBRIDIZATION; CONSERVATION; SPECIATION; COMPLEX; PLEISTOCENE; POPULATIONS	Conservation priorities are calculated on the basis of species richness, endemism, and threats. However, areas ranked highly for these factors may not represent regions of maximal evolutionary potential. The relationship between geography and evolutionary innovation was analyzed in a dominant complex of Caribbean reef corals, in which morphological and genetic data concur on species differences. Based on geometric morphometrics of Pleistocene corals and genetically characterized modern colonies, we found that morphological disparity varies from the center to the edge of the Caribbean, and we show that lineages are static at well-connected central locations but split or fuse in edge zones where gene flow is limited. Thus, conservation efforts in corals should focus not only on the centers of diversity but also on peripheral areas of species ranges and population connectivity.	[Budd, Ann F.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Ctr Marine Studies, Brisbane, Qld, Australia; [Pandolfi, John M.] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia	University of Iowa; University of Queensland; University of Queensland	Budd, AF (corresponding author), Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA.	ann-budd@uiowa.edu	Pandolfi, John M/A-3121-2009	Pandolfi, John M/0000-0003-3047-6694	NSF [EAR97-25273, DEB-0343208]; Smithsonian Institution Marine Science Network; Smithsonian Tropical Research Institute; Australian Research Council Centre of Excellence	NSF(National Science Foundation (NSF)); Smithsonian Institution Marine Science Network; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Australian Research Council Centre of Excellence(Australian Research Council)	We thank T. Fadiga for assistance with measurements; N. Knowlton and H. Fukami for genetic analyses; and D. Carlon, N. Knowlton, and R. Steneck for comments. The specimens that were analyzed are listed in appendix S1. This research was supported by NSF grants EAR97-25273 and DEB-0343208 to A. F. B. and Smithsonian Institution Marine Science Network and Biodiversity grants, a Smithsonian Tropical Research Institute Tupper Fellowship, and an Australian Research Council Centre of Excellence grant to J.M.P.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Budd AE, 2004, PALEOBIOLOGY, V30, P396, DOI 10.1666/0094-8373(2004)030<0396:OSBAHW>2.0.CO;2; Budd AF, 2001, J PALEONTOL, V75, P527, DOI 10.1666/0022-3360(2001)075<0527:TOAEEO>2.0.CO;2; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chiba S, 2005, EVOLUTION, V59, P1712, DOI 10.1111/j.0014-3820.2005.tb01820.x; Draper G., 1994, CARIBBEAN GEOLOGY IN, P129; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; KNOWLTON N, 1992, SCIENCE, V255, P330, DOI 10.1126/science.255.5042.330; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lister A, 2004, PHILOS T R SOC B, V359, P195; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; MANN P, 1999, SED BAS WOR, V4, P3; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2002, EVOLUTION, V56, P479; Pandolfi JM, 2008, MAR ECOL PROG SER, V369, P89, DOI 10.3354/meps07570; Pandolfi JM, 2007, J PALEONTOL, V81, P472, DOI 10.1666/pleo05046.1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136	35	72	74	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1558	1561		10.1126/science.1188947	http://dx.doi.org/10.1126/science.1188947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558718				2022-12-28	WOS:000278859200046
J	Tisdale, WA; Williams, KJ; Timp, BA; Norris, DJ; Aydil, ES; Zhu, XY				Tisdale, William A.; Williams, Kenrick J.; Timp, Brooke A.; Norris, David J.; Aydil, Eray S.; Zhu, X. -Y.			Hot-Electron Transfer from Semiconductor Nanocrystals	SCIENCE			English	Article							OPTICAL 2ND-HARMONIC GENERATION; COLLOIDAL QUANTUM DOTS; SOLAR-CELLS; DYNAMICS; NANOPARTICLES; SPECTROSCOPY; EFFICIENCY; INTERFACE; SOLIDS; ENERGY	In typical semiconductor solar cells, photons with energies above the semiconductor bandgap generate hot charge carriers that quickly cool before all of their energy can be captured, a process that limits device efficiency. Although fabricating the semiconductor in a nanocrystalline morphology can slow this cooling, the transfer of hot carriers to electron and hole acceptors has not yet been thoroughly demonstrated. We used time-resolved optical second harmonic generation to observe hot-electron transfer from colloidal lead selenide (PbSe) nanocrystals to a titanium dioxide (TiO(2)) electron acceptor. With appropriate chemical treatment of the nanocrystal surface, this transfer occurred much faster than expected. Moreover, the electric field resulting from sub-50-femtosecond charge separation across the PbSe-TiO(2) interface excited coherent vibrations of the TiO(2) surface atoms, whose motions could be followed in real time.	[Tisdale, William A.; Norris, David J.; Aydil, Eray S.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Williams, Kenrick J.; Timp, Brooke A.; Zhu, X. -Y.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Williams, Kenrick J.; Zhu, X. -Y.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Austin	Norris, DJ (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	dnorris@umn.edu; aydil@umn.edu; zhu@cm.utexas.edu	Aydil, Eray/M-5503-2019; Tisdale, William A/E-8466-2012; Norris, David J/F-4022-2010; Selopal, Gurpreet Singh/D-5801-2018	Tisdale, William A/0000-0002-6615-5342; Norris, David J/0000-0002-3765-0678; Aydil, Eray/0000-0002-8377-9480	U.S. Department of Energy [DE-FG02-07ER46468]; NSF Nanoscale Interdisciplinary Research Team (NIRT) [CBET-0506672]; Materials Research Science and Engineering Center (MRSEC) [DMR-0819885]; University of Minnesota	U.S. Department of Energy(United States Department of Energy (DOE)); NSF Nanoscale Interdisciplinary Research Team (NIRT)(National Science Foundation (NSF)); Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	We thank K. S. Leschkies, A. Wolcott, C. Nelson, and G. Haugstad for assistance with PbSe nanocrystal synthesis and atomic force microscopy imaging. This work was supported by the U.S. Department of Energy (DE-FG02-07ER46468). Partial support from the NSF Nanoscale Interdisciplinary Research Team (NIRT) program (CBET-0506672) and the Materials Research Science and Engineering Center (MRSEC) programs (DMR-0819885) in the form of student assistantships to B. A. T. and W. A. T. are acknowledged. W. A. T. received support from a University of Minnesota Doctoral Dissertation Fellowship.	Aktsipetrov OA, 1999, PHYS REV B, V60, P8924, DOI 10.1103/PhysRevB.60.8924; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Anderson NA, 2005, ANNU REV PHYS CHEM, V56, P491, DOI 10.1146/annurev.physchem.55.091602.094347; Blackburn JL, 2005, J PHYS CHEM B, V109, P2625, DOI 10.1021/jp046781y; Chang YM, 1997, PHYS REV LETT, V78, P4649, DOI 10.1103/PhysRevLett.78.4649; CORN RM, 1994, CHEM REV, V94, P107, DOI 10.1021/cr00025a004; HALL RN, 1961, J APPL PHYS, V32, P2078, DOI 10.1063/1.1777021; Heinz T. F., 1991, NONLINEAR SURFACE EL, P353; Hendry E, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.081101; Hyun BR, 2008, ACS NANO, V2, P2206, DOI 10.1021/nn800336b; Jin SY, 2009, NANO LETT, V9, P2448, DOI 10.1021/nl9011744; Johnson JC, 2004, NANO LETT, V4, P197, DOI 10.1021/nl034780w; Lindsay R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246102; Luther JM, 2008, ACS NANO, V2, P271, DOI 10.1021/nn7003348; McArthur EA, 2006, J AM CHEM SOC, V128, P1068, DOI 10.1021/ja056518q; Mukai K, 1999, SEMICONDUCT SEMIMET, V60, P209, DOI 10.1016/S0080-8784(08)62531-4; Nahata A, 1998, OPT LETT, V23, P67, DOI 10.1364/OL.23.000067; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Nozik AJ, 2001, ANNU REV PHYS CHEM, V52, P193, DOI 10.1146/annurev.physchem.52.1.193; Omote M, 2005, J PHYS-CONDENS MAT, V17, pS175, DOI 10.1088/0953-8984/17/8/001; Pandey A, 2008, SCIENCE, V322, P929, DOI 10.1126/science.1159832; Pandey A, 2010, J PHYS CHEM LETT, V1, P45, DOI 10.1021/jz900022z; Prezhdo OV, 2009, PROG SURF SCI, V84, P30, DOI 10.1016/j.progsurf.2008.10.005; Robel I, 2006, J AM CHEM SOC, V128, P2385, DOI 10.1021/ja056494n; ROSS RT, 1982, J APPL PHYS, V53, P3813, DOI 10.1063/1.331124; Schaller RD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196401; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Williams KJ, 2009, ACS NANO, V3, P1532, DOI 10.1021/nn9001819; Wise FW, 2000, ACCOUNTS CHEM RES, V33, P773, DOI 10.1021/ar970220q; Yu D, 2003, SCIENCE, V300, P1277, DOI 10.1126/science.1084424	32	718	725	10	743	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1543	1547		10.1126/science.1185509	http://dx.doi.org/10.1126/science.1185509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558714				2022-12-28	WOS:000278859200042
J	Swain, S; Krause, T; Laramee, P; Stewart, S				Swain, Sharon; Krause, Taryn; Laramee, Phillipe; Stewart, Stephen		Guideline Dev Grp	Guidelines Diagnosis and clinical management of alcohol related physical complications: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							WITHDRAWAL		[Swain, Sharon; Krause, Taryn; Laramee, Phillipe] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England; [Stewart, Stephen] Freeman Rd Hosp, Liver Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	Swain, S (corresponding author), Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England.	Sharon.swain@rcplondon.co.uk		Mortimore, Gerri/0000-0001-6890-4346	National Institute for Health and Clinical Excellence; NIHR-HTA; National Institute for Health Research	National Institute for Health and Clinical Excellence; NIHR-HTA; National Institute for Health Research(National Institute for Health Research (NIHR))	The National Clinical Guideline Centre was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) All of the authors have no financial support for the submitted work from anyone other than their employers; (2) In the previous three years S Stewart has been a member of the trial management group for a study (steroids or pentoxifylline in alcoholic hepatitis) funded by the NIHR-HTA, the Health Technology Assessment programme, which is part of the National Institute for Health Research; (3) All authors have no spouses, partners, or children with financial relationships that may be relevant to the submitted work; and (4) All authors were members of the Guideline Development Group for the NICE guideline (S Swain the systematic reviewer, PL the health economist, TK the project manager, and S Stewart the clinical lead) but have no other non-financial interests that may be relevant to the submitted work.	CARITHERS RL, 1989, ANN INTERN MED, V110, P685, DOI 10.7326/0003-4819-110-9-685; *CTR PUBL HLTH EXC, 2010, ALC US DIS PREV DEV; *CTR PUBL HLTH EXC, ALC US DIS IN PRESS; Department of Health, 2003, COST ALC HARM NHS EN; *INF CTR HLTH SOC, 2009, STAT ALC ENGL; National Institute for Health and Clinical Excellence, 2010, ALC US DIS DIAGN CLI; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; UK Liver Transplant Group, 2005, LIV ADV GROUP ALC GU; Ward D, 2009, QJM-INT J MED, V102, P773, DOI 10.1093/qjmed/hcp116; 2010, BRIT NATL FORMULARLY	10	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c2942	10.1136/bmj.c2942	http://dx.doi.org/10.1136/bmj.c2942			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JB	20554661				2022-12-28	WOS:000279051900003
J	Hopley, C; Stengel, D; Ekkernkamp, A; Wich, M				Hopley, Colin; Stengel, Dirk; Ekkernkamp, Axel; Wich, Michael			Primary total hip arthroplasty versus hemiarthroplasty for displaced intracapsular hip fractures in older patients: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FEMORAL-NECK FRACTURES; RANDOMIZED CONTROLLED-TRIAL; ELDERLY-PATIENTS; INTERNAL-FIXATION; BIPOLAR HEMIARTHROPLASTY; OPERATIVE MANAGEMENT; SUBCAPITAL FRACTURES; INDEPENDENT PATIENTS; VITAMIN-D; REPLACEMENT	Objective To determine whether total hip arthroplasty is associated with lower reoperation rates, mortality, and complications, and better function and quality of life than hemiarthroplasty for displaced fractures of the femoral neck in older patients. Design Systematic review and meta-analysis of randomised trials, quasirandomised trials, and cohort studies. Data sources Medline, Embase, Cochrane register of controlled trials, publishers' databases, and manual search of bibliographies. Study selection Randomised controlled trials, quasirandomised trials, and cohort studies (retrospective and prospective) comparing hemiarthroplasty with total hip arthroplasty for treating displaced femoral neck fractures in patients aged more than 60 years. Data extraction Relative risks, risk differences, and mean differences from each trial, aggregated using random effects models. Analyses were stratified for experimental and non-experimental designs, and two way sensitivity analyses and tests for interaction were done to assess the influence of various criteria of methodological quality on pooled estimates. Data synthesis 3821 references were identified. Of the 202 full papers inspected, 15 were included (four randomised controlled trials, three quasirandomised trials, and eight retrospective cohort studies, totalling 1890 patients). Meta-analysis of 14 studies showed a lower risk of reoperation after total hip arthroplasty compared with hemiarthroplasty (relative risk 0.57, 95% confidence interval 0.34 to 0.96, risk difference 4.4%, 95% confidence interval 0.2% to 8.5%), although this effect was mainly driven by investigations without concealed treatment allocation. Total hip arthroplasty consistently showed better ratings in the Harris hip score (three studies, 246 patients, weighted mean difference 5.4, 95% confidence interval 2.7 to 8.2) after follow-up periods of 12 to 48 months. The standardised mean difference of different scores from five studies was 0.42 (95% confidence interval 0.24 to 0.61), indicating a medium functional advantage of total hip arthroplasty over hemiarthroplasty. Total hip arthroplasty was associated with a slightly higher risk of dislocation (relative risk 1.48, 95% confidence interval 0.89 to 2.46) and general complications (1.14, 0.87 to 1.48). Conclusion Single stage total hip arthroplasty may lead to lower reoperation rates and better functional outcomes compared with hemiarthroplasty in older patients with displaced femoral neck fractures. However, heterogeneity across the available trials and distinct subgroup effects preclude definitive statements and require further research in this area.	[Hopley, Colin] DePuy Int, Leeds LS11 8DT, W Yorkshire, England; [Stengel, Dirk; Ekkernkamp, Axel; Wich, Michael] Unfallkrankenhaus Berlin, Dept Trauma & Orthopaed Surg, Berlin, Germany; [Stengel, Dirk; Ekkernkamp, Axel] Ernst Moritz Arndt Univ Hosp, Dept Trauma & Orthopaed Surg, Greifswald, Germany; [Wich, Michael] Alice Salomon Univ Appl Sci, Berlin, Germany	Johnson & Johnson	Hopley, C (corresponding author), DePuy Int, Leeds LS11 8DT, W Yorkshire, England.	chopley@its.jnj.com	Stengel, Dirk/AAF-6470-2019		DePuy International a Johnson & Johnson company	DePuy International a Johnson & Johnson company	Funding All authors are independent of funders except CH who is an employee of DePuy International, a manufacturer of hip arthroplasty prostheses, which may have a financial interest in the results of this review.; Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) CH has support from DePuy International a Johnson & Johnson company for the submitted work; (2) DS, AE, and MW have no relationships with DePuy International a Johnson & Johnson Company that might have an interest in the submitted work in the previous three years; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) CH, DS, AE, and MW have no non-financial interests that may be relevant to the submitted work.	Abrahamsen B, 2010, OSTEOPOROSIS INT, V21, P373, DOI 10.1007/s00198-009-0957-3; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Baker RP, 2006, J BONE JOINT SURG AM, V88A, P2583, DOI 10.2106/JBJS.E.01373; Berry DJ, 2005, J BONE JOINT SURG AM, V87A, P2456, DOI 10.2106/JBJS.D.02860; Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P2122, DOI 10.2106/JBJS.E.00535; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Blomfeldt R, 2007, J BONE JOINT SURG BR, V89B, P160, DOI 10.1302/0301-620X.89B2.18576; BROOS PLO, 1987, UNFALLCHIRURG, V90, P347; Dawson J, 1996, QUAL HEALTH CARE, V5, P81, DOI 10.1136/qshc.5.2.81; Dawson J, 2001, J BONE JOINT SURG BR, V83B, P1125, DOI 10.1302/0301-620X.83B8.11643; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dodds MK, 2009, OSTEOPOROSIS INT, V20, P2105, DOI 10.1007/s00198-009-0922-1; Dorner T, 2009, WIEN MED WOCHENSCHR, V159, P221, DOI 10.1007/s10354-009-0649-9; Dorr L D, 1986, J Arthroplasty, V1, P21, DOI 10.1016/S0883-5403(86)80006-7; Dzupa V, 2002, Acta Chir Orthop Traumatol Cech, V69, P39; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eklund F, 2009, CALCIFIED TISSUE INT, V85, P10, DOI 10.1007/s00223-009-9265-3; EYSSEL M, 1994, UNFALLCHIRURG, V97, P347; Fisher AA, 2009, BONE, V45, P246, DOI 10.1016/j.bone.2009.04.244; Frihagen F, 2007, BMJ-BRIT MED J, V335, P1251, DOI 10.1136/bmj.39399.456551.25; GEBHARD JS, 1992, CLIN ORTHOP RELAT R, P123; Geiger F, 2006, ORTHOPADE, V35, P651, DOI 10.1007/s00132-006-0930-1; Geiger F, 2007, ARCH ORTHOP TRAUM SU, V127, P959, DOI 10.1007/s00402-007-0423-7; Goh SK, 2009, J ARTHROPLASTY, V24, P400, DOI 10.1016/j.arth.2007.12.009; Haentjens P, 1994, Acta Orthop Belg, V60 Suppl 1, P124; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Healy WL, 2004, CLIN ORTHOP RELAT R, P43, DOI 10.1097/01.blo.0000150273.13949.62; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holt G, 2009, INJURY, V40, P722, DOI 10.1016/j.injury.2008.11.004; HUSSAIN A, 2003, JK PRACT, V10, P4; Icks A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-114; Iwamoto J, 2008, CLIN INTERV AGING, V3, P483, DOI 10.2147/CIA.S3177; Jackson C, 2007, QJM-INT J MED, V100, P185, DOI 10.1093/qjmed/hcm005; JOHANSON NA, 1992, J BONE JOINT SURG AM, V74A, P587, DOI 10.2106/00004623-199274040-00015; Jorgensen EB, 2008, KAIS, V2021, P1, DOI [DOI 10.1002/14651858.CD001155.PUB2, 10.1002/mp.15257]; Kakar S, 2007, J TRAUMA, V63, P641, DOI 10.1097/01.ta.0000249296.55245.97; Keating JF, 2006, J BONE JOINT SURG AM, V88A, P249, DOI 10.2106/JBJS.E.00215; Keating JF, 2005, HEALTH TECHNOL ASSES, V9, P1; Levi N, 1996, INJURY, V27, P565, DOI 10.1016/S0020-1383(96)00077-0; Macaulay W, 2008, J ARTHROPLASTY, V23, P2, DOI 10.1016/j.arth.2008.05.013; Macaulay William, 2008, HSS J, V4, P48, DOI 10.1007/s11420-007-9061-4; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Mouzopoulos G, 2008, INT ORTHOP, V32, P367, DOI 10.1007/s00264-007-0321-1; Narayan KK, 2006, ARCH ORTHOP TRAUM SU, V126, P545, DOI 10.1007/s00402-006-0182-x; Nieves JW, 2010, OSTEOPOROSIS INT, V21, P399, DOI 10.1007/s00198-009-0962-6; Oliver D, 2007, BRIT MED J, V334, P82, DOI 10.1136/bmj.39049.706493.55; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub3; Parker MJ, 2006, COCHRANE DB SYST REV, V2; Ravikumar KJ, 2000, INJURY, V31, P793, DOI 10.1016/S0020-1383(00)00125-X; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; Rogmark C, 2006, ACTA ORTHOP, V77, P359, DOI 10.1080/17453670610046262; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sayana MK, 2008, ACTA ORTHOP BELG, V74, P54; Schleicher I, 2003, UNFALLCHIRURG, V106, P467, DOI 10.1007/s00113-003-0597-6; Scottish Intercollegiate Guidelines Network, 2009, MAN HIP FRACT OLD PE; Sirois MJ, 2009, J TRAUMA, V66, P1402, DOI 10.1097/TA.0b013e31818cc1cc; SKINNER P, 1989, INJURY, V20, P291, DOI 10.1016/0020-1383(89)90171-X; Squires B, 1999, INJURY, V30, P345, DOI 10.1016/S0020-1383(99)00097-2; Tsang SWY, 2009, OSTEOPOROSIS INT, V20, P1939, DOI 10.1007/s00198-009-0906-1; Xu Xinxiang, 2002, Chin J Traumatol, V5, P28	64	147	154	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2010	340								c2332	10.1136/bmj.c2332	http://dx.doi.org/10.1136/bmj.c2332			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611MH	20543010	hybrid			2022-12-28	WOS:000278818900001
J	Holmes, EC				Holmes, Edward C.			Helping the Resistance	SCIENCE			English	Editorial Material							OSELTAMIVIR; VIRUSES		[Holmes, Edward C.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Holmes, EC (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	ech15@psu.edu	Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022	Holmes, Edward/0000-0001-9596-3552; 				Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Ciancio BC, 2009, EUROSURVEILLANCE, V14, P13; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Kramarz P, 2009, EUROSURVEILLANCE, V14; Lackenby A., 2008, Eurosurveillance, V13, P8026; Nicoll A., 2008, EUROSURVEILLANCE, V13, P8025, DOI [10.2807/ese.13.05.08025-en, DOI 10.2807/ESE.13.05.08025-EN]; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103	8	12	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1243	1244		10.1126/science.1190994	http://dx.doi.org/10.1126/science.1190994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522766				2022-12-28	WOS:000278318600023
J	Scully, MO; Svidzinsky, AA				Scully, Marlan O.; Svidzinsky, Anatoly A.			The Lamb Shift-Yesterday, Today, and Tomorrow	SCIENCE			English	Editorial Material							SUPERRADIANCE; EMISSION		[Scully, Marlan O.] Texas A&M Univ, College Stn, TX 77843 USA; [Svidzinsky, Anatoly A.] Princeton Univ, Princeton, NJ 08544 USA	Texas A&M University System; Texas A&M University College Station; Princeton University	Scully, MO (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	scully@tamu.edu						Adams BW, 2009, J MOD OPTIC, V56, P1974, DOI 10.1080/09500340903199921; BETHE HA, 1947, PHYS REV, V72, P339, DOI 10.1103/PhysRev.72.339; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Dirac PAM, 1927, P R SOC LOND A-CONTA, V114, P243, DOI 10.1098/rspa.1927.0039; Friedberg R., 1973, Physics Reports. Physics Letters Section C, V7c, P101, DOI 10.1016/0370-1573(73)90001-X; Friedberg R, 2010, ANN PHYS-NEW YORK, V325, P345, DOI 10.1016/j.aop.2009.10.003; GARRETT WR, 1990, PHYS REV LETT, V64, P1717, DOI 10.1103/PhysRevLett.64.1717; HANSCH TW, 1975, PHYS REV LETT, V34, P307, DOI 10.1103/PhysRevLett.34.307; Kramers H. A., 1938, NUOVO CIMENTO, V15, P108; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; Oppenheimer JR, 1930, PHYS REV, V35, P0461, DOI 10.1103/PhysRev.35.461; PRASAD S, 1985, PHYS REV A, V31, P1583, DOI 10.1103/PhysRevA.31.1583; Rohlsberger R, 2010, SCIENCE, V328, P1248, DOI 10.1126/science.1187770; Scully MO, 2007, LASER PHYS, V17, P635, DOI 10.1134/S1054660X07050064; Scully MO, 2009, SCIENCE, V325, P1510, DOI 10.1126/science.1176695; Scully MO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.143601; Svidzinsky AA, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.053821; TRIEBWASSER S, 1953, PHYS REV, V89, P98, DOI 10.1103/PhysRev.89.98; van Burck U, 1999, HYPERFINE INTERACT, V123, P483, DOI 10.1023/A:1017080008712	19	66	66	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1239	1241		10.1126/science.1190737	http://dx.doi.org/10.1126/science.1190737			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522764				2022-12-28	WOS:000278318600021
J	Marso, SP; Amin, AP; House, JA; Kennedy, KF; Spertus, JA; Rao, SV; Cohen, DJ; Messenger, JC; Rumsfeld, JS				Marso, Steven P.; Amin, Amit P.; House, John A.; Kennedy, Kevin F.; Spertus, John A.; Rao, Sunil V.; Cohen, David J.; Messenger, John C.; Rumsfeld, John S.		Natl Cardiovasc Data Registry	Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITION; EARLY INVASIVE MANAGEMENT; PROPENSITY SCORE; CARDIAC-CATHETERIZATION; ECONOMIC-EVALUATION; AMERICAN-COLLEGE; BIVALIRUDIN; PREDICTORS; IMPACT; HEPARIN	Context Bleeding complications with percutaneous coronary intervention (PCI) are associated with adverse patient outcomes. The association between the use of bleeding avoidance strategies and post-PCI bleeding as a function of a patient's preprocedural risk of bleeding is unknown. Objective To describe the use of 2 bleeding avoidance strategies, vascular closure devices and bivalirudin, and associated post-PCI bleeding rates in a nationally representative PCI population. Design, Setting, and Patients Analysis of data from 1 522 935 patients undergoing PCI procedures performed at 955 US hospitals participating in the National Cardiovascular Data Registry (NCDR) CathPCI Registry from January 1, 2004, through September 30, 2008. Main Outcome Measure Periprocedural bleeding. Results Bleeding occurred in 30 654 patients (2%). Manual compression, vascular closure devices, bivalirudin, or vascular closure devices plus bivalirudin were used in 35%, 24%, 23%, and 18% of patients, respectively. Bleeding events were reported in 2.8% of patients who received manual compression, compared with 2.1%, 1.6%, and 0.9% of patients receiving vascular closure devices, bivalirudin, and both strategies, respectively (P<.001). Bleeding rates differed by preprocedural risk assessed with the NCDR bleeding risk model (low risk, 0.72%; intermediate risk, 1.73%; high risk, 4.69%). In high-risk patients, use of both strategies was associated with lower bleeding rates (manual compression, 6.1%; vascular closure devices, 4.6%; bivalirudin, 3.8%; vascular closure devices plus bivalirudin, 2.3%; P<.001). This association persisted following adjustment using a propensity-matched and site-controlled model. Use of both strategies was used least often in high-risk patients (14.4% vs 21.0% in low-risk patients, P<.001). Conclusions In a large national PCI registry, vascular closure devices and bivalirudin were associated with significantly lower bleeding rates, particularly among patients at greatest risk for bleeding. However, these strategies were less often used among higher-risk patients. JAMA. 2010; 303(21): 2156-2164	[Marso, Steven P.; Amin, Amit P.; House, John A.; Kennedy, Kevin F.; Spertus, John A.; Cohen, David J.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Rao, Sunil V.] Duke Clin Res Inst, Durham, NC USA; [Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Denver, CO 80202 USA; [Messenger, John C.; Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Duke University; University of Colorado System; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Marso, SP (corresponding author), Univ Missouri, St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	smarso@saint-lukes.org	Spertus, John/ABD-3075-2021		American Diabetes Association; Amylin Pharmaceuticals; Boston Scientific; Medicines Company; Volcano Corporation; Terumo Corporation; National Institutes of Health; American College of Cardiology Foundation; American Heart Association; Amgen; Lilly; Bristol-Myers Squibb/Sanofi-Aventis; EvaHeart; Cordis Corporation; Atherotech; Roche Diagnostics; Momenta Pharmaceuticals; Portola Pharmaceuticals; Schering-Plough; Eli Lilly; Daichi Sankyo; Pfizer; Medtronic; Sanofi-Aventis; Society for Cardiac Angiography and Interventions	American Diabetes Association(American Diabetes Association); Amylin Pharmaceuticals(Bristol-Myers Squibb); Boston Scientific(Boston Scientific); Medicines Company; Volcano Corporation; Terumo Corporation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Cardiology Foundation(General Electric); American Heart Association(American Heart Association); Amgen(Amgen); Lilly(Eli Lilly); Bristol-Myers Squibb/Sanofi-Aventis(Sanofi-AventisBristol-Myers Squibb); EvaHeart; Cordis Corporation; Atherotech; Roche Diagnostics; Momenta Pharmaceuticals; Portola Pharmaceuticals; Schering-Plough(Merck & CompanySchering Plough Corporation); Eli Lilly(Eli Lilly); Daichi Sankyo; Pfizer(Pfizer); Medtronic(Medtronic); Sanofi-Aventis(Sanofi-Aventis); Society for Cardiac Angiography and Interventions	Dr Marso reported receiving research support from the American Diabetes Association, Amylin Pharmaceuticals, Boston Scientific, The Medicines Company, Volcano Corporation, and Terumo Corporation and serving as a consultant for Abbott Vascular, NovoNordisk, Volcano Corporation, and The Medicines Company. Mr House reported receiving consulting fees from Volcano Corporation. Dr Spertus reported receiving research funding from the National Institutes of Health, American College of Cardiology Foundation, American Heart Association, Amgen, Lilly, Bristol-Myers Squibb/Sanofi-Aventis, EvaHeart, and Cordis Corporation; receiving in-kind research support from Atherotech and Roche Diagnostics; serving as a consultant for United Healthcare, St Jude Medical, and Amgen; serving as a copyright holder of the Seattle Angina Questionnaire, the Kansas City Cardiomyopathy Questionnaire, and the Peripheral Artery Questionnaire; having equity ownership in Health Outcomes Sciences; and holding a patent on the PRISM technology, which executes multivariable models at the point of clinical care. Dr Rao reported receiving research support from Momenta Pharmaceuticals, Portola Pharmaceuticals, and Cordis Corporation and serving as a consultant for Bristol-Myers Squibb, Sanofi-Aventis, The Medicines Company, AstraZeneca, and Terumo Corporation. Dr Cohen reported receiving research support from The Medicines Company, Schering-Plough, Eli Lilly, and Daichi Sankyo; serving as a consultant for Schering-Plough and Eli Lilly; and receiving speaking honoraria from The Medicines Company, Eli Lilly, and St Jude Medical. Dr Messenger reported receiving research support from Pfizer, Medtronic, and Sanofi-Aventis. Dr Rumsfeld reported receiving salary support for the position of chief science officer for the NCDR. No other authors reported financial disclosures.; The views expressed in this article represent those of the authors and do not necessarily represent the American College of Cardiology Foundation or the Society for Cardiac Angiography and Interventions, which cosponsor the National Cardiovascular Data Registry.	*AG HEALTHC RES QU, DAT REL TOOLS HEALTH; Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; [Anonymous], 2008, CATHPCI REG COMP GUI; ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; Aronow HD, 2001, AM HEART J, V142, P799, DOI 10.1067/mhj.2001.119371; Arora N, 2007, AM HEART J, V153, P606, DOI 10.1016/j.ahj.2006.12.014; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1202, DOI 10.1002/pds.1673; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Chatellier G, 1996, BRIT MED J, V312, P426; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; *CTR MED MED SERV, DET MED AC CAR EP AC; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026; Grantham JA, 2009, JACC-CARDIOVASC INTE, V2, P479, DOI 10.1016/j.jcin.2009.02.008; Halon DA, 2004, J AM COLL CARDIOL, V43, P346, DOI 10.1016/j.jacc.2003.08.044; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Kirtane AJ, 2006, J AM COLL CARDIOL, V47, P2374, DOI 10.1016/j.jacc.2005.09.080; Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lincoff AM, 2004, AM J CARDIOL, V93, P1092, DOI 10.1016/j.amjcard.2004.01.033; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; McAlister FA, 2007, ARCH INTERN MED, V167, P1019, DOI 10.1001/archinte.167.10.1019; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; National Priorities Partnership, 2008, NAT PRIOR GOALS AL O; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; Pinto DS, 2008, J AM COLL CARDIOL, V52, P1758, DOI 10.1016/j.jacc.2008.08.021; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Sanborn TA, 2010, CIRC-CARDIOVASC INTE, V3, P57, DOI 10.1161/CIRCINTERVENTIONS.109.896704; Segev A, 2005, AM HEART J, V150, P690, DOI 10.1016/j.ahj.2004.11.012; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; SPERTUS JA, 1995, ARCH INTERN MED, V155, P2309, DOI 10.1001/archinte.155.21.2309; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Tavris Dale R, 2005, J Invasive Cardiol, V17, P644; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yan AT, 2009, ARCH INTERN MED, V169, P372, DOI 10.1001/archinternmed.2008.563	49	232	236	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2156	2164		10.1001/jama.2010.708	http://dx.doi.org/10.1001/jama.2010.708			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516416	Bronze			2022-12-28	WOS:000278182100024
J	Ferner, RE; Lenney, W; Marriott, JF				Ferner, R. E.; Lenney, Warren; Marriott, John F.			Controversy over generic substitution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUGS; BIOEQUIVALENCE; ADHERENCE		[Ferner, R. E.] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England; [Ferner, R. E.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Lenney, Warren] Univ Hosp N Staffordshire, Acad Dept Child Hlth, Stoke On Trent ST4 6QG, Staffs, England; [Lenney, Warren] Keele Univ, Stoke On Trent ST4 6QG, Staffs, England; [Marriott, John F.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Birmingham; University of Birmingham; Keele University; Keele University; Aston University	Ferner, RE (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	r.e.ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346	GlaxoSmithKline; Novartis; Astra Zeneca; Abbott	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Astra Zeneca(AstraZeneca); Abbott(Abbott Laboratories)	Competing interests: All authors have completed the unified competing interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare (1) no financial support for the submitted work from anyone other than their employer; (2) WL has received research grants, lecture fees, or travel expenses for meetings from GlaxoSmithKline, Novartis, Astra Zeneca, and Abbott; (3) no spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; and (4) REF chairs a healthcare-wide drug and therapeutics committee that encourages generic prescribing.	Borgherini G, 2003, CLIN THER, V25, P1578, DOI 10.1016/S0149-2918(03)80157-1; Briesacher BA, 2009, AM J MANAG CARE, V15, P450; *DAN MED AG, BIOEQ LAB MED PROD R; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; Department of Health, 2009, PROP IMPL GEN SUBST; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; *FOOD DRUG ADM, 2010, GEN COMP DRUG PRIC; Kalisch LM, 2008, PHARMACOEPIDEM DR S, V17, P620, DOI 10.1002/pds.1580; Kanazawa S, 2001, EUR J CLIN PHARMACOL, V56, P799, DOI 10.1007/s002280000229; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; McCartney M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1514; *UK DEP HLTH ASS B, 2009, PHARM PRIC REG SCHEM; Vogler S., 2008, PHARM PRICING REIMBU; Vrijens B, 2008, BMJ-BRIT MED J, V336, P1114, DOI 10.1136/bmj.39553.670231.25; WELLING PG, 1977, ANTIMICROB AGENTS CH, V11, P462, DOI 10.1128/AAC.11.3.462	16	32	32	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2010	340								c2548	10.1136/bmj.c2548	http://dx.doi.org/10.1136/bmj.c2548			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BK	20516014				2022-12-28	WOS:000278556300002
J	Hudson, B				Hudson, Ben			10 Minute Consultation Vitamin B-12 deficiency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch 8140, New Zealand	University of Otago	Hudson, B (corresponding author), Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch 8140, New Zealand.	ben.hudson@otago.ac.nz		Hudson, Ben/0000-0002-2794-8876				Galloway M, 2007, BMJ-BRIT MED J, V335, P884, DOI 10.1136/bmj.39325.689641.471; Hvas AM, 2006, HAEMATOLOGICA, V91, P1506	2	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2010	340								c2305	10.1136/bmj.c2305	http://dx.doi.org/10.1136/bmj.c2305			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BK	20516005				2022-12-28	WOS:000278556300001
J	Nakakuki, T; Birtwistle, MR; Saeki, Y; Yumoto, N; Ide, K; Nagashima, T; Brusch, L; Ogunnaike, BA; Okada-Hatakeyama, M; Kholodenko, BN				Nakakuki, Takashi; Birtwistle, Marc R.; Saeki, Yuko; Yumoto, Noriko; Ide, Kaori; Nagashima, Takeshi; Brusch, Lutz; Ogunnaike, Babatunde A.; Okada-Hatakeyama, Mariko; Kholodenko, Boris N.			Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics	CELL			English	Article							IMMEDIATE-EARLY GENE; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; SERUM RESPONSE FACTOR; ERK PHOSPHORYLATION; TRANSCRIPTION; TRANSDUCTION; PHOSPHATASE; SEQUENCE; HORMONE	Activation of ErbB receptors by epidermal growth factor (EGF) or heregulin (HRG) determines distinct cell-fate decisions, although signals propagate through shared pathways. Using mathematical modeling and experimental approaches, we unravel how HRG and EGF generate distinct, all-or-none responses of the phosphorylated transcription factor c-Fos. In the cytosol, EGF induces transient and HRG induces sustained ERK activation. In the nucleus, however, ERK activity and c-fos mRNA expression are transient for both ligands. Knockdown of dual-specificity phosphatases extends HRG-stimulated nuclear ERK activation, but not c-fos mRNA expression, implying the existence of a HRG-induced repressor of c-fos transcription. Further experiments confirmed that this repressor is mainly induced by HRG, but not EGF, and requires new protein synthesis. We show how a spatially distributed, signaling-transcription cascade robustly discriminates between transient and sustained ERK activities at the c-Fos system level. The proposed control mechanisms are general and operate in different cell types, stimulated by various ligands.	[Nakakuki, Takashi; Saeki, Yuko; Yumoto, Noriko; Ide, Kaori; Nagashima, Takeshi; Okada-Hatakeyama, Mariko] RIKEN Adv Sci Inst, Adv Computat Sci Dept, Computat Syst Biol Res Grp, Kanagawa 2300045, Japan; [Birtwistle, Marc R.; Kholodenko, Boris N.] Univ Coll Dublin, Dublin 4, Ireland; [Birtwistle, Marc R.; Ogunnaike, Babatunde A.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA; [Birtwistle, Marc R.; Kholodenko, Boris N.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Saeki, Yuko; Yumoto, Noriko; Nagashima, Takeshi; Okada-Hatakeyama, Mariko] RIKEN Res Ctr Allergy & Immunol, Lab Cellular Syst Modeling, Yokohama, Kanagawa 2300045, Japan; [Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany	RIKEN; University College Dublin; University of Delaware; Jefferson University; RIKEN; Technische Universitat Dresden	Okada-Hatakeyama, M (corresponding author), RIKEN Adv Sci Inst, Adv Computat Sci Dept, Computat Syst Biol Res Grp, 1-7-22 Tsurumi Ku, Kanagawa 2300045, Japan.	marikoh@rcai.riken.jp; boris.kholodenko@ucd.ie	Ogunnaike, Babatunde/A-4894-2008; Admin, SBI/HGB-2738-2022	Ogunnaike, Babatunde/0000-0002-8246-070X; Kholodenko, Boris/0000-0002-9483-4975; Birtwistle, Marc/0000-0002-0341-0705; Birtwistle, Marc/0000-0003-0415-6523	Science Foundation Ireland [06/CE/B1129]; National Institutes of Health [GM059570]; Marie Curie International Incoming Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059570] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Incoming Fellowship(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rony Seger and Walter Kolch for helpful discussions. Parameter estimation was performed with the RIKEN Super Combined Cluster system. This work was supported in part by Science Foundation Ireland under grant number 06/CE/B1129, National Institutes of Health grant GM059570, and a Marie Curie International Incoming Fellowship (for M.R.B.).	Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; CHARLES CH, 1992, ONCOGENE, V7, P187; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 1997, FEBS LETT, V414, P430, DOI 10.1016/S0014-5793(97)01018-1; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; KIMURA S, 2003, INT C SYST MAN CYB; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Ogunnaike B., 1994, PROCESS DYNAMICS MOD, V1; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; SARIBAN E, 1988, MOL CELL BIOL, V8, P340, DOI 10.1128/MCB.8.1.340; Sauro HM, 2004, PROG BIOPHYS MOL BIO, V86, P5, DOI 10.1016/j.pbiomolbio.2004.03.002; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SUPERTIFURGA G, 1991, P NATL ACAD SCI USA, V88, P5114, DOI 10.1073/pnas.88.12.5114; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	41	162	164	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					884	896		10.1016/j.cell.2010.03.054	http://dx.doi.org/10.1016/j.cell.2010.03.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20493519	Bronze, Green Accepted			2022-12-28	WOS:000278132900022
J	Lam, CK; Yoo, T; Hiner, B; Liu, ZQ; Grutzendler, J				Lam, Carson K.; Yoo, Taehwan; Hiner, Bennett; Liu, Zhiqiang; Grutzendler, Jaime			Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization	NATURE			English	Article							BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; MATRIX METALLOPROTEINASES; ALZHEIMERS-DISEASE; IN-VIVO; VESSELS; STROKE; CAPILLARIES; ISCHEMIA; DECLINE	Cerebral microvascular occlusion is a common phenomenon throughout life 1,2 that might require greater recognition as a mechanism of brain pathology. Failure to recanalize microvessels promptly may lead to the disruption of brain circuits and significant functional deficits(3). Haemodynamic forces and the fibrinolytic system(4) are considered to be the principal mechanisms responsible for recanalization of occluded cerebral capillaries and terminal arterioles. Here we identify a previously unrecognized cellular mechanism that may also be critical for this recanalization. By using high-resolution fixed-tissue microscopy and two-photon imaging in living mice we observed that a large fraction of microemboli infused through the internal carotid artery failed to be lysed or washed out within 48 h. Instead, emboli were found to translocate outside the vessel lumen within 2-7 days, leading to complete re-establishment of blood flow and sparing of the vessel. Recanalization occurred by a previously unknown mechanism of microvascular plasticity involving the rapid envelopment of emboli by endothelial membrane projections that subsequently form a new vessel wall. This was followed by the formation of an endothelial opening through which emboli translocated into the perivascular parenchyma. The rate of embolus extravasation was significantly decreased by pharmacological inhibition of matrix metalloproteinase 2/9 activity. In aged mice, extravasation was markedly delayed, resulting in persistent tissue hypoxia, synaptic damage and cell death. Alterations in the efficiency of the protective mechanism that we have identified may have important implications in microvascular pathology, stroke recovery and age-related cognitive decline.	[Lam, Carson K.; Yoo, Taehwan; Hiner, Bennett; Liu, Zhiqiang; Grutzendler, Jaime] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Grutzendler, J (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	grutzj@northwestern.edu	Grutzendler, Jaime/F-3691-2010	Lam, Carson/0000-0002-8255-4423	National Institutes of Health/National Institute on Aging [AG027855]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [R01AG027855] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Lo, C. Freitas, D. Choi and C. Whiteus for help with experiments; A. Schain for suggesting the use of ACTB-eGFP mice; E. Mugnaini for advice with transmission electron microscopy experiments; and G. D'avossa, J. Garcia-Anoveros, J. Kessler and P. Opal for helpful discussions and critical review of the manuscript. This work was supported by National Institutes of Health/National Institute on Aging grant AG027855 (J.G.) and a Howard Hughes Medical Institute medical student research fellowship ( C. K. L.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; GLEERUP G, 1995, ANGIOLOGY, V46, P715, DOI 10.1177/000331979504600810; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; LEVIN EG, 1994, AM J PATHOL, V144, P855; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; MARKUS HS, 1995, BRAIN, V118, P1005, DOI 10.1093/brain/118.4.1005; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393; Rapp JH, 2000, J VASC SURG, V32, P68, DOI 10.1067/mva.2000.107315; SIEBLER M, 1994, NEUROLOGY, V44, P615, DOI 10.1212/WNL.44.4.615; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; ZLOKOVIC BV, 1995, NEUROSURGERY, V37, P955, DOI 10.1227/00006123-199511000-00015	30	115	121	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					478	U101		10.1038/nature09001	http://dx.doi.org/10.1038/nature09001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505729	Green Accepted			2022-12-28	WOS:000278043700035
J	Luzuriaga, K; Sullivan, JL				Luzuriaga, Katherine; Sullivan, John L.			Infectious Mononucleosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPSTEIN-BARR-VIRUS; CD8(+) T-CELLS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; DOUBLE-BLIND; HETEROPHILE ANTIBODY; UNIVERSITY-STUDENTS; EBV INFECTION; YOUNG-ADULTS; IN-VIVO; PHARYNGITIS	A 16-year-old, previously healthy girl presents with a several-day history of fever, sore throat, and malaise. She appears very tired and has a temperature of 39 C. A physical examination is remarkable for diffuse pharyngeal erythema with moderately enlarged tonsils and the presence of several enlarged, tender anterior and posterior cervical lymph nodes. How should this case be managed?	[Luzuriaga, Katherine; Sullivan, John L.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; [Luzuriaga, Katherine; Sullivan, John L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Sullivan, John L.] Univ Massachusetts, Sch Med, Off Vice Provost Res, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Luzuriaga, K (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, 373 Plantat St,Suite 318, Worcester, MA 01605 USA.	katherine.luzuriaga@umassmed.edu			Tibotec	Tibotec	Dr. Luzuriaga reports receiving consulting fees and grant support from Tibotec. No other potential conflicts of interest relevant to this article are reported.	Alcaide ML, 2007, INFECT DIS CLIN N AM, V21, P847, DOI 10.1016/j.idc.2007.07.008; Alcaide ML, 2007, INFECT DIS CLIN N AM, V21, P449, DOI 10.1016/j.idc.2007.03.001; Balfour HH, 2007, J CLIN VIROL, V39, P16, DOI 10.1016/j.jcv.2007.02.002; Balfour HH, 2005, J INFECT DIS, V192, P1505, DOI 10.1086/491740; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Bolden K J, 1972, J R Coll Gen Pract, V22, P87; Buchwald DS, 2000, AM J MED, V109, P531, DOI 10.1016/S0002-9343(00)00560-X; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Candy B, 2006, COCHRANE DB SYST REV, V3; Catalina MD, 2001, J IMMUNOL, V167, P6045; Catalina MD, 2001, J IMMUNOL, V167, P4450, DOI 10.4049/jimmunol.167.8.4450; *CDCP, EPSTEINBARR VIR INF; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cohen JI, 2005, EPSTEIN-BARR VIRUS, P35; Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400; Ebell MH, 2004, AM FAM PHYSICIAN, V70, P1279; Filipovich Alexandra H, 2009, Hematology Am Soc Hematol Educ Program, P127, DOI 10.1182/asheducation-2009.1.127; Grose C, 1985, PEDIAT REV, V7, P35, DOI DOI 10.1542/PIR.7-2-35; Hadinoto V, 2008, BLOOD, V111, P1420, DOI 10.1182/blood-2007-06-093278; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Hochberg D, 2004, J VIROL, V78, P5194, DOI 10.1128/JVI.78.10.5194-5204.2004; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; Hoshino Y, 2009, J VIROL, V83, P11857, DOI 10.1128/JVI.01005-09; Hurt C, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.12.011; Imashuku S, 2003, MED PEDIATR ONCOL, V41, P103, DOI 10.1002/mpo.10314; Ishii E, 2007, INT J HEMATOL, V86, P58, DOI 10.1532/IJH97.07012; Jenson Hal B., 2004, Curr Infect Dis Rep, V6, P200, DOI 10.1007/s11908-004-0009-2; Jenson HB, 2000, CURR OPIN PEDIATR, V12, P263, DOI 10.1097/00008480-200006000-00016; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; KLEIN E, 1969, J AMER COLL HEALTH A, V17, P446; Leigh Randi, 2009, Curr Infect Dis Rep, V11, P449, DOI 10.1007/s11908-009-0065-8; Lunemann JD, 2009, TRENDS IMMUNOL, V30, P243, DOI 10.1016/j.it.2009.03.007; Luzuriaga K., 2009, Clinical virology, P521; Maakaroun NR, 2010, REV MED VIROL, V20, P93, DOI 10.1002/rmv.638; Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456; Nagy N, 2010, IMMUNOL LETT, V130, P13, DOI 10.1016/j.imlet.2010.01.002; Precopio ML, 2003, J IMMUNOL, V170, P2590, DOI 10.4049/jimmunol.170.5.2590; Putukian M, 2008, CLIN J SPORT MED, V18, P309, DOI 10.1097/JSM.0b013e31817e34f8; Rea T D, 2001, J Am Board Fam Pract, V14, P234; Rider LG, 2009, NEW ENGL J MED, V360, P1540; Roy M, 2004, ARCH PEDIAT ADOL MED, V158, P250, DOI 10.1001/archpedi.158.3.250; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; Souza TA, 2005, P NATL ACAD SCI USA, V102, P18093, DOI 10.1073/pnas.0509311102; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Vidrih JA, 2001, AM J MED, V111, P192, DOI 10.1016/S0002-9343(01)00804-X; Walensky RP, 2001, CLIN INFECT DIS, V33, P570, DOI 10.1086/321903	52	296	335	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1993	2000		10.1056/NEJMcp1001116	http://dx.doi.org/10.1056/NEJMcp1001116			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601JI	20505178				2022-12-28	WOS:000278054000007
J	Lachapelle, J; Gilbert, L; Artho, G; Alcindor, T; Amre, R; Arseneau, J; Foulkes, WD				Lachapelle, Jonathan; Gilbert, Lucy; Artho, Giovanni; Alcindor, Thierry; Amre, Ramila; Arseneau, Jocelyne; Foulkes, William D.			Colonic or coelomic?	LANCET			English	Editorial Material							BRCA2 MUTATION; PERITONEAL; OVARIAN		[Lachapelle, Jonathan; Amre, Ramila; Arseneau, Jocelyne] McGill Univ, Ctr Hlth, Dept Pathol, Montreal, PQ H2W 1S6, Canada; [Gilbert, Lucy] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H2W 1S6, Canada; [Artho, Giovanni] McGill Univ, Ctr Hlth, Dept Diagnost Radiol, Montreal, PQ H2W 1S6, Canada; [Alcindor, Thierry] McGill Univ, Ctr Hlth, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Foulkes, William D.] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Foulkes, WD (corresponding author), McGill Univ, Program Canc Genet, Dept Oncol, Gerald Bronfman Ctr Clin Res Oncol, 546 Pine Ave W, Montreal, PQ H2W 1S6, Canada.	William.foulkes@mcgill.ca	Foulkes, William D./AAR-9586-2021; Gilbert, Lucy/M-6879-2019	Foulkes, William D./0000-0001-7427-4651; Gilbert, Lucy/0000-0001-8605-5472				Barda G, 2004, AM J OBSTET GYNECOL, V190, P1039, DOI 10.1016/j.ajog.2003.09.073; Chand Manish, 2007, World J Surg Oncol, V5, P102, DOI 10.1186/1477-7819-5-102; Finch A, 2006, JAMA-J AM MED ASSOC, V296, P185, DOI 10.1001/jama.296.2.185; MCDEVITT T, 2009, EUR HUM GEN C MAY 23; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1844	1844		10.1016/S0140-6736(10)60411-4	http://dx.doi.org/10.1016/S0140-6736(10)60411-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603NY	20494731				2022-12-28	WOS:000278216500035
J	Strang, J; Metrebian, N; Lintzeris, N; Potts, L; Carnwath, T; Mayet, S; Williams, H; Zador, D; Evers, R; Groshkova, T; Charles, V; Martin, A; Forzisi, L				Strang, John; Metrebian, Nicola; Lintzeris, Nicholas; Potts, Laura; Carnwath, Tom; Mayet, Soraya; Williams, Hugh; Zador, Deborah; Evers, Richard; Groshkova, Teodora; Charles, Vikki; Martin, Anthea; Forzisi, Luciana			Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial	LANCET			English	Article							DEPENDENT DRUG-USERS; ASSISTED TREATMENT; OPIOID DEPENDENCE; ILLICIT HEROIN; MAINTENANCE; PRESCRIPTION; FEASIBILITY; MANAGEMENT; DOCTORS	Background Some heroin addicts persistently fail to benefit from conventional treatments. We aimed to compare the effectiveness of supervised injectable treatment with medicinal heroin (diamorphine or diacetylmorphine) or supervised injectable methadone versus optimised oral methadone for chronic heroin addiction. Methods In this multisite, open-label, randomised controlled trial, we enrolled chronic heroin addicts who were receiving conventional oral treatment (>= 6 months), but continued to inject street heroin regularly (>= 50% of days in preceding 3 months). Randomisation by minimisation was used to assign patients to receive supervised injectable methadone, supervised injectable heroin, or optimised oral methadone. Treatment was provided for 26 weeks in three supervised injecting clinics in England. Primary outcome was 50% or more of negative specimens for street heroin on weekly urinalysis during weeks 14-26. Primary analysis was by intention to treat; data were adjusted for centre, regular crack use at baseline, and treatment with optimised oral methadone at baseline. Percentages were calculated with Rubin's rules and were then used to estimate numbers of patients in the multiple imputed samples. This study is registered, ISRCTN01338071. Findings Of 301 patients screened, 127 were enrolled and randomly allocated to receive injectable methadone (n=42 patients), injectable heroin (n=43), or oral methadone (n=42); all patients were included in the primary analysis. At 26 weeks, 80% (n=101) patients remained in assigned treatment: 81% (n=34) on injectable methadone, 88% (n=38) on injectable heroin, and 69% (n=29) on oral methadone. Patients on injectable heroin were significantly more likely to have achieved the primary outcome (72% [n=31]) than were those on oral methadone (27% [n=11], OR 7.42,95% CI 2.69-20.46, p<0.0001; adjusted: 66% [n=28] vs 19% [n=8], 8.17, 2.88-23.16, p<0.0001), with number needed to treat of 2.17 (95% CI 1.60-3.97). For injectable methadone (39% [n=16]; adjusted: 30% [n=14]) versus oral methadone, the difference was not significant (OR 1.74,95% CI 0.66-4.60, p=0.264; adjusted: 1.79, 0.67-4.82, p=0.249). For injectable heroin versus injectable methadone, a significant difference was recorded (4 26, 1.63-11.14, p=0.003; adjusted: 4.57, 1.71-12.19, p=0.002), but the study was not powered for this comparison. Differences were evident within the first 6 weeks of treatment. Interpretation Treatment with supervised injectable heroin leads to significantly lower use of street heroin than does supervised injectable methadone or optimised oral methadone. UK Government proposals should be rolled out to support the positive response that can be achieved with heroin maintenance treatment for previously unresponsive chronic heroin addicts.	[Strang, John] Kings Coll London, Natl Addict Ctr, Addict Dept, London SE5 8BB, England; [Strang, John; Lintzeris, Nicholas; Mayet, Soraya; Zador, Deborah] S London & Maudsley NHS Fdn Trust, London, England; [Lintzeris, Nicholas] Univ Sydney, Langton Ctr, Sydney, NSW 2006, Australia; [Evers, Richard] Kings Coll Hosp London, London, England	University of London; King's College London; South London & Maudsley NHS Trust; University of Sydney; King's College Hospital NHS Foundation Trust; King's College Hospital	Strang, J (corresponding author), Kings Coll London, Natl Addict Ctr, Addict Dept, 4 Windsor Walk, London SE5 8BB, England.	john.strang@kcl.ac.uk	Strang, John/H-5460-2011; Evers, Richard/I-4787-2019	Strang, John/0000-0002-5413-2725; Evers, Richard/0000-0002-2983-3642	Department of Health (England); National Treatment Agency (England); Reckitt Benckiser; Schering-Plough; Community Fund (Big Lottery) Research section; Hedley Foundation; UK National Health Service Research and Development; National Health Medical Research Council, Australia; Tees, Esk and Wear Valleys Foundation NHS NIHR Flexibility and Sustainability Funding	Department of Health (England); National Treatment Agency (England); Reckitt Benckiser; Schering-Plough(Merck & CompanySchering Plough Corporation); Community Fund (Big Lottery) Research section; Hedley Foundation; UK National Health Service Research and Development; National Health Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Tees, Esk and Wear Valleys Foundation NHS NIHR Flexibility and Sustainability Funding	JS and NL have contributed to UK National Treatment Agency for Substance Misuse and Department of Health guidelines on the role of injectable prescribing in the management of opiate addiction (2003; chaired by (S), and JS also chaired the broader-scope pan-UK working group preparing the 2007 Orange Guidelines for the UK Departments of Health, providing guidance on management and treatment of drug dependence and misuse. JS has provided consultancy advice to Britannia/Genus, Auralis, and Martindale Pharmaceuticals; JS and JS's institution have received support and funding from the Department of Health (England) and National Treatment Agency (England); and JS has close associations with the charity Action on Addiction. NL has received honoraria, travel and conference support, and consultancy fees from Reckitt Benckiser and Schering-Plough. NL has an untied educational grant for research related to buprenorphine in the management of opioid dependence. JS, NM, NL, and TC have previously undertaken research study of British heroin policy and have given varied commentaries and contributed to professional and public debate. LP, SM, HW, DZ, RE, TG, VC, AM, and LF declare that they have no conflicts of interest.; We thank all participants of this trial; the staff and colleagues without whom the trial would not have been possible; research and treatment funders; Ed Day, chairman of the trial steering committee; members of the data monitoring committee (Sheila Bird, Senior Statistician, Medical Research Council Biostatistics Unit, Cambridge, UK; Louise Sell, Consultant Addiction Psychiatrist and Service Director, Greater Manchester West Mental Health NHS Foundation Trust, Manchester, UK; and Philip Robson, Consultant Addiction Psychiatrist, GW Pharmaceuticals, Wiltshire, UK); Jenny Hellier (Clinical Trials Unit, Institute of Psychiatry, King's College London, London, UK) for additional statistical analysis; David Taylor, Glynis Ivin, and Godwin Achunine (South London and Maudsley NHS Foundation Trust, London, UK) for pharmacy advice, coordination, and support; and Rob van der Waal (South London and Maudsley NHS Foundation Trust, London, UK) for help with development of the clinical protocol and for training nursing staff. Diamorphine ampoules were supplied by DiaMo (Switzerland) and Auralis (UK). Research funding was provided by the Community Fund (Big Lottery) Research section, through Action on Addiction; Hedley Foundation; and UK National Health Service Research and Development support. Organisational support was provided by the Clinical Trials Unit at the Institute of Psychiatry, and by the UK Mental Health Research Network. Funding for treatment was provided through the UK National Treatment Agency for Substance Misuse for the Department of Health and the Home Office, and local commissioners. NL was partly funded by the National Health Medical Research Council, Australia. Tees, Esk and Wear Valleys Foundation NHS NIHR Flexibility and Sustainability Funding provided supplementary funding for TG. King's College London and South London and Maudsley NHS Foundation Trust are now within the Academic Health Sciences Centre, King's Health Partners.	Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; [Anonymous], 2008, DRUGS PROT FAM COMM; Ferri M, 2006, J SUBST ABUSE TREAT, V30, P63, DOI 10.1016/j.jsat.2005.09.003; Haasen C, 2007, BRIT J PSYCHIAT, V191, P55, DOI 10.1192/bjp.bp.106.026112; *HOM OFF, 2002, UPD DRUG STRAT 2002, P56; Lintzeris Nicholas, 2006, Harm Reduct J, V3, P28, DOI 10.1186/1477-7517-3-28; Lintzeris N, 2009, CNS DRUGS, V23, P463, DOI 10.2165/00023210-200923060-00002; March JC, 2006, J SUBST ABUSE TREAT, V31, P203, DOI 10.1016/j.jsat.2006.04.007; Metrebian N, 2002, ADDICTION, V97, P1155, DOI 10.1046/j.1360-0443.2002.00193.x; Metrebian N, 2001, DRUG ALCOHOL REV, V20, P267; MITCHESON M, 2005, HEROIN ADDICTION BRI, V2, P41; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Paterson S, 2006, J ANAL TOXICOL, V30, P267, DOI 10.1093/jat/30.4.267; Paterson S, 2005, ADDICTION, V100, P1832, DOI 10.1111/j.1360-0443.2005.01225.x; Perneger TV, 1998, BMJ-BRIT MED J, V317, P13, DOI 10.1136/bmj.317.7150.13; Rehm J, 2001, LANCET, V358, P1417, DOI 10.1016/S0140-6736(01)06529-1; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sell L, 2004, ADDICTION, V99, P442, DOI 10.1111/j.1360-0443.2003.00668.x; Strang J, 1996, BMJ-BRIT MED J, V313, P270, DOI 10.1136/bmj.313.7052.270; Strang J, 2000, ADDICTION, V95, P1631, DOI 10.1046/j.1360-0443.2000.951116314.x; STRANG J, 1990, AIDS DRUG MISUSE CHA, P142; Strang J, 2005, HEROIN ADDICTION BRI, V2, P1; TOBER G, 2003, METHADONE MATTERS EV, P131; UCHTENHAGEN A, 1999, PRESCRIPTION NARCOTI; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310; Verthein U, 2008, ADDICTION, V103, P960, DOI 10.1111/j.1360-0443.2008.02185.x; Witton J, 2005, J DRUG ISSUES, V35, P779, DOI 10.1177/002204260503500406; Zador D, 2001, ADDICTION, V96, P547, DOI 10.1046/j.1360-0443.2001.9645473.x; ZADOR D, 2005, HEROIN ADDICTION BRI, V2, P121	29	127	128	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2010	375	9729					1885	1895		10.1016/S0140-6736(10)60349-2	http://dx.doi.org/10.1016/S0140-6736(10)60349-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20511018				2022-12-28	WOS:000278628800030
J	Hu, QC; Milenkovic, L; Jin, H; Scott, MP; Nachury, MV; Spiliotis, ET; Nelson, WJ				Hu, Qicong; Milenkovic, Ljiljana; Jin, Hua; Scott, Matthew P.; Nachury, Maxence V.; Spiliotis, Elias T.; Nelson, W. James			A Septin Diffusion Barrier at the Base of the Primary Cilium Maintains Ciliary Membrane Protein Distribution	SCIENCE			English	Article							CHLAMYDOMONAS-REINHARDTII; PLASMA-MEMBRANE; COMPARTMENTALIZATION; TRANSPORT; ORGANIZATION; POLARITY	In animal cells, the primary cilium transduces extracellular signals through signaling receptors localized in the ciliary membrane, but how these ciliary membrane proteins are retained in the cilium is unknown. We found that ciliary membrane proteins were highly mobile, but their diffusion was impeded at the base of the cilium by a diffusion barrier. Septin 2 (SEPT2), a member of the septin family of guanosine triphosphatases that form a diffusion barrier in budding yeast, localized at the base of the ciliary membrane. SEPT2 depletion resulted in loss of ciliary membrane protein localization and Sonic hedgehog signal transduction, and inhibited ciliogenesis. Thus, SEPT2 is part of a diffusion barrier at the base of the ciliary membrane and is essential for retaining receptor-signaling pathways in the primary cilium.	[Spiliotis, Elias T.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Hu, Qicong; Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Milenkovic, Ljiljana; Scott, Matthew P.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Milenkovic, Ljiljana; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Jin, Hua; Nachury, Maxence V.; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Drexel University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Spiliotis, ET (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	ets33@drexel.edu; wjnelson@stanford.edu	Nachury, Maxence/A-8759-2008; Nachury, Maxence/H-3695-2019	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562	NIH [GM35527, GM089933]; Department of Defense [BC083077]; State of Pennsylvania Tobacco Settlement Funds; American Heart Association; March of Dimes; Sloan Foundation; Klingenstein Foundation; Searle Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM089933, R01GM035527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); State of Pennsylvania Tobacco Settlement Funds; American Heart Association(American Heart Association); March of Dimes(March of Dimes); Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Foundation(Klingenstein Philanthropies); Searle Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kinoshita, S. Munro, G. J. Pazour, K. Mykytyn, D. R. Beier, C. Janke, J. Christianson, R. Kopito, and T. Stearns for reagents, and J. Atkins (Applied Precision, Inc.) for technical support. Supported by NIH grant GM35527 (W.J.N.), Department of Defense Breast Cancer Research Program Predoctoral Fellowship BC083077 (Q. H.), and Drexel CURE award from the State of Pennsylvania Tobacco Settlement Funds (E. T. S.). Supported in part by grants (M.V.N.) from the American Heart Association, the March of Dimes, NIH (GM089933), and the Sloan, Klingenstein and Searle Foundations. L. M. is a Research Specialist, and M. P. S. an Investigator of the Howard Hughes Medical Institute.	Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; MUSGRAVE A, 1986, PLANTA, V167, P544, DOI 10.1007/BF00391231; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sloboda RD, 2007, J CELL BIOL, V179, P575, DOI 10.1083/jcb.200709039; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	30	332	344	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					436	439		10.1126/science.1191054	http://dx.doi.org/10.1126/science.1191054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558667	Green Accepted			2022-12-28	WOS:000280196500036
J	Chodavarapu, RK; Feng, SH; Bernatavichute, YV; Chen, PY; Stroud, H; Yu, YC; Hetzel, JA; Kuo, F; Kim, J; Cokus, SJ; Casero, D; Bernal, M; Huijser, P; Clark, AT; Kramer, U; Merchant, SS; Zhang, XY; Jacobsen, SE; Pellegrini, M				Chodavarapu, Ramakrishna K.; Feng, Suhua; Bernatavichute, Yana V.; Chen, Pao-Yang; Stroud, Hume; Yu, Yanchun; Hetzel, Jonathan A.; Kuo, Frank; Kim, Jin; Cokus, Shawn J.; Casero, David; Bernal, Maria; Huijser, Peter; Clark, Amander T.; Kraemer, Ute; Merchant, Sabeeha S.; Zhang, Xiaoyu; Jacobsen, Steven E.; Pellegrini, Matteo			Relationship between nucleosome positioning and DNA methylation	NATURE			English	Article							GENOME; ORGANIZATION; PLANTS; RESOLUTION; SEQUENCE; PARTICLE; ANIMALS; REVEALS; H2A.Z; MARKS	Nucleosomes compact and regulate access to DNA in the nucleus, and are composed of approximately 147 bases of DNA wrapped around a histone octamer(1,2). Here we report a genome-wide nucleosome positioning analysis of Arabidopsis thaliana using massively parallel sequencing of mononucleosomes. By combining this data with profiles of DNA methylation at single base resolution, we identified 10-base periodicities in the DNA methylation status of nucleosome-bound DNA and found that nucleosomal DNA was more highly methylated than flanking DNA. These results indicate that nucleosome positioning influences DNA methylation patterning throughout the genome and that DNA methyltransferases preferentially target nucleosome-bound DNA. We also observed similar trends in human nucleosomal DNA, indicating that the relationships between nucleosomes and DNA methyltransferases are conserved. Finally, as has been observed in animals, nucleosomes were highly enriched on exons, and preferentially positioned at intron-exon and exon-intron boundaries. RNA polymerase II (Pol II) was also enriched on exons relative to introns, consistent with the hypothesis that nucleosome positioning regulates Pol II processivity. DNA methylation is also enriched on exons, consistent with the targeting of DNA methylation to nucleosomes, and suggesting a role for DNA methylation in exon definition.	[Chodavarapu, Ramakrishna K.; Feng, Suhua; Bernatavichute, Yana V.; Chen, Pao-Yang; Stroud, Hume; Hetzel, Jonathan A.; Kuo, Frank; Kim, Jin; Cokus, Shawn J.; Casero, David; Clark, Amander T.; Jacobsen, Steven E.; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Bernatavichute, Yana V.; Merchant, Sabeeha S.; Jacobsen, Steven E.; Pellegrini, Matteo] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Yu, Yanchun; Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Bernal, Maria; Kraemer, Ute] Univ Heidelberg, D-69120 Heidelberg, Germany; [Huijser, Peter] Max Planck Inst Plant Breeding Res, Dept Mol Plant Genet, D-50829 Cologne, Germany; [Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia; Ruprecht Karls University Heidelberg; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; matteop@mcdb.ucla.edu	Bernal, Maria/AAA-4068-2020; Kraemer, Ute/C-5025-2008; Zhang, xiaoyu/GXA-3206-2022; Chen, Pao-Yang/ABG-9939-2020; Casero, David/E-7365-2010	Bernal, Maria/0000-0001-9585-4268; Kraemer, Ute/0000-0001-7870-4508; Chen, Pao-Yang/0000-0002-7402-3075; Casero, David/0000-0002-7347-3330; Pellegrini, Matteo/0000-0001-9355-9564	Department of Energy, Institute for Genomics and Proteomics; NIH [GM07104, GM60398, GM42143]; Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA; Alexander-von-Humboldt Fellowship; Heisenberg Fellowship; University of Georgia [JR-040]; NSF [0701745]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042143, R37GM060398, T32GM007104, R37GM042143, R01GM060398, R29GM042143] Funding Source: NIH RePORTER	Department of Energy, Institute for Genomics and Proteomics(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA; Alexander-von-Humboldt Fellowship(Alexander von Humboldt Foundation); Heisenberg Fellowship(German Research Foundation (DFG)); University of Georgia; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratories for input and guidance, and the Department of Energy, Institute for Genomics and Proteomics for support. R. K. C. is supported by NIH training grant GM07104. S. F. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. P.-Y.C. is funded by Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA. M. B. was supported by an Alexander-von-Humboldt Fellowship and U. K. by a Heisenberg Fellowship. X.Z. was supported by a Faculty Research Grant (JR-040) from the University of Georgia. Research was supported by an Innovation Award from the Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA, NIH grants GM60398 and GM42143, and NSF Plant Genome Research Program #0701745. S.E.J. is an Investigator of the Howard Hughes Medical Institute.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kobor MS, 2009, TRENDS BIOCHEM SCI, V34, P158, DOI 10.1016/j.tibs.2008.12.006; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Ponts N, 2010, GENOME RES, V20, P228, DOI 10.1101/gr.101063.109; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; ZEMACH A, 2010, SCIENCE         0415, DOI DOI 10.1126/SCIENCE.1186366; Zhang J, 2007, J HUAZHONG U SCI-MED, V27, P5, DOI 10.1007/s11596-007-0102-5	29	510	526	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					388	392		10.1038/nature09147	http://dx.doi.org/10.1038/nature09147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20512117	Green Accepted			2022-12-28	WOS:000279867100053
J	Pinto, D; Pagnamenta, AT; Klei, L; Anney, R; Merico, D; Regan, R; Conroy, J; Magalhaes, TR; Correia, C; Abrahams, BS; Almeida, J; Bacchelli, E; Bader, GD; Bailey, AJ; Baird, G; Battaglia, A; Berney, T; Bolshakova, N; Bolte, S; Bolton, PF; Bourgeron, T; Brennan, S; Brian, J; Bryson, SE; Carson, AR; Casallo, G; Casey, J; Chung, BHY; Cochrane, L; Corsello, C; Crawford, EL; Crossett, A; Cytrynbaum, C; Dawson, G; de Jonge, M; Delorme, R; Drmic, I; Duketis, E; Duque, F; Estes, A; Farrar, P; Fernandez, BA; Folstein, SE; Fombonne, E; Freitag, CM; Gilbert, J; Gillberg, C; Glessner, JT; Goldberg, J; Green, A; Green, J; Guter, SJ; Hakonarson, H; Heron, EA; Hill, M; Holt, R; Howe, JL; Hughes, G; Hus, V; Igliozzi, R; Kim, C; Klauck, SM; Kolevzon, A; Korvatska, O; Kustanovich, V; Lajonchere, CM; Lamb, JA; Laskawiec, M; Leboyer, M; Le Couteur, A; Leventhal, BL; Lionel, AC; Liu, XQ; Lord, C; Lotspeich, L; Lund, SC; Maestrini, E; Mahoney, W; Mantoulan, C; Marshall, CR; McConachie, H; McDougle, CJ; McGrath, J; McMahon, WM; Merikangas, A; Migita, O; Minshew, NJ; Mirza, GK; Munson, J; Nelson, SF; Noakes, C; Noor, A; Nygren, G; Oliveira, G; Papanikolaou, K; Parr, JR; Parrini, B; Paton, T; Pickles, A; Pilorge, M; Piven, J; Ponting, CP; Posey, DJ; Poustka, A; Poustka, F; Prasad, A; Ragoussis, J; Renshaw, K; Rickaby, J; Roberts, W; Roeder, K; Roge, B; Rutter, ML; Bierut, LJ; Rice, JP; Salt, J; Sansom, K; Sato, D; Segurado, R; Sequeira, AF; Senman, L; Shah, N; Sheffield, VC; Soorya, L; Sousa, I; Stein, O; Sykes, N; Stoppioni, V; Strawbridge, C; Tancredi, R; Tansey, K; Thiruvahindrapduram, B; Thompson, AP; Thomson, S; Tryfon, A; Tsiantis, J; Van Engeland, H; Vincent, JB; Volkmar, F; Wallace, S; Wang, K; Wang, ZZ; Wassink, TH; Webber, C; Weksberg, R; Wing, K; Wittemeyer, K; Wood, S; Wu, J; Yaspan, BL; Zurawiecki, D; Zwaigenbaum, L; Buxbaum, JD; Cantor, RM; Cook, EH; Coon, H; Cuccaro, ML; Devlin, B; Ennis, S; Gallagher, L; Geschwind, DH; Gill, M; Haines, JL; Hallmayer, J; Miller, J; Monaco, AP; Nurnberger, JI; Paterson, AD; Pericak-Vance, MA; Schellenberg, GD; Szatmari, P; Vicente, AM; Vieland, VJ; Wijsman, EM; Scherer, SW; Sutcliffe, JS; Betancur, C				Pinto, Dalila; Pagnamenta, Alistair T.; Klei, Lambertus; Anney, Richard; Merico, Daniele; Regan, Regina; Conroy, Judith; Magalhaes, Tiago R.; Correia, Catarina; Abrahams, Brett S.; Almeida, Joana; Bacchelli, Elena; Bader, Gary D.; Bailey, Anthony J.; Baird, Gillian; Battaglia, Agatino; Berney, Tom; Bolshakova, Nadia; Boelte, Sven; Bolton, Patrick F.; Bourgeron, Thomas; Brennan, Sean; Brian, Jessica; Bryson, Susan E.; Carson, Andrew R.; Casallo, Guillermo; Casey, Jillian; Chung, Brian H. Y.; Cochrane, Lynne; Corsello, Christina; Crawford, Emily L.; Crossett, Andrew; Cytrynbaum, Cheryl; Dawson, Geraldine; de Jonge, Maretha; Delorme, Richard; Drmic, Irene; Duketis, Eftichia; Duque, Frederico; Estes, Annette; Farrar, Penny; Fernandez, Bridget A.; Folstein, Susan E.; Fombonne, Eric; Freitag, Christine M.; Gilbert, John; Gillberg, Christopher; Glessner, Joseph T.; Goldberg, Jeremy; Green, Andrew; Green, Jonathan; Guter, Stephen J.; Hakonarson, Hakon; Heron, Elizabeth A.; Hill, Matthew; Holt, Richard; Howe, Jennifer L.; Hughes, Gillian; Hus, Vanessa; Igliozzi, Roberta; Kim, Cecilia; Klauck, Sabine M.; Kolevzon, Alexander; Korvatska, Olena; Kustanovich, Vlad; Lajonchere, Clara M.; Lamb, Janine A.; Laskawiec, Magdalena; Leboyer, Marion; Le Couteur, Ann; Leventhal, Bennett L.; Lionel, Anath C.; Liu, Xiao-Qing; Lord, Catherine; Lotspeich, Linda; Lund, Sabata C.; Maestrini, Elena; Mahoney, William; Mantoulan, Carine; Marshall, Christian R.; McConachie, Helen; McDougle, Christopher J.; McGrath, Jane; McMahon, William M.; Merikangas, Alison; Migita, Ohsuke; Minshew, Nancy J.; Mirza, Ghazala K.; Munson, Jeff; Nelson, Stanley F.; Noakes, Carolyn; Noor, Abdul; Nygren, Gudrun; Oliveira, Guiomar; Papanikolaou, Katerina; Parr, Jeremy R.; Parrini, Barbara; Paton, Tara; Pickles, Andrew; Pilorge, Marion; Piven, Joseph; Ponting, Chris P.; Posey, David J.; Poustka, Annemarie; Poustka, Fritz; Prasad, Aparna; Ragoussis, Jiannis; Renshaw, Katy; Rickaby, Jessica; Roberts, Wendy; Roeder, Kathryn; Roge, Bernadette; Rutter, Michael L.; Bierut, Laura J.; Rice, John P.; Salt, Jeff; Sansom, Katherine; Sato, Daisuke; Segurado, Ricardo; Sequeira, Ana F.; Senman, Lili; Shah, Naisha; Sheffield, Val C.; Soorya, Latha; Sousa, Ines; Stein, Olaf; Sykes, Nuala; Stoppioni, Vera; Strawbridge, Christina; Tancredi, Raffaella; Tansey, Katherine; Thiruvahindrapduram, Bhooma; Thompson, Ann P.; Thomson, Susanne; Tryfon, Ana; Tsiantis, John; Van Engeland, Herman; Vincent, John B.; Volkmar, Fred; Wallace, Simon; Wang, Kai; Wang, Zhouzhi; Wassink, Thomas H.; Webber, Caleb; Weksberg, Rosanna; Wing, Kirsty; Wittemeyer, Kerstin; Wood, Shawn; Wu, Jing; Yaspan, Brian L.; Zurawiecki, Danielle; Zwaigenbaum, Lonnie; Buxbaum, Joseph D.; Cantor, Rita M.; Cook, Edwin H.; Coon, Hilary; Cuccaro, Michael L.; Devlin, Bernie; Ennis, Sean; Gallagher, Louise; Geschwind, Daniel H.; Gill, Michael; Haines, Jonathan L.; Hallmayer, Joachim; Miller, Judith; Monaco, Anthony P.; Nurnberger, John I., Jr.; Paterson, Andrew D.; Pericak-Vance, Margaret A.; Schellenberg, Gerard D.; Szatmari, Peter; Vicente, Astrid M.; Vieland, Veronica J.; Wijsman, Ellen M.; Scherer, Stephen W.; Sutcliffe, James S.; Betancur, Catalina			Functional impact of global rare copy number variation in autism spectrum disorders	NATURE			English	Article							HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; GENETIC DISORDER; ASSOCIATION; MUTATIONS; LINKAGE; LOCI; ANCESTRY; REVEALS; COMPLEX	The autism spectrum disorders (ASDs) are a group of conditions characterized by impairments in reciprocal social interaction and communication, and the presence of restricted and repetitive behaviours(1). Individuals with an ASD vary greatly in cognitive development, which can range from above average to intellectual disability(2). Although ASDs are known to be highly heritable (similar to 90%)(3), the underlying genetic determinants are still largely unknown. Here we analysed the genome-wide characteristics of rare (<1% frequency) copy number variation in ASD using dense genotyping arrays. When comparing 996 ASD individuals of European ancestry to 1,287 matched controls, cases were found to carry a higher global burden of rare, genic copy number variants (CNVs) (1.19 fold, P=0.012), especially so for loci previously implicated in either ASD and/or intellectual disability (1.69 fold, P=3.4 x 10(-4)). Among the CNVs there were numerous de novo and inherited events, sometimes in combination in a given family, implicating many novel ASD genes such as SHANK2, SYNGAP1, DLGAP2 and the X-linked DDX53-PTCHD1 locus. We also discovered an enrichment of CNVs disrupting functional gene sets involved in cellular proliferation, projection and motility, and GTPase/Ras signalling. Our results reveal many new genetic and functional targets in ASD that may lead to final connected pathways.	[Pinto, Dalila; Carson, Andrew R.; Casallo, Guillermo; Chung, Brian H. Y.; Cytrynbaum, Cheryl; Howe, Jennifer L.; Lionel, Anath C.; Liu, Xiao-Qing; Marshall, Christian R.; Migita, Ohsuke; Paton, Tara; Prasad, Aparna; Rickaby, Jessica; Sansom, Katherine; Sato, Daisuke; Thiruvahindrapduram, Bhooma; Wang, Zhouzhi; Weksberg, Rosanna; Paterson, Andrew D.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Pinto, Dalila; Carson, Andrew R.; Casallo, Guillermo; Chung, Brian H. Y.; Cytrynbaum, Cheryl; Howe, Jennifer L.; Lionel, Anath C.; Liu, Xiao-Qing; Marshall, Christian R.; Migita, Ohsuke; Paton, Tara; Prasad, Aparna; Rickaby, Jessica; Sansom, Katherine; Sato, Daisuke; Thiruvahindrapduram, Bhooma; Wang, Zhouzhi; Weksberg, Rosanna; Paterson, Andrew D.; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Pagnamenta, Alistair T.; Farrar, Penny; Holt, Richard; Mirza, Ghazala K.; Ragoussis, Jiannis; Sousa, Ines; Sykes, Nuala; Wing, Kirsty; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Klei, Lambertus; Wood, Shawn; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Anney, Richard; Bolshakova, Nadia; Brennan, Sean; Cochrane, Lynne; Heron, Elizabeth A.; Hill, Matthew; Hughes, Gillian; McGrath, Jane; Merikangas, Alison; Segurado, Ricardo; Tansey, Katherine; Gallagher, Louise; Gill, Michael] Trinity Coll Dublin, Sch Med, Dept Psychiat, Autism Genet Grp, Dublin 8, Ireland; [Merico, Daniele; Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Regan, Regina; Conroy, Judith; Casey, Jillian; Green, Andrew; Shah, Naisha; Ennis, Sean] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] Inst Nacl Saude Dr Ricardo Jorge, P-1649016 Lisbon, Portugal; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] Gulbenkian Inst Sci, P-2780156 Oeiras, Portugal; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Res & Treatment, Semel Inst, Los Angeles, CA 90095 USA; [Almeida, Joana; Duque, Frederico; Oliveira, Guiomar] Hosp Pediat Coimbra, P-3000076 Coimbra, Portugal; [Bacchelli, Elena; Maestrini, Elena] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Bailey, Anthony J.; Laskawiec, Magdalena; Renshaw, Katy; Wallace, Simon] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Baird, Gillian] Guys Hosp, Newcomen Ctr, London SE1 9RT, England; [Battaglia, Agatino; Igliozzi, Roberta; Parrini, Barbara; Tancredi, Raffaella] Stella Maris Inst Child & Adolescent Neuropsychia, I-56128 Pisa, Italy; [Berney, Tom; Le Couteur, Ann; McConachie, Helen] Univ Newcastle, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Boelte, Sven; Duketis, Eftichia; Freitag, Christine M.; Poustka, Fritz] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat, D-60528 Frankfurt, Germany; [Bolton, Patrick F.] Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; [Bourgeron, Thomas] Univ Paris 07, CNRS, URA 2182, Inst Pasteur, F-75015 Paris, France; [Brian, Jessica; Drmic, Irene; Noakes, Carolyn; Roberts, Wendy; Senman, Lili] Univ Toronto, Hosp Sick Children & Bloorview Kids Rehab, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Bryson, Susan E.] Dalhousie Univ, Dept Pediat & Psychol, Halifax, NS B3K 6R8, Canada; [Corsello, Christina; Hus, Vanessa; Lord, Catherine] Univ Michigan, Autism & Communicat Disorders Ctr, Ann Arbor, MI 48109 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Crossett, Andrew; Roeder, Kathryn; Wu, Jing] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Dawson, Geraldine] Autism Speaks, New York, NY 10016 USA; [Dawson, Geraldine] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [de Jonge, Maretha; Van Engeland, Herman] Univ Med Ctr, Dept Child Psychiat, NL-3508 GA Utrecht, Netherlands; [Delorme, Richard] Hop Robert Debre, AP HP, Fdn FondaMental, INSERM,U955, F-75019 Paris, France; [Estes, Annette] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3V6, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF A1B 3V6, Canada; [Folstein, Susan E.; Gilbert, John; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33101 USA; [Fombonne, Eric] McGill Univ, Div Psychiat, Montreal, PQ H3A 1A1, Canada; [Gillberg, Christopher; Nygren, Gudrun] Univ Gothenburg, Dept Child & Adolescent Psychiat, S-41345 Gothenburg, Sweden; [Glessner, Joseph T.; Hakonarson, Hakon; Kim, Cecilia; Wang, Kai] Childrens Hosp Philadelphia, Ctr Appl Genom, Div Human Genet, Philadelphia, PA 19104 USA; [Goldberg, Jeremy; Strawbridge, Christina; Thompson, Ann P.; Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; [Green, Jonathan] Booth Hall Childrens Hosp, Acad Dept Child Psychiat, Manchester M9 7AA, Lancs, England; [Guter, Stephen J.; Salt, Jeff; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60612 USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Klauck, Sabine M.; Poustka, Annemarie] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Kolevzon, Alexander; Soorya, Latha; Tryfon, Ana; Zurawiecki, Danielle; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Korvatska, Olena] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Kustanovich, Vlad; Lajonchere, Clara M.] Autism Speaks, Autism Genet Resource Exchange, Los Angeles, CA 90036 USA; [Lamb, Janine A.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [Leboyer, Marion] Univ Paris 12, AP HP, Grp Hosp Henri Mondor Albert Chenevier, INSERM,U995,Dept Psychiat,Fdn FondaMental, F-94000 Creteil, France; [Leventhal, Bennett L.] Nathan S Kline Inst Psychiat Res NKI, Orangeburg, NY 10962 USA; [Leventhal, Bennett L.] NYU, Dept Child & Adolescent Psychiat, New York, NY 10016 USA; [Leventhal, Bennett L.] NYU, Ctr Child Study, New York, NY 10016 USA; [Lotspeich, Linda; Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat & Child Dev, Palo Alto, CA 94304 USA; [Mahoney, William] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Mantoulan, Carine; Roge, Bernadette; Wittemeyer, Kerstin] Univ Toulouse Le Mirail, Ctr Eudes & Rech Psychopathol, F-31200 Toulouse, France; [McDougle, Christopher J.; Posey, David J.; Nurnberger, John I., Jr.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McMahon, William M.; Coon, Hilary; Miller, Judith] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84108 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; [Munson, Jeff] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Nelson, Stanley F.; Cantor, Rita M.] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Noor, Abdul; Vincent, John B.] Univ Toronto, Ctr Addict & Mental Hlth, Clarke Inst, Toronto, ON M5G 1X8, Canada; [Noor, Abdul; Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Papanikolaou, Katerina; Tsiantis, John] Univ Athens, Sch Med, Agia Sophia Childrens Hosp, Univ Dept Child Psychiat, GR-11527 Athens, Greece; [Berney, Tom; Le Couteur, Ann; McConachie, Helen; Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Berney, Tom; Le Couteur, Ann; McConachie, Helen; Parr, Jeremy R.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pickles, Andrew] Univ Manchester, Sch Epidemiol & Hlth Sci, Dept Med, Manchester M13 9PT, Lancs, England; [Pilorge, Marion; Betancur, Catalina] INSERM, U952, F-75005 Paris, France; [Pilorge, Marion; Betancur, Catalina] CNRS, UMR 7224, F-75005 Paris, France; [Pilorge, Marion; Betancur, Catalina] UPMC, F-75005 Paris, France; [Piven, Joseph] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Ponting, Chris P.; Webber, Caleb] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Rutter, Michael L.] Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Bierut, Laura J.; Rice, John P.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Stein, Olaf; Vieland, Veronica J.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Stein, Olaf; Vieland, Veronica J.] Ohio State Univ, Columbus, OH 43205 USA; [Stoppioni, Vera] Osped Santa Croce, I-61032 Fano, Italy; [Volkmar, Fred] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Wassink, Thomas H.] Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2J3, Canada; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; [Schellenberg, Gerard D.] Univ Penn, Philadelphia, PA 19104 USA; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Bader, Gary D.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; Wellcome Centre for Human Genetics; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Trinity College Dublin; University of Toronto; University College Dublin; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Bologna; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; IRCCS Fondazione Stella Maris; Newcastle University - UK; Goethe University Frankfurt; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; Hospital for Sick Children (SickKids); Dalhousie University; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Vanderbilt University; Carnegie Mellon University; University of North Carolina; University of North Carolina Chapel Hill; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Washington; University of Washington Seattle; Memorial University Newfoundland; Memorial University Newfoundland; University of Miami; McGill University; University of Gothenburg; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McMaster University; Royal Manchester Children's Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Helmholtz Association; German Cancer Research Center (DKFZ); Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Nathan Kline Institute for Psychiatric Research; New York University; New York University; Stanford University; McMaster University; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Newcastle University - UK; Newcastle University - UK; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; University of London; King's College London; Washington University (WUSTL); University of Iowa; Howard Hughes Medical Institute; University of Iowa; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Yale University; University of Alberta; Vanderbilt University; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada.	stephen.scherer@sickkids.ca	Scherer, Stephen W./B-3785-2013; Fombonne, Eric/M-4893-2018; Heron, Elizabeth Ann/HCI-9636-2022; Bölte, Sven/AAH-8675-2019; bacchelli, elena/R-3675-2016; Buxbaum, Joseph D/G-6001-2010; Pinto, Dalila/C-4218-2016; Green, Andrew/AAJ-7592-2020; Rutter, Michael/C-8570-2013; Duque, Frederico/H-3692-2014; Betancur, Catalina/K-3791-2017; Koo, Jawoo/F-9397-2010; Ragoussis, Ioannis/AAD-9790-2022; Tansey, Katherine E/B-1033-2013; Ponting, Chris/AAV-2621-2021; Sutcliffe, James S/C-1348-2012; Oliveira, Guiomar/I-7255-2013; Paterson, Andrew/AAQ-7511-2020; Bal, Vanessa Hus/AAN-2381-2020; Noor, Abdul/J-2345-2016; Prasad, Aparna/N-4253-2015; Oliveira, Guiomar/AAF-3911-2021; Bailey, Anthony/J-2860-2014; Paterson, Andrew D/A-4088-2011; Papanikolaou, Katerina/AAB-4771-2020; Maestrini, Elena/K-7508-2012; Vicente, Astrid/F-8692-2014; Battaglia, Agatino/AAG-1406-2020; Leboyer, Marion/AAW-3648-2021; Haines, Jonathan/C-3374-2012; Mahoney, William/GQB-0802-2022; Igliozzi, Roberta/AAA-4568-2021; Hill, Matthew/E-7730-2010; Volkmar, Fred/AEB-0666-2022; Monaco, Anthony P/A-4495-2010; Bierut, Laura Jean/W-6806-2019; De Jonge, Maretha V/F-4942-2013; Tancredi, Raffaella/C-3868-2018; Pickles, Andrew/A-9625-2011; Bader, Gary/C-1176-2009; Nelson, Stanley F/D-4771-2009; Segurado, Ricardo/K-6116-2014	Scherer, Stephen W./0000-0002-8326-1999; Fombonne, Eric/0000-0002-8605-3538; Heron, Elizabeth Ann/0000-0003-2219-4005; Bölte, Sven/0000-0002-4579-4970; bacchelli, elena/0000-0001-8800-9568; Pinto, Dalila/0000-0002-8769-0846; Duque, Frederico/0000-0001-5684-1472; Betancur, Catalina/0000-0002-3327-4804; Koo, Jawoo/0000-0003-3424-9229; Tansey, Katherine E/0000-0002-9663-3376; Sutcliffe, James S/0000-0001-5200-6007; Paterson, Andrew/0000-0002-9169-118X; Bal, Vanessa Hus/0000-0003-0750-823X; Prasad, Aparna/0000-0002-6786-2313; Oliveira, Guiomar/0000-0002-7049-1277; Bailey, Anthony/0000-0003-4257-972X; Paterson, Andrew D/0000-0002-9169-118X; Maestrini, Elena/0000-0001-5924-3179; Vicente, Astrid/0000-0001-7134-8037; Battaglia, Agatino/0000-0002-7128-7606; Leboyer, Marion/0000-0001-5473-3697; Haines, Jonathan/0000-0002-4351-4728; Igliozzi, Roberta/0000-0002-1245-972X; Hill, Matthew/0000-0001-6776-8709; Monaco, Anthony P/0000-0001-7480-3197; Bierut, Laura Jean/0000-0002-9952-4810; Tancredi, Raffaella/0000-0003-3517-4919; Pickles, Andrew/0000-0003-1283-0346; Bader, Gary/0000-0003-0185-8861; Nelson, Stanley F/0000-0002-2082-3114; Estes, Annette/0000-0003-2687-4155; Wassink, Thomas/0000-0002-0952-8333; Gallagher, Louise/0000-0001-9462-2836; Dawson, Geraldine/0000-0003-1410-2764; Sequeira, Ana Filipa/0000-0001-8445-6221; Bolshakova, Nadia/0000-0003-2173-6562; Guter, Stephen/0000-0002-4476-2045; Ragoussis, Ioannis/0000-0002-8515-0934; Lamb, Janine/0000-0002-7248-0539; Segurado, Ricardo/0000-0002-3547-6733; Merikangas, Alison/0000-0003-2253-839X; Buxbaum, Joseph/0000-0001-8898-8313; Delorme, Richard/0000-0002-5614-3663; Ennis, Sean/0000-0002-4330-1386; Girao Meireles de Sousa, Ines/0000-0001-6983-8870; R Magalhaes, Tiago/0000-0002-5528-2119; Roeder, Kathryn/0000-0002-8869-6254; Ponting, Chris/0000-0003-0202-7816; Bourgeron, Thomas/0000-0001-8164-9220; Green, Andrew/0000-0002-1077-7417; Yaspan, Brian/0000-0002-3787-2510; Simpson, Nuala/0000-0003-3390-9993; Rutter, Michael Llewellyn/0000-0003-1577-7405; Merico, Daniele/0000-0002-3728-4401; Lund, Sabata/0000-0002-6092-5131; McGrath, Jane/0000-0002-4894-4823; Gill, Michael/0000-0003-0206-5337; Oliveira, Guiomar Goncalves/0000-0003-4031-3880; Green, Jonathan/0000-0002-0143-181X; Liu, Xiao-Qing/0000-0002-4034-5156; Correia, Catarina/0000-0001-5481-2010; Nurnberger, John/0000-0002-7674-1767; McNeil, Kirsty/0000-0003-0437-3608; Wijsman, Ellen/0000-0002-2725-6669; Sheffield, Val/0000-0002-6282-0835; Webber, Caleb/0000-0001-8063-7674; Anney, Richard/0000-0002-6083-407X; Freitag, Christine Margarete/0000-0001-9676-4782; Glessner, Joseph/0000-0001-5131-2811	Autism Genome Project Consortium (AGP): Autism Speaks (USA); Health Research Board (HRB; Ireland); Medical Research Council (MRC; UK); Genome Canada/Ontario Genomics Institute; Hilibrand Foundation (USA); US National Institutes of Health (NIH) [HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261]; Canadian Institute for Advanced Research (CIFAR); Canadian Institutes for Health Research (CIHR); Assistance Publique-Hopitaux de Paris (France); Autistica; Canada Foundation for Innovation/Ontario Innovation Trust; Deutsche Forschungsgemeinschaft (Germany) [Po 255/17-4]; EC; Fundacao Calouste Gulbenkian (Portugal); Fondation de France; Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France); Fundacao para a Ciencia e Tecnologia (Portugal); Hospital for Sick Children Foundation; University of Toronto (Canada); INSERM (France); Institut Pasteur (France); Italian Ministry of Health [181]; John P Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK) [075491/Z/04]; Royal Netherlands Academy of Arts and Sciences [TMF/DA/5801]; Netherlands Organization for Scientific Research [825.06.031]; GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto; Hospital for Sick Children (Canada); MRC [MC_U137761446, G0601030] Funding Source: UKRI; Medical Research Council [G0601030, MC_U137761446, G9817803B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748, U19HD035469, P50HD055751, P01HD035465, P50HD055782] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R10MH055284, R01MH055284, R01MH061009, R01MH057881, R01MH080647, R01MH052708, T32MH065215, U54MH066673, R37MH057881, R01MH081754, U10MH066766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS049261, R01NS042165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423, R01DA019963] Funding Source: NIH RePORTER	Autism Genome Project Consortium (AGP): Autism Speaks (USA); Health Research Board (HRB; Ireland); Medical Research Council (MRC; UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Genome Canada/Ontario Genomics Institute(Genome Canada); Hilibrand Foundation (USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Assistance Publique-Hopitaux de Paris (France); Autistica(Autistica); Canada Foundation for Innovation/Ontario Innovation Trust(Canada Foundation for Innovation); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); Fundacao Calouste Gulbenkian (Portugal); Fondation de France(Fondation de France); Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Hospital for Sick Children Foundation; University of Toronto (Canada)(University of Toronto); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur (France); Italian Ministry of Health(Ministry of Health, Italy); John P Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada)(Ministry of Research and Innovation, Ontario); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK)(Wellcome Trust); Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children (Canada); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors acknowledge the families participating in the study and the main funders of the Autism Genome Project Consortium (AGP): Autism Speaks (USA), the Health Research Board (HRB; Ireland), The Medical Research Council (MRC; UK), Genome Canada/Ontario Genomics Institute, and the Hilibrand Foundation (USA). Additional support for individual groups was provided by the US National Institutes of Health (NIH grants HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261), the Canadian Institute for Advanced Research (CIFAR), the Canadian Institutes for Health Research (CIHR), Assistance Publique-Hopitaux de Paris (France), Autistica, Canada Foundation for Innovation/Ontario Innovation Trust, Deutsche Forschungsgemeinschaft (grant Po 255/17-4) (Germany), EC Sixth FP AUTISM MOLGEN, Fundacao Calouste Gulbenkian (Portugal), Fondation de France, Fondation FondaMental (France), Fondation Orange (France), Fondation pour la Recherche Medicale (France), Fundacao para a Ciencia e Tecnologia (Portugal), the Hospital for Sick Children Foundation and University of Toronto (Canada), INSERM (France), Institut Pasteur (France), the Italian Ministry of Health (convention 181 of 19.10.2001), the John P Hussman Foundation (USA), McLaughlin Centre (Canada), Ontario Ministry of Research and Innovation (Canada), the Seaver Foundation (USA), the Swedish Science Council, The Centre for Applied Genomics (Canada), the Utah Autism Foundation (USA) and the Wellcome Trust core award 075491/Z/04 (UK). D. P. is supported by fellowships from the Royal Netherlands Academy of Arts and Sciences (TMF/DA/5801) and the Netherlands Organization for Scientific Research (Rubicon 825.06.031). S.W.S. holds the GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children (Canada).	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meechan DW, 2009, P NATL ACAD SCI USA, V106, P16434, DOI 10.1073/pnas.0905696106; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490	30	1420	1516	4	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					368	372		10.1038/nature09146	http://dx.doi.org/10.1038/nature09146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20531469	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-28	WOS:000279867100049
J	Wu, FCW; Tajar, A; Beynon, JM; Pye, SR; Silman, AJ; Finn, JD; O'Neill, TW; Bartfai, G; Casanueva, FF; Forti, G; Giwercman, A; Han, TS; Kula, K; Lean, MEJ; Pendleton, N; Punab, M; Boonen, S; Vanderschueren, D; Labrie, F; Huhtaniemi, IT				Wu, Frederick C. W.; Tajar, Abdelouahid; Beynon, Jennifer M.; Pye, Stephen R.; Silman, Alan J.; Finn, Joseph D.; O'Neill, Terence W.; Bartfai, Gyorgy; Casanueva, Felipe F.; Forti, Gianni; Giwercman, Aleksander; Han, Thang S.; Kula, Krzysztof; Lean, Michael E. J.; Pendleton, Neil; Punab, Margus; Boonen, Steven; Vanderschueren, Dirk; Labrie, Fernand; Huhtaniemi, Ilpo T.		EMAS Grp	Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	88th Annual Meeting of the Endocrine-Society	JUN 24-27, 2006	Boston, MA	Endocrine Soc			MALE TESTOSTERONE THERAPY; ANDROGEN DEFICIENCY; OLDER MEN; SERUM TESTOSTERONE; SCREENING QUESTIONNAIRES; SEXUAL FUNCTION; AGING MEN; ADULT MEN; PREVALENCE; DIAGNOSIS	BACKGROUND The association between aging-related testosterone deficiency and late-onset hypogonadism in men remains a controversial concept. We sought evidence-based criteria for identifying late-onset hypogonadism in the general population on the basis of an association between symptoms and a low testosterone level. METHODS We surveyed a random population sample of 3369 men between the ages of 40 and 79 years at eight European centers. Using questionnaires, we collected data with regard to the subjects' general, sexual, physical, and psychological health. Levels of total testosterone were measured in morning blood samples by mass spectrometry, and free testosterone levels were calculated with the use of Vermeulen's formula. Data were randomly split into separate training and validation sets for confirmatory analyses. RESULTS In the training set, symptoms of poor morning erection, low sexual desire, erectile dysfunction, inability to perform vigorous activity, depression, and fatigue were significantly related to the testosterone level. Increased probabilities of the three sexual symptoms and limited physical vigor were discernible with decreased testosterone levels (ranges, 8.0 to 13.0 nmol per liter [2.3 to 3.7 ng per milliliter] for total testosterone and 160 to 280 pmol per liter [46 to 81 pg per milliliter] for free testosterone). However, only the three sexual symptoms had a syndromic association with decreased testosterone levels. An inverse relationship between an increasing number of sexual symptoms and a decreasing testosterone level was observed. These relationships were independently confirmed in the validation set, in which the strengths of the association between symptoms and low testosterone levels determined the minimum criteria necessary to identify late-onset hypogonadism. CONCLUSIONS Late-onset hypogonadism can be defined by the presence of at least three sexual symptoms associated with a total testosterone level of less than 11 nmol per liter (3.2 ng per milliliter) and a free testosterone level of less than 220 pmol per liter (64 pg per milliliter).	[Wu, Frederick C. W.] Univ Manchester, Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Dev & Regenerat Biomed Res Grp,Androl Res Unit, Manchester M13 9WL, Lancs, England; [Tajar, Abdelouahid; Pye, Stephen R.; O'Neill, Terence W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester M13 9WL, Lancs, England; [Silman, Alan J.] Arthrit Res UK, Chesterfield, England; [Han, Thang S.] UCL, Dept Endocrinol, London, England; [Lean, Michael E. J.] Univ Glasgow, Dept Human Nutr, Glasgow, Lanark, Scotland; [Pendleton, Neil] Univ Manchester, Sch Community Based Med, Salford Royal NHS Trust, Salford, Lancs, England; [Huhtaniemi, Ilpo T.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Bartfai, Gyorgy] Albert Szent Gyorgy Med Univ, Dept Obstet Gynaecol & Androl, Szeged, Hungary; [Casanueva, Felipe F.] Univ Santiago de Compostela, Dept Med, Complejo Hosp Univ Santiago,Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Santiago De Compostela, Spain; [Forti, Gianni] Univ Florence, Endocrinol Unit, Dept Clin Physiopathol, Florence, Italy; [Giwercman, Aleksander] Lund Univ, Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden; [Kula, Krzysztof] Med Univ Lodz, Dept Androl & Reprod Endocrinol, Lodz, Poland; [Punab, Margus] Tartu Univ Clin, United Labs, Androl Unit, Tartu, Estonia; [Boonen, Steven] Katholieke Univ Leuven, Dept Geriatr Med, Leuven, Belgium; [Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Androl & Endocrinol, Leuven, Belgium; [Labrie, Fernand] Univ Laval, Lab Mol Endocrinol & Oncol, Quebec City, PQ, Canada	University of Manchester; University of Manchester; University of London; University College London; University of Glasgow; Salford Royal NHS Foundation Trust; University of Manchester; Imperial College London; Szeged University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; University of Florence; Lund University; Skane University Hospital; Medical University Lodz; University of Tartu; KU Leuven; KU Leuven; Laval University	Wu, FCW (corresponding author), Univ Manchester, Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Dev & Regenerat Biomed Res Grp,Androl Res Unit, Grafton St, Manchester M13 9WL, Lancs, England.	frederick.wu@manchester.ac.uk	Pye, Stephen R/D-9236-2011; Pendleton, Neil/F-2333-2015	Pye, Stephen R/0000-0002-7263-2897; Pendleton, Neil/0000-0003-0794-2386; vanderschueren, dirk/0000-0003-1395-0104; Han, Thang/0000-0003-2570-0938; Punab, Margus/0000-0001-9601-6311; O'Neill, Terence/0000-0002-8896-4677				Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573; Benzecri J.P., 1992, CORRES ANAL HDB; Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P678, DOI 10.1210/jc.2004-1184; Bhasin S, 2006, NAT CLIN PRACT ENDOC, V2, P529, DOI 10.1038/ncpendmet0299; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Delhez M, 2003, PSYCHONEUROENDOCRINO, V28, P863, DOI 10.1016/S0306-4530(02)00102-6; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Gladh YM, 2005, MATURITAS, V50, P161, DOI 10.1016/j.maturitas.2004.05.008; Gray PB, 2005, J CLIN ENDOCR METAB, V90, P3838, DOI 10.1210/jc.2005-0247; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Heinemann L A J, 2004, Aging Male, V7, P211; Kelleher S, 2004, J CLIN ENDOCR METAB, V89, P3813, DOI 10.1210/jc.2004-0143; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Lee DM, 2009, INT J ANDROL, V32, P11, DOI 10.1111/j.1365-2605.2008.00879.x; Liverman CT, 2004, TESTOSTERONE AGING C; McKinlay JB, 2007, MENOPAUSE, V14, P973, DOI 10.1097/gme.0b013e31815708ee; Miner MM, 2007, INT J CLIN PRACT, V61, P622, DOI 10.1111/j.1742-1241.2007.01317.x; Morales A, 2006, EUR UROL, V50, P407, DOI 10.1016/j.eururo.2006.07.001; Morley JE, 1997, METABOLISM, V46, P410, DOI 10.1016/S0026-0495(97)90057-3; Morley JE, 2006, MATURITAS, V53, P424, DOI 10.1016/j.maturitas.2005.07.004; Nieschlag E, 2006, J ANDROL, V27, P135, DOI 10.2164/jandrol.05047; O'Connor DB, 2008, J SEX MED, V5, P1374, DOI 10.1111/j.1743-6109.2008.00781.x; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Shames D, 2007, J CLIN ENDOCR METAB, V92, P414, DOI 10.1210/jc.2006-2642; Snyder PJ, 2004, NEW ENGL J MED, V350, P440, DOI 10.1056/NEJMp038207; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Tancredi A, 2004, EUR J ENDOCRINOL, V151, P355, DOI 10.1530/eje.0.1510355; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859; Travison TG, 2006, MATURITAS, V54, P305, DOI 10.1016/j.maturitas.2006.02.006; Travison TG, 2006, J CLIN ENDOCR METAB, V91, P2509, DOI 10.1210/jc.2005-2508; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Wu FCW, 2007, J CLIN ENDOCR METAB, V92, P418, DOI 10.1210/jc.2006-2799; Zitzmann M, 2006, J CLIN ENDOCR METAB, V91, P4335, DOI 10.1210/jc.2006-0401	38	898	947	4	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					123	135		10.1056/NEJMoa0911101	http://dx.doi.org/10.1056/NEJMoa0911101			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	621JY	20554979	Green Published, Bronze			2022-12-28	WOS:000279574100005
J	Grubb, MS; Burrone, J				Grubb, Matthew S.; Burrone, Juan			Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability	NATURE			English	Article							ACTION-POTENTIAL INITIATION; CA1 PYRAMIDAL NEURONS; CA2+ CHANNELS; HOMEOSTASIS; GENERATION; HIPPOCAMPAL; PROPAGATION; NA(V)1.6; SITE	In neurons, the axon initial segment (AIS) is a specialized region near the start of the axon that is the site of action potential initiation(1-6). The precise location of the AIS varies across and within different neuronal types(7,8), and has been linked to cells' information-processing capabilities(8); however, the factors determining AIS position in individual neurons remain unknown. Here we show that changes in electrical activity can alter the location of the AIS. In dissociated hippocampal cultures, chronic depolarization with high extracellular potassium moves multiple components of the AIS, including voltage-gated sodium channels, up to 17 mu m away from the soma of excitatory neurons. This movement reverses when neurons are returned to non-depolarized conditions, and depends on the activation of T- and/or L-type voltage-gated calcium channels. The AIS also moved distally when we combined long-term LED (light-emitting diode) photostimulation with sparse neuronal expression of the light-activated cation channel channelrhodopsin-2; here, burst patterning of activity was successful where regular stimulation at the same frequency failed. Furthermore, changes in AIS position correlate with alterations in current thresholds for action potential spiking. Our results show that neurons can regulate the position of an entire subcellular structure according to their ongoing levels and patterns of electrical activity. This novel form of activity-dependent plasticity may fine-tune neuronal excitability during development.	[Grubb, Matthew S.; Burrone, Juan] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Grubb, MS (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Campus, London SE1 1UL, England.	matthew.grubb@kcl.ac.uk; juan.burrone@kcl.ac.uk	Grubb, Matthew S/B-4939-2008	Grubb, Matthew S/0000-0002-2673-274X; Burrone, Juan/0000-0003-1233-668X	Wellcome Trust; Lister Institute; MRC [G0901899] Funding Source: UKRI; Medical Research Council [G0901899, G0901899B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Lister Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Komada for the anti-bIV-spectrin antibody, K. Deisseroth for the ChR2 construct, N. Ben Fredj for assistance with cell culture, S. Poopalasundaramfor help with molecular biology, P. Degenaar and N. Grossman for assistance with LED photostimulation, and I. Thompson and K. Bender for comments on the manuscript. This work was supported by the Wellcome Trust and a Lister Institute Research Prize to J.B.	AKRITAS MG, 1990, J AM STAT ASSOC, V85, P73, DOI 10.2307/2289527; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Cendes F, 2005, CURR OPIN NEUROL, V18, P173, DOI 10.1097/01.wco.0000162860.49842.90; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Foust A, 2010, J NEUROSCI, V30, P6891, DOI 10.1523/JNEUROSCI.0552-10.2010; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kress GJ, 2010, HIPPOCAMPUS, V20, P558, DOI 10.1002/hipo.20667; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PALMER MN, 2010, J PHYSL, V588, P1709; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	32	405	406	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1070	U131		10.1038/nature09160	http://dx.doi.org/10.1038/nature09160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543823	Green Accepted			2022-12-28	WOS:000279056900051
J	Green, J; Charman, T; McConachie, H; Aldred, C; Slonims, V; Howlin, P; Le Couteur, A; Leadbitter, K; Hudry, K; Byford, S; Barrett, B; Temple, K; Macdonald, W; Pickles, A				Green, Jonathan; Charman, Tony; McConachie, Helen; Aldred, Catherine; Slonims, Vicky; Howlin, Pat; Le Couteur, Ann; Leadbitter, Kathy; Hudry, Kristelle; Byford, Sarah; Barrett, Barbara; Temple, Kathryn; Macdonald, Wendy; Pickles, Andrew		PACT Consortium	Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial	LANCET			English	Article							JOINT ATTENTION; YOUNG-CHILDREN; SPECTRUM; INTERVENTION; LANGUAGE; BEHAVIORS; DISORDER; PLAY	Background Results of small trials suggest that early interventions for social communication are effective for the treatment of autism in children. We therefore investigated the efficacy of such an intervention in a larger trial. Methods Children with core autism (aged 2 years to 4 years and 11 months) were randomly assigned in a one-to-one ratio to a parent-mediated communication-focused (Preschool Autism Communication Trial [PACT]) intervention or treatment as usual at three specialist centres in the UK. Those assigned to PACT were also given treatment as usual. Randomisation was by use of minimisation of probability in the marginal distribution of treatment centre, age (<= 42 months or >42 months), and autism severity (Autism Diagnostic Observation Schedule-Generic [ADOS-G] algorithm score 12-17 or 18-24). Primary outcome was severity of autism symptoms (a total score of social communication algorithm items from ADOS-G, higher score indicating greater severity) at 13 months. Complementary secondary outcomes were measures of parent-child interaction, child language, and adaptive functioning in school. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN58133827. Results 152 children were recruited. 77 were assigned to PACT (London [n=26], Manchester [n=26], and Newcastle [n=25]); and 75 to treatment as usual (London [n=26], Manchester [n=26], and Newcastle [n=23]). At the 13-month endpoint, the severity of symptoms was reduced by 3.9 points (SD 4.7) on the ADOS-G algorithm in the group assigned to PACT, and 2.9 (3.9) in the group assigned to treatment as usual, representing a between-group effect size of 0.24 (95% CI 0.59 to 0.11), after adjustment for centre, sex, socioeconomic status, age, and verbal and nonverbal abilities. Treatment effect was positive for parental synchronous response to child (1.22, 0.85 to 1.59), child initiations with parent (0.41, 0.08 to 0.74), and for parent-child shared attention (0.33, 0.02 to 0.68). Effects on directly assessed language and adaptive functioning in school were small. Interpretation On the basis of our findings, we cannot recommend the addition of the PACT intervention to treatment as usual for the reduction of autism symptoms; however, a clear benefit was noted for parent-child dyadic social communication.	[Green, Jonathan; Aldred, Catherine; Leadbitter, Kathy] Univ Manchester, Psychiat Res Grp, Manchester, Lancs, England; [Pickles, Andrew] Univ Manchester, Hlth Sci Res Grp, Manchester, Lancs, England; [Macdonald, Wendy] Univ Manchester, Natl Inst Hlth Res, Sch Primary Care Res, Manchester, Lancs, England; [Green, Jonathan] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England; [Green, Jonathan] Manchester Biomed Res Ctr, Manchester, Lancs, England; [Charman, Tony; Hudry, Kristelle] Univ London, Inst Educ, Ctr Res Autism & Educ, London WC1N 1AZ, England; [McConachie, Helen; Le Couteur, Ann; Temple, Kathryn] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Aldred, Catherine] Stockport Primary Care Trust, Childrens Therapy Serv, Stockport, Lancs, England; [Slonims, Vicky] Guys & St Thomas NHS Fdn Trust, Newcomen Ctr, London, England; [Howlin, Pat] Kings Coll London, Inst Psychiat, Dept Clin Psychol, London WC2R 2LS, England; [Byford, Sarah; Barrett, Barbara] Kings Coll London, Ctr Econ Mental Hlth, London WC2R 2LS, England	University of Manchester; University of Manchester; University of Manchester; Royal Manchester Children's Hospital; University of Manchester; University of London; University College London; UCL Institute of Education; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Green, J (corresponding author), Room 4-319,Univ Pl,Oxford Rd, Manchester M13 9PL, Lancs, England.	jonathan.green@manchester.ac.uk	Pickles, Andrew/A-9625-2011; Howlin, Patricia/A-7622-2011; Charman, Tony/A-2085-2014; Byford, Sarah/D-1699-2010; Barrett, Barbara M/F-7606-2010	Pickles, Andrew/0000-0003-1283-0346; Charman, Tony/0000-0003-1993-6549; Byford, Sarah/0000-0001-7084-1495; Barrett, Barbara M/0000-0002-0270-6256; Green, Jonathan/0000-0002-0143-181X; Leadbitter, Kathy/0000-0002-0744-2800; Hudry, Kristelle/0000-0002-2752-8345; Howlin, Patricia/0000-0002-1804-6053	UK Medical Research Council; UK Department for Children, Schools and Families; University of Manchester; Medical Research Council [G0401546]; UK Department of Health; UK National Autistic Society; UK Mental Health Research Network; MRC [G0401546] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for Children, Schools and Families; University of Manchester; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health; UK National Autistic Society; UK Mental Health Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was sponsored by the University of Manchester. PACT was funded by the Medical Research Council (G0401546), the UK Department for Children, Schools and Families; with a UK Department of Health award for excess treatment and support costs. We gratefully thank all families participating in the study and the referring professionals. We acknowledge invaluable support and guidance from our trial steering committee (Eric Taylor, Alan Emond, Francis Creed, Richard Mills, and Tina McClelland), and our data monitoring and ethics committee (Patrick Bolton, Paula Williamson, and Brain Neville). Other support for trial design and management was provided by Barbara Farrell, and Richard Mills. We are grateful for the support and collaboartion of the UK National Autistic Society throughout the trial. The study was adopted by the UK Mental Health Research Network, who provided valuable officer support clinical studies. UK Medical Research Council.	Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; CHAKRABARTI S, 2001, JAMA-J AM MED ASSOC, V285, P3141; COHEN DJ, 1977, STAT POWER ANAL BEHA; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; DIGGLE T, 2003, COCHRANE REV; Fenson L., 1993, MACARTHUR COMMUNICAT; Goldstein H, 2002, J AUTISM DEV DISORD, V32, P373, DOI 10.1023/A:1020589821992; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 2009, AJIDD-AM J INTELLECT, V114, P23, DOI [10.1352/2009.114:23-41, 10.1352/2009.114:23;nd41]; Kasari C, 2006, J CHILD PSYCHOL PSYC, V47, P611, DOI 10.1111/j.1469-7610.2005.01567.x; Kasari C, 2008, J CONSULT CLIN PSYCH, V76, P125, DOI 10.1037/0022-006X.76.1.125; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Le Couteur A, 2003, NATL AUTISM PLAN CHI; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lord C, 2005, J AUTISM DEV DISORD, V35, P695, DOI 10.1007/s10803-005-0017-6; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; McConachie H, 2007, J EVAL CLIN PRACT, V13, P120, DOI 10.1111/j.1365-2753.2006.00674.x; McMahon B, 2008, EUR CHILD ADOLES PSY, V17, P432, DOI 10.1007/s00787-008-0685-9; Mullen E.M., 1995, MULLEN SCALES EARLY; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Siller M, 2002, J AUTISM DEV DISORD, V32, P77, DOI 10.1023/A:1014884404276; Siller M, 2008, DEV PSYCHOL, V44, P1691, DOI 10.1037/a0013771; Sparrow S. S., 2006, PARENT CAREGIVER RAT, VSecond, DOI 10.1037/t15164-000; Spreckley M, 2009, J PEDIATR-US, V154, P338, DOI 10.1016/j.jpeds.2008.09.012; Taylor A., 1998, RECENT ADV STAT ANAL, P127; Wetherby A. M, 2002, COMMUNICATION SYMBOL, DOI 10.1037/t11529-000; Yoder P, 2006, J CONSULT CLIN PSYCH, V74, P426, DOI 10.1037/0022-006X.74.3.426; ZIMMER IL, 1992, PRESCHOOL LANGUAGE S	32	464	470	8	200	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2010	375	9732					2152	2160		10.1016/S0140-6736(10)60587-9	http://dx.doi.org/10.1016/S0140-6736(10)60587-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20494434	Green Published			2022-12-28	WOS:000279255100025
J	Smith, J; Wigginton, N; Ash, C; Fahrenkamp-Uppenbrink, J; Pennisi, E				Smith, Jesse; Wigginton, Nick; Ash, Caroline; Fahrenkamp-Uppenbrink, Julia; Pennisi, Elizabeth			Changing Oceans INTRODUCTION	SCIENCE			English	Editorial Material													Wigginton, Nicholas S/F-1747-2011	Wigginton, Nicholas S/0000-0001-9161-6131					0	5	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1497	1497		10.1126/science.328.5985.1497	http://dx.doi.org/10.1126/science.328.5985.1497			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558699				2022-12-28	WOS:000278859200027
J	Huesch, MD				Huesch, Marco D.			Payment Policy Based on Measurement of Health Care Spending and Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURVIVAL		[Huesch, Marco D.] Duke Univ, Fuqua Sch Business, Strategy Area, Durham, NC 27708 USA; [Huesch, Marco D.] Duke Sch Med, Dept Community & Family Med, Durham, NC USA; [Huesch, Marco D.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Huesch, MD (corresponding author), Duke Univ, Fuqua Sch Business, Strategy Area, 1 Towerview Dr, Durham, NC 27708 USA.	m.huesch@duke.edu		Huesch, Marco/0000-0003-3010-1243				Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; *DARTM I HLTH POL, 2008, DARTM ATL HLTH CAR T; Elkin EB, 2010, JAMA-J AM MED ASSOC, V303, P1086, DOI 10.1001/jama.2010.283; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Harris Gardiner, 2010, NEW YORK TIMES  0713, pA16; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706	10	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2405	2406		10.1001/jama.2010.817	http://dx.doi.org/10.1001/jama.2010.817			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551412				2022-12-28	WOS:000278759200032
J	Rockey, SJ; Collins, FS				Rockey, Sally J.; Collins, Francis S.			Managing Financial Conflict of Interest in Biomedical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Collins, Francis S.] NIH, Off Director, Bethesda, MD 20892 USA; [Rockey, Sally J.] NIH, Off Extramural Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Off Director, 9000 Rockville Pike, Bethesda, MD 20892 USA.	collinsf@mail.nih.gov			Intramural NIH HHS [Z99 OD999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)			0	21	22	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2400	2402		10.1001/jama.2010.774	http://dx.doi.org/10.1001/jama.2010.774			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20498237	Green Accepted			2022-12-28	WOS:000278759200030
J	Belknap, SM				Belknap, Steven M.			Review: Rapid-response teams do not reduce mortality in hospital patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIAL		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Belknap, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Belknap, Steven/0000-0002-3670-7409				AKRE M, 2010, PEDIATRICS      0322; Hillman K, 2005, LANCET, V365, P2091; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; 2009, HEALTHCARE BENCHMARK, V16, P52	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-3	10.7326/0003-4819-152-12-201006150-02003	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547897				2022-12-28	WOS:000278827700024
J	Jarillo-Herrero, P				Jarillo-Herrero, Pablo			Pulling Apart Molecular Magnetism	SCIENCE			English	Editorial Material									MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Jarillo-Herrero, P (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	pjarillo@mit.edu	Jarillo-Herrero, Pablo/E-3755-2013	Jarillo-Herrero, Pablo/0000-0001-8217-8213				Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Kouwenhoven L, 2001, PHYS WORLD, V14, P33; NOZIERES P, 1980, J PHYS-PARIS, V41, P193, DOI 10.1051/jphys:01980004103019300; Otte AF, 2008, NAT PHYS, V4, P847, DOI 10.1038/nphys1072; Parks JJ, 2010, SCIENCE, V328, P1370, DOI 10.1126/science.1186874; Posazhennikova A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036802; Roch N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.197202	8	5	5	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1362	1363		10.1126/science.1191411	http://dx.doi.org/10.1126/science.1191411			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538938	Green Submitted			2022-12-28	WOS:000278598400025
J	Tarsy, D; Sweadner, KJ; Song, PC				Tarsy, Daniel; Sweadner, Kathleen J.; Song, Phillip C.			A Woman with Flexion of the Left Hand and Foot and Difficulty Speaking Rapid-onset dystonia-parkinsonism due to a mutation in the ATP1A3 gene.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMOSOME 19Q13; FAMILY; RDP; HETEROGENEITY; LINKAGE		[Tarsy, Daniel] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Sweadner, Kathleen J.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Song, Phillip C.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Tarsy, Daniel] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Sweadner, Kathleen J.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Song, Phillip C.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Tarsy, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058949] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Brashear A, 1997, NEUROLOGY, V48, P1066, DOI 10.1212/WNL.48.4.1066; Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J; Brashear A, 1998, ANN NEUROL, V43, P521, DOI 10.1002/ana.410430417; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Carbon M, 2008, MOVEMENT DISORD, V23, P234, DOI 10.1002/mds.21806; Defazio G, 2007, BRAIN, V130, P1183, DOI 10.1093/brain/awl355; DOBYNS WB, 1993, NEUROLOGY, V43, P2596, DOI 10.1212/WNL.43.12.2596; Fabbrini G, 2005, MOVEMENT DISORD, V20, P81, DOI 10.1002/mds.20267; Kabakci K, 2005, J NEUROL NEUROSUR PS, V76, P860, DOI 10.1136/jnnp.2004.046730; Kamm C, 2008, NEUROLOGY, V70, P1501, DOI 10.1212/01.wnl.0000310431.41036.e0; Kamphuis DJ, 2006, MOVEMENT DISORD, V21, P118, DOI 10.1002/mds.20695; Kramer PL, 1999, ANN NEUROL, V46, P176, DOI 10.1002/1531-8249(199908)46:2<176::AID-ANA6>3.0.CO;2-2; Lee JY, 2007, MOVEMENT DISORD, V22, P1808, DOI 10.1002/mds.21638; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKeon A, 2007, MOVEMENT DISORD, V22, P1325, DOI 10.1002/mds.21335; Pittock SJ, 2000, NEUROLOGY, V55, P991, DOI 10.1212/WNL.55.7.991; Schneider SA, 2009, MOVEMENT DISORD, V24, P490, DOI 10.1002/mds.22314; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Tarsy D, 2006, NEW ENGL J MED, V355, P818, DOI 10.1056/NEJMra055549; Zaremba J, 2004, MOVEMENT DISORD, V19, P1506, DOI 10.1002/mds.20258; 2006, N ENGL J MED, V355, P831	24	12	12	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2213	2219		10.1056/NEJMcpc1002112	http://dx.doi.org/10.1056/NEJMcpc1002112			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558373				2022-12-28	WOS:000278551500012
J	Runchey, S; McGee, S				Runchey, Shauna; McGee, Steven			Does This Patient Have a Hemorrhagic Stroke? Clinical Findings Distinguishing Hemorrhagic Stroke From Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIAGNOSTIC-ACCURACY; SIRIRAJ; SCORE; MANAGEMENT; LIKELIHOOD; INFARCTION	Context The 2 fundamental subtypes of stroke are hemorrhagic stroke and ischemic stroke. Although neuroimaging is required to distinguish these subtypes, the diagnostic accuracy of bedside findings has not been systematically reviewed. Objective To determine the accuracy of clinical examination in distinguishing hemorrhagic stroke from ischemic stroke. Data Sources MEDLINE and EMBASE searches of English-language articles published from January 1966 to April 2010. Study Selection Prospective studies of adult patients with stroke that compared initial clinical findings with accepted diagnostic standards of hemorrhagic stroke (computed tomography or autopsy). Data Extraction Both authors independently appraised study quality and extracted relevant data. Data Synthesis Nineteen prospective studies meeting inclusion criteria were identified (N=6438 patients; n=1528 [24%] with hemorrhage stroke). Several findings significantly increase the probability of hemorrhagic stroke: coma (likelihood ratio [LR], 6.2; 95% confidence interval [CI], 3.2-12), neck stiffness (LR, 5.0; 95% CI, 1.9-12.8), seizures accompanying the neurologic deficit (LR, 4.7; 95% CI, 1.6-14), diastolic blood pressure greater than 110 mm Hg (LR, 4.3; 95% CI, 1.4-14), vomiting (LR, 3.0; 95% CI, 1.7-5.5), and headache (LR, 2.9; 95% CI, 1.7-4.8). Other findings decrease the probability of hemorrhage: cervical bruit (LR, 0.12; 95% CI, 0.03-0.47) and prior transient ischemic attack (LR, 0.34; 95% CI, 0.18-0.65). A Siriraj score greater than 1 increases the probability of hemorrhage (LR, 5.7; 95% CI, 4.4-7.4) while a score lower than -1 decreases the probability (LR, 0.29; 95% CI, 0.23-0.37). Nonetheless, many patients with stroke lack any diagnostic finding, and 20% have Siriraj scores between 1 and -1, which are diagnostically unhelpful (LR, 0.94; 95% CI, 0.77-1.1). Conclusion In patients with acute stroke, certain findings accurately increase or decrease the probability of intracranial hemorrhage, but no finding or combination of findings is definitively diagnostic in all patients, and diagnostic certainty requires neuroimaging. JAMA. 2010; 303(22): 2280-2286	[Runchey, Shauna; McGee, Steven] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Runchey, S (corresponding author), Univ Washington, Dept Med, Box 356426,1959 NE Pacific St,Hlth Sci Bldg, Seattle, WA 98195 USA.	srunchey@u.washington.edu						Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ALLEN CMC, 1983, Q J MED, V52, P515; Badam P, 2003, NATL MED J INDIA, V16, P8; BESSON G, 1995, STROKE, V26, P1205, DOI 10.1161/01.STR.26.7.1205; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Brainin M, 2007, LANCET NEUROL, V6, P553, DOI 10.1016/S1474-4422(07)70005-4; BRITTON M, 1983, ACTA MED SCAND, V214, P3; Daga M K, 1994, J Assoc Physicians India, V42, P302; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Efstathiou SP, 2002, J INTERN MED, V252, P121, DOI 10.1046/j.1365-2796.2002.01013.x; Fisher CM, 2002, NEW ENGL J MED, V347, P1642, DOI 10.1056/NEJMp020129; Goldstein LB, 2005, JAMA-J AM MED ASSOC, V293, P2391, DOI 10.1001/jama.293.19.2391; Hui A. C. F., 2002, Hong Kong Medical Journal, V8, P177; Hui ACF, 2002, INTERN MED J, V32, P311, DOI 10.1046/j.1445-5994.2002.00228.x; Ilic T, 1997, Vojnosanit Pregl, V54, P299; Kan CH, 2000, INT J CLIN PRACT, V54, P645; Kleindorfer D, 2004, STROKE, V35, pE27, DOI 10.1161/01.STR.0000109767.11426.17; Kochar D K, 2000, J Assoc Physicians India, V48, P1222; Kolapo KO, 2006, STROKE, V37, P1997, DOI 10.1161/01.STR.0000229893.02732.02; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mader Timothy J., 1998, Journal of Emergency Medicine, V16, P9, DOI 10.1016/S0736-4679(97)00237-0; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Massaro AR, 2002, ARQ NEURO-PSIQUIAT, V60, P185, DOI 10.1590/S0004-282X2002000200001; McGee S, 2002, J GEN INTERN MED, V17, P646; Ng PW, 1996, STROKE, V27, P773; Nouira S, 2009, ANN EMERG MED, V53, P373, DOI 10.1016/j.annemergmed.2008.06.005; Nyandaiti YW, 2008, NIGER J CLIN PRACT, V11, P176; Ozeren A, 2006, EUR J NEUROL, V13, P611, DOI 10.1111/j.1468-1331.2006.01296.x; Pandian JD, 2007, INT J STROKE, V2, P17, DOI 10.1111/j.1747-4949.2007.00089.x; PANZER RJ, 1985, ARCH INTERN MED, V145, P1800, DOI 10.1001/archinte.145.10.1800; POUNGVARIN N, 1991, BRIT MED J, V302, P1565, DOI 10.1136/bmj.302.6792.1565; SACKETT DL, 2006, CLIN EPIDEMIOLOGY BA; Shah Farid Ullah, 2003, J Coll Physicians Surg Pak, V13, P391; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; Wadhwani Jyoti, 2002, J Assoc Physicians India, V50, P777; *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105, DOI [DOI 10.1016/0895-4356(88)90084-4, 10.1016/0895-4356(88)90084-4]; Woisetschlager C, 2000, INTENS CARE MED, V26, P1561, DOI 10.1007/s001340000663; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	38	58	59	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2280	2286		10.1001/jama.2010.754	http://dx.doi.org/10.1001/jama.2010.754			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530782				2022-12-28	WOS:000278496800027
J	Garcia, MS; De la Torre, MA; Morales, G; Pelaez, B; Tolon, MJ; Domingo, S; Candel, FJ; Andrade, R; Arribi, A; Garcia, N; Sagasti, FM; Fereres, J; Picazo, J				Sanchez Garcia, Miguel; Angeles De la Torre, Maria; Morales, Gracia; Pelaez, Beatriz; Jose Tolon, Maria; Domingo, Sara; Javier Candel, Francisco; Andrade, Raquel; Arribi, Ana; Garcia, Nicolas; Martinez Sagasti, Fernando; Fereres, Jose; Picazo, Juan			Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIELD GEL-ELECTROPHORESIS; ENTEROCOCCUS-FAECALIS; RIBOSOMAL-RNA; 1ST REPORT; GENE; EMERGENCE; INFECTION; EPIDERMIDIS; SITUATION; STRAINS	Context Linezolid resistance is extremely uncommon in Staphylococcus aureus. Objective To report an outbreak with linezolid and methicillin-resistant S aureus (LRSA) in an intensive care department and the effective control measures taken. Design, Setting, and Patients Outbreak study of consecutive critically ill patients colonized and/or infected with LRSA at an intensive care department of a 1000-bed tertiary care university teaching hospital in Madrid, Spain. Patients were placed under strict contact isolation. Daily updates of outbreak data and recommendations for the use of linezolid were issued. Extensive environmental sampling and screening of the hands of health care workers were performed. Main Outcome Measures Linezolid use and clinical and epidemiological characteristics and outcomes using minimal inhibitory concentrations, pulsed-field gel electrophoresis, and polymerase chain reaction of LRSA isolates. Results Between April 13 and June 26, 2008, 12 patients with LRSA were identified. In 6 patients, LRSA caused ventilator-associated pneumonia and in 3 patients it caused bacteremia. Isolates were susceptible to trimethoprim-sulfamethoxazole, glycopeptides, tigecycline, and daptomycin. Genotyping identified 1 predominant clone and 3 other types. Cfr-mediated linezolid resistance was demonstrated in all isolates. Potential hospital staff carriers and environmental samples were negative except for one. Six patients died, 5 of them in the intensive care unit, with 1 death attributed to LRSA infection. Linezolid use decreased from 202 defined daily doses in April 2008 to 25 defined daily doses in July 2008. Between July 2008 and April 2010, no new cases have been identified in the weekly surveillance cultures or diagnostic samples. Conclusions The first clinical outbreak, to our knowledge, with LRSA mediated by the cfr gene developed at our center, was associated with nosocomial transmission and extensive usage of linezolid. Reduction of linezolid use and infection-control measures were associated with the termination of the outbreak. JAMA. 2010; 303(22): 2260-2264	[Sanchez Garcia, Miguel; Angeles De la Torre, Maria; Jose Tolon, Maria; Domingo, Sara; Martinez Sagasti, Fernando] Hosp Clin San Carlos, Dept Intens Care, Madrid 28040, Spain; [Morales, Gracia; Javier Candel, Francisco; Arribi, Ana; Picazo, Juan] Hosp Clin San Carlos, Microbiol Serv, Madrid 28040, Spain; [Pelaez, Beatriz; Andrade, Raquel; Garcia, Nicolas; Fereres, Jose] Hosp Clin San Carlos, Prevent Med Serv, Madrid 28040, Spain; Univ Complutense, E-28040 Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid	Garcia, MS (corresponding author), Hosp Clin San Carlos, Dept Intens Care, Madrid 28040, Spain.	msanchezga.hcsc@salud.madrid.org	González, Francisco Javier Candel/Z-5068-2019	González, Francisco Javier Candel/0000-0002-9840-6556; arribi, ana/0000-0003-0716-1897; Martinez-Sagasti, Fernando/0000-0001-8599-1250	Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos	Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos	Dr Morales has a research contract of the Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos.	Álvarez-Lerma F., 2007, Med. Intensiva, V31, P6; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Burleson BS, 2004, PHARMACOTHERAPY, V24, P1225, DOI 10.1592/phco.24.13.1225.38086; CABEZASMARTIN MH, 2006, MED INTENSIVA, V30; *CLIN LAB STAND I, 2008, 17 INF SUPPL DOC; Cuevas O, 2008, ENFERM INFEC MICR CL, V26, P269, DOI 10.1157/13120413; Diekema DJ, 2001, LANCET, V358, P1975, DOI 10.1016/S0140-6736(01)06964-1; Gales AC, 2006, INT J ANTIMICROB AG, V27, P300, DOI 10.1016/j.ijantimicag.2005.11.008; Hentschke M, 2008, INFECTION, V36, P85, DOI 10.1007/s15010-007-7220-7; Howden BP, 2004, CLIN INFECT DIS, V38, P521, DOI 10.1086/381202; Jones RN, 2009, DIAGN MICR INFEC DIS, V64, P191, DOI 10.1016/j.diagmicrobio.2009.03.001; Jones RN, 2008, DIAGN MICR INFEC DIS, V62, P416, DOI 10.1016/j.diagmicrobio.2008.10.010; Kelly S, 2008, J ANTIMICROB CHEMOTH, V61, P901, DOI 10.1093/jac/dkn043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kola A, 2007, SCAND J INFECT DIS, V39, P463, DOI 10.1080/00365540601071875; Kollef MH, 2004, INTENS CARE MED, V30, P388, DOI 10.1007/s00134-003-2088-1; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; Meka VG, 2004, J INFECT DIS, V190, P311, DOI 10.1086/421471; Meka VG, 2004, J ANTIMICROB CHEMOTH, V54, P818, DOI 10.1093/jac/dkh423; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Miller K, 2008, ANTIMICROB AGENTS CH, V52, P1940, DOI 10.1128/AAC.01302-07; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Paterson DL, 2003, ANN INTERN MED, V139, P863, DOI 10.7326/0003-4819-139-10-200311180-00017; Peeters MJ, 2005, AM J MED SCI, V330, P102, DOI 10.1097/00000441-200508000-00007; Rahim S, 2003, CLIN INFECT DIS, V36, pE146, DOI 10.1086/374929; Roberts SM, 2006, PEDIATR INFECT DIS J, V25, P562, DOI 10.1097/01.inf.0000219401.70804.1a; Ruggero KA, 2003, DIAGN MICR INFEC DIS, V47, P511, DOI 10.1016/S0732-8893(03)00153-6; Scheetz MH, 2008, ANTIMICROB AGENTS CH, V52, P2256, DOI 10.1128/AAC.00070-08; Schulte B, 2008, EPIDEMIOL INFECT, V136, P1131, DOI 10.1017/S0950268807009508; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Trevino M, 2009, EUR J CLIN MICROBIOL, V28, P527, DOI 10.1007/s10096-008-0657-5; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104	38	173	176	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2260	2264		10.1001/jama.2010.757	http://dx.doi.org/10.1001/jama.2010.757			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530779	Bronze			2022-12-28	WOS:000278496800024
J	Wolf, ET; Toon, OB				Wolf, E. T.; Toon, O. B.			Fractal Organic Hazes Provided an Ultraviolet Shield for Early Earth	SCIENCE			English	Article							PHOTOLYSIS; GREENHOUSE; ATMOSPHERE; EVOLUTION; AMMONIA; METHANE; MODEL	The Archean Earth (3.8 to 2.5 billion years ago) was probably enshrouded by a photochemical haze composed of fractal aggregate hydrocarbon aerosols. The fractal structure of the aerosols would have had a strong effect on the radiative properties of the haze. In this study, a fractal aggregate haze was found to be optically thick in the ultraviolet wavelengths while remaining relatively transparent in the mid-visible wavelengths. At an annual production rate of 10(14) grams per year and an average monomer radius of 50 nanometers, the haze would have provided a strong shield against ultraviolet light while causing only minimal antigreenhouse cooling.	[Wolf, E. T.; Toon, O. B.] Univ Colorado, Dept Atmospher & Ocean Sci, Lab Atmospher & Space Phys, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Wolf, ET (corresponding author), Univ Colorado, Dept Atmospher & Ocean Sci, Lab Atmospher & Space Phys, Boulder, CO 80309 USA.				NASA [NNX08AG93G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA grant NNX08AG93G.	BARNUN A, 1988, J GEOPHYS RES-ATMOS, V93, P8383, DOI 10.1029/JD093iD07p08383; Botet R, 1997, APPL OPTICS, V36, P8791, DOI 10.1364/AO.36.008791; CABANE M, 1993, PLANET SPACE SCI, V41, P257, DOI 10.1016/0032-0633(93)90021-S; DeWitt HL, 2009, ASTROBIOLOGY, V9, P447, DOI 10.1089/ast.2008.0289; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; MANDLEBROT BB, 1977, FRACTALS FORM CHANCE; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; *NASA, NNX08AG93G NASA; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Pham M, 1995, J GEOPHYS RES-ATMOS, V100, P26061, DOI 10.1029/95JD02095; Rannou P, 2003, PLANET SPACE SCI, V51, P963, DOI 10.1016/j.pss.2003.05.008; Rannou P, 1997, J GEOPHYS RES-PLANET, V102, P10997, DOI 10.1029/97JE00719; Rannou P, 1995, ICARUS, V118, P355, DOI 10.1006/icar.1995.1196; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; Sleep NH, 2006, EARTH PLANET SC LETT, V241, P594, DOI 10.1016/j.epsl.2005.11.020; Tomasko MG, 2008, PLANET SPACE SCI, V56, P669, DOI 10.1016/j.pss.2007.11.019; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819	25	99	101	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1266	1268		10.1126/science.1183260	http://dx.doi.org/10.1126/science.1183260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522772				2022-12-28	WOS:000278318600031
J	Kim, K; Chang, MS; Korenblit, S; Islam, R; Edwards, EE; Freericks, JK; Lin, GD; Duan, LM; Monroe, C				Kim, K.; Chang, M. -S.; Korenblit, S.; Islam, R.; Edwards, E. E.; Freericks, J. K.; Lin, G. -D.; Duan, L. -M.; Monroe, C.			Quantum simulation of frustrated Ising spins with trapped ions	NATURE			English	Article							ENTANGLEMENT; SYSTEMS; COMPUTATION; GLASSES; STATE	A network is frustrated when competing interactions between nodes prevent each bond from being satisfied. This compromise is central to the behaviour of many complex systems, from social(1) and neural(2) networks to protein folding(3) and magnetism(4,5). Frustrated networks have highly degenerate ground states, with excess entropy and disorder even at zero temperature. In the case of quantum networks, frustration can lead to massively entangled ground states, underpinning exotic materials such as quantum spin liquids and spin glasses(6-9). Here we realize a quantum simulation of frustrated Ising spins in a system of three trapped atomic ions(10-12), whose interactions are precisely controlled using optical forces(13). We study the ground state of this system as it adiabatically evolves from a transverse polarized state, and observe that frustration induces extra degeneracy. We also measure the entanglement in the system, finding a link between frustration and ground-state entanglement. This experimental system can be scaled to simulate larger numbers of spins, the ground states of which (for frustrated interactions) cannot be simulated on a classical computer.	[Kim, K.; Chang, M. -S.; Korenblit, S.; Islam, R.; Edwards, E. E.; Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Kim, K.; Chang, M. -S.; Korenblit, S.; Islam, R.; Edwards, E. E.; Monroe, C.] NIST, College Pk, MD 20742 USA; [Freericks, J. K.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Lin, G. -D.; Duan, L. -M.] Univ Michigan, MCTP, Ann Arbor, MI 48109 USA; [Lin, G. -D.; Duan, L. -M.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; Georgetown University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kim, K (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.	khkim@umd.edu	Chang, Ming-Shien/F-7922-2012; Freericks, James K/D-7502-2011; Monroe, Christopher R/G-8105-2011	Chang, Ming-Shien/0000-0002-6385-0374; Freericks, James K/0000-0002-6232-9165; LIN, GUIN-DAR/0000-0002-2243-9490	US Army Research Office (ARO) [W911NF0710576, W911NF0410234]; US National Science Foundation (NSF); NSF Physics Frontier Center at the Joint Quantum Institute	US Army Research Office (ARO); US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Physics Frontier Center at the Joint Quantum Institute	We acknowledge discussions with J. Moore, M. Newman, J. Wang and S. Das Sarma. This work is supported by US Army Research Office (ARO) award W911NF0710576 with funds from the Defense Advanced Research Projects Agency Optical Lattice Emulator programme, the Intelligence Advanced Research Projects Agency under ARO award W911NF0410234, the US National Science Foundation (NSF) Physics at the Information Frontier programme and the NSF Physics Frontier Center at the Joint Quantum Institute.	BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Dawson CM, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.052316; Deng XL, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063407; Diep HT, 2005, FRUSTRATED SPIN SYSTEMS, P1, DOI 10.1142/9789812567819; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Guhne O, 2009, PHYS REP, V474, P1, DOI 10.1016/j.physrep.2009.02.004; Han YJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.150404; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Milburn GJ, 2000, FORTSCHR PHYS, V48, P801, DOI 10.1002/1521-3978(200009)48:9/11<801::AID-PROP801>3.0.CO;2-1; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Normand B, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094427; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; PAULING LC, 1945, NATURE CHEM BOND, P464; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Sachdev S., 1999, QUANTUM PHASE TRANSI; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schmitz H, 2009, APPL PHYS B-LASERS O, V95, P195, DOI 10.1007/s00340-009-3455-6; VAKS VG, 1966, SOV PHYS JETP-USSR, V22, P820; Wasserman S., 1994, SOCIAL NETWORK ANAL, P98; Zhu SL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050505	29	583	588	6	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					590	U81		10.1038/nature09071	http://dx.doi.org/10.1038/nature09071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520708				2022-12-28	WOS:000278249000035
J	Glazier, RH; Redelmeier, DA				Glazier, Richard H.; Redelmeier, Donald A.			Building the Patient-Centered Medical Home in Ontario	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Glazier, Richard H.; Redelmeier, Donald A.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Glazier, Richard H.] Univ Toronto, St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Glazier, Richard H.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Redelmeier, Donald A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Glazier, RH (corresponding author), 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	rick.glazier@ices.on.ca	Glazier, Richard H/E-5255-2012					Baron RJ, 2009, JAMA-J AM MED ASSOC, V301, P1922, DOI 10.1001/jama.2009.558; Glazier Richard H, 2009, CMAJ, V180, pE72, DOI 10.1503/cmaj.081316; Green Michael E, 2009, Healthc Policy, V5, pe161; *HEALTHFORCEONTARI, PRIM HLTH CAR; Howard Michelle, 2009, Healthc Policy, V5, P106; Larson EB, 2010, JAMA-J AM MED ASSOC, V303, P1644, DOI 10.1001/jama.2010.524; Mitka M, 2008, JAMA-J AM MED ASSOC, V300, P1875, DOI 10.1001/jama.2008.501; O'Hare C Dennis, 2004, Fam Pract Manag, V11, P35; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Rosser WW, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911519	10	39	39	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2186	2187		10.1001/jama.2010.753	http://dx.doi.org/10.1001/jama.2010.753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516421				2022-12-28	WOS:000278182100029
J	Puri, S				Puri, Sunita			Worn	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sunita.puri@ucsf.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2117	2118		10.1001/jama.2010.714	http://dx.doi.org/10.1001/jama.2010.714			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516405				2022-12-28	WOS:000278182100001
J	Jones, KL; Adekola, AS; Bardayan, DW; Blackmon, JC; Chae, KY; Chipps, KA; Cizewski, JA; Erikson, L; Harlin, C; Hatarik, R; Kapler, R; Kozub, RL; Liang, JF; Livesay, R; Ma, Z; Moazen, BH; Nesaraja, CD; Nunes, FM; Pain, SD; Patterson, NP; Shapira, D; Shriner, JF; Smith, MS; Swan, TP; Thomas, JS				Jones, K. L.; Adekola, A. S.; Bardayan, D. W.; Blackmon, J. C.; Chae, K. Y.; Chipps, K. A.; Cizewski, J. A.; Erikson, L.; Harlin, C.; Hatarik, R.; Kapler, R.; Kozub, R. L.; Liang, J. F.; Livesay, R.; Ma, Z.; Moazen, B. H.; Nesaraja, C. D.; Nunes, F. M.; Pain, S. D.; Patterson, N. P.; Shapira, D.; Shriner, J. F., Jr.; Smith, M. S.; Swan, T. P.; Thomas, J. S.			The magic nature of Sn-132 explored through the single-particle states of Sn-133	NATURE			English	Article							D,P REACTIONS; PB-208	Atomic nuclei have a shell structure(1) in which nuclei with 'magic numbers' of neutrons and protons are analogous to the noble gases in atomic physics. Only ten nuclei with the standard magic numbers of both neutrons and protons have so far been observed. The nuclear shell model is founded on the precept that neutrons and protons can move as independent particles in orbitals with discrete quantum numbers, subject to a mean field generated by all the other nucleons. Knowledge of the properties of single-particle states outside nuclear shell closures in exotic nuclei is important(2-5) for a fundamental understanding of nuclear structure and nucleo-synthesis (for example the r-process, which is responsible for the production of about half of the heavy elements). However, as a result of their short lifetimes, there is a paucity of knowledge about the nature of single-particle states outside exotic doubly magic nuclei. Here we measure the single-particle character of the levels in Sn-133 that lie outside the double shell closure present at the short-lived nucleus Sn-132. We use an inverse kinematics technique that involves the transfer of a single nucleon to the nucleus. The purity of the measured single-particle states clearly illustrates the magic nature of Sn-132.	[Jones, K. L.; Chae, K. Y.; Kapler, R.; Ma, Z.; Moazen, B. H.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Jones, K. L.; Cizewski, J. A.; Hatarik, R.; Pain, S. D.; Swan, T. P.] Rutgers State Univ, Dept Phys & Astron, New Brunswick, NJ 08903 USA; [Adekola, A. S.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Bardayan, D. W.; Blackmon, J. C.; Liang, J. F.; Nesaraja, C. D.; Shapira, D.; Smith, M. S.] Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA; [Chipps, K. A.; Erikson, L.; Livesay, R.] Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA; [Harlin, C.; Patterson, N. P.; Swan, T. P.; Thomas, J. S.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Kozub, R. L.; Shriner, J. F., Jr.] Tennessee Technol Univ, Dept Phys, Cookeville, TN 38505 USA; [Nunes, F. M.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Nunes, F. M.] Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA	University of Tennessee System; University of Tennessee Knoxville; Rutgers State University New Brunswick; University System of Ohio; Ohio University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Colorado School of Mines; University of Surrey; Tennessee Technological University; Michigan State University; Michigan State University	Jones, KL (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.	kgrzywac@utk.edu	Jones, Kate L/B-8487-2011; Smith, Michael/I-3359-2018; Pain, Steven D/E-1188-2011	Jones, Kate L/0000-0001-7335-1379; Smith, Michael/0000-0002-4737-4099; Pain, Steven D/0000-0003-3081-688X; Chipps, Kelly/0000-0003-3050-1298; Nesaraja, Caroline/0000-0001-5571-8341; Chae, Kyungyuk/0000-0003-1819-079X	US Department of Energy [DEFG02-96ER40995, DE-FG52-03NA00143, DE-AC05-00OR22725, DE-FG02-96ER40990, DE-FG03-93ER40789, DE-FG02-96ER40983, DE-FG52-08NA28552, DE-AC02-06CH11357]; National Science Foundation [NSF-PHY0354870, NSF-PHY0757678, NSF-PHY-0555893]; UK Science and Technology Funding Council [PP/F000715/1]	US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); UK Science and Technology Funding Council	This work was supported by the US Department of Energy under contract numbers DEFG02-96ER40995 (Tennessee Technological University (TTU)), DE-FG52-03NA00143 (Rutgers, Oak Ridge Associated Universities), DE-AC05-00OR22725 (Oak Ridge National Laboratory), DE-FG02-96ER40990 (TTU), DE-FG03-93ER40789 (Colorado School of Mines), DE-FG02-96ER40983 (University of Tennessee, Knoxville), DE-FG52-08NA28552 (Michigan State University (MSU)), DE-AC02-06CH11357 (MSU), the National Science Foundation under contract numbers NSF-PHY0354870 and NSF-PHY0757678 (Rutgers) and NSF-PHY-0555893 (MSU), and the UK Science and Technology Funding Council under contract number PP/F000715/1.	Barbieri C, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.064313; Coraggio L, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.021305; COWAN JJ, 1991, PHYS REP, V208, P267, DOI 10.1016/0370-1573(91)90070-3; ELLEGAARD C, 1969, NUCL PHYS A, VA129, P113, DOI 10.1016/0375-9474(69)90912-9; Grawe H, 2007, REP PROG PHYS, V70, P1525, DOI 10.1088/0034-4885/70/9/R02; Hirota K, 1998, NUCL PHYS A, V628, P547, DOI 10.1016/S0375-9474(97)00641-6; Hoff P, 1996, PHYS REV LETT, V77, P1020, DOI 10.1103/PhysRevLett.77.1020; Kartamyshev MP, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.024313; Kozub RL, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044307; Kramer GJ, 2001, NUCL PHYS A, V679, P267, DOI 10.1016/S0375-9474(00)00379-1; Mayer M., 1955, THEORY NUCL SHELL ST; Pain SD, 2007, NUCL INSTRUM METH B, V261, P1122, DOI 10.1016/j.nimb.2007.04.289; Pang DY, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.024601; Rehm KE, 1998, PHYS REV LETT, V80, P676, DOI 10.1103/PhysRevLett.80.676; REID RV, 1968, ANN PHYS-NEW YORK, V50, P411, DOI 10.1016/0003-4916(68)90126-7; Sarkar S, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.014312; Stracener DW, 2004, NUCL INSTRUM METH A, V521, P126, DOI 10.1016/j.nima.2003.11.142; STROMICH A, 1977, PHYS REV C, V16, P2193, DOI 10.1103/PhysRevC.16.2193; Terasaki J, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.054313; Thomas JS, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.044302; THOMPSON IJ, 1988, COMPUT PHYS REP, V7, P167, DOI 10.1016/0167-7977(88)90005-6; Urban W, 1999, EUR PHYS J A, V5, P239, DOI 10.1007/s100500050280; WIZA JL, 1979, NUCL INSTRUM METHODS, V162, P587, DOI 10.1016/0029-554X(79)90734-1	23	176	180	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					454	457		10.1038/nature09048	http://dx.doi.org/10.1038/nature09048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505723	Green Submitted			2022-12-28	WOS:000278043700029
J	Pogach, L; Aron, D				Pogach, Leonard; Aron, David			Balancing Hypoglycemia and Glycemic Control A Public Health Approach for Insulin Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVERSE DRUG EVENTS; HEMOGLOBIN A(1C); TYPE-2		[Pogach, Leonard] Dept Vet Affairs New Jersey Healthcare Syst, Res Serv 15, E Orange, NJ 07018 USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Aron, David] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Cleveland, OH USA; [Aron, David] Case Western Reserve Univ, Cleveland, OH 44106 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Pogach, L (corresponding author), Dept Vet Affairs New Jersey Healthcare Syst, Res Serv 15, 385 Tremont Ave, E Orange, NJ 07018 USA.	leonard.pogach@va.gov						Aron D, 2009, JAMA-J AM MED ASSOC, V301, P210, DOI 10.1001/jama.2008.930; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Holmes EW, 2008, AM J CLIN PATHOL, V129, P540, DOI 10.1309/U3GPPTCBP1VLL8AW; Moen MF, 2009, CLIN J AM SOC NEPHRO, V4, P1121, DOI 10.2215/CJN.00800209; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; *NGSP, 2009 NGSP CLIN ADV C; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012	10	27	27	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2076	2077		10.1001/jama.2010.655	http://dx.doi.org/10.1001/jama.2010.655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501929				2022-12-28	WOS:000278018200033
J	Sessions, SY; Detsky, AS				Sessions, Samuel Y.; Detsky, Allan S.			Washington, Ottawa, and Health Care Reform A Tale of 2 Capitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; INSURANCE		[Detsky, Allan S.] Univ Toronto, Mt Sinai Hosp, Dept Hlth Policy Management & Evaluat, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Nework, Toronto, ON, Canada; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, Dept Psychiat & Biobehav Sci, Torrance, CA 90509 USA; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, LABiomed, Torrance, CA 90509 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Detsky, AS (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Hlth Policy Management & Evaluat, Dept Med, 429-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Aaron HJ, 2010, NEW ENGL J MED, V362, P1259, DOI 10.1056/NEJMp1003394; Blumenthal D, 2006, NEW ENGL J MED, V355, P82, DOI 10.1056/NEJMhpr060703; Chernew ME, 2010, NEW ENGL J MED, V362, P1166, DOI 10.1056/NEJMp1002873; Detsky AS, 2003, NEW ENGL J MED, V349, P804, DOI 10.1056/NEJMhpr035304; KLEIN E, 2010, NEWSWEEK        0305; Oberlander J, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1002878; Peterson M., 2005, HLTH WEALTHY FAIR HL, P205; Ross JS, 2008, JAMA-J AM MED ASSOC, V300, P1934, DOI 10.1001/jama.300.16.1934; Sessions SY, 2009, JAMA-J AM MED ASSOC, V302, P2252, DOI 10.1001/jama.2009.1712	9	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2078	2079		10.1001/jama.2010.654	http://dx.doi.org/10.1001/jama.2010.654			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501930				2022-12-28	WOS:000278018200034
J	Morris, RV; Ruff, SW; Gellert, R; Ming, DW; Arvidson, RE; Clark, BC; Golden, DC; Siebach, K; Klingelhofer, G; Schroder, C; Fleischer, I; Yen, AS; Squyres, SW				Morris, Richard V.; Ruff, Steven W.; Gellert, Ralf; Ming, Douglas W.; Arvidson, Raymond E.; Clark, Benton C.; Golden, D. C.; Siebach, Kirsten; Klingelhoefer, Goestar; Schroeder, Christian; Fleischer, Iris; Yen, Albert S.; Squyres, Steven W.			Identification of Carbonate-Rich Outcrops on Mars by the Spirit Rover	SCIENCE			English	Article							MARTIAN METEORITE ALH84001; TERRESTRIAL ANALOG; MINERALS; SPITSBERGEN; GLOBULES; SVALBARD; OLIVINE; ORIGIN; ROCKS; AGE	Decades of speculation about a warmer, wetter Mars climate in the planet's first billion years postulate a denser CO2-rich atmosphere than at present. Such an atmosphere should have led to the formation of outcrops rich in carbonate minerals, for which evidence has been sparse. Using the Mars Exploration Rover Spirit, we have now identified outcrops rich in magnesium-iron carbonate (16 to 34 weight percent) in the Columbia Hills of Gusev crater. Its composition approximates the average composition of the carbonate globules in martian meteorite ALH 84001. The Gusev carbonate probably precipitated from carbonate-bearing solutions under hydrothermal conditions at near-neutral pH in association with volcanic activity during the Noachian era.	[Morris, Richard V.; Ming, Douglas W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Ruff, Steven W.] Arizona State Univ, Tempe, AZ 85287 USA; [Gellert, Ralf] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Arvidson, Raymond E.; Siebach, Kirsten] Washington Univ, St Louis, MO 63130 USA; [Clark, Benton C.] Space Sci Inst, Boulder, CO 80301 USA; [Golden, D. C.] Engn & Sci Contract Grp Hamilton Sundstrand, Houston, TX 77058 USA; [Klingelhoefer, Goestar; Fleischer, Iris] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Schroeder, Christian] Univ Bayreuth, Tubingen, Germany; [Schroeder, Christian] Univ Tubingen, Tubingen, Germany; [Yen, Albert S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Squyres, Steven W.] Cornell Univ, Ithaca, NY 14853 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Arizona State University; Arizona State University-Tempe; University of Guelph; Washington University (WUSTL); Johannes Gutenberg University of Mainz; University of Bayreuth; Eberhard Karls University of Tubingen; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University	Morris, RV (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	richard.v.morris@nasa.gov	Schröder, Christian/B-3870-2009	Schröder, Christian/0000-0002-7935-6039; Siebach, Kirsten/0000-0002-6628-6297	NASA Johnson Space Center; NASA; NASA Ames Astrobiology Institute; German Space Agency DLR [50QM9902]	NASA Johnson Space Center(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA Ames Astrobiology Institute; German Space Agency DLR(Helmholtz AssociationGerman Aerospace Centre (DLR))	R.V.M. and D.W.M. acknowledge the NASA Johnson Space Center and the NASA Mars Exploration Program for support. R. V. M. acknowledges the NASA Ames Astrobiology Institute for support. S. W. R. acknowledges the NASA Mars Data Analysis Program for support. G. K. and I. F. acknowledge support by the German Space Agency DLR under contract 50QM9902. A portion of the research described in this paper was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. We thank P. B. Niles for carbonate samples, L. Le for carbonate microprobe analyses, and J. L. Campbell for calculation of excess light-element concentrations from APXS data.	AMUNDSEN HEF, 1987, TECTONOPHYSICS, V139, P169, DOI 10.1016/0040-1951(87)90095-3; Arvidson RE, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003183; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Banks D, 1999, GEOTHERMICS, V28, P713, DOI 10.1016/S0375-6505(99)00019-X; Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Campbell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002959; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Ehlmann BL, 2008, SCIENCE, V322, P1828, DOI 10.1126/science.1164759; GAFFEY SJ, 1987, J GEOPHYS RES-SOLID, V92, P1429, DOI 10.1029/JB092iB02p01429; Golden DC, 2000, METEORIT PLANET SCI, V35, P457, DOI 10.1111/j.1945-5100.2000.tb01428.x; Golombek MP, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002503; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; GOODING JL, 1986, SOLAR SYSTEM OBSERVA, V4, P208; Hamilton VE, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002501; Hamilton VE, 2005, GEOLOGY, V33, P433, DOI 10.1130/G21258.1; Harvey RP, 1996, NATURE, V382, P49, DOI 10.1038/382049a0; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; KINGELHOFER G, 2003, J GEOPHYS RES, V108, P8067; Lane MD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021231; Mccoy TJ, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003041; Ming DW, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003195; Ming DW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002560; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Morris RV, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003201; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002584; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Squyres SW, 2008, SCIENCE, V320, P1063, DOI 10.1126/science.1155429; Squyres SW, 2007, SCIENCE, V316, P738, DOI 10.1126/science.1139045; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002562; Steele A, 2007, METEORIT PLANET SCI, V42, P1549, DOI 10.1111/j.1945-5100.2007.tb00590.x; TREIMAN AH, 1995, METEORITICS, V30, P294, DOI 10.1111/j.1945-5100.1995.tb01127.x; Treiman AH, 2002, EARTH PLANET SC LETT, V204, P323, DOI 10.1016/S0012-821X(02)00998-6; Usui T, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003225; Yen AS, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002978	38	283	289	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					421	424		10.1126/science.1189667	http://dx.doi.org/10.1126/science.1189667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20522738				2022-12-28	WOS:000280196500032
J	Noman, A; Ang, DSC; Ogston, S; Lang, CC; Struthers, AD				Noman, Awsan; Ang, Donald S. C.; Ogston, Simon; Lang, Chim C.; Struthers, Allan D.			Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial	LANCET			English	Article							CHRONIC HEART-FAILURE; XANTHINE-OXIDASE INHIBITION; CORONARY-ARTERY-DISEASE; ENDOTHELIAL FUNCTION; ERECTILE DYSFUNCTION; ATENOLOL; PECTORIS; CARDIOMYOPATHY; SILDENAFIL; AMLODIPINE	Background Experimental evidence suggests that xanthine oxidase inhibitors can reduce myocardial oxygen consumption for a particular stroke volume. If such an effect also occurs in man, this class of inhibitors could become a new treatment for ischaemia in patients with angina pectoris. We ascertained whether high-dose allopurinol prolongs exercise capability in patients with chronic stable angina. Methods 65 patients (aged 18-85 years) with angiographically documented coronary artery disease, a positive exercise tolerance test, and stable chronic angina pectoris (for at least 2 months) were recruited into a double-blind, randomised, placebo-controlled, crossover study in a hospital and two infirmaries in the UK. We used computer-generated randomisation to assign patients to allopurinol (600 mg per day) or placebo for 6 weeks before crossover. Our primary endpoint was the time to ST depression, and the secondary endpoints were total exercise time and time to chest pain. We did a completed case analysis. This study is registered as an International Standard Randomised Controlled Trial, number IS RCTN 82040078. Findings In the first treatment period, 31 patients were allocated to allopurinol and 28 were analysed, and 34 were allocated to placebo and 32 were analysed. In the second period, all 60 patients were analysed. Allopurinol increased the median time to ST depression to 298 s (IQR 211-408) from a baseline of 232 s (182-380), and placebo increased it to 249 s (200-375; p=0.0002). The point estimate (absolute difference between allopurinol and placebo) was 43 s (95% CI 31-58). Allopurinol increased median total exercise time to 393 s (IQR 280-519) from a baseline of 301 s (251-447), and placebo increased it to 307s (232-430; p=0.0003); the point estimate was 58 s (95% Cl 45-77). Allopurinol increased the time to chest pain from a baseline of 234 s (IQR 189-382) to 304 s (222-421), and placebo increased it to 272 s (200-380; p=0.001); the point estimate was 38s (95% Cl 17-55). No adverse effects of treatment were reported. Interpretation Allopurinol seems to be a useful, inexpensive, well tolerated, and safe anti-ischaemic drug for patients with angina.	[Struthers, Allan D.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Cardiovasc & Lung Biol, Div Med Sci, Dundee DD1 9SY, Scotland; [Ogston, Simon] Univ Dundee, Div Clin & Populat Sci & Educ, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Struthers, AD (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Cardiovasc & Lung Biol, Div Med Sci, Mail Box 2, Dundee DD1 9SY, Scotland.	a.d.struthers@dundee.ac.uk		Lang, Chim/0000-0002-4530-3078; Struthers, Allan/0000-0002-2926-2528	British Heart Foundation [FS/06/029]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (FS/06/029). We thank June Anderson for assistance during the exercise tests (data collection).	Baldus S, 2005, FREE RADICAL BIO MED, V39, P1184, DOI 10.1016/j.freeradbiomed.2005.06.004; Beltrame JF, 2009, ARCH INTERN MED, V169, P1491, DOI 10.1001/archinternmed.2009.295; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Cappola TP, 2001, CIRCULATION, V104, P2407, DOI 10.1161/hc4501.098928; Cardillo C, 1997, HYPERTENSION, V30, P57, DOI 10.1161/01.HYP.30.1.57; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Dunselman PHJM, 1998, AM J CARDIOL, V81, P128, DOI 10.1016/S0002-9149(97)00877-1; Ekelund UEG, 1999, CIRC RES, V85, P437, DOI 10.1161/01.RES.85.5.437; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Fox KM, 2003, EUR HEART J, V24, P2206, DOI 10.1016/j.ehj.2003.09.021; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Gavin AD, 2005, HEART, V91, P749, DOI 10.1136/hrt.2004.040477; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; George J, 2009, J AM COLL CARDIOL, V53, P2405, DOI 10.1016/j.jacc.2008.07.076; Guthikonda S, 2003, CIRCULATION, V107, P416, DOI 10.1161/01.CIR.0000046448.26751.58; Halcox JPJ, 2002, J AM COLL CARDIOL, V40, P1232, DOI 10.1016/S0735-1097(02)02139-3; Hollander M, 1973, NONPARAMETRIC STAT M, P27; Khan F, 2008, CARDIOVASC THER, V26, P247, DOI 10.1111/j.1755-5922.2008.00057.x; Khatib SY, 2001, BIOCHEMISTRY-MOSCOW+, V66, P328, DOI 10.1023/A:1010264216357; Knight CJ, 1998, AM J CARDIOL, V81, P133, DOI 10.1016/S0002-9149(97)00893-X; Mellin V, 2005, EUR HEART J, V26, P1544, DOI 10.1093/eurheartj/ehi305; Mercuro G, 2004, AM J CARDIOL, V94, P932, DOI 10.1016/j.amjcard.2004.06.032; O'Driscoll JG, 1999, CLIN EXP PHARMACOL P, V26, P779, DOI 10.1046/j.1440-1681.1999.03125.x; Perez NG, 1998, CIRC RES, V83, P423, DOI 10.1161/01.RES.83.4.423; Rentoukas E, 2010, INT J CARDIOL, V145, P257, DOI 10.1016/j.ijcard.2009.08.037; Rousseau MF, 2005, AM J CARDIOL, V95, P311, DOI 10.1016/j.amjcard.2004.09.025; Saavedra WF, 2002, CIRC RES, V90, P297, DOI 10.1161/hh0302.104531; Saugstad OD, 1996, PEDIATRICS, V98, P103; Stull LB, 2004, CIRC RES, V95, P1005, DOI 10.1161/01.RES.0000148635.73331.c5; Tardif JC, 2009, EUR HEART J, V30, P540, DOI 10.1093/eurheartj/ehn571; Thadani U, 2002, J AM COLL CARDIOL, V40, P2006, DOI 10.1016/S0735-1097(02)02563-9; Ukai T, 2001, CIRCULATION, V103, P750	35	249	261	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2010	375	9732					2161	2167		10.1016/S0140-6736(10)60391-1	http://dx.doi.org/10.1016/S0140-6736(10)60391-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	617BF	20542554	Green Published			2022-12-28	WOS:000279255100026
J	Oppo, DW; Rosenthal, Y				Oppo, Delia W.; Rosenthal, Yair			The Great Indo-Pacific Communicator	SCIENCE			English	Editorial Material							OCEAN		[Oppo, Delia W.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Rosenthal, Yair] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Yair] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA	Woods Hole Oceanographic Institution; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Oppo, DW (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	doppo@whoi.edu						Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Gordon AL, 2010, DYNAM ATMOS OCEANS, V50, P115, DOI 10.1016/j.dynatmoce.2009.12.002; Gordon A.L, 2005, OCEANOGRAPHY, V18, P15, DOI [10.5670/oceanog.2005.01, DOI 10.5670/OCEANOG.2005.01]; Gordon AL, 2003, NATURE, V421, P904, DOI 10.1038/421904a; GORDON AL, 2010, ESA PUBLICATION; Guilyardi E, 2006, CLIM DYNAM, V26, P329, DOI 10.1007/s00382-005-0084-6; McPhaden MJ, 2002, NATURE, V415, P603, DOI 10.1038/415603a; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; Potemra JT, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003808; Saji NH, 2003, CLIM RES, V25, P151, DOI 10.3354/cr025151; SMITH RL, 1991, J PHYS OCEANOGR, V21, P323, DOI 10.1175/1520-0485(1991)021<0323:TLCOWA>2.0.CO;2; Sprintall J, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005257; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Xu J, 2008, EARTH PLANET SC LETT, V273, P152, DOI 10.1016/j.epsl.2008.06.029	16	6	10	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1492	1494		10.1126/science.1187273	http://dx.doi.org/10.1126/science.1187273			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558696				2022-12-28	WOS:000278859200024
J	van Zoest, T; Gaaloul, N; Singh, Y; Ahlers, H; Herr, W; Seidel, ST; Ertmer, W; Rasel, E; Eckart, M; Kajari, E; Arnold, S; Nandi, G; Schleich, WP; Walser, R; Vogel, A; Sengstock, K; Bongs, K; Lewoczko-Adamczyk, W; Schiemangk, M; Schuldt, T; Peters, A; Konemann, T; Muntinga, H; Lammerzahl, C; Dittus, H; Steinmetz, T; Hansch, TW; Reichel, J				van Zoest, T.; Gaaloul, N.; Singh, Y.; Ahlers, H.; Herr, W.; Seidel, S. T.; Ertmer, W.; Rasel, E.; Eckart, M.; Kajari, E.; Arnold, S.; Nandi, G.; Schleich, W. P.; Walser, R.; Vogel, A.; Sengstock, K.; Bongs, K.; Lewoczko-Adamczyk, W.; Schiemangk, M.; Schuldt, T.; Peters, A.; Koenemann, T.; Muentinga, H.; Laemmerzahl, C.; Dittus, H.; Steinmetz, T.; Haensch, T. W.; Reichel, J.			Bose-Einstein Condensation in Microgravity	SCIENCE			English	Article							ANDERSON LOCALIZATION; NOBEL LECTURE; ATOMS; WAVES; CHIP	Albert Einstein's insight that it is impossible to distinguish a local experiment in a "freely falling elevator" from one in free space led to the development of the theory of general relativity. The wave nature of matter manifests itself in a striking way in Bose-Einstein condensates, where millions of atoms lose their identity and can be described by a single macroscopic wave function. We combine these two topics and report the preparation and observation of a Bose-Einstein condensate during free fall in a 146-meter-tall evacuated drop tower. During the expansion over 1 second, the atoms form a giant coherent matter wave that is delocalized on a millimeter scale, which represents a promising source for matter-wave interferometry to test the universality of free fall with quantum matter.	[van Zoest, T.; Gaaloul, N.; Singh, Y.; Ahlers, H.; Herr, W.; Seidel, S. T.; Ertmer, W.; Rasel, E.] Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany; [Eckart, M.; Kajari, E.; Arnold, S.; Nandi, G.; Schleich, W. P.] Univ Ulm, Inst Quantenphys, D-89081 Ulm, Germany; [Walser, R.] Tech Univ Darmstadt, Inst Angew Phys, D-64289 Darmstadt, Germany; [Vogel, A.; Sengstock, K.] Univ Hamburg, Inst Laser Phys, D-22761 Hamburg, Germany; [Bongs, K.] Midlands Ultracold Atom Res Ctr, Birmingham B15 2TT, W Midlands, England; [Lewoczko-Adamczyk, W.; Schiemangk, M.; Schuldt, T.; Peters, A.] Humboldt Univ, D-10117 Berlin, Germany; [Koenemann, T.; Muentinga, H.; Laemmerzahl, C.; Dittus, H.] Univ Bremen, Ctr Appl Space Technol & Micrograv ZARM, D-28359 Bremen, Germany; [Steinmetz, T.; Haensch, T. W.] Univ Munich, Max Planck Inst Quantenopt, D-80799 Munich, Germany; [Steinmetz, T.; Haensch, T. W.] Univ Munich, Sekt Phys, D-80799 Munich, Germany; [Reichel, J.] Ecole Normale Super, Lab Kastler Brossel, F-75231 Paris, France	Leibniz University Hannover; Ulm University; Technical University of Darmstadt; University of Hamburg; University of Birmingham; Humboldt University of Berlin; University of Bremen; Max Planck Society; University of Munich; University of Munich; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Rasel, E (corresponding author), Leibniz Univ Hannover, Inst Quantenopt, Welfengarten 1, D-30167 Hannover, Germany.	rasel@iqo.uni-hannover.de	Gaaloul, Naceur/K-1937-2012; Laemmerzahl, Claus/P-3552-2016; Walser, Reinhold/AAD-8083-2019; Tomastik, Christian/C-4864-2013; Reichel, Jakob/AAW-1107-2021; Peters, Achim/G-3742-2010	Gaaloul, Naceur/0000-0001-8233-5848; Laemmerzahl, Claus/0000-0002-8276-5415; Walser, Reinhold/0000-0003-4937-1008; Reichel, Jakob/0000-0003-3420-4178; Peters, Achim/0000-0001-5538-9250; Schuldt, Thilo/0000-0003-0818-2438; Muntinga, Hauke/0000-0002-6599-6481; Bongs, Kai/0000-0002-7334-1848	Federal Ministry of Economics and Technology (BMWi) [DLR 50 WM 0346]; German Research Foundation	Federal Ministry of Economics and Technology (BMWi)(Federal Ministry for Economic Affairs and Energy (BMWi)); German Research Foundation(German Research Foundation (DFG))	This project is supported by the German Space Agency Deutsches Zentrum fur Luft- und Raumfahrt (DLR) with funds provided by the Federal Ministry of Economics and Technology (BMWi) under grant number DLR 50 WM 0346. We thank the German Research Foundation for funding the Cluster of Excellence QUEST Centre for Quantum Engineering and Space-Time Research.	ARIMONDO E, 2009, P INT SCH PHYS E FER; Berman P., 1997, ATOM INTERFEROMETRY; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Castin Y, 1996, PHYS REV LETT, V77, P5315, DOI 10.1103/PhysRevLett.77.5315; Ciufolini I, 2004, NATURE, V431, P958, DOI 10.1038/nature03007; Ciufolini I., 1995, GRAVITATION INERTIA; Ciufolini I, 2007, NATURE, V449, P41, DOI 10.1038/nature06071; Cornell EA, 2002, REV MOD PHYS, V74, P875, DOI 10.1142/S0217979202014681; Dimopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.111102; Dimopoulos S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.122002; Folman R, 2002, ADV ATOM MOL OPT PHY, V48, P263; Fortagh J, 2007, REV MOD PHYS, V79, P235, DOI 10.1103/RevModPhys.79.235; Fray S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.240404; Hansel W, 2001, NATURE, V413, P498, DOI 10.1038/35097032; Kagan Y, 1996, PHYS REV A, V54, pR1753, DOI 10.1103/PhysRevA.54.R1753; Ketterle W, 2002, REV MOD PHYS, V74, P1131, DOI [10.1103/RevModPhys.74.1131, 10.1142/S0217979202014668]; Leanhardt AE, 2003, SCIENCE, V301, P1513, DOI 10.1126/science.1088827; Misner C. W., 1973, GRAVITATION; Nandi G, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063617; Pasquini TA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.093201; Peters A, 1999, NATURE, V400, P849, DOI 10.1038/23655; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Stern G, 2009, EUR PHYS J D, V53, P353, DOI 10.1140/epjd/e2009-00150-5; Storey P, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.033604; Vogel A, 2006, APPL PHYS B-LASERS O, V84, P663, DOI 10.1007/s00340-006-2359-y; [No title captured]	26	205	206	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1540	1543		10.1126/science.1189164	http://dx.doi.org/10.1126/science.1189164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558713				2022-12-28	WOS:000278859200041
J	Brinks, D; Stefani, FD; Kulzer, F; Hildner, R; Taminiau, TH; Avlasevich, Y; Mullen, K; Van Hulst, NF				Brinks, Daan; Stefani, Fernando D.; Kulzer, Florian; Hildner, Richard; Taminiau, Tim H.; Avlasevich, Yuri; Muellen, Klaus; Van Hulst, Niek F.			Visualizing and controlling vibrational wave packets of single molecules	NATURE			English	Article							COHERENT CONTROL; QUANTUM CONTROL; LASER-PULSES; DYNAMICS; SPECTROSCOPY; FLUORESCENCE; CHEMISTRY; BOND	The active steering of the pathways taken by chemical reactions and the optimization of energy conversion processes(1-3) provide striking examples of the coherent control of quantum interference through the use of shaped laser pulses. Experimentally, coherence is usually established by synchronizing a subset of molecules in an ensemble(4-7) with ultra-short laser pulses(8). But in complex systems where even chemically identical molecules exist with different conformations and in diverse environments, the synchronized subset will have an intrinsic inhomogeneity that limits the degree of coherent control that can be achieved. A natural-and, indeed, the ultimate-solution to overcoming intrinsic inhomogeneities is the investigation of the behaviour of one molecule at a time. The single-molecule approach(9,10) has provided useful insights into phenomena as diverse as biomolecular interactions(11-13), cellular processes(14) and the dynamics of supercooled liquids(15) and conjugated polymers(16.) Coherent state preparation of single molecules has so far been restricted to cryogenic conditions(17), whereas at room temperature only incoherent vibrational relaxation pathways have been probed(18). Here we report the observation and manipulation of vibrational wave-packet interference in individual molecules at ambient conditions. We show that adapting the time and phase distribution of the optical excitation field to the dynamics of each molecule results in a high degree of control, and expect that the approach can be extended to achieve single-molecule coherent control in other complex inhomogeneous systems.	[Brinks, Daan; Stefani, Fernando D.; Kulzer, Florian; Hildner, Richard; Taminiau, Tim H.; Van Hulst, Niek F.] ICFO, Barcelona 08860, Spain; [Avlasevich, Yuri; Muellen, Klaus] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Van Hulst, Niek F.] ICREA, Barcelona 08015, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Max Planck Society; ICREA	Stefani, FD (corresponding author), ICFO, Mediterranean Technol Pk, Barcelona 08860, Spain.	Fernando.Stefani@df.uba.ar; Niek.vanHulst@ICFO.es	Stefani, Fernando/I-9229-2012; Taminiau, Tim Hugo H/A-8094-2008; Hildner, Richard/O-6386-2014; van Hulst, Niek/J-2121-2012	Stefani, Fernando/0000-0001-5120-2356; Taminiau, Tim Hugo H/0000-0002-2355-727X; Hildner, Richard/0000-0002-7282-3730; van Hulst, Niek/0000-0003-4630-1776; Brinks, Daan/0000-0002-5550-5140; Stefani, Fernando/0000-0002-3277-7215	Koerber foundation (Hamburg); Spanish Ministry of Science and Innovation [CSD2007-046-NanoLight.es, MAT2006-08184]; ICREA Funding Source: Custom	Koerber foundation (Hamburg); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	We thank P. Fendel from Menlo Systems for lending us an Octavius system and for technical assistance. We are grateful to Biophotonic Solutions Inc. for collaborating with us in developing the double-pass pulse shaper. We appreciate discussions with A. G. Curto and M. Castro Lopez. This work was supported by the 'Molecular walker' project of the Koerber foundation (Hamburg) and by the Spanish Ministry of Science and Innovation (CSD2007-046-NanoLight.es and MAT2006-08184).	AMSTRUP B, 1991, J PHYS CHEM-US, V95, P8019, DOI 10.1021/j100174a007; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Avlasevich Y, 2007, CHEM-EUR J, V13, P6555, DOI 10.1002/chem.200700523; Bandrauk AD, 2002, LASER CONTROL MANIPU; Barbara PF, 2005, ACCOUNTS CHEM RES, V38, P602, DOI 10.1021/ar040141w; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P151, DOI 10.1016/S0009-2614(97)01081-6; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Basche T., 1996, SINGLE MOL OPTICAL D; Dantus M, 2004, CHEM REV, V104, P1813, DOI 10.1021/cr020668r; Dudovich N, 2002, NATURE, V418, P512, DOI 10.1038/nature00933; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Gerhardt I, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.011402; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Hornung T, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.021403; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kuroda DG, 2009, SCIENCE, V326, P263, DOI 10.1126/science.1176524; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Moerner WE, 2002, J PHYS CHEM B, V106, P910, DOI 10.1021/jp012992g; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; SCHERER NF, 1991, J CHEM PHYS, V95, P1487, DOI 10.1063/1.461064; Shapiro M, 2003, REP PROG PHYS, V66, P859, DOI 10.1088/0034-4885/66/6/201; van Dijk EMHP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078302; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h; Zondervan R, 2007, P NATL ACAD SCI USA, V104, P12628, DOI 10.1073/pnas.0610521104	30	141	143	6	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					905	U5		10.1038/nature09110	http://dx.doi.org/10.1038/nature09110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559383				2022-12-28	WOS:000278804500033
J	Shapiro, RL; Hughes, MD; Ogwu, A; Kitch, D; Lockman, S; Moffat, C; Makhema, J; Moyo, S; Thior, I; McIntosh, K; van Widenfelt, E; Leidner, J; Powis, K; Asmelash, A; Tumbare, E; Zwerski, S; Sharma, U; Handelsman, E; Mburu, K; Jayeoba, O; Moko, E; Souda, S; Lubega, E; Akhtar, M; Wester, C; Tuomola, R; Snowden, W; Martinez-Tristani, M; Mazhani, L; Essex, M				Shapiro, R. L.; Hughes, M. D.; Ogwu, A.; Kitch, D.; Lockman, S.; Moffat, C.; Makhema, J.; Moyo, S.; Thior, I.; McIntosh, K.; van Widenfelt, E.; Leidner, J.; Powis, K.; Asmelash, A.; Tumbare, E.; Zwerski, S.; Sharma, U.; Handelsman, E.; Mburu, K.; Jayeoba, O.; Moko, E.; Souda, S.; Lubega, E.; Akhtar, M.; Wester, C.; Tuomola, R.; Snowden, W.; Martinez-Tristani, M.; Mazhani, L.; Essex, M.			Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOTHER-TO-CHILD; HIV-INFECTED WOMEN; LOW-BIRTH-WEIGHT; RANDOMIZED-TRIAL; PREMATURE DELIVERY; LOPINAVIR EXPOSURE; EQUIVALENCE TRIAL; PRETERM DELIVERY; INCREASED RISK; COTE-DIVOIRE	Background The most effective highly active antiretroviral therapy (HAART) to prevent mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) in pregnancy and its efficacy during breast-feeding are unknown. Methods We randomly assigned 560 HIV-1-infected pregnant women (CD4+ count, >= 200 cells per cubic millimeter) to receive coformulated abacavir, zidovudine, and lamivudine (the nucleoside reverse-transcriptase inhibitor [NRTI] group) or lopinavir-ritonavir plus zidovudine-lamivudine (the protease-inhibitor group) from 26 to 34 weeks' gestation through planned weaning by 6 months post partum. A total of 170 women with CD4+ counts of less than 200 cells per cubic millimeter received nevirapine plus zidovu-dine-lamivudine (the observational group). Infants received single-dose nevirapine and 4 weeks of zidovudine. Results The rate of virologic suppression to less than 400 copies per milliliter was high and did not differ significantly among the three groups at delivery (96% in the NRTI group, 93% in the protease-inhibitor group, and 94% in the observational group) or throughout the breast-feeding period (92% in the NRTI group, 93% in the protease-inhibitor group, and 95% in the observational group). By 6 months of age, 8 of 709 live-born infants (1.1%) were infected (95% confidence interval [CI], 0.5 to 2.2): 6 were infected in utero (4 in the NRTI group, 1 in the protease-inhibitor group, and 1 in the observational group), and 2 were infected during the breast-feeding period (in the NRTI group). Treatment-limiting adverse events occurred in 2% of women in the NRTI group, 2% of women in the protease-inhibitor group, and 11% of women in the observational group. Conclusions All regimens of HAART from pregnancy through 6 months post partum resulted in high rates of virologic suppression, with an overall rate of mother-to-child transmission of 1.1%. (ClinicalTrials.gov number, NCT00270296.)	[Shapiro, R. L.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Shapiro, R. L.; Lockman, S.; Thior, I.; McIntosh, K.; Leidner, J.; Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Hughes, M. D.; Kitch, D.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lockman, S.] Brigham & Womens Hosp, Infect Dis Unit, Boston, MA 02115 USA; [Tuomola, R.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [McIntosh, K.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Powis, K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Powis, K.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Ogwu, A.; Moffat, C.; Makhema, J.; Moyo, S.; Thior, I.; van Widenfelt, E.; Asmelash, A.; Tumbare, E.; Mburu, K.; Jayeoba, O.; Moko, E.; Souda, S.; Lubega, E.; Akhtar, M.; Wester, C.] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Mazhani, L.] Botswana Minist Hlth, Gaborone, Botswana; [Zwerski, S.; Sharma, U.; Handelsman, E.] NIAID, NIH, Bethesda, MD 20892 USA; [Snowden, W.] GlaxoSmithKline Inc, Greenford, Middx, England; [Martinez-Tristani, M.] Abbott Virol, Abbott Pk, IL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Botswana-Harvard AIDS Institute Partnership; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); GlaxoSmithKline	Shapiro, RL (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St,Suite GB, Boston, MA 02215 USA.	rshapiro@hsph.harvard.edu	Powis, Kathleen/AAU-5123-2021; Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592	National Institute of Allergy and Infectious Diseases [U01-AI066454]; Fogarty International Cente [D43 TW00004]; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066454] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Cente(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a grant (U01-AI066454) from the National Institute of Allergy and Infectious Diseases and by a grant (D43 TW00004) from the Fogarty International Center, which supported several of the trainees who were involved in this study.	Aebi C, 2000, AIDS, V14, P2913, DOI 10.1097/00002030-200012220-00013; ARENDT V, 2007, 4 INT AIDS SOC C HIV; Bouillon-Pichault M, 2009, J ANTIMICROB CHEMOTH, V63, P1223, DOI 10.1093/jac/dkp123; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Bussmann H, 2009, JAIDS-J ACQ IMM DEF, V51, P37, DOI 10.1097/QAI.0b013e31819ff102; Chasela C, 2009, 5 INT AIDS SOC C HIV; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; De Vincenzi I, 2009, 5 INT AIDS SOC C HIV; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kourtis AP, 2007, AIDS, V21, P607, DOI 10.1097/QAD.0b013e32802ef2f6; Kumar Princy N, 2009, AIDS Res Ther, V6, P3, DOI 10.1186/1742-6405-6-3; LANGSTON C, 1995, J INFECT DIS, V172, P1451, DOI 10.1093/infdis/172.6.1451; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Leroy V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001645; Lockman S, 2009, 16 C RETR OPP INF MO; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Lyons F, 2007, AIDS, V21, P1053, DOI 10.1097/QAD.0b013e3281053a1e; Martin F, 2007, J INFECT DIS, V196, P558, DOI 10.1086/519848; Mirochnick M, 2008, JAIDS-J ACQ IMM DEF, V49, P485, DOI 10.1097/QAI.0b013e318186edd0; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; *PUBL HLTH SERV TA, REC US ANT DRUGS PRE; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; Stek AM, 2006, AIDS, V20, P1931, DOI 10.1097/01.aids.0000247114.43714.90; Szyld EG, 2006, AIDS, V20, P2345, DOI 10.1097/01.aids.0000253362.01696.9d; TEMMERMAN M, 1990, AIDS, V4, P1087, DOI 10.1097/00002030-199011000-00006; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; THOMAS T, 2008, 15 C RETR OPP INF BO; Thorne C, 2004, AIDS, V18, P2337, DOI 10.1097/00002030-200411190-00019; Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; Tuomala RK, 2005, JAIDS-J ACQ IMM DEF, V38, P449, DOI 10.1097/01.qai.0000139398.38236.4d; Vibhagool A, 2004, CURR MED RES OPIN, V20, P1103, DOI 10.1185/030079904125004006; WHO, 2006, ANT DRUGS TREAT PREG; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; 2006, MMWR MORB MORTAL WKL, V55, P592; 2002, LANCET, V359, P1178	44	362	370	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2282	2294		10.1056/NEJMoa0907736	http://dx.doi.org/10.1056/NEJMoa0907736			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554983	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000278816300007
J	Yu, L; McPhee, CK; Zheng, LX; Mardones, GA; Rong, YG; Peng, JY; Mi, N; Zhao, Y; Liu, ZH; Wan, FY; Hailey, DW; Oorschot, V; Klumperman, J; Baehrecke, EH; Lenardo, MJ				Yu, Li; McPhee, Christina K.; Zheng, Lixin; Mardones, Gonzalo A.; Rong, Yueguang; Peng, Junya; Mi, Na; Zhao, Ying; Liu, Zhihua; Wan, Fengyi; Hailey, Dale W.; Oorschot, Viola; Klumperman, Judith; Baehrecke, Eric H.; Lenardo, Michael J.			Termination of autophagy and reformation of lysosomes regulated by mTOR	NATURE			English	Article							CELL-DEATH; MATURATION; SURVIVAL; PROGRAM; TOR	Autophagy is an evolutionarily conserved process by which cytoplasmic proteins and organelles are catabolized(1,2). During starvation, the protein TOR (target of rapamycin), a nutrient-responsive kinase, is inhibited, and this induces autophagy. In autophagy, double-membrane autophagosomes envelop and sequester intracellular components and then fuse with lysosomes to form autolysosomes, which degrade their contents to regenerate nutrients. Current models of autophagy terminate with the degradation of the autophagosome cargo in autolysosomes(3-5), but the regulation of autophagy in response to nutrients and the subsequent fate of the autolysosome are poorly understood. Here we show that mTOR signalling in rat kidney cells is inhibited during initiation of autophagy, but reactivated by prolonged starvation. Reactivation of mTOR is autophagy-dependent and requires the degradation of autolysosomal products. Increased mTOR activity attenuates autophagy and generates proto-lysosomal tubules and vesicles that extrude from autolysosomes and ultimately mature into functional lysosomes, thereby restoring the full complement of lysosomes in the cell-a process we identify in multiple animal species. Thus, an evolutionarily conserved cycle in autophagy governs nutrient sensing and lysosome homeostasis during starvation.	[Yu, Li; Zheng, Lixin; Liu, Zhihua; Wan, Fengyi; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Yu, Li; Rong, Yueguang; Peng, Junya; Mi, Na] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Li; Rong, Yueguang; Peng, Junya; Mi, Na] State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [McPhee, Christina K.; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [McPhee, Christina K.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Mardones, Gonzalo A.; Hailey, Dale W.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Mardones, Gonzalo A.] Univ Austral Chile, Dept Physiol, Valdivia 5099200, Chile; [Zhao, Ying] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Oorschot, Viola; Klumperman, Judith] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tsinghua University; University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad Austral de Chile; Peking University; Utrecht University; Utrecht University Medical Center	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov		Kary, Christina/0000-0002-2586-4185; RONG, YUEGUANG/0000-0001-6661-9664; Mi, Na/0000-0003-3090-197X	Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services; NIH [GM079431]; 973 program [2010CB833704]; NSF [20091300700]; Tsinghua University [20091081391]; Netherlands Organisation for Scientific Research (NWO) [918.56.611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 program(National Basic Research Program of China); NSF(National Science Foundation (NSF)); Tsinghua University; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of Allergy and Infectious Diseases (NIAID) imaging core facility and Olympus China for technical support; O. Schwartz, J. Kabat, L. Koo, M. Czapiga (Bio-imaging facility (BIF), NIAID, NIH) and Q. Dong (Olympus China) for assistance with confocal microscopy and imaging processing; K. Nagashima and M. J. de la Cruz (NCI) for TEM analyses: J. Lippincott-Schwartz, H Bernstein, and J. Bonifacino for helpful discussions; D. Yamamoto, G. Davis and H. Kramer for constructs and fly strains; and M. v. Peski and R. Scriwanek for assistance with the preparation of the EM figures. This research was supported by the Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services and NIH Grant GM079431 to E. B., 973 program 2010CB833704, NSF grant 20091300700, and Tsinghua University grant 20091081391 to Y.L. J. K. is the recipient of VICI grant 918.56.611 of the Netherlands Organisation for Scientific Research (NWO).	Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yu L, 2004, CELL CYCLE, V3, P1124; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902	17	1037	1095	7	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					942	U11		10.1038/nature09076	http://dx.doi.org/10.1038/nature09076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20526321	Green Accepted			2022-12-28	WOS:000278804500041
J	Bronson, DL; Franco, KS				Bronson, David L.; Franco, Kathleen S.			Review: Exercise interventions reduce anxiety in patients with chronic illness	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bronson, David L.; Franco, Kathleen S.] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Bronson, DL (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Herring, Matthew/O-2265-2014	Herring, Matthew/0000-0002-6835-5321				*NIH CLIN EXC, 2004, CLIN GUID NIH CLIN E, V22; Stein MB, 2004, AM J PSYCHIAT, V161, P2230, DOI 10.1176/appi.ajp.161.12.2230; Wang JL, 2005, CAN J PSYCHIAT, V50, P652, DOI 10.1177/070674370505001012	3	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-4	10.7326/0003-4819-152-12-201006150-02004	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547898				2022-12-28	WOS:000278827700025
J	Cools, F; Askie, LM; Offringa, M; Asselin, JM; Calvert, SA; Courtney, SE; Dani, C; Durand, DJ; Gerstmann, DR; Henderson-Smart, DJ; Marlow, N; Peacock, JL; Pillow, JJ; Soll, RF; Thome, UH; Truffert, P; Schreiber, MD; Van Reempts, P; Vendettuoli, V; Vento, G				Cools, Filip; Askie, Lisa M.; Offringa, Martin; Asselin, Jeanette M.; Calvert, Sandra A.; Courtney, Sherry E.; Dani, Carlo; Durand, David J.; Gerstmann, Dale R.; Henderson-Smart, David J.; Marlow, Neil; Peacock, Janet L.; Pillow, J. Jane; Soll, Roger F.; Thome, Ulrich H.; Truffert, Patrick; Schreiber, Michael D.; Van Reempts, Patrick; Vendettuoli, Valentina; Vento, Giovanni		PreVILIG Collaboration	Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data	LANCET			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MECHANICAL VENTILATION; LUNG INFLAMMATION; RANDOMIZED-TRIAL; VOLUME GUARANTEE; BLOOD-FLOW; PULMONARY; PRESSURE; DISEASE; INJURY	Background Population and study design heterogeneity has confounded previous meta-analyses, leading to uncertainty about effectiveness and safety of elective high-frequency oscillatory ventilation (HFOV) in preterrn infants. We assessed effectiveness of elective HFOV versus conventional ventilation in this group. Methods We did a systematic review and meta-analysis of individual patients' data from 3229 participants in ten randomised controlled trials, with the primary outcomes of death or bronchopulmonary dysplasia at 36 weeks' postmenstrual age, death or severe adverse neurological event, or any of these outcomes. Findings For infants ventilated with HFOV, the relative risk of death or bronchopulmonary dysplasia at 36 weeks' postmenstrual age was 0.95 (95% CI 0.88-1.03), of death or severe adverse neurological event 1.00 (0.88-1.13), or any of these outcomes 0.98 (0.91-1.05). No subgroup of infants (eg, gestational age, birthweight for gestation, initial lung disease severity, or exposure to antenatal corticosteroids) benefited more or less from HFOV. Ventilator type or ventilation strategy did not change the overall treatment effect. Interpretation HFOV seems equally effective to conventional ventilation in preterm infants. Our results do not support selection of preterm infants for HFOV on the basis of gestational age, birthweight for gestation, initial lung disease severity, or exposure to antenatal corticosteroids.	[Cools, Filip] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Neonatal Intens Care Unit, B-1090 Brussels, Belgium; [Askie, Lisa M.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Offringa, Martin] Univ Amsterdam, Acad Med Ctr, Dept Neonatol, NL-1105 AZ Amsterdam, Netherlands; [Asselin, Jeanette M.; Durand, David J.] Childrens Hosp, Div Neonatol, Oakland, CA 94609 USA; [Asselin, Jeanette M.; Durand, David J.] Res Ctr Oakland, Oakland, CA USA; [Calvert, Sandra A.] Univ London St Georges Hosp, Neonatol Unit, Dept Child Hlth, London, England; [Courtney, Sherry E.] SUNY Stony Brook, Med Ctr, Dept Neonatol, Stony Brook, NY 11794 USA; [Dani, Carlo] Univ Florence, Sect Neonatol, Dept Surg & Med Crit Care, Florence, Italy; [Gerstmann, Dale R.] Timpanogos Reg Hosp, Neonatal Intens Care Unit, Orem, UT USA; [Henderson-Smart, David J.] Univ Sydney, Ctr Perinatal Hlth Serv Res, Sydney, NSW 2006, Australia; [Marlow, Neil] UCL, Dept Acad Neonatol, Elizabeth Garrett Anderson Inst Womens Hlth, London, England; [Peacock, Janet L.] Univ Southampton, Southampton Gen Hosp, Sch Med, Southampton, Hants, England; [Pillow, J. Jane] Univ Western Australia, Sch Womens & Infants Hlth, King Edward Mem Hosp, Subiaco, WA, Australia; [Soll, Roger F.] Fletcher Allen Hlth Care, Div Neonatal Perinatal Med, Burlington, VT USA; [Thome, Ulrich H.] Univ Hosp Children & Adolescents, Womens & Childrens Hosp, Dept Neonatol, Leipzig, Germany; [Truffert, Patrick] Univ Lille, Jeanne Flanders Hosp, Reg Hosp Ctr, Lille, France; [Schreiber, Michael D.] Univ Chicago, Med Ctr, Dept Pediat, Chicago, IL 60637 USA; [Van Reempts, Patrick] Univ Antwerp Hosp, Dept Neonatol, Antwerp, Belgium; [Vendettuoli, Valentina] Univ Milan, Dept Maternal & Paediat Sci, Div Neonatol, Milan, Italy; [Vento, Giovanni] Univ Cattolica Sacro Cuore, Dept Paediat, Div Neonatol, I-00168 Rome, Italy	University Hospital Brussels; Vrije Universiteit Brussel; University of Sydney; University of Amsterdam; Academic Medical Center Amsterdam; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; St Georges University London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Florence; University of Sydney; University of London; University College London; University of Southampton; King Edward Memorial Hospital; University of Western Australia; University of Vermont Medical Center; Leipzig University; Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Chicago; University of Chicago Medical Center; University of Antwerp; University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Cools, F (corresponding author), Vrije Univ Brussel, Univ Ziekenhuis Brussel, Neonatal Intens Care Unit, Laarbeeklaan 101, B-1090 Brussels, Belgium.	filip.cools@uzbrussel.be	Marlow, Neil/D-2918-2009; Pillow, Jane/A-3335-2009; Plavka, Richard/K-2222-2017	Marlow, Neil/0000-0001-5890-2953; Pillow, Jane/0000-0002-6500-0138; Vento, Giovanni/0000-0003-3121-9569; Plavka, Richard/0000-0003-2579-2393; Durand, David/0000-0003-1181-0941; Cools, Filip/0000-0002-6581-7009; Offringa, Martin/0000-0002-4402-5299; Peacock, Janet/0000-0002-0310-2518	Nestle Belgium; Belgian Red Cross; Drager International	Nestle Belgium(Nestle SA); Belgian Red Cross; Drager International	Funding Nestle Belgium, Belgian Red Cross, and Drager International.	Bjorklund LJ, 1997, PEDIATR RES, V42, P348; Cambonie G, 2003, ACTA PAEDIATR, V92, P1068, DOI 10.1080/08035250310004856; CLARK RH, 1992, PEDIATRICS, V89, P5; Cools F, 2009, COCHRANE DB SYST REV, V3; Cools F, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-33; Courtney SE, 2002, NEW ENGL J MED, V347, P643, DOI 10.1056/NEJMoa012750; Courtney SE, 2003, CRIT CARE, V7, P423, DOI 10.1186/cc2178; Craft Alissa P, 2003, J Perinatol, V23, P14; Dani C, 2006, PEDIATR PULM, V41, P242, DOI 10.1002/ppul.20350; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Durand D J, 2001, J Perinatol, V21, P221, DOI 10.1038/sj.jp.7210527; GARNER A, 1984, PEDIATRICS, V74, P127; Gerstmann DR, 1996, PEDIATRICS, V98, P1044; HENDERSONSMART DJ, 2007, COCHRANE DB SYST REV, V3, P104; HIFI Study Group, 1989, N Engl J Med, V320, P88; Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; Katz-Salamon M, 2000, ARCH DIS CHILD-FETAL, V83, pF1, DOI 10.1136/fn.83.1.F1; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Lista G, 2008, ARCH DIS CHILD-FETAL, V93, pF252, DOI 10.1136/adc.2006.112102; MCCULLOCH PR, 1988, AM REV RESPIR DIS, V137, P1185, DOI 10.1164/ajrccm/137.5.1185; MEREDITH KS, 1989, J APPL PHYSIOL, V66, P2150, DOI 10.1152/jappl.1989.66.5.2150; Moriette G, 2001, PEDIATRICS, V107, P363, DOI 10.1542/peds.107.2.363; OGAWA Y, 1993, EARLY HUM DEV, V32, P1, DOI 10.1016/0378-3782(93)90088-C; Osborn DA, 2003, J PEDIATR-US, V143, P192, DOI 10.1067/S0022-3476(03)00359-7; PAPILE LU, 1987, J PEDIAT, V92, P529; Pillow JJ, 2001, AM J RESP CRIT CARE, V164, P1019, DOI 10.1164/ajrccm.164.6.2005008; Pillow JJ, 1999, J APPL PHYSIOL, V87, P407, DOI 10.1152/jappl.1999.87.1.407; Plavka R, 1999, INTENS CARE MED, V25, P68, DOI 10.1007/s001340050789; Polglase GR, 2008, J APPL PHYSIOL, V105, P603, DOI 10.1152/japplphysiol.00041.2008; Rettwitz-Volk W, 1998, J PEDIATR-US, V132, P249, DOI 10.1016/S0022-3476(98)70440-8; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Termote J, 2000, J PEDIAT OPHTH STRAB, V37, P142; Thome U, 1999, J PEDIATR-US, V135, P39, DOI 10.1016/S0022-3476(99)70325-2; Van Reempts P, 2003, EUR J PEDIATR, V162, P219, DOI 10.1007/s00431-002-01145-z; Vento G, 2005, INTENS CARE MED, V31, P463, DOI 10.1007/s00134-005-2556-x	38	87	93	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2082	2091		10.1016/S0140-6736(10)60278-4	http://dx.doi.org/10.1016/S0140-6736(10)60278-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20552718				2022-12-28	WOS:000279069300020
J	Su, TH; Liou, JM; Wang, HP				Su, Tung-Hung; Liou, Jyh-Ming; Wang, Hsiu-Po			The passage of a colonic cast	LANCET			English	Editorial Material									[Su, Tung-Hung; Liou, Jyh-Ming; Wang, Hsiu-Po] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei 100, Taiwan; [Su, Tung-Hung; Liou, Jyh-Ming; Wang, Hsiu-Po] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wang, HP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, 7 Chung Shan S Rd, Taipei 100, Taiwan.	wanghp@ntu.edu.tw		SU, TUNG-HUNG/0000-0002-6747-7941; LIOU, JYH-MING/0000-0002-7945-5408					0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2099	2099		10.1016/S0140-6736(09)60299-3	http://dx.doi.org/10.1016/S0140-6736(09)60299-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20542163				2022-12-28	WOS:000279069300022
J	Chow, JC; Ciaudo, C; Fazzari, MJ; Mise, N; Servant, N; Glass, JL; Attreed, M; Avner, P; Wutz, A; Barillot, E; Greally, JM; Voinnet, O; Heard, E				Chow, Jennifer C.; Ciaudo, Constance; Fazzari, Melissa J.; Mise, Nathan; Servant, Nicolas; Glass, Jacob L.; Attreed, Matthew; Avner, Philip; Wutz, Anton; Barillot, Emmanuel; Greally, John M.; Voinnet, Olivier; Heard, Edith			LINE-1 Activity in Facultative Heterochromatin Formation during X Chromosome Inactivation	CELL			English	Article							LYON REPEAT HYPOTHESIS; SMALL INTERFERING RNAS; XIST RNA; RETROTRANSPOSON SUBFAMILY; L1 RETROTRANSPOSITION; DOSAGE COMPENSATION; GENE-EXPRESSION; MOUSE; ELEMENTS; CELLS	During X chromosome inactivation (XCI), Xist RNA coats and silences one of the two X chromosomes in female cells. Little is known about how XCI spreads across the chromosome, although LINE-1 elements have been proposed to play a role. Here we show that LINEs participate in creating a silent nuclear compartment into which genes become recruited. A subset of young LINE-1 elements, however, is expressed during XCI, rather than being silenced. We demonstrate that such LINE expression requires the specific heterochromatic state induced by Xist. These LINEs often lie within escape-prone regions of the X chromosome, but close to genes that are subject to XCI, and are associated with putative endo-siRNAs. LINEs may thus facilitate XCI at different levels, with silent LINEs participating in assembly of a heterochromatic nuclear compartment induced by Xist, and active LINEs participating in local propagation of XCI into regions that would otherwise be prone to escape.	[Chow, Jennifer C.; Ciaudo, Constance; Servant, Nicolas; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Chow, Jennifer C.; Ciaudo, Constance; Heard, Edith] Univ Strasbourg, CNRS UMR3215, F-67084 Strasbourg, France; [Chow, Jennifer C.; Ciaudo, Constance; Heard, Edith] Univ Strasbourg, INSERM U934, F-67084 Strasbourg, France; [Ciaudo, Constance; Voinnet, Olivier] Univ Strasbourg, Inst Biol Mol Plantes, CNRS UPR2357, F-67084 Strasbourg, France; [Fazzari, Melissa J.; Glass, Jacob L.; Attreed, Matthew; Greally, John M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Fazzari, Melissa J.; Glass, Jacob L.; Attreed, Matthew; Greally, John M.] Albert Einstein Coll Med, Ctr Epigenom, Bronx, NY 10461 USA; [Mise, Nathan; Avner, Philip] Inst Pasteur, URA1968, F-75015 Paris, France; [Mise, Nathan] Jichi Med Univ, Dept Pharmacol, Mibu, Tochigi 3290431, Japan; [Servant, Nicolas; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Servant, Nicolas; Barillot, Emmanuel] INSERM U900, F-77300 Fontainebleau, France; [Wutz, Anton] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QN, England	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Jichi Medical University; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cambridge	Heard, E (corresponding author), Inst Curie, F-75248 Paris, France.	edith.heard@curie.fr	Ciaudo, Constance/A-2014-2012; 名丹, 三瀬/AAD-1036-2021; Heard, Edith/D-7197-2017; Greally, John/AAF-9540-2019	Ciaudo, Constance/0000-0002-0857-4506; Heard, Edith/0000-0001-8052-7117; Greally, John/0000-0001-6069-7960; BARILLOT, Emmanuel/0000-0003-2724-2002; Voinnet, Olivier/0000-0001-6982-9544; Servant, Nicolas/0000-0003-1678-7410; Fazzari, Melissa/0000-0002-5674-3589	ANR; FRM; European Union [LSHG-CT-2005-018883]; Canceropole IdF; ERC [ERC-210890]; Prix Liliane Bettencourt for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; Medical Research Council [G0800784B, G0300723B, G0800784] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); European Union(European Commission); Canceropole IdF(Region Ile-de-France); ERC(European Research Council (ERC)European Commission); Prix Liliane Bettencourt for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank members of the Heard laboratory and Vincent Colot for critical reading of the manuscript; John Goodier and Deborah Bourc'his for advice and mouse LINE-1 plasmid constructs; and Valerie Cognat (IBMP) for expert bioinformatics analyses. This work was supported by grants from the ANR ("RNA ES"; to both E. H. and O.V.); FRM (Equipe FRM to E. H. and FRM fellowship to J.C.); HEROIC, an Integrated Project funded by the European Union under the 6th Framework Programme (LSHG-CT-2005-018883); and Canceropole IdF (GET project) to E. H; O.V.'s laboratory was further supported by an ERC Young Investigator Award (Grant ERC-210890 "Frontiers of RNAi") and Prix Liliane Bettencourt for Life Sciences.	Abrusan G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000172; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 2006, PLOS GENET, V2, P1477, DOI 10.1371/journal.pgen.0020151; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Heitz E., 1928, JAHRB WISS BOT, V69, P762; Horman SR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/32713; Huntley D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-501; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Li N, 2008, P NATL ACAD SCI USA, V105, P17055, DOI 10.1073/pnas.0807765105; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Popova BC, 2006, P NATL ACAD SCI USA, V103, P7706, DOI 10.1073/pnas.0602021103; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008	55	227	239	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					956	969		10.1016/j.cell.2010.04.042	http://dx.doi.org/10.1016/j.cell.2010.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550932	Bronze			2022-12-28	WOS:000278618800011
J	Gerdes, K; Howard, M; Szardenings, F				Gerdes, Kenn; Howard, Martin; Szardenings, Florian			Pushing and Pulling in Prokaryotic DNA Segregation	CELL			English	Review							ESCHERICHIA-COLI CHROMOSOME; MICROTUBULE DYNAMIC INSTABILITY; DIVISION SITE SELECTION; UNIT-COPY MINIPLASMIDS; SEPARATE CELL HALVES; ACTIN-LIKE FILAMENTS; PROTEIN SPO0J PARB; BACILLUS-SUBTILIS; PLASMID SEGREGATION; P1 PLASMID	In prokaryotes, DNA can be segregated by three different types of cytoskeletal filaments. The best-understood type of partitioning (par) locus encodes an actin homolog called ParM, which forms dynamically unstable filaments that push plasmids apart in a process reminiscent of mitosis. However, the most common type of par locus, which is present on many plasmids and most bacterial chromosomes, encodes a P loop ATPase (ParA) that distributes plasmids equidistant from one another on the bacterial nucleoid. A third type of par locus encodes a tubulin homolog (TubZ) that forms cytoskeletal filaments that move rapidly with treadmill dynamics.	[Gerdes, Kenn; Szardenings, Florian] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Howard, Martin] John Innes Inst, Dept Computat & Syst Biol, Norwich NR4 7UH, Norfolk, England	Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Gerdes, K (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	kenn.gerdes@ncl.ac.uk	Gerdes, Kenn/M-2420-2014; Gerdes, Kenn/AAS-5548-2021; Howard, Martin/C-3629-2016	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; Howard, Martin/0000-0001-7670-0781	Biotechnology and Biological Sciences Research Council of the UK; Royal Society; BBSRC [BBS/E/J/000C0620] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0620] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to S. Gruber, J. Errington, H. Murray, and L.J. Wu for critical comments on the manuscript and to the Errington and Gerdes groups for stimulating discussions. This work was supported by the Biotechnology and Biological Sciences Research Council of the UK by a grant to K.G. and by core support to M.H. M.H. is also supported financially by The Royal Society.	ABELES AL, 1985, J MOL BIOL, V185, P261, DOI 10.1016/0022-2836(85)90402-4; Adachi S, 2008, GENES CELLS, V13, P181, DOI 10.1111/j.1365-2443.2007.01157.x; Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; AUSTIN S, 1983, J MOL BIOL, V169, P353, DOI 10.1016/S0022-2836(83)80055-2; Autret S, 2001, MOL MICROBIOL, V41, P743, DOI 10.1046/j.1365-2958.2001.02551.x; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Batt SM, 2009, J MOL BIOL, V385, P1361, DOI 10.1016/j.jmb.2008.12.016; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BIEK DP, 1994, P NATL ACAD SCI USA, V91, P8027, DOI 10.1073/pnas.91.17.8027; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Bouet JY, 2006, MOL MICROBIOL, V62, P1447, DOI 10.1111/j.1365-2958.2006.05454.x; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Carmelo E, 2005, J BIOL CHEM, V280, P28683, DOI 10.1074/jbc.M501173200; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; Choi CL, 2008, J BIOL CHEM, V283, P28081, DOI 10.1074/jbc.M803833200; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Doubrovinski K, 2005, P NATL ACAD SCI USA, V102, P9808, DOI 10.1073/pnas.0500529102; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2005, MOL MICROBIOL, V56, P1430, DOI 10.1111/j.1365-2958.2005.04643.x; Ebersbach G, 2004, MOL MICROBIOL, V52, P385, DOI 10.1111/j.1365-2958.2004.04002.x; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Edgar R, 2001, MOL MICROBIOL, V42, P1363, DOI 10.1046/j.1365-2958.2001.02717.x; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; ERICKSON HP, 1992, ANNU REV BIOPH BIOM, V21, P145, DOI 10.1146/annurev.bb.21.060192.001045; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P15423, DOI 10.1073/pnas.0807859105; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hirano M, 1998, MOL GEN GENET, V257, P392, DOI 10.1007/s004380050663; Howard M, 2005, J CELL BIOL, V168, P533, DOI 10.1083/jcb.200411122; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hui MP, 2010, P NATL ACAD SCI USA, V107, P4590, DOI 10.1073/pnas.0913060107; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; Jensen RB, 1999, EMBO J, V18, P4076, DOI 10.1093/emboj/18.14.4076; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; LE QB, 2009, MOL MICROBIOL, DOI DOI 10.1111/J.1365-2958.2009.06678.X; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lewis RA, 2002, MICROBIOL-SGM, V148, P537, DOI 10.1099/00221287-148-2-537; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Li Z, 2009, CURR OPIN MICROBIOL, V12, P333, DOI 10.1016/j.mib.2009.03.007; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; MARGOLIS RL, 1978, NATURE, V272, P450, DOI 10.1038/272450a0; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Ogura Y, 2003, J BACTERIOL, V185, P6316, DOI 10.1128/JB.185.21.6316-6324.2003; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Radnedge L, 1998, EMBO J, V17, P6076, DOI 10.1093/emboj/17.20.6076; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Ringgaard S, 2007, J BIOL CHEM, V282, P28216, DOI 10.1074/jbc.M703733200; Ringgaard S, 2007, J BIOL CHEM, V282, P3134, DOI 10.1074/jbc.M609092200; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Sengupta M, 2010, J BACTERIOL, V192, P1175, DOI 10.1128/JB.01245-09; Sharpe ME, 1996, MOL MICROBIOL, V21, P501, DOI 10.1111/j.1365-2958.1996.tb02559.x; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Thompson SR, 2006, P NATL ACAD SCI USA, V103, P8209, DOI 10.1073/pnas.0600919103; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Yamaichi Y, 2007, J BACTERIOL, V189, P5314, DOI 10.1128/JB.00416-07	152	238	241	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 11	2010	141	6					927	942		10.1016/j.cell.2010.05.033	http://dx.doi.org/10.1016/j.cell.2010.05.033			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550930	Bronze			2022-12-28	WOS:000278618800009
J	Harvey, J; Warwick, I				Harvey, Julie; Warwick, Ian			A Patient's Journey Endometriosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Warwick, Ian] Lisburn Hlth Ctr, Lisburn BT28 1LU, England			julesharvey@yahoo.co.uk							0	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2010	340								c2661	10.1136/bmj.c2661	http://dx.doi.org/10.1136/bmj.c2661			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611MF	20538637				2022-12-28	WOS:000278818700006
J	Abraham, T				Abraham, Thomas			Personal View The price of poor pandemic communication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Journalism & Media Studies Ctr, Publ Hlth Commun Programme, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Abraham, T (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Publ Hlth Commun Programme, Hong Kong, Hong Kong, Peoples R China.	thomas@hku.hk						[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249	1	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2010	340								c2952	10.1136/bmj.c2952	http://dx.doi.org/10.1136/bmj.c2952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534678	Green Submitted			2022-12-28	WOS:000278818500021
J	Cohen, D; Carter, P				Cohen, Deborah; Carter, Philip			WHO and the pandemic flu "conspiracies"	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; INFLUENZA; OSELTAMIVIR; INFECTION; PREVENTION		[Carter, Philip] Bur Investigat Journalism, London, England			dcohen@bmj.com						Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3471; *EUR SCI WORK GROU, REV POL PLAN 2006 20; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2003, J INFECT DIS, V188, P1355, DOI 10.1086/379049; *HOLM REP, TAM LAUNCH MED CAMP; *INF DIS SOC AM, CONGR 2009 SOC AW RE; *INT FED PHARM MAN, 2008, WHO INFL VIR SURV SY; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Monto AS, 2004, CLIN INFECT DIS, V39, P459, DOI 10.1086/422646; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OSTERHAUS A, PROPHYLACTIC ROLE; *US FDA, FDA APPR DRUGS INFL; World Health Organization, 2003, GUID WHO GUID	19	84	88	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c2912	10.1136/bmj.c2912	http://dx.doi.org/10.1136/bmj.c2912			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BM	20525679				2022-12-28	WOS:000278556500017
J	Deal, RB; Henikoff, JG; Henikoff, S				Deal, Roger B.; Henikoff, Jorja G.; Henikoff, Steven			Genome-Wide Kinetics of Nucleosome Turnover Determined by Metabolic Labeling of Histones	SCIENCE			English	Article							H3.3 REPLACEMENT; REPLICATION; PROMOTERS; CHROMATIN; MARKS; EXCHANGE; GENES; SITES; CELLS; YEAST	Nucleosome disruption and replacement are crucial activities that maintain epigenomes, but these highly dynamic processes have been difficult to study. Here, we describe a direct method for measuring nucleosome turnover dynamics genome-wide. We found that nucleosome turnover is most rapid over active gene bodies, epigenetic regulatory elements, and replication origins in Drosophila cells. Nucleosomes turn over faster at sites for trithorax-group than polycomb-group protein binding, suggesting that nucleosome turnover differences underlie their opposing activities and challenging models for epigenetic inheritance that rely on stability of histone marks. Our results establish a general strategy for studying nucleosome dynamics and uncover nucleosome turnover differences across the genome that are likely to have functional importance for epigenome maintenance, gene regulation, and control of DNA replication.	[Deal, Roger B.; Henikoff, Jorja G.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685	NIH [1R21DA025758, 1F32GM083449]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Furuyama for suggesting this approach, members of our lab for helpful discussions, and the Hutchinson Center Genomics Shared Resource for microarray processing. This work was supported by NIH grant 1R21DA025758 to S. H. and NIH Postdoctoral Fellowship 1F32GM083449 to R. B. D. All data sets can be found in GEO: GSE19788.	Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Jamai A, 2007, MOL CELL, V25, P345, DOI 10.1016/j.molcel.2007.01.019; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; YAMASU K, 1990, J BIOCHEM-TOKYO, V107, P15, DOI 10.1093/oxfordjournals.jbchem.a122999	23	341	349	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1161	1164		10.1126/science.1186777	http://dx.doi.org/10.1126/science.1186777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508129	Green Accepted			2022-12-28	WOS:000278104700045
J	Zielinska, DF; Gnad, F; Wisniewski, JR; Mann, M				Zielinska, Dorota F.; Gnad, Florian; Wisniewski, Jacek R.; Mann, Matthias			Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints	CELL			English	Article							CAENORHABDITIS-ELEGANS; LINKED GLYCOPROTEINS; HYDRAZIDE CHEMISTRY; ALZHEIMERS-DISEASE; IDENTIFICATION; MEMBRANE; GLYCOSYLATION; PROTEINS; QUANTIFICATION; CYTOSCAPE	N-linked glycosylation is a biologically important protein modification, but only a small fraction of modification sites have been mapped. We developed a "filter aided sample preparation" (FASP)-based method in which glycopeptides are enriched by binding to lectins on the top of a filter and mapped 6367 N-glycosylation sites on 2352 proteins in four mouse tissues and blood plasma using high-accuracy mass spectrometry. We found 74% of known mouse N-glycosites and discovered an additional 5753 sites on a diverse range of proteins. Sites almost always have the N-!P-[SjT]-!P (where ! P is not proline) and rarely the N-X-C motif or nonconsensus sequences. Combining the FASP approach with analysis of subcellular glycosite localization reveals that the sites always orient toward the extracellular space or toward the lumen of ER, Golgi, lysosome, or peroxisome. The N-glycoproteome contains a plethora of modification sites on factors important in development, organ-specific functions, and disease.	[Zielinska, Dorota F.; Gnad, Florian; Wisniewski, Jacek R.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Gnad, Florian] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Max Planck Society; Harvard University; Harvard Medical School	Wisniewski, JR (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany.	jwisniew@biochem.mpg.de; mmann@biochem.mpg.de	Mann, Matthias/A-3454-2013	Mann, Matthias/0000-0003-1292-4799; Gnad, Florian/0000-0002-2287-2251	European Union [HEALTH-F4-2008-201648/PROSPECTS]	European Union(European Commission)	We thank Alexandre Zougman, Nagarjuna Nagaraj, Korbinian Mayr, Mara Monetti, Ina Rohwedder, Markus Moser, and Pawel Ostasiewicz for help and fruitful discussions. This work was supported by PROSPECT, a 7<SUP>th</SUP> framework program of the European Union ( grant agreement HEALTH-F4-2008-201648/PROSPECTS).	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bradford BM, 2009, J NEUROSCI, V29, P15445, DOI 10.1523/JNEUROSCI.4195-09.2009; Bunkenborg J, 2004, PROTEOMICS, V4, P454, DOI 10.1002/pmic.200300556; Chandra NC, 1998, J BIOL CHEM, V273, P19715, DOI 10.1074/jbc.273.31.19715; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Gnad F, 2009, NUCLEIC ACIDS RES, V37, pD902, DOI 10.1093/nar/gkn773; GUNDRY RL, 2008, MOL CELL PROTEOMICS, V2555, P2569; Hulsmeier AJ, 2007, MOL CELL PROTEOMICS, V6, P2132, DOI 10.1074/mcp.M700361-MCP200; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Kaji H, 2007, MOL CELL PROTEOMICS, V6, P2100, DOI 10.1074/mcp.M600392-MCP200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kung LA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.64; Kuster B, 1999, ANAL CHEM, V71, P1431, DOI 10.1021/ac981012u; Lee A, 2009, J PROTEOME RES, V8, P770, DOI 10.1021/pr800910w; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Medzihradszky KF, 2005, METHOD ENZYMOL, V405, P116, DOI 10.1016/S0076-6879(05)05006-8; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; OLSEN JV, 2010, QUANTITATIVE PHOSPHO, V3, pRA3; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PEDEMONTE CH, 1990, P NATL ACAD SCI USA, V87, P9789, DOI 10.1073/pnas.87.24.9789; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Ramachandran P, 2006, J PROTEOME RES, V5, P1493, DOI 10.1021/pr050492k; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; REEVES R, 1981, P NATL ACAD SCI-BIOL, V78, P6704, DOI 10.1073/pnas.78.11.6704; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suzuki T, 2006, J BIOCHEM, V139, P949, DOI 10.1093/jb/mvj121; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; WOODS RJ, 1994, NAT STRUCT BIOL, V1, P499, DOI 10.1038/nsb0894-499; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yang ZP, 2004, J CHROMATOGR A, V1053, P79, DOI 10.1016/j.chroma.2004.08.150; Zajonc DM, 2008, P NATL ACAD SCI USA, V105, P17925, DOI 10.1073/pnas.0809814105; Zhang H, 2005, MOL CELL PROTEOMICS, V4, P144, DOI 10.1074/mcp.M400090-MCP200; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zielinska DF, 2009, J PROTEOME RES, V8, P4039, DOI 10.1021/pr900384k; 2007, GENOME BIOL, V8, pR250	54	686	699	16	252	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					897	907		10.1016/j.cell.2010.04.012	http://dx.doi.org/10.1016/j.cell.2010.04.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510933	Bronze			2022-12-28	WOS:000278132900023
J	Ohye, RG; Sleeper, LA; Mahony, L; Newburger, JW; Pearson, GD; Lu, MM; Goldberg, CS; Tabbutt, S; Frommelt, PC; Ghanayem, NS; Laussen, PC; Rhodes, JF; Lewis, AB; Mital, S; Ravishankar, C; Williams, IA; Dunbar-Masterson, C; Atz, AM; Colan, S; Minich, LL; Pizarro, C; Kanter, KR; Jaggers, J; Jacobs, JP; Krawczeski, CD; Pike, N; McCrindle, BW; Virzi, L; Gaynor, JW				Ohye, Richard G.; Sleeper, Lynn A.; Mahony, Lynn; Newburger, Jane W.; Pearson, Gail D.; Lu, Minmin; Goldberg, Caren S.; Tabbutt, Sarah; Frommelt, Peter C.; Ghanayem, Nancy S.; Laussen, Peter C.; Rhodes, John F.; Lewis, Alan B.; Mital, Seema; Ravishankar, Chitra; Williams, Ismee A.; Dunbar-Masterson, Carolyn; Atz, Andrew M.; Colan, Steven; Minich, L. LuAnn; Pizarro, Christian; Kanter, Kirk R.; Jaggers, James; Jacobs, Jeffrey P.; Krawczeski, Catherine Dent; Pike, Nancy; McCrindle, Brian W.; Virzi, Lisa; Gaynor, J. William		Pediat Heart Network Investigators	Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle Lesions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY-ARTERY CONDUIT; LEFT-HEART SYNDROME; BLALOCK-TAUSSIG SHUNT; OPERATION; OUTCOMES; PALLIATION; EXPERIENCE; RECONSTRUCTION; HEMODYNAMICS; CHILDREN	Background: The Norwood procedure with a modified Blalock-Taussig (MBT) shunt, the first palliative stage for single-ventricle lesions with systemic outflow obstruction, is associated with high mortality. The right ventricle-pulmonary artery (RVPA) shunt may improve coronary flow but requires a ventriculotomy. We compared the two shunts in infants with hypoplastic heart syndrome or related anomalies. Methods: Infants undergoing the Norwood procedure were randomly assigned to the MBT shunt (275 infants) or the RVPA shunt (274 infants) at 15 North American centers. The primary outcome was death or cardiac transplantation 12 months after randomization. Secondary outcomes included unintended cardiovascular interventions and right ventricular size and function at 14 months and transplantation-free survival until the last subject reached 14 months of age. Results: Transplantation-free survival 12 months after randomization was higher with the RVPA shunt than with the MBT shunt (74% vs. 64%, P=0.01). However, the RVPA shunt group had more unintended interventions (P=0.003) and complications (P=0.002). Right ventricular size and function at the age of 14 months and the rate of nonfatal serious adverse events at the age of 12 months were similar in the two groups. Data collected over a mean (+/-SD) follow-up period of 32+/-11 months showed a nonsignificant difference in transplantation-free survival between the two groups (P=0.06). On nonproportional-hazards analysis, the size of the treatment effect differed before and after 12 months (P=0.02). Conclusions: In children undergoing the Norwood procedure, transplantation-free survival at 12 months was better with the RVPA shunt than with the MBT shunt. After 12 months, available data showed no significant difference in transplantation-free survival between the two groups. (ClinicalTrials.gov number, NCT00115934.) N Engl J Med 2010;362:1980-92.	[Ohye, Richard G.; Goldberg, Caren S.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Sleeper, Lynn A.; Lu, Minmin; Virzi, Lisa] New England Res Inst, Watertown, MA 02172 USA; [Mahony, Lynn] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Newburger, Jane W.; Laussen, Peter C.; Dunbar-Masterson, Carolyn; Colan, Steven] Childrens Hosp Boston, Boston, MA USA; [Pearson, Gail D.] NHLBI, Bethesda, MD 20892 USA; [Tabbutt, Sarah; Ravishankar, Chitra; Gaynor, J. William] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Frommelt, Peter C.; Ghanayem, Nancy S.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Frommelt, Peter C.; Ghanayem, Nancy S.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; N Carolina Consortium Duke Univ, Durham, NC USA; E Carolina Univ, Greenville, NC 27858 USA; [Rhodes, John F.; Jaggers, James] Wake Forest Univ, Winston Salem, NC 27109 USA; [Lewis, Alan B.; Pike, Nancy] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Mital, Seema; McCrindle, Brian W.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Williams, Ismee A.] Childrens Hosp New York, New York, NY USA; [Atz, Andrew M.] Med Univ S Carolina, Charleston, SC 29425 USA; [Minich, L. LuAnn] Univ Utah, Salt Lake City, UT USA; [Minich, L. LuAnn] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Pizarro, Christian] Nemours Cardiac Ctr, Wilmington, DE USA; [Kanter, Kirk R.] Emory Univ, Atlanta, GA 30322 USA; [Jacobs, Jeffrey P.] Congenital Heart Inst Florida, St Petersburg, FL USA; [Krawczeski, Catherine Dent] Cincinnati Childrens Med Ctr, Cincinnati, OH USA	University of Michigan System; University of Michigan; HealthCore, Inc; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital of Wisconsin; Medical College of Wisconsin; Duke University; University of North Carolina; East Carolina University; Wake Forest University; Children's Hospital Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Medical University of South Carolina; Utah System of Higher Education; University of Utah; Emory University; Cincinnati Children's Hospital Medical Center	Ohye, RG (corresponding author), 5144 CVC,1500 E Med Ctr Dr,SPC 5864, Ann Arbor, MI 48109 USA.	ohye@umich.edu	Colan, Steven/ABB-4580-2020; Pizarro, Christian/AAO-9546-2021; Mital, Seema/G-7456-2011; Atz, Andrew/J-9196-2015; gaynor, J william/E-5194-2013	Atz, Andrew/0000-0002-4744-3832; gaynor, J william/0000-0001-7955-5604; Pizarro, Christian/0000-0001-5738-6504	National Heart, Lung, and Blood Institute [HL068269, HL068270, HL068279, HL068281, HL068285, HL068288, HL068290, HL068292, HL085057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL068290, U01HL068285, U01HL085057, U01HL068292, U10HL109816, U01HL068270, U01HL068279, U01HL068288, U01HL068281, U01HL068269, U10HL109778, U10HL068270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (HL068269, HL068270, HL068279, HL068281, HL068285, HL068288, HL068290, HL068292, and HL085057) from the National Heart, Lung, and Blood Institute.	Alsoufi B, 2007, PEDIATRICS, V119, P109, DOI 10.1542/peds.2006-1592; [Anonymous], 2007, MMWR MORB MORTAL WKL, V56, P25; Azakie A, 2004, ANN THORAC SURG, V77, P1727, DOI 10.1016/j.athoracsur.2003.10.002; Azakie A, 2001, ANN THORAC SURG, V72, P1349, DOI 10.1016/S0003-4975(01)02795-3; Charpie JR, 2000, J THORAC CARDIOV SUR, V120, P73, DOI 10.1067/mtc.2000.106838; Cua CL, 2006, PEDIATR CRIT CARE ME, V7, P238, DOI 10.1097/01.PCC.0000201003.38320.63; Hehir DA, 2008, J THORAC CARDIOV SUR, V136, P94, DOI 10.1016/j.jtcvs.2007.12.012; HELBING WA, 1995, AM J CARDIOL, V76, P589, DOI 10.1016/S0002-9149(99)80161-1; KHOURI EM, 1965, CIRC RES, V17, P427, DOI 10.1161/01.RES.17.5.427; Kussman BD, 2007, J THORAC CARDIOV SUR, V133, P648, DOI 10.1016/j.jtcvs.2006.09.034; Lai L, 2007, ANN THORAC SURG, V83, P1768, DOI 10.1016/j.athoracsur.2006.11.076; Mahle WT, 2003, ANN THORAC SURG, V76, P1084, DOI 10.1016/S0003-4975(03)00343-6; Mahle WT, 2001, ANN THORAC SURG, V71, P61, DOI 10.1016/S0003-4975(00)02324-9; Mahony L, 2006, PEDIATR CARDIOL, V27, P191, DOI 10.1007/s00246-005-1151-9; Mair R, 2003, J THORAC CARDIOV SUR, V126, P1378, DOI 10.1016/S0022-5223(03)00389-1; NAKATA S, 1984, J THORAC CARDIOV SUR, V88, P610; NORWOOD WI, 1981, J THORAC CARDIOV SUR, V82, P511; Ohye RG, 2004, ANN THORAC SURG, V78, P1090, DOI 10.1016/S0003-4975(03)01386-9; Ohye RG, 2008, J THORAC CARDIOV SUR, V136, P968, DOI 10.1016/j.jtcvs.2008.01.013; Pizarro C, 2004, ANN THORAC SURG, V78, P1959, DOI 10.1016/j.athoracsur.2004.06.020; Pizarro C, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.cir.0000087390.94142.1d; Sano S, 2004, ANN THORAC SURG, V78, P1951, DOI 10.1016/j.athoracsur.2004.05.055; Tabbutt S, 2005, ANN THORAC SURG, V80, P1582, DOI 10.1016/j.athoracsur.2005.04.046; Tanoue Y, 2004, ANN THORAC SURG, V78, P1965, DOI 10.1016/j.athoracsur.2004.06.014; Tweddell JS, 2000, ANN THORAC SURG, V69, P1893, DOI 10.1016/S0003-4975(00)01349-7; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	26	584	592	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1980	1992		10.1056/NEJMoa0912461	http://dx.doi.org/10.1056/NEJMoa0912461			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601JI	20505177	Green Accepted			2022-12-28	WOS:000278054000006
J	Jost, TS				Jost, Timothy Stoltzfus			The Independent Payment Advisory Board	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							ELMENDORF DE, 2009, COMMUNICATION   1219; Horney James, 2009, HOUSE PASSED SENATE; *OFF PERS MAN, 2010, SAL TABL 2010 EX	3	19	19	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					103	105		10.1056/NEJMp1005402	http://dx.doi.org/10.1056/NEJMp1005402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	621JY	20505171				2022-12-28	WOS:000279574100002
J	Guang, SH; Bochner, AF; Burkhart, KB; Burton, N; Pavelec, DM; Kennedy, S				Guang, Shouhong; Bochner, Aaron F.; Burkhart, Kirk B.; Burton, Nick; Pavelec, Derek M.; Kennedy, Scott			Small regulatory RNAs inhibit RNA polymerase II during the elongation phase of transcription	NATURE			English	Article							PRE-MESSENGER-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENETIC INTERFERENCE; MEDIATED PATHWAYS; REVEALS; NUCLEUS; TARGET; LIN-15	Eukaryotic cells express a wide variety of endogenous small regulatory RNAs that regulate heterochromatin formation, developmental timing, defence against parasitic nucleic acids and genome rearrangement. Many small regulatory RNAs are thought to function in nuclei(1,2). For instance, in plants and fungi, short interfering RNA (siRNAs) associate with nascent transcripts and direct chromatin and/or DNA modifications(1,2). To understand further the biological roles of small regulatory RNAs, we conducted a genetic screen to identify factors required for RNA interference (RNAi) in Caenorhabditis elegans nuclei(3). Here we show that the gene nuclear RNAi defective-2 (nrde-2) encodes an evolutionarily conserved protein that is required for siRNA-mediated silencing in nuclei. NRDE-2 associates with the Argonaute protein NRDE-3 within nuclei and is recruited by NRDE-3/siRNA complexes to nascent transcripts that have been targeted by RNAi. We find that nuclear-localized siRNAs direct an NRDE-2-dependent silencing of pre-messenger RNAs (pre-mRNAs) 3' to sites of RNAi, an NRDE-2-dependent accumulation of RNA polymerase (RNAP) II at genomic loci targeted by RNAi, and NRDE-2-dependent decreases in RNAP II occupancy and RNAP II transcriptional activity 39 to sites of RNAi. These results define NRDE-2 as a component of the nuclear RNAi machinery and demonstrate that metazoan siRNAs can silence nuclear-localized RNAs co-transcriptionally. In addition, these results establish a novel mode of RNAP II regulation: siRNA-directed recruitment of NRDE factors that inhibit RNAP II during the elongation phase of transcription.	[Guang, Shouhong; Bochner, Aaron F.; Burkhart, Kirk B.; Burton, Nick; Kennedy, Scott] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Pavelec, Derek M.; Kennedy, Scott] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, S (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	sgkennedy@wisc.edu		Kennedy, Scott/0000-0002-7974-8155; Burton, Nicholas/0000-0002-5495-3988	Pew and Shaw scholars programmes; National Institutes of Health; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076619, R01GM088289] Funding Source: NIH RePORTER	Pew and Shaw scholars programmes; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Anderson, members of the Anderson laboratory, D. Wassarman and D. Brow for comments, and the Caenorhabditis Genetics Center for strains. This work was supported by grants from the Pew and Shaw scholars programmes, the National Institutes of Health and the American Heart Association.	Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bosher JM, 1999, GENETICS, V153, P1245; CLARK SG, 1994, GENETICS, V137, P987; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; ROGALSKI TM, 1990, GENETICS, V126, P889; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	20	207	218	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1097	U165		10.1038/nature09095	http://dx.doi.org/10.1038/nature09095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543824	Green Accepted			2022-12-28	WOS:000279056900057
J	Smith, LN; James, R; Barber, M; Ramsay, S; Gillespie, D; Chung, C				Smith, Lorraine N.; James, Roberta; Barber, Mark; Ramsay, Scott; Gillespie, David; Chung, Charlie		Guideline Dev Grp	Guidelines Rehabilitation of patients with stroke: summary of SIGN guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECOVERY; PAIN		[Smith, Lorraine N.] Univ Glasgow, Fac Med, Glasgow G12 8LL, Lanark, Scotland; [James, Roberta] SIGN, Edinburgh EH7 5EA, Midlothian, Scotland; [Ramsay, Scott] St Johns Hosp, Livingston EH54 6PP, Scotland; [Gillespie, David] Astley Ainslie Hosp, Dept Clin Psychol, Edinburgh EH9 2HL, Midlothian, Scotland	University of Glasgow	Smith, LN (corresponding author), Univ Glasgow, Fac Med, Glasgow G12 8LL, Lanark, Scotland.	l.n.smith@clinmed.gla.ac.uk		Barber, Mark/0000-0002-2893-1566; Todhunter-Brown, Alex/0000-0003-4941-7985				[Anonymous], 1988, USERS GUIDE GEN HLTH; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; De Wit L, 2007, STROKE, V38, P2101, DOI 10.1161/STROKEAHA.107.482869; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Jensen MP, 2003, J PAIN, V4, P2, DOI 10.1054/jpai.2003.1; Kalra L, 2007, J REHABIL MED, V39, P97, DOI 10.2340/16501977-0043; Langhorne P, 2007, J REHABIL MED, V39, P103, DOI 10.2340/16501977-0042; LEIJON G, 1989, PAIN, V36, P27, DOI 10.1016/0304-3959(89)90108-5; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; *NHS NAT SERV SCOT, ANN PUBL SUMM NHS NA; Saunders DH, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003316.PUB2; Scottish Intercollegiate Guidelines Network (SIGN), 2008, SIGN PUBL, V108; Scottish Intercollegiate Guidelines Network (SIGN), 2010, SIGN PUBL, V119; Scottish Intercollegiate Guidelines Network (SIGN), 2010, SIGN PUBL, V118; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; Teasell RW, 2005, STROKE, V36, P215, DOI 10.1161/01.STR.0000153061.02375.04	16	6	7	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2010	340								c2845	10.1136/bmj.c2845	http://dx.doi.org/10.1136/bmj.c2845			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551122	Green Accepted			2022-12-28	WOS:000279051800005
J	Abraha, I; Montedori, A				Abraha, Iosief; Montedori, Alessandro			Modified intention to treat reporting in randomised controlled trials: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIPOSOMAL AMPHOTERICIN-B; TO-TREAT; CLINICAL-TRIAL; EXCLUDING PATIENTS; CONSORT STATEMENT; PERSISTENT FEVER; PLACEBO; BIAS; PUBLICATIONS; THERAPY	Objectives To determine the incidence and characteristics of randomised controlled trials that report using the modified intention to treat approach, and how the approach is described. Design Systematic review. Data sources PubMed, Embase, Cochrane central register of controlled trials, ISI Web of Knowledge, Ovid, HighWire Press, Science-Direct, Ingenta, Medscape, BioMed Central, Springer, and Wiley, from inception to December 2006. Main outcome measures Incidence of trials in which use of modified intention to treat was reported, and how the approach was described (classified according to the type and number of deviations from the intention to treat approach). Results 475 randomised controlled trials reported use of a modified intention to treat analysis. Of these, 76 (16%) were published in five highly cited general medical journals. The incidence of all trials that reported use of modified intention to treat published in journals indexed in Medline increased from 0.006% in 1982-6 to 0.5% in 2002-6 (P<0.001 for linear trend). When the description of the modified intention to treat was examined in each trial, 192 (40%) reported one type of deviation from the intention to treat approach, 261 (55%) reported two or more types, and 22 (5%) did not describe any type. In 266 (56%) of the trials the deviation was related to the treatment received, in 196 (41%) to a post-baseline assessment, in 118 (25%) to a baseline assessment, in 108 (23%) to a target condition, and in 23 (5%) to follow-up. Post-randomisation exclusions occurred in 380 (80%) trials. The results reported by 270 of the 352 (77%) superiority trials favoured the drug under investigation. All of the 123 trials using equivalence or non-inferiority methods to investigate interventions reported results that favoured their assumptions. Conclusions Randomised controlled trials that report using a modified intention to treat are increasingly being published in the medical literature. The descriptions of such an approach were ambiguous, and may cover any type of descriptions for exclusion, such as missing data and deviation from protocol. Explicit statements about post-randomisation exclusions should replace the ambiguous terminology of modified intention to treat.	[Abraha, Iosief; Montedori, Alessandro] Reg Hlth Author Umbria, I-06123 Perugia, Italy		Abraha, I (corresponding author), Reg Hlth Author Umbria, Via Mario Angeloni 61, I-06123 Perugia, Italy.	iosief_a@yahoo.it	Abraha, Iosief/K-4327-2018	Abraha, Iosief/0000-0002-5440-775X; MONTEDORI, ALESSANDRO/0000-0001-7719-573X				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 2007, BRIT MED J, V334, P424, DOI 10.1136/bmj.38977.682025.2C; Altman Douglas G, 2009, Open Med, V3, pe51; Berek JS, 2004, J CLIN ONCOL, V22, P3507, DOI 10.1200/JCO.2004.09.016; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chene G, 1998, CONTROL CLIN TRIALS, V19, P233, DOI 10.1016/S0197-2456(97)00145-1; Chong G, 2006, ANN ONCOL, V17, P437, DOI 10.1093/annonc/mdj090; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; *EUR COR SURG STUD, 1979, LANCET, V1, P889; Farnier M, 2005, EUR HEART J, V26, P897, DOI 10.1093/eurheartj/ehi231; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Greenspan S, 2002, MAYO CLIN PROC, V77, P1044, DOI 10.4065/77.10.1044; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Kruse RL, 2002, J FAM PRACTICE, V51, P969; LEWIS JA, 1993, BRIT J CANCER, V68, P647, DOI 10.1038/bjc.1993.402; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; NEWELL DJ, 1992, INT J EPIDEMIOL, V21, P837, DOI 10.1093/ije/21.5.837; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Oudard S, 2005, J CLIN ONCOL, V23, P3343, DOI 10.1200/JCO.2005.12.187; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Ruiz-Canela M, 2000, BMJ-BRIT MED J, V320, P1007, DOI 10.1136/bmj.320.7240.1007; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Sheng D, 2006, STAT MED, V25, P1183, DOI 10.1002/sim.2230; Solomkin JS, 2001, ANN SURG, V233, P79, DOI 10.1097/00000658-200101000-00013; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Walsh TJ, 2004, NEW ENGL J MED, V351, P1391, DOI 10.1056/NEJMoa040446; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; Wood Angela M, 2004, Clin Trials, V1, P368; Young JM, 2005, J ANDROL, V26, P310, DOI 10.2164/jandrol.04126	43	133	134	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2010	340								c2697	10.1136/bmj.c2697	http://dx.doi.org/10.1136/bmj.c2697			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614IZ	20547685	Green Published, hybrid			2022-12-28	WOS:000279051600001
J	Yeh, RW; Sidney, S; Chandra, M; Sorel, M; Selby, JV; Go, AS				Yeh, Robert W.; Sidney, Stephen; Chandra, Malini; Sorel, Michael; Selby, Joseph V.; Go, Alan S.			Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; UNITED-STATES; CHOLESTEROL LEVELS; TEMPORAL TRENDS; MEDICAL-CARE; US; MORTALITY; PREVENTION; RISK	Background: Few studies have characterized recent population trends in the incidence and outcomes of myocardial infarction. Methods: We identified patients 30 years of age or older in a large, diverse, community-based population who were hospitalized for incident myocardial infarction between 1999 and 2008. Age- and sex-adjusted incidence rates were calculated for myocardial infarction overall and separately for ST-segment elevation and non-ST-segment elevation myocardial infarction. Patient characteristics, outpatient medications, and cardiac biomarker levels during hospitalization were identified from health plan databases, and 30-day mortality was ascertained from administrative databases, state death data, and Social Security Administration files. Results: We identified 46,086 hospitalizations for myocardial infarctions during 18,691,131 person-years of follow-up from 1999 to 2008. The age- and sex-adjusted incidence of myocardial infarction increased from 274 cases per 100,000 person-years in 1999 to 287 cases per 100,000 person-years in 2000, and it decreased each year thereafter, to 208 cases per 100,000 person-years in 2008, representing a 24% relative decrease over the study period. The age- and sex-adjusted incidence of ST-segment elevation myocardial infarction decreased throughout the study period (from 133 cases per 100,000 person-years in 1999 to 50 cases per 100,000 person-years in 2008, P<0.001 for linear trend). Thirty-day mortality was significantly lower in 2008 than in 1999 (adjusted odds ratio, 0.76; 95% confidence interval, 0.65 to 0.89). Conclusions: Within a large community-based population, the incidence of myocardial infarction decreased significantly after 2000, and the incidence of ST-segment elevation myocardial infarction decreased markedly after 1999. Reductions in short-term case fatality rates for myocardial infarction appear to be driven, in part, by a decrease in the incidence of ST-segment elevation myocardial infarction and a lower rate of death after non-ST-segment elevation myocardial infarction. N Engl J Med 2010;362:2155-65.	[Sidney, Stephen; Chandra, Malini; Sorel, Michael; Selby, Joseph V.; Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Yeh, Robert W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Cardiol Div, Boston, MA USA; [Sidney, Stephen; Selby, Joseph V.; Go, Alan S.] Permanente Med Grp Inc, Oakland, CA USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Kaiser Permanente; Harvard University; Harvard Medical School; Massachusetts General Hospital; Permanente Medical Groups; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Fl, Oakland, CA 94612 USA.	alan.s.go@kp.org	s, s/HIK-1178-2022; Yeh, Robert/AAJ-3463-2020; s, s/GYR-2278-2022; Go, Alan S./AAE-7745-2019; s, s/HHD-0404-2022		Permanente Medical Group; Schering-Plough Future Leaders in Cardiovascular Medical Research	Permanente Medical Group; Schering-Plough Future Leaders in Cardiovascular Medical Research	Supported by research funding from the Permanente Medical Group and by a Schering-Plough Future Leaders in Cardiovascular Medical Research grant.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; ANDERSON JL, 2008, J AM COLL CARDIOL, V51, P974; [Anonymous], 1981, JAMA-J AM MED ASSOC, V246, P2073; [Anonymous], 2008, KAIS PERM 2008 HEDIS; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; ANTMAN EM, 2008, CIRCULATION, V117, pE162; Arciero TJ, 2004, AM J MED, V117, P228, DOI 10.1016/j.amjmed.2004.04.008; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Go AS, 2006, JAMA-J AM MED ASSOC, V296, P2105, DOI 10.1001/jama.296.17.2105; Go AS, 2006, ANN INTERN MED, V144, P229, DOI 10.7326/0003-4819-144-4-200602210-00004; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldberg RJ, 2004, AM J CARDIOL, V94, P1373, DOI 10.1016/j.amjcard.2004.07.142; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Parikh NI, 2009, CIRCULATION, V119, P1203, DOI 10.1161/CIRCULATIONAHA.108.825364; PEDERSEN TR, 1994, LANCET, V344, P1383; Pottenger BC, 2008, ANN EMERG MED, V52, P677, DOI 10.1016/j.annemergmed.2008.06.004; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Selby JV, 2010, MED CARE, V48, P133, DOI 10.1097/MLR.0b013e3181c15a6e; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Steinberg BA, 2008, AM HEART J, V156, P719, DOI 10.1016/j.ahj.2008.05.020; Sytkowski PA, 1996, AM J EPIDEMIOL, V143, P338, DOI 10.1093/oxfordjournals.aje.a008748; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 2000, NEW ENGL J MED, V342, P1376; [No title captured]; 2003, JAMA, V289, P176	55	1183	1236	0	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2155	2165		10.1056/NEJMoa0908610	http://dx.doi.org/10.1056/NEJMoa0908610			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558366				2022-12-28	WOS:000278551500004
J	Batty, GD; Whitley, E; Deary, IJ; Gale, CR; Tynelius, P; Rasmussen, F				Batty, G. David; Whitley, Elise; Deary, Ian J.; Gale, Catharine R.; Tynelius, Per; Rasmussen, Finn			Psychosis alters association between IQ and future risk of attempted suicide: cohort study of 1 109 475 Swedish men	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; NATIONAL INTELLIGENCE; PSYCHIATRIC-DISORDERS; COGNITIVE-ABILITY; DOMESTIC VIOLENCE; EARLY ADULTHOOD; BLOOD-PRESSURE; CHILDHOOD IQ; SELF-HARM; CHILDREN	Objectives To explore associations between IQ measured in early adulthood and subsequent hospital admissions for attempted suicide and to explore the role of psychosis and examine associations of IQ with specific methods of attempted suicide. Design Cohort study. Setting Sweden. Participants 1 109 475 Swedish men with IQ measured in early adulthood followed up for an average 24 years. Main outcome measures Hospital admission for attempted suicide. Results 17 736 (1.6%) men had at least one hospital admission for attempted suicide by any means during follow-up. After adjustment for age and socioeconomic status, lower IQ scores were associated with an elevated risk of attempted suicide by any means (hazard ratio per standard deviation decrease in IQ=1.57, 95% confidence interval 1.54 to 1.60), with stepwise increases in risk across the full IQ range (P for trend<0.001). Similar associations were observed for all specific methods of attempted suicide. Separate analyses indicated that associations between IQ and attempted suicide were restricted to participants without psychosis and that IQ had no marked impact on risk of attempted suicide in those with psychosis. Conclusions Low IQ scores in early adulthood were associated with a subsequently increased risk of attempted suicide in men free from psychosis. A greater understanding of the mechanisms underlying these associations may provide opportunities and strategies for prevention.	[Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, SE-17176 Stockholm, Sweden; [Batty, G. David; Whitley, Elise] Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Batty, G. David; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Batty, G. David] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Gale, Catharine R.] Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton SO9 5NH, Hants, England	Karolinska Institutet; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Edinburgh; University of Sydney; University of Southampton	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, SE-17176 Stockholm, Sweden.	finn.rasmussen@ki.se	Batty, GD/Y-4401-2018; Deary, Ian J/C-6297-2009; Gale, Catharine R/B-1653-2012	Batty, GD/0000-0003-1822-5753; Deary, Ian J/0000-0002-1733-263X; Gale, Catharine/0000-0002-3361-8638; Tynelius, Per/0000-0001-8155-7406; Rasmussen, Finn/0000-0001-7915-7809	Wellcome Trust [WBS U. 1300.00.006.00012.01]; UK MRC; Chief Scientist Office at the Scottish Government Health Directorates; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; University of Edinburgh; Swedish Research Council; Labour Market Insurance Ltd (AFA); Swedish Council for Working Life and Social Research; Medical Research Council [U1475000002, MC_UP_A620_1015, MC_U130059821, G0700704] Funding Source: researchfish; MRC [G0700704, MC_UP_A620_1015, MC_U130059821] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office at the Scottish Government Health Directorates; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Edinburgh; Swedish Research Council(Swedish Research CouncilEuropean Commission); Labour Market Insurance Ltd (AFA); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GDB is a Wellcome Trust fellow (WBS U. 1300.00.006.00012.01), funding from which also supports EW. The Medical Research Council (MRC) Social and Public Health Sciences Unit receives funding from the UK MRC and the Chief Scientist Office at the Scottish Government Health Directorates. The Centre for Cognitive Ageing and Cognitive Epidemiology is supported by the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, the MRC, and the University of Edinburgh as part of the cross council lifelong health and wellbeing initiative. FR is supported by the Swedish Research Council, the Labour Market Insurance Ltd (AFA), and the Swedish Council for Working Life and Social Research.	Afifi TO, 2008, AM J PUBLIC HEALTH, V98, P946, DOI 10.2105/AJPH.2007.120253; Alaraisanen A, 2006, ACTA PSYCHIAT SCAND, V114, P357, DOI 10.1111/j.1600-0447.2006.00800.x; Andersson L, 2008, ACTA PSYCHIAT SCAND, V118, P99, DOI 10.1111/j.1600-0447.2008.01171.x; Batty GD, 2007, ANN ONCOL, V18, P21, DOI 10.1093/annonc/mdl473; Batty GD, 2006, J EPIDEMIOL COMMUN H, V60, P872, DOI 10.1136/jech.2005.045039; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Biddle L, 2008, BRIT MED J, V336, P539, DOI 10.1136/bmj.39475.603935.25; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Brock A, 2003, HLTH STAT Q, V20, P7; Cha CB, 2009, J AM ACAD CHILD PSY, V48, P422, DOI 10.1097/CHI.0b013e3181984f44; Chandola T, 2006, INT J OBESITY, V30, P1422, DOI 10.1038/sj.ijo.0803279; Claassen CA, 2006, SUICIDE LIFE-THREAT, V36, P192, DOI 10.1521/suli.2006.36.2.192; Delaney-Black V, 2002, ARCH PEDIAT ADOL MED, V156, P280, DOI 10.1001/archpedi.156.3.280; Enns MW, 2006, PSYCHOL MED, V36, P1769, DOI 10.1017/S0033291706008646; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P850, DOI 10.1111/j.1469-7610.2005.01472.x; Fergusson DM, 1996, J CHILD PSYCHOL PSYC, V37, P281, DOI 10.1111/j.1469-7610.1996.tb01405.x; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; Gale CR, 2008, PSYCHOSOM MED, V70, P397, DOI 10.1097/PSY.0b013e31816a719e; Gale CR, 2008, ARCH GEN PSYCHIAT, V65, P1410, DOI 10.1001/archpsyc.65.12.1410; Gunnell D, 2005, BMJ-BRIT MED J, V330, P167, DOI 10.1136/bmj.38310.473565.8F; Gunnell D, 2002, INT J EPIDEMIOL, V31, P390, DOI 10.1093/ije/31.2.390; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Hemmingsson T, 2005, INT J EPIDEMIOL, V34, P260, DOI 10.1093/ije/dyh314; Jiang GX, 1999, ACTA PSYCHIAT SCAND, V100, P433, DOI 10.1111/j.1600-0447.1999.tb10893.x; Kelly S, 1998, Popul Trends, P29; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Kolbo JR, 1996, J INTERPERS VIOLENCE, V11, P281, DOI 10.1177/088626096011002010; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; MALINOSKYRUMMELL R, 1993, PSYCHOL BULL, V114, P68, DOI 10.1037/0033-2909.114.1.68; Masten AS, 1995, CHILD DEV, V66, P1635, DOI 10.2307/1131901; Osler M, 2008, J EPIDEMIOL COMMUN H, V62, P23, DOI 10.1136/jech.2006.053330; OToole BI, 1995, SUICIDE LIFE-THREAT, V25, P475; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; PEARCE CM, 1993, ACTA PSYCHIAT SCAND, V88, P409, DOI 10.1111/j.1600-0447.1993.tb03482.x; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; Starr JM, 2004, J HYPERTENS, V22, P893, DOI 10.1097/00004872-200405000-00009; Terry PD, 2007, AM J EPIDEMIOL, V165, P294, DOI 10.1093/aje/kwk014; Voracek M, 2005, J BIOSOC SCI, V37, P721, DOI 10.1017/S0021932004006959; Voracek M, 2004, PERS INDIV DIFFER, V37, P543, DOI 10.1016/j.paid.2003.09.025; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354	42	41	41	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2010	340								c2506	10.1136/bmj.c2506	http://dx.doi.org/10.1136/bmj.c2506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BM	20522657	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000278556500004
J	Huang, Z; White, PS; Brookhart, M				Huang, Zheng; White, Peter S.; Brookhart, Maurice			Ligand exchanges and selective catalytic hydrogenation in molecular single crystals	NATURE			English	Article							COORDINATION POLYMER; TRANSFER DEHYDROGENATION; PINCER COMPLEXES; IRIDIUM; TRANSFORMATION; ELIMINATION; CONVERSION; FRAMEWORK; NETWORK; BONDS	Chemical reactions inside single crystals are likely to be highly selective, but examples of single crystal to single crystal (SC-SC) transformations are uncommon, because crystallinity is difficult to retain following the rearrangement of atoms in the solid state(1-19). The most widely studied SC-SC transformations involve solvent exchange reactions in porous coordination polymers or metal-organic frameworks, which take advantage of the robust polymeric networks of the hosts(2,8,9-11). Examples of reactions occurring within molecular organic crystals generally involve photo-induced reactions, such as the coupling of alkenes or alkynes within the crystal(1,2,12-15). For nonporous molecular inorganic or organometallic crystals, single-crystal transformations involving the formation or cleavage of metal-ligand bonds are rare(17-21); known examples usually involve ligand loss from the single crystal and reversible religation, a process sometimes accompanied by decay of the single crystal to a microcrystalline powder(20,21). Here we report a series of SC-SC transformations that involve the interchange of multiple small gaseous ligands (N(2), CO, NH(3), C(2)H(4), H(2) and O(2)) at an iridium centre in molecular single crystals of a pincer Ir(I) complex. The single crystal remains intact during these ligand-exchange reactions, which occur within the crystal and do not require prior ligand extrusion. We reveal a selective catalytic transformation within a nonporous molecular crystal: pincer iridium single crystals ligated with nitrogen, ethylene or hydrogen show selective hydrogenation of ethylene relative to propylene (25:1) when surface sites are passified by CO.	[Huang, Zheng; White, Peter S.; Brookhart, Maurice] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Brookhart, M (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	mbrookhart@unc.edu		Huang, Zheng/0000-0001-7524-098X	National Science Foundation under the auspices of the Centre for Enabling New Technologies through Catalysis (CENTC)	National Science Foundation under the auspices of the Centre for Enabling New Technologies through Catalysis (CENTC)	This work is financially supported by the National Science Foundation under the auspices of the Centre for Enabling New Technologies through Catalysis (CENTC).	Albrecht M, 2000, NATURE, V406, P970, DOI 10.1038/35023107; Atwood JL, 2002, SCIENCE, V298, P1000, DOI 10.1126/science.1077591; Bezzu CG, 2010, SCIENCE, V327, P1627, DOI 10.1126/science.1184228; Bucar DK, 2007, J AM CHEM SOC, V129, P32, DOI 10.1021/ja0671161; Cotton FA, 2007, INORG CHEM, V46, P3245, DOI 10.1021/ic062443v; FOXMAN BM, 2007, MOL SOLID STATE, P534; Garcia-Garibay MA, 2007, ANGEW CHEM INT EDIT, V46, P8945, DOI 10.1002/anie.200702443; Ghosh R, 2006, ORGANOMETALLICS, V25, P5668, DOI 10.1021/om0607043; Ghosh SK, 2008, ANGEW CHEM INT EDIT, V47, P8843, DOI 10.1002/anie.200802803; Ghosh SK, 2007, ANGEW CHEM INT EDIT, V46, P7965, DOI 10.1002/anie.200703086; Goldman AS, 2006, SCIENCE, V312, P257, DOI 10.1126/science.1123787; Gottker-Schnetmann I, 2004, ORGANOMETALLICS, V23, P1766, DOI 10.1021/om030670o; Haneda T, 2008, J AM CHEM SOC, V130, P1578, DOI 10.1021/ja7111564; Hebden TJ, 2010, INORG CHEM, V49, P1733, DOI 10.1021/ic902163w; Hu CH, 2006, ANGEW CHEM INT EDIT, V45, P3457, DOI 10.1002/anie.200504460; Huang Z, 2009, ADV SYNTH CATAL, V351, P188, DOI 10.1002/adsc.200800615; Iordanidis L, 2000, ANGEW CHEM INT EDIT, V39, P1928; Kanzelberger M, 2003, J AM CHEM SOC, V125, P13644, DOI 10.1021/ja037363u; Kawano M, 2007, COORDIN CHEM REV, V251, P2592, DOI 10.1016/j.ccr.2007.07.022; Kobatake S, 2007, NATURE, V446, P778, DOI 10.1038/nature05669; Lennartson A, 2007, NEW J CHEM, V31, P344, DOI 10.1039/b615579k; Li B, 2010, J AM CHEM SOC, V132, P1558, DOI 10.1021/ja909695f; Libri S, 2008, ANGEW CHEM INT EDIT, V47, P1693, DOI 10.1002/anie.200703194; Morales-Morales D, 2001, CAN J CHEM, V79, P823, DOI 10.1139/cjc-79-5-6-823; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; Supriya S, 2007, J AM CHEM SOC, V129, P3464, DOI 10.1021/ja067572p; Vittal JJ, 2007, COORDIN CHEM REV, V251, P1781, DOI 10.1016/j.ccr.2007.02.002; Warren MR, 2009, ANGEW CHEM INT EDIT, V48, P5711, DOI 10.1002/anie.200901706; Williams DB, 2008, CHEM COMMUN, P4195, DOI 10.1039/b802739k; Xue DX, 2008, CHEM COMMUN, P1551, DOI 10.1039/b717885a	30	138	140	7	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					598	601		10.1038/nature09085	http://dx.doi.org/10.1038/nature09085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520710				2022-12-28	WOS:000278249000037
J	Fendorf, S; Michael, HA; van Geen, A				Fendorf, Scott; Michael, Holly A.; van Geen, Alexander			Spatial and Temporal Variations of Groundwater Arsenic in South and Southeast Asia	SCIENCE			English	Review							RED-RIVER DELTA; DRINKING-WATER; BENGAL BASIN; HYDROGEOLOGICAL CONTROL; GEOCHEMICAL PROCESSES; CONTAMINATED AQUIFER; BANGLADESH; RELEASE; ARAIHAZAR; SHALLOW	Over the past few decades, groundwater wells installed in rural areas throughout the major river basins draining the Himalayas have become the main source of drinking water for tens of millions of people. Groundwater in this region is much less likely to contain microbial pathogens than surface water but often contains hazardous amounts of arsenic-a known carcinogen. Arsenic enters groundwater naturally from rocks and sediment by coupled biogeochemical and hydrologic processes, some of which are presently affected by human activity. Mitigation of the resulting health crisis in South and Southeast Asia requires an understanding of the transport of arsenic and key reactants such as organic carbon that could trigger release in zones with presently low groundwater arsenic levels.	[Fendorf, Scott] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Michael, Holly A.] Univ Delaware, Dept Geol Sci, Newark, DE 19716 USA; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Stanford University; University of Delaware; Columbia University	Fendorf, S (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.	fendorf@stanford.edu; hmichael@udel.edu; avangeen@ldeo.columbia.edu	Michael, Holly A/F-8447-2010	Michael, Holly A/0000-0003-1107-7698; Fendorf, Scott/0000-0002-9177-1809	Stanford's Woods Institute for the Environment; Stanford NSF Environmental Molecular Science Institute [NSF-CHE-0431425]; U.S. Geological Survey; U.S. Agency for International Development; British Department for International Development; UNICEF; National Institute of Environmental Health Sciences SRP [1 P42 ES10349]; NIH FIC [5 D43 TW05724]; NSF [EAR 0345688]; FOGARTY INTERNATIONAL CENTER [D43TW005724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	Stanford's Woods Institute for the Environment; Stanford NSF Environmental Molecular Science Institute; U.S. Geological Survey(United States Geological Survey); U.S. Agency for International Development(United States Agency for International Development (USAID)); British Department for International Development; UNICEF; National Institute of Environmental Health Sciences SRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NSF(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. W. Rosenboom of Water Supply Program/World Bank and M. A. Sampson, founder and director of RDI International, Cambodia (deceased 19 March 2009), for help in organizing the AGU Chapman conference held in Siem Reap, Cambodia, in March 2009 that resulted in this review. Travel support for the conference was contributed by the Woods Institute for the Environment at Stanford University and the European Union Asia-Link CALIBRE Project. We also acknowledge research funding by the Environmental Venture Projects program of Stanford's Woods Institute for the Environment and the Stanford NSF Environmental Molecular Science Institute (NSF-CHE-0431425) (S. E. F.), the U.S. Geological Survey, the U.S. Agency for International Development, the British Department for International Development, and UNICEF (H. A. M.), National Institute of Environmental Health Sciences SRP grant 1 P42 ES10349, NIH FIC grant 5 D43 TW05724, and NSF grant EAR 0345688 (AvG). We thank R. Beckie, G. Breit, C. Harvey, J. Lloyd, and an anonymous reviewer for helpful comments. This is Lamont-Doherty Earth Observatory contribution no. 7355.	Acharyya SK, 1999, NATURE, V401, P545, DOI 10.1038/44052; Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Aziz Z, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006000; Benner SG, 2008, APPL GEOCHEM, V23, P3072, DOI 10.1016/j.apgeochem.2008.06.013; Berg M, 2008, CHEM GEOL, V249, P91, DOI 10.1016/j.chemgeo.2007.12.007; Buschmann J, 2007, ENVIRON SCI TECHNOL, V41, P2146, DOI 10.1021/es062056k; Buschmann J, 2009, APPL GEOCHEM, V24, P1278, DOI 10.1016/j.apgeochem.2009.04.002; Chen CJ, 1996, ARTERIOSCL THROM VAS, V16, P504, DOI 10.1161/01.ATV.16.4.504; Chen Y, 2004, AM J PUBLIC HEALTH, V94, P741, DOI 10.2105/AJPH.94.5.741; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Dowling CB, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000968; Eiche E, 2008, APPL GEOCHEM, V23, P3143, DOI 10.1016/j.apgeochem.2008.06.023; Goodbred SL, 2000, SEDIMENT GEOL, V133, P227, DOI 10.1016/S0037-0738(00)00041-5; Gurung J, 2005, ENVIRON GEOL, V49, P98, DOI 10.1007/s00254-005-0063-6; Harvey CF, 2006, CHEM GEOL, V228, P112, DOI 10.1016/j.chemgeo.2005.11.025; Harvey CF, 2002, SCIENCE, V298, P1602, DOI 10.1126/science.1076978; Horneman A, 2004, GEOCHIM COSMOCHIM AC, V68, P3459, DOI 10.1016/j.gca.2004.01.026; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Jessen S, 2008, APPL GEOCHEM, V23, P3116, DOI 10.1016/j.apgeochem.2008.06.015; Kinniburgh D.G., 2001, WC0019 BGS, V2; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Kocar BD, 2008, APPL GEOCHEM, V23, P3059, DOI 10.1016/j.apgeochem.2008.06.026; Larsen F, 2008, APPL GEOCHEM, V23, P3099, DOI 10.1016/j.apgeochem.2008.06.014; Lowers HA, 2007, GEOCHIM COSMOCHIM AC, V71, P2699, DOI 10.1016/j.gca.2007.03.022; Mailloux BJ, 2009, APPL ENVIRON MICROB, V75, P2558, DOI 10.1128/AEM.02440-07; McArthur JM, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006552; Michael HA, 2008, P NATL ACAD SCI USA, V105, P8531, DOI 10.1073/pnas.0710477105; Mladenov N, 2010, ENVIRON SCI TECHNOL, V44, P123, DOI 10.1021/es901472g; Mukherjee A, 2007, HYDROGEOL J, V15, P1397, DOI 10.1007/s10040-007-0208-7; Nath B, 2009, J HYDROL, V364, P236, DOI 10.1016/j.jhydrol.2008.10.025; Neumann RB, 2010, NAT GEOSCI, V3, P46, DOI 10.1038/NGEO685; Nickson R, 2007, J ENVIRON SCI HEAL A, V42, P1707, DOI 10.1080/10934520701564194; Papacostas NC, 2008, GEOLOGY, V36, P891, DOI 10.1130/G24791A.1; Polizzotto ML, 2008, NATURE, V454, P505, DOI 10.1038/nature07093; Postma D, 2007, GEOCHIM COSMOCHIM AC, V71, P5054, DOI 10.1016/j.gca.2007.08.020; Ravenscroft P, 2005, HYDROGEOL J, V13, P727, DOI 10.1007/s10040-003-0314-0; Ravenscroft P., 2009, ARSENIC POLLUTION GL; Rowland HAL, 2007, GEOBIOLOGY, V5, P281, DOI 10.1111/j.1472-4669.2007.00100.x; Seddique AA, 2008, APPL GEOCHEM, V23, P2236, DOI 10.1016/j.apgeochem.2008.03.007; Sengupta S, 2008, ENVIRON SCI TECHNOL, V42, P5156, DOI 10.1021/es702988m; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; Stollenwerk KG, 2007, SCI TOTAL ENVIRON, V379, P133, DOI 10.1016/j.scitotenv.2006.11.029; Stute M, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004499; Swartz CH, 2004, GEOCHIM COSMOCHIM AC, V68, P4539, DOI 10.1016/j.gca.2004.04.020; Tufano KJ, 2008, ENVIRON SCI TECHNOL, V42, P8283, DOI 10.1021/es801059s; van Geen A, 2008, ENVIRON SCI TECHNOL, V42, P2283, DOI 10.1021/es702316k; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; Van Geen A, 2007, J ENVIRON SCI HEAL A, V42, P1729, DOI 10.1080/10934520701564236; von Bromssen M, 2007, SCI TOTAL ENVIRON, V379, P121, DOI 10.1016/j.scitotenv.2006.06.028; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Weinman B, 2008, GEOL SOC AM BULL, V120, P1567, DOI 10.1130/B26209.1; Winkel L, 2008, NAT GEOSCI, V1, P536, DOI 10.1038/ngeo254; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	53	797	868	35	747	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1123	1127		10.1126/science.1172974	http://dx.doi.org/10.1126/science.1172974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508123				2022-12-28	WOS:000278104700034
J	Parmet, WE				Parmet, Wendy E.			Pandemic Vaccines -- The Legal Landscape.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northeastern Univ, Sch Law, Boston, MA 02115 USA	Northeastern University	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.							DUCHIN JS, 2009, SPRING 2009 INFLUENZ; Fisher B. L., 2009, POLITICS PROFITS PAN; MCNEIL DG, 2010, NY TIMES        0313, pA11; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477	4	14	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1949	1952		10.1056/NEJMp1000938	http://dx.doi.org/10.1056/NEJMp1000938			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	601JI	20505176				2022-12-28	WOS:000278054000001
J	McCrory, E; Viding, E				McCrory, Eamon; Viding, Essi			The neurobiology of maltreatment and adolescent violence	LANCET			English	Editorial Material							BRAIN		[McCrory, Eamon; Viding, Essi] UCL, Div Psychol & Language Sci, Res Dept Clin Educ & Hlth Psychol, Dev Risk & Resilience Unit, London WC1H 0AP, England	University of London; University College London	McCrory, E (corresponding author), UCL, Div Psychol & Language Sci, Res Dept Clin Educ & Hlth Psychol, Dev Risk & Resilience Unit, London WC1H 0AP, England.	e.mccrory@ucl.ac.uk		Viding, Essi/0000-0001-8468-8874	ESRC [ES/G000131/1] Funding Source: UKRI; Economic and Social Research Council [ES/G000131/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		BATMANGHELIDJH C, 2009, TIMESONLINE     1126; BATMANGHELIDJH C, 2010, TIMESONLINE     0313; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Kim J, 2010, J CHILD PSYCHOL PSYC, V51, P706, DOI 10.1111/j.1469-7610.2009.02202.x; Lansford JE, 2002, ARCH PEDIAT ADOL MED, V156, P824, DOI 10.1001/archpedi.156.8.824; Lee V, 2007, CHILD MALTREATMENT, V12, P281, DOI 10.1177/1077559507303778; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; MCCRORY E, J CHILD PSY IN PRESS; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Taylor A, 2007, DEV PSYCHOPATHOL, V19, P1029, DOI 10.1017/S095457940700051X	12	10	10	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1856	1857		10.1016/S0140-6736(10)60842-2	http://dx.doi.org/10.1016/S0140-6736(10)60842-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609BC	20511003				2022-12-28	WOS:000278628800009
J	Greer, EL; Maures, TJ; Hauswirth, AG; Green, EM; Leeman, DS; Maro, GS; Han, S; Banko, MR; Gozani, O; Brunet, A				Greer, Eric L.; Maures, Travis J.; Hauswirth, Anna G.; Green, Erin M.; Leeman, Dena S.; Maro, Geraldine S.; Han, Shuo; Banko, Max R.; Gozani, Or; Brunet, Anne			Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans	NATURE			English	Article							SYSTEMATIC RNAI SCREEN; SET-DOMAIN PROTEIN; CAENORHABDITIS-ELEGANS; HISTONE H3; GENE-EXPRESSION; LONGEVITY; METHYLATION; METHYLTRANSFERASE; METABOLISM; COMPONENTS	The plasticity of ageing suggests that longevity may be controlled epigenetically by specific alterations in chromatin state. The link between chromatin and ageing has mostly focused on histone deacetylation by the Sir2 family(1,2), but less is known about the role of other histone modifications in longevity. Histone methylation has a crucial role in development and in maintaining stem cell pluripotency in mammals(3). Regulators of histone methylation have been associated with ageing in worms(4-7) and flies(8), but characterization of their role and mechanism of action has been limited. Here we identify the ASH-2 trithorax complex(9), which trimethylates histone H3 at lysine 4 (H3K4), as a regulator of lifespan in Caenorhabditis elegans in a directed RNA interference (RNAi) screen in fertile worms. Deficiencies in members of the ASH-2 complex-ASH-2 itself, WDR-5 and the H3K4 methyltransferase SET-2-extend worm lifespan. Conversely, the H3K4 demethylase RBR-2 is required for normal lifespan, consistent with the idea that an excess of H3K4 trimethylation-a mark associated with active chromatin is detrimental for longevity. Lifespan extension induced by ASH-2 complex deficiency requires the presence of an intact adult germline and the continuous production of mature eggs. ASH-2 and RBR-2 act in the germline, at least in part, to regulate lifespan and to control a set of genes involved in lifespan determination. These results indicate that the longevity of the soma is regulated by an H3K4 methyltransferase/demethylase complex acting in the C. elegans germline.	[Greer, Eric L.; Maures, Travis J.; Hauswirth, Anna G.; Leeman, Dena S.; Han, Shuo; Banko, Max R.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Greer, Eric L.; Leeman, Dena S.; Gozani, Or; Brunet, Anne] Stanford Univ, Canc Biol Grad Program, Stanford, CA 94305 USA; [Green, Erin M.; Maro, Geraldine S.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Maro, Geraldine S.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Gozani, Or P/I-6157-2013; Green, Erin/J-6098-2019	Greer, Eric/0000-0002-7501-7371; Green, Erin/0000-0003-3923-6726; Gozani, Or/0000-0002-1365-4463; han, shuo/0000-0003-1181-351X	NIH [R01-AG31198, T32-CA009302, ARRA-AG31198, T32-HG000044, F31-AG032837]; NSF; Stanford graduate fellowship; Human Frontier Science Program post-doctoral fellowship; Searle Scholar award; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032837, R56AG031198, R01AG031198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Stanford graduate fellowship(Stanford University); Human Frontier Science Program post-doctoral fellowship(Human Frontier Science Program); Searle Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Fire, K. Helin, S. Kim, K. Shen, T. Stiernagle and the Caenorhabditis Genetics Center, M. W. Tan and A. Villeneuve for gifts of strains, reagents and antibodies. We thank S. Kim, G. Seydoux, C. Slightam and K. Shen for advice on worm transgenesis, and S. Kim, A. Morgan and Y. Kobayashi for help with microarray analysis. We thank A. Fire, S. Kim, G. Seydoux, M. W. Tan and J. Wysocka for discussions. We thank members of the Brunet laboratory, M. Kaeberlein, J. Lieberman, J. Sage and J. Wysocka for critical reading of the manuscript. This work was supported by NIH grant R01-AG31198 to A. B.; E. L. G. was supported by NIH training grant T32-CA009302, an NSF graduate fellowship and by NIH ARRA-AG31198. T. J. M. was supported by NIH grant T32-HG000044. D. S. L. and E. M. G. were supported by NIH training grant T32-CA009302. S. H. was supported by a Stanford graduate fellowship. G. S. M. was supported by a Human Frontier Science Program post-doctoral fellowship. M. R. B. was supported by NIH fellowship F31-AG032837. O.G. was supported by a Searle Scholar award.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Kelly WG, 1997, GENETICS, V146, P227; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; MERRITT C, 2010, WORMBOOK, DOI DOI 10.1895/W0RMBOOK.1.148.1; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Praitis V, 2001, GENETICS, V157, P1217; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu L, 2001, GENETICS, V159, P1019	42	335	392	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					383	U137		10.1038/nature09195	http://dx.doi.org/10.1038/nature09195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20555324	Green Accepted			2022-12-28	WOS:000279867100052
J	Agrawal, K; Certain, M				Agrawal, Kush; Certain, Matthew			Visible Peristalsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Agrawal, Kush; Certain, Matthew] Emory Univ, Atlanta, GA 30322 USA	Emory University	Agrawal, K (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	kagraw2@emory.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					E68	E68		10.1056/NEJMicm0910079	http://dx.doi.org/10.1056/NEJMicm0910079			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554980				2022-12-28	WOS:000278816300010
J	Guiducci, C; Gong, M; Xu, ZH; Gill, M; Chaussabel, D; Meeker, T; Chan, JH; Wright, T; Punaro, M; Bolland, S; Soumelis, V; Banchereau, J; Coffman, RL; Pascual, V; Barrat, FJ				Guiducci, Cristiana; Gong, Mei; Xu, Zhaohui; Gill, Michelle; Chaussabel, Damien; Meeker, Thea; Chan, Jean H.; Wright, Tracey; Punaro, Marilynn; Bolland, Silvia; Soumelis, Vassili; Banchereau, Jacques; Coffman, Robert L.; Pascual, Virginia; Barrat, Franck J.			TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; SYSTEMIC-LUPUS; AUTOIMMUNE-DISEASES; I INTERFERON; ERYTHEMATOSUS; RECEPTOR; BLOOD; GENE; MICE; CORTICOSTEROIDS	Glucocorticoids are widely used to treat patients with autoimmune diseases such as systemic lupus erythematosus (SLE)(1,2). However, regimens used to treat many such conditions cannot maintain disease control in the majority of SLE patients and more aggressive approaches such as high-dose methylprednisolone pulse therapy are used to provide transient reductions in disease activity(3,4). The primary anti-inflammatory mechanism of glucocorticoids is thought to be NF-kappa B inhibition(5). Recognition of self nucleic acids by toll-like receptors TLR7 and TLR9 on B cells and plasmacytoid dendritic cells (PDCs) is an important step in the pathogenesis of SLE(6), promoting anti-nuclear antibodies and the production of type I interferon (IFN), both correlated with the severity of disease(1,7). Following their activation by self-nucleic acid-associated immune complexes, PDCs migrate to the tissues(8,9). We demonstrate, in vitro and in vivo, that stimulation of PDCs through TLR7 and 9 can account for the reduced activity of glucocorticoids to inhibit the IFN pathway in SLE patients and in two lupus-prone mouse strains. The triggering of PDCs through TLR7 and 9 by nucleic acid-containing immune complexes or by synthetic ligands activates the NF-kappa B pathway essential for PDC survival. Glucocorticoids do not affect NF-kappa B activation in PDCs, preventing glucocorticoid induction of PDC death and the consequent reduction of systemic IFN-alpha levels. These findings unveil a new role for self nucleic acid recognition by TLRs and indicate that inhibitors of TLR7 and 9 signalling could prove to be effective corticosteroid-sparing drugs.	[Guiducci, Cristiana; Gong, Mei; Meeker, Thea; Chan, Jean H.; Coffman, Robert L.; Barrat, Franck J.] Dynavax Technol Corp, Berkeley, CA 94710 USA; [Xu, Zhaohui; Gill, Michelle; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Wright, Tracey; Punaro, Marilynn; Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Wright, Tracey; Punaro, Marilynn] Univ Texas Dallas, SW Med Ctr, Dallas, TX 75235 USA; [Wright, Tracey; Punaro, Marilynn] Childrens Med Ctr, Dallas, TX 75235 USA; [Bolland, Silvia] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Soumelis, Vassili] Inst Curie, Dept Immunol, F-75005 Paris, France	Baylor Scott & White Health; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Barrat, FJ (corresponding author), Dynavax Technol Corp, 2929 7th St,Suite 100, Berkeley, CA 94710 USA.	fbarrat@dynavax.com	Chaussabel, Damien/AAX-1909-2020; Pascual, Virginia/ABD-3099-2020	Chaussabel, Damien/0000-0002-6131-7242; Xu, Zhaohui/0000-0003-0645-1737	NIH [P50-ARO54083-01CORT, U19-AI082715-01]; Alliance for Lupus Research; Mary Kirkland Foundation; SBIR [2R44AI066483-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI066483, ZIAAI000912, U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Mary Kirkland Foundation; SBIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank A. O'Garra, G. Trinchieri, J.-L. Casanova and our colleagues at Dynavax Technologies for their critical reading of the manuscript. We thank S. Noonan and H. Lopez (Murigenics) for invaluable assistance with animal work. This work was supported by NIH grants P50-ARO54083-01CORT, U19-AI082715-01, The Alliance for Lupus Research, The Mary Kirkland Foundation (to V. P.) and SBIR grant 2R44AI066483-02 (to R. L. C.).	Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boor P, 2006, AM J TRANSPLANT, V6, P2332, DOI 10.1111/j.1600-6143.2006.01476.x; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Franchin G, 2006, AUTOIMMUN REV, V5, P111, DOI 10.1016/j.autrev.2005.08.003; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Montague J W, 1995, Curr Top Microbiol Immunol, V200, P51; Parker BJ, 2007, LUPUS, V16, P387, DOI 10.1177/0961203307079502; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Shodell M, 2003, LUPUS, V12, P222, DOI 10.1191/0961203303lu362xx; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Tucci M, 2008, ARTHRITIS RHEUM-US, V58, P251, DOI 10.1002/art.23186; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96	30	262	278	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					937	U10		10.1038/nature09102	http://dx.doi.org/10.1038/nature09102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559388	Green Accepted			2022-12-28	WOS:000278804500040
J	Fekete, T				Fekete, Thomas			Pneumococcal vaccine reduced pneumococcal pneumonia and associated mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022					Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-5	10.7326/0003-4819-152-12-201006150-02005	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547899				2022-12-28	WOS:000278827700026
J	Cowling, BJ; Chan, KH; Fang, VJ; Lau, LLH; So, HC; Fung, ROP; Ma, ESK; Kwong, ASK; Chan, C; Tsui, WWS; Ngai, H; Chu, DWS; Lee, PWY; Chiu, M; Leung, GM; Peiris, JSM				Cowling, Benjamin J.; Chan, Kwok Hung; Fang, Vicky J.; Lau, Lincoln L. H.; So, Hau Chi; Fung, Rita O. P.; Ma, Edward S. K.; Kwong, Alfred S. K.; Chan, Chi-Wai; Tsui, Wendy W. S.; Ngai, Ho-Yin; Chu, Daniel W. S.; Lee, Paco W. Y.; Chiu, Ming-Chee; Leung, Gabriel M.; Peiris, Joseph S. M.			Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OSELTAMIVIR TREATMENT; CLINICAL ILLNESS; TRANSMISSION; VIRUS; INFECTION; DIAGNOSIS; CHILDREN; DURATION; A(H1N1); DISEASE	Background: There are few data on the comparative epidemiology and virology of the pandemic 2009 influenza A (H1N1) virus and cocirculating seasonal influenza A viruses in community settings. Methods: We recruited 348 index patients with acute respiratory illness from 14 outpatient clinics in Hong Kong in July and August 2009. We then prospectively followed household members of 99 patients who tested positive for influenza A virus on rapid diagnostic testing. We collected nasal and throat swabs from all household members at three home visits within 7 days for testing by means of quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay and viral culture. Using hemagglutination-inhibition and viral-neutralization assays, we tested baseline and convalescent serum samples from a subgroup of patients for antibody responses to the pandemic and seasonal influenza A viruses. Results: Secondary attack rates (as confirmed on RT-PCR assay) among household contacts of index patients were similar for the pandemic influenza virus (8%; 95% confidence interval [CI], 3 to 14) and seasonal influenza viruses (9%; 95% CI, 5 to 15). The patterns of viral shedding and the course of illness among index patients were also similar for the pandemic and seasonal influenza viruses. In a subgroup of patients for whom baseline and convalescent serum samples were available, 36% of household contacts who had serologic evidence of pandemic influenza virus infection did not shed detectable virus or report illness. Conclusions: Pandemic 2009 H1N1 virus has characteristics that are broadly similar to those of seasonal influenza A viruses in terms of rates of viral shedding, clinical illness, and transmissibility in the household setting. N Engl J Med 2010;362:2175-84.	[Cowling, Benjamin J.; Fang, Vicky J.; Lau, Lincoln L. H.; So, Hau Chi; Fung, Rita O. P.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Pokfulam, Hong Kong, Peoples R China; [Chan, Kwok Hung; Ma, Edward S. K.; Peiris, Joseph S. M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Kwong, Alfred S. K.; Chan, Chi-Wai; Tsui, Wendy W. S.; Ngai, Ho-Yin; Chu, Daniel W. S.] Govt Hong Kong Special Adm Reg, Hosp Author, Hong Kong, Hong Kong, Peoples R China; [Lee, Paco W. Y.] St Pauls Hosp, Hong Kong, Hong Kong, Peoples R China; [Chiu, Ming-Chee] St Teresas Hosp, Hong Kong, Hong Kong, Peoples R China; [Peiris, Joseph S. M.] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong St. Paul's Hospital; University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Units 624-7,Core F Cyberport 3, Pokfulam, Hong Kong, Peoples R China.	bcowling@hku.hk	Chan, Kwok Hung/ABD-5399-2021; Cowling, Benjamin John/C-4263-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; So, Hau Chi/0000-0003-3119-1527; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Lau, Lincoln/0000-0002-7386-4104	National Institute of Allergy and Infectious Diseases [HHS-N266200700005C, N01-AI-70005]; Hong Kong University Grants Committee [AoE/M-12/06]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hong Kong University Grants Committee	Supported by grants from the National Institute of Allergy and Infectious Diseases (HHS-N266200700005C and N01-AI-70005) and the Hong Kong University Grants Committee (AoE/M-12/06).	Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, 2009, GUID BUS EMPL PLAN R; *CDCP, 2009, HOM CAR GUID PHYS DI; *CDCP, 2009, CDC REC AM TIM PERS; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chen TH, 2009, COMPUT ELECTR ENG, V35, P41, DOI 10.1016/j.compeleceng.2008.05.003; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Perez CM, 2010, EMERG INFECT DIS, V16, P156, DOI 10.3201/eid1601.091420; Shao J, 1995, JACKKNIFE BOOTSTRAP, P129; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	38	266	278	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2175	2184		10.1056/NEJMoa0911530	http://dx.doi.org/10.1056/NEJMoa0911530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558368	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000278551500006
J	Kalentzos, VN				Kalentzos, Vasileios N.			Cutis Marmorata in Decompression Sickness.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Naval & Vet Hosp Athens, Athens, Greece		Kalentzos, VN (corresponding author), Naval & Vet Hosp Athens, Athens, Greece.	vkalentzos@gmail.com							0	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					E67	E67		10.1056/NEJMicm0909444	http://dx.doi.org/10.1056/NEJMicm0909444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558363				2022-12-28	WOS:000278551500011
J	Sansone, G; Kelkensberg, F; Perez-Torres, JF; Morales, F; Kling, MF; Siu, W; Ghafur, O; Johnsson, P; Swoboda, M; Benedetti, E; Ferrari, F; Lepine, F; Sanz-Vicario, JL; Zherebtsov, S; Znakovskaya, I; L'Huillier, A; Ivanov, MY; Nisoli, M; Martin, F; Vrakking, MJJ				Sansone, G.; Kelkensberg, F.; Perez-Torres, J. F.; Morales, F.; Kling, M. F.; Siu, W.; Ghafur, O.; Johnsson, P.; Swoboda, M.; Benedetti, E.; Ferrari, F.; Lepine, F.; Sanz-Vicario, J. L.; Zherebtsov, S.; Znakovskaya, I.; L'Huillier, A.; Ivanov, M. Yu.; Nisoli, M.; Martin, F.; Vrakking, M. J. J.			Electron localization following attosecond molecular photoionization	NATURE			English	Article							RESONANT DISSOCIATIVE PHOTOIONIZATION; REAL-TIME OBSERVATION; LASER-PULSES; H-2; D-2; SPECTROSCOPY; DYNAMICS; SCIENCE; FIELDS; BOND	For the past several decades, we have been able to directly probe the motion of atoms that is associated with chemical transformations and which occurs on the femtosecond (10(-15)-s) timescale. However, studying the inner workings of atoms and molecules on the electronic timescale(1-4) has become possible only with the recent development of isolated attosecond (10(-18)-s) laser pulses(5). Such pulses have been used to investigate atomic photoexcitation and photoionization(6,7) and electron dynamics in solids(8), and in molecules could help explore the prompt charge redistribution and localization that accompany photoexcitation processes. In recent work, the dissociative ionization of H(2) and D(2) was monitored on femtosecond timescales(9) and controlled using few-cycle near-infrared laser pulses(10). Here we report a molecular attosecond pump-probe experiment based on that work: H(2) and D(2) are dissociatively ionized by a sequence comprising an isolated attosecond ultraviolet pulse and an intense few-cycle infrared pulse, and a localization of the electronic charge distribution within the molecule is measured that depends-with attosecond time resolution-on the delay between the pump and probe pulses. The localization occurs by means of two mechanisms, where the infrared laser influences the photoionization or the dissociation of the molecular ion. In the first case, charge localization arises from quantum mechanical interference involving autoionizing states and the laser-altered wavefunction of the departing electron. In the second case, charge localization arises owing to laser-driven population transfer between different electronic states of the molecular ion. These results establish attosecond pump-probe strategies as a powerful tool for investigating the complex molecular dynamics that result from the coupling between electronic and nuclear motions beyond the usual Born-Oppenheimer approximation.	[Kelkensberg, F.; Siu, W.; Ghafur, O.; Johnsson, P.; Vrakking, M. J. J.] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Sansone, G.; Benedetti, E.; Ferrari, F.; Nisoli, M.] Politecn Milan, Dept Phys, Natl Lab Ultrafast & Ultraintense Opt Sci, CNR,INFM, I-20133 Milan, Italy; [Perez-Torres, J. F.; Morales, F.; Martin, F.] Univ Autonoma Madrid, Dept Quim, E-28049 Madrid, Spain; [Kling, M. F.; Zherebtsov, S.; Znakovskaya, I.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Johnsson, P.; Swoboda, M.; L'Huillier, A.] Lund Univ, Dept Phys, SE-22100 Lund, Sweden; [Lepine, F.] Univ Lyon 1, CNRS, UMR 5579, LASIM, F-69622 Villeurbanne, France; [Sanz-Vicario, J. L.] Univ Antioquia, Inst Fis, Grp Fis Atom & Mol, Medellin 1226, Colombia; [Ivanov, M. Yu.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Vrakking, M. J. J.] Max Born Inst, D-12489 Berlin, Germany	AMOLF; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Polytechnic University of Milan; Autonomous University of Madrid; Max Planck Society; Lund University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de Antioquia; Imperial College London; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Vrakking, MJJ (corresponding author), FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	vrakking@mbi-berlin.de	Hädrich, Steffen/B-4331-2008; L'Huillier, Anne/P-4379-2015; Ghafur, Omair/D-5171-2016; Martin, Fernando/C-3972-2014; Kling, Matthias F/D-3742-2014; Ivanov, Mikhail/AAG-1727-2021; Swoboda, Marko/H-7451-2012; Kling, Matthias Friedrich/AHH-0080-2022; Morales, Felipe/F-8089-2016; Johnsson, Per J/A-5191-2010; Nisoli, Mauro/K-8563-2017; Perez-Torres, Jhon Fredy/G-4448-2014; Vrakking, Marc JJ/F-6770-2014	L'Huillier, Anne/0000-0002-1335-4022; Ghafur, Omair/0000-0001-8484-8858; Martin, Fernando/0000-0002-7529-925X; Swoboda, Marko/0000-0003-2572-1149; Kling, Matthias Friedrich/0000-0002-1710-0775; Johnsson, Per J/0000-0003-2135-0248; Nisoli, Mauro/0000-0003-2309-732X; Vrakking, Marc JJ/0000-0002-3249-1663	Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Spanish Ministerio de Ciencia e Innovacion [FIS2007-60064]; MC-RTN XTRA [FP6-505138]; MC-EST MAXLAS, Laserlab Europe [RII3-CT-2003-506350]; European COST Action CUSPFEL [CM0702]; Mare Nostrum Barcelona Supercomputer Center; Centro de Computacion Cientifica UAM; Netherlands National Computing Facilities foundation, Stichting Academisch Rekencentrum Amsterdam [E07D401391CO]; Universidad de Antioquia; COLCIENCIAS agency; Swedish Research Council; Deutsche Forschungsgemeinschaft; Cluster of Excellence: Munich Centre for Advanced Photonics; Engineering and Physical Sciences Research Council [EP/E036112/1] Funding Source: researchfish; EPSRC [EP/E036112/1] Funding Source: UKRI	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MC-RTN XTRA; MC-EST MAXLAS, Laserlab Europe; European COST Action CUSPFEL; Mare Nostrum Barcelona Supercomputer Center; Centro de Computacion Cientifica UAM; Netherlands National Computing Facilities foundation, Stichting Academisch Rekencentrum Amsterdam; Universidad de Antioquia; COLCIENCIAS agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence: Munich Centre for Advanced Photonics; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is part of the research programs of the Stichting voor Fundamenteel Onderzoek der Materie, which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek, and of the Spanish Ministerio de Ciencia e Innovacion, project no. FIS2007-60064. We acknowledge support from MC-RTN XTRA (FP6-505138), the MC-EST MAXLAS, Laserlab Europe (Integrated Infrastructure Initiative Contract RII3-CT-2003-506350, proposal cusbo001275), the European COST Action CUSPFEL (CM0702), the Mare Nostrum Barcelona Supercomputer Center, the Centro de Computacion Cientifica UAM, the Netherlands National Computing Facilities foundation, Stichting Academisch Rekencentrum Amsterdam, Programme Alssan for Latin America (E07D401391CO), the Universidad de Antioquia, the COLCIENCIAS agency, the Swedish Research Council, the Deutsche Forschungsgemeinschaft via the Emmy Noether Programme and the Cluster of Excellence: Munich Centre for Advanced Photonics.	BUCKSBAUM PH, 1990, PHYS REV LETT, V64, P1883, DOI 10.1103/PhysRevLett.64.1883; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; Dietrich P, 1996, PHYS REV LETT, V77, P4150, DOI 10.1103/PhysRevLett.77.4150; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Frasinski LJ, 1999, PHYS REV LETT, V83, P3625, DOI 10.1103/PhysRevLett.83.3625; Ghafur O, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3085799; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Ito K, 1996, J CHEM PHYS, V104, P8449, DOI 10.1063/1.471594; Kapteyn H, 2007, SCIENCE, V317, P775, DOI 10.1126/science.1143679; Kelkensberg F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.123005; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kling MF, 2008, ANNU REV PHYS CHEM, V59, P463, DOI 10.1146/annurev.physchem.59.032607.093532; Kling MF, 2006, SCIENCE, V312, P246, DOI 10.1126/science.1126259; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kuleff AI, 2007, CHEM PHYS, V338, P320, DOI 10.1016/j.chemphys.2007.04.012; Martin F, 2007, SCIENCE, V315, P629, DOI 10.1126/science.1136598; MAURITSSON J, PHYS REV LETT UNPUB; Remacle F, 2006, P NATL ACAD SCI USA, V103, P6793, DOI 10.1073/pnas.0601855103; Remetter T, 2006, NAT PHYS, V2, P323, DOI 10.1038/nphys290; Rudenko A, 2006, CHEM PHYS, V329, P193, DOI 10.1016/j.chemphys.2006.06.038; Sanchez I, 1997, PHYS REV LETT, V79, P1654, DOI 10.1103/PhysRevLett.79.1654; Sanchez I, 1998, PHYS REV A, V57, P1006, DOI 10.1103/PhysRevA.57.1006; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Sanz-Vicario JL, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033410; Sola IJ, 2006, NAT PHYS, V2, P319, DOI 10.1038/nphys281; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Uphues T, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025009; Wickenhauser M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.023002	30	563	568	7	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					763	U3		10.1038/nature09084	http://dx.doi.org/10.1038/nature09084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535207	Green Submitted			2022-12-28	WOS:000278551800041
J	Cock, JM; Sterck, L; Rouze, P; Scornet, D; Allen, AE; Amoutzias, G; Anthouard, V; Artiguenave, F; Aury, JM; Badger, JH; Beszteri, B; Billiau, K; Bonnet, E; Bothwell, JH; Bowler, C; Boyen, C; Brownlee, C; Carrano, CJ; Charrier, B; Cho, GY; Coelho, SM; Collen, J; Corre, E; Da Silva, C; Delage, L; Delaroque, N; Dittami, SM; Doulbeau, S; Elias, M; Farnham, G; Gachon, CMM; Gschloessl, B; Heesch, S; Jabbari, K; Jubin, C; Kawai, H; Kimura, K; Kloareg, B; Kupper, FC; Lang, D; Le Bail, A; Leblanc, C; Lerouge, P; Lohr, M; Lopez, PJ; Martens, C; Maumus, F; Michel, G; Miranda-Saavedra, D; Morales, J; Moreau, H; Motomura, T; Nagasato, C; Napoli, CA; Nelson, DR; Nyvall-Collen, P; Peters, AF; Pommier, C; Potin, P; Poulain, J; Quesneville, H; Read, B; Rensing, SA; Ritter, A; Rousvoal, S; Samanta, M; Samson, G; Schroeder, DC; Segurens, B; Strittmatter, M; Tonon, T; Tregear, JW; Valentin, K; von Dassow, P; Yamagishi, T; Van de Peer, Y; Wincker, P				Cock, J. Mark; Sterck, Lieven; Rouze, Pierre; Scornet, Delphine; Allen, Andrew E.; Amoutzias, Grigoris; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Badger, Jonathan H.; Beszteri, Bank; Billiau, Kenny; Bonnet, Eric; Bothwell, John H.; Bowler, Chris; Boyen, Catherine; Brownlee, Colin; Carrano, Carl J.; Charrier, Benedicte; Cho, Ga Youn; Coelho, Susana M.; Collen, Jonas; Corre, Erwan; Da Silva, Corinne; Delage, Ludovic; Delaroque, Nicolas; Dittami, Simon M.; Doulbeau, Sylvie; Elias, Marek; Farnham, Garry; Gachon, Claire M. M.; Gschloessl, Bernhard; Heesch, Svenja; Jabbari, Kamel; Jubin, Claire; Kawai, Hiroshi; Kimura, Kei; Kloareg, Bernard; Kuepper, Frithjof C.; Lang, Daniel; Le Bail, Aude; Leblanc, Catherine; Lerouge, Patrice; Lohr, Martin; Lopez, Pascal J.; Martens, Cindy; Maumus, Florian; Michel, Gurvan; Miranda-Saavedra, Diego; Morales, Julia; Moreau, Herve; Motomura, Taizo; Nagasato, Chikako; Napoli, Carolyn A.; Nelson, David R.; Nyvall-Collen, Pi; Peters, Akira F.; Pommier, Cyril; Potin, Philippe; Poulain, Julie; Quesneville, Hadi; Read, Betsy; Rensing, Stefan A.; Ritter, Andres; Rousvoal, Sylvie; Samanta, Manoj; Samson, Gaelle; Schroeder, Declan C.; Segurens, Beatrice; Strittmatter, Martina; Tonon, Thierry; Tregear, James W.; Valentin, Klaus; von Dassow, Peter; Yamagishi, Takahiro; Van de Peer, Yves; Wincker, Patrick			The Ectocarpus genome and the independent evolution of multicellularity in brown algae	NATURE			English	Article							RECEPTOR-LIKE KINASES; LAMINARIA-DIGITATA; GENE FAMILY; PHAEOPHYCEAE; SILICULOSUS; PROPAGATION; EUKARYOTES; PATTERNS; BLADES; PLANTS	Brown algae (Phaeophyceae) are complex photosynthetic organisms with a very different evolutionary history to green plants, to which they are only distantly related(1). These seaweeds are the dominant species in rocky coastal ecosystems and they exhibit many interesting adaptations to these, often harsh, environments. Brown algae are also one of only a small number of eukaryotic lineages that have evolved complex multicellularity (Fig. 1). We report the 214 million base pair (Mbp) genome sequence of the filamentous seaweed Ectocarpus siliculosus (Dillwyn) Lyngbye, a model organism for brown algae(2-5), closely related to the kelps(6,7) (Fig. 1). Genome features such as the presence of an extended set of light-harvesting and pigment biosynthesis genes and new metabolic processes such as halide metabolism help explain the ability of this organism to cope with the highly variable tidal environment. The evolution of multicellularity in this lineage is correlated with the presence of a rich array of signal transduction genes. Of particular interest is the presence of a family of receptor kinases, as the independent evolution of related molecules has been linked with the emergence of multicellularity in both the animal and green plant lineages. The Ectocarpus genome sequence represents an important step towards developing this organism as a model species, providing the possibility to combine genomic and genetic(2) approaches to explore these and other(4,5) aspects of brown algal biology further.	[Cock, J. Mark; Scornet, Delphine; Boyen, Catherine; Charrier, Benedicte; Cho, Ga Youn; Coelho, Susana M.; Collen, Jonas; Delage, Ludovic; Dittami, Simon M.; Gschloessl, Bernhard; Heesch, Svenja; Kloareg, Bernard; Le Bail, Aude; Leblanc, Catherine; Michel, Gurvan; Nyvall-Collen, Pi; Peters, Akira F.; Potin, Philippe; Ritter, Andres; Rousvoal, Sylvie; Tonon, Thierry] Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, France; [Cock, J. Mark; Scornet, Delphine; Boyen, Catherine; Charrier, Benedicte; Cho, Ga Youn; Coelho, Susana M.; Collen, Jonas; Delage, Ludovic; Dittami, Simon M.; Gschloessl, Bernhard; Heesch, Svenja; Kloareg, Bernard; Le Bail, Aude; Leblanc, Catherine; Michel, Gurvan; Nyvall-Collen, Pi; Peters, Akira F.; Potin, Philippe; Ritter, Andres; Rousvoal, Sylvie; Tonon, Thierry] CNRS, UMR 7139, Lab Int Associe Dispersal & Adaptat Marine Specie, Stn Biol Roscoff, F-29682 Roscoff, France; [Sterck, Lieven; Rouze, Pierre; Amoutzias, Grigoris; Billiau, Kenny; Bonnet, Eric; Martens, Cindy; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Sterck, Lieven; Rouze, Pierre; Amoutzias, Grigoris; Billiau, Kenny; Bonnet, Eric; Martens, Cindy; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Da Silva, Corinne; Jabbari, Kamel; Jubin, Claire; Poulain, Julie; Samson, Gaelle; Segurens, Beatrice; Wincker, Patrick] CEA, DSV, Inst Genom, F-91057 Evry, France; [Beszteri, Bank; Valentin, Klaus] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Bothwell, John H.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Bothwell, John H.] Queens Univ, Marine Lab, Portaferry BT22 1PF, Co Down, North Ireland; [Bothwell, John H.; Brownlee, Colin; Farnham, Garry; Schroeder, Declan C.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Bowler, Chris; Jabbari, Kamel; Lopez, Pascal J.; Maumus, Florian] Ecole Normale Super, CNRS, UMR8197, Inst Biol, F-75005 Paris, France; [Bowler, Chris] Stn Zool, I-80121 Naples, Italy; [Carrano, Carl J.] San Diego State Univ, San Diego, CA 92182 USA; [Corre, Erwan] Comp & Genom Resource Ctr, FR 2424, Stn Biol Roscoff, F-29682 Roscoff, France; [Delaroque, Nicolas] Fraunhofer Inst Cell Therapy & Immunol IZI, D-04103 Leipzig, Germany; [Doulbeau, Sylvie; Tregear, James W.] IRD, CIRAD Palm Dev Biol Grp, UMR DIAPC 1097, F-34394 Montpellier, France; [Elias, Marek] Charles Univ Prague, Fac Sci, Dept Bot, Prague 1280 12, Czech Republic; [Elias, Marek] Charles Univ Prague, Dept Parasitol, Prague 1280 12, Czech Republic; [Gachon, Claire M. M.; Kuepper, Frithjof C.; Strittmatter, Martina] Scottish Assoc Marine Sci, Dept Microbial & Mol Biol, Scottish Marine Inst, Oban PA37 1QA, Argyll, Scotland; [Kawai, Hiroshi; Yamagishi, Takahiro] Kobe Univ, Res Ctr Inland Seas, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kimura, Kei; Motomura, Taizo; Nagasato, Chikako] Hokkaido Univ, Field Sci Ctr No Biosphere, Muroran Marine Stn, Muroran, Hokkaido 0510003, Japan; [Lang, Daniel; Rensing, Stefan A.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Lerouge, Patrice] Univ Rouen, IFRMP 23, Lab Glyco MEV EA 4358, F-76821 Mont St Aignan, France; [Lohr, Martin] Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55099 Mainz, Germany; [Miranda-Saavedra, Diego] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England; [Morales, Julia] Univ Paris 06, UMR Mer & Sante 7150, Equipe Traduct Cycle Cellulaire & Dev, Stn Biol Roscoff, F-29680 Roscoff, France; [Morales, Julia] CNRS, UMR Mer & Sante 7150, Stn Biol Roscoff, F-29680 Roscoff, France; [Moreau, Herve] Lab Arago, F-66651 Banyuls Sur Mer, France; [Napoli, Carolyn A.] Univ Arizona, Inst Bio5, Tucson, AZ 85719 USA; [Napoli, Carolyn A.] Univ Arizona, Dept Plant Sci, Tucson, AZ 85719 USA; [Nelson, David R.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Pommier, Cyril; Quesneville, Hadi] INRA, Unite Rech Genom Info UR INRA 1164, Ctr Rech Versailles, F-78026 Versailles, France; [Read, Betsy] Cal State Univ, San Marcos, CA 92096 USA; [Ritter, Andres] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [von Dassow, Peter] CNRS, UMR 7144, Stn Biol Roscoff, F-29682 Roscoff, France; [Samanta, Manoj] Systemix Inst, Redmond, WA 98053 USA	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; J. Craig Venter Institute; CEA; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Queens University Belfast; Marine Biological Association United Kingdom; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); California State University System; San Diego State University; UDICE-French Research Universities; Sorbonne Universite; Fraunhofer Gesellschaft; CIRAD; Institut de Recherche pour le Developpement (IRD); Charles University Prague; Charles University Prague; UHI Millennium Institute; Kobe University; Hokkaido University; University of Freiburg; Universite de Rouen Normandie; Johannes Gutenberg University of Mainz; University of Cambridge; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; University of Arizona; University of Tennessee System; University of Tennessee Health Science Center; INRAE; UDICE-French Research Universities; Universite Paris Saclay; California State University System; California State University Monterey Bay; California State University San Marcos; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Cock, JM (corresponding author), Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, Pl Georges Teissier,BP74, F-29682 Roscoff, France.	cock@sb-roscoff.fr	Lohr, Martin/A-1214-2009; Yamagishi, Toshio/E-2384-2013; corre, erwan/O-4669-2019; Beszteri, Bank M/D-1961-2010; amoutzias, Grigoris/O-4565-2019; Van de Peer, Yves/D-4388-2009; Tonon, Thierry/A-3214-2009; Bowler, Chris/AAC-6256-2019; Van de Peer, Yves/AAE-7666-2019; Miranda-Saavedra, Diego/C-2707-2012; Lang, Daniel/C-7238-2008; Gachon, Claire/C-2787-2009; Valentin, Klaus/G-5862-2014; Dittami, Simon/E-8354-2011; Tregear, James/E-6954-2011; Allen, Andrew E/C-4896-2012; Schroeder, Declan C./O-9131-2019; Quesneville, Hadi/AAG-1048-2020; Coelho, Susana/ABH-8166-2020; Sterck, Lieven/A-9439-2016; Elias, Marek/D-6851-2014; Maumus, Florian/O-5426-2016; Nagasato, Chikako/A-3392-2012; MICHEL, Gurvan/B-3490-2008; Lopez, Pascal Jean/A-7427-2011; Aury, Jean-Marc/N-1621-2019; Lopez, Pascal Jean/P-5813-2019; von Dassow, Peter/A-5399-2012; Lang, Daniel/M-5597-2019	Lohr, Martin/0000-0002-4335-9887; Yamagishi, Toshio/0000-0002-8890-1115; corre, erwan/0000-0001-6354-2278; Beszteri, Bank M/0000-0002-6852-1588; amoutzias, Grigoris/0000-0001-5961-964X; Van de Peer, Yves/0000-0003-4327-3730; Tonon, Thierry/0000-0002-1454-6018; Van de Peer, Yves/0000-0003-4327-3730; Lang, Daniel/0000-0002-2166-0716; Valentin, Klaus/0000-0001-7401-9423; Dittami, Simon/0000-0001-7987-7523; Allen, Andrew E/0000-0001-5911-6081; Schroeder, Declan C./0000-0001-5991-2838; Quesneville, Hadi/0000-0003-3001-4908; Sterck, Lieven/0000-0001-7116-4000; Elias, Marek/0000-0003-0066-6542; Maumus, Florian/0000-0001-7325-0527; Aury, Jean-Marc/0000-0003-1718-3010; Lopez, Pascal Jean/0000-0002-9914-4252; Lang, Daniel/0000-0002-2166-0716; Bonnet, Eric/0000-0002-8468-2867; Strittmatter, Martina/0000-0002-1258-9751; Nelson, David/0000-0003-0583-5421; Bothwell, John/0000-0003-2964-5980; Gachon, Claire/0000-0002-3702-7472; Morales, Julia/0000-0003-1632-5419; Bowler, Chris/0000-0003-3835-6187; Peters, Akira/0000-0001-5332-199X; MICHEL, Gurvan/0000-0002-3009-6205; Heesch, Svenja/0000-0002-4531-0921; POTIN, Philippe/0000-0001-7358-6282; Poulain, Julie/0000-0002-8744-3116; von Dassow, Peter/0000-0002-1858-1953; Kuepper, Frithjof/0000-0003-1273-7109; Pommier, Cyril/0000-0002-9040-8733; Cock, J. Mark/0000-0002-2650-0383; Ritter, Andres/0000-0001-7011-6824; Charrier, Benedicte/0000-0001-5721-1640; DA SILVA, Corinne/0000-0002-7618-7831	French GIS 'Institut de la Genomique Marine'; Centre National de Recherche Scientifique; European Union; GIS Europole Mer; Inter-University Network for Fundamental Research [P6/25]; 'Conseil General' of the Finistere department; University Pierre and Marie Curie; NERC [NE/F012578/1, NE/D521522/1, mba010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [REI20579, P18266] Funding Source: researchfish; Natural Environment Research Council [mba010003, NE/D521522/1, NE/F012578/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22370024] Funding Source: KAKEN	French GIS 'Institut de la Genomique Marine'; Centre National de Recherche Scientifique; European Union(European Commission); GIS Europole Mer; Inter-University Network for Fundamental Research; 'Conseil General' of the Finistere department; University Pierre and Marie Curie; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank Dieter G. Muller for his help and advice. The project was supported by the French GIS 'Institut de la Genomique Marine', the Centre National de Recherche Scientifique, the European Union network of excellence Marine Genomics Europe, the GIS Europole Mer, the Inter-University Network for Fundamental Research (P6/25, BioMaGNet), the 'Conseil General' of the Finistere department and the University Pierre and Marie Curie.	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Charrier B, 2008, NEW PHYTOL, V177, P319, DOI 10.1111/j.1469-8137.2007.02304.x; Cock JM, 2002, CURR OPIN CELL BIOL, V14, P230, DOI 10.1016/S0955-0674(02)00305-8; Coelho SM, 2002, PLANT CELL, V14, P2369, DOI 10.1105/tpc.003285; Coelho SM, 2007, GENE, V406, P152, DOI 10.1016/j.gene.2007.07.025; Colin C, 2003, J BIOL CHEM, V278, P23545, DOI 10.1074/jbc.M300247200; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dixon NM, 2000, PHYCOLOGIA, V39, P258, DOI 10.2216/i0031-8884-39-3-258.1; Goddard H, 2000, P NATL ACAD SCI USA, V97, P1932, DOI 10.1073/pnas.020516397; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Kawai H, 2007, J PHYCOL, V43, P186, DOI 10.1111/j.1529-8817.2006.00308.x; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Muller DG, 2000, BOT MAR, V43, P157, DOI 10.1515/BOT.2000.016; Nakayama Y, 2007, P NATL ACAD SCI USA, V104, P5883, DOI 10.1073/pnas.0609996104; Peters AF, 2004, J PHYCOL, V40, P1079, DOI 10.1111/j.1529-8817.2004.04058.x; Peters AF, 2008, DEVELOPMENT, V135, P1503, DOI 10.1242/dev.016303; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Phillips N, 2008, J PHYCOL, V44, P394, DOI 10.1111/j.1529-8817.2008.00473.x; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; RUSSELL G, 1983, MAR ECOL PROG SER, V13, P303, DOI 10.3354/meps013303; RUSSELL G, 1983, MAR ECOL PROG SER, V11, P181, DOI 10.3354/meps011181; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	29	598	640	6	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					617	621		10.1038/nature09016	http://dx.doi.org/10.1038/nature09016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520714	Green Published, hybrid			2022-12-28	WOS:000278249000042
J	Edelman, D; Fredrickson, SK; Melnyk, SD; Coffman, CJ; Jeffreys, AS; Datta, S; Jackson, GL; Harris, AC; Hamilton, NS; Stewart, H; Stein, J; Weinberger, M				Edelman, David; Fredrickson, Sonja K.; Melnyk, Stephanie D.; Coffman, Cynthia J.; Jeffreys, Amy S.; Datta, Santanu; Jackson, George L.; Harris, Amy C.; Hamilton, Natia S.; Stewart, Helen; Stein, Jeannette; Weinberger, Morris			Medical Clinics Versus Usual Care for Patients With Both Diabetes and Hypertension A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SELF-MANAGEMENT PROGRAM; BLOOD-PRESSURE; GROUP VISITS; HEALTH-STATUS; ASSOCIATION; OUTCOMES; AGREE	Background: Group medical clinics (GMCs) are widely used in the management of diabetes and hypertension, but data on their effectiveness are limited. Objective: To test the effectiveness of GMCs in the management of comorbid diabetes and hypertension. Design: Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00286741) Setting: 2 Veterans Affairs Medical Centers in North Carolina and Virginia. Patients: 239 patients with poorly controlled diabetes (hemoglobin A(1c) [HbA(1c)] level >= 7.5%) and hypertension (systolic blood pressure >140 mm Hg or diastolic blood pressure >90 mm Hg). Intervention: Patients were randomly assigned within each center to either attend a GMC or receive usual care. Clinics comprised 7 to 8 patients and a care team that consisted of a primary care general internist, a pharmacist, and a nurse or other certified diabetes educator. Each session included structured group interactions moderated by the educator. The pharmacist and physician adjusted medication to manage each patient's HbA(1c) level and blood pressure. Measurements: Hemoglobin A(1c) level and systolic blood pressure, measured by blinded research personnel at baseline, study midpoint (median, 6.8 months), and study completion (median follow-up, 12.8 months). Linear mixed models, adjusted for clustering within GMCs, were used to compare HbA(1c) levels and systolic blood pressure between the intervention and control groups. Results: Mean baseline systolic blood pressure and HbA(1c) level were 152.9 mm Hg (SD, 14.2) and 9.2% (SD, 1.4), respectively. At the end of the study, mean systolic blood pressure improved by 13.7 mm Hg in the GMC group and 6.4 mm Hg in the usual care group (P = 0.011 by linear mixed model), whereas mean HbA(1c) level improved by 0.8% in the GMC group and 0.5% in the usual care group (P = 0.159). Limitation: Measurements of effectiveness may have been limited by concomitant improvements in the usual care group that were due to co-intervention. Conclusion: Group medical clinics are a potent strategy for improving blood pressure but not HbA(1c) level in diabetic patients.	[Edelman, David] Durham Vet Affairs Med Ctr, Durham, NC 27705 USA; Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Hunter Holmes McGuire Veterinary Affairs Medical Center	Edelman, D (corresponding author), Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	dedelman@duke.edu		Edelman, David/0000-0001-7112-6151	Department of Veterans Affairs Health Services Research and Development Service [IIR 03-084]	Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Grant Support: By the Department of Veterans Affairs Health Services Research and Development Service (grant IIR 03-084).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS85, DOI 10.2337/dc09-S085; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Balding DJ, 2004, APPL LONGITUDINAL AN; Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; Bent S, 2006, ANN INTERN MED, V144, P257, DOI 10.7326/0003-4819-144-4-200602210-00007; CALLAHAN CM, 1995, ANN INTERN MED, V122, P422, DOI 10.7326/0003-4819-122-6-199503150-00004; *CDCP, 2005, NAT DIAB FACT SHEET; Clancy DE, 2007, J GEN INTERN MED, V22, P620, DOI 10.1007/s11606-007-0150-3; Coleman EA, 1999, J AM GERIATR SOC, V47, P775, DOI 10.1111/j.1532-5415.1999.tb03832.x; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Heisler M, 2003, J GEN INTERN MED, V18, P893, DOI 10.1046/j.1525-1497.2003.21132.x; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Jaber R, 2006, J AM BOARD FAM MED, V19, P276, DOI 10.3122/jabfm.19.3.276; Kim JW, 2005, J GEN INTERN MED, V20, P647, DOI 10.1007/s11606-005-0112-6; LITTLE RJA, 2002, STAT ANAL MISSING DA, P112; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2004, MED CARE, V42, P346, DOI 10.1097/01.mlr.0000118709.74348.65; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Mancia G, 2005, ACTA DIABETOL, V42, pS17, DOI 10.1007/s00592-005-0177-z; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; OSSIPKLEIN DJ, 1984, ADDICT BEHAV, V9, P85, DOI 10.1016/0306-4603(84)90010-8; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pogach LM, 2006, DIABETES CARE, V29, P241, DOI 10.2337/diacare.29.02.06.dc05-1468; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; SCHMUCKER D, 2006, GROUP MED APPOINTMEN; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Trento M, 2001, DIABETES CARE, V24, P995, DOI 10.2337/diacare.24.6.995; Villano CL, 2002, AM J DRUG ALCOHOL AB, V28, P213, DOI 10.1081/ADA-120002971; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695	36	116	118	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					689	W287		10.7326/0003-4819-152-11-201006010-00001	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00001			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608CT	20513826				2022-12-28	WOS:000278560000001
J	Starrels, JL; Becker, WC; Alford, DP; Kapoor, A; Williams, AR; Turner, BJ				Starrels, Joanna L.; Becker, William C.; Alford, Daniel P.; Kapoor, Alok; Williams, Arthur Robinson; Turner, Barbara J.			Systematic Review: Treatment Agreements and Urine Drug Testing to Reduce Opioid Misuse in Patients With Chronic Pain	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC NONCANCER PAIN; CHRONIC NONMALIGNANT PAIN; PRIMARY-CARE PHYSICIANS; SUBSTANCE USE; MANAGEMENT; MEDICINE; THERAPY; QUALITY; EFFICACY; TRENDS	Background: Experts recommend opioid treatment agreements and urine drug testing to reduce opioid analgesia misuse, but evidence of their effectiveness has not been systematically reviewed. Purpose: To synthesize studies of the association of treatment agreements and urine drug testing with opioid misuse outcomes in outpatients with chronic noncancer pain. Data Sources: MEDLINE, PsycINFO, EMBASE, Cochrane Central Register of Controlled Clinical Trials (January 1966 to June 2009), reference lists, and expert contacts. Study Selection: Original research addressing opioid medications, chronic pain, and treatment agreements or urine drug testing, with a sample size of 50 participants or more and published in English, Spanish, or French. Data Extraction: Two investigators independently identified eligible studies, extracted data, and assessed study quality. The outcome of opioid misuse was defined as drug abuse, drug misuse, aberrant drug-related behavior, diversion, or addiction. Data Synthesis: Of 102 eligible studies, 11 met inclusion criteria; 6 were in pain clinics and 5 were in primary care settings. Four primary care studies examined multicomponent strategies that included interdisciplinary support. All studies were observational and rated as poor to fair quality. In 4 studies with comparison groups, opioid misuse was modestly reduced (7% to 23%) after treatment agreements with or without urine drug testing. In the other 7 studies, the proportion of patients with opioid misuse after treatment agreements, urine drug testing, or both varied widely (3% to 43%). Limitations: Diversity of interventions and opioid misuse measures precluded meta-analysis. Most studies evaluated combinations of interventions. Conclusion: Relatively weak evidence supports the effectiveness of opioid treatment agreements and urine drug testing in reducing opioid misuse by patients with chronic pain. Further research on effective ways to monitor and reduce opioid misuse is needed, especially in primary care settings.	[Turner, Barbara J.] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19134 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Montefiore Med Ctr, Bronx, NY 10467 USA; Yale Univ, Sch Med, New Haven, CT 06520 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Med Ctr, Boston, MA 02118 USA	University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yale University; Boston University; Boston Medical Center	Turner, BJ (corresponding author), Univ Penn, Sch Med, Div Gen Internal Med, 1123 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19134 USA.	bturner@mail.med.upenn.edu	Williams, Arthur Robin/H-8511-2019	Williams, Arthur Robin/0000-0002-7380-6203; Alford, Daniel/0000-0002-6250-8390; Becker, William/0000-0002-0788-1467; Kapoor, Alok/0000-0003-1300-7124	Robert Wood Johnson Foundation; National Institute on Drug Abuse; Substance Abuse and Mental Health Services Administration; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA027719] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: Through the Program of Research Integrating Substance Use Issues into Mainstream Health Care, funded by the Robert Wood Johnson Foundation, the National Institute on Drug Abuse, and the Substance Abuse and Mental Health Services Administration. Dr. Starrels was supported in part by the Robert Wood Johnson Foundation Clinical Scholars Program.	Adams NJ, 2001, J PAIN SYMPTOM MANAG, V22, P791, DOI 10.1016/S0885-3924(01)00320-7; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Atluri Sairam, 2003, Pain Physician, V6, P407; Bair MJ, 2007, PAIN MED, V8, P544, DOI 10.1111/j.1526-4637.2007.00384.x; Ballantyne JC, 2007, PAIN, V129, P235, DOI 10.1016/j.pain.2007.03.028; Ballantyne JC, 2006, SOUTH MED J, V99, P1245, DOI 10.1097/01.smj.0000223946.19256.17; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; BERNDT S, 1993, PAIN, V52, P331, DOI 10.1016/0304-3959(93)90167-N; Bhamb B, 2006, CURR MED RES OPIN, V22, P1859, DOI 10.1185/030079906X132398; Bosch-Capblanch X, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004808.pub3; Boulanger A, 2007, PAIN RES MANAG, V12, P39, DOI 10.1155/2007/762180; BURCHMAN SL, 1995, J PAIN SYMPTOM MANAG, V10, P556, DOI 10.1016/0885-3924(95)00085-D; Caudill-Slosberg MA, 2004, PAIN, V109, P514, DOI 10.1016/j.pain.2004.03.006; Chelminski PR, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-3; Cherry Donald K, 2007, Adv Data, P1; Chou R, 2009, J PAIN, V10, P131, DOI 10.1016/j.jpain.2008.10.009; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Clark JD, 2002, J PAIN SYMPTOM MANAG, V23, P131, DOI 10.1016/S0885-3924(01)00396-7; Compton PA, 2008, J PAIN SYMPTOM MANAG, V36, P383, DOI 10.1016/j.jpainsymman.2007.11.006; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; *DRG AB WARN NET, 2010, DAWN REP NAT EST DRU; Eisenberg E, 2005, JAMA-J AM MED ASSOC, V293, P3043, DOI 10.1001/jama.293.24.3043; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Fagan MJ, 2008, CLIN J PAIN, V24, P35, DOI 10.1097/AJP.0b013e318156dadf; *FED STAT MED BOAR, 2004, MOD POL US CONTR SUB; Fine PG, 2004, CLIN GUIDE OPIOID AN; Fishbain DA, 1999, CLIN J PAIN, V15, P184, DOI 10.1097/00002508-199909000-00005; Fishman SM, 1999, J PAIN SYMPTOM MANAG, V18, P27, DOI 10.1016/S0885-3924(99)00035-4; Fleming MF, 2007, J PAIN, V8, P573, DOI 10.1016/j.jpain.2007.02.432; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gilson AM, 2004, J PAIN SYMPTOM MANAG, V28, P176, DOI 10.1016/j.jpainsymman.2004.01.003; Gitlin MC, 1999, J PAIN SYMPTOM MANAG, V18, P6; Goldberg KC, 2005, J CLIN OUTCOMES MANA, V12, P621; Gourlay DL, 2005, PAIN MED, V6, P107, DOI 10.1111/j.1526-4637.2005.05031.x; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Haddox JD, 1997, CLIN J PAIN, V13, P6; Hariharan J, 2007, J GEN INTERN MED, V22, P485, DOI 10.1007/s11606-006-0084-1; Heit HA, 2004, J PAIN SYMPTOM MANAG, V27, P260, DOI 10.1016/j.jpainsymman.2003.07.008; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; *I CLIN SYST IMPR, 2008, ASS MAN CHRON PAIN P; *IMS HLTH, 2008 TOP THER CLASS; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kahan M, 2006, CAN FAM PHYSICIAN, V52, P1081; Katz NP, 2003, ANESTH ANALG, V97, P1097, DOI 10.1213/01.ANE.0000080159.83342.B5; Linzer M, 2009, ANN INTERN MED, V151, P28, DOI 10.7326/0003-4819-151-1-200907070-00006; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P57; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P123; Manchikanti Laxmaiah, 2003, Pain Physician, V6, P281; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McCleane Gary, 2007, Anesthesiol Clin, V25, P787, DOI 10.1016/j.anclin.2007.08.002; Noble M, 2008, J PAIN SYMPTOM MANAG, V35, P214, DOI 10.1016/j.jpainsymman.2007.03.015; Olsen Y, 2006, J PAIN, V7, P225, DOI 10.1016/j.jpain.2005.11.006; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; PORTENOY RK, 1986, PAIN, V25, P171, DOI 10.1016/0304-3959(86)90091-6; Reisfield Gary M, 2007, J Opioid Manag, V3, P333; Roskos SE, 2007, J PAIN, V8, P753, DOI 10.1016/j.jpain.2007.01.005; Sampson JM, 2004, SOUTH MED J, V97, P916, DOI 10.1097/01.SMJ.0000125175.88223.98; Schuckman H, 2008, SUBST USE MISUSE, V43, P589, DOI 10.1081/JA-200030572; *SUBST AB MENT HLT, 2007, OAS SER, V40; Substance Abuse and Mental Health Services Administration, 2008, NSDUH SER H; Sung HE, 2005, J ADOLESCENT HEALTH, V37, P44, DOI 10.1016/j.jadohealth.2005.02.013; Tellioglu Tahir, 2008, Med Health R I, V91, P279; Touchet Bryan Keith, 2005, J Opioid Manag, V1, P195; Vaglienti Richard M, 2003, W V Med J, V99, P67; Wiedemer NL, 2007, PAIN MED, V8, P573, DOI 10.1111/j.1526-4637.2006.00254.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Zerzan JT, 2006, MED CARE, V44, P1005, DOI 10.1097/01.mlr.0000228025.04535.25	69	209	211	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					712	W292		10.7326/0003-4819-152-11-201006010-00004	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20513829				2022-12-28	WOS:000278560000004
J	Bateup, HS; Sabatini, BL				Bateup, Helen S.; Sabatini, Bernardo L.			For Synapses, It's Depression Not Death	CELL			English	Editorial Material							PLASTICITY; GELSOLIN; SPINES		[Bateup, Helen S.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu						Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lu CB, 2002, NEUROMOL MED, V1, P69; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635	9	4	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					750	752		10.1016/j.cell.2010.05.013	http://dx.doi.org/10.1016/j.cell.2010.05.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510921	Bronze			2022-12-28	WOS:000278132900009
J	Hyman, SE				Hyman, Steven E.			A Bone to Pick with Compulsive Behavior	CELL			English	Editorial Material							MICE		Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA	Harvard University	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Massachusetts Hall, Cambridge, MA 02138 USA.	seh@harvard.edu						Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Schrag A, 2009, NEUROLOGY, V73, P1256, DOI 10.1212/WNL.0b013e3181bd10fd; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104	8	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					752	754		10.1016/j.cell.2010.05.010	http://dx.doi.org/10.1016/j.cell.2010.05.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510922	Bronze			2022-12-28	WOS:000278132900010
J	Sycuro, LK; Pincus, Z; Gutierrez, KD; Biboy, J; Stern, CA; Vollmer, W; Salama, NR				Sycuro, Laura K.; Pincus, Zachary; Gutierrez, Kimberley D.; Biboy, Jacob; Stern, Chelsea A.; Vollmer, Waldemar; Salama, Nina R.			Peptidoglycan Crosslinking Relaxation Promotes Helicobacter pylori's Helical Shape and Stomach Colonization	CELL			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; CELL-SHAPE; CAMPYLOBACTER-PYLORIDIS; BACTERIAL CYTOSKELETON; SPIROPLASMA-CITRI; GENE; MUREIN; WALL; ULTRASTRUCTURE	The mechanisms by which bacterial cells generate helical cell shape and its functional role are poorly understood. Helical shape of the human pathogen Helicobacter pylori may facilitate penetration of the thick gastric mucus where it replicates. We identified four genes required for helical shape: three LytM peptidoglycan endopeptidase homologs (csd1-3) and a ccmA homolog. Surrounding the cytoplasmic membrane of most bacteria, the peptidoglycan (murein) sacculus is a meshwork of glycan strands joined by peptide crosslinks. Intact cells and isolated sacculi from mutants lacking any single csd gene or ccmA formed curved rods and showed increased peptidoglycan crosslinking. Quantitative morphological analyses of multiple-gene deletion mutants revealed each protein uniquely contributes to a shape-generating pathway. This pathway is required for robust colonization of the stomach in spite of normal directional motility. Our findings suggest that the coordinated action of multiple proteins relaxes peptidoglycan crosslinking, enabling helical cell curvature and twist.	[Gutierrez, Kimberley D.; Stern, Chelsea A.; Salama, Nina R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Sycuro, Laura K.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Sycuro, Laura K.; Stern, Chelsea A.; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Pincus, Zachary] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Yale University; Newcastle University - UK	Salama, NR (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	nsalama@fhcrc.org	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Pincus, Zachary/0000-0001-9785-5977; Sycuro, Laura/0000-0002-2011-6305	NIH [AI054423, AI082026]; National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/F001231/1]; European Commission; BBSRC [BB/F001231/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054423, R21AI082026] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI054423 and AI082026 (N.R.S.), a National Science Foundation Graduate Research Fellowship (LK.S.), and grants from the Biotechnology and Biological Sciences Research Council (grant No. BB/F001231/1) and the European Commission (EUR-INTAFAR project) (W.V.). The contents are solely the responsibility of the authors and do not necessarily represent the official views of these funding agencies. We thank J. Fero, C. Tung, G. Cromie, S. Talarico, B. Stoddard, and D. Vollmer for technical assistance and consultation, P. Born for peptidoglycan analysis, R. Burmeister for graphic design, E. Gaynor and S. Miller for strains, and B. Schneider and staff (FHCRC Electron Microscopy Shared Resource), as well as V. Thompson and T. Davies (Newcastle University Electron Microscopy Research Service), for assistance with TEM.	Alyahya SA, 2009, P NATL ACAD SCI USA, V106, P1239, DOI 10.1073/pnas.0810794106; Andersen LP, 2009, FEMS IMMUNOL MED MIC, V56, P112, DOI 10.1111/j.1574-695X.2009.00556.x; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Benaissa M, 1996, INFECT IMMUN, V64, P2331, DOI 10.1128/IAI.64.6.2331-2335.1996; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DeLoney CR, 1999, ANTIMICROB AGENTS CH, V43, P2702, DOI 10.1128/AAC.43.11.2702; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; GOLDSTEIN SF, 1994, P NATL ACAD SCI USA, V91, P3433, DOI 10.1073/pnas.91.8.3433; GOODWIN CS, 1985, J MED MICROBIOL, V19, P257, DOI 10.1099/00222615-19-2-257; Hay NA, 1999, J BACTERIOL, V181, P2008, DOI 10.1128/JB.181.7.2008-2016.1999; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Humbert O, 2008, NUCLEIC ACIDS RES, V36, P6893, DOI 10.1093/nar/gkn718; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KOVACH ME, 1994, GENE, V148, P91, DOI 10.1016/0378-1119(94)90239-9; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ragurnani S, 2008, PROTEINS, V72, P1096, DOI 10.1002/prot.22095; Rasband W, 2009, IMAGEJ; Ruby JD, 1997, J BACTERIOL, V179, P1628, DOI 10.1128/jb.179.5.1628-1635.1997; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Smeets LC, 2000, J BACTERIOL, V182, P3948, DOI 10.1128/JB.182.14.3948-3954.2000; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Trachtenberg S, 2004, J MOL MICROB BIOTECH, V7, P78, DOI 10.1159/000077872; Trachtenberg S, 2008, J MOL BIOL, V378, P778, DOI 10.1016/j.jmb.2008.02.020; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Varma A, 2004, J BACTERIOL, V186, P6768, DOI 10.1128/JB.186.20.6768-6774.2004; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; Wolgemuth CW, 2006, J MOL MICROB BIOTECH, V11, P221, DOI 10.1159/000094056; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	47	183	186	3	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					822	833		10.1016/j.cell.2010.03.046	http://dx.doi.org/10.1016/j.cell.2010.03.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510929	Bronze, Green Accepted			2022-12-28	WOS:000278132900017
J	Young, RC				Young, Robert C.			Cancer Clinical Trials - A Chronic but Curable Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									RCY Med, Philadelphia, PA USA		Young, RC (corresponding author), RCY Med, Philadelphia, PA USA.							Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Editorial, 2010, NY TIMES        0424; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Nass S, 2010, NATL CANC CLIN TRIAL; National Cancer Institute, 1997, REP NAT CANC I CLIN	5	35	35	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					306	309		10.1056/NEJMp1005843	http://dx.doi.org/10.1056/NEJMp1005843			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628RU	20554976				2022-12-28	WOS:000280139300003
J	Berenson, RA				Berenson, Robert A.			Implementing Health Care Reform - Why Medicare Matters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Urban Inst, Washington, DC 20037 USA	Urban Institute	Berenson, RA (corresponding author), Urban Inst, Washington, DC 20037 USA.							[Anonymous], 2010, COMMUNICATION   0320; Berenson RA, 2010, WHAT ALL PHYS SERVIC; *MED ADV PROGR, 2005, ISS MOD MED PROGR RE, P59; *MED PAYM ADV COMM, 2009, MEAS REG VAR SERV US	4	12	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					101	103		10.1056/NEJMp1005588	http://dx.doi.org/10.1056/NEJMp1005588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	621JY	20505172				2022-12-28	WOS:000279574100001
J	Brott, TG; Hobson, RW; Howard, G; Roubin, GS; Clark, WM; Brooks, W; Mackey, A; Hill, MD; Leimgruber, PP; Sheffet, AJ; Howard, VJ; Moore, WS; Voeks, JH; Hopkins, LN; Cutlip, DE; Cohen, DJ; Popma, JJ; Ferguson, RD; Cohen, SN; Blackshear, JL; Silver, FL; Mohr, JP; Lal, BK; Meschia, JF				Brott, Thomas G.; Hobson, Robert W., II; Howard, George; Roubin, Gary S.; Clark, Wayne M.; Brooks, William; Mackey, Ariane; Hill, Michael D.; Leimgruber, Pierre P.; Sheffet, Alice J.; Howard, Virginia J.; Moore, Wesley S.; Voeks, Jenifer H.; Hopkins, L. Nelson; Cutlip, Donald E.; Cohen, David J.; Popma, Jeffrey J.; Ferguson, Robert D.; Cohen, Stanley N.; Blackshear, Joseph L.; Silver, Frank L.; Mohr, J. P.; Lal, Brajesh K.; Meschia, James F.		CREST Investigators	Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISCHEMIC-STROKE; REVASCULARIZATION ENDARTERECTOMY; PREVENTION; ASSOCIATION; SELECTION; SYMPTOMS; EVENTS; DEATH; SF-36	BACKGROUND Carotid-artery stenting and carotid endarterectomy are both options for treating carotid-artery stenosis, an important cause of stroke. METHODS We randomly assigned patients with symptomatic or asymptomatic carotid stenosis to undergo carotid-artery stenting or carotid endarterectomy. The primary composite end point was stroke, myocardial infarction, or death from any cause during the periprocedural period or any ipsilateral stroke within 4 years after randomization. RESULTS For 2502 patients over a median follow-up period of 2.5 years, there was no significant difference in the estimated 4-year rates of the primary end point between the stenting group and the endarterectomy group (7.2% and 6.8%, respectively; hazard ratio with stenting, 1.11; 95% confidence interval, 0.81 to 1.51; P = 0.51). There was no differential treatment effect with regard to the primary end point according to symptomatic status (P = 0.84) or sex (P = 0.34). The 4-year rate of stroke or death was 6.4% with stenting and 4.7% with endarterectomy (hazard ratio, 1.50; P = 0.03); the rates among symptomatic patients were 8.0% and 6.4% (hazard ratio, 1.37; P = 0.14), and the rates among asymptomatic patients were 4.5% and 2.7% (hazard ratio, 1.86; P = 0.07), respectively. Periprocedural rates of individual components of the end points differed between the stenting group and the endarterectomy group: for death (0.7% vs. 0.3%, P = 0.18), for stroke (4.1% vs. 2.3%, P = 0.01), and for myocardial infarction (1.1% vs. 2.3%, P = 0.03). After this period, the incidences of ipsilateral stroke with stenting and with endarterectomy were similarly low (2.0% and 2.4%, respectively; P = 0.85). CONCLUSIONS Among patients with symptomatic or asymptomatic carotid stenosis, the risk of the composite primary outcome of stroke, myocardial infarction, or death did not differ significantly in the group undergoing carotid-artery stenting and the group undergoing carotid endarterectomy. During the periprocedural period, there was a higher risk of stroke with stenting and a higher risk of myocardial infarction with endarterectomy. (ClinicalTrials.gov number, NCT00004732.)	[Brott, Thomas G.; Blackshear, Joseph L.; Meschia, James F.] Mayo Clin, Jacksonville, FL 32224 USA; [Brott, Thomas G.; Hobson, Robert W., II; Sheffet, Alice J.] Univ Med & Dent New Jersey, Newark, NJ 07103 USA; [Howard, George; Howard, Virginia J.; Voeks, Jenifer H.] Univ Alabama Birmingham, Birmingham, AL USA; [Roubin, Gary S.] Lenox Hill Hosp, New York, NY 10021 USA; [Mohr, J. P.] Columbia Univ, Med Ctr, New York, NY USA; [Clark, Wayne M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Brooks, William] Cent Baptist Hosp, Lexington, KY USA; [Mackey, Ariane] Hop Enfants Jesus, Ctr Hosp, Quebec City, PQ, Canada; [Hill, Michael D.] Univ Calgary, Calgary, AB, Canada; [Silver, Frank L.] Univ Toronto, Toronto, ON, Canada; [Leimgruber, Pierre P.] Spokane Cardiol Heart & Vasc Hlth, Spokane, WA USA; [Moore, Wesley S.] Univ Calif Los Angeles, Los Angeles, CA USA; [Hopkins, L. Nelson] SUNY Buffalo, Buffalo, NY 14260 USA; [Cutlip, Donald E.] Harvard Clin Res Inst, Boston, MA USA; [Popma, Jeffrey J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Cohen, David J.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Ferguson, Robert D.] Metrohlth Med Ctr, Cleveland, OH USA; [Cohen, Stanley N.] Nevada Neurosci Inst, Las Vegas, NV USA; [Lal, Brajesh K.] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA	Mayo Clinic; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Alabama System; University of Alabama Birmingham; Northwell Health; Columbia University; Oregon Health & Science University; Central Baptist Hospital; Laval University; University of Calgary; University of Toronto; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Saint Luke's Mid America Heart Institute; MetroHealth System; University System of Maryland; University of Maryland Baltimore	Brott, TG (corresponding author), Mayo Clin, Griffin 304,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	brott.thomas@mayo.edu	Meschia, James/GPP-1636-2022; Lal, Brajesh/AAA-2620-2022; Mohr, J/AAO-9694-2020; Hill, Michael D/C-9073-2012; Buchan, Alastair M/B-9095-2009	Meschia, James/0000-0002-4475-8142; Hill, Michael D/0000-0002-6269-1543; Buchan, Alastair M/0000-0002-2918-5200; Howard, George/0000-0002-3068-5720; Arthur, Adam/0000-0002-1536-1613; Cutter, Gary/0000-0002-8455-980X	National Institute of Neurological Disorders and Stroke (NINDS); NIH [R01 NS 038384]; Abbott Vascular Solutions (Guidant); Accunet and Acculink systems; Vernalis Group; Hoffmann La Roche Canada; Bayer Canada; Merck Canada; Abbott Vascular; Boston Scientific; Cordis; Micrus; W. L. Gore Endovascular; Medical Research Council [G0500495] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS038384, R01NS038384] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Vascular Solutions (Guidant); Accunet and Acculink systems; Vernalis Group; Hoffmann La Roche Canada(Hoffmann-La Roche); Bayer Canada(Bayer AG); Merck Canada(Merck & Company); Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis; Micrus; W. L. Gore Endovascular; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institute of Neurological Disorders and Stroke (NINDS) and the NIH (R01 NS 038384) and supplemental funding from Abbott Vascular Solutions (formerly Guidant), including donations of Accunet and Acculink systems, equivalent to approximately 15% of the total study cost, to CREST centers in Canada and to CREST centers in the United States that were at Veterans Affairs sites.; Dr. Roubin reports receiving consulting fees, honoraria, payments for the development of educational presentations, and travel reimbursement from Abbott Vascular, and royalties from Abbott Vascular and Cook; Dr. Mackey reports serving on the Board of Directors of the Canadian Stroke Consortium; Dr. Hill reports receiving consulting fees from Vernalis Group, honoraria from Hoffmann-La Roche Canada, Stem Cell Therapeutics, Portola Therapeutics, Sanofi-Aventis Canada, Bristol-Myers Squibb, and Merck Canada; grant support from Hoffmann La Roche Canada, Bayer Canada, and Merck Canada; payment for the development of educational presentations from BoehringerIngelheim Canada; stock options from Calgary Scientific; and travel reimbursement from GE Canada Healthcare; Dr. Sheffet reports being a member of the Society for Clinical Trials; Dr. Hopkins reports serving on the boards of AccessClosure and Micrus; receiving consulting fees from Abbott Vascular, Boston Scientific, Cordis, Micrus, and W. L. Gore Endovascular; providing expert testimony for Brown and Tarantino; Bollinger, Ruberry and Garvey; Kevin Ricotta; Hamilton, Altman, Canale and Dillon; Martin, Clearwater and Bell; and Bunnell, Woulfe, Kirschbaum, Keller, McIntyre, Gregoire and Klein; receiving honoraria from Lenox Hill Hospital, Accumetrics, Society for Cardiac Angiography and Interventions (SCAI), Penn State College of Medicine, the Vascular Interventional Advances (VIVA) Conference, Northwest-Canada; P. Teal, Vancouver General Hospital, Vancouver, BC, Canada; F. Hellinger, Florida Hospital, Orlando; G. Petrossian, R. B. Berroya, St. Francis Hospital, Roslyn, NY; M. Bates, Charleston Area Medical Center, Charleston, WV; J. Mills, University of Arizona College of Medicine, Tucson; M. Golden, R. Fairman, Hospital of the University of Pennsylvania, Philadelphia; A. Mansour, Butterworth Hospital, Grand Rapids, MI; A. MacBeth, H. Madyoon, St. Joseph's Medical Center, Stockton, CA; L. A. Iannone, Iowa Heart Center, Des Moines; K. Hansen, Wake Forest University Health Sciences, Winston-Salem, NC; J. Biller, Loyola University Medical Center, Maywood, IL; J. Shuck, Christiana Care Health Services, Newark, DE; P. Gobin, Weill Cornell Medical College of New York Presbyterian Hospital, New York; K. Dauterman, Rogue Valley Medical Center, Medford, OR; J. Melton, Oklahoma Foundation for Cardiovascular Research, Oklahoma City; D. Benckart, Allegheny General Hospital, Pittsburgh; W. Lesley, Scott and White Memorial Hospital, Temple, TX; M. Belkin, Brigham and Women's Hospital, Boston; T. Bajwa, St. Luke's Medical Center, Milwaukee; S. Myla, Hoag Memorial Hospital, Newport Beach, CA; J. Snell, Rush University Medical Center, Chicago; H. Shownkeen, Central DuPage Hospital, Winfield, IL; A. AbouChebl, University of Louisville, Louisville, KY; Executive Committee: T. G. Brott (chair), R. W. Hobson, II (deceased), K. W. Beach, D. J. Cohen, J. Cordell, D. E. Cutlip, R. D. Ferguson, L. N. Hopkins, G. Howard, V. J. Howard, L. Keene, B. K. Lal, J. F. Meschia, J. P. Mohr, W. S. Moore, J. Popma, G. S. Roubin, A. J. Sheffet, F. L. Silver; Stroke Adjudication Committee: S. N. Cohen (chair), J. Biller, J. P. Broderick, S. Chaturvedi, M. A. Kalafut, E. J. Skalabrin; Myocardial Infarction Adjudication Committee: J. L. Blackshear (chair), S. P. Glasser, R. J. Prineas; Data and Safety Monitoring Board: J. Marsh (chair), R. Higashida, G. Lamas, B. Tilley, M. Walker, and G. R. Cutter (2001 -2002).	Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; Arias Elizabeth, 2008, Natl Vital Stat Rep, V57, P1; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chiam PTL, 2008, CATHETER CARDIO INTE, V72, P318, DOI 10.1002/ccd.21620; Ederle J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000515.pub3; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Goldstein LB, 2007, STROKE, V38, P222, DOI 10.1161/01.STR.0000254717.89942.67; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Halliday A, 2004, LANCET, V363, P1491; Hobson R W 2nd, 2000, Semin Vasc Surg, V13, P139; Hopkins LN, 2010, J STROKE CEREBROVASC, V19, P153, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.001; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Meschia JF, 2000, STROKE, V31, P1076, DOI 10.1161/01.STR.31.5.1076; MOORE WS, 1991, STROKE, V22, P1353, DOI 10.1161/01.STR.22.11.1353; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Roubin GS, 2006, CIRCULATION, V113, P2021, DOI 10.1161/CIRCULATIONAHA.105.595512; Schouten O, 2009, NEW ENGL J MED, V361, P980, DOI 10.1056/NEJMoa0808207; Sheffet AJ, 2010, INT J STROKE, V5, P40, DOI 10.1111/j.1747-4949.2009.00405.x; Stingele R, 2008, LANCET NEUROL, V7, P216, DOI 10.1016/S1474-4422(08)70024-3; Taylor JMG, 2002, AM J EPIDEMIOL, V156, P774, DOI 10.1093/aje/kwf110; van Wijk I, 2008, J NEUROL NEUROSUR PS, V79, P895, DOI 10.1136/jnnp.2007.133132; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	31	1940	2096	1	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					11	23		10.1056/NEJMoa0912321	http://dx.doi.org/10.1056/NEJMoa0912321			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20505173	Green Accepted			2022-12-28	WOS:000279343000004
J	Armitage, JJ; Collier, JS; Minshull, TA				Armitage, John J.; Collier, Jenny S.; Minshull, Tim A.			The importance of rift history for volcanic margin formation	NATURE			English	Article							SMALL-SCALE CONVECTION; CONTINENTAL MARGINS; NORTHEAST ATLANTIC; FLOOD BASALTS; MAGMATISM; GENERATION; EXTENSION; RIDGES; OCEAN; SEA	Rifting and magmatism are fundamental geological processes that shape the surface of our planet. A relationship between the two is widely acknowledged but its precise nature has eluded geoscientists and remained controversial. Largely on the basis of detailed observations from the North Atlantic Ocean, mantle temperature was identified as the primary factor controlling magmatic production 1, with most authors seeking to explain observed variations in volcanic activity at rifted margins in terms of the mantle temperature at the time of break-up(2,3). However, as more detailed observations have been made at other rifted margins worldwide, the validity of this interpretation and the importance of other factors in controlling break-up style have been much debated(4-7). One such observation is from the northwest Indian Ocean, where, despite an unequivocal link between an onshore flood basalt province, continental break-up and a hot-spot track leading to an active ocean island volcano, the associated continental margins show little magmatism(5,8). Here we reconcile these observations by applying a numerical model that accounts explicitly for the effects of earlier episodes of extension. Our approach allows us to directly compare break-up magmatism generated at different locations and so isolate the key controlling factors. We show that the volume of rift-related magmatism generated, both in the northwest Indian Ocean and at the better-known North Atlantic margins, depends not only on the mantle temperature but, to a similar degree, on the rift history. The inherited extensional history can either suppress or enhance melt generation, which can explain previously enigmatic observations.	[Armitage, John J.; Collier, Jenny S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Minshull, Tim A.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Imperial College London; NERC National Oceanography Centre; University of Southampton	Armitage, JJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England.	j.armitage@imperial.ac.uk	Armitage, John/E-9265-2017; Minshull, Timothy A/D-1147-2010	Armitage, John/0000-0003-2806-8181; Minshull, Timothy A/0000-0002-8202-1379; Collier, Jennifer/0000-0003-0453-1928	UK Natural Environment Research Council	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to J. Hopper and R. White for giving us the southeast Greenland and Hatton Bank velocity grids. We are also grateful to T. Henstock for help developing the model. An earlier version of this manuscript was improved by comments from M. Coffin, K. Gallagher, S. Goes, S. Gupta and E. Rohling. This work was partly funded by the UK Natural Environment Research Council.	Armitage JJ, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002404; Behn MD, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000393; BOWN JW, 1995, J GEOPHYS RES-SOL EA, V100, P18011, DOI 10.1029/94JB01478; BOWN JW, 1994, EARTH PLANET SC LETT, V121, P435, DOI 10.1016/0012-821X(94)90082-5; Campbell IH, 2007, CHEM GEOL, V241, P153, DOI 10.1016/j.chemgeo.2007.01.024; Collier JS, 2008, EARTH PLANET SC LETT, V272, P264, DOI 10.1016/j.epsl.2008.04.045; Collier JS, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005898; DORE A. G., 2005, PETROLEUM GEOLOGY N, P947; Edwards JWF, 2002, MAR PETROL GEOL, V19, P193, DOI 10.1016/S0264-8172(01)00052-6; HOLBROOK WS, 1994, J GEOPHYS RES-SOL EA, V99, P17871, DOI 10.1029/94JB00729; Holbrook WS, 2001, EARTH PLANET SC LETT, V190, P251, DOI 10.1016/S0012-821X(01)00392-2; Hopper JR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001996; HOPPER JR, 1992, GEOLOGY, V20, P853, DOI 10.1130/0091-7613(1992)020<0853:MARMEE>2.3.CO;2; Keen CE, 2000, J GEOPHYS RES-SOL EA, V105, P13375, DOI 10.1029/2000JB900027; Lizarralde D, 2007, NATURE, V448, P466, DOI 10.1038/nature06035; Minshull TA, 2008, NAT GEOSCI, V1, P463, DOI 10.1038/ngeo228; MORESI LN, 1995, PHYS FLUIDS, V7, P2154, DOI 10.1063/1.868465; Nielsen TK, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000662; Niu YL, 1997, J PETROL, V38, P1047, DOI 10.1093/petrology/38.8.1047; Reston TJ, 2005, EARTH PLANET SC LETT, V237, P561, DOI 10.1016/j.epsl.2005.06.019; SCOTT DR, 1992, GEOPH MONOG SERIES, V71, P327; SHANNON PM, 1993, PETROLEUM GEOLOGY OF NORTHWEST EUROPE: PROCEEDINGS OF THE 4TH CONFERENCE, P1057, DOI 10.1144/0041057; Shillington DJ, 2009, GEOLOGY, V37, P7, DOI 10.1130/G25302A.1; Simon K, 2009, GEOPHYS J INT, V176, P327, DOI 10.1111/j.1365-246X.2008.03891.x; Storey M, 2007, SCIENCE, V316, P587, DOI 10.1126/science.1135274; Voss M, 2009, GEOPHYS J INT, V177, P755, DOI 10.1111/j.1365-246X.2009.04077.x; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; White RS, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005856; WHITE RS, 1995, J GEOPHYS RES-SOL EA, V100, P17543, DOI 10.1029/95JB01585	29	68	70	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					913	917		10.1038/nature09063	http://dx.doi.org/10.1038/nature09063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559385				2022-12-28	WOS:000278804500035
J	Macilwain, C				Macilwain, Colin			Talking the talk	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					867	867		10.1038/465867a	http://dx.doi.org/10.1038/465867a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	611HN	20559363	Bronze			2022-12-28	WOS:000278804500014
J	Cruz-Flores, S				Cruz-Flores, Salvador			Rosuvastatin prevented ischemic stroke in healthy older adults with elevated C-reactive protein	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Louis Univ, Sch Med, St Louis, MO 63103 USA	Saint Louis University	Cruz-Flores, S (corresponding author), St Louis Univ, Sch Med, St Louis, MO 63103 USA.		Cruz-Flores, Salvador/AAR-1233-2020	Cruz-Flores, Salvador/0000-0003-4998-1471				Campbell-Scherer DL, 2009, ANN INTERN MED, V150, DOI 10.7326/0003-4819-150-2-200901200-02004; Montori V, 2008, USERS GUIDES MED LIT, P153	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-6	10.7326/0003-4819-152-12-201006150-02006	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547900				2022-12-28	WOS:000278827700027
J	Gillam, S				Gillam, Steve			Should the Quality and Outcomes Framework be abolished? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							UK GENERAL-PRACTICE; PRIMARY-CARE; PERFORMANCE; PAY		Lea Vale Med Grp, Luton, Beds, England		Gillam, S (corresponding author), Lea Vale Med Grp, Luton, Beds, England.	sjg67@medschl.cam.ac.uk						Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Belsey J, 2008, CURR MED RES OPIN, V24, P2551, DOI 10.1185/03007990802321964 ; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Grant S, 2009, SOCIOL HEALTH ILL, V31, P229, DOI 10.1111/j.1467-9566.2008.01129.x; Harrison S., 2002, BRIT J POLIT INT REL, V4, P1, DOI DOI 10.1111/1467-856X.41068; Maisey S, 2008, J HEALTH SERV RES PO, V13, P133, DOI 10.1258/jhsrp.2008.007118; MASON A, 2008, GMS QUALITY OUTCOMES; Ritzer G, 2008, MCDONALDIZATION SOC; STARFIELD B, QUALITY OUT IN PRESS	9	11	11	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2010	340								c2710	10.1136/bmj.c2710	http://dx.doi.org/10.1136/bmj.c2710			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LZ	20530083				2022-12-28	WOS:000278818000015
J	Lu, WJ; Chapo, J; Roig, I; Abrams, JM				Lu, Wan-Jin; Chapo, Joseph; Roig, Ignasi; Abrams, John M.			Meiotic Recombination Provokes Functional Activation of the p53 Regulatory Network	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; DNA-DAMAGE; SUPPRESSOR GENE; MICE; CHECKPOINT; OOGENESIS; SYNAPSIS; HOMOLOG; COMPLEX; REPAIR	The evolutionary appearance of p53 protein probably preceded its role in tumor suppression, suggesting that there may be unappreciated functions for this protein. Using genetic reporters as proxies to follow in vivo activation of the p53 network in Drosophila, we discovered that the process of meiotic recombination instigates programmed activation of p53 in the germ line. Specifically, double-stranded breaks in DNA generated by the topoisomerase Spo11 provoked functional p53 activity, which was prolonged in cells defective for meiotic DNA repair. This intrinsic stimulus for the p53 regulatory network is highly conserved because Spo11-dependent activation of p53 also occurs in mice. Our findings establish a physiological role for p53 in meiosis and suggest that tumor-suppressive functions may have been co-opted from primordial activities linked to recombination.	[Lu, Wan-Jin; Chapo, Joseph; Abrams, John M.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Roig, Ignasi] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Memorial Sloan Kettering Cancer Center	Abrams, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	john.abrams@utsouthwestern.edu	Roig, Ignasi/A-9697-2012	Roig, Ignasi/0000-0003-0313-3581; Lu, Wan-Jin/0000-0002-2186-9800	National Institute of General Medical Sciences [R01GM072124]; National Institute on Alcohol Abuse and Alcoholism [R01AA017328]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017328] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Keeney for helpful discussions and reading of the manuscript and A. Ali, A. D'Brot, and A. Olivo for assisting experiments. We also thank the following individuals, laboratories, or facilities for helpful discussions, access to instruments, or providing reagents: S. Barolo, M. Buszczak, D. Castrillon, O. Cleaver, K. Hamra, J. Maines, D. McKearin, T. Schupbach, Y. Rong, J. Shelton, T. Wilkie, R. Bachoo, T. Mashimo, B. Thaden, Live Cell Imaging Facility (Univ. of Texas Southwestern), Bloomington Stock Center (Indiana Univ.), Developmental Studies Hybridoma Bank (Univ. of Iowa). This work was supported by the National Institute of General Medical Sciences (grant R01GM072124) and the National Institute on Alcohol Abuse and Alcoholism (grant R01AA017328).	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; Aranda-Anzaldo A, 2007, MECH AGEING DEV, V128, P293, DOI 10.1016/j.mad.2007.01.001; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Gersten KM, 1997, NAT GENET, V17, P378, DOI 10.1038/ng1297-378; Ghafari F, 2009, HUM REPROD, V24, P1460, DOI 10.1093/humrep/dep022; Habu T, 2004, CARCINOGENESIS, V25, P889, DOI 10.1093/carcin/bgh099; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Nedelcu AM, 2007, DEV GENES EVOL, V217, P801, DOI 10.1007/s00427-007-0185-9; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	29	70	70	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1278	1281		10.1126/science.1185640	http://dx.doi.org/10.1126/science.1185640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522776	Green Accepted			2022-12-28	WOS:000278318600035
J	Zuk, M				Zuk, Marlene			Dance Like No One Is Watching, Sing Like No One Is Listening?	SCIENCE			English	Editorial Material							SEXUAL SELECTION; SUCCESS; RANK		Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Zuk, M (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	marlene.zuk@ucr.edu						[Anonymous], 1994, SEXUAL SELECTION; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; DERUITER JR, 1993, PRIMATES, V34, P553, DOI 10.1007/BF02382666; Hall MD, 2010, MOL ECOL, V19, P610, DOI 10.1111/j.1365-294X.2009.04496.x; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V60, P695, DOI 10.1007/s00265-006-0213-1; Manson J.H., 2007, PRIMATES PERSPECTIVE, P447; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; [No title captured]	12	1	1	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1237	1238		10.1126/science.1191036	http://dx.doi.org/10.1126/science.1191036			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522762				2022-12-28	WOS:000278318600019
J	Ebers, GC				Ebers, G. C.			Commentary: Outcome measures were flawed	BRITISH MEDICAL JOURNAL			English	Editorial Material							REMITTING MULTIPLE-SCLEROSIS; PLACEBO-CONTROLLED TRIAL; INTERFERON BETA-1B; CLINICAL-TRIALS; DOUBLE-BLIND; DISABILITY; MS; MULTICENTER; THERAPY		Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford	Ebers, GC (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England.	George.Ebers@clneuro.ox.ac.uk		Ebers, George/0000-0003-4771-4177				Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; Daumer M, 2009, NEUROLOGY, V72, P705, DOI 10.1212/01.wnl.0000336916.38629.43; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Ebers GC, 2001, LANCET, V357, P1547, DOI 10.1016/S0140-6736(00)04778-4; Ebers GC, 2009, CLIN THER, V31, P1724, DOI 10.1016/j.clinthera.2009.08.003; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; Ford C, 2010, MULT SCLER, V16, P342, DOI 10.1177/1352458509358088; GOODKIN DE, 1992, NEUROLOGY, V42, P859, DOI 10.1212/WNL.42.4.859; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 2006, NEUROLOGY, V67, P944, DOI 10.1212/01.wnl.0000237994.95410.ce; Panitch H, 2004, NEUROLOGY, V63, P1788; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419	14	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c2693	10.1136/bmj.c2693	http://dx.doi.org/10.1136/bmj.c2693			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BM	20522659				2022-12-28	WOS:000278556500007
J	Shank, EA; Cecconi, C; Dill, JW; Marqusee, S; Bustamante, C				Shank, Elizabeth A.; Cecconi, Ciro; Dill, Jesse W.; Marqusee, Susan; Bustamante, Carlos			The folding cooperativity of a protein is controlled by its chain topology	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; T4 LYSOZYME; SINGLE-MOLECULE; FLUCTUATION THEOREM; CONFORMATIONS; STABILITY; FRAGMENT; DNA	The three-dimensional structures of proteins often show a modular architecture comprised of discrete structural regions or domains. Cooperative communication between these regions is important for catalysis, regulation and efficient folding; lack of coupling has been implicated in the formation of fibrils and other misfolding pathologies(1). How different structural regions of a protein communicate and contribute to a protein's overall energetics and folding, however, is still poorly understood. Here we use a single-molecule optical tweezers approach to induce the selective unfolding of particular regions of T4 lysozyme and monitor the effect on other regions not directly acted on by force. We investigate how the topological organization of a protein (the order of structural elements along the sequence) affects the coupling and folding cooperativity between its domains. To probe the status of the regions not directly subjected to force, we determine the free energy changes during mechanical unfolding using Crooks' fluctuation theorem. We pull on topological variants (circular permutants) and find that the topological organization of the polypeptide chain critically determines the folding cooperativity between domains and thus what parts of the folding/unfolding landscape are explored. We speculate that proteins may have evolved to select certain topologies that increase coupling between regions to avoid areas of the landscape that lead to kinetic trapping and misfolding.	[Shank, Elizabeth A.; Cecconi, Ciro; Marqusee, Susan; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shank, Elizabeth A.; Cecconi, Ciro; Dill, Jesse W.; Marqusee, Susan; Bustamante, Carlos] Univ Calif Berkeley, Inst Quantitat Biosci, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Dill, Jesse W.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Marqusee, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	Marqusee@berkeley.edu; Carlos@alice.berkeley.edu	Cecconi, Ciro/K-5028-2016; Shank, Elizabeth A./AAV-9050-2021	Cecconi, Ciro/0000-0002-6101-2609; Shank, Elizabeth A./0000-0002-4804-1966; Bustamante, Carlos/0000-0002-2970-0073	NIH [GM 32543, GM 50945]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050945, R01GM032543, R29GM050945, R37GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank G. Crooks for assistance in use of Crooks fluctuation analysis, R. Dahlquist and B. Matthews for help in initiating this study, and the entire Bustamante and Marqusee labs for advice and technical help. We would particularly like to thank E. Kwon for her assistance in reagent preparation and data collection. This work was supported in part by NIH grants GM 32543 (C.B.), GM 50945 (S.M.) and a grant from the NSF (S.M.).	ANDERSON DE, 1993, NMR PROTEINS, pCH9; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Bornschlog T, 2008, LANGMUIR, V24, P1338, DOI 10.1021/la7023567; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y; Cellitti J, 2007, PROTEIN SCI, V16, P842, DOI 10.1110/ps.062628607; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collin D, 2005, NATURE, V437, P231, DOI 10.1038/nature04061; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; ELWELL M, 1975, BIOCHIM BIOPHYS ACTA, V386, P309, DOI 10.1016/0005-2795(75)90273-1; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Llinas M, 1999, NAT STRUCT BIOL, V6, P1072; Llinas M, 1998, PROTEIN SCI, V7, P96, DOI 10.1002/pro.5560070110; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; Ng Sean P., 2007, V350, P139; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Yang GL, 2000, P NATL ACAD SCI USA, V97, P139, DOI 10.1073/pnas.97.1.139; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396	28	172	174	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					637	U134		10.1038/nature09021	http://dx.doi.org/10.1038/nature09021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20495548	Green Accepted			2022-12-28	WOS:000278249000046
J	Bueno, H; Ross, JS; Wang, Y; Chen, J; Vidan, MT; Normand, SLT; Curtis, JP; Drye, EE; Lichtman, JH; Keenan, PS; Kosiborod, M; Krumholz, HM				Bueno, Hector; Ross, Joseph S.; Wang, Yun; Chen, Jersey; Vidan, Maria T.; Normand, Sharon-Lise T.; Curtis, Jeptha P.; Drye, Elizabeth E.; Lichtman, Judith H.; Keenan, Patricia S.; Kosiborod, Mikhail; Krumholz, Harlan M.			Trends in Length of Stay and Short-term Outcomes Among Medicare Patients Hospitalized for Heart Failure, 1993-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							READMISSION RATES; TEMPORAL TRENDS; MORTALITY; SURVIVAL; CARE; PERFORMANCE	Context Whether decreases in the length of stay during the past decade for patients with heart failure (HF) may be associated with changes in outcomes is unknown. Objective To describe the temporal changes in length of stay, discharge disposition, and short-term outcomes among older patients hospitalized for HF. Design, Setting, and Participants An observational study of 6 955 461 Medicare fee-for-service hospitalizations for HF between 1993 and 2006, with a 30-day follow-up. Main Outcome Measures Length of hospital stay, in-patient and 30-day mortality, and 30-day readmission rates. Results Between 1993 and 2006, mean length of stay decreased from 8.81 days (95% confidence interval [CI], 8.79-8.83 days) to 6.33 days (95% CI, 6.32-6.34 days). In-hospital mortality decreased from 8.5% (95% CI, 8.4%-8.6%) in 1993 to 4.3% (95% CI, 4.2%-4.4%) in 2006, whereas 30-day mortality decreased from 12.8% (95% CI, 12.8%-12.9%) to 10.7% (95% CI, 10.7%-10.8%). Discharges to home or under home care service decreased from 74.0% to 66.9% and discharges to skilled nursing facilities increased from 13.0% to 19.9%. Thirty-day readmission rates increased from 17.2% (95% CI, 17.1%-17.3%) to 20.1% (95% CI, 20.0%-20.2%; all P<.001). Consistent with the unadjusted analyses, the 2005-2006 risk-adjusted 30-day mortality risk ratio was 0.92 (95% CI, 0.91-0.93) compared with 1993-1994, and the 30-day readmission risk ratio was 1.11 (95% CI, 1.10-1.11). Conclusion For patients admitted with HF during the past 14 years, reductions in length of stay and in-hospital mortality, less marked reductions in 30-day mortality, and changes in discharge disposition accompanied by increases in 30-day readmission rates were observed. JAMA. 2010; 303(21): 2141-2147	[Bueno, Hector] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain; [Vidan, Maria T.] Hosp Gen Univ Gregorio Maranon, Serv Geriatr Med, Madrid, Spain; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, HSR&D Res Enhancement Award Program, Bronx, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; [Wang, Yun; Chen, Jersey; Curtis, Jeptha P.; Drye, Elizabeth E.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sch Publ Hlth, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Lichtman, Judith H.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Chron Dis Epidemiol, New Haven, CT 06510 USA; [Keenan, Patricia S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kosiborod, Mikhail] Univ Missouri, St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO USA; [Kosiborod, Mikhail] Univ Missouri, Dept Med, Kansas City, MO USA	General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sch Publ Hlth, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Bueno, Hector/I-3910-2015; Kosiborod, Mikhail/HDO-1541-2022	Bueno, Hector/0000-0003-0277-7596; Kosiborod, Mikhail/0000-0002-3750-9789; Normand, Sharon-Lise/0000-0001-7027-4769; Ross, Joseph/0000-0002-9218-3320	Centers for Medicare & Medicaid Services, US Department of Health and Human Services [HHSM-500-2005-CO001C]; Centers for Disease Control and Prevention [K01 DP000085-05]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III, Spain [BA08/90010, BA08/90012]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research; American Heart Association; Almirall; Bayer; Bristol-Myers Squibb; Sanofi-Aventis; Astra-Zeneca; Pfizer; Centers for Medicare & Medicaid Services; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [K01DP000085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services, US Department of Health and Human Services; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; American Heart Association(American Heart Association); Almirall(Almirall); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Astra-Zeneca(AstraZeneca); Pfizer(Pfizer); Centers for Medicare & Medicaid Services; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The analyses upon which this publication is based were performed under contract HHSM-500-2005-CO001C, entitled "Utilization and Quality Control Quality Improvement Organization for the State (commonwealth) of Colorado," which was funded by the Centers for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services. This work was also funded by grant K01 DP000085-05 from the Centers for Disease Control and Prevention. Drs Bueno and Vidan were supported in part by grants BA08/90010 and BA08/90012, respectively, from the Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III, Spain, while at the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, where they participated in the development of this study. Dr Ross is supported by grant K08 AG032886 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. Dr Kosiborod is supported by the American Heart Association Career Development Award in Implementation Research.; Dr Bueno reported having received consulting fees from Almirall, Bayer, Bristol-Myers Squibb, and Sanofi-Aventis, and research grants from Astra-Zeneca, Bristol-Myers Squibb, and Pfizer. Drs Wang, Chen, Normand, Curtis, Drye, Keenan, and Krumholz reported that they develop and maintain performance measures under contract with the Centers for Medicare & Medicaid Services. Dr Kosiborod reported serving on the advisory board of Sanofi-Aventis and receiving speaking honoraria from the Vascular Biology Working Group and DiaVed Inc. Dr Krumholz reported chairing a scientific advisory board for United Healthcare. Drs Ross, Vidan, and Lichtman did not report any disclosures.	*AM HOSP ASS, TRENDW CHARTB 2008 T; Baker DW, 2004, ARCH INTERN MED, V164, P538, DOI 10.1001/archinte.164.5.538; Baker DW, 2003, AM HEART J, V146, P258, DOI 10.1016/S0002-8703(02)94784-8; Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Feldman DE, 2001, CAN MED ASSOC J, V165, P1033; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]; Haldeman GA, 1999, AM HEART J, V137, P352, DOI 10.1053/hj.1999.v137.95495; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P3611, DOI 10.1001/jama.260.24.3611; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kosiborod M, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.11.019; Krumholz HM, 2008, CIRCULATION, V118, P1885, DOI 10.1161/CIRCULATIONAHA.108.190500; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lee DS, 2004, AM J MED, V116, P581, DOI 10.1016/j.amjmed.2003.11.025; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; McDermontt MM, 1997, AM HEART J, V134, P901, DOI 10.1016/S0002-8703(97)80013-0; *MEDPAC, REP C REF DEL SYST; Polanczyk CA, 2000, ARCH INTERN MED, V160, P325, DOI 10.1001/archinte.160.3.325; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Setoguchi S, 2008, INT J CARDIOL, V125, P172, DOI 10.1016/j.ijcard.2007.10.009; Shimada SL, 2009, MED CARE, V47, P517, DOI 10.1097/MLR.0b013e318195f86e; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0	27	463	475	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2141	2147		10.1001/jama.2010.748	http://dx.doi.org/10.1001/jama.2010.748			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516414	Green Accepted, Bronze			2022-12-28	WOS:000278182100022
J	Lambert, L; Brown, K; Segal, E; Brophy, J; Rodes-Cabau, J; Bogaty, P				Lambert, Laurie; Brown, Kevin; Segal, Eli; Brophy, James; Rodes-Cabau, Josep; Bogaty, Peter			Association Between Timeliness of Reperfusion Therapy and Clinical Outcomes in ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS-CORONARY-INTERVENTION; SEGMENT-ELEVATION; PROPENSITY-SCORE; NATIONAL REGISTRY; SELECTION BIAS; STEMI REGISTRY; MORTALITY; GUIDELINES; THROMBOLYSIS; STRATEGIES	Context Guidelines emphasize the importance of rapid reperfusion of patients with ST-elevation myocardial infarction (STEMI) and specify a maximum delay of 30 minutes for fibrinolysis and 90 minutes for primary percutaneous coronary intervention (PPCI). However, randomized trials and selective registries are limited in their ability to assess the effect of timeliness of reperfusion on outcomes in real-world STEMI patients. Objectives To obtain a complete interregional portrait of contemporary STEMI care and to investigate timeliness of reperfusion and outcomes. Design, Setting, and Patients Systematic evaluation of STEMI care for 6 months during 2006-2007 in 80 hospitals that treated more than 95% of patients with acute myocardial infarction in the province of Quebec, Canada (population, 7.8 million). Main Outcome Measures Death at 30 days and at 1 year and the combined end point of death or hospital readmission for acute myocardial infarction or congestive heart failure at 1 year by linkage to Quebec's medicoadministrative databases. Results Of 1832 patients treated with reperfusion, 392 (21.4%) received fibrinolysis and 1440 (78.6%) received PPCI. Fibrinolysis was untimely (>30 minutes) in 54% and PPCI was untimely (>90 minutes) in 68%. Death or readmission for acute myocardial infarction or heart failure at 1 year occurred in 13.5% of fibrinolysis patients and 13.6% of PPCI patients. When the 2 treatment groups were combined, patients treated outside of recommended delays had an adjusted higher risk of death at 30 days (6.6% vs 3.3%; odds ratio [OR], 2.14; 95% confidence interval [CI], 1.21-3.93) and a statistically nonsignificant increase in risk of death at 1 year (9.3% vs 5.2%; OR, 1.61; 95% CI, 1.00-2.66) compared with patients who received timely treatment. Patients treated outside of recommended delays also had an adjusted higher risk for the combined outcome of death or hospital readmission for congestive heart failure or acute myocardial infarction at 1 year (15.0% vs 9.2%; OR, 1.57; 95% CI, 1.08-2.30). At the regional level, after adjustment, each 10% increase in patients treated within the recommended time was associated with a decrease in the region-level odds of overall 30-day mortality (OR, 0.80; 95% CI, 0.65-0.98). Conclusion Among patients in Quebec with STEMI, reperfusion delivered outside guideline-recommend delays was associated with significantly increased 30-day mortality, a statistically nonsignificant increase in 1-year mortality, and significantly increased risk of the composite of mortality or readmission for acute myocardial infarction or heart failure at 1 year. JAMA. 2010; 303(21): 2148-2155	[Lambert, Laurie] Agence Evaluat Technol & Modes Intervent Sante Qu, Cardiol Evaluat Unit, Montreal, PQ H3A 2S9, Canada; [Segal, Eli] McGill Univ Urgences Sante, Jewish Gen Hosp, Montreal, PQ, Canada; [Brophy, James] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Rodes-Cabau, Josep] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	McGill University; McGill University	Lambert, L (corresponding author), Agence Evaluat Technol & Modes Intervent Sante Qu, Cardiol Evaluat Unit, 2021 Union Ave, Montreal, PQ H3A 2S9, Canada.	laurie.lambert@aetmis.gouv.qc.ca	brophy, james/H-6673-2019; Segal, Eli/GPW-8146-2022	brophy, james/0000-0001-8049-6875; Brown, Kevin Antoine/0000-0002-1483-2188	Ministry of Health of the province of Quebec; Boston Scientific; Abbott; Cordis	Ministry of Health of the province of Quebec; Boston Scientific(Boston Scientific); Abbott(Abbott Laboratories); Cordis	This evaluation was funded by the Ministry of Health of the province of Quebec.; Dr Rodes-Cabau reports that he is recipient of a research grant from Boston Scientific and lecture fees from Abbott, Cordis, and Boston Scientific. No other disclosures were reported.	Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1218, DOI 10.1002/pds.1674; Bates D., 2009, IME4 LINEAR MIXED EF; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Danchin N, 2008, CIRCULATION, V118, P268, DOI 10.1161/CIRCULATIONAHA.107.762765; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Ferreira-Gonzalez I, 2009, CIRC-CARDIOVASC QUAL, V2, P540, DOI 10.1161/CIRCOUTCOMES.108.844399; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Huynh T, 2009, CIRCULATION, V119, P3101, DOI 10.1161/CIRCULATIONAHA.108.793745; Kalla K, 2006, CIRCULATION, V113, P2398, DOI 10.1161/CIRCULATIONAHA.105.586198; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P517, DOI 10.1161/CIRCOUTCOMES.109.916601; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lambert LJ, 2009, CIRC-CARDIOVASC QUAL, V2, pe40; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Mehta RH, 2008, AM HEART J, V155, P1059, DOI 10.1016/j.ahj.2008.01.010; Nallamothu BK, 2007, HEART, V93, P1552, DOI 10.1136/hrt.2006.112847; Nallamothu BK, 2006, CIRCULATION, V113, P222, DOI 10.1161/CIRCULATIONAHA.105.578195; R Core Team, 2020, R LANG ENV STAT COMP; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; SAS Institute. Inc, 2005, SAS VERS 9 1 3; SEKHON JS, 2009, MATCHING MULTIVARIAT; So DYF, 2006, AM J CARDIOL, V97, P458, DOI 10.1016/j.amjcard.2005.08.069; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; THIBAULT N, 2007, SUIVI CYCLE NAISSANC; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Westfall JM, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-22; Wiviott SD, 2004, J AM COLL CARDIOL, V44, P783, DOI 10.1016/j.jacc.2004.05.045	29	172	177	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2148	2155		10.1001/jama.2010.712	http://dx.doi.org/10.1001/jama.2010.712			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516415	Bronze			2022-12-28	WOS:000278182100023
J	Brenner, H; Altenhofen, L; Hoffmeister, M				Brenner, Hermann; Altenhofen, Lutz; Hoffmeister, Michael			Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms A Cohort Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER INCIDENCE; RISK; COLONOSCOPY; PARTICIPATION; PREVALENCE; POLYPS	Background: Prevalence of advanced colorectal neoplasms increases with age and is higher among men than women. Cross-sectional analyses estimated that men reach an equivalent prevalence at a much younger age than women. However, cross-sectional estimates may be confounded by birth cohort effects. Objective: To estimate age and cohort effects in advanced colorectal neoplasms and to adjust risk-advancement periods for men compared with women for birth cohort effects. Design: Age-cohort analyses. Setting: German screening colonoscopy program, 2003 to 2007. Participants: 2 185 153 participants aged 55 to 75 years. Measurements: Sex-and age-specific prevalence of colorectal cancer (CRC) and advanced neoplasms (CRC or advanced adenoma) were plotted with and without stratification by birth cohort. Risk-advancement periods with 95% CI for men compared with women were estimated from log-binomial regression models with and without cross-sectional analysis adjustment for birth cohort effects. Results: Overall, 17 196 participants (0.8%) had CRC and 152 429 (7.0%) had any advanced neoplasm. Age-specific prevalence was higher in men than in women and in later birth cohorts. The apparent modest increase in prevalence by age in cross-sectional analysis was much steeper after birth cohort effects were controlled for. In cross-sectional analysis, risk-advancement periods (95% CI) for men compared with women were 8.4 years (CI, 7.7 to 9.0 years) and 16.1 years (CI, 15.8 to 16.5 years) for CRC and any advanced neoplasm, respectively, and 3.4 years (CI, 2.6 to 4.3 years) and 6.9 years (CI, 6.4 to 7.4 years) after controlling for birth cohort effects. Limitation: Information on covariates that could explain cohort effects was lacking. Conclusion: In this population, strong cohort effects reduced age gradients in advanced colorectal neoplasms and inflated risk-advancement periods for men compared with women, but major risk advancement persisted, even after birth cohort effects were controlled for.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69115 Heidelberg, Germany; Cent Res Inst Ambulatory Hlth Care Germany, D-10623 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Bergheimer Str 20, D-69115 Heidelberg, Germany.		Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/AAB-2321-2022; Hoffmeister, Michael/B-5745-2012	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197				Blom J, 2008, INT J CANCER, V122, P1618, DOI 10.1002/ijc.23208; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; BOYLE P, 1985, INT J CANCER, V36, P9, DOI 10.1002/ijc.2910360103; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; BRENNER H, 1993, EPIDEMIOLOGY, V4, P229, DOI 10.1097/00001648-199305000-00006; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2009, EUR J CANCER, V45, P2027, DOI 10.1016/j.ejca.2009.02.017; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; *CENTR I AMB HLTH, SCI EV SCREEN COL GE; Cress RD, 2006, CANCER, V107, P1142, DOI 10.1002/cncr.22011; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Larsen IK, 2006, EUR J CANCER PREV, V15, P10, DOI 10.1097/01.cej.0000186636.27496.bb; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; McCaffery K, 2002, J MED SCREEN, V9, P104, DOI 10.1136/jms.9.3.104; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Pan Sai Yi, 2009, V472, P191, DOI 10.1007/978-1-60327-492-0_8; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raum E, 2007, EUR J CARDIOV PREV R, V14, P809, DOI 10.1097/HJR.0b013e3282eeb308; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Thorpe LE, 2005, CANCER-AM CANCER SOC, V104, P1075, DOI 10.1002/cncr.21274; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x	26	36	37	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					697	W288		10.7326/0003-4819-152-11-201006010-00002	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20513827				2022-12-28	WOS:000278560000002
J	Horii, KA; Jackson, MA				Horii, Kimberly A.; Jackson, Mary Anne			Piercing-Related Nontuberculous Mycobacterial Infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Horii, Kimberly A.; Jackson, Mary Anne] Childrens Mercy Hosp & Clin, Kansas City, MO USA	Children's Mercy Hospital	Horii, KA (corresponding author), Childrens Mercy Hosp & Clin, Kansas City, MO USA.	kahorii@cmh.edu							0	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					2012	2012		10.1056/NEJMicm0906854	http://dx.doi.org/10.1056/NEJMicm0906854			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601JI	20505180				2022-12-28	WOS:000278054000009
J	Nussenzveig, P; Barata, JCA				Nussenzveig, Paulo; Barata, Joao C. A.			A Drop of Quantum Matter	SCIENCE			English	Editorial Material							GRAVITY		[Nussenzveig, Paulo; Barata, Joao C. A.] Univ Sao Paulo, Inst Fis, BR-05314970 Sao Paulo, Brazil	Universidade de Sao Paulo	Nussenzveig, P (corresponding author), Univ Sao Paulo, Inst Fis, POB 66318, BR-05314970 Sao Paulo, Brazil.	nussen@if.usp.br; jbarata@fma.if.usp.br	Nussenzveig, Paulo/P-3270-2016; quantica, Inct Informacao/H-9493-2013	Nussenzveig, Paulo/0000-0002-8789-7505; 				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Barrow JD, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.103515; Buchman S, 2000, ADV SPACE RES, V25, P1177, DOI 10.1016/S0273-1177(99)00982-5; Ciufolini I, 2007, NATURE, V449, P41, DOI 10.1038/nature06071; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; Dimopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.111102; Dyson F., 1998, IMAGINED WORLDS; Einstein Albert, 1938, EVOLUTION PHYS; Ertmer W, 2009, EXP ASTRON, V23, P611, DOI 10.1007/s10686-008-9125-6; Misner C. W., 1973, GRAVITATION; Muller H, 2010, NATURE, V463, P926, DOI 10.1038/nature08776; Pfister H, 2007, GEN RELAT GRAVIT, V39, P1735, DOI 10.1007/s10714-007-0521-4; Stairs IH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.141101; van Zoest T, 2010, SCIENCE, V328, P1540, DOI 10.1126/science.1189164; Weinberg S., 1972, GRAVITATION COSMOLOG; Williams JG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.261101	16	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1491	1492		10.1126/science.1191666	http://dx.doi.org/10.1126/science.1191666			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558695				2022-12-28	WOS:000278859200023
J	Dabis, F; Newell, ML; Hirschel, B				Dabis, Francois; Newell, Marie-Louise; Hirschel, Bernard			HIV drugs for treatment, and for prevention	LANCET			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL LOAD; TRANSMISSION		[Dabis, Francois] Univ Victor Segalen, INSERM, U897, ISPED, F-33076 Bordeaux, France; [Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, KwaZulu Natal, South Africa; [Hirschel, Bernard] Hop Cantonal Univ Geneva, Unite VIH SIDA, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Kwazulu Natal; University of Geneva	Dabis, F (corresponding author), Univ Victor Segalen, INSERM, U897, ISPED, F-33076 Bordeaux, France.	francois.dabis@isped.u-bordeaux2.fr	DABIS, FRANCOIS/S-9298-2019; Newell, Marie-Louise/AAE-8222-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Newell, Marie-Louise/0000-0002-1074-7699				Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; MOHAMMED I, 2009, 16 C RETR OPP INF MO, pLB137; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; *UNAIDS, 2010, S AFR LAUNCH MASS HI; *WHO, 2009, UN ACC UN ACC SCAL P; 2009, PREVENTING SEXUAL TR	12	20	29	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 12	2010	375	9731					2056	2057		10.1016/S0140-6736(10)60838-0	http://dx.doi.org/10.1016/S0140-6736(10)60838-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20537377				2022-12-28	WOS:000279069300006
J	Immerzeel, WW; van Beek, LPH; Bierkens, MFP				Immerzeel, Walter W.; van Beek, Ludovicus P. H.; Bierkens, Marc F. P.			Climate Change Will Affect the Asian Water Towers	SCIENCE			English	Article							SUMMER MONSOON; GLACIER; SIMULATIONS; FORECAST; DATABASE; BASINS	More than 1.4 billion people depend on water from the Indus, Ganges, Brahmaputra, Yangtze, and Yellow rivers. Upstream snow and ice reserves of these basins, important in sustaining seasonal water availability, are likely to be affected substantially by climate change, but to what extent is yet unclear. Here, we show that meltwater is extremely important in the Indus basin and important for the Brahmaputra basin, but plays only a modest role for the Ganges, Yangtze, and Yellow rivers. A huge difference also exists between basins in the extent to which climate change is predicted to affect water availability and food security. The Brahmaputra and Indus basins are most susceptible to reductions of flow, threatening the food security of an estimated 60 million people.	[Immerzeel, Walter W.] FutureWater, NL-6702 AA Wageningen, Netherlands; [Immerzeel, Walter W.; van Beek, Ludovicus P. H.; Bierkens, Marc F. P.] Univ Utrecht, Dept Phys Geog, Utrecht, Netherlands; [Bierkens, Marc F. P.] Deltares, Utrecht, Netherlands	Utrecht University; Deltares	Immerzeel, WW (corresponding author), FutureWater, Costerweg 1G, NL-6702 AA Wageningen, Netherlands.	w.immerzeel@futurewater.nl	Bierkens, Marc F.P./AAE-8176-2019; Immerzeel, Walter/E-2489-2012; Van Beek, Rens/B-4904-2014	Immerzeel, Walter/0000-0002-2010-9543; Van Beek, Rens/0000-0002-4758-108X; Bierkens, Marc F.P./0000-0002-7411-6562	Netherlands Organisation for Scientific Research (NWO) [018 003 002]; European Commission [212921]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was financially supported by the Netherlands Organisation for Scientific Research (NWO) through a CASIMIR grant (018 003 002) and by the European Commission (Call FP7-ENV-2007-1 grant 212921) as part of the CEOP-AEGIS project (www.ceop-aegis.org/) coordinated by the Universite de Strasbourg. We thank P. Ditmar (Department of Earth Observation and Space Systems, Technical University of Delft) for assistance with the GRACE trend analysis.	Annamalai H, 2007, J CLIMATE, V20, P1071, DOI 10.1175/JCL14035.1; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Barry RG, 2006, PROG PHYS GEOG, V30, P285, DOI 10.1191/0309133306pp478ra; Bates B.C., 2008, CLIMATE CHANGE WATER; Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017; Bierkens MFP, 2009, J HYDROMETEOROL, V10, P953, DOI 10.1175/2009JHM1034.1; Bolch T, 2008, J GLACIOL, V54, P592, DOI 10.3189/002214308786570782; Cruz R.V., 2007, CLIMATE CHANGE 2007; Cyranoski D, 2005, NATURE, V438, P275, DOI 10.1038/438275a; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Immerzeel WW, 2009, REMOTE SENS ENVIRON, V113, P40, DOI 10.1016/j.rse.2008.08.010; Jansson P, 2003, J HYDROL, V282, P116, DOI 10.1016/S0022-1694(03)00258-0; Kehrwald NM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035556; Klees R, 2008, GEOPHYS J INT, V175, P417, DOI 10.1111/j.1365-246X.2008.03922.x; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Martinec J., 1975, HYDROL RES, V6, P145, DOI [10.2166/nh.1975.0010, DOI 10.2166/NH.1975.0010]; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Raup B, 2007, GLOBAL PLANET CHANGE, V56, P101, DOI 10.1016/j.gloplacha.2006.07.018; Rees HG, 2006, HYDROL PROCESS, V20, P2157, DOI 10.1002/hyp.6209; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Singh P, 2005, J HYDROL, V300, P140, DOI 10.1016/j.jhydrol.2004.06.005; Viviroli D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005653; Yang S, 2008, J CLIMATE, V21, P3755, DOI 10.1175/2008JCLI1961.1	23	2151	2320	111	1066	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1382	1385		10.1126/science.1183188	http://dx.doi.org/10.1126/science.1183188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538947				2022-12-28	WOS:000278598400034
J	Uemura, T; Lee, SJ; Yasumura, M; Takeuchi, T; Yoshida, T; Ra, M; Taguchi, R; Sakimura, K; Mishina, M				Uemura, Takeshi; Lee, Sung-Jin; Yasumura, Misato; Takeuchi, Tomonori; Yoshida, Tomoyuki; Ra, Moonjin; Taguchi, Ryo; Sakimura, Kenji; Mishina, Masayoshi			Trans-Synaptic Interaction of GluR delta 2 and Neurexin through Cbln1 Mediates Synapse Formation in the Cerebellum	CELL			English	Article							LONG-TERM DEPRESSION; GLUTAMATE-RECEPTOR DELTA-2; PURKINJE-CELLS; ALPHA-NEUREXINS; BETA-NEUREXINS; MUTANT MICE; 2 SUBUNIT; NEUROLIGINS; EXPRESSION; PARALLEL	Elucidation of molecular mechanisms that regulate synapse formation is required for the understanding of neural wiring, higher brain functions, and mental disorders. Despite the wealth of in vitro information, fundamental questions about how glutamatergic synapses are formed in the mammalian brain remain unanswered. Glutamate receptor (GluR) delta 2 is essential for cerebellar synapse formation in vivo. Here, we show that the N-terminal domain (NTD) of GluR delta 2 interacts with presynaptic neurexins (NRXNs) through cerebellin 1 precursor protein (Cbln1). The synaptogenic activity of GluR delta 2 is abolished in cerebellar primary cultures from Cbln1 knockout mice and is restored by recombinant Cbln1. Knockdown of NRXNs in cerebellar granule cells also hinders the synaptogenic activity of GluR delta 2. Both the NTD of GluR delta 2 and the extracellular domain of NRXN1 beta suppressed the synaptogenic activity of Cbln1 in cerebellar primary cultures and in vivo. These results suggest that GluR delta 2 mediates cerebellar synapse formation by interacting with presynaptic NRXNs through Cbln1.	[Uemura, Takeshi; Lee, Sung-Jin; Yasumura, Misato; Takeuchi, Tomonori; Yoshida, Tomoyuki; Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo 1130033, Japan; [Ra, Moonjin; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata 9518585, Japan	University of Tokyo; University of Tokyo; Niigata University	Mishina, M (corresponding author), Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo 1130033, Japan.	mishina@m.u-tokyo.ac.jp	ra, moonjin/AAK-3816-2021; Takeuchi, Tomonori/P-5988-2016	Takeuchi, Tomonori/0000-0002-9981-4260; Yoshida, Tomoyuki/0000-0002-8476-3798; Yasumura, Misato/0000-0003-1965-4867	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22700392] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank M. Watanabe for antibodies against Cbln1, GluR alpha 1, GluR alpha 2, GluR alpha 2, VGluT1 and calbindin, J. Miyazaki for CAG-cre transgenic mice and pCAGCS, M. Kataoka for pEGFP-VAMP2, and Y. Miwa for pEB6-CAGMCS. We are grateful to H. Sagara, T. Miyazaki, and Y. Mikami for helpful advice on electron microscopy, T. Shimizu and S. Tokuoka for use of Biacore 3000 biosensor, T. Fuse for advice on cerebellar culture, A. Maeda for technical assistance, K. Osaki and R. Natsume for help in knockout mouse generation, and Y. Nakajima for help in preparation of the manuscript.	ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Katayama H, 2004, RAPID COMMUN MASS SP, V18, P2388, DOI 10.1002/rcm.1637; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Kurihara H, 1997, J NEUROSCI, V17, P9613; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Mishina M, 2003, INT CONGR SER, V1250, P473, DOI 10.1016/S0531-5131(03)00186-9; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SLEMMON JR, 1984, P NATL ACAD SCI-BIOL, V81, P6866, DOI 10.1073/pnas.81.21.6866; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Takeuchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002297; Tsujita M, 1999, J NEUROSCI, V19, P10318; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Uemura T, 2007, J NEUROSCI, V27, P12096, DOI 10.1523/JNEUROSCI.2680-07.2007; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4	46	333	337	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1068	1079		10.1016/j.cell.2010.04.035	http://dx.doi.org/10.1016/j.cell.2010.04.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20537373	Green Submitted, Bronze			2022-12-28	WOS:000278618800020
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling What I learnt from Mom	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2010	340								c2973	10.1136/bmj.c2973	http://dx.doi.org/10.1136/bmj.c2973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MB	20530558				2022-12-28	WOS:000278818300011
J	Salter, CL; Stevenson, RM; Farrer, I; Nicoll, CA; Ritchie, DA; Shields, AJ				Salter, C. L.; Stevenson, R. M.; Farrer, I.; Nicoll, C. A.; Ritchie, D. A.; Shields, A. J.			An entangled-light-emitting diode	NATURE			English	Article							PHOTON PAIRS; QUANTUM	An optical quantum computer, powerful enough to solve problems so far intractable using conventional digital logic, requires a large number of entangled photons(1,2). At present, entangled-light sources are optically driven with lasers(3-7), which are impractical for quantum computing owing to the bulk and complexity of the optics required for large-scale applications. Parametric down-conversion is the most widely used source of entangled light, and has been used to implement non-destructive quantum logic gates(8,9). However, these sources are Poissonian(4,5) and probabilistically emit zero or multiple entangled photon pairs in most cycles, fundamentally limiting the success probability of quantum computational operations. These complications can be overcome by using an electrically driven on-demand source of entangled photon pairs(10), but so far such a source has not been produced. Here we report the realization of an electrically driven source of entangled photon pairs, consisting of a quantum dot embedded in a semiconductor light-emitting diode (LED) structure. We show that the device emits entangled photon pairs under d.c. and a.c. injection, the latter achieving an entanglement fidelity of up to 0.82. Entangled light with such high fidelity is sufficient for application in quantum relays(11), in core components of quantum computing such as teleportation(12-14), and in entanglement swapping(15,16). The a.c. operation of the entangled-lightemitting diode (ELED) indicates its potential function as an ondemand source without the need for a complicated laser driving system; consequently, the ELED is at present the best source on which to base future scalable quantum information applications(17).	[Salter, C. L.; Stevenson, R. M.; Shields, A. J.] Toshiba Res Europe Ltd, Cambridge CB4 0GZ, England; [Salter, C. L.; Farrer, I.; Nicoll, C. A.; Ritchie, D. A.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Toshiba Corporation; University of Cambridge	Shields, AJ (corresponding author), Toshiba Res Europe Ltd, 208 Cambridge Sci Pk, Cambridge CB4 0GZ, England.	andrew.shields@crl.toshiba.co.uk	Farrer, Ian/A-7671-2009; Ritchie, David/K-2206-2014	Farrer, Ian/0000-0002-3033-4306; Ritchie, David/0000-0002-9844-8350	Engineering and Physical Sciences Research Council; Quantum Information Processing Interdisciplinary Research Collaboration; EU; Engineering and Physical Sciences Research Council [EP/E058019/1] Funding Source: researchfish; EPSRC [EP/E058019/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Quantum Information Processing Interdisciplinary Research Collaboration; EU(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to acknowledge funding for this work from the Engineering and Physical Sciences Research Council, the Quantum Information Processing Interdisciplinary Research Collaboration, the EU Integrated Projects, Qubit Applications and Quantum Interfaces, Sensors and Communication based on Entanglement and Nanoscience in the European Research Area, and we thank K. Cooper for his advice and support in device fabrication.	Akopian N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130501; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Edamatsu K, 2004, NATURE, V431, P167, DOI 10.1038/nature02838; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Gasparoni S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020504; Hafenbrak R, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/315; Hudson AJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.266802; Jacobs BC, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052307; KIESS TE, 1993, PHYS REV LETT, V71, P3893, DOI 10.1103/PhysRevLett.71.3893; KNILL E, 2001, NATURE, V46, P409; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; Michler P., 2003, SINGLE QUANTUM DOTS; Mohan A, 2010, NAT PHOTONICS, V4, P302, DOI 10.1038/NPHOTON.2010.2; Moreau E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.183601; Nicoll CA, 2009, J CRYST GROWTH, V311, P1811, DOI 10.1016/j.jcrysgro.2008.10.006; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Shields AJ, 2009, NANOSCI TECHNOL, P227, DOI 10.1007/978-3-540-87446-1_7; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; Stevenson RM, 2006, NATURE, V439, P179, DOI 10.1038/nature04446; Young RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.030406; Young RJ, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/029; Young RJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.113305; Yuan ZL, 2002, SCIENCE, V295, P102, DOI 10.1126/science.1066790; Zhao Z, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.030501; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	30	269	273	3	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					594	597		10.1038/nature09078	http://dx.doi.org/10.1038/nature09078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520709				2022-12-28	WOS:000278249000036
J	Coombes, R				Coombes, Rebecca			Profile Richard Budgett: Olympic challenge	BRITISH MEDICAL JOURNAL			English	Biographical-Item									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmj.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 2	2010	340								c2904	10.1136/bmj.c2904	http://dx.doi.org/10.1136/bmj.c2904			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BL	20519270				2022-12-28	WOS:000278556400005
J	Anderson, RF; Carr, ME				Anderson, Robert F.; Carr, Mary-Elena			Uncorking the Southern Ocean's Vintage CO2	SCIENCE			English	Editorial Material							LAST; CIRCULATION; RECORD		[Anderson, Robert F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Carr, Mary-Elena] Columbia Univ, Columbia Climate Ctr, New York, NY 10025 USA	Columbia University; Columbia University	Anderson, RF (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	boba@ldeo.columbia.edu		Anderson, Robert/0000-0002-8472-2494				Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Broecker W, 2008, EARTH PLANET SC LETT, V274, P322, DOI 10.1016/j.epsl.2008.07.035; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Chiang JCH, 2009, ANNU REV EARTH PL SC, V37, P263, DOI 10.1146/annurev.earth.031208.100217; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590	15	15	19	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1117	1118		10.1126/science.1190765	http://dx.doi.org/10.1126/science.1190765			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508121				2022-12-28	WOS:000278104700032
J	Bouillon, R				Bouillon, Roger			Genetic and environmental determinants of vitamin D status	LANCET			English	Editorial Material							HEALTH		Katholieke Univ Leuven, Clin & Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium	KU Leuven	Bouillon, R (corresponding author), Katholieke Univ Leuven, Clin & Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium.	roger.bouillon@med.kuleuven.ac.be						Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bouillon R, 2008, J BONE MINER RES, V23, P974, DOI 10.1359/JBMR.080420; Fu L, 2009, CLIN BIOCHEM, V42, P1174, DOI 10.1016/j.clinbiochem.2009.03.008; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; NORMAN AW, EXP BIOL ME IN PRESS; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0	10	31	33	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					148	149		10.1016/S0140-6736(10)60635-6	http://dx.doi.org/10.1016/S0140-6736(10)60635-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20541253				2022-12-28	WOS:000280313100007
J	Mello, MM; Wolf, LE				Mello, Michelle M.; Wolf, Leslie E.			The Havasupai Indian Tribe Case -- Lessons for Research Involving Stored Biologic Samples.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Wolf, Leslie E.] Georgia State Univ, Coll Law, Atlanta, GA 30303 USA	Harvard University; Harvard T.H. Chan School of Public Health; University System of Georgia; Georgia State University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Wolf, Leslie/0000-0002-4660-8383; Mello, Michelle/0000-0003-2877-4270				Glantz L, 2008, NEW ENGL J MED, V358, P298, DOI 10.1056/NEJMhle074597; Harmon A., 2010, NY TIMES 0918, pA1; *PRIM R HUM TISS S, 2007, REP PUBL RESP MED RE; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544	4	251	253	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					204	207		10.1056/NEJMp1005203	http://dx.doi.org/10.1056/NEJMp1005203			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625AR	20538622				2022-12-28	WOS:000279864200002
J	Braun, T; Bergstrom, CT; Frey, BS; Osterloh, M; West, JD; Pendlebury, D; Rohn, J				Braun, Tibor; Bergstrom, Carl T.; Frey, Bruno S.; Osterloh, Margit; West, Jevin D.; Pendlebury, David; Rohn, Jennifer			How to improve the use of metrics	NATURE			English	Editorial Material									[Braun, Tibor] Hungarian Acad Sci, H-1051 Budapest, Hungary; [Bergstrom, Carl T.; West, Jevin D.] Univ Washington, Seattle, WA 98195 USA; [Frey, Bruno S.; Osterloh, Margit] Univ Zurich, CH-8006 Zurich, Switzerland; [Rohn, Jennifer] UCL, London WC1E 6BT, England	Hungarian Academy of Sciences; University of Washington; University of Washington Seattle; University of Zurich; University of London; University College London	Braun, T (corresponding author), Hungarian Acad Sci, H-1051 Budapest, Hungary.		Bergstrom, Carl T./H-2299-2011; Frey, Bruno/AAW-9103-2021; Pendlebury, David/W-3906-2019	Bergstrom, Carl T./0000-0002-2070-385X; 				Butler L, 2003, RES POLICY, V32, P143, DOI 10.1016/S0048-7333(02)00007-0; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Frey BS, 2008, Z PSYCHOL, V216, P198, DOI 10.1027/0044-3409.216.4.198; Frey BS, 2003, PUBLIC CHOICE, V116, P205, DOI 10.1023/A:1024208701874; Langfeldt L, 2006, RES EVALUAT, V15, P31, DOI 10.3152/147154406781776039; Moed HF., 2005, CITATION ANAL RES EV; Nalimov V.V., 1971, MEASUREMENT SCI STUD; PRICE J., 1986, LITTLE SCI BIG SCI; Stern S, 2004, MANAGE SCI, V50, P835, DOI 10.1287/mnsc.1040.0241; Vinkler P, 2010, EVALUATION RES SCIEN	10	38	42	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					870	872		10.1038/465870a	http://dx.doi.org/10.1038/465870a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	611HN	20559368	Bronze, Green Accepted			2022-12-28	WOS:000278804500019
J	Eaves, CJ; Humphries, RK				Eaves, Connie J.; Humphries, R. Keith			Acute Myeloid Leukemia and the Wnt Pathway	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS; LEUKEMOGENESIS; HEMATOPOIESIS; CATENIN		[Eaves, Connie J.; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.			Humphries, Richard/0000-0003-0540-7005; Eaves, Connie/0000-0002-3452-1926				Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624	5	41	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2326	2327		10.1056/NEJMcibr1003522	http://dx.doi.org/10.1056/NEJMcibr1003522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554989				2022-12-28	WOS:000278816300015
J	Papai, G; Tripathi, MK; Ruhlmann, C; Layer, JH; Weil, PA; Schultz, P				Papai, Gabor; Tripathi, Manish K.; Ruhlmann, Christine; Layer, Justin H.; Weil, P. Anthony; Schultz, Patrick			TFIIA and the transactivator Rap1 cooperate to commit TFIID for transcription initiation	NATURE			English	Article							YEAST TFIIA/TBP/DNA COMPLEX; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PROMOTER; ACTIVATION; PROTEIN; TAFS; DISTINCT	Transcription of eukaryotic messenger RNA (mRNA) encoding genes by RNA polymerase II (Pol II) is triggered by the binding of transactivating proteins to enhancer DNA, which stimulates the recruitment of general transcription factors (TFIIA, B, D, E, F, H) and Pol II on the cis-linked promoter, leading to pre-initiation complex formation and transcription(1). In TFIID-dependent activation pathways, this general transcription factor containing TATA-box-binding protein is first recruited on the promoter through interaction with activators(1-3) and cooperates with TFIIA to form a committed pre-initiation complex(4). However, neither the mechanisms by which activation signals are communicated between these factors nor the structural organization of the activated pre-initiation complex are known. Here we used cryo-electron microscopy to determine the architecture of nucleoprotein complexes composed of TFIID, TFIIA, the transcriptional activator Rap1 and yeast enhancer-promoter DNA. These structures revealed the mode of binding of Rap1 and TFIIA to TFIID, as well as a reorganization of TFIIA induced by its interaction with Rap1. We propose that this change in position increases the exposure of TATA-box-binding protein within TFIID, consequently enhancing its ability to interact with the promoter. A large Rap1-dependent DNA loop forms between the activator-binding site and the proximal promoter region. This loop is topologically locked by a TFIIA-Rap1 protein bridge that folds over the DNA. These results highlight the role of TFIIA in transcriptional activation, define a molecular mechanism for enhancer-promoter communication and provide structural insights into the pathways of intramolecular communication that convey transcription activation signals through the TFIID complex.	[Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] IGBMC, Dept Struct Biol & Genom, F-67404 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] INSERM, U964, F-67400 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] Univ Strasbourg, F-67000 Strasbourg, France; [Tripathi, Manish K.; Layer, Justin H.; Weil, P. Anthony] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Vanderbilt University	Schultz, P (corresponding author), IGBMC, Dept Struct Biol & Genom, 1 Rue Laurent Fries,BP10142, F-67404 Illkirch Graffenstaden, France.	tony.weil@vanderbilt.edu; patrick.schultz@igbmc.fr		schultz, patrick/0000-0002-7310-6186; Papai, Gabor/0000-0002-2779-8679	Institut National de la Sante et de la Recherche Medicale; Centre National pour la Recherche Scientifique; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; Agence Nationale pour le Recherche; EU [QLG2-CT-00988]; National Institutes of Health [GM52461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052461, R56GM052461] Funding Source: NIH RePORTER	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National pour la Recherche Scientifique; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour le Recherche(French National Research Agency (ANR)); EU(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Centre National pour la Recherche Scientifique, the Association pour la Recherche sur le Cancer, the Fondation pour la Recherche Medicale, the Agence Nationale pour le Recherche and the European SPINE program (G. P., C. R. and P. S., EU contract number QLG2-CT-00988), and the National Institutes of Health (M. K. T., J.H.L. and P. A. W., National Institutes of Health grant number GM52461).	Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Lieberman PM, 1997, MOL CELL BIOL, V17, P6624, DOI 10.1128/MCB.17.11.6624; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RATHJEN J, 1990, NUCLEIC ACIDS RES, V18, P3219, DOI 10.1093/nar/18.11.3219; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; WANG WD, 1992, GENE DEV, V6, P1716, DOI 10.1101/gad.6.9.1716	38	49	49	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					956	U14		10.1038/nature09080	http://dx.doi.org/10.1038/nature09080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559389	Green Accepted			2022-12-28	WOS:000278804500044
J	Donnell, D; Baeten, JM; Kiarie, J; Thomas, KK; Stevens, W; Cohen, CR; McIntyre, J; Lingappa, JR; Celum, C				Donnell, Deborah; Baeten, Jared M.; Kiarie, James; Thomas, Katherine K.; Stevens, Wendy; Cohen, Craig R.; McIntyre, James; Lingappa, Jairam R.; Celum, Connie		Partners Prevention HSV HIV Transm	Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis	LANCET			English	Article							CD4 CELL COUNT; VIRAL LOAD; SEXUAL-BEHAVIOR; INFECTION; DISEASE; RISK; RNA	Background High plasma HIV-1 RNA concentrations are associated with increased risk of HIV-1 transmission. Initiation of antiretroviral therapy (ART) reduces plasma HIV-1 concentrations. We aimed to assess the effect of ART use by patients infected with HIV-1 on risk of transmission to their uninfected partners. Methods Participants in our prospective cohort analysis were from a randomised placebo-controlled trial that enrolled heterosexual African adults who were seropositive for both HIV-1 and herpes simplex virus type 2, and their HIV-1 seronegative partners. At enrolment, HIV-1 infected participants had CD4 counts of 250 cells per mu L or greater and did not meet national guidelines for ART initiation; during 24 months of follow-up, CD4 counts were measured every 6 months and ART was initiated in accordance with national guidelines. Uninfected partners were tested for HIV-1 every 3 months. The primary outcome was genetically-linked HIV-1 transmission within the study partnership. We assessed rates of HIV-1 transmission by ART status of infected participants. Findings 3381 couples were eligible for analysis. 349 (10%) participants with HIV-1 initiated ART during the study, at a median CD4 cell count of 198 (IQR 161-265) cells per mu L. Only one of 103 genetically-linked HIV-1 transmissions was from an infected participant who had started ART, corresponding to transmission rates of 0.37 (95% CI 0.09-2.04) per 100 person-years in those who had initiated treatment and 2.24 (1.84-2.72) per 100 person-years in those who had not-a 92% reduction (adjusted incidence rate ratio 0.08,95% CI 0.00-0.57, p=0.004). In participants not on ART, the highest HIV-1 transmission rate (8.79 per 100 person-years) was from those with CD4 cell counts lower than 200 cells per pL. In couples in whom the untreated HIV-1 infected partner had a CD4 cell count greater than 200 cells per pL, 66 (70%) of 94 transmissions occurred when plasma HIV-1 concentrations exceeded 50 000 copies per mL. Interpretation Low CD4 cell counts and high plasma HIV-1 concentrations might guide use of ART to achieve an HIV-1 prevention benefit. Provision of ART to HIV-1 infected patients could be an effective strategy to achieve population-level reductions in HIV-1 transmission.	[Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [Donnell, Deborah; Baeten, Jared M.; Kiarie, James; Thomas, Katherine K.; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baeten, Jared M.; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Natl Hlth Lab Serv, Johannesburg, South Africa; [McIntyre, James] Anova Hlth Inst, Johannesburg, South Africa; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; National Health Laboratory Service; University of Witwatersrand; University of California System; University of California San Francisco	Donnell, D (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1100 Fairview Ave N, Seattle, WA 98109 USA.	deborah@fhcrc.org	Lingappa, Jairam/N-7760-2017; McIntyre, James/V-7115-2019	Were, Edwin/0000-0002-4783-0795; Thomas, Katherine K/0000-0002-7024-468X; Donnell, Deborah/0000-0002-0587-7480; Kapiga, Saidi/0000-0003-1753-4060; kiarie, james/0000-0003-4180-7858	Bill & Melinda Gates Foundation; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757, R01AI083034, U01AI038858] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding Bill & Melinda Gates Foundation; US National Institutes of Health.	[Anonymous], [No title captured]; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Eisele TP, 2009, AIDS BEHAV, V13, P1097, DOI 10.1007/s10461-008-9473-2; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Luchters S, 2008, AIDS PATIENT CARE ST, V22, P587, DOI 10.1089/apc.2007.0247; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Mofenson LM, 1999, JAMA-J AM MED ASSOC, V282, P577, DOI 10.1001/jama.282.6.577; Munderi P, 2010, CURR OPIN HIV AIDS, V5, P6, DOI 10.1097/COH.0b013e32833384d3; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Stevens WS, 2010, J INFECT DIS, V201, pS16, DOI 10.1086/650392; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wood E, 2007, LANCET, V370, P8, DOI 10.1016/S0140-6736(07)61025-3; World Health Organization, 2009, RAP ADV ANT THER HIV	28	688	716	3	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2092	2098		10.1016/S0140-6736(10)60705-2	http://dx.doi.org/10.1016/S0140-6736(10)60705-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20537376	Green Accepted			2022-12-28	WOS:000279069300021
J	Shanbhag, NM; Rafalska-Metcalf, IU; Balane-Bolivar, C; Janicki, SM; Greenberg, RA				Shanbhag, Niraj M.; Rafalska-Metcalf, Ilona U.; Balane-Bolivar, Carlo; Janicki, Susan M.; Greenberg, Roger A.			ATM-Dependent Chromatin Changes Silence Transcription In cis to DNA Double-Strand Breaks	CELL			English	Article							RNA-POLYMERASE-II; ATAXIA-TELANGIECTASIA; GENE-EXPRESSION; DAMAGE RESPONSE; REPAIR; UBIQUITINATION; PHOSPHORYLATION; IDENTIFICATION; UBIQUITYLATION; CHECKPOINT	DNA double-strand breaks (DSBs) initiate extensive local and global alterations in chromatin structure, many of which depend on the ATM kinase. Histone H2A ubiquitylation (uH2A) on chromatin surrounding DSBs is one example, thought to be important for recruitment of repair proteins. uH2A is also implicated in transcriptional repression; an intriguing yet untested hypothesis is that this function is conserved in the context of DSBs. Using a novel reporter that allows for visualization of repair protein recruitment and local transcription in single cells, we describe an ATM-dependent transcriptional silencing program in cis to DSBs. ATM prevents RNA polymerase II elongation-dependent chromatin decondensation at regions distal to DSBs. Silencing is partially dependent on E3 ubiquitin ligases RNF8 and RNF168, whereas reversal of silencing relies on the uH2A deubiquitylating enzyme USP16. These findings give insight into the role of posttranslational modifications in mediating crosstalk between diverse processes occurring on chromatin.	[Shanbhag, Niraj M.; Balane-Bolivar, Carlo; Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA; [Rafalska-Metcalf, Ilona U.; Janicki, Susan M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			NCI [1R01CA138835-01, 1K08CA106597-01, 3K08CA106597-04S1]; ACS; Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; Penn Genome Frontiers Institute;  [1-T32-CA-115299-01A2]; NATIONAL CANCER INSTITUTE [K08CA106597, R01CA138835, T32CA115299] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; Penn Genome Frontiers Institute; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Genentech for providing linkage-specific antibodies; E. Brown, B. Johnson, G. Blobel, M. Lampson, and members of the Greenberg lab for critical discussion. R.A.G. gratefully acknowledges funding from the following: 1R01CA138835-01 from the NCI, an ACS Research Scholar Grant, K08 awards 1K08CA106597-01 and 3K08CA106597-04S1 from the NCI, the Sidney Kimmel Foundation Scholar Award, and funds from the Abramson Family Cancer Research Institute and from the Penn Genome Frontiers Institute. N.M.S. was supported by training grant 1-T32-CA-115299-01A2.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WAUGH DS, 1993, P NATL ACAD SCI USA, V90, P9596, DOI 10.1073/pnas.90.20.9596; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	46	500	510	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					970	981		10.1016/j.cell.2010.04.038	http://dx.doi.org/10.1016/j.cell.2010.04.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550933	Green Accepted, Bronze			2022-12-28	WOS:000278618800012
J	Wood, BJ; Halliday, AN				Wood, Bernard J.; Halliday, Alex N.			The lead isotopic age of the Earth can be explained by core formation alone	NATURE			English	Article							OXIDATION-STATE; GIANT IMPACT; MOON; PB; CONSTRAINTS; DRIVEN; ORIGIN; CR	The meaning of the age of the Earth defined by lead isotopes has long been unclear. Recently it has been proposed(1) that the age of the Earth deduced from lead isotopes reflects volatile loss to space at the time of the Moon-forming giant impact rather than partitioning into metallic liquids during protracted core formation. Here we show that lead partitioning into liquid iron depends strongly on carbon content and that, given a content of similar to 0.2% carbon(2,3), experimental and isotopic data both provide evidence of strong partitioning of lead into the core throughout the Earth's accretion. Earlier conclusions that lead is weakly partitioned into iron arose from the use of carbon-saturated (about 5% C) iron alloys. The lead isotopic age of the Earth is therefore consistent with partitioning into the core and with no significant late losses of moderately volatile elements to space during the giant impact.	[Wood, Bernard J.; Halliday, Alex N.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Wood, Bernard J.] Macquarie Univ, Dept Earth & Planetary Sci, N Ryde, NSW 2109, Australia	University of Oxford; Macquarie University	Wood, BJ (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	berniew@earth.ox.ac.uk	GAU, geochemist/H-1985-2016; Wood, Bernard J/E-8173-2010	Wood, Bernard J/0000-0003-1038-7301	Australian Research Council [FF 0456999]; NERC (UK) [NE/F018266/1]; STFC; EU [505320]; NERC [NE/F018266/1] Funding Source: UKRI; STFC [ST/F001940/1, ST/G00272X/1, PP/D001250/1] Funding Source: UKRI; Natural Environment Research Council [NE/F018266/1] Funding Source: researchfish; Science and Technology Facilities Council [PP/D001250/1, ST/F001940/1, ST/G00272X/1] Funding Source: researchfish	Australian Research Council(Australian Research Council); NERC (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The assistance of N. Pearson (Macquarie), N. Charnley (Oxford) and J. Day (Cambridge) with microprobe and laser ICP-MS analysis is acknowledged with thanks. B. J. W. acknowledges the support of the Australian Research Council through Federation Fellowship FF 0456999 and the NERC (UK) through grant NE/F018266/1. A. N. H. acknowledges support from STFC. Experiments at the Bayerisches Geoinstitut were performed under the EU 'Research Infrastructures: Transnational Access' Programme (contract number 505320; RITA-High Pressure).	ALLEGRE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1445, DOI 10.1016/0016-7037(95)00054-4; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; Barin I, 1989, THERMOCHEMICAL DATA, DOI DOI 10.1002/ANGE.19901020738; Barin I., 1989, THERMOCHEMICAL DAT 2; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Chabot NL, 2009, METEORIT PLANET SCI, V44, P505, DOI 10.1111/j.1945-5100.2009.tb00747.x; Dasgupta R, 2008, GEOCHIM COSMOCHIM AC, V72, P4627, DOI 10.1016/j.gca.2008.06.023; Dreibus G, 1996, GEOCHIM COSMOCHIM AC, V60, P1125, DOI 10.1016/0016-7037(96)00028-2; Galer S. J. G., 1996, ISOTOPIC STUDIES CRU, P75; Halliday AN, 2008, PHILOS T R SOC A, V366, P4163, DOI 10.1098/rsta.2008.0209; Halliday AN, 2004, NATURE, V427, P505, DOI 10.1038/nature02275; KLEINE T, GEOCHIM COS IN PRESS; Lagos M, 2008, NATURE, V456, P89, DOI 10.1038/nature07375; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Malavergne V, 2007, GEOCHIM COSMOCHIM AC, V71, P2637, DOI 10.1016/j.gca.2007.03.011; Malhotra S, 1998, ISIJ INT, V38, P1, DOI 10.2355/isijinternational.38.1; MCDONOUGH WF, 1992, GEOCHIM COSMOCHIM AC, V56, P1001, DOI 10.1016/0016-7037(92)90043-I; Norman MD, 2003, METEORIT PLANET SCI, V38, P645, DOI 10.1111/j.1945-5100.2003.tb00031.x; Norman MD, 1996, GEOSTANDARD NEWSLETT, V20, P247, DOI 10.1111/j.1751-908X.1996.tb00186.x; NYQUIST LE, 2004, LUNAR PLANET SCI C, V34, P1388; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Pepin RO, 1997, ICARUS, V126, P148, DOI 10.1006/icar.1996.5639; Pepin RO, 2006, EARTH PLANET SC LETT, V250, P470, DOI 10.1016/j.epsl.2006.08.014; The Japan Society for the Promotion of Science and The Nineteenth Committee on Steelmaking Part 2, 1988, STEELMAKING DATA SOU, P273; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Van Actherbergh E., 2001, LASER ABLATION ICP M, P239, DOI DOI 10.1016/S0277-3791(02)00016-1; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; WASSERBURG GJ, 1977, PHILOS T R SOC A, V285, P7, DOI 10.1098/rsta.1977.0039; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wood BJ, 2008, EARTH PLANET SC LETT, V269, P325, DOI 10.1016/j.epsl.2008.01.027; Wood BJ, 2008, GEOCHIM COSMOCHIM AC, V72, P1415, DOI 10.1016/j.gca.2007.11.036; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z	36	72	76	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					767	U4		10.1038/nature09072	http://dx.doi.org/10.1038/nature09072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535208				2022-12-28	WOS:000278551800042
J	Arwady, MA				Arwady, M. Allison			Collaterals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												allison.arwady@yale.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2229	2230		10.1001/jama.2010.762	http://dx.doi.org/10.1001/jama.2010.762			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530767				2022-12-28	WOS:000278496800001
J	Bonneux, L; Van Damme, W				Bonneux, Luc; Van Damme, Wim			Personal View Preventing iatrogenic pandemics of panic. Do it in a NICE way	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA; EPIDEMICS; VIRUS		[Bonneux, Luc] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); Institute of Tropical Medicine (ITM)	Bonneux, L (corresponding author), Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands.	bonneux@nidi.nl	Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007				Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Bonneux L, 2006, BMJ-BRIT MED J, V332, P786, DOI 10.1136/bmj.332.7544.786; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Institute of Medicine, 2009, CONFL INT MED RES ED; Kickbusch I, 2008, HEALTH PROMOT INT, V23, P1, DOI 10.1093/heapro/dan006; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Van Damme W, 2000, TROP MED INT HEALTH, V5, P511; Watson R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c641	10	6	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2010	340								c3065	10.1136/bmj.c3065	http://dx.doi.org/10.1136/bmj.c3065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534667				2022-12-28	WOS:000278818500019
J	Peters, J; Dieppa-Perea, LM; Melendez, LM; Quirk, GJ				Peters, Jamie; Dieppa-Perea, Laura M.; Melendez, Loyda M.; Quirk, Gregory J.			Induction of Fear Extinction with Hippocampal-Infralimbic BDNF	SCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; MEMORY; CONSOLIDATION; AMYGDALA; NEURONS; MECHANISMS; EXPRESSION	The extinction of conditioned fear memories requires plasticity in the infralimbic medial prefrontal cortex (IL mPFC), but little is known about the molecular mechanisms involved. Brain-derived neurotrophic factor (BDNF) is a key mediator of synaptic plasticity in multiple brain areas. In rats subjected to auditory fear conditioning, BDNF infused into the IL mPFC reduced conditioned fear for up to 48 hours, even in the absence of extinction training, which suggests that BDNF substituted for extinction. Similar to extinction, BDNF-induced reduction in fear required N-methyl-D-aspartate receptors and did not erase the original fear memory. Rats failing to learn extinction showed reduced BDNF in hippocampal inputs to the IL mPFC, and augmenting BDNF in this pathway prevented extinction failure. Hence, boosting BDNF activity in hippocampal-infralimbic circuits may ameliorate disorders of learned fear.	[Peters, Jamie; Dieppa-Perea, Laura M.; Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA; [Peters, Jamie; Dieppa-Perea, Laura M.; Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Melendez, Loyda M.] Univ Puerto Rico, Sch Med, Dept Microbiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Quirk, GJ (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA.	gjquirk@yahoo.com	Peters, Jamie/B-4288-2013		NIH [MH058883, MH081975, NS043011, MH083516, MH085383, RR003051]; University of Puerto Rico; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058883, R01MH083516, R01MH081975, R37MH058883, F32MH085383, R29MH058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS043011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank V. Garcia, D. Merced, N. Padilla, C. Rodriguez, J. Rodriguez-Romaguera, D. Sierra-Mercado, and A. Torrado for technical assistance and D. Pare and J. F. McGinty for helpful comments. Supported by NIH grants MH058883, MH081975, NS043011, MH083516, MH085383, and RR003051 and by the University of Puerto Rico.	Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; FALLS WA, 1992, J NEUROSCI, V12, P854; Garcia R, 2008, NEUROBIOL LEARN MEM, V89, P560, DOI 10.1016/j.nlm.2007.10.005; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Sotres-Bayon F, 2009, CEREB CORTEX, V19, P474, DOI 10.1093/cercor/bhn099	27	345	359	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1288	1290		10.1126/science.1186909	http://dx.doi.org/10.1126/science.1186909			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522777	Green Accepted			2022-12-28	WOS:000278318600038
J	Bohlen, CJ; Priel, A; Zhou, S; King, D; Siemens, J; Julius, D				Bohlen, Christopher J.; Priel, Avi; Zhou, Sharleen; King, David; Siemens, Jan; Julius, David			A Bivalent Tarantula Toxin Activates the Capsaicin Receptor, TRPV1, by Targeting the Outer Pore Domain	CELL			English	Article							GATING MODIFIER TOXINS; SPIDER SELENOCOSMIA-HUWENA; DEPENDENT K+ CHANNELS; VOLTAGE-SENSOR; POTASSIUM CHANNEL; ION-CHANNEL; MOLECULAR DETERMINANTS; SODIUM-CHANNELS; PEPTIDE TOXINS; SENSITIVITY	Toxins have evolved to target regions of membrane ion channels that underlie ligand binding, gating, or ion permeation, and have thus served as invaluable tools for probing channel structure and function. Here, we describe a peptide toxin from the Earth Tiger tarantula that selectively and irreversibly activates the capsaicin- and heat-sensitive channel, TRPV1. This high-avidity interaction derives from a unique tandem repeat structure of the toxin that endows it with an antibody-like bivalency. The "double-knot" toxin traps TRPV1 in the open state by interacting with residues in the presumptive pore-forming region of the channel, highlighting the importance of conformational changes in the outer pore region of TRP channels during activation.	[Bohlen, Christopher J.; Priel, Avi; Siemens, Jan; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Zhou, Sharleen; King, David] Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Siemens, J (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	jan.siemens@mdc-berlin.de; julius@cmp.ucsf.edu	Priel, Avi/ABB-1721-2020	Priel, Avi/0000-0002-6105-5035; Siemens, Jan/0000-0001-9051-9217	National Institutes of Health (NIH) National Center for Research Resources; NIH/National Institute of Neurological Disorders and Stroke (NINDS); Damon Runyon Cancer Research Foundation; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047723, R01NS065071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Damon Runyon Cancer Research Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ben Myers for cloning the frog TRPV1 cDNA and making it available for this study, and Roger Nicoll, Alex Chesler, Julio Cordero, Erhu Cao, and other members of our lab for helpful criticism and reading of the manuscript. We also thank the University of California, San Francisco, Mass Spectrometry Resource for instrumentation and technical assistance, supported by the National Institutes of Health (NIH) National Center for Research Resources. This work was supported by a NIH/National Institute of Neurological Disorders and Stroke (NINDS) Ruth Kirschstein predoctoral fellowship (C.B.), postdoctoral fellowships from the Damon Runyon Cancer Research Foundation (A.P.) and the International Human Frontier Science Program Organization (J.S.), and grants from the NIH/NINDS (D.J.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Roy A, 2010, J BIOL CHEM, V285, P8302, DOI 10.1074/jbc.M109.074161; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d	49	228	245	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					834	845		10.1016/j.cell.2010.03.052	http://dx.doi.org/10.1016/j.cell.2010.03.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510930	Green Accepted, Bronze			2022-12-28	WOS:000278132900018
J	Hsu, NY; Ilnytska, O; Belov, G; Santiana, M; Chen, YH; Takvorian, PM; Pau, C; van der Schaar, H; Kaushik-Basu, N; Balla, T; Cameron, CE; Ehrenfeld, E; van Kuppeveld, FJM; Altan-Bonnet, N				Hsu, Nai-Yun; Ilnytska, Olha; Belov, Georgiy; Santiana, Marianita; Chen, Ying-Han; Takvorian, Peter M.; Pau, Cyrilla; van der Schaar, Hilde; Kaushik-Basu, Neerja; Balla, Tamas; Cameron, Craig E.; Ehrenfeld, Ellie; van Kuppeveld, Frank J. M.; Altan-Bonnet, Nihal			Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication	CELL			English	Article							HEPATITIS-C VIRUS; ENDOPLASMIC-RETICULUM; EXCHANGE FACTOR; COP-I; PROTEIN; TRANSPORT; DYNAMICS; BETA; ARF; TRAFFICKING	Many RNA viruses remodel intracellular membranes to generate specialized sites for RNA replication. How membranes are remodeled and what properties make them conducive for replication are unknown. Here we show how RNA viruses can manipulate multiple components of the cellular secretory pathway to generate organelles specialized for replication that are distinct in protein and lipid composition from the host cell. Specific viral proteins modulate effector recruitment by Arf1 GTPase and its guanine nucleotide exchange factor GBF1, promoting preferential recruitment of phosphatidylinositol-4-kinase IIIb (PI4KIIIb) to membranes over coat proteins, yielding uncoated phosphatidylinositol-4-phosphate (PI4P) lipid-enriched organelles. The PI4P-rich lipid micro-environment is essential for both enteroviral and flaviviral RNA replication; PI4KIIIb inhibition interferes with this process; and enteroviral RNA polymerases specifically bind PI4P. These findings reveal how RNA viruses can selectively exploit specific elements of the host to form specialized organelles where cellular phosphoinositide lipids are key to regulating viral RNA replication.	[Hsu, Nai-Yun; Ilnytska, Olha; Santiana, Marianita; Chen, Ying-Han; Takvorian, Peter M.; Pau, Cyrilla; Altan-Bonnet, Nihal] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Belov, Georgiy; Ehrenfeld, Ellie] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [van der Schaar, Hilde; van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Kaushik-Basu, Neerja] Univ Med & Dent Newark, Dept Biochem & Mol Biol, Newark, NJ 07101 USA; [Balla, Tamas] NICHD, Sect Mol Signal Transduct, NIH, Bethesda, MD 20892 USA; [Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16803 USA	Rutgers State University Newark; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Radboud University Nijmegen; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Altan-Bonnet, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA.	nabonnet@andromeda.rutgers.edu	Belov, George/B-4625-2008	Belov, George/0000-0002-0892-1731; Ilnytska, Olga/0000-0003-0807-9158; Balla, Tamas/0000-0002-9077-3335; van Kuppeveld, Frank/0000-0001-5800-749X	NIH (NIAID) [AI053531]; NIH(NICHD); Netherlands Organisation for Scientific Research [NWO-VIDI-917.46.306, NWO-ECHO-700.57.001]; NIDDK, NIH [DK06687]; National Science Foundation [MCB0822058]; Busch Foundation [649117]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000816, R01AI053531] Funding Source: NIH RePORTER	NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); Busch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Lippincott-Schwartz, S. M. Simon, K. Hirschberg, T. Ward, R. Hegde, R. Collins, J. Arnold, and G. Altan-Bonnet for insightful discussions. E.E. and G.B. were supported by the Intramural Research Program of the NIH (NIAID); T.B. was supported by the Intramural Research Program of the NIH(NICHD); C.E.C. was supported by grant AI053531 (NIAID, NIH); F.J.M.v.K. was supported by Netherlands Organisation for Scientific Research (NWO-VIDI-917.46.306, NWO-ECHO-700.57.001); N.K.B. was supported by grant DK06687 (NIDDK, NIH); and N.A.-B. was supported with grant MCB0822058 from the National Science Foundation and grant 649117 from the Busch Foundation.	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; BARTON DJ, 1993, J VIROL, V67, P822, DOI 10.1128/JVI.67.2.822-831.1993; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Fogg MH, 2003, J VIROL, V77, P11408, DOI 10.1128/JVI.77.21.11408-11416.2003; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ishiyama N, 2002, CHEM PHYS LIPIDS, V114, P103, DOI 10.1016/S0009-3084(02)00002-6; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Magliano D, 1998, VIROLOGY, V240, P57, DOI 10.1006/viro.1997.8906; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; RICHARDS OC, 1990, CURR TOP MICROBIOL, V161, P89; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142	51	492	503	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					799	811		10.1016/j.cell.2010.03.050	http://dx.doi.org/10.1016/j.cell.2010.03.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510927	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000278132900015
J	Ammann, MW; Brodholt, JP; Wookey, J; Dobson, DP				Ammann, M. W.; Brodholt, J. P.; Wookey, J.; Dobson, D. P.			First-principles constraints on diffusion in lower-mantle minerals and a weak D '' layer	NATURE			English	Article							POST-PEROVSKITE PHASE; FE-MG INTERDIFFUSION; MGSIO3 PEROVSKITE; SEISMIC ANISOTROPY; SELF-DIFFUSION; PRESSURE; SILICON; BENEATH; OXYGEN	Post-perovskite MgSiO3 is believed to be present in the D '' region of the Earth's lower most mantle(1-4). Its existence has been used to explain a number of seismic observations, such as the D '' reflector and the high degree of seismic anisotropy within the D '' layer(5-8). Ionic diffusion in post-perovskite controls its viscosity, which in turn controls the thermal and chemical coupling between the core and the mantle, the development of plumes and the stability of deep chemical reservoirs(9). Here we report the use of first-principles methods to calculate absolute diffusion rates in post-perovskite under the conditions found in the Earth's lower mantle. We find that the diffusion of Mg2+ and Si4+ in post-perovskite is extremely anisotropic, with almost eight orders of magnitude difference between the fast and slow directions. If post-perovskite in the D '' layer shows significant lattice-preferred orientation, the fast diffusion direction will render post-perovskite up to four orders of magnitude weaker than perovskite. The presence of weak postperovskite strongly increases the heat flux across the core-mantle boundary and alters the geotherm(9). It also provides an explanation for laterally varying viscosity in the lowermost mantle, as required by long-period geoid models(10). Moreover, the behaviour of very weak post-perovskite can reconcile seismic observation of a D '' reflector with recent experiments showing that the width of the perovskite-to-post-perovskite transition is too wide to cause sharp reflectors(11). We suggest that the observed sharp D '' reflector is caused by a rapid change in seismic anisotropy. Once sufficient perovskite has transformed into post-perovskite, post-perovskite becomes interconnected and strain is partitioned into this weaker phase. At this point, the weaker post-perovskite will start to deform rapidly, thereby developing a strong crystallographic texture. We show that the expected seismic contrast between the deformed perovskite-plus-post-perovskite assemblage and the overlying isotropic perovskite-plus-post-perovskite assemblage is consistent with seismic observations.	[Ammann, M. W.; Brodholt, J. P.; Dobson, D. P.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Wookey, J.] Univ Bristol, Dept Earth Sci, Bristol BS6 6LL, Avon, England	University of London; University College London; University of Bristol	Ammann, MW (corresponding author), UCL, Dept Earth Sci, Gower St, London WC1E 6BT, England.	m.ammann@ucl.ac.uk; j.brodholt@ucl.ac.uk	Brodholt, John P/B-7136-2011; Wookey, James/G-6113-2011	Brodholt, John P/0000-0001-7395-5834; Wookey, James/0000-0002-7403-4380; Dobson, David/0000-0002-0890-0121	European Commission [MRTN-CT-2006-035957]; Office of Science and Technology; NERC [hpc010001] Funding Source: UKRI; Natural Environment Research Council [hpc010001] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Office of Science and Technology; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank D. Prior and J. Wheeler for discussions. This work was funded by the European Commission through the Marie Curie Research Training Network c2c (Crust to Core) contract no. MRTN-CT-2006-035957. The authors acknowledge the use of University College London's Research Computing facility Legion and the use of HECToR, the UK national high-performance computing service, which is provided by UoE HPCx Ltd at the University of Edinburgh, Cray Inc. and NAG Ltd, and funded by the Office of Science and Technology through the Engineering and Physical Research Council's High-End Computing Programme.	Ammann MW, 2009, PHYS CHEM MINER, V36, P151, DOI 10.1007/s00269-008-0265-z; Ammann MW, 2010, REV MINERAL GEOCHEM, V71, P201, DOI 10.2138/rmg.2010.71.10; Cadek O, 2006, STUD GEOPHYS GEOD, V50, P217, DOI 10.1007/s11200-006-0013-0; Catalli K, 2009, NATURE, V462, P782, DOI 10.1038/nature08598; Cizkova H., PHYS EARTH IN PRESS; Dobson D, 2003, PHYS EARTH PLANET IN, V139, P55, DOI 10.1016/S0031-9201(03)00144-4; Dobson DP, 2008, EARTH PLANET SC LETT, V270, P125, DOI 10.1016/j.epsl.2008.03.029; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Holzapfel C, 2005, SCIENCE, V309, P1707, DOI 10.1126/science.1111895; Holzapfel C, 2003, PHYS EARTH PLANET IN, V139, P21, DOI 10.1016/S0031-9201(03)00142-0; Hunt SA, 2009, NAT GEOSCI, V2, P794, DOI 10.1038/NGEO663; Hutko AR, 2008, SCIENCE, V320, P1070, DOI 10.1126/science.1155822; Hutko AR, 2006, NATURE, V441, P333, DOI 10.1038/nature04757; KARATO S, 1995, SCIENCE, V270, P458, DOI 10.1126/science.270.5235.458; Karki BB, 2007, EARTH PLANET SC LETT, V260, P201, DOI 10.1016/j.epsl.2007.05.031; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; Mitrovica JX, 2004, EARTH PLANET SC LETT, V225, P177, DOI 10.1016/j.epsl.2004.06.005; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Oganov AR, 2001, NATURE, V411, P934, DOI 10.1038/35082048; Solomatov VS, 2002, PHYS EARTH PLANET IN, V129, P265, DOI 10.1016/S0031-9201(01)00295-3; Stacey FD, 2004, PHYS EARTH PLANET IN, V142, P137, DOI 10.1016/j.pepi.2004.02.003; Stackhouse S, 2005, EARTH PLANET SC LETT, V230, P1, DOI 10.1016/j.epsl.2004.11.021; Stackhouse S, 2007, GEOPHYS MONOGR SER, V174, P99, DOI 10.1029/174GM09; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; Van Orman JA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016343; Wentzcovitch RM, 2006, P NATL ACAD SCI USA, V103, P543, DOI 10.1073/pnas.0506879103; Wentzcovitch RM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.018501; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345; Wookey J, 2005, GEOPHYS J INT, V161, P829, DOI 10.1111/j.1365-246X.2005.02623.x; Yamazaki D, 2000, PHYS EARTH PLANET IN, V119, P299, DOI 10.1016/S0031-9201(00)00135-7; Yamazaki D, 2003, EARTH PLANET SC LETT, V216, P301, DOI 10.1016/S0012-821X(03)00534-X	32	173	177	12	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					462	465		10.1038/nature09052	http://dx.doi.org/10.1038/nature09052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505725				2022-12-28	WOS:000278043700031
J	Holt, JW; Fishbaugh, KE; Byrne, S; Christian, S; Tanaka, K; Russell, PS; Herkenhoff, KE; Safaeinili, A; Putzig, NE; Phillips, RJ				Holt, J. W.; Fishbaugh, K. E.; Byrne, S.; Christian, S.; Tanaka, K.; Russell, P. S.; Herkenhoff, K. E.; Safaeinili, A.; Putzig, N. E.; Phillips, R. J.			The construction of Chasma Boreale on Mars	NATURE			English	Article							NORTH POLAR-REGION; LAYERED DEPOSITS; GEOLOGIC HISTORY; STRATIGRAPHY; ORIGIN	The polar layered deposits of Mars contain the planet's largest known reservoir of water ice(1,2) and the prospect of revealing a detailed Martian palaeoclimate record(3,4), but the mechanisms responsible for the formation of the dominant features of the north polar layered deposits (NPLD) are unclear, despite decades of debate. Stratigraphic analyses of the exposed portions of Chasma Boreale-a large canyon 500 km long, up to 100 km wide, and nearly 2 km deep-have led most researchers to favour an erosional process for its formation following initial NPLD accumulation. Candidate mechanisms include the catastrophic outburst of water(5), protracted basal melting(6), erosional undercutting(7), aeolian downcutting(7-9) and a combination of these processes(10). Here we use new data from the Mars Reconnaissance Orbiter to show that Chasma Boreale is instead a long-lived, complex feature resulting primarily from non-uniform accumulation of the NPLD. The initial valley that later became Chasma Boreale was matched by a second, equally large valley that was completely filled in by subsequent deposition, leaving no evidence on the surface to indicate its former presence. We further demonstrate that topography existing before the NPLD began accumulating influenced successive episodes of deposition and erosion, resulting in most of the present-day topography. Long-term and large-scale patterns of mass balance achieved through sedimentary processes, rather than catastrophic events, ice flow or highly focused erosion, have produced the largest geomorphic anomaly in the north polar ice of Mars.	[Holt, J. W.; Christian, S.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Fishbaugh, K. E.] Smithsonian Natl Air & Space Museum, Washington, DC 20560 USA; [Byrne, S.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Christian, S.] Bryn Mawr Coll, Bryn Mawr, PA 19010 USA; [Tanaka, K.; Herkenhoff, K. E.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Russell, P. S.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Safaeinili, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Putzig, N. E.; Phillips, R. J.] SW Res Inst, Boulder, CO 80302 USA	University of Texas System; University of Texas Austin; Smithsonian Institution; University of Arizona; Bryn Mawr College; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Holt, JW (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	jack@ig.utexas.edu	Holt, John/C-4896-2009; Byrne, Shane/B-8104-2012	Putzig, Nathaniel/0000-0003-4485-6321	Institute for Geophysics of the Jackson School of Geosciences; NASA [NAG5-12693]; Mars Reconnaissance Orbiter (MRO); Italian Space Agency	Institute for Geophysics of the Jackson School of Geosciences; NASA(National Aeronautics & Space Administration (NASA)); Mars Reconnaissance Orbiter (MRO); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	We thank P. Choudhary for assistance with radar data analysis. Work at the University of Texas was supported by the Institute for Geophysics of the Jackson School of Geosciences, a NASA grant (NAG5-12693) to J.W.H. and a Mars Reconnaissance Orbiter (MRO) Participating Scientist grant to J.W.H. MRO is operated for NASA by Caltech's Jet Propulsion Laboratory. SHARAD was provided to MRO by the Italian Space Agency through a contract with Thales Alenia Space Italia, and is operated by the INFOCOM Department, University of Rome. We thank the SHARAD Operations Center in Rome for their critical support. We honour the memory of our co-author and colleague A. S. This is UTIG contribution number 2186.	Byrne S, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001615; Byrne S, 2009, ANNU REV EARTH PL SC, V37, P535, DOI 10.1146/annurev.earth.031208.100101; CLIFFORD SM, 1987, J GEOPHYS RES-SOLID, V92, P9135, DOI 10.1029/JB092iB09p09135; Clifford SM, 2000, ICARUS, V144, P210, DOI 10.1006/icar.1999.6290; CLIFFORD SM, 1980, B AM ASTRON SOC, V12, P678; Edgett KS, 2003, GEOMORPHOLOGY, V52, P289, DOI 10.1016/S0169-555X(02)00262-3; Fishbaugh KE, 2005, ICARUS, V174, P444, DOI 10.1016/j.icarus.2004.06.021; Fishbaugh KE, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001351; Greve R, 2008, ICARUS, V196, P359, DOI 10.1016/j.icarus.2007.10.020; Grima C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036326; Herkenhoff KE, 2007, SCIENCE, V317, P1711, DOI 10.1126/science.1143544; Howard AD, 2000, ICARUS, V144, P267, DOI 10.1006/icar.1999.6305; Kolb E.J., 2006, INT J MARS SCI EXPLO, V2, P1, DOI [10.1038/s41598-021-83329-3, 10.1555/mars.2006.0001, DOI 10.1555/MARS.2006.0001]; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Milkovich SM, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003162; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Putzig NE, 2009, ICARUS, V204, P443, DOI 10.1016/j.icarus.2009.07.034; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Tanaka KL, 2008, ICARUS, V196, P318, DOI 10.1016/j.icarus.2008.01.021; Tanaka KL, 2005, NATURE, V437, P991, DOI 10.1038/nature04065; TANAKA KL, 1987, USGS MISC MAP SERIES; Warner NH, 2008, ICARUS, V196, P368, DOI 10.1016/j.icarus.2007.08.043	26	42	42	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					446	449		10.1038/nature09050	http://dx.doi.org/10.1038/nature09050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505721				2022-12-28	WOS:000278043700027
J	Feldmann, H				Feldmann, Heinz			Are we any closer to combating Ebola infections?	LANCET			English	Editorial Material							POSTEXPOSURE TREATMENT; VIRUS; FEVER		[Feldmann, Heinz] NIAID, Rocky Mt Labs, Hamilton, MT 59840 USA; [Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Feldmann, Heinz] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Manitoba	Feldmann, H (corresponding author), NIAID, Rocky Mt Labs, Hamilton, MT 59840 USA.	feldmannh@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; Bray M, 2002, ANTIVIR RES, V54, P1, DOI 10.1016/S0166-3542(02)00005-0; Enterlein S, 2006, ANTIMICROB AGENTS CH, V50, P984, DOI 10.1128/AAC.50.3.984-993.2006; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Feldmann Heinz, 2005, Curr Opin Investig Drugs, V6, P823; Geisbert TW, 2006, J INFECT DIS, V193, P1650, DOI 10.1086/504267; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Tuffs A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1223; Warfield Kelly L., 2006, PLoS Pathogens, V2, P5	14	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1850	1852		10.1016/S0140-6736(10)60597-1	http://dx.doi.org/10.1016/S0140-6736(10)60597-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609BC	20511001	Green Accepted			2022-12-28	WOS:000278628800006
J	Martin, DF; Maguire, MG; Fine, SL				Martin, Daniel F.; Maguire, Maureen G.; Fine, Stuart L.			Identifying and Eliminating the Roadblocks to Comparative-Effectiveness Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MACULAR DEGENERATION; RANIBIZUMAB		[Martin, Daniel F.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Maguire, Maureen G.; Fine, Stuart L.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; University of Pennsylvania	Martin, DF (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.							Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481	4	29	29	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					105	107		10.1056/NEJMp1001201	http://dx.doi.org/10.1056/NEJMp1001201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20519677				2022-12-28	WOS:000279574100003
J	Wang, ZX; Song, JK; Milne, TA; Wang, GG; Li, HT; Allis, CD; Patel, DJ				Wang, Zhanxin; Song, Jikui; Milne, Thomas A.; Wang, Gang G.; Li, Haitao; Allis, C. David; Patel, Dinshaw J.			Pro Isomerization in MLL1 PHD3-Bromo Cassette Connects H3K4me Readout to CyP33 and HDAC-Mediated Repression	CELL			English	Article							HISTONE MODIFICATIONS; PHD FINGERS; PROLINE ISOMERIZATION; CIS/TRANS ISOMERASES; BINDING MODULES; PROTEIN; METHYLTRANSFERASE; RECOGNITION; BROMODOMAIN; LEUKEMIA	The MLL1 gene is a frequent target for recurrent chromosomal translocations, resulting in transformation of hematopoietic precursors into leukemia stem cells. Here, we report on structure-function studies that elucidate molecular events in MLL1 binding of histone H3K4me3/2 marks and recruitment of the cyclophilin CyP33. CyP33 contains a PPIase and a RRM domain and regulates MLL1 function through HDAC recruitment. We find that the PPIase domain of CyP33 regulates the conformation of MLL1 through proline isomerization within the PHD3-Bromo linker, thereby disrupting the PHD3-Bromo interface and facilitating binding of the MLL1-PHD3 domain to the CyP33-RRM domain. H3K4me3/2 and CyP33-RRM target different surfaces of MLL1-PHD3 and can bind simultaneously to form a ternary complex. Furthermore, the MLL1-CyP33 interaction is required for repression of HOXA9 and HOXC8 genes in vivo. Our results highlight the role of PHD3-Bromo cassette as a regulatory platform, orchestrating MLL1 binding of H3K4me3/2 marks and cyclophilin-mediated repression through HDAC recruitment.	[Wang, Zhanxin; Song, Jikui; Li, Haitao; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Milne, Thomas A.; Wang, Gang G.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org	Milne, Tom/E-1872-2016; Wang, G Greg/L-6666-2014; Li, Haitao/B-2668-2012	Milne, Tom/0000-0002-0413-4271; Wang, G Greg/0000-0002-7210-9940; Li, Haitao/0000-0001-6741-293X	Leukemia and Lymphoma Society [LLS-SCOR 7132-08]; Starr Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, K99CA151683] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Leukemia and Lymphoma Society Program Project grant LLS-SCOR 7132-08 and a Starr Foundation grant, both of them jointly to D.J.P. and C.D.A. D.J.P. is a consultant in GlaxoSmithKline's epigenetic programs.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linggi BE, 2005, J CELL BIOCHEM, V96, P938, DOI 10.1002/jcb.20604; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Milne Thomas A., 2009, V538, P409, DOI 10.1007/978-1-59745-418-6_21; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang T, 2005, BIOCHEM BIOPH RES CO, V333, P845, DOI 10.1016/j.bbrc.2005.06.006; Wang Y, 2008, FEBS LETT, V582, P835, DOI 10.1016/j.febslet.2008.01.055; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	47	137	142	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1183	U151		10.1016/j.cell.2010.05.016	http://dx.doi.org/10.1016/j.cell.2010.05.016			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20541251	Green Accepted, Bronze			2022-12-28	WOS:000279148100015
J	Spence, SJ; Thurm, A				Spence, Sarah J.; Thurm, Audrey			Testing autism interventions: trials and tribulations	LANCET			English	Editorial Material							SPECTRUM DISORDERS; CHILDREN		[Spence, Sarah J.; Thurm, Audrey] NIMH, Pediat & Behav Neurosci Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spence, SJ (corresponding author), NIMH, Pediat & Behav Neurosci Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA.	spences2@mail.nih.gov						Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Green J, 2010, LANCET, V375, P2152, DOI 10.1016/S0140-6736(10)60587-9; Kasari C, 2002, J AUTISM DEV DISORD, V32, P447, DOI 10.1023/A:1020546006971; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lord C, 2005, J AUTISM DEV DISORD, V35, P695, DOI 10.1007/s10803-005-0017-6; Lord C, 1999, AUTISM DIAGNOSTIC OB, DOI DOI 10.1037/T17256-000; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; Spreckley M, 2009, J PEDIATR-US, V154, P338, DOI 10.1016/j.jpeds.2008.09.012; Turner LM, 2007, J CHILD PSYCHOL PSYC, V48, P793, DOI 10.1111/j.1469-7610.2007.01744.x	10	18	21	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2124	2125		10.1016/S0140-6736(10)60757-X	http://dx.doi.org/10.1016/S0140-6736(10)60757-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20494435				2022-12-28	WOS:000279255100005
J	Benowitz, NL				Benowitz, Neal L.			Nicotine Addiction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; BRAIN REWARD SYSTEMS; CIGARETTE-SMOKING; ACETYLCHOLINE-RECEPTOR; LUNG-CANCER; PSYCHIATRIC-DISORDERS; SUSCEPTIBILITY LOCUS; TOBACCO WITHDRAWAL; MONOAMINE-OXIDASE; SEX-DIFFERENCES		[Benowitz, Neal L.] San Francisco Gen Hosp, Med Ctr, Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94110 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Benowitz, NL (corresponding author), Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, Box 1220, San Francisco, CA 94143 USA.	nbenowitz@medsfgh.ucsf.edu			Flight Attendants Medical Research Institute; National Institute on Drug Abuse (U.S. Public Health Service) [DA02277, DA20830]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002277, U01DA020830, R37DA002277] Funding Source: NIH RePORTER	Flight Attendants Medical Research Institute; National Institute on Drug Abuse (U.S. Public Health Service)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)United States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from the Flight Attendants Medical Research Institute and the National Institute on Drug Abuse (U.S. Public Health Service grants DA02277 and DA20830).	Aberger K, 2001, BRAIN RES, V892, P138, DOI 10.1016/S0006-8993(00)03250-9; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1227; Balfour DJK, 2005, NICOTINE TOB RES, V7, P307, DOI 10.1080/14622200500077867; Benowitz NL, 2006, CLIN PHARMACOL THER, V79, P480, DOI 10.1016/j.clpt.2006.01.008; BENOWITZ NL, 1992, MED CLIN N AM, V76, P415, DOI 10.1016/S0025-7125(16)30360-1; BENOWITZ NL, 2001, NIH PUBLICATION, P3964; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P907, DOI 10.1001/archpsyc.63.8.907; Brody AL, 2006, J PSYCHIATR RES, V40, P404, DOI 10.1016/j.jpsychires.2005.04.012; Carpenter CM, 2007, ADDICTION, V102, P136, DOI 10.1111/j.1360-0443.2006.01649.x; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Davis Jennifer A, 2008, Curr Drug Abuse Rev, V1, P9; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Fowler JS, 2003, NEUROTOXICOLOGY, V24, P75, DOI 10.1016/S0161-813X(02)00109-2; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Henningfield JE, 2004, TOB CONTROL, V13, P132, DOI 10.1136/tc.2003.006890; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; Ho MK, 2007, PHARMACOGENOMICS J, V7, P81, DOI 10.1038/sj.tpj.6500436; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Houtsmuller EJ, 2003, PSYCHOPHARMACOLOGY, V167, P20, DOI 10.1007/s00213-002-1361-2; Hughes JR, 2006, NICOTINE TOB RES, V8, P153, DOI 10.1080/14622200500494856; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kalman D, 2005, AM J ADDICTION, V14, P106, DOI 10.1080/10550490590924728; Kandel D, 2005, J PEDIATR PSYCHOL, V30, P319, DOI 10.1093/jpepsy/jsi027; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kenny PJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1203, DOI 10.1038/sj.npp.1300905; Kenny PJ, 2005, J NEUROSCI, V25, P6208, DOI 10.1523/JNEUROSCI.4785-04.2005; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; KNOTT V, 2009, J PSYCHOPHARMAC 1125; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Le Moal M, 2007, EUR NEUROPSYCHOPHARM, V17, P377, DOI 10.1016/j.euroneuro.2006.10.006; Lerman C, 2006, CLIN PHARMACOL THER, V79, P600, DOI 10.1016/j.clpt.2006.02.006; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Lewis A, 2007, NEUROTOXICOLOGY, V28, P182, DOI 10.1016/j.neuro.2006.05.019; Lynch BS, 1994, GROWING TOBACCO FREE, P28; Malaiyandi V, 2005, CLIN PHARMACOL THER, V77, P145, DOI 10.1016/j.clpt.2004.10.011; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Mineur YS, 2008, BIOCHEM PHARMACOL, V75, P323, DOI 10.1016/j.bcp.2007.06.010; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Olausson P, 2004, PSYCHOPHARMACOLOGY, V173, P98, DOI 10.1007/s00213-003-1702-9; Perkins KA, 2002, PSYCHOPHARMACOLOGY, V163, P194, DOI 10.1007/s00213-002-1168-1; Perkins KA, 2008, NICOTINE TOB RES, V10, P1245, DOI 10.1080/14622200802097506; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Placzek AN, 2009, BIOCHEM PHARMACOL, V78, P686, DOI 10.1016/j.bcp.2009.05.014; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; ROSE JE, 1993, PHARMACOL BIOCHEM BE, V44, P891, DOI 10.1016/0091-3057(93)90021-K; Rose JE, 2000, PHARMACOL BIOCHEM BE, V67, P71, DOI 10.1016/S0091-3057(00)00301-4; Rubinstein ML, 2008, PEDIATRICS, V122, pE643, DOI 10.1542/peds.2007-3679; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Samaha AN, 2005, BIOL PSYCHIAT, V57, P351, DOI 10.1016/j.biopsych.2004.11.040; Schulenberg, 2007, MONITORING FUTURE NA; Shiffman S, 2006, J CONSULT CLIN PSYCH, V74, P276, DOI 10.1037/0022-006X.74.2.276; Shiffman S, 2009, NICOTINE TOB RES, V11, P122, DOI 10.1093/ntr/ntn020; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thunnissen FB, 2009, J THORAC ONCOL, V4, P943, DOI 10.1097/JTO.0b013e3181ad83fc; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Wang H, 2005, BRAIN RES REV, V48, P420, DOI 10.1016/j.brainresrev.2004.09.003; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Xian H, 2005, PSYCHOL MED, V35, P409, DOI 10.1017/S0033291704003289; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	80	883	907	6	171	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2295	2303		10.1056/NEJMra0809890	http://dx.doi.org/10.1056/NEJMra0809890			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554984	Green Accepted			2022-12-28	WOS:000278816300008
J	Goldkind, SF; Sahin, L; Gallauresi, B				Goldkind, Sara F.; Sahin, Leyla; Gallauresi, Beverly			Enrolling Pregnant Women in Research - Lessons from the H1N1 Influenza Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldkind, Sara F.; Gallauresi, Beverly] US FDA, Off Commissioner, Silver Spring, MD USA; [Goldkind, Sara F.] US FDA, Off Good Clin Practice, Silver Spring, MD USA; [Sahin, Leyla] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Sahin, Leyla] US FDA, Maternal Hlth Team, Silver Spring, MD USA; [Gallauresi, Beverly] US FDA, Off Womens Hlth, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Goldkind, SF (corresponding author), US FDA, Off Commissioner, Silver Spring, MD USA.							Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Andrew MA, 2007, CLIN PHARMACOL THER, V81, P547, DOI 10.1038/sj.clpt.6100126; Coverdale JH, 2008, OBSTET GYNECOL, V112, P1361, DOI 10.1097/AOG.0b013e31818c2a27; McCullough LB, 2005, AM J OBSTET GYNECOL, V193, P901, DOI 10.1016/j.ajog.2005.06.020; Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb	5	63	64	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2241	2243		10.1056/NEJMp1003462	http://dx.doi.org/10.1056/NEJMp1003462			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20554981				2022-12-28	WOS:000278816300001
J	McCartney, M				McCartney, Margaret			Medical Screening Smear fears	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				*AM C OBST GYNC, 2009, ACOG PRACT B, P109	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2010	340								c2830	10.1136/bmj.c2830	http://dx.doi.org/10.1136/bmj.c2830			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614IZ	20547686				2022-12-28	WOS:000279051600002
J	Huen, MSY; Chen, JJ				Huen, Michael S. Y.; Chen, Junjie			ATM Creates a Veil of Transcriptional Silence	CELL			English	Editorial Material							DOUBLE-STRAND BREAKS; REPAIR		[Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Huen, Michael S. Y.] Univ Hong Kong, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org	Huen, Michael Shing Yan/E-9862-2010	Huen, Michael Shing-Yan/0000-0003-1774-2425				Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	9	5	5	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					924	926		10.1016/j.cell.2010.05.035	http://dx.doi.org/10.1016/j.cell.2010.05.035			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550929	Bronze			2022-12-28	WOS:000278618800008
J	Strand, JD; Bahr, DJ; Van Harlingen, DJ; Davis, JP; Gannon, WJ; Halperin, WP				Strand, J. D.; Bahr, D. J.; Van Harlingen, D. J.; Davis, J. P.; Gannon, W. J.; Halperin, W. P.			The Transition Between Real and Complex Superconducting Order Parameter Phases in UPt3	SCIENCE			English	Article							MUON SPIN RELAXATION; THERMAL-CONDUCTIVITY; SYMMETRY; PARALLEL; LATTICE	Order parameter symmetry is one of the basic characteristics of a superconductor. The heavy fermion compound UPt3 provides a rich system for studying the competition between superconductivity and other forms of electronic order and exhibits two distinct superconducting phases that are characterized by different symmetries. We fabricated a series of Josephson tunnel junctions on the as-grown surfaces of UPt3 single crystals spanning the a-b plane. By measuring their critical current, we mapped out the magnitude of the superconducting order parameter as a function of the momentum-space direction and temperature. In the high-temperature phase, we observed a sharp node in the superconducting gap at 45 with respect to the a axis; an out-of-phase component appeared in the low-temperature phase, creating a complex order parameter.	[Strand, J. D.; Bahr, D. J.; Van Harlingen, D. J.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Davis, J. P.; Gannon, W. J.; Halperin, W. P.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Strand, JD (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	strand2@illinois.edu; dvh@illinois.edu	Davis, John/C-8274-2011	Davis, John/0000-0002-3798-0976; Gannon, William/0000-0001-5635-2185; Strand, Joel/0000-0002-8454-1191	NSF [DMR07-05214]; Department of Energy Basic Energy Sciences [DE-FG02-05ER46248]; Division Of Materials Research [0705214] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Energy Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The measurements were carried out at the University of Illinois at Urbana-Champaign in the Frederick Seitz Materials Research Laboratory and supported by NSF grant DMR07-05214. The UPt<INF>3</INF> crystals were grown and annealed at Northwestern University supported by the Department of Energy Basic Energy Sciences grant DE-FG02-05ER46248. We acknowledge the help of J. Pollanen, H. Choi, and T. Lippman with crystal growth and characterization.	ADENWALLA S, 1990, PHYS REV LETT, V65, P2298, DOI 10.1103/PhysRevLett.65.2298; BEHNIA K, 1991, J LOW TEMP PHYS, V84, P261, DOI 10.1007/BF00683610; Champel T, 2001, PHYS REV LETT, V86, P4903, DOI 10.1103/PhysRevLett.86.4903; DEREOTIER PD, 1995, PHYS LETT A, V205, P239, DOI 10.1016/0375-9601(95)00548-H; FISHER RA, 1989, PHYS REV LETT, V62, P1411, DOI 10.1103/PhysRevLett.62.1411; GOLL G, 1993, PHYS REV LETT, V70, P2008, DOI 10.1103/PhysRevLett.70.2008; Graf MJ, 2000, PHYS REV B, V62, P14393, DOI 10.1103/PhysRevB.62.14393; Huxley A, 2000, NATURE, V406, P160, DOI 10.1038/35018020; Joynt R, 2002, REV MOD PHYS, V74, P235, DOI 10.1103/RevModPhys.74.235; LUKE GM, 1993, PHYS REV LETT, V71, P1466, DOI 10.1103/PhysRevLett.71.1466; SAULS JA, 1994, ADV PHYS, V43, P113, DOI 10.1080/00018739400101475; Smilde HJH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257001; Strand JD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.197002; Suderow H, 1997, J LOW TEMP PHYS, V108, P11, DOI 10.1007/BF02396814; Tou H, 1996, PHYS REV LETT, V77, P1374, DOI 10.1103/PhysRevLett.77.1374; Wu WC, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104502	18	60	60	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1368	1369		10.1126/science.1187943	http://dx.doi.org/10.1126/science.1187943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538942				2022-12-28	WOS:000278598400029
J	Baker, M				Baker, Monya			STRUCTURAL BIOLOGY The gatekeepers revealed	NATURE			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; RESOLUTION; MEMBRANE; RHODOPSIN											Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	12	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					823	828		10.1038/465823a	http://dx.doi.org/10.1038/465823a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535212				2022-12-28	WOS:000278551800054
J	Pitman, RK				Pitman, Roger K.			Posttraumatic Stress Disorder and Dementia What Is the Origin of the Association?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTELLIGENCE; RISK		[Pitman, Roger K.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Pitman, Roger K.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pitman, RK (corresponding author), MGH East,120 2nd Ave, Charlestown, MA 02129 USA.	roger_pitman@hms.harvard.edu						Churchland P. M., 1984, MATTER CONSCIOUSNESS; Fritsch T, 2005, J AM GERIATR SOC, V53, P1191, DOI 10.1111/j.1532-5415.2005.53361.x; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McGurn B, 2008, NEUROLOGY, V71, P1051, DOI 10.1212/01.wnl.0000319692.20283.10; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Sapolsky RM, 2001, HIPPOCAMPUS, V11, P90, DOI 10.1002/hipo.1026; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61	10	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2287	2288		10.1001/jama.2010.767	http://dx.doi.org/10.1001/jama.2010.767			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	607IY	20540170				2022-12-28	WOS:000278496800028
J	Parvatiyar, K; Harhaj, EW				Parvatiyar, Kislay; Harhaj, Edward W.			Anchors Away for Ubiquitin Chains	SCIENCE			English	Editorial Material							UNANCHORED POLYUBIQUITIN CHAINS; ANTIVIRAL RESPONSES; RIG-I; ACTIVATION; KINASES; LIGASE		[Parvatiyar, Kislay; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami	Parvatiyar, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	eharhaj@med.miami.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083143, R01 GM083143-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*EWH, RO1CA135362 EWH NIH; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	11	7	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1244	1245		10.1126/science.1192296	http://dx.doi.org/10.1126/science.1192296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522767	Green Accepted			2022-12-28	WOS:000278318600024
J	Lee, JC; Chou, YL				Lee, Jih-Chin; Chou, Ying-Liang			Antrochoanal Polyp	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Jih-Chin; Chou, Ying-Liang] Tri Serv Gen Hosp, Taipei, Taiwan	Tri-Service General Hospital	Lee, JC (corresponding author), Tri Serv Gen Hosp, Taipei, Taiwan.	doc30450@yahoo.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2113	2113		10.1056/NEJMicm0908423	http://dx.doi.org/10.1056/NEJMicm0908423			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20519682				2022-12-28	WOS:000278242200010
J	Li, Z; Jo, J; Jia, JM; Lo, SC; Whitcomb, DJ; Jiao, S; Cho, K; Sheng, M				Li, Zheng; Jo, Jihoon; Jia, Jie-Min; Lo, Shih-Ching; Whitcomb, Daniel J.; Jiao, Song; Cho, Kwangwook; Sheng, Morgan			Caspase-3 Activation via Mitochondria Is Required for Long-Term Depression and AMPA Receptor Internalization	CELL			English	Article							SYNAPTIC PLASTICITY; CELL-DEATH; INDUCED APOPTOSIS; STRUCTURAL BASIS; CLEAVAGE; LTD; INHIBITION; FAMILY; XIAP; HIPPOCAMPUS	NMDA receptor-dependent synaptic modifications, such as long-term potentiation (LTP) and long-term depression (LTD), are essential for brain development and function. LTD occurs mainly by the removal of AMPA receptors from the postsynaptic membrane, but the underlying molecular mechanisms remain unclear. Here, we show that activation of caspase-3 via mitochondria is required for LTD and AMPA receptor internalization in hippocampal neurons. LTD and AMPA receptor internalization are blocked by peptide inhibitors of caspase-3 and -9. In hippocampal slices from caspase-3 knockout mice, LTD is abolished whereas LTP remains normal. LTD is also prevented by overexpression of the anti-apoptotic proteins XIAP or Bcl-xL, and by a mutant Akt1 protein that is resistant to caspase-3 proteolysis. NMDA receptor stimulation that induces LTD transiently activates caspase-3 in dendrites, without causing cell death. These data indicate an unexpected causal link between the molecular mechanisms of apoptosis and LTD.	[Li, Zheng; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Jo, Jihoon; Whitcomb, Daniel J.; Cho, Kwangwook] Univ Bristol, Fac Med & Dent, Henry Wellcome LINE & MRC Ctr Synapt Plast, Bristol BS1 3NY, Avon, England; [Li, Zheng; Jia, Jie-Min; Jiao, Song] NIMH, Unit Synapse Dev & Plast, Gene Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Lo, Shih-Ching; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Massachusetts Institute of Technology (MIT); Northwell Health; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Roche Holding; Genentech	Li, Z (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lizheng2@mail.nih.gov; Kei.Cho@bristol.ac.uk	Jiao, Song/L-2803-2015; Jia, Jie-Min/O-1150-2013; Li, Zheng/I-8016-2014	Jiao, Song/0000-0003-0496-6454; Jia, Jie-Min/0000-0001-8446-3819; Li, Zheng/0000-0002-2978-2531; Lo, Shih-Ching/0000-0002-5187-0730; Cho, Kwangwook/0000-0001-6724-7073; Whitcomb, Daniel/0000-0003-2703-1643	NIH [F32-NS046126]; NIMH; BBSRC; Alzheimer's Research Trust UK; BBSRC [BB/G003963/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003963/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002882, ZIAMH002881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS046126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer's Research Trust UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Colin S. Duckett and Azad Bonni for plasmid constructs. M. S. was Investigator of the Howard Hughes Medical Institute. Z. L. was a recipient of NIH fellowship (F32-NS046126) and is supported by NIMH Division of Intramural Research Programs. This work is supported by BBSRC (K.C.) Alzheimer's Research Trust UK (K.C.), and the Intramural Program of the NIH, NIMH (Z.L., J.J. and S.J.). M.S. and S.-C.L. are employees of Genentech Inc, a member of the Roche Group.	Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Barry MF, 1996, HIPPOCAMPUS, V6, P3; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chan SL, 1999, J NEUROSCI RES, V57, P315, DOI 10.1002/(SICI)1097-4547(19990801)57:3<315::AID-JNR3>3.3.CO;2-R; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; CHRISTIE BR, 1995, J NEUROPHYSIOL, V74, P1244, DOI 10.1152/jn.1995.74.3.1244; DENNY JB, 1990, BRAIN RES, V534, P317, DOI 10.1016/0006-8993(90)90148-5; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Glazner GW, 2000, J NEUROSCI, V20, P3641, DOI 10.1523/JNEUROSCI.20-10-03641.2000; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lu CB, 2002, NEUROMOL MED, V1, P69; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pivovarova NB, 2002, J NEUROSCI, V22, P10653; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rokudai S, 2000, J CELL PHYSIOL, V182, P290, DOI 10.1002/(SICI)1097-4652(200002)182:2<290::AID-JCP18>3.0.CO;2-8; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scanziani M, 1996, J PHYSIOLOGY-PARIS, V90, P165, DOI 10.1016/S0928-4257(97)81416-7; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Ye B, 2002, NEUROSCIENCE, V114, P217, DOI 10.1016/S0306-4522(02)00142-2; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan JY, 2006, MOL CELL, V23, P1, DOI 10.1016/j.molcel.2006.06.008; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	56	399	420	2	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					859	871		10.1016/j.cell.2010.03.053	http://dx.doi.org/10.1016/j.cell.2010.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510932	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000278132900020
J	de Oliveira, C; Watt, R; Hamer, M				de Oliveira, Cesar; Watt, Richard; Hamer, Mark			Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PERIODONTAL-DISEASE; ORAL-HEALTH; CHLAMYDIA-PNEUMONIAE; ATHEROSCLEROSIS; MARKERS; METAANALYSIS; CHOLESTEROL; MORTALITY	Objective To examine if self reported toothbrushing behaviour is associated with cardiovascular disease and markers of inflammation (C reactive protein) and coagulation (fibrinogen). Design National population based survey. Setting Scottish Health Survey, which draws a nationally representative sample of the general population living in households in Scotland. Participants 11 869 men and women, mean age 50 (SD 11). Main outcome measures Oral hygiene assessed from self reported frequency of toothbrushing. Surveys were linked prospectively to clinical hospital records, and Cox proportional hazards models were used to estimate the risk of cardiovascular disease events or death according to oral hygiene. The association between oral hygiene and inflammatory markers and coagulation was examined in a subsample of participants (n=4830) by using general linear models with adjustments. Results There were a total of 555 cardiovascular disease events over an average of 8.1 (SD 3.4) years of follow-up, of which 170 were fatal. In about 74% (411) of cardiovascular disease events the principal diagnosis was coronary heart disease. Participants who reported poor oral hygiene (never/rarely brushed their teeth) had an increased risk of a cardiovascular disease event (hazard ratio 1.7, 95% confidence interval 1.3 to 2.3; P<0.001) in a fully adjusted model. They also had increased concentrations of both C reactive protein (beta 0.04, 0.01 to 0.08) and fibrinogen (0.08, -0.01 to 0.18). Conclusions Poor oral hygiene is associated with higher levels of risk of cardiovascular disease and low grade inflammation, though the causal nature of the association is yet to be determined.	[de Oliveira, Cesar; Watt, Richard; Hamer, Mark] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Watt, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	r.watt@ucl.ac.uk	Hamer, Mark/C-1602-2008; de Oliveira, Cesar/B-5251-2019; Hamer, Mark/AAJ-6814-2021	Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Watt, Richard/0000-0001-6229-8584; De Oliveira, Cesar/0000-0002-4099-4762	National Institute of Aging/National Institute of Health and British government departments; British Heart Foundation; Scottish Executive	National Institute of Aging/National Institute of Health and British government departments(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Scottish Executive	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. CdeO is funded by the National Institute of Aging/National Institute of Health and British government departments. MH is funded by the British Heart Foundation. The Scottish Health Survey is funded by the Scottish Executive. The funders had no role in the present study.	Astrom AN, 2004, COMMUNITY DENT ORAL, V32, P354, DOI 10.1111/j.1600-0528.2004.00174.x; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P236, DOI 10.1111/j.1600-0765.2004.00731.x; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Nardin E, 2001, Ann Periodontol, V6, P30, DOI 10.1902/annals.2001.6.1.30; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Emberson JR, 2003, EUR HEART J, V24, P1719, DOI 10.1016/S0195-668X(03)00471-8; Hamer M, 2008, ARCH INTERN MED, V168, P2474, DOI 10.1001/archinte.168.22.2474; *INF SERV DIV, 2010, NHS NAT SERV SCOTL; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Miller K, 2007, J PERIODONTOL, V78, P1455, DOI 10.1902/jop.2007.060384; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Persson GR, 2008, J CLIN PERIODONTOL, V35, P362, DOI 10.1111/j.1600-051X.2008.01281.x; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; *SCOTT GOV STAT, SCOTT HLTH SURV PUBL; Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Stone AFM, 2002, CIRCULATION, V106, P1219, DOI 10.1161/01.CIR.0000027820.66786.CF; Wiesli P, 2002, CIRCULATION, V105, P2646, DOI 10.1161/01.CIR.0000017862.08503.15; Wu TJ, 2000, AM J EPIDEMIOL, V151, P273, DOI 10.1093/oxfordjournals.aje.a010203	30	191	199	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2010	340								c2451	10.1136/bmj.c2451	http://dx.doi.org/10.1136/bmj.c2451			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604LD	20508025	hybrid, Green Published			2022-12-28	WOS:000278279600001
J	Efremov, RG; Baradaran, R; Sazanov, LA				Efremov, Rouslan G.; Baradaran, Rozbeh; Sazanov, Leonid A.			The architecture of respiratory complex I	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI NDH-1; UBIQUINONE OXIDOREDUCTASE; MEMBRANE DOMAIN; ELECTRON-TRANSFER; BINDING-SITE; SUBUNIT; MITOCHONDRIAL; TOPOLOGY; NUOM	Complex I is the first enzyme of the respiratory chain and has a central role in cellular energy production, coupling electron transfer between NADH and quinone to proton translocation by an unknown mechanism. Dysfunction of complex I has been implicated in many human neurodegenerative diseases. We have determined the structure of its hydrophilic domain previously. Here, we report the alpha-helical structure of the membrane domain of complex I from Escherichia coli at 3.9 angstrom resolution. The antiporter-like subunits NuoL/M/N each contain 14 conserved transmembrane (TM) helices. Two of them are discontinuous, as in some transporters. Unexpectedly, subunit NuoL also contains a 110-angstrom long amphipathic alpha-helix, spanning almost the entire length of the domain. Furthermore, we have determined the structure of the entire complex I from Thermus thermophilus at 4.5 angstrom resolution. The L-shaped assembly consists of the alpha-helical model for the membrane domain, with 63 TM helices, and the known structure of the hydrophilic domain. The architecture of the complex provides strong clues about the coupling mechanism: the conformational changes at the interface of the two main domains may drive the long amphipathic alpha-helix of NuoL in a piston-like motion, tilting nearby discontinuous TM helices, resulting in proton translocation.	[Efremov, Rouslan G.; Baradaran, Rozbeh; Sazanov, Leonid A.] Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Wellcome Trust Sanger Institute	Sazanov, LA (corresponding author), Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021; Efremov, Rouslan/P-9085-2015	Sazanov, Leonid A/0000-0002-0977-7989; Efremov, Rouslan/0000-0001-7516-8658; Baradaran, Rozbeh/0000-0002-6096-9169	Medical Research Council; Medical Research Council [MC_U105674180] Funding Source: researchfish; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council. We thank the European Synchrotron Radiation Facility and the Swiss Light Source for provision of synchrotron radiation facilities. We are grateful to the staff of beamlines ID23, ID29 (ESRF, Grenoble) and X06SA (Swiss Light Source, Villigen) for assistance. We thank J. E. Walker and A. Leslie for discussions of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; GONDAL JA, 1985, J BIOL CHEM, V260, P2690; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kao MC, 2002, BIOCHEMISTRY-US, V41, P4377, DOI 10.1021/bi025525d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roth R, 2001, BBA-BIOENERGETICS, V1504, P352, DOI 10.1016/S0005-2728(00)00265-6; Rudolph MG, 2004, ACTA CRYSTALLOGR D, V60, P656, DOI 10.1107/S0907444904002239; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Sekiguchi K, 2009, BBA-BIOENERGETICS, V1787, P1106, DOI 10.1016/j.bbabio.2009.02.016; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i	57	458	471	8	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					441	U61		10.1038/nature09066	http://dx.doi.org/10.1038/nature09066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505720				2022-12-28	WOS:000278043700026
J	Bostwick, A; Speck, F; Seyller, T; Horn, K; Polini, M; Asgari, R; MacDonald, AH; Rotenberg, E				Bostwick, Aaron; Speck, Florian; Seyller, Thomas; Horn, Karsten; Polini, Marco; Asgari, Reza; MacDonald, Allan H.; Rotenberg, Eli			Observation of Plasmarons in Quasi-Freestanding Doped Graphene	SCIENCE			English	Article								A hallmark of graphene is its unusual conical band structure that leads to a zero-energy band gap at a single Dirac crossing point. By measuring the spectral function of charge carriers in quasi-freestanding graphene with angle-resolved photoemission spectroscopy, we showed that at finite doping, this well-known linear Dirac spectrum does not provide a full description of the charge-carrying excitations. We observed composite "plasmaron" particles, which are bound states of charge carriers with plasmons, the density oscillations of the graphene electron gas. The Dirac crossing point is resolved into three crossings: the first between pure charge bands, the second between pure plasmaron bands, and the third a ring-shaped crossing between charge and plasmaron bands.	[Bostwick, Aaron; Rotenberg, Eli] EO Lawrence Berkeley Lab, ALS, Berkeley, CA 94720 USA; [Speck, Florian; Seyller, Thomas] Univ Erlangen Nurnberg, Lehrstuhl Tech Phys, D-91058 Erlangen, Germany; [Horn, Karsten] Max Planck Gesell, Fritz Haber Inst, Dept Mol Phys, D-14195 Berlin, Germany; [Polini, Marco] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Polini, Marco] CNR, Ist Nanosci, I-56126 Pisa, Italy; [Asgari, Reza] Inst Res Fundamental Sci, Sch Phys, Tehran 193955531, Iran; [MacDonald, Allan H.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Erlangen Nuremberg; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Texas System; University of Texas Austin	Rotenberg, E (corresponding author), EO Lawrence Berkeley Lab, ALS, MS6-2100, Berkeley, CA 94720 USA.	erotenberg@lbl.gov	MacDonald, Allan/M-9883-2019; Seyller, Thomas K/F-8410-2011; Polini, Marco/L-3419-2013; MacDonald, Allan/GPF-8212-2022; Rotenberg, Eli/B-3700-2009; Bostwick, Aaron/E-8549-2010	Seyller, Thomas K/0000-0002-4953-2142; MacDonald, Allan/0000-0003-3561-3379; Rotenberg, Eli/0000-0002-3979-8844; Bostwick, Aaron/0000-0002-9008-2980	Office of Science; Office of Basic Energy Sciences; U.S. Department of Energy [DE-AC02-05CH11231]; Deutsche Forschungsgemeinschaft [SE1087/5-1]; University of Erlangen-Nuremberg; Welch Foundation; Defense Applications Research Projects Agency; Program on Carbon Electronics for RF Applications	Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Erlangen-Nuremberg; Welch Foundation(The Welch Foundation); Defense Applications Research Projects Agency; Program on Carbon Electronics for RF Applications	The ALS is supported by the director of the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. Work in Erlangen was supported by the Deutsche Forschungsgemeinschaft through research grant SE1087/5-1 and the Cluster of Excellence "Engineering of Advanced Materials" at the University of Erlangen-Nuremberg. A.H.M. was supported by the Welch Foundation and the Defense Applications Research Projects Agency, Program on Carbon Electronics for RF Applications.	BOHM D, 1953, PHYS REV, V92, P609, DOI 10.1103/PhysRev.92.609; Bostwick A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/385; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; Brar VW, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2771084; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; DIAL OE, 2007, THESIS MIT; Emtsev KV, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155303; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Forbeaux I, 1998, PHYS REV B, V58, P16396, DOI 10.1103/PhysRevB.58.16396; Hill A, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/27005; Hwang EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081412; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Kim BJ, 2006, NAT PHYS, V2, P397, DOI 10.1038/nphys316; Kim S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.176802; Kuzmenko AB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.117401; Liu Y, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.201403; LUNDQVIST BI, 1967, PHYS KONDENS MATER, V6, P193, DOI 10.1007/BF02422716; Mucha-Kruczynski M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195403; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Perfetti L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.216404; Polini M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081411; Qaiumzadeh A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/095023; Rana F, 2008, IEEE T NANOTECHNOL, V7, P91, DOI 10.1109/TNANO.2007.910334; Riedl C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246804; Ryzhii V, 2006, JPN J APPL PHYS 2, V45, pL923, DOI 10.1143/JJAP.45.L923; Sekiyama A, 2000, NATURE, V403, P396, DOI 10.1038/35000140; SHAY JL, 1971, PHYS REV LETT, V27, P711, DOI 10.1103/PhysRevLett.27.711; SPECK F, 2009, 13 INT C SIL CARB RE; Tediosi R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016406; Vafek O, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266406; Varchon F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235412; VONALLMEN P, 1992, PHYS REV B, V46, P13345, DOI 10.1103/PhysRevB.46.13345	32	340	344	1	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2010	328	5981					999	1002		10.1126/science.1186489	http://dx.doi.org/10.1126/science.1186489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489018	Green Submitted			2022-12-28	WOS:000277877100033
J	Boyd, MA; Nwizu, CA				Boyd, Mark A.; Nwizu, Chidi A.			Operational research in HIV priority areas: the African way	LANCET			English	Editorial Material									[Boyd, Mark A.] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2043, Australia; [Boyd, Mark A.] St Vincents Hosp, Sydney, NSW 2043, Australia; [Nwizu, Chidi A.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; University System of Maryland; University of Maryland Baltimore	Boyd, MA (corresponding author), Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2043, Australia.	mboyd@nchecr.unsw.edu.au		Boyd, Mark/0000-0002-6848-3307				Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Cooper D, 2007, LANCET, V370, P7, DOI 10.1016/S0140-6736(07)61024-1; Renaud-Thery F, 2007, AIDS, V21, pS89, DOI 10.1097/01.aids.0000279711.54922.f0; SANNE I, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60894-X; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; *UN, 2001, UN GEN ASS SPEC SESS; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI	7	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 3	2010	376	9734					4	6		10.1016/S0140-6736(10)60972-5	http://dx.doi.org/10.1016/S0140-6736(10)60972-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20557929				2022-12-28	WOS:000279841600005
J	Seppala, S; Slusky, JS; Lloris-Garcera, P; Rapp, M; von Heijne, G				Seppala, Susanna; Slusky, Joanna S.; Lloris-Garcera, Pilar; Rapp, Mikaela; von Heijne, Gunnar			Control of Membrane Protein Topology by a Single C-Terminal Residue	SCIENCE			English	Article							POSITIVELY CHARGED RESIDUES; MULTIDRUG TRANSPORTER EMRE; EVOLUTION; MODEL	The mechanism by which multispanning helix-bundle membrane proteins are inserted into their target membrane remains unclear. In both prokaryotic and eukaryotic cells, membrane proteins are inserted cotranslationally into the lipid bilayer. Positively charged residues flanking the transmembrane helices are important topological determinants, but it is not known whether they act strictly locally, affecting only the nearest transmembrane helices, or can act globally, affecting the topology of the entire protein. Here we found that the topology of an Escherichia coli inner membrane protein with four or five transmembrane helices could be controlled by a single positively charged residue placed in different locations throughout the protein, including the very C terminus. This observation points to an unanticipated plasticity in membrane protein insertion mechanisms.	[Seppala, Susanna; Slusky, Joanna S.; Lloris-Garcera, Pilar; Rapp, Mikaela; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Solna, Sweden	Stockholm University; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Rapp, Mikaela/K-2298-2015; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569; Rapp, Mikaela/0000-0002-4401-9518; Seppala, Susanna/0000-0002-2983-3669; Slusky, Joanna/0000-0003-0842-6340	European Research Council [ERC-2008-AdG 232648]; Swedish Cancer Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; International Human Frontier Science Program Organization; European Communities [TranSys PITN-2008-215524]	European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); International Human Frontier Science Program Organization(Human Frontier Science Program); European Communities(European Commission)	We thank Ann-Louise Johansson for technical assistance. This work was supported by grants to G. v. H. from the European Research Council (ERC-2008-AdG 232648), the Swedish Cancer Foundation, the Swedish Research Council, and the Swedish Foundation for Strategic Research, to J.S.S. from the International Human Frontier Science Program Organization, and to P. L. G. from the European Communities (TranSys PITN-2008-215524).	Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Monne M, 1999, EUR J BIOCHEM, V263, P264, DOI 10.1046/j.1432-1327.1999.00498.x; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200	18	111	114	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1698	1700		10.1126/science.1188950	http://dx.doi.org/10.1126/science.1188950			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20508091				2022-12-28	WOS:000279107400044
J	Lubchenco, J; Sutley, N				Lubchenco, Jane; Sutley, Nancy			Proposed US Policy for Ocean, Coast, and Great Lakes Stewardship	SCIENCE			English	Editorial Material							MANAGEMENT		[Lubchenco, Jane] Under Secretary Commerce Oceans & Atmosphere, Washington, DC 20230 USA; [Lubchenco, Jane] NOAA, Washington, DC 20230 USA; [Sutley, Nancy] Council Environm Qual & Interagency Ocean Policy, Washington, DC 20050 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Lubchenco, J (corresponding author), Under Secretary Commerce Oceans & Atmosphere, Washington, DC 20230 USA.	jane.lubchenco@noaa.gov						[Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2006, MARINE COASTAL ECOSY; *COUNC ENV QUAL, 2009, INT OC POL TASK FORC; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Daily GC., 1997, ISSUES ECOL, V2, P1; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lubchenco J, 2010, OCEANOGRAPHY, V23, P115, DOI 10.5670/oceanog.2010.55; McLeod K., 2009, ECOSYSTEM BASED MANA; Murawski SA, 2007, MAR POLICY, V31, P681, DOI 10.1016/j.marpol.2007.03.011; Obama B., 2009, COMMUNICATION   0612; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Rosenberg A. A., 2009, ECOSYSTEM BASED MANA, P294; Stokstad E, 2009, SCIENCE, V326, P1618, DOI 10.1126/science.326.5960.1618; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI	15	70	72	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1485	1486		10.1126/science.1190041	http://dx.doi.org/10.1126/science.1190041			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	611XW	20558691				2022-12-28	WOS:000278859200019
J	Chasela, CS; Hudgens, MG; Jamieson, DJ; Kayira, D; Hosseinipour, MC; Kourtis, AP; Martinson, F; Tegha, G; Knight, RJ; Ahmed, YI; Kamwendo, DD; Hoffman, IF; Ellington, SR; Kacheche, Z; Soko, A; Wiener, JB; Fiscus, SA; Kazembe, P; Mofolo, IA; Chigwenembe, M; Sichali, DS; van der Horst, CM				Chasela, Charles S.; Hudgens, Michael G.; Jamieson, Denise J.; Kayira, Dumbani; Hosseinipour, Mina C.; Kourtis, Athena P.; Martinson, Francis; Tegha, Gerald; Knight, Rodney J.; Ahmed, Yusuf I.; Kamwendo, Deborah D.; Hoffman, Irving F.; Ellington, Sascha R.; Kacheche, Zebrone; Soko, Alice; Wiener, Jeffrey B.; Fiscus, Susan A.; Kazembe, Peter; Mofolo, Innocent A.; Chigwenembe, Maggie; Sichali, Dorothy S.; van der Horst, Charles M.		BAN Study Grp	Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TO-CHILD TRANSMISSION; RANDOMIZED-TRIAL; DOSE NEVIRAPINE; POOLED ANALYSIS; PREVENTION; ZIDOVUDINE; MORTALITY; THERAPY; MALAWI; PLUS	Background We evaluated the efficacy of a maternal triple-drug antiretroviral regimen or infant nevirapine prophylaxis for 28 weeks during breast-feeding to reduce postnatal transmission of human immunodeficiency virus type 1 (HIV-1) in Malawi. Methods We randomly assigned 2369 HIV-1-positive, breast-feeding mothers with a CD4+ lymphocyte count of at least 250 cells per cubic millimeter and their infants to receive a maternal antiretroviral regimen, infant nevirapine, or no extended postnatal antiretroviral regimen (control group). All mothers and infants received perinatal prophylaxis with single-dose nevirapine and 1 week of zidovudine plus lamivudine. We used the Kaplan-Meier method to estimate the cumulative risk of HIV-1 transmission or death by 28 weeks among infants who were HIV-1-negative 2 weeks after birth. Rates were compared with the use of the log-rank test. Results Among mother-infant pairs, 5.0% of infants were HIV-1-positive at 2 weeks of life. The estimated risk of HIV-1 transmission between 2 and 28 weeks was higher in the control group (5.7%) than in either the maternal-regimen group (2.9%, P = 0.009) or the infant-regimen group (1.7%, P<0.001). The estimated risk of infant HIV-1 infection or death between 2 and 28 weeks was 7.0% in the control group, 4.1% in the maternal-regimen group (P = 0.02), and 2.6% in the infant-regimen group (P<0.001). The proportion of women with neutropenia was higher among those receiving the antiretroviral regimen (6.2%) than among those in either the nevirapine group (2.6%) or the control group (2.3%). Among infants receiving nevirapine, 1.9% had a hypersensitivity reaction. Conclusions The use of either a maternal antiretroviral regimen or infant nevirapine for 28 weeks was effective in reducing HIV-1 transmission during breast-feeding. (ClinicalTrials.gov number, NCT00164736.)	[van der Horst, Charles M.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Chasela, Charles S.; Kayira, Dumbani; Hosseinipour, Mina C.; Martinson, Francis; Tegha, Gerald; Kamwendo, Deborah D.; Kacheche, Zebrone; Soko, Alice; Mofolo, Innocent A.; Chigwenembe, Maggie; Sichali, Dorothy S.] Univ N Carolina Project, Lilongwe, Malawi; [Knight, Rodney J.] Principia, Chapel Hill, NC USA; [Jamieson, Denise J.; Kourtis, Athena P.; Ahmed, Yusuf I.; Ellington, Sascha R.; Wiener, Jeffrey B.] Ctr Dis Control & Prevent, Atlanta, GA USA	University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	van der Horst, CM (corresponding author), Univ N Carolina, Dept Med, CB 3368, Chapel Hill, NC 27599 USA.	cvdh@med.unc.edu	Kayira, Dumbani Lyspin/I-4449-2019	Kayira, Dumbani Lyspin/0000-0002-7772-8070; Jamieson, Denise/0000-0003-2597-1201; Sellers, Christopher/0000-0003-4672-8198; Kourtis, Athena/0000-0003-1585-1310	Centers for Disease Control and Prevention [SIP 13-01 U48-CCU409660-09, SIP 26-04 U48-DP000059-01]; National Institute of Allergy and Infectious Diseases; University of North Carolina Center for AIDS Research [P30-AI50410]; NIH [DHHS/NIH/FIC 2-D43 Tw01039-06]; Abbott Laboratories; GlaxoSmithKline; Boehringer Ingelheim; Roche Pharmaceuticals; Bristol-Myers Squibb; Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson Johnson; U.S. Agency for International Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Laboratories(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Roche Pharmaceuticals(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); U.S. Agency for International Development(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention (SIP 13-01 U48-CCU409660-09 and SIP 26-04 U48-DP000059-01), the National Institute of Allergy and Infectious Diseases, the University of North Carolina Center for AIDS Research (P30-AI50410), the NIH Fogarty AIDS International Training and Research Program (DHHS/NIH/FIC 2-D43 Tw01039-06), Abbott Laboratories, GlaxoSmithKline, Boehringer Ingelheim, Roche Pharmaceuticals, Bristol-Myers Squibb, the Elizabeth Glaser Pediatric AIDS Foundation, the United Nations Children's Fund, the World Food Program, the Malawi Ministry of Health and Population, Johnson & Johnson, and the U.S. Agency for International Development.	[Anonymous], 2009, HIV INF FEED REV PRI; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Darwich L, 2008, ANTIVIR THER, V13, P945; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; *JOINT UN PROGR HI, 2007, AIDS EP UPD; Kafulafula G, 2010, JAIDS-J ACQ IMM DEF, V53, P6, DOI 10.1097/QAI.0b013e3181bd5a47; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kourtis Athena P, 2005, J Int Assoc Physicians AIDS Care (Chic), V4, P73, DOI 10.1177/1545109705282591; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; LIDSTROM J, 2010, 17 C RETR OPP INF SA, P433; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; SHAPIRO RL, 2009, P INT AIDS SOC C HIV, P175; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; THOMAS T, 2008, 15 C RETR OPP INF BO, P87; van der Horst C, 2009, CONTEMP CLIN TRIALS, V30, P24, DOI 10.1016/j.cct.2008.09.001; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; World Health Organization, 2008, HIV TRANSM BREASTF R; ZEH C, 2008, 15 C RETR OPP INF BO, P102; 2006, MMWR MORB MORTAL WKL, V55, P592	27	322	332	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2271	2281		10.1056/NEJMoa0911486	http://dx.doi.org/10.1056/NEJMoa0911486			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554982	Green Accepted, Green Published			2022-12-28	WOS:000278816300006
J	Anderson, R				Anderson, Ross			Do summary care records have the potential to do more harm than good? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England	University of Cambridge	Anderson, R (corresponding author), Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England.	Ross.Anderson@cl.cam.ac.uk						Anderson Ross, 2009, DATABASE STATE; BYRNE E, 2010, PRIVACY IS NOT JUST; Greenhalgh T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3111; *MEDICALERT, RESP SUMM CAR REC	4	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2010	340								c3020	10.1136/bmj.c3020	http://dx.doi.org/10.1136/bmj.c3020			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554685				2022-12-28	WOS:000279051900006
J	French, AN				French, Andrew N.			Clean, Green Chiral Reactions-Just Add a Salt	SCIENCE			English	Editorial Material							M-CHLOROPERBENZOIC ACID; IODINE; DIRECTIONS; OXIDATIONS; KETONES		Albion Coll, Dept Chem, Albion, MI 49224 USA	Albion College	French, AN (corresponding author), Albion Coll, Dept Chem, Albion, MI 49224 USA.	afrench@albion.edu						ABOUSHOER M, 1988, PHYTOCHEMISTRY, V27, P2795, DOI 10.1016/0031-9422(88)80665-4; Dohi T, 2005, ANGEW CHEM INT EDIT, V44, P6193, DOI 10.1002/anie.200501688; Dohi T, 2005, CHEM COMMUN, P2205, DOI 10.1039/b501475a; Dohi T, 2008, ANGEW CHEM INT EDIT, V47, P3787, DOI 10.1002/anie.200800464; Herrerias CI, 2006, TETRAHEDRON LETT, V47, P13, DOI 10.1016/j.tetlet.2005.10.123; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Maruoka K, 2008, ORG PROCESS RES DEV, V12, P679, DOI 10.1021/op7002979; Moriarty RM, 2005, J ORG CHEM, V70, P2893, DOI 10.1021/jo050117b; Richardson RD, 2007, SYNLETT, P538, DOI 10.1055/s-2007-967960; Richardson RD, 2006, ANGEW CHEM INT EDIT, V45, P4402, DOI 10.1002/anie.200601817; Shi GQ, 2005, J MED CHEM, V48, P5589, DOI 10.1021/jm050373g; Uyanik M, 2010, SCIENCE, V328, P1376, DOI 10.1126/science.1188217; Uyanik M, 2010, ANGEW CHEM INT EDIT, V49, P2175, DOI 10.1002/anie.200907352; Wirth T, 2005, ANGEW CHEM INT EDIT, V44, P3656, DOI 10.1002/anie.200500115; Yamamoto Y, 2006, SYNLETT, P798, DOI 10.1055/s-2006-933120	15	5	5	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1365	1366		10.1126/science.1191408	http://dx.doi.org/10.1126/science.1191408			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538940				2022-12-28	WOS:000278598400027
J	Bird, JC; de Ruiter, R; Courbin, L; Stone, HA				Bird, James C.; de Ruiter, Rielle; Courbin, Laurent; Stone, Howard A.			Daughter bubble cascades produced by folding of ruptured thin films	NATURE			English	Article							FREE-SURFACE; AIR; INSTABILITY; MECHANISM; DYNAMICS; FLUID; WATER	Thin liquid films, such as soap bubbles, have been studied extensively for over a century because they are easily formed and mediate a wide range of transport processes in physics, chemistry and engineering(1-3). When a bubble on a liquid-gas or solid-gas interface (referred to herein as an interfacial bubble) ruptures, the general expectation is that the bubble vanishes. More precisely, the ruptured thin film is expected to retract rapidly until it becomes part of the interface, an event that typically occurs within milliseconds(4-6). The assumption that ruptured bubbles vanish is central to theories on foam evolution(7) and relevant to health(8) and climate(9) because bubble rupture is a source for aerosol droplets(10,11). Here we show that for a large range of fluid parameters, interfacial bubbles can create numerous small bubbles when they rupture, rather than vanishing. We demonstrate, both experimentally and numerically, that the curved film of the ruptured bubble can fold and entrap air as it retracts. The resulting toroidal geometry of the trapped air is unstable, leading to the creation of a ring of smaller bubbles. The higher pressure associated with the higher curvature of the smaller bubbles increases the absorption of gas into the liquid, and increases the efficiency of rupture-induced aerosol dispersal.	[Bird, James C.; de Ruiter, Rielle; Stone, Howard A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Courbin, Laurent] Univ Rennes 1, CNRS, UMR 6251, Inst Phys Rennes, F-35042 Rennes, France; [Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes; Princeton University	Bird, JC (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jbird@fas.harvard.edu; hastone@princeton.edu	Courbin, Laurent/E-4880-2010	Courbin, Laurent/0000-0003-1210-0597	NSF via the Harvard MRSEC	NSF via the Harvard MRSEC(National Science Foundation (NSF))	We thank P. Howell for discussions regarding our numerical simulations, and E. Villermaux and M. Brenner for feedback. We are grateful to the NSF via the Harvard MRSEC for support of this research.	Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; BAYLOR ER, 1977, SCIENCE, V198, P575, DOI 10.1126/science.918656; Beerkens RGC, 2006, J AM CERAM SOC, V89, P24, DOI 10.1111/j.1551-2916.2005.00691.x; BLANCHARD DC, 1970, SCIENCE, V170, P626, DOI 10.1126/science.170.3958.626; BOULTONSTONE JM, 1993, J FLUID MECH, V254, P437, DOI 10.1017/S0022112093002216; Brenner MP, 1999, PHYS FLUIDS, V11, P737, DOI 10.1063/1.869942; CULICK FEC, 1960, J APPL PHYS, V31, P1128, DOI 10.1063/1.1735765; da Silveira R, 2000, SCIENCE, V287, P1468, DOI 10.1126/science.287.5457.1468; De Gennes P-G., 2004, CAPILLARITY WETTING, V336; Debregeas G, 1998, SCIENCE, V279, P1704, DOI 10.1126/science.279.5357.1704; DEBREGEAS G, 1995, PHYS REV LETT, V75, P3886, DOI 10.1103/PhysRevLett.75.3886; Duchemin L, 2002, PHYS FLUIDS, V14, P3000, DOI 10.1063/1.1494072; Dupre A, 1867, ANN CHIM PHYS, V11, P194; Eggers J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/3/036601; FARMER DM, 1993, NATURE, V361, P620, DOI 10.1038/361620a0; Handa A, 1987, Dev Biol Stand, V66, P241; Isenberg C., 1978, SCI SOAP FILMS SOAP; JARVIS NL, 1967, LIMNOL OCEANOGR, V12, P88, DOI 10.4319/lo.1967.12.1.0088; KENDALL JM, 1986, PHYS FLUIDS, V29, P2086, DOI 10.1063/1.865595; KNELMAN F, 1954, NATURE, V172, P261; Leifer I, 2000, GEOPHYS RES LETT, V27, P4077, DOI 10.1029/2000GL012135; MACINTYRE F, 1972, J GEOPHYS RES, V77, P5211, DOI 10.1029/JC077i027p05211; PANDIT AB, 1990, J FLUID MECH, V212, P11, DOI 10.1017/S0022112090001823; RAYLEIGH, 1879, P ROY SOC LONDON, V29, P71; Savva N, 2009, J FLUID MECH, V626, P211, DOI 10.1017/S0022112009005795; TAYLOR G, 1959, PROC R SOC LON SER-A, V253, P313, DOI 10.1098/rspa.1959.0196; Weaire D., 1999, PHYS FOAMS, P144; WOODCOCK AH, 1953, NATURE, V172, P1144, DOI 10.1038/1721144a0; WU J, 1981, SCIENCE, V212, P324, DOI 10.1126/science.212.4492.324; Zeff BW, 2000, NATURE, V403, P401, DOI 10.1038/35000151	30	154	159	7	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					759	762		10.1038/nature09069	http://dx.doi.org/10.1038/nature09069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535206				2022-12-28	WOS:000278551800040
J	Charnoz, S; Salmon, J; Crida, A				Charnoz, Sebastien; Salmon, Julien; Crida, Aurelien			The recent formation of Saturn's moonlets from viscous spreading of the main rings	NATURE			English	Article							SATELLITES; ACCRETION; EVOLUTION; PLANETS; DISK	The regular satellites of the giant planets are believed to have finished their accretion concurrent with the planets, about 4.5 Gyr ago(1-4). A population of Saturn's small moons orbiting just outside the main rings are dynamically young(5,6) (less than 10(7) yr old), which is inconsistent with the formation timescale for the regular satellites. They are also underdense(7) (similar to 600 kgm(-3)) and show spectral characteristics similar to those of the main rings(8,9). It has been suggested that they accreted at the rings' edge(7,10,11), but hitherto it has been impossible to model the formation process fully owing to a lack of computational power. Here we report a hybrid simulation in which the viscous spreading of Saturn's rings beyond the Roche limit (the distance beyond which the rings are gravitationally unstable) gives rise to the small moons. The moonlets' mass distribution and orbital architecture are reproduced. The current confinement of the main rings and the existence of the dusty F ring are shown to be direct consequences of the coupling of viscous evolution and satellite formation. Saturn's rings, like a mini protoplanetary disk, may be the last place where accretion was recently active in the Solar System, some 10(6)-10(7) yr ago.	[Charnoz, Sebastien; Salmon, Julien] Univ Paris Diderot, CEA, CNRS, Lab AIM, F-91191 Gif Sur Yvette, France; [Crida, Aurelien] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; [Crida, Aurelien] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Lab Cassiopee, F-06304 Nice 4, France	UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Charnoz, S (corresponding author), Univ Paris Diderot, CEA, CNRS, Lab AIM, F-91191 Gif Sur Yvette, France.	charnoz@cea.fr		CRIDA, Aurelien/0000-0002-1293-9782	Universite Paris Diderot; CEA/IRFU/SAp	Universite Paris Diderot; CEA/IRFU/SAp(French Atomic Energy Commission)	This work was funded by Universite Paris Diderot and CEA/IRFU/SAp. The authors thank F. Bournaud, J. Burns, L. Dones, Z. Leinhardt and H. Throop.	CANUP RM, 1995, ICARUS, V113, P331, DOI 10.1006/icar.1995.1026; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; Canup RM, 2006, NATURE, V441, P834, DOI 10.1038/nature04860; Charnoz S, 2007, SCIENCE, V318, P1622, DOI 10.1126/science.1148631; Charnoz S, 2009, ICARUS, V201, P191, DOI 10.1016/j.icarus.2008.12.036; Charnoz S, 2009, ICARUS, V199, P413, DOI 10.1016/j.icarus.2008.10.019; Coradini A, 2009, EARTH MOON PLANETS, V105, P289, DOI 10.1007/s11038-009-9334-7; Cuzzi J, 2009, SATURN FROM CASSINI-HUYGENS, P459, DOI 10.1007/978-1-4020-9217-6_15; Daisaka H, 2001, ICARUS, V154, P296, DOI 10.1006/icar.2001.6716; Estrada P. R., 2009, EUROPA, P27; Guillot T, 2009, SATURN FROM CASSINI-HUYGENS, P745, DOI 10.1007/978-1-4020-9217-6_23; Karjalainen R, 2004, ICARUS, V172, P328, DOI 10.1016/j.icarus.2004.05.022; Karjalainen R, 2007, ICARUS, V189, P523, DOI 10.1016/j.icarus.2007.02.009; Kokubo E, 2000, ICARUS, V148, P419, DOI 10.1006/icar.2000.6496; LISSAUER JJ, 1982, ASTRON J, V87, P1051, DOI 10.1086/113189; MEYERVERNET N, 1987, ICARUS, V69, P157, DOI 10.1016/0019-1035(87)90011-X; Mosqueira I, 2003, ICARUS, V163, P198, DOI 10.1016/S0019-1035(03)00076-9; Murray CD, 2008, NATURE, V453, P739, DOI 10.1038/nature06999; OHTSUKI K, 1993, ICARUS, V106, P228, DOI 10.1006/icar.1993.1168; Porco CC, 2007, SCIENCE, V318, P1602, DOI 10.1126/science.1143977; Poulet F, 2003, ASTRON ASTROPHYS, V412, P305, DOI 10.1051/0004-6361:20031123; Poulet F, 2001, MON NOT R ASTRON SOC, V322, P343, DOI 10.1046/j.1365-8711.2001.04128.x; SALMON J, ICARUS IN PRESS; SHOWALTER MR, 1992, ICARUS, V100, P394, DOI 10.1016/0019-1035(92)90107-I; Spitale JN, 2009, ASTRON J, V138, P1520, DOI 10.1088/0004-6256/138/5/1520; Takeuchi T, 1996, ASTROPHYS J, V460, P832, DOI 10.1086/177013; Weidenschilling S.J., 1984, PLANETARY RINGS, P367	27	93	93	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					752	754		10.1038/nature09096	http://dx.doi.org/10.1038/nature09096			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535205				2022-12-28	WOS:000278551800038
J	Lee, VJ; Yap, J; Cook, AR; Chen, MI; Tay, JK; Tan, BH; Loh, JP; Chew, SW; Koh, WH; Lin, R; Cui, L; Lee, CWH; Sung, W; Wong, CW; Hibberd, ML; Kang, WL; Seet, B; Tambyah, PA				Lee, Vernon J.; Yap, Jonathan; Cook, Alex R.; Chen, Mark I.; Tay, Joshua K.; Tan, Boon Huan; Loh, Jin Phang; Chew, Seok Wei; Koh, Wee Hong; Lin, Raymond; Cui, Lin; Lee, Charlie W. H.; Sung, Wing-Kin; Wong, Christopher W.; Hibberd, Martin L.; Kang, Wee Lee; Seet, Benjamin; Tambyah, Paul A.			Oseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANDEMIC INFLUENZA; AMANTADINE	Background: From June 22 through June 25, 2009, four outbreaks of infection with the pandemic influenza A (H1N1) virus occurred in Singapore military camps. We report the efficacy of ring chemoprophylaxis (geographically targeted containment by means of prophylaxis) with oseltamivir to control outbreaks of 2009 H1N1 influenza in semiclosed environments. Methods: All personnel with suspected infection were tested and clinically isolated if infection was confirmed. In addition, we administered postexposure ring chemoprophylaxis with oseltamivir and segregated the affected military units to contain the spread of the virus. All personnel were screened three times weekly both for virologic infection, by means of nasopharyngeal swabs and reverse-transcriptase-polymerase-chain-reaction assay with sequencing, and for clinical symptoms, by means of questionnaires. Results: A total of 1175 personnel were at risk across the four sites, with 1100 receiving oseltamivir prophylaxis. A total of 75 personnel (6.4%) were infected before the intervention, and 7 (0.6%) after the intervention. There was a significant reduction in the overall reproductive number (the number of new cases attributable to the index case), from 1.91 (95% credible interval, 1.50 to 2.36) before the intervention to 0.11 (95% credible interval, 0.05 to 0.20) after the intervention. Three of the four outbreaks showed a significant reduction in the rate of infection after the intervention. Molecular analysis revealed that all four outbreaks were derived from the New York lineage of the 2009 H1N1 virus and that cases within each outbreak were due to transmission rather than unrelated episodes of infection. Of the 816 personnel treated with oseltamivir who were surveyed, 63 (7.7%) reported mild, nonrespiratory side effects of the drug, with no severe adverse events. Conclusions: Oseltamivir ring chemoprophylaxis, together with prompt identification and isolation of infected personnel, was effective in reducing the impact of outbreaks of 2009 H1N1 influenza in semiclosed settings. N Engl J Med 2010;362:2166-74.	[Lee, Vernon J.; Yap, Jonathan; Tay, Joshua K.] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Lee, Vernon J.; Chen, Mark I.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tambyah, Paul A.] Natl Univ Singapore, Div Infect Dis, Singapore 117548, Singapore; [Chen, Mark I.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Tan, Boon Huan; Loh, Jin Phang; Chew, Seok Wei; Koh, Wee Hong] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Lin, Raymond; Cui, Lin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Lee, Charlie W. H.; Sung, Wing-Kin; Wong, Christopher W.; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Kang, Wee Lee; Seet, Benjamin] Headquarters Med Corps, Singapore Armed Forces, Singapore, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital; Ministry of Health-Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Australian National University	Lee, VJ (corresponding author), 42 How Sun Dr, Singapore 538611, Singapore.	vernonljm@hotmail.com	Hibberd, Martin L/D-5050-2009; Chen, Mark/AGC-5338-2022; Cook, Alex/B-5941-2011; Chen, Mark/CAG-2949-2022; Tan, Boon Huan/ABB-8381-2021; Wong, Christopher/C-5830-2008; Yap, Jonathan/AAJ-7266-2020; Cook, Alex/S-3576-2019	Chen, Mark/0000-0001-9369-5830; Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830; Tan, Boon Huan/0000-0002-4976-7988; Yap, Jonathan/0000-0002-5227-8536; Sung, Wing-Kin/0000-0001-7806-7086; Hibberd, Martin/0000-0001-8587-1849	Singapore Ministry of Defence; National University of Singapore; Singapore Agency for Science, Research, and Technology	Singapore Ministry of Defence(Ministry of Defence, Singapore); National University of Singapore(National University of Singapore); Singapore Agency for Science, Research, and Technology	Supported by the Singapore Ministry of Defence, the National University of Singapore (for the statistical analysis), and the Singapore Agency for Science, Research, and Technology (for the genetic sequencing).	Anderson RM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2897; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P213; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; *CDC DEP HLTH ROC, 2009, INFL PAND STRAT PLAN; *CDCP, 2009, INT GUID ANT REC PAT; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; DAVIES JR, 1988, J ROY COLL GEN PRACT, V38, P346; DELBIN DJ, 1979, J R COLL GEN PRACT, V29, P151; Earhart KC, 2001, EMERG INFECT DIS, V7, P463, DOI 10.3201/eid0703.017320; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; LEE CW, 2010, NUCL ACIDS RES  0225; Lee PM, 2009, BAYESIAN STAT INTRO; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Liu PY, 2009, J MICROBIOL IMMUNOL, V42, P114; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MILNE DG, 1949, BRIT MED J, V1, P571, DOI 10.1136/bmj.1.4604.571; *MIN HLTH SING, 2009, 16 NEW CONF CAS INFL; *MIN HLTH SING, 2009, 1 CONF CAS INFL A H1; *MIN HLTH SING, 2009, CONF NEW CAS INFL H1; Ministry of Health Singapore, 2009, INFL PAND READ RESP; *MOH SING, 2009, 792009 MOH; *MOH SING, CAS DEF MAN HUM INF; *MOH SING, 2009, 442009 MOH; R Development Core Team, 2009, R LANG ENV STAT COMP; Rubin MS, 2008, CLIN INFECT DIS, V47, P47, DOI 10.1086/588658; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; *STAT SING, KEY ANN IND; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; *WHO, 2009, DG DIR GEN STAT FOLL; WHO, 2009, CDC PROT REALT RT PC; World Health Organization, 2009, PROD AV PAND H1N1 20	36	64	65	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2166	2174		10.1056/NEJMoa0908482	http://dx.doi.org/10.1056/NEJMoa0908482			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558367	Green Accepted			2022-12-28	WOS:000278551500005
J	Sacks, FM; Campos, H				Sacks, Frank M.; Campos, Hannia			Dietary Therapy in Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDITERRANEAN-STYLE DIET; BLOOD-PRESSURE; WEIGHT-LOSS; STOP HYPERTENSION; DASH DIET; ENDOTHELIAL FUNCTION; CARDIOVASCULAR MORTALITY; MICROVASCULAR FUNCTION; SODIUM REDUCTION; UNITED-STATES	A 57-year-old woman presents to an outpatient clinic for evaluation of hypertension. She has no history or symptoms of cardiovascular disease and reports having gained 15 kg over the past 30 years. Her blood pressure is 155/95 mm Hg, her weight 86 kg, her height 165 cm, her body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) 31, and her waist circumference 98 cm. Her serum triglyceride level is 175 mg per deciliter (2.0 mmol per liter), high-density lipoprotein cholesterol 42 mg per deciliter (1.1 mmol per liter), low-density lipoprotein cholesterol 110 mg per deciliter (2.8 mmol per liter), and glucose 85 mg per deciliter (4.7 mmol per liter). Her clinical profile is thus consistent with the metabolic syndrome. 1 She is a nonsmoker, is sedentary, and eats a diet that is high in white bread, processed meats, and snacks and drinks containing sugars and sodium and is low in fruits and vegetables. She is interested in adopting a healthier lifestyle.	[Sacks, Frank M.; Campos, Hannia] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sacks, Frank M.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Sacks, Frank M.] Brigham & Womens Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA; [Sacks, Frank M.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, FM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Bldg 1,2nd Fl, Boston, MA 02115 USA.	fsacks@hsph.harvard.edu						Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Akita S, 2003, HYPERTENSION, V42, P8, DOI 10.1161/01.HYP.0000074668.08704.6E; Al-Solaiman Y, 2009, J HUM HYPERTENS, V23, P826, DOI 10.1038/jhh.2009.32; American Heart Association, 2005, NO FAD DIET PERS PLA; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; BERK BC, 2004, BRENNER RECTORS KIDN, V2, P1999; Blacher J, 2005, NAT CLIN PRACT CARD, V2, P450, DOI 10.1038/ncpcardio0307; Blanck Heidi Michels, 2008, Prev Chronic Dis, V5, pA35; Blumenthal JA, 2010, ARCH INTERN MED, V170, P126, DOI 10.1001/archinternmed.2009.470; Bray GA, 2010, AM J CARDIOL, V105, P579, DOI 10.1016/j.amjcard.2009.10.002; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conlin PR, 2003, AM J HYPERTENS, V16, P337, DOI 10.1016/S0895-7061(03)00056-6; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; CTR. FOR STRATEGIC & INT'L STUD, 2008, SEL DEV APPR, P1; de Jongh RT, 2007, J HYPERTENS, V25, P1887, DOI 10.1097/HJH.0b013e32825e1db7; Elliott, 1997, BRIT MED J, V315, P458; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; EPSTEIN FREDERICK H., 1967, P155; Eriksson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005195; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Esposito K, 2009, ANN INTERN MED, V151, P591, DOI 10.7326/0003-4819-151-8-200910200-00026; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Esposito K, 2009, ANN INTERN MED, V151, P306, DOI 10.7326/0003-4819-151-5-200909010-00004; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Feldstein C, 2009, J AM SOC HYPERTENS, V3, P353, DOI 10.1016/j.jash.2009.10.001; Gates PE, 2009, EXP PHYSIOL, V94, P311, DOI 10.1113/expphysiol.2008.043349; Goff DC, 2001, ANN EPIDEMIOL, V11, P271, DOI 10.1016/S1047-2797(00)00224-6; Grimes CA, 2009, APPETITE, V53, P189, DOI 10.1016/j.appet.2009.06.007; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hall JE, 2001, AM J HYPERTENS, V14, p103S, DOI 10.1016/S0895-7061(01)02077-5; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Ho JT, 2007, HORM METAB RES, V39, P694, DOI 10.1055/s-2007-985354; Hsieh YC, 2009, PUBLIC HEALTH NUTR, V12, P570, DOI 10.1017/S1368980008002875; Kaplan N., 2006, KAPLANS CLIN HYPERTE, V9th, P50; Karanja N, 2007, J AM DIET ASSOC, V107, P1530, DOI 10.1016/j.jada.2007.06.013; KATZEN M, 2006, EAT DRINK WEIGH LESS; Kokkinos Peter, 2005, J Clin Hypertens (Greenwich), V7, P165, DOI 10.1111/j.1524-6175.2005.04079.x; LANDSBERG L, 1981, INT J OBESITY, V5, P79; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; LEE MA, 1993, CIRCULATION, V87, P7; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; *MAYOCLINIC COM, DASH DIET REC; McCall DO, 2009, CIRCULATION, V119, P2153, DOI 10.1161/CIRCULATIONAHA.108.831297; Mellen PB, 2008, ARCH INTERN MED, V168, P308, DOI 10.1001/archinternmed.2007.119; MOORE T, 2001, DASH DIET HYPERTENSI, P1; National Heart Lung and Blood Institute & National Heart Lung and Blood Institute, 2006, YOUR GUID LOW YOUR B, V1st; O'Shaughnessy KM, 2006, ANNU REV NUTR, V26, P343, DOI 10.1146/annurev.nutr.26.061505.111316; Obarzanek E, 2003, HYPERTENSION, V42, P459, DOI 10.1161/01.HYP.0000091267.39066.72; Okosun IS, 1999, J HUM HYPERTENS, V13, P425, DOI 10.1038/sj.jhh.1000862; PEAR RNEW, 2010, NY TIMES        0405, pA10; Pierce GL, 2008, HYPERTENSION, V52, P72, DOI 10.1161/HYPERTENSIONAHA.108.111427; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Rallidis LS, 2009, AM J CLIN NUTR, V90, P263, DOI 10.3945/ajcn.2008.27290; Rankins J, 2005, J NUTR EDUC BEHAV, V37, P259, DOI 10.1016/S1499-4046(06)60281-9; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Re RN, 2004, NAT CLIN PRACT CARD, V1, P42, DOI 10.1038/ncpcardio0012; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; RODRIGUEZ BL, 1994, HYPERTENSION, V24, P779, DOI 10.1161/01.HYP.24.6.779; SACKS FM, 1988, AM J CLIN NUTR, V48, P795, DOI 10.1093/ajcn/48.3.795; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SACKS FM, 1974, AM J EPIDEMIOL, V100, P390, DOI 10.1093/oxfordjournals.aje.a112050; Sacks Frank M., 1995, Annals of Epidemiology, V5, P108, DOI 10.1016/1047-2797(94)00055-X; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Safar ME, 2009, HYPERTENSION, V54, P203, DOI 10.1161/HYPERTENSIONAHA.109.129585; SAILE F, 1930, MED KLIN, V25, P929; SEALEY JE, 1988, J HYPERTENS, V6, P763, DOI 10.1097/00004872-198811000-00001; Seals DR, 2006, EXP GERONTOL, V41, P501, DOI 10.1016/j.exger.2006.01.001; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Straznicky NE, 2005, J CLIN ENDOCR METAB, V90, P5998, DOI 10.1210/jc.2005-0961; Straznicky NE, 2010, DIABETES, V59, P71, DOI 10.2337/db09-0934; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Swain JF, 2008, J AM DIET ASSOC, V108, P257, DOI 10.1016/j.jada.2007.10.040; Trichopoulou A, 2001, Nutr Metab Cardiovasc Dis, V11, P1; Uzu T, 2006, J HYPERTENS, V24, P1627, DOI 10.1097/01.hjh.0000239299.71001.77; Victor RG, 2008, CURR HYPERTENS REP, V10, P241, DOI 10.1007/s11906-008-0045-7; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Williamson DA, 2010, J BEHAV MED, V33, P35, DOI 10.1007/s10865-009-9230-7; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Young CM, 2008, J CLIN HYPERTENS, V10, P603, DOI 10.1111/j.1751-7176.2008.08199.x; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a	86	147	154	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2102	2112		10.1056/NEJMct0911013	http://dx.doi.org/10.1056/NEJMct0911013			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20519681				2022-12-28	WOS:000278242200009
J	Lee, W; Jiang, ZS; Liu, JF; Haverty, PM; Guan, YH; Stinson, J; Yue, P; Zhang, Y; Pant, KP; Bhatt, D; Ha, C; Johnson, S; Kennemer, MI; Mohan, S; Nazarenko, I; Watanabe, C; Sparks, AB; Shames, DS; Gentleman, R; de Sauvage, FJ; Stern, H; Pandita, A; Ballinger, DG; Drmanac, R; Modrusan, Z; Seshagiri, S; Zhang, ZM				Lee, William; Jiang, Zhaoshi; Liu, Jinfeng; Haverty, Peter M.; Guan, Yinghui; Stinson, Jeremy; Yue, Peng; Zhang, Yan; Pant, Krishna P.; Bhatt, Deepali; Ha, Connie; Johnson, Stephanie; Kennemer, Michael I.; Mohan, Sankar; Nazarenko, Igor; Watanabe, Colin; Sparks, Andrew B.; Shames, David S.; Gentleman, Robert; de Sauvage, Frederic J.; Stern, Howard; Pandita, Ajay; Ballinger, Dennis G.; Drmanac, Radoje; Modrusan, Zora; Seshagiri, Somasekar; Zhang, Zemin			The mutation spectrum revealed by paired genome sequences from a lung cancer patient	NATURE			English	Article							SOMATIC MUTATIONS; GENE; IDENTIFICATION; REARRANGEMENT; EXPRESSION; PATHWAYS; PATTERNS; FUSION	Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small-cell lung carcinomas in smokers being the predominant form of the disease(1,2). Although previous studies have identified important common somatic mutations in lung cancers, they have primarily focused on a limited set of genes and have thus provided a constrained view of the mutational spectrum(3-8). Recent cancer sequencing efforts have used next-generation sequencing technologies to provide a genome-wide view of mutations in leukaemia, breast cancer and cancer cell lines(9-13). Here we present the complete sequences of a primary lung tumour (603 coverage) and adjacent normal tissue (463). Comparing the two genomes, we identify a wide variety of somatic variations, including >50,000 high-confidence single nucleotide variants. We validated 530 somatic single nucleotide variants in this tumour, including one in the KRAS proto-oncogene and 391 others in coding regions, as well as 43 large-scale structural variations. These constitute a large set of new somatic mutations and yield an estimated 17.7 per megabase genome-wide somatic mutation rate. Notably, we observe a distinct pattern of selection against mutations within expressed genes compared to non-expressed genes and in promoter regions up to 5 kilobases upstream of all protein-coding genes. Furthermore, we observe a higher rate of amino acid-changing mutations in kinase genes. We present a comprehensive view of somatic alterations in a single lung tumour, and provide the first evidence, to our knowledge, of distinct selective pressures present within the tumour environment.	[Lee, William; Jiang, Zhaoshi; Liu, Jinfeng; Haverty, Peter M.; Yue, Peng; Zhang, Yan; Watanabe, Colin; Gentleman, Robert; Zhang, Zemin] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Guan, Yinghui; Stinson, Jeremy; Pant, Krishna P.; Bhatt, Deepali; de Sauvage, Frederic J.; Modrusan, Zora; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Pant, Krishna P.; Kennemer, Michael I.; Nazarenko, Igor; Sparks, Andrew B.; Ballinger, Dennis G.; Drmanac, Radoje] Complete Genom Inc, Mountain View, CA 94043 USA; [Johnson, Stephanie; Stern, Howard] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Mohan, Sankar; Shames, David S.; Pandita, Ajay] Genentech Inc, Dept Oncol Diagnost, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Zhang, ZM (corresponding author), Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA.	zemin@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Seshagiri, Somasekar/0000-0003-4272-6443; Lee, William/0000-0001-9582-4413; Liu, Jinfeng/0000-0002-0343-8222				Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chu PGG, 2002, MODERN PATHOL, V15, P6, DOI 10.1038/modpathol.3880483; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tan DF, 2003, HUM PATHOL, V34, P597, DOI 10.1016/S0046-8177(03)00180-1; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103	29	385	430	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					473	477		10.1038/nature09004	http://dx.doi.org/10.1038/nature09004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505728				2022-12-28	WOS:000278043700034
J	Osi, A; Butler, RJ; Weishampel, DB				Osi, Attila; Butler, Richard J.; Weishampel, David B.			A Late Cretaceous ceratopsian dinosaur from Europe with Asian affinities	NATURE			English	Article							NEOCERATOPSIAN DINOSAUR; EARLY EVOLUTION; REMAINS; HUNGARY; CHINA	Ceratopsians (horned dinosaurs) represent a highly diverse and abundant radiation of non-avian dinosaurs(1-5) known primarily from the Cretaceous period (65-145 million years ago). This radiation has been considered to be geographically limited to Asia and western North America(1-3), with only controversial remains reported from other continents. Here we describe new ceratopsian cranial material from the Late Cretaceous of Iharkut, Hungary(6), from a coronosaurian ceratopsian, Ajkaceratops kozmai. Ajkaceratops is most similar to 'bagaceratopsids' such as Bagaceratops and Magnirostris, previously known only from Late Cretaceous east Asia(3,5,7,8). The new material unambiguously demonstrates that ceratopsians occupied Late Cretaceous Europe and, when considered with the recent discovery of possible leptoceratopsid teeth from Sweden(9), indicates that the clade may have reached Europe on at least two independent occasions. European Late Cretaceous dinosaur faunas have been characterized as consisting of a mix of endemic 'relictual' taxa and 'Gondwanan' taxa, with typical Asian and North American groups largely absent(10,11). Ajkaceratops demonstrates that this prevailing biogeographical hypothesis is overly simplified and requires reassessment. Iharkut was part of the western Tethyan archipelago, a tectonically complex series of island chains between Africa and Europe(12), and the occurrence of a coronosaurian ceratopsian in this locality may represent an early Late Cretaceous 'island-hopping' dispersal across the Tethys Ocean.	[Osi, Attila] Hungarian Acad Sci, Res Grp Paleontol, Hungarian Nat Hist Museum, H-1083 Budapest, Hungary; [Butler, Richard J.] Bayer Staatssammlung Palaontol & Geol, D-80333 Munich, Germany; [Weishampel, David B.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD 21205 USA	Hungarian Academy of Sciences; Johns Hopkins University	Osi, A (corresponding author), Hungarian Acad Sci, Res Grp Paleontol, Hungarian Nat Hist Museum, Ludovika Ter 2, H-1083 Budapest, Hungary.	hungaros@freemail.hu	Ősi, Attila/K-2414-2018; Butler, Richard J./A-5239-2011	Ősi, Attila/0000-0003-2967-997X; Butler, Richard J./0000-0003-2136-7541	Hungarian Scientific Research Fund (OTKA) [PD 73021]; Hantken Foundation; Humboldt Postdoctoral Fellowship	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hantken Foundation; Humboldt Postdoctoral Fellowship	We thank L. Kocsis, P. Barrett, D. Norman, P. Dodson, J. Kirkland, P. Makovicky, S. Sampson, P. Godefroit, Z. Csiki, J. Palfy and R. Sissons for discussion, R. Blakey for the use of the palaeogeographical reconstruction, P. Gulyas for preparation, J. Kirkland for unpublished data and U. Gohlich for logistical support. Research was supported by the Hungarian Scientific Research Fund (OTKA PD 73021) and the Hantken Foundation (A.O.), and a Humboldt Postdoctoral Fellowship (R.J.B.). This is MTA-MTM Paleo contribution 109.	BENTON MJ, PALAEOGEOGR IN PRESS; Bonaparte Jose F., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P73; Csontos L, 2004, PALAEOGEOGR PALAEOCL, V210, P1, DOI 10.1016/j.palaeo.2004.02.033; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Godefroit P, 2007, BULL INST R SC N B-S, V77, P83; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P627; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Kirkland James I., 2007, P90; KIRKLAND JI, NEW PERSPEC IN PRESS; Knauer J, 1992, PALYNOSTRATIGRAPHIC, P463; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; Lindgren J, 2007, PALAEONTOLOGY, V50, P929, DOI 10.1111/j.1475-4983.2007.00690.x; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; Osi A, 2005, J VERTEBR PALEONTOL, V25, P370, DOI 10.1671/0272-4634(2005)025[0370:HTANAD]2.0.CO;2; Osi A, 2004, GEOBIOS-LYON, V37, P749, DOI 10.1016/j.geobios.2003.06.005; Pereda-Suberbiola X, 2009, CR PALEVOL, V8, P559, DOI 10.1016/j.crpv.2009.05.002; Pereda-Suberbiola X, 2009, B SOC GEOL FR, V180, P57, DOI 10.2113/gssgfbull.180.1.57; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Rich Thomas H., 2003, Records of the Queen Victoria Museum, V113, P1; Sampson Scott D., 2001, Journal of Vertebrate Paleontology, V21, p96A; Sereno Paul C., 2000, P480; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Wolfe Douglas G., 2007, P159; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; You Hailu, 2004, P478; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P299; You HL, 2003, ACTA PALAEONTOL POL, V48, P261	30	44	46	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					466	468		10.1038/nature09019	http://dx.doi.org/10.1038/nature09019			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505726				2022-12-28	WOS:000278043700032
J	Hodi, FS; O'Day, SJ; McDermott, DF; Weber, RW; Sosman, JA; Haanen, JB; Gonzalez, R; Robert, C; Schadendorf, D; Hassel, JC; Akerley, W; van den Eertwegh, AJM; Lutzky, J; Lorigan, P; Vaubel, JM; Linette, GP; Hogg, D; Ottensmeier, CH; Lebbe, C; Peschel, C; Quirt, I; Clark, JI; Wolchok, JD; Weber, JS; Tian, J; Yellin, MJ; Nichol, GM; Hoos, A; Urba, WJ				Hodi, F. Stephen; O'Day, Steven J.; McDermott, David F.; Weber, Robert W.; Sosman, Jeffrey A.; Haanen, John B.; Gonzalez, Rene; Robert, Caroline; Schadendorf, Dirk; Hassel, Jessica C.; Akerley, Wallace; van den Eertwegh, Alfons J. M.; Lutzky, Jose; Lorigan, Paul; Vaubel, Julia M.; Linette, Gerald P.; Hogg, David; Ottensmeier, Christian H.; Lebbe, Celeste; Peschel, Christian; Quirt, Ian; Clark, Joseph I.; Wolchok, Jedd D.; Weber, Jeffrey S.; Tian, Jason; Yellin, Michael J.; Nichol, Geoffrey M.; Hoos, Axel; Urba, Walter J.			Improved Survival with Ipilimumab in Patients with Metastatic Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-LYMPHOCYTE ANTIGEN-4; STAGE-IV MELANOMA; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; RESPONSE CRITERIA; CLINICAL-RESPONSE; TUMOR-REGRESSION; ADVERSE EVENTS; SOLID TUMORS; DOUBLE-BLIND	BACKGROUND An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3 study, ipilimumab - which blocks cytotoxic T-lymphocyte-associated antigen 4 to potentiate an antitumor T-cell response - administered with or without a glycoprotein 100 (gp100) peptide vaccine was compared with gp100 alone in patients with previously treated metastatic melanoma. METHODS A total of 676 HLA-A*0201-positive patients with unresectable stage III or IV melanoma, whose disease had progressed while they were receiving therapy for metastatic disease, were randomly assigned, in a 3: 1: 1 ratio, to receive ipilimumab plus gp100 (403 patients), ipilimumab alone (137), or gp100 alone (136). Ipilimumab, at a dose of 3 mg per kilogram of body weight, was administered with or without gp100 every 3 weeks for up to four treatments (induction). Eligible patients could receive reinduction therapy. The primary end point was overall survival. RESULTS The median overall survival was 10.0 months among patients receiving ipilimumab plus gp100, as compared with 6.4 months among patients receiving gp100 alone (hazard ratio for death, 0.68; P<0.001). The median overall survival with ipilimumab alone was 10.1 months (hazard ratio for death in the comparison with gp100 alone, 0.66; P = 0.003). No difference in overall survival was detected between the ipilimumab groups (hazard ratio with ipilimumab plus gp100, 1.04; P = 0.76). Grade 3 or 4 immune-related adverse events occurred in 10 to 15% of patients treated with ipilimumab and in 3% treated with gp100 alone. There were 14 deaths related to the study drugs (2.1%), and 7 were associated with immune-related adverse events. CONCLUSIONS Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma. Adverse events can be severe, long-lasting, or both, but most are reversible with appropriate treatment. (Funded by Medarex and Bristol-Myers Squibb; ClinicalTrials.gov number, NCT00094653.)	[Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [McDermott, David F.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [O'Day, Steven J.] Angeles Clin & Res Inst, Los Angeles, CA USA; [Weber, Robert W.] St Marys Hosp, San Francisco, CA USA; [Sosman, Jeffrey A.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Haanen, John B.] Netherlands Canc Inst, Amsterdam, Netherlands; [van den Eertwegh, Alfons J. M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Gonzalez, Rene] Univ Colorado, Ctr Canc, Aurora, CO USA; [Robert, Caroline] Inst Gustave Roussy, Villejuif, France; [Schadendorf, Dirk; Vaubel, Julia M.] Univ Hosp Essen, Essen, Germany; [Hassel, Jessica C.] Univ Mannheim, German Canc Res Ctr, Mannheim, Germany; [Peschel, Christian] Tech Univ Munich, Munich, Germany; [Akerley, Wallace] Huntsman Canc Inst, Salt Lake City, UT USA; [Lutzky, Jose] Mt Sinai Comprehens Canc Ctr, Miami, FL USA; [Lorigan, Paul] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England; [Ottensmeier, Christian H.] Southampton Univ Hosp, Southampton, Hants, England; [Linette, Gerald P.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Hogg, David; Quirt, Ian] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Lebbe, Celeste] Hop St Louis, Paris, France; [Clark, Joseph I.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Weber, Jeffrey S.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Tian, Jason; Yellin, Michael J.; Nichol, Geoffrey M.] Medarex, Bloomsbury, NJ USA; [Hoos, Axel] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Urba, Walter J.] Earle A Chiles Res Inst, Portland, OR USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Angeles Clinic & Research Institute; Vanderbilt University; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; University of Colorado System; University of Colorado Anschutz Medical Campus; UNICANCER; Gustave Roussy; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Mannheim; Technical University of Munich; Huntsman Cancer Institute; Christie NHS Foundation Trust; Christie Hospital; University of Southampton; Washington University (WUSTL); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Loyola University Chicago; Memorial Sloan Kettering Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Bristol-Myers Squibb	Hodi, FS (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	stephen_hodi@dfci.harvard.edu	Robert, Caroline/G-6157-2018; gonzález, rene/W-2081-2019; Hug, Balthasar L./G-1568-2010; Haanen, John/AAD-8534-2022; Ottensmeier, Christian H/E-8131-2012; Schadendorf, Dirk/AAE-8206-2019; Ottensmeier, Christian/ABE-9056-2020; Haanen, John/AAD-8578-2022; Lorigan, Paul/J-6898-2015	Robert, Caroline/0000-0002-9493-0238; Haanen, John/0000-0001-5884-7704; Ottensmeier, Christian H/0000-0003-3619-1657; Ottensmeier, Christian/0000-0003-3619-1657; Lorigan, Paul/0000-0002-8875-2164; Weber, Jeffrey/0000-0002-4962-2957; Yellin, Michael/0000-0002-1164-7614; Lutzky, Jose/0000-0002-9503-2130	Medarex; Bristol-Myers Squibb; Novartis; Genentech; Bristol-Myers Squibb-Medarex; NATIONAL CANCER INSTITUTE [K24CA097588] Funding Source: NIH RePORTER	Medarex; Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); Genentech(Roche HoldingGenentech); Bristol-Myers Squibb-Medarex; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Medarex and Bristol-Myers Squibb.; Dr. Hodi reports receiving consulting fees from Bristol-Myers Squibb-Medarex, Novartis, and Genentech; Dr. O'Day, receiving consulting fees, grants, honoraria, and fees for participation in speakers' bureaus from Bristol-Myers Squibb; Dr. McDermott, receiving consulting fees from Bristol-Myers Squibb-Medarex; Dr. Gonzalez, receiving honoraria from Bristol-Myers Squibb; Dr. Schadendorf, serving on a board for and receiving consulting fees, fees for expert testimony, and fees for participation in speakers' bureaus from Bristol-Myers Squibb; Dr. Lutzky, receiving consulting fees and honoraria from Bristol-Myers Squibb; Dr. Lorigan, receiving consulting fees from Bristol-Myers Squibb; Dr. Hogg, serving on a board for Bristol-Myers Squibb (pending); Dr. Ottensmeier, receiving honoraria and grant funding from Bristol-Myers Squibb; Dr. Lebbe, serving on a board for Bristol-Myers Squibb; Dr. Wolchok, serving on a board for Bristol-Myers Squibb; Dr. J.S. Weber, receiving consulting fees from Bristol-Myers Squibb; Drs. Tian, Yellin, and Nichol being former employees of Medarex; Dr. Hoos being currently employed by Bristol-Myers Squibb with stock or stock options; and Dr. Urba, receiving consulting fees from Bristol-Myers Squibb-Medarex. No other potential conflicts of interest relevant to this article were reported.	Agarwala SS, 2010, MELANOMA RES, V20, P1, DOI 10.1097/CMR.0b013e328333bbc8; Agarwala SS, 2009, EXPERT REV ANTICANC, V9, P587, DOI [10.1586/era.09.25, 10.1586/ERA.09.25]; American Cancer Society, CANC FACTS FIG 2009; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bedikian AY, 2008, CANCER INVEST, V26, P624, DOI 10.1080/07357900802027073; *CLINICALTRIALS GO, DAC IP VS DAC PLAC U; Downey SG, 2007, CLIN CANCER RES, V13, P6681, DOI 10.1158/1078-0432.CCR-07-0187; EGGERMONT AM, 2008, J CLIN ONCOL S, V26, pS484; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Eisen T, 2010, CANCER-AM CANCER SOC, V116, P146, DOI 10.1002/cncr.24686; Fong L, 2008, J CLIN ONCOL, V26, P5275, DOI 10.1200/JCO.2008.17.8954; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; LIN R, 2008, J CLIN ONCOL S, V26, pS497; Maker AV, 2005, ANN SURG ONCOL, V12, P1005, DOI 10.1245/ASO.2005.03.536; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; MORTON DL, 2007, J CLIN ONCOL, V25, pS474; O'Day SJ, 2010, ANN ONCOL       0210; O'Day SJ, 2007, CANCER-AM CANCER SOC, V110, P2614, DOI 10.1002/cncr.23086; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Petrella T, 2007, CANCER TREAT REV, V33, P484, DOI 10.1016/j.ctrv.2007.04.003; Robert C, 2009, ONCOLOGIST, V14, P848, DOI 10.1634/theoncologist.2009-0028; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schwartzentruber D, 2009, J CLIN ONCOL S, V27, p463S; Sosman JA, 2002, J CLIN ONCOL, V20, P2067, DOI 10.1200/JCO.2002.08.072; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Trinh VA, 2008, AM J HEALTH-SYST PH, V65, pS3, DOI 10.2146/ajhp080460; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Tsao H, 2004, NEW ENGL J MED, V351, P2461; Weber J, 2007, ONCOLOGIST, V12, P864, DOI 10.1634/theoncologist.12-7-864; Weber J, 2009, CLIN CANCER RES, V15, P5591, DOI 10.1158/1078-0432.CCR-09-1024; Weber J, 2009, CANCER IMMUNOL IMMUN, V58, P823, DOI 10.1007/s00262-008-0653-8; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; World Health Organization, SKIN CANC	39	10358	10768	28	1199	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2010	363	8					711	723		10.1056/NEJMoa1003466	http://dx.doi.org/10.1056/NEJMoa1003466			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639TE	20525992	Green Accepted, Green Published			2022-12-28	WOS:000280996600005
J	Yu, R; Zhang, W; Zhang, HJ; Zhang, SC; Dai, X; Fang, Z				Yu, Rui; Zhang, Wei; Zhang, Hai-Jun; Zhang, Shou-Cheng; Dai, Xi; Fang, Zhong			Quantized Anomalous Hall Effect in Magnetic Topological Insulators	SCIENCE			English	Article							HGTE QUANTUM-WELLS; SINGLE DIRAC CONE; SEMICONDUCTORS; TEMPERATURE; REALIZATION; SURFACE; BI2TE3	The anomalous Hall effect is a fundamental transport process in solids arising from the spin-orbit coupling. In a quantum anomalous Hall insulator, spontaneous magnetic moments and spin-orbit coupling combine to give rise to a topologically nontrivial electronic structure, leading to the quantized Hall effect without an external magnetic field. Based on first-principles calculations, we predict that the tetradymite semiconductors Bi2Te3, Bi2Se3, and Sb2Te3 form magnetically ordered insulators when doped with transition metal elements (Cr or Fe), in contrast to conventional dilute magnetic semiconductors where free carriers are necessary to mediate the magnetic coupling. In two-dimensional thin films, this magnetic order gives rise to a topological electronic structure characterized by a finite Chern number, with the Hall conductance quantized in units of e(2)/h (where e is the charge of an electron and h is Planck's constant).	[Yu, Rui; Zhang, Wei; Zhang, Hai-Jun; Dai, Xi; Fang, Zhong] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Yu, Rui; Zhang, Wei; Zhang, Hai-Jun; Dai, Xi; Fang, Zhong] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Zhang, Hai-Jun; Zhang, Shou-Cheng] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Zhang, Shou-Cheng] Tsinghua Univ, Ctr Adv Study, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; Stanford University; Tsinghua University	Dai, X (corresponding author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China.	daix@aphy.iphy.ac.cn; zfang@aphy.iphy.ac.cn	Zhang, Shou-Cheng/B-2794-2010; Fang, Zhong/D-4132-2009; Zhang, Haijun/E-5098-2013; li, yuan/B-4627-2011; Dai, Xi/HCG-9886-2022; Dai, Xi/C-4236-2008	Dai, Xi/0000-0002-2396-0966; yu, rui/0000-0002-6633-2337; Zhang, Haijun/0000-0002-9958-1102	National Science Foundation of China; 973 Program of China [2007CB925000, 2010CB923000]; International Science and Technology Cooperation Program of China; U.S. NSF [DMR-0904264]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); International Science and Technology Cooperation Program of China; U.S. NSF(National Science Foundation (NSF))	We acknowledge valuable discussions with C. X. Liu, X. L. Qi, Q. Niu, and S. Q. Shen and support from the National Science Foundation of China, the 973 Program of China (nos. 2007CB925000 and 2010CB923000), and the International Science and Technology Cooperation Program of China. S.C.Z. is supported by the U.S. NSF under grant number DMR-0904264.	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Chien YJ., 2007, THESIS U MICHIGAN AN; Dyck JS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.115212; Fang Z, 2003, SCIENCE, V302, P92, DOI 10.1126/science.1089408; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hall E H, 1880, PHILOS MAG, V10, P301; Hall E. H., 1881, PHILOS MAG, V12, P157, DOI DOI 10.1080/14786448108627086; Jungwirth T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207208; Jungwirth T, 2006, REV MOD PHYS, V78, P809, DOI 10.1103/RevModPhys.78.809; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Kul'bachinskii VA, 2001, JETP LETT+, V73, P352, DOI 10.1134/1.1378118; Liu CX, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041307; Liu CX, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.146802; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; NAGAOSA N, 2009, ANOMALOUS HALL EFFEC; NUNEZ AS, 2010, COLOSSAL ANISOTROPY; Onoda M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.206601; Qi XL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085308; Sanvito S, 2002, J SUPERCOND, V15, P85, DOI 10.1023/A:1014083312066; Sato K, 2003, PHYSICA B, V340, P863, DOI 10.1016/j.physb.2003.09.241; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Van Vleck JH, 1932, THEORY ELECT MAGNETI; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266803; ZHANG Y, 2009, CROSSOVER 3 DIMENSIO, P41304	28	1463	1507	24	1013	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					61	64		10.1126/science.1187485	http://dx.doi.org/10.1126/science.1187485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20522741	Green Submitted			2022-12-28	WOS:000279402700031
J	Wills, TJ; Cacucci, F; Burgess, N; O'Keefe, J				Wills, Tom J.; Cacucci, Francesca; Burgess, Neil; O'Keefe, John			Development of the Hippocampal Cognitive Map in Preweanling Rats	SCIENCE			English	Article							FREELY MOVING RATS; ENTORHINAL CORTEX; SPATIAL REPRESENTATION; THETA-RHYTHM; GRID CELLS; NAVIGATION	Orienting in large-scale space depends on the interaction of environmental experience and preconfigured, possibly innate, constructs. Place, head-direction, and grid cells in the hippocampal formation provide allocentric representations of space. Here we show how these cognitive representations emerge and develop as rat pups first begin to explore their environment. Directional, locational, and rhythmic organization of firing are present during initial exploration, including adultlike directional firing. The stability and precision of place cell firing continue to develop throughout juvenility. Stable grid cell firing appears later but matures rapidly to adult levels. Our results demonstrate the presence of three neuronal representations of space before extensive experience and show how they develop with age.	[Wills, Tom J.; Cacucci, Francesca; O'Keefe, John] UCL, London WC1E 6BT, England; [Cacucci, Francesca] UCL, Div Psychol & Language Sci, UC Inst Behav Neurosci, London WC1H 0AP, England; [Burgess, Neil] UCL, UC Inst Cognit Neurosci, London WC1N 3AR, England; [Burgess, Neil] UCL, UC Inst Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Wills, TJ (corresponding author), UCL, Gower St, London WC1E 6BT, England.	t.wills@ucl.ac.uk; f.cacucci@ucl.ac.uk	Wills, Tom J/B-3621-2011; Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Wills, Thomas/0000-0002-1331-2869; Cacucci, Francesca/0000-0002-1968-5156	European Union; Wellcome Trust; U.K. Medical Research Council; U.K. Royal Society; Research Councils U.K.; Medical Research Council [G0501672] Funding Source: researchfish; MRC [G0501672] Funding Source: UKRI	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.K. Royal Society(Royal Society of London); Research Councils U.K.(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Barry for use of adult grid cell data, A. Jeewajee and C. Barry for assistance with data analysis, S. Burton and R. Varriale for technical assistance, and C. Lever and J. Krupic for helpful discussions. This work was supported by the European Union SpaceBrain grant, the Wellcome Trust, the U.K. Medical Research Council, the U.K. Royal Society and a Research Councils U.K. academic fellowship to F. C.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burton BG, 2008, J NEUROPHYSIOL, V100, P3144, DOI 10.1152/jn.90424.2008; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Gerrish CJ, 1996, DEV PSYCHOBIOL, V29, P483, DOI 10.1002/(SICI)1098-2302(199609)29:6<483::AID-DEV1>3.0.CO;2-I; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; LEBLANC MO, 1979, EXP NEUROL, V66, P220, DOI 10.1016/0014-4886(79)90076-1; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Martin PD, 2002, HIPPOCAMPUS, V12, P465, DOI 10.1002/hipo.10021; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; NADEL L, 2009, DEV TIME TIMING, P233; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rivas J, 1996, EXP BRAIN RES, V108, P113; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; SCHENK F, 1985, BEHAV NEURAL BIOL, V43, P69, DOI 10.1016/S0163-1047(85)91510-9; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; VANCAUTER T, 1933, EUR J NEUROSCI, V27, P2008	29	367	373	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1573	1576		10.1126/science.1188224	http://dx.doi.org/10.1126/science.1188224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558720	Green Accepted			2022-12-28	WOS:000278859200051
J	Motani, R				Motani, Ryosuke			Warm-Blooded "Sea Dragons"?	SCIENCE			English	Editorial Material							CONSEQUENCES		Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis	Motani, R (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053				Bernal D, 2005, NATURE, V437, P1349, DOI 10.1038/nature04007; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Buffrenil V, 1990, PALEOBIOLOGY, V16, P435; Dickson KA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P998, DOI 10.1086/423743; Graham JB, 2004, J EXP BIOL, V207, P4015, DOI 10.1242/jeb.01267; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; MOTANI R, 2008, SOCIOL PAP, V14, P147; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Wallace BP, 2008, J EXP MAR BIOL ECOL, V356, P8, DOI 10.1016/j.jembe.2007.12.023; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007	13	27	32	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1361	1362		10.1126/science.1191409	http://dx.doi.org/10.1126/science.1191409			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538937				2022-12-28	WOS:000278598400024
J	Zhang, RY				Zhang, Renyi			Getting to the Critical Nucleus of Aerosol Formation	SCIENCE			English	Editorial Material							PARTICLE FORMATION; SULFURIC-ACID; NUCLEATION; NANOPARTICLES; CLUSTERS		[Zhang, Renyi] Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China; [Zhang, Renyi] Fudan Univ, Coll Environm Sci & Engn, Shanghai 200433, Peoples R China; [Zhang, Renyi] Texas A&M Univ, Ctr Atmospher Chem & Environm, Dept Atmospher Sci & Chem, College Stn, TX 77843 USA	Peking University; Fudan University; Texas A&M University System; Texas A&M University College Station	Zhang, RY (corresponding author), Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China.	renyi-zhang@tamu.edu	Zhang, Renyi/A-2942-2011	Zhang, Renyi/0000-0001-8708-3862	Div Atmospheric & Geospace Sciences [0938352] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Berndt T, 2005, SCIENCE, V307, P698, DOI 10.1126/science.1104054; Fan JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026295; Fan JW, 2004, ENVIRON CHEM, V1, P140, DOI 10.1071/EN04045; Kulmala M, 2000, NATURE, V404, P66, DOI 10.1038/35003550; McGraw R, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2830030; McMurry PH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005901; Metzger A, 2010, P NATL ACAD SCI USA, V107, P6646, DOI 10.1073/pnas.0911330107; Nadykto AB, 2007, CHEM PHYS LETT, V435, P14, DOI 10.1016/j.cplett.2006.12.050; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Wang L, 2010, NAT GEOSCI, V3, P238, DOI 10.1038/NGEO778; Young LH, 2008, ATMOS CHEM PHYS, V8, P4997, DOI 10.5194/acp-8-4997-2008; Zhang RY, 2009, P NATL ACAD SCI USA, V106, P17650, DOI 10.1073/pnas.0910125106; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139; Zhao J, 2009, J PHYS CHEM A, V113, P680, DOI 10.1021/jp806693r	15	258	271	12	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1366	1367		10.1126/science.1189732	http://dx.doi.org/10.1126/science.1189732			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538941				2022-12-28	WOS:000278598400028
J	Frank, F; Sonenberg, N; Nagar, B				Frank, Filipp; Sonenberg, Nahum; Nagar, Bhushan			Structural basis for 5 '-nucleotide base-specific recognition of guide RNA by human AGO2	NATURE			English	Article							MESSENGER-RNA; CRYSTAL-STRUCTURE; ARGONAUTE; MICRORNAS; COMPLEXES; STRAND	MicroRNAs (miRNAs) mediate post-transcriptional gene regulation through association with Argonaute proteins (AGOs)(1). Crystal structures of archaeal and bacterial homologues of AGOs have shown that the MID(middle) domain mediates the interaction with the phosphorylated 5' end of the miRNA guide strand and this interaction is thought to be independent of the identity of the 5' nucleotide in these systems(2,3). However, analysis of the known sequences of eukaryotic miRNAs and co-immunoprecipitation experiments indicate that there is a clear bias for U or A at the 5' position(4-7). Here we report the crystal structure of a MID domain from a eukaryotic AGO protein, human AGO2. The structure, in complex with nucleoside monophosphates (AMP, CMP, GMP, and UMP) mimicking the 5' end of miRNAs, shows that there are specific contacts made between the base of UMP or AMP and a rigid loop in the MID domain. Notably, the structure of the loop discriminates against CMP and GMP and dissociation constants calculated from NMR titration experiments confirm these results, showing that AMP (0.26 mM) and UMP (0.12 mM) bind with up to 30-fold higher affinity than either CMP (3.6 mM) or GMP (3.3 mM). This study provides structural evidence for nucleotide-specific interactions in the MID domain of eukaryotic AGO proteins and explains the observed preference for U or A at the 5' end of miRNAs.	[Frank, Filipp; Sonenberg, Nahum; Nagar, Bhushan] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Frank, Filipp; Sonenberg, Nahum] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 0B1, Canada; [Frank, Filipp; Nagar, Bhushan] Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Nagar, B (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca		Frank, Filipp/0000-0001-8680-2757	Canada Research Chair; Human Frontiers Science Program [CDA 0018/2006-C/1]; Canadian Institutes of Health Research (CIHR) [MOP-82929]; Boehringer Ingelheim Fonds	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Human Frontiers Science Program(Human Frontier Science Program); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank O. Larsson for help with bioinformatic analysis; J.-F. Trempe, G. Kozlov, S. Azeroual and D. Rodionov for help with X-ray and NMR data collection at the QANUC NMR facility; and K. Gehring and A. Berghuis for sharing resources and critical reading of the manuscript. We also thank M. Fabian, T. Sundermeier and T. Duchaine for comments on the manuscript; W. Filipowicz for discussions; R. Szittner, K. Illes and G. Virgili for technical assistance. B. N. is supported by a Canada Research Chair, a Career Development Award from the Human Frontiers Science Program (CDA 0018/2006-C/1) and an operating grant from the Canadian Institutes of Health Research (CIHR grant MOP-82929). N. S. is funded by a CIHR grant. F. F. is supported by a Boehringer Ingelheim Fonds PhD Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Felice KM, 2009, BIOCHEM J, V422, P329, DOI 10.1042/BJ20090534; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938	30	402	429	2	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					818	822		10.1038/nature09039	http://dx.doi.org/10.1038/nature09039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20505670	Green Published			2022-12-28	WOS:000278551800053
J	Tahirov, TH; Babayeva, ND; Varzavand, K; Cooper, JJ; Sedore, SC; Price, DH				Tahirov, Tahir H.; Babayeva, Nigar D.; Varzavand, Katayoun; Cooper, Jeffrey J.; Sedore, Stanley C.; Price, David H.			Crystal structure of HIV-1 Tat complexed with human P-TEFb	NATURE			English	Article							POLYMERASE-II TRANSCRIPTION; HUMAN CYCLIN T1; DEPENDENT KINASE REGULATION; CARBOXYL-TERMINAL DOMAIN; ELONGATION-FACTOR-B; RNA-POLYMERASE; MUTATIONAL ANALYSIS; VIRUS-REPLICATION; 7SK SNRNA; IN-VITRO	Regulation of the expression of the human immunodeficiency virus (HIV) genome is accomplished in large part by controlling transcription elongation. The viral protein Tat hijacks the host cell's RNA polymerase II elongation control machinery through interaction with the positive transcription elongation factor, P-TEFb, and directs the factor to promote productive elongation of HIV mRNA. Here we describe the crystal structure of the Tat center dot P-TEFb complex containing HIV-1 Tat, human Cdk9 (also known as CDK9), and human cyclin T1 (also known as CCNT1). Tat adopts a structure complementary to the surface of P-TEFb and makes extensive contacts, mainly with the cyclin T1 subunit of P-TEFb, but also with the T-loop of the Cdk9 subunit. The structure provides a plausible explanation for the tolerance of Tat to sequence variations at certain sites. Importantly, Tat induces significant conformational changes in P-TEFb. This finding lays a foundation for the design of compounds that would specifically inhibit the Tat center dot P-TEFb complex and block HIV replication.	[Tahirov, Tahir H.; Babayeva, Nigar D.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Varzavand, Katayoun; Cooper, Jeffrey J.; Sedore, Stanley C.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Nebraska System; University of Nebraska Medical Center; University of Iowa	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Price, David H/F-6173-2010	Tahirov, Tahir/0000-0002-1238-0069; Price, David/0000-0002-5597-385X	NIH [GM35500, AI074392, GM082923]; Department of Health and Human Services [LB506]; National Center for Research Resources at the National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Cancer Center [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074392, R33AI074392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082923, R01GM035500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lovelace and G. E. Borgstahl for maintenance and management of the Eppley Institute's X-ray Crystallography facility; D. G. Vassylyev for the zonal scaling instruction files. This work is supported by the NIH grants GM35500 and AI074392 to D. H. P., by Nebraska Department of Health and Human Services grant LB506 and in part by NIH grant GM082923 to T. H. T. This work is also based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The Eppley Institute's X-ray Crystallography facility is supported by Cancer Center Support Grant P30CA036727.	Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; DERSE D, 1993, VIROLOGY, V194, P530, DOI 10.1006/viro.1993.1291; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kuiken C, 2009, LAUR0903280 LOS AL N; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Letvin NL, 2009, SCIENCE, V326, P1196, DOI 10.1126/science.1183278; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Michels Annemieke A., 2008, Biotechnology Journal, V3, P1022, DOI 10.1002/biot.200800104; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; RICE AP, 1990, J VIROL, V64, P1864, DOI 10.1128/JVI.64.4.1864-1868.1990; Richter S, 2002, P NATL ACAD SCI USA, V99, P7928, DOI 10.1073/pnas.122119999; RUBEN S, 1989, J VIROL, V63, P1; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; SADAIE MR, 1990, AIDS RES HUM RETROV, V6, P1257, DOI 10.1089/aid.1990.6.1257; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Tahirov TH, 1998, J STRUCT BIOL, V121, P68, DOI 10.1006/jsbi.1997.3940; Taube R, 2000, J VIROL, V74, P892, DOI 10.1128/JVI.74.2.892-898.2000; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang Y, 2009, MINI-REV MED CHEM, V9, P379, DOI 10.2174/1389557510909030379; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	48	214	222	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					747	U2		10.1038/nature09131	http://dx.doi.org/10.1038/nature09131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535204	Green Accepted			2022-12-28	WOS:000278551800037
J	Yamanaka, S; Blau, HM				Yamanaka, Shinya; Blau, Helen M.			Nuclear reprogramming to a pluripotent state by three approaches	NATURE			English	Review							HEPATOMA-CELL HYBRIDS; STEM-CELLS; GENE-EXPRESSION; SOMATIC-CELLS; DIFFERENTIATED FUNCTIONS; HEMATOPOIETIC-CELLS; DNA DEMETHYLATION; PURKINJE NEURONS; MAMMALIAN-CELLS; MUSCLE GENES	The stable states of differentiated cells are now known to be controlled by dynamic mechanisms that can easily be perturbed. An adult cell can therefore be reprogrammed, altering its pattern of gene expression, and hence its fate, to that typical of another cell type. This has been shown by three distinct experimental approaches to nuclear reprogramming: nuclear transfer, cell fusion and transcription-factor transduction. Using these approaches, nuclei from 'terminally differentiated' somatic cells can be induced to express genes that are typical of embryonic stem cells, which can differentiate to form all of the cell types in the body. This remarkable discovery of cellular plasticity has important medical applications.	[Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Stanford University; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Blau, HM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	hblau2@stanford.edu			Japanese Ministry of Education, Culture, Sports, Science Technology; Japan Science and Technology Agency; National Institute of Biomedical Innovation (Japan); National Institutes of Health [AG009521, AG020961, HL096113, MDA (4320)]; Juvenile Diabetes Research Foundation [34-2008-623, LLS (6025-09)]; California Institute for Regenerative Medicine [RT1-01001, RB1-02192]; Baxter International Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, R01HL096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R37AG009521, R01AG009521] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Institute of Biomedical Innovation (Japan)(National Institute of Biomedical Innovation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Baxter International Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We apologize to those whose work is not cited because of space constraints. We are grateful to our colleagues J. Gurdon, T. Graf, J. Pomerantz and T. Tada, as well as to members of our laboratories for their insightful comments on the manuscript and especially to N. Bhutani and S. Corbel for figure design. We also thank our funding sources: S.Y. acknowledges support from the Japanese Ministry of Education, Culture, Sports, Science & Technology, the Japan Science and Technology Agency and the National Institute of Biomedical Innovation (Japan); and H. M. B. acknowledges support from the National Institutes of Health (grants AG009521, AG020961 and HL096113), MDA (4320), the Juvenile Diabetes Research Foundation (34-2008-623), LLS (6025-09), the California Institute for Regenerative Medicine (RT1-01001 and RB1-02192) and the Baxter International Foundation.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Agarwal S, 2010, CELL RES, V20, P253, DOI 10.1038/cr.2010.30; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; DAVIDSON RL, 1972, P NATL ACAD SCI USA, V69, P951, DOI 10.1073/pnas.69.4.951; DAVIDSON RL, 1966, P NATL ACAD SCI USA, V56, P1437, DOI 10.1073/pnas.56.5.1437; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farah MH, 2000, DEVELOPMENT, V127, P693; GEHRING W, 1967, DEV BIOL, V16, P438, DOI 10.1016/0012-1606(67)90058-9; Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; HADORN E, 1966, DEV BIOL, V13, P424, DOI 10.1016/0012-1606(66)90058-3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; HARRIS H, 1966, J CELL SCI, V1, P1; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MILLER SC, 1988, GENE DEV, V2, P330, DOI 10.1101/gad.2.3.330; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PAVLATH GK, 1986, J CELL BIOL, V102, P124, DOI 10.1083/jcb.102.1.124; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; PETERSEN JA, 1972, P NATL ACAD SCI USA, V69, P571, DOI 10.1073/pnas.69.3.571; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; Ptashne M., 1986, A GENETIC SWITCH; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; RINGERTZ NR, 1977, CELL HYBRIDS; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; SPEAR BT, 1990, MOL CELL BIOL, V10, P5047, DOI 10.1128/MCB.10.10.5047; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wakayama S, 2008, P NATL ACAD SCI USA, V105, P17318, DOI 10.1073/pnas.0806166105; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; WEISS MC, 1971, P NATL ACAD SCI USA, V68, P3026, DOI 10.1073/pnas.68.12.3026; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; WRIGHT WE, 1984, J CELL BIOL, V98, P427, DOI 10.1083/jcb.98.2.427; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamamoto T, 2007, PATHOL INT, V57, P1, DOI 10.1111/j.1440-1827.2007.02049.x; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	98	533	576	1	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					704	712		10.1038/nature09229	http://dx.doi.org/10.1038/nature09229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535199	Green Accepted			2022-12-28	WOS:000278551800032
J	Raftery, J				Raftery, James			Multiple sclerosis risk sharing scheme: a costly failure	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACCESS; DRUGS		Univ Southampton, Sch Med, Wessex Inst, Southampton SO16 7NS, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Sch Med, Wessex Inst, Southampton SO16 7NS, Hants, England.	raftery@soton.ac.uk						Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; Department of Health, 2009, PHARM PRIC REG SCHEM; *HC HLTH COMM, 2009, HOUS COMM HLTH COMM; *HSC, 2002, COST EFF PROV DIS MO; KEEN A, 2008, MULTIPLE SCLEROSIS D; KEEN A, 2008, PARLIAMENTARY WRITTE; Keogh A, 2009, INTERN MED J; MCCABE C, 2009, BRIT MED J, V340, pC1786; McCabe CJ, 2010, PHARMACOECONOMICS, V28, P143, DOI 10.2165/11530850-000000000-00000; Menon D, 2010, PHARMACOECONOMICS, V28, P109, DOI 10.2165/11530860-000000000-00000; *MULT SCLER SOC, 2007, RISK SHAR SCHEM DIS; *NICE, 2002, 32 NICE; *NICE, 2007, 27 NICE; Owen Aj, 2008, J Med Econ, V11, P235, DOI 10.3111/13696990802034525; Pickin M, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-1; Sudlow CLM, 2003, BRIT MED J, V326, P388, DOI 10.1136/bmj.326.7385.388; WARLOW C, 2003, PRACT NEUROL, V3, P194	17	42	42	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c1672	10.1136/bmj.c1672	http://dx.doi.org/10.1136/bmj.c1672			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BM	20522654				2022-12-28	WOS:000278556500001
J	Paleri, V; Staines, K; Sloan, P; Douglas, A; Wilson, J				Paleri, Vinidh; Staines, Konrad; Sloan, Philip; Douglas, Adam; Wilson, Janet			Evaluation of oral ulceration in primary care	BRITISH MEDICAL JOURNAL			English	Review							CLINICAL ASPECTS.; NECK-CANCER; ULCERS; METAANALYSIS; HEAD; TOOL		[Paleri, Vinidh; Staines, Konrad; Sloan, Philip; Wilson, Janet] Newcastle upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Douglas, Adam] Cestria Hlth Ctr, Durham DH2 3DJ, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust	Paleri, V (corresponding author), Newcastle upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	vinidh.paleri@ncl.ac.uk		, konrad/0000-0001-9108-2790; wilson, janet/0000-0002-6416-5870				Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Bruce AJ, 2003, DERMATOL CLIN, V21, P1, DOI 10.1016/S0733-8635(02)00064-5; *CLIN KNOWL SUMM, OR HLTH; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Department of Health, 2000, REF GUID SUSP CANC, P39; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Kujan O, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004150.PUB2.; Lopez EPM, 2003, BRIT J CANCER, V88, P1702, DOI 10.1038/sj.bjc.6600975; Mckie C, 2008, ORAL ONCOL, V44, P851, DOI 10.1016/j.oraloncology.2007.10.010; Munoz-Corcuera M, 2009, CLIN EXP DERMATOL, V34, P456, DOI 10.1111/j.1365-2230.2009.03219.x; Munoz-Corcuera M, 2009, CLIN EXP DERMATOL, V34, P289, DOI 10.1111/j.1365-2230.2009.03220.x; NHS Scotland, 2021, SCOTT REF GUID SUSP; ROBINSON CM, ORAL ONCOLO IN PRESS; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Scully C, 2008, AM J DENT, V21, P199; Shulman JD, 2004, J AM DENT ASSOC, V135, P1279, DOI 10.14219/jada.archive.2004.0403; Speight PM, 2006, HEALTH TECHNOL ASSES, V10, P1; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; Wade J, 2010, FAM PRACT, V27, P77, DOI 10.1093/fampra/cmp064; ORAL LICHEN PLANUS	22	9	10	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2010	340								c2639	10.1136/bmj.c2639	http://dx.doi.org/10.1136/bmj.c2639			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BL	20519268				2022-12-28	WOS:000278556400002
J	Fu, Q; Li, WX; Yao, YX; Liu, HY; Su, HY; Ma, D; Gu, XK; Chen, LM; Wang, Z; Zhang, H; Wang, B; Bao, XH				Fu, Qiang; Li, Wei-Xue; Yao, Yunxi; Liu, Hongyang; Su, Hai-Yan; Ma, Ding; Gu, Xiang-Kui; Chen, Limin; Wang, Zhen; Zhang, Hui; Wang, Bing; Bao, Xinhe			Interface-Confined Ferrous Centers for Catalytic Oxidation	SCIENCE			English	Article							PREFERENTIAL OXIDATION; CARBON-MONOXIDE; CO OXIDATION; OXIDE LAYERS; FE; SURFACES; SITES; NANOPARTICLES; ADSORPTION; ZEOLITES	Coordinatively unsaturated ferrous (CUF) sites confined in nanosized matrices are active centers in a wide range of enzyme and homogeneous catalytic reactions. Preparation of the analogous active sites at supported catalysts is of great importance in heterogeneous catalysis but remains a challenge. On the basis of surface science measurements and density functional calculations, we show that the interface confinement effect can be used to stabilize the CUF sites by taking advantage of strong adhesion between ferrous oxides and metal substrates. The interface-confined CUF sites together with the metal supports are active for dioxygen activation, producing reactive dissociated oxygen atoms. We show that the structural ensemble was highly efficient for carbon monoxide oxidation at low temperature under typical operating conditions of a proton-exchange membrane fuel cell.	[Fu, Qiang; Li, Wei-Xue; Yao, Yunxi; Liu, Hongyang; Su, Hai-Yan; Ma, Ding; Gu, Xiang-Kui; Chen, Limin; Wang, Zhen; Bao, Xinhe] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China; [Li, Wei-Xue; Su, Hai-Yan; Gu, Xiang-Kui] Chinese Acad Sci, Dalian Inst Chem Phys, Ctr Theoret & Computat Chem, Dalian 116023, Peoples R China; [Zhang, Hui; Wang, Bing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Bao, XH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China.	xhbao@dicp.ac.cn	Li, Wei-Xue/A-1414-2011; Wang, Bing/D-3535-2009; Bao, Xinhe/P-5373-2014; Fu, Qiang/E-7109-2015; Gu, Xiangkui/H-3706-2014; Yao, Yunxi/F-3451-2013	Wang, Bing/0000-0002-2953-2196; Bao, Xinhe/0000-0001-9404-6429; Fu, Qiang/0000-0001-5316-6758; Li, Wei-Xue/0000-0002-5043-3088; Gu, Xiangkui/0000-0001-6537-7026; Yao, Yunxi/0000-0002-0814-6675	Natural Science Foundation of China; Chinese Academy of Sciences; Ministry of Science and Technology of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We gratefully acknowledge the Natural Science Foundation of China, Chinese Academy of Sciences, and Ministry of Science and Technology of China for the support of this work. We thank the SSRF and Sunrise Power Co. for the beamline and assistance with the PEMFC test.	Alayoglu S, 2008, NAT MATER, V7, P333, DOI 10.1038/nmat2156; CAMPBELL CT, 1980, J CHEM PHYS, V73, P5862, DOI 10.1063/1.440029; Das TK, 2001, P NATL ACAD SCI USA, V98, P479, DOI 10.1073/pnas.98.2.479; Ensing B, 2004, J AM CHEM SOC, V126, P4355, DOI 10.1021/ja038865a; Fu Q, 2007, SURF SCI REP, V62, P431, DOI 10.1016/j.surfrep.2007.07.001; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Huang WX, 2006, SURF SCI, V600, P793, DOI 10.1016/j.susc.2005.11.026; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kotobuki M, 2005, J CATAL, V236, P262, DOI 10.1016/j.jcat.2005.09.026; Kwak JH, 2009, SCIENCE, V325, P1670, DOI 10.1126/science.1176745; Liu XS, 2002, APPL CATAL A-GEN, V226, P293, DOI 10.1016/S0926-860X(01)00915-2; Ma T, 2009, CHEMPHYSCHEM, V10, P1013, DOI 10.1002/cphc.200900053; Merte LR, 2009, SURF SCI, V603, pL15, DOI 10.1016/j.susc.2008.11.014; Meyer R, 2005, SURF SCI, V586, P174, DOI 10.1016/j.susc.2005.05.011; Netzer FP, 2002, SURF REV LETT, V9, P1553, DOI 10.1142/S0218625X02003950; Panov GI, 1998, CATAL TODAY, V41, P365, DOI 10.1016/S0920-5861(98)00026-1; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; Somorjai GA, 2008, ANGEW CHEM INT EDIT, V47, P9212, DOI 10.1002/anie.200803181; Sun YN, 2009, J CATAL, V266, P359, DOI 10.1016/j.jcat.2009.07.002; Thomas JM, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2832309; Weiss W, 2002, PROG SURF SCI, V70, P1, DOI 10.1016/S0079-6816(01)00056-9; Yeo YY, 1997, J CHEM PHYS, V106, P392, DOI 10.1063/1.473203; Zecchina A, 2007, PHYS CHEM CHEM PHYS, V9, P3483, DOI 10.1039/b703445h	23	750	773	64	1641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1141	1144		10.1126/science.1188267	http://dx.doi.org/10.1126/science.1188267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508127				2022-12-28	WOS:000278104700039
J	Ou, CY; Poon, VY; Maeder, CI; Watanabe, S; Lehrman, EK; Fu, AKY; Park, M; Fu, WY; Jorgensen, EM; Ip, NY; Shen, K				Ou, Chan-Yen; Poon, Vivian Y.; Maeder, Celine I.; Watanabe, Shigeki; Lehrman, Emily K.; Fu, Amy K. Y.; Park, Mikyoung; Fu, Wing-Yu; Jorgensen, Erik M.; Ip, Nancy Y.; Shen, Kang			Two Cyclin-Dependent Kinase Pathways Are Essential for Polarized Trafficking of Presynaptic Components	CELL			English	Article							AXONAL-TRANSPORT; CDK5; NEURONS; PROTEIN; EXPRESSION; PHOSPHORYLATION; DISRUPTION; MECHANISMS; REGULATOR; PCTAIRE-1	Polarized trafficking of synaptic proteins to axons and dendrites is crucial to neuronal function. Through forward genetic analysis in C. elegans, we identified a cyclin (CYY-1) and a cyclin-dependent Pctaire kinase (PCT-1) necessary for targeting presynaptic components to the axon. Another cyclin-dependent kinase, CDK-5, and its activator p35, act in parallel to and partially redundantly with the CYY-1/PCT-1 pathway. Synaptic vesicles and active zone proteins mostly mislocalize to dendrites in animals defective for both PCT-1 and CDK-5 pathways. Unlike the kinesin-3 motor, unc-104/Kif1a mutant, cyy-1 cdk-5 double mutants have no reduction in anterogradely moving synaptic vesicle precursors (SVPs) as observed by dynamic imaging. Instead, the number of retrogradely moving SVPs is dramatically increased. Furthermore, this mislocalization defect is suppressed by disrupting the retrograde motor, the cytoplasmic dynein complex. Thus, PCT-1 and CDK-5 pathways direct polarized trafficking of presynaptic components by inhibiting dynein-mediated retrograde transport and setting the balance between anterograde and retrograde motors.	[Ou, Chan-Yen; Maeder, Celine I.; Lehrman, Emily K.; Park, Mikyoung; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Poon, Vivian Y.] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA; [Watanabe, Shigeki; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA; [Fu, Amy K. Y.; Fu, Wing-Yu; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Biotechnol Res Inst, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Fu, Amy K. Y.; Fu, Wing-Yu; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China	Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu		Fu, Kit Yu/0000-0003-4085-6201; Watanabe, Shigeki/0000-0001-7580-8141; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; OU, CHAN-YEN/0000-0002-6627-5088	Human Frontier Science Foundation; W.M. Keck Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392, R01NS034307] Funding Source: NIH RePORTER	Human Frontier Science Foundation(Human Frontier Science Program); W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Human Frontier Science Foundation, the W.M. Keck Foundation, and the Howard Hughes Medical Institute. We thank the International C. elegans Gene Knockout Consortium, the National Bioresource Project-Japan, and the Nonet lab for strains. We also thank Y. Wu, M. Margeta, C. Gao, and Y. Fu for technical assistance, and C. Bargmann, L. H. Tsai, and members of the Shen lab for thoughtful comments on the manuscript.	BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Cai Q, 2007, J NEUROSCI, V27, P7284, DOI 10.1523/JNEUROSCI.0731-07.2007; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Furukawa Y, 2000, BRIT J HAEMATOL, V110, P663, DOI 10.1046/j.1365-2141.2000.02253.x; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Graeser R, 2002, J CELL SCI, V115, P3479; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Herskovits AZ, 2006, NEUROBIOL DIS, V23, P398, DOI 10.1016/j.nbd.2006.04.004; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; KIESS M, 1995, ONCOGENE, V10, P159; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Le Boffant F, 1998, EUR J BIOCHEM, V257, P112, DOI 10.1046/j.1432-1327.1998.2570112.x; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Ma S, 2002, J CELL SCI, V115, P1453; Margeta MA, 2009, P NATL ACAD SCI USA, V106, P1632, DOI 10.1073/pnas.0812078106; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; MIYAJIMA M, 1995, NEUROREPORT, V6, P1130, DOI 10.1097/00001756-199505300-00014; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Ratner N, 1998, J NEUROSCI, V18, P7717; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Smith D, 2003, NEUROSIGNALS, V12, P239, DOI 10.1159/000074626; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; UCHIDA T, 1994, FEBS LETT, V355, P35, DOI 10.1016/0014-5793(94)01163-X; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITE JG, 1986, PHILOS T R SOC LON B, V314, P340; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yamochi T, 2001, BIOCHEM BIOPH RES CO, V286, P1045, DOI 10.1006/bbrc.2001.5493; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Yip YP, 2007, J COMP NEUROL, V503, P297, DOI 10.1002/cne.21377; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	49	113	126	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					846	858		10.1016/j.cell.2010.04.011	http://dx.doi.org/10.1016/j.cell.2010.04.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510931	Bronze, Green Accepted			2022-12-28	WOS:000278132900019
J	Skinner, LC; Fallon, S; Waelbroeck, C; Michel, E; Barker, S				Skinner, L. C.; Fallon, S.; Waelbroeck, C.; Michel, E.; Barker, S.			Ventilation of the Deep Southern Ocean and Deglacial CO2 Rise	SCIENCE			English	Article							ATMOSPHERIC CO2; CARBON-CYCLE; ICE CORES; LAST; CALIBRATION; ATLANTIC; EVENTS; KYR; VARIABILITY; TRANSPORT	Past glacial-interglacial increases in the concentration of atmospheric carbon dioxide (CO2) are thought to arise from the rapid release of CO2 sequestered in the deep sea, primarily via the Southern Ocean. Here, we present radiocarbon evidence from the Atlantic sector of the Southern Ocean that strongly supports this hypothesis. We show that during the last glacial period, deep water circulating around Antarctica was more than two times older than today relative to the atmosphere. During deglaciation, the dissipation of this old and presumably CO2-enriched deep water played an important role in the pulsed rise of atmospheric CO2 through its variable influence on the upwelling branch of the Antarctic overturning circulation.	[Skinner, L. C.] Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; [Fallon, S.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Waelbroeck, C.; Michel, E.] UVSQ, CEA, Lab CNRS,Inst Pierre Simon Laplace, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; [Barker, S.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales	University of Cambridge; Australian National University; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Cardiff University	Skinner, LC (corresponding author), Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Downing St, Cambridge CB2 3EQ, England.	lcs32@esc.cam.ac.uk	Fallon, Stewart J/G-6645-2011; Stephen, Barker/C-2770-2009	Fallon, Stewart J/0000-0002-8064-5903; Stephen, Barker/0000-0001-7870-6431; waelbroeck, claire/0000-0002-7256-5727; Michel, Elisabeth/0000-0001-7810-8888	Royal Society; Natural Environment Research Council [1245.1007]; ANU; Christ's College; Centre National de la Recherche Scientifique; Institut National des Sciences de l'Univers; Commissariat a l'Energie Atomique; Natural Environment Research Council [NRCF010001] Funding Source: researchfish; NERC [NRCF010001] Funding Source: UKRI	Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ANU(Australian National University); Christ's College; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National des Sciences de l'Univers; Commissariat a l'Energie Atomique(French Atomic Energy Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to N. Caillon, F. Dewilde, G. Isguder, H. Rebaubier, L. Booth, P. Ljubic, and K. James for technical assistance. A. Parnell provided generous and invaluable help with Bchron, and P. Kohler very kindly provided unpublished Delta<SUP>14</SUP>C<INF>atm</INF> simulations. We thank R. Gersonde and A. Mackensen for sharing their South Atlantic expertise, and we acknowledge the crew of the R/V Marion Dufresne and the Paul Emile Victor Institute (IPEV) who collected core MD07-3076CQ. This work was funded by the Royal Society, by Natural Environment Research Council Radiocarbon grant 1245.1007, and via a University Fellowship held by L. C. S. This work was facilitated by a visiting fellowship held by L. C. S. at ANU and by travel grants from the Royal Society and Christ's College. C. W. and E. M. are supported financially by Centre National de la Recherche Scientifique, Institut National des Sciences de l'Univers, and Commissariat a l'Energie Atomique. This is Laboratoire des Sciences du Climat et l'Environnement contribution 4188.	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2008, EARTH PLANET SC LETT, V274, P322, DOI 10.1016/j.epsl.2008.07.035; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Fischer H, 2007, EARTH PLANET SC LETT, V260, P340, DOI 10.1016/j.epsl.2007.06.014; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kohler P, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001228; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Laj C, 2004, GEOPHYS MONOGR SER, V145, P255, DOI 10.1029/145GM19; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; Parnell AC, 2008, QUATERNARY SCI REV, V27, P1872, DOI 10.1016/j.quascirev.2008.07.009; Pena LD, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001620; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; Primeau F, 2005, J PHYS OCEANOGR, V35, P545, DOI 10.1175/JPO2699.1; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401	28	336	345	5	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1147	1151		10.1126/science.1183627	http://dx.doi.org/10.1126/science.1183627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508128				2022-12-28	WOS:000278104700041
J	Rothberg, MB; Pekow, PS; Lahti, M; Brody, O; Skiest, DJ; Lindenauer, PK				Rothberg, Michael B.; Pekow, Penelope S.; Lahti, Maureen; Brody, Oren; Skiest, Daniel J.; Lindenauer, Peter K.			Antibiotic Therapy and Treatment Failure in Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGEMENT; DIAGNOSIS; COPD	Context Guidelines recommend antibiotic therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD), but the evidence is based on small, heterogeneous trials, few of which include hospitalized patients. Objective To compare the outcomes of patients treated with antibiotics in the first 2 hospital days with those treated later or not at all. Design, Setting, and Patients Retrospective cohort of patients aged 40 years or older who were hospitalized from January 1, 2006, through December 31, 2007, for acute exacerbations of COPD at 413 acute care facilities throughout the United States. Main Outcome Measures A composite measure of treatment failure, defined as the initiation of mechanical ventilation after the second hospital day, inpatient mortality, or readmission for acute exacerbations of COPD within 30 days of discharge; length of stay, and hospital costs. Results Of 84 621 patients, 79% received at least 2 consecutive days of antibiotic treatment. Treated patients were less likely than nontreated patients to receive mechanical ventilation after the second hospital day (1.07%; 95% confidence interval [CI], 1.06%-1.08% vs 1.80%; 95% CI, 1.78%-1.82%), had lower rates of inpatient mortality (1.04%; 95% CI, 1.03%-1.05% vs 1.59%; 95% CI, 1.57%-1.61%), and had lower rates of readmission for acute exacerbations of COPD (7.91%; 95% CI, 7.89%-7.94% vs 8.79%; 95% CI, 8.74%-8.83%). Patients treated with antibiotic agents had a higher rate of readmissions for Clostridium difficile (0.19%; 95% CI, 0.187%-0.193%) than those who were not treated (0.09%; 95% CI, 0.086%-0.094%). After multivariable adjustment, including the propensity for antibiotic treatment, the risk of treatment failure was lower in antibiotic-treated patients (odds ratio, 0.87; 95% CI, 0.82-0.92). A grouped treatment approach and hierarchical modeling to account for potential confounding of hospital effects yielded similar results. Analysis stratified by risk of treatment failure found similar magnitudes of benefit across all subgroups. Conclusion Early antibiotic administration was associated with improved outcomes among patients hospitalized for acute exacerbations of COPD regardless of the risk of treatment failure. JAMA. 2010;303(20):2035-2042 www.jama.com	[Rothberg, Michael B.; Brody, Oren] Baystate Med Ctr, Div Gen Med & Geriatr, Springfield, MA 01199 USA; [Rothberg, Michael B.; Pekow, Penelope S.; Lindenauer, Peter K.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Skiest, Daniel J.] Baystate Med Ctr, Div Infect Dis, Springfield, MA 01199 USA; [Rothberg, Michael B.; Brody, Oren; Lindenauer, Peter K.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Pekow, Penelope S.; Lahti, Maureen] Univ Massachusetts, Sch Publ Hlth, Amherst, MA 01003 USA	Baystate Medical Center; Baystate Medical Center; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Rothberg, MB (corresponding author), Baystate Med Ctr, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	michael.rothberg@bhs.org						ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Daniels JMA, 2010, AM J RESP CRIT CARE, V181, P150, DOI 10.1164/rccm.200906-0837OC; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Groenewegen KH, 2003, RESP MED, V97, P770, DOI 10.1016/S0954-6111(03)00026-X; Johnston SC, 2002, AM J EPIDEMIOL, V156, P753, DOI 10.1093/aje/kwf095; Lieberman D, 2001, DIAGN MICR INFEC DIS, V40, P95, DOI 10.1016/S0732-8893(01)00255-3; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Moody A, 2004, THORAX, V59, P1; *NAT HEART LUNG BL, TAK 1 STEP BREATH BE; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nouira S, 2001, LANCET, V358, P2020, DOI 10.1016/S0140-6736(01)07097-0; O'Donnell DE, 2008, CAN RESPIR J, V15, p1A, DOI 10.1155/2008/641965; Parsons L, 2001, REDUCING BIAS PROPEN; Patil SP, 2003, ARCH INTERN MED, V163, P1180, DOI 10.1001/archinte.163.10.1180; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ram FSF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004403.pub2; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; SACHS APE, 1995, THORAX, V50, P758, DOI 10.1136/thx.50.7.758; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, AM J RESP CRIT CARE, V177, P491, DOI 10.1164/rccm.200708-1234OC; Snow V, 2001, ANN INTERN MED, V134, P595, DOI 10.7326/0003-4819-134-7-200104030-00015; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278	25	149	159	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2035	2042		10.1001/jama.2010.672	http://dx.doi.org/10.1001/jama.2010.672			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501925	Bronze			2022-12-28	WOS:000278018200027
J	Widmer, M; Blum, J; Hofmeyr, GJ; Carroli, G; Abdel-Aleem, H; Lumbiganon, P; Nguyen, TNN; Wojdyla, D; Thinkhamrop, J; Singata, M; Mignini, LE; Abdel-Aleem, MA; Tran, ST; Winikoff, B				Widmer, Mariana; Blum, Jennifer; Hofmeyr, G. Justus; Carroli, Guillermo; Abdel-Aleem, Hany; Lumbiganon, Pisake; Nguyen Thi Nhu Ngoc; Wojdyla, Daniel; Thinkhamrop, Jadsada; Singata, Mandisa; Mignini, Luciano E.; Abdel-Aleem, Mahmoud Ahmad; Tran Son Thach; Winikoff, Beverly			Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial	LANCET			English	Article							ORAL MISOPROSTOL; DIFFERENT ROUTES; MANAGEMENT; OXYTOCIN; PPH	Background Post-partum haemorrhage is a leading cause of global maternal morbidity and mortality. Misoprostol, a prostaglandin analogue with uterotonic activity, is an attractive option for treatment because it is stable, active orally, and inexpensive. We aimed to assess the effectiveness of misoprostol as an adjunct to standard uterotonics compared with standard uterotonics alone for treatment of post-partum haemorrhage. Methods Women delivering vaginally who had clinically diagnosed post-partum haemorrhage due to uterine atony were enrolled from participating hospitals in Argentina, Egypt, South Africa, Thailand, and Vietnam between July, 2005, and August, 2008. Computer-generated randomisation was used to assign women to receive 600 mu g misoprostol or matching placebo sublingually; both groups were also given routine injectable uterotonics. Allocation was concealed by distribution of sealed and sequentially numbered treatment packs in the order that women were enrolled. Providers and women were masked to treatment assignment. The primary outcome was blood loss of 500 mL or more within 60 min after randomisation. Analysis was by intention to treat. This study is registered, number ISRCTN34455240. Findings 1422 women were assigned to receive misoprostol (n=705) or placebo (n=717). The proportion of women with blood loss of 500 mL or more within 60 min was similar between the misoprostol group (100 [14%]) and the placebo group (100 [14%]; relative risk 1-02, 95% CI 0.79-1.32). In the first 60 min, an increased proportion of women on misoprostol versus placebo, had shivering (455/704 [65%] vs 230/717 [32%]; 2.01, 1.79-2.27) and body temperature of 38 C or higher (303/704 [43%] vs 107/717 [15%]; 2.88, 2.37-2.50). Interpretation Findings from this study do not support clinical use of 600 mu g sublingual misoprostol in addition to standard injectable uterotonics for treatment of post-partum haemorrhage.	[Widmer, Mariana] WHO, Dept Reprod Hlth & Res, UNDP UNFPA WHO World Bank Special Programme Res D, CH-1211 Geneva, Switzerland; [Blum, Jennifer; Winikoff, Beverly] Gynu Hlth Projects, New York, NY USA; [Hofmeyr, G. Justus; Singata, Mandisa] Univ Witwatersrand, Effect Care Res Unit, Eastern Cape Dept Hlth, Eastern Cape, South Africa; [Hofmeyr, G. Justus; Singata, Mandisa] Univ Ft Hare, Eastern Cape Dept Hlth, Effect Care Res Unit, Eastern Cape, South Africa; [Carroli, Guillermo; Wojdyla, Daniel; Mignini, Luciano E.] Ctr Rosarino Estudios Perinatales, Rosario, Santa Fe, Argentina; [Abdel-Aleem, Hany; Abdel-Aleem, Mahmoud Ahmad] Assiut Univ Hosp, Dept Obstet & Gynaecol, Assiut, Egypt; [Lumbiganon, Pisake; Thinkhamrop, Jadsada] Khon Kaen Univ, Dept Obstet & Gynaecol, Khon Kaen, Thailand; [Nguyen Thi Nhu Ngoc; Tran Son Thach] Hung Vuong Hosp, Ho Chi Minh City, Vietnam	United Nations Population Fund; World Health Organization; University of Witwatersrand; University of Fort Hare; Egyptian Knowledge Bank (EKB); Assiut University; Khon Kaen University	Widmer, M (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP UNFPA WHO World Bank Special Programme Res D, 20 Ave Appia, CH-1211 Geneva, Switzerland.	widmerm@who.int	Lumbiganon, Pisake/E-8634-2010; Tran, Thach/G-9608-2012; abdelaleem, mahmoud/B-6567-2015	Lumbiganon, Pisake/0000-0001-9372-0071; abdelaleem, mahmoud/0000-0003-3942-9325; Tran, Thach/0000-0002-6454-124X	Bill & Melinda Gates Foundation; UNDP/UNFPA/WHO/World Bank	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNDP/UNFPA/WHO/World Bank(World Health Organization)	Funding Bill & Melinda Gates Foundation, and UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction.	Alfirevic Z, 2006, COCHRANE DB SYST REV, V2; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Blum J, 2007, INT J GYNECOL OBSTET, V99, pS202, DOI 10.1016/j.ijgo.2007.09.013; Blum J, 2010, LANCET, V375, P217, DOI 10.1016/S0140-6736(09)61923-1; Chong YS, 2006, LANCET, V368, P1216, DOI 10.1016/S0140-6736(06)69497-X; Chong YS, 2004, EUR J OBSTET GYN R B, V113, P191, DOI 10.1016/j.ejogrb.2003.09.011; Chong YS, 2001, BRIT J OBSTET GYNAEC, V108, P41; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Elsedeek MSE, 2009, BJOG-INT J OBSTET GY, V116, P431, DOI 10.1111/j.1471-0528.2008.02054.x; Geller SE, 2008, INT J GYNECOL OBSTET, V101, P94, DOI 10.1016/j.ijgo.2007.08.025; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hofmeyr G Justus, 2004, BMC Pregnancy Childbirth, V4, P16, DOI 10.1186/1471-2393-4-16; Hofmeyr GJ, 2008, BEST PRACT RES CL OB, V22, P1025, DOI 10.1016/j.bpobgyn.2008.08.005; Hofmeyr GJ, 2005, BJOG-INT J OBSTET GY, V112, P547, DOI 10.1111/j.1471-0528.2004.00512.x; Hofmeyr GJ, 2003, COCHRANE DB SYST REV, V1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lokugamage AU, 2001, ACTA OBSTET GYN SCAN, V80, P835, DOI 10.1034/j.1600-0412.2001.080009835.x; Lovold A, 2008, INT J GYNECOL OBSTET, V103, P276, DOI 10.1016/j.ijgo.2008.08.009; Lumbiganon P, 2002, BJOG-INT J OBSTET GY, V109, P1222, DOI 10.1016/S1470-0328(02)02919-1; Mousa HA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub2; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Schulz KF, 2006, LANCET HDB ESSENTIAL; Selo-Ojeme D O, 2002, J Obstet Gynaecol, V22, P463; Tang OS, 2007, INT J GYNECOL OBSTET, V99, pS160, DOI 10.1016/j.ijgo.2007.09.004; Tang OS, 2002, HUM REPROD, V17, P332, DOI 10.1093/humrep/17.2.332; Walraven G, 2004, BJOG-INT J OBSTET GY, V111, P1014, DOI 10.1111/j.1471-0528.2004.00217.x; Winikoff B, 2010, LANCET, V375, P210, DOI 10.1016/S0140-6736(09)61924-3; Zuberi Nadeem F, 2008, BMC Pregnancy Childbirth, V8, P40, DOI 10.1186/1471-2393-8-40	28	54	58	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1808	1813		10.1016/S0140-6736(10)60348-0	http://dx.doi.org/10.1016/S0140-6736(10)60348-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603NY	20494730				2022-12-28	WOS:000278216500032
J	Pasquinelli, AE				Pasquinelli, Amy E.			Paring MiRNAs Through Pairing	SCIENCE			English	Editorial Material							MICRORNA; RNAS		Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pasquinelli, AE (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	apasquinelli@ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071654] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071654] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; LEE SI, 1988, CELL, V54, P599, DOI 10.1016/S0092-8674(88)80004-7	9	9	9	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1494	1495		10.1126/science.1191531	http://dx.doi.org/10.1126/science.1191531			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558697				2022-12-28	WOS:000278859200025
J	Yu, JM; Broecker, WS				Yu, Jimin; Broecker, Wally S.			Comment on "Deep-Sea Temperature and Ice Volume Changes Across the Pliocene-Pleistocene Climate Transitions"	SCIENCE			English	Editorial Material							FORAMINIFERAL MG/CA-PALEOTHERMOMETRY	Sosdian and Rosenthal (Reports, 17 July 2009, p. 306) used magnesium/calcium ratios in benthic foraminifera from the North Atlantic to reconstruct past bottom-water temperatures. They suggested that both ice volume change and ice-sheet dynamics played important roles during the late Pliocene and mid-Pleistocene climate transitions. We present evidence that their record of deep ocean temperature is not reliable, thus raising doubts about their conclusions.	[Yu, Jimin; Broecker, Wally S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Yu, JM (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W,POB 1000, Palisades, NY 10964 USA.	jiminyu@ldeo.columbia.edu	Yu, Jimin/I-7770-2012	Yu, Jimin/0000-0002-3896-1777				Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Lear CH, 2002, GEOCHIM COSMOCHIM AC, V66, P3375, DOI 10.1016/S0016-7037(02)00941-9; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Yu JM, 2008, EARTH PLANET SC LETT, V276, P129, DOI 10.1016/j.epsl.2008.09.015	6	16	17	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985								10.1126/science.1186544	http://dx.doi.org/10.1126/science.1186544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558688				2022-12-28	WOS:000278859200016
J	Laraque, D; Sia, CCJ				Laraque, Danielle; Sia, Calvin C. J.			Health Care Reform and the Opportunity to Implement a Family-Centered Medical Home for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Laraque, Danielle] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Sia, Calvin C. J.] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA	Icahn School of Medicine at Mount Sinai; University of Hawaii System	Laraque, D (corresponding author), Mt Sinai Sch Med, Dept Pediat, 1 Gustave L Levy Pl,Box 1198, New York, NY 10029 USA.	danielle.laraque@mssm.edu						Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; DICKENS MD, 1992, PEDIATRICS, V90, P774; Forrest CB, 1997, JAMA-J AM MED ASSOC, V277, P1787, DOI 10.1001/jama.277.22.1787; Jennings CC, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1003709; Landers SH, 2009, JAMA-J AM MED ASSOC, V301, P97, DOI 10.1001/jama.2008.917; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Sia C, 2004, PEDIATRICS, V113, P1473; Sia CJ, 2002, PEDIATRICS, V110, P184; Stille C, 2010, ACAD PEDIATR, V10, P211, DOI 10.1016/j.acap.2010.05.002	9	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2407	2408		10.1001/jama.2010.809	http://dx.doi.org/10.1001/jama.2010.809			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551413				2022-12-28	WOS:000278759200033
J	Chase, JM				Chase, Jonathan M.			Stochastic Community Assembly Causes Higher Biodiversity in More Productive Environments	SCIENCE			English	Article							SPECIES-RICHNESS; SCALE-DEPENDENCE; BETA-DIVERSITY; NEUTRAL THEORY; SPATIAL SCALE; DISPERSAL; ABUNDANCE; PATTERNS; NICHES	Net primary productivity is a principal driver of biodiversity; large-scale regions with higher productivity generally have more species. This pattern emerges because beta-diversity (compositional variation across local sites) increases with productivity, but the mechanisms underlying this phenomenon are unknown. Using data from a long-term experiment in replicate ponds, I show that higher beta-diversity at higher productivity resulted from a stronger role for stochastic relative to deterministic assembly processes with increasing productivity. This shift in the relative importance of stochasticity was most consistent with the hypothesis of more intense priority effects leading to multiple stable equilibria at higher productivity. Thus, shifts in community assembly mechanisms across a productivity gradient may underlie one of the most prominent biodiversity gradients on the planet.	[Chase, Jonathan M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chase, Jonathan M.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Chase, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jchase@wustl.edu	B, A/AHB-5155-2022		Washington University; NSF [DEB-0241080, 0816113]	Washington University; NSF(National Science Foundation (NSF))	I thank T. Knight, E. Marnocha, and C. Goss for help setting up the experiment; R. Shulman, B. Biro, J. Mihjalevic, P. Hanley, A. Strauss, and dozens of Tyson researchers for help sampling organisms; Tyson staff for logistical support; and T. Knight, K. Smith, R. Ricklefs, J. Losos, the reviewers, and my lab group for discussions and comments. Supported by Washington University and by NSF grants DEB-0241080 and 0816113.	Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bonn A, 2004, P ROY SOC B-BIOL SCI, V271, P1685, DOI 10.1098/rspb.2004.2745; BROWN JH, 1981, AM ZOOL, V21, P877; Chalcraft DR, 2008, ECOLOGY, V89, P2165, DOI 10.1890/07-0971.1; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2003, OIKOS, V101, P187, DOI 10.1034/j.1600-0706.2003.12062.x; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Evans KL, 2008, J ANIM ECOL, V77, P395, DOI 10.1111/j.1365-2656.2007.01332.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fukami T, 2004, POPUL ECOL, V46, P137, DOI 10.1007/s10144-004-0182-z; Gardezi T, 2008, AM NAT, V171, P800, DOI 10.1086/587520; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Grime J. P., 2001, PLANT STRATEGIES VEG; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; He K, 2009, ECOL INFORM, V4, P93, DOI 10.1016/j.ecoinf.2009.01.003; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Steiner CF, 2004, ECOLOGY, V85, P107, DOI 10.1890/03-3010; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211	32	625	640	38	530	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1388	1391		10.1126/science.1187820	http://dx.doi.org/10.1126/science.1187820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20508088				2022-12-28	WOS:000278598400036
J	Murray, SA; Kendall, M; Boyd, K; Grant, L; Highet, G; Sheikh, A				Murray, Scott A.; Kendall, Marilyn; Boyd, Kirsty; Grant, Liz; Highet, Gill; Sheikh, Aziz			Archetypal trajectories of social, psychological, and spiritual wellbeing and distress in family care givers of patients with lung cancer: secondary analysis of serial qualitative interviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SIGNIFICANT OTHERS; PALLIATIVE CARE; HEART-FAILURE; OF-LIFE; CAREGIVERS; ILLNESS; SURVIVORS; PATTERNS; DECLINE; HEALTH	Objective To assess if family care givers of patients with lung cancer experience the patterns of social, psychological, and spiritual wellbeing and distress typical of the patient, from diagnosis to death. Design Secondary analysis of serial qualitative interviews carried out every three months for up to a year or to bereavement. Setting South east Scotland. Participants 19 patients with lung cancer and their 19 family carers, totalling 88 interviews (42 with patients and 46 with carers). Results Carers followed clear patterns of social, psychological, and spiritual wellbeing and distress that mirrored the experiences of those for whom they were caring, with some carers also experiencing deterioration in physical health that impacted on their ability to care. Psychological and spiritual distress were particularly dynamic and commonly experienced. In addition to the "Why us?" response, witnessing suffering triggered personal reflections in carers on the meaning and purpose of life. Certain key time points in the illness tended to be particularly problematic for both carers and patients: at diagnosis, at home after initial treatment, at recurrence, and during the terminal stage. Conclusions Family carers witness and share much of the illness experience of the dying patient. The multidimensional experience of distress suffered by patients with lung cancer was reflected in the suffering of their carers in the social, psychological, and spiritual domains, with psychological and spiritual distress being most pronounced. Carers may need to be supported throughout the period of illness not just in the terminal phase and during bereavement, as currently tends to be the case.	[Murray, Scott A.; Kendall, Marilyn; Boyd, Kirsty; Grant, Liz; Highet, Gill; Sheikh, Aziz] Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	scott.murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078; Grant, Liz/0000-0001-7248-7792	Chief Scientist's Office of the Scottish government	Chief Scientist's Office of the Scottish government	The Chief Scientist's Office of the Scottish government funded the studies.	Bowman KF, 2003, PSYCHO-ONCOLOGY, V12, P226, DOI 10.1002/pon.630; *DEP HLTH, 2008, END LIF STRAT; Department of Health, 2000, NHS CANC PLAN PLAN I; *FOR QUAL SOC RES, 2005, SEC AN QUAL DAT; Grant Elizabeth, 2004, Palliat Support Care, V2, P371; Heaton J, 2004, REWORKING QUALITATIV; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; KIM Y, 2009, PSYCHOONCOLOGY; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Kim Y, 2007, SUPPORT CARE CANCER, V15, P1367, DOI 10.1007/s00520-007-0265-4; KISSANE DW, 1994, PSYCHO-ONCOLOGY, V3, P47, DOI DOI 10.1002/P0N.2960030109; Kurtz ME, 2004, MED SCI MONITOR, V10, pCR447; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.656319.94; Manne S.L., 2007, CANC INVEST, V16, P188; Moore N., 2007, HERITAGE MEMORY AND; MURRAY S, 2009, BRIT MED J, V3009, pB3702; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Northouse L, 1989, Oncol Nurs Forum, V16, P511; Ostlund U, 2010, PSYCHO-ONCOLOGY, V19, P29, DOI 10.1002/pon.1433; Persson C, 2008, PALLIATIVE MED, V22, P239, DOI 10.1177/0269216307085339; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; *QSR, QSR NVIV VERS 7; Ryan PJ, 2008, PALLIATIVE MED, V22, P233, DOI 10.1177/0269216307087145; SAVAGE M, 2007, CHANGING SOCIAL CLAS; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183	33	110	111	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2010	340								c2581	10.1136/bmj.c2581	http://dx.doi.org/10.1136/bmj.c2581			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MF	20538635	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000278818700003
J	Reynolds, LE; Watson, AR; Baker, M; Jones, TA; D'Amico, G; Robinson, SD; Joffre, C; Garrido-Urbani, S; Rodriguez-Manzaneque, JC; Martino-Echarri, E; Aurrand-Lions, M; Sheer, D; Dagna-Bricarelli, F; Nizetic, D; McCabe, CJ; Turnell, AS; Kermorgant, S; Imhof, BA; Adams, R; Fisher, EMC; Tybulewicz, VLJ; Hart, IR; Hodivala-Dilke, KM				Reynolds, Louise E.; Watson, Alan R.; Baker, Marianne; Jones, Tania A.; D'Amico, Gabriela; Robinson, Stephen D.; Joffre, Carine; Garrido-Urbani, Sarah; Carlos Rodriguez-Manzaneque, Juan; Martino-Echarri, Estefania; Aurrand-Lions, Michel; Sheer, Denise; Dagna-Bricarelli, Franca; Nizetic, Dean; McCabe, Christopher J.; Turnell, Andrew S.; Kermorgant, Stephanie; Imhof, Beat A.; Adams, Ralf; Fisher, Elizabeth M. C.; Tybulewicz, Victor L. J.; Hart, Ian R.; Hodivala-Dilke, Kairbaan M.			Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome	NATURE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; GROWTH; MICE; APOPTOSIS; VEGF; ETS2; ADAMTS-1; CADHERIN; DSCR1; GENE	Down's syndrome (DS) is a genetic disorder caused by full or partial trisomy of human chromosome 21 and presents with many clinical phenotypes including a reduced incidence of solid tumours(1,2). Recent work with the Ts65Dn model of DS, which has orthologues of about 50% of the genes on chromosome 21 (Hsa21), has indicated that three copies of the ETS2 (ref. 3) or DS candidate region 1 (DSCR1) genes(4) (a previously known suppressor of angiogenesis(5,6)) is sufficient to inhibit tumour growth. Here we use the Tc1 transchromosomic mouse model of DS(7) to dissect the contribution of extra copies of genes on Hsa21 to tumour angiogenesis. This mouse expresses roughly 81% of Hsa21 genes but not the human DSCR1 region. We transplanted B16F0 and Lewis lung carcinoma tumour cells into Tc1 mice and showed that growth of these tumours was substantially reduced compared with wild-type littermate controls. Furthermore, tumour angiogenesis was significantly repressed in Tc1 mice. In particular, in vitro and in vivo angiogenic responses to vascular endothelial growth factor (VEGF) were inhibited. Examination of the genes on the segment of Hsa21 in Tc1 mice identified putative anti-angiogenic genes (ADAMTS1(8,9) and ERG(10)) and novel endothelial cell-specific genes(11), never previously shown to be involved in angiogenesis (JAM-B(12) and PTTG1IP), that, when overexpressed, are responsible for inhibiting angiogenic responses to VEGF. Three copies of these genes within the stromal compartment reduced tumour angiogenesis, explaining the reduced tumour growth in DS. Furthermore, we expect that, in addition to the candidate genes that we show to be involved in the repression of angiogenesis, the Tc1 mouse model of DS will permit the identification of other endothelium-specific anti-angiogenic targets relevant to a broad spectrum of cancer patients.	[Reynolds, Louise E.; Watson, Alan R.; Baker, Marianne; D'Amico, Gabriela; Robinson, Stephen D.; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, John Vane Sci Ctr, Adhes & Angiogenesis Lab, Barts Inst Canc,Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Joffre, Carine; Kermorgant, Stephanie; Hart, Ian R.] Queen Mary Univ London, John Vane Sci Ctr, Tumor Biol Ctr, Inst Canc,Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Jones, Tania A.; Sheer, Denise] Queen Mary Univ London, Ctr Neurosci, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England; [Nizetic, Dean] Queen Mary Univ London, Paediat Ctr, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England; [Garrido-Urbani, Sarah; Imhof, Beat A.] Univ Geneva, Sch Med CMU, Dept Pathol & Immunol, Ctr Med Univ, CH-1211 Geneva, Switzerland; [Carlos Rodriguez-Manzaneque, Juan; Martino-Echarri, Estefania] GENYO, Granada, Spain; [Aurrand-Lions, Michel] INSERM, F-13009 Marseille, France; [Dagna-Bricarelli, Franca] Galliera Hosp, Inst Human Genet, I-16128 Genoa, Italy; [McCabe, Christopher J.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Turnell, Andrew S.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Adams, Ralf] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Ente Ospedaliero Ospedali Galliera; University of Birmingham; University of Birmingham; Max Planck Society; University of London; University College London; MRC National Institute for Medical Research	Reynolds, LE (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Adhes & Angiogenesis Lab, Barts Inst Canc,Barts & London Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.	l.reynolds@qmul.ac.uk	Adams, Ralf H/AAE-9274-2019; Sheer, Denise/C-6705-2011; Fisher, Elizabeth MC/C-2168-2008; D'Amico, Gabriela/H-6310-2011; JOFFRE, Carine/P-1551-2014; Nizetic, Dean/F-9509-2015; Aurrand-Lions, Michel/O-9953-2016; Corbett-Jones, Tania A/E-4891-2013; Jones, Tania/C-8912-2011; Rodriguez-Manzaneque, Juan Carlos/F-3899-2012; D'Amico, Gabriela/AAD-1182-2020; Kermorgant, Stephanie/AAB-4931-2020	Sheer, Denise/0000-0001-9067-1796; Fisher, Elizabeth MC/0000-0003-2850-9936; JOFFRE, Carine/0000-0002-7551-356X; Aurrand-Lions, Michel/0000-0002-8361-3034; Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Tania/0000-0002-0067-3382; Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029; Kermorgant, Stephanie/0000-0001-5921-479X; Robinson, Stephen/0000-0002-6606-7588; D'Amico, Gabriela/0000-0002-5619-6749; Tybulewicz, Victor/0000-0003-2439-0798; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Nizetic, Dean/0000-0001-5486-5761	MRC [G0601056, MC_U117527252, G0501003] Funding Source: UKRI; Cancer Research UK [A12007, 12007, A3585] Funding Source: Medline; Medical Research Council [G0901609, G0501003, U.1175.02.001.00001(60485), G0601056, MC_U117527252, G0501003(75694)] Funding Source: Medline; Wellcome Trust [080174] Funding Source: Medline; British Lung Foundation [CAN09-4] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Lung Foundation		Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Kelly PA, 2005, MOL BIOL CELL, V16, P3562, DOI 10.1091/mbc.E04-12-1085; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; MAHADEVAN V, 1989, CANCER RES, V49, P415; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shozu M, 2005, J MOL ENDOCRINOL, V35, P343, DOI 10.1677/jme.1.01735; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	29	88	91	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					813	U13		10.1038/nature09106	http://dx.doi.org/10.1038/nature09106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535211	Green Accepted, Green Submitted			2022-12-28	WOS:000278551800052
J	Heath, I				Heath, Iona			Life and Death Crocodile tears for health inequality	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk							0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2010	340								c2970	10.1136/bmj.c2970	http://dx.doi.org/10.1136/bmj.c2970			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MB	20530565				2022-12-28	WOS:000278818300004
J	Siriwardena, AN				Siriwardena, A. Niroshan			Should the Quality and Outcomes Framework be abolished? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; FINANCIAL INCENTIVES; PERFORMANCE; PAY; ENGLAND; PHYSICIANS		Lincoln Univ, Fac Hlth Life & Social Sci, Lincoln LN6 7TS, England	University of Lincoln	Siriwardena, AN (corresponding author), Lincoln Univ, Fac Hlth Life & Social Sci, Lincoln LN6 7TS, England.	nsiriwardena@lincoln.ac.uk	Siriwardena, A Niroshan/M-3805-2017	Siriwardena, A Niroshan/0000-0003-2484-8201				Ashworth Mark, 2010, Qual Prim Care, V18, P127; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Checkland K, 2008, SOCIOL HEALTH ILL, V30, P788, DOI 10.1111/j.1467-9566.2008.01081.x; Checkland Kath, 2010, Qual Prim Care, V18, P139; De Maeseneer J, 2008, BRIT J GEN PRACT, V58, P3, DOI 10.3399/bjgp08X263721; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Gravelle H, 2007, 28 CHE; Heath I, 2007, BRIT MED J, V335, P1075, DOI 10.1136/bmj.39377.387373.AD; Hippisley-Cox J, 2007, TIME SERIES ANAL 200; Lester H, 2007, BRIT MED J, V335, P1130, DOI 10.1136/bmj.39385.406192.AD; Lester Helen, 2010, Qual Prim Care, V18, P103; Marshall M, 2005, QUAL SAF HEALTH CARE, V14, P4, DOI 10.1136/qshc.2004.013193; Reeves D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1717; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2006, PRIM HEALTH CARE RES, V7, P18, DOI DOI 10.1191/1463423606PC2720A; Shohet C, 2007, SEIZURE-EUR J EPILEP, V16, P351, DOI 10.1016/j.seizure.2007.02.005; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Steel Nicholas, 2010, Qual Prim Care, V18, P117; Walker S, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X501859	22	7	7	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2010	340								c2794	10.1136/bmj.c2794	http://dx.doi.org/10.1136/bmj.c2794			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LZ	20530084	Green Accepted			2022-12-28	WOS:000278818000016
J	von Braun, J				von Braun, Joachim			Strategic body needed to beat food crises	NATURE			English	Editorial Material									[von Braun, Joachim] Univ Bonn, Res Dev Ctr, D-53113 Bonn, Germany	University of Bonn	von Braun, J (corresponding author), Univ Bonn, Res Dev Ctr, D-53113 Bonn, Germany.	jvonbraun@uni-bonn.de	von Braun, Joachim/AAA-7044-2020	von Braun, Joachim/0000-0001-6571-4838					0	14	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					548	549		10.1038/465548a	http://dx.doi.org/10.1038/465548a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	604AF	20520692				2022-12-28	WOS:000278249000018
J	Rozenbaum, MH; Sanders, EAM; van Hoek, AJ; Jansen, AGSC; van der Ende, A; van den Dobbelsteen, G; Rodenburg, GD; Hak, E; Postma, MJ				Rozenbaum, Mark H.; Sanders, Elisabeth A. M.; van Hoek, Albert Jan; Jansen, Angelique G. S. C.; van der Ende, Arie; van den Dobbelsteen, Germie; Rodenburg, Gerwin D.; Hak, Eelko; Postma, Maarten J.			Cost effectiveness of pneumococcal vaccination among Dutch infants: an economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE; IMMUNOGENICITY; PREVENTION; EFFICACY; IMPACT; SEROTYPES; ERA; AGE	Objectives To update cost effectiveness estimates for the four dose (3+1) schedule of the seven valent pneumococcal conjugated vaccine (PCV-7) in the Netherlands and to explore the impact on cost effectiveness of reduced dose schedules and implementation of 10 valent and 13 valent pneumococcal vaccines (PCV-10 and PCV-13). Design Economic evaluation comparing PCV-7, PCV-10, and PCV-13 with no vaccination using a decision tree analytic model built from data in previous studies. Setting The Netherlands. Population A cohort of 180 000 newborns followed until 5 years of age. Main outcome measures Costs; gains in life years and quality adjusted life years (QALYs); and incremental cost effectiveness ratios. Results Under base case assumptions-that is, assuming a five year protective period of the vaccine and no assumed net indirect effects (herd protection minus serotype replacement) among children aged over 5 years-vaccination with PVC-7 in a four dose (3+1) schedule was estimated to prevent 71 and 5778 cases of invasive and non-invasive pneumococcal disease, respectively, in children aged up to 5 years. This corresponds with a total net gain of 173 life years or 277 QALYs. The incremental cost effectiveness ratio of PCV-7 was estimated at (sic)113 891 (98 pound 300; $145 000) per QALY, well over the ratio of (sic)50 000 per QALY required for PCV-7 to be regarded as potentially cost effective. A three dose (2+1) schedule of PCV-7 reduced the incremental cost effectiveness ratio to (sic)82 975 per QALY. For various assumptions and including 10% of the maximum net indirect effects among individuals aged 5 years and over, PCV-10 and PCV-13 had incremental cost effectiveness ratios ranging from (sic)31 250 to (sic)52 947 per QALY. Conclusions The current Dutch infant vaccination programme of four doses of PCV-7 is not cost effective because of increases in invasive disease caused by nonvaccine serotypes, which reduces the overall direct effects of vaccination and offsets potential positive herd protection benefits in unvaccinated individuals. The 10 valent and 13 valent pneumococcal vaccines could have better net health benefits than PCV-7 through less replacement disease and increased herd protection. Both these effects could substantially reduce the incremental cost effectiveness ratio to possibly acceptable levels, if total programme costs can be lowered by reduced schedules, reductions in vaccine prices, or both.	[Rozenbaum, Mark H.; van Hoek, Albert Jan; Hak, Eelko; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Sanders, Elisabeth A. M.; Jansen, Angelique G. S. C.; Rodenburg, Gerwin D.; Hak, Eelko] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Jansen, Angelique G. S. C.; Hak, Eelko] Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Ende, Arie] Univ Amsterdam, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Acad Med Ctr Amsterdam, Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands; [van den Dobbelsteen, Germie] Netherlands Vaccine Inst, Bilthoven, Netherlands; [Hak, Eelko; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Rozenbaum, MH (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands.	m.h.rozenbaum@rug.nl	van der Ende, Arie/A-4346-2012	van der Ende, Arie/0000-0003-1298-3086; Postma, Maarten/0000-0002-6306-3653	Wyeth Hoofddorp; Netherlands Vaccine Institute, Bilthoven; GlaxoSmithKline Netherlands; Wyeth	Wyeth Hoofddorp; Netherlands Vaccine Institute, Bilthoven; GlaxoSmithKline Netherlands(GlaxoSmithKline); Wyeth(Wyeth)	Funding: MHR was funded by an unrestricted grant from Wyeth Hoofddorp. AJvH was financed by the Netherlands Vaccine Institute, Bilthoven. This work has been previously presented at a workshop on pneumococcal vaccines at the European Public Health Association conference in Lisbon, Portugal, which was supported by a research grant from GlaxoSmithKline Netherlands. The authors' work was independent of the funders, who had no role in the study design, analysis of data, writing of the manuscript, or decision to submit for publication.; Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: (1) MHR was funded by an unrestricted grant from Wyeth Hoofddorp; and AJvH was financed by the Netherlands Vaccine Institute, Bilthoven; (2) MJP has received travel grants from GlaxoSmithKline and Wyeth to attend expert meetings in Reykjavik, Iceland, and Istanbul, Turkey; EAMS has received unrestricted grants from Wyeth and Baxter for research, consulting fees from Wyeth and GlaxoSmithKline, lecturing fees from Wyeth, and grant support from Wyeth and GlaxoSmithKline for vaccine studies; and AvdE has received unrestricted grants from Wyeth and Novartis; (3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; (4) No non-financial interests that may be relevant to the submitted work.	Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Bos JM, 2003, CLIN THER, V25, P2614, DOI 10.1016/S0149-2918(03)80322-3; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Claes C, 2009, EUR J HEALTH ECON, V10, P25, DOI 10.1007/s10198-008-0098-1; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Giorgi-Rossi P, 2009, HEALTH POLICY, V89, P225, DOI 10.1016/j.healthpol.2008.05.016; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; *HLTH COUNC NETH, 2005, VACC INF PNEUM INF; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Hubben GAA, 2007, VACCINE, V25, P3669, DOI 10.1016/j.vaccine.2007.01.088; Jansen AGSC, 2009, VACCINE, V27, P2394, DOI 10.1016/j.vaccine.2009.01.127; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kayhty H, 2005, PEDIATR INFECT DIS J, V24, P108, DOI 10.1097/01.inf.0000151022.92222.be; LEPOUTRE A, 2008, EURO SURVEILL, V13; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; McIntosh EDG, 2005, VACCINE, V23, P1739, DOI 10.1016/j.vaccine.2004.08.051; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Oostenbrink JB, 2004, GUIDELINES COSTING R; Prosser LA, 2004, PEDIATRICS, V113, P283, DOI 10.1542/peds.113.2.283; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Rozenbaum MH, 2008, EXPERT REV VACCINES, V7, P753, DOI 10.1586/14760584.7.6.753; Silfverdal SA, 2009, VACCINE, V27, P1601, DOI 10.1016/j.vaccine.2008.12.033; Tilson L, 2008, VALUE HEALTH, V11, P898, DOI 10.1111/j.1524-4733.2008.00341.x; Tilson L, 2008, EUR J PUBLIC HEALTH, V18, P275, DOI 10.1093/eurpub/ckm123; Vespa G, 2009, REV PANAM SALUD PUBL, V26, P518, DOI 10.1590/S1020-49892009001200007; Vestrheim DF, 2008, VACCINE, V26, P3277, DOI 10.1016/j.vaccine.2008.03.087; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; [No title captured]	41	72	74	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2010	340								c2509	10.1136/bmj.c2509	http://dx.doi.org/10.1136/bmj.c2509			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BL	20519267	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000278556400001
J	Yoshida, S; Maruyama, S; Nozaki, H; Shirasu, K				Yoshida, Satoko; Maruyama, Shinichiro; Nozaki, Hisayoshi; Shirasu, Ken			Horizontal Gene Transfer by the Parasitic Plant Striga hermonthica	SCIENCE			English	Article									[Yoshida, Satoko; Shirasu, Ken] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Maruyama, Shinichiro; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Shirasu, K (corresponding author), RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan.	ken.shirasu@psc.riken.jp	Maruyama, Shinichiro/AAO-4764-2021; Yoshida, Satoko/AAZ-4757-2021; Yoshida, Satoko/G-5003-2010; yoshida, satoko/AAO-4892-2020; NOZAKI, HISAYOSHI/G-4926-2014; Shirasu, Ken/A-4455-2010; Shirasu, Ken/ABF-5306-2020	Yoshida, Satoko/0000-0002-9999-7861; yoshida, satoko/0000-0002-9999-7861; Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; Nozaki, Hisayoshi/0000-0002-9308-4498	Ministry of Education, Culture, Sports, Science, and Technology [19678001, 20247032, 21780044]; RIKEN president fund; Gatsby Charitable Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN president fund; Gatsby Charitable Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by the Ministry of Education, Culture, Sports, Science, and Technology grants (nos. 19678001 to K. S., 20247032 to H.N., and 21780044 to S.Y.), the RIKEN president fund, and the Gatsby Charitable Foundation. S. M. is supported by a Japan Society for the Promotion of Science fellowship. cDNA and genomic sequences of ShContig9483 and its S. gesnerioides homolog have been deposited in DNA Data Bank of Japan (DDBJ) under accession numbers AB530325, AB530324, and AB542056, respectively.	Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Yoshida S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-55	4	108	118	8	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1128	1128		10.1126/science.1187145	http://dx.doi.org/10.1126/science.1187145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508124				2022-12-28	WOS:000278104700035
J	Hidvegi, T; Ewing, M; Hale, P; Dippold, C; Beckett, C; Kemp, C; Maurice, N; Mukherjee, A; Goldbach, C; Watkins, S; Michalopoulos, G; Perlmutter, DH				Hidvegi, Tunda; Ewing, Michael; Hale, Pamela; Dippold, Christine; Beckett, Caroline; Kemp, Carolyn; Maurice, Nicholas; Mukherjee, Amitava; Goldbach, Christina; Watkins, Simon; Michalopoulos, George; Perlmutter, David H.			An Autophagy-Enhancing Drug Promotes Degradation of Mutant alpha 1-Antitrypsin Z and Reduces Hepatic Fibrosis	SCIENCE			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; LIVER-DISEASE; PROTEIN; INHIBITOR; PATHWAYS; DISPOSAL	In the classical form of alpha(1)-antitrypsin (AT) deficiency, a point mutation in AT alters the folding of a liver-derived secretory glycoprotein and renders it aggregation-prone. In addition to decreased serum concentrations of AT, the disorder is characterized by accumulation of the mutant alpha(1)-antitrypsin Z (ATZ) variant inside cells, causing hepatic fibrosis and/or carcinogenesis by a gain-of-toxic function mechanism. The proteasomal and autophagic pathways are known to mediate degradation of ATZ. Here we show that the autophagy-enhancing drug carbamazepine (CBZ) decreased the hepatic load of ATZ and hepatic fibrosis in a mouse model of AT deficiency-associated liver disease. These results provide a basis for testing CBZ, which has an extensive clinical safety profile, in patients with AT deficiency and also provide a proof of principle for therapeutic use of autophagy enhancers.	[Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Perlmutter, DH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.	david.perlmutter@chp.edu	Mukherjee, Amitava/AAK-4002-2020; Watkins, Simon/ABG-2590-2021	Mukherjee, Amitava/0000-0001-5603-5147; Watkins, Simon/0000-0003-4092-1552	NIH [HL037784, DK076918, RR022241]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084512, R01DK076918] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to J. Englert for the hydroxyproline assay and to G. Silverman and J. Brodsky for critical review of the manuscript. The work was partially supported by NIH grants HL037784, DK076918, and RR022241.	Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hidvegi T, 2007, J BIOL CHEM, V282, P27769, DOI 10.1074/jbc.M704330200; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Perlmutter DH, 2009, CELL DEATH DIFFER, V16, P39, DOI 10.1038/cdd.2008.103; Piitulainen E, 2005, CHEST, V128, P2076, DOI 10.1378/chest.128.4.2076; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Ravikumar Brinda, 2008, V445, P195, DOI 10.1007/978-1-59745-157-4_13; Rudnick DA, 2004, HEPATOLOGY, V39, P1048, DOI 10.1002/hep.20118; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	14	439	467	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					229	232		10.1126/science.1190354	http://dx.doi.org/10.1126/science.1190354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20522742				2022-12-28	WOS:000279635200053
J	Humphries, NE; Queiroz, N; Dyer, JRM; Pade, NG; Musyl, MK; Schaefer, KM; Fuller, DW; Brunnschweiler, JM; Doyle, TK; Houghton, JDR; Hays, GC; Jones, CS; Noble, LR; Wearmouth, VJ; Southall, EJ; Sims, DW				Humphries, Nicolas E.; Queiroz, Nuno; Dyer, Jennifer R. M.; Pade, Nicolas G.; Musyl, Michael K.; Schaefer, Kurt M.; Fuller, Daniel W.; Brunnschweiler, Juerg M.; Doyle, Thomas K.; Houghton, Jonathan D. R.; Hays, Graeme C.; Jones, Catherine S.; Noble, Leslie R.; Wearmouth, Victoria J.; Southall, Emily J.; Sims, David W.			Environmental context explains Levy and Brownian movement patterns of marine predators	NATURE			English	Article							FLIGHT SEARCH PATTERNS; POWER-LAW DISTRIBUTIONS; WANDERING ALBATROSSES; STRATEGIES; BEHAVIOR; PACIFIC; SUCCESS; SPEED; OCEAN; PREY	An optimal search theory, the so-called Levy-flight foraging hypothesis(1), predicts that predators should adopt search strategies known as Levy flights where prey is sparse and distributed unpredictably, but that Brownian movement is sufficiently efficient for locating abundant prey(2-4). Empirical studies have generated controversy because the accuracy of statistical methods that have been used to identify Levy behaviour has recently been questioned(5,6). Consequently, whether foragers exhibit Levy flights in the wild remains unclear. Crucially, moreover, it has not been tested whether observed movement patterns across natural landscapes having different expected resource distributions conform to the theory's central predictions. Here we use maximum-likelihood methods to test for Levy patterns in relation to environmental gradients in the largest animal movement data set assembled for this purpose. Strong support was found for Levy search patterns across 14 species of open-ocean predatory fish (sharks, tuna, billfish and ocean sunfish), with some individuals switching between Levy and Brownian movement as they traversed different habitat types. We tested the spatial occurrence of these two principal patterns and found Levy behaviour to be associated with less productive waters (sparser prey) and Brownian movements to be associated with productive shelf or convergence-front habitats (abundant prey). These results are consistent with the Levy-flight foraging hypothesis(1,7), supporting the contention(8,9) that organism search strategies naturally evolved in such a way that they exploit optimal Levy patterns.	[Humphries, Nicolas E.; Queiroz, Nuno; Dyer, Jennifer R. M.; Pade, Nicolas G.; Wearmouth, Victoria J.; Southall, Emily J.; Sims, David W.] Marine Biol Assoc UK, The Lab, Plymouth PL1 2PB, Devon, England; [Humphries, Nicolas E.; Sims, David W.] Univ Plymouth, Sch Marine Sci & Engn, Inst Marine, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Queiroz, Nuno] Univ Porto, CIBIO, P-4485668 Vairao, Portugal; [Queiroz, Nuno; Pade, Nicolas G.; Jones, Catherine S.; Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland; [Musyl, Michael K.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Kewalo Res Facil, NOAA Fisheries, Honolulu, HI 96814 USA; [Schaefer, Kurt M.; Fuller, Daniel W.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Brunnschweiler, Juerg M.] ETH, CH-8092 Zurich, Switzerland; [Doyle, Thomas K.] Univ Coll Cork, Glucksman Marine Facil, ERI, Coastal & Marine Resources Ctr, Cork, Ireland; [Houghton, Jonathan D. R.] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Hays, Graeme C.] Swansea Univ, Inst Environm Sustainabil, Dept Pure & Appl Ecol, Swansea SA2 8PP, W Glam, Wales	Marine Biological Association United Kingdom; University of Plymouth; Universidade do Porto; University of Aberdeen; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; Swiss Federal Institutes of Technology Domain; ETH Zurich; University College Cork; Queens University Belfast; Swansea University	Sims, DW (corresponding author), Marine Biol Assoc UK, The Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Brunnschweiler, Juerg/A-2110-2008; SOUTHALL, EMILY J/AGP-5395-2022; Queiroz, Nuno/G-3850-2010; Humphries, Nick/AAE-7170-2019	Brunnschweiler, Juerg/0000-0002-9901-3279; SOUTHALL, EMILY J/0000-0001-7246-278X; Queiroz, Nuno/0000-0002-3860-7356; Humphries, Nick/0000-0003-3741-1594; Sims, David/0000-0002-0916-7363; Pade, Nicolas/0000-0003-2733-9752; Noble, leslie/0000-0003-3076-0759; Hays, Graeme/0000-0002-3314-8189; Doyle, Thomas/0000-0003-1616-5590	UK Natural Environment Research Council (NERC); Save Our Seas Foundation; Leverhulme Trust; UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia [SFRH/BD/21354/2005]; UK Royal Society; Fisheries Society of the British Isles; Udaras na Gaeltachta; Taighde Mara Teo; Marine Institute (Ireland); Irish Research Council for Science Engineering and Technology; Shark Foundation Switzerland; University of Aberdeen; PADI Project; Japan Fisheries Agency; US Tuna Foundation; Tagging of Pacific Pelagics programme in the Census of Marine Life; National Oceanic and Atmospheric Administration (US Department of Commerce) [NA37RJ0199, NA67RJ0154]; University of Hawaii [NA37RJ0199, NA67RJ0154]; Royal Society; Marine Biological Association of the UK; UK NERC; Natural Environment Research Council [mba010004] Funding Source: researchfish; NERC [mba010004] Funding Source: UKRI	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Save Our Seas Foundation; Leverhulme Trust(Leverhulme Trust); UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia(Department for Environment, Food & Rural Affairs (DEFRA)Portuguese Foundation for Science and Technology); UK Royal Society(Royal Society of London); Fisheries Society of the British Isles; Udaras na Gaeltachta; Taighde Mara Teo; Marine Institute (Ireland); Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Shark Foundation Switzerland; University of Aberdeen; PADI Project; Japan Fisheries Agency; US Tuna Foundation; Tagging of Pacific Pelagics programme in the Census of Marine Life; National Oceanic and Atmospheric Administration (US Department of Commerce)(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii; Royal Society(Royal Society of London); Marine Biological Association of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was facilitated through the European Tracking of Predators in the Atlantic programme in the European Census of Marine Life. Funding was provided by the UK Natural Environment Research Council (NERC) Oceans 2025 Strategic Research Programme (Theme 6 Science for Sustainable Marine Resources), the Save Our Seas Foundation, the Leverhulme Trust, the UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia grant SFRH/BD/21354/2005, the UK Royal Society, the Fisheries Society of the British Isles, the Udaras na Gaeltachta, the Taighde Mara Teo, the Marine Institute (Ireland), the Irish Research Council for Science Engineering and Technology, the Shark Foundation Switzerland, a University of Aberdeen Scholarship and PADI Project Aware. The tuna research of K. M. S. and D. W. F. was made possible through financial contributions by the Japan Fisheries Agency, the US Tuna Foundation and the Tagging of Pacific Pelagics programme in the Census of Marine Life. M. K. M. was funded by Cooperative Agreements NA37RJ0199 and NA67RJ0154 between the National Oceanic and Atmospheric Administration (US Department of Commerce) and the Pelagic Fisheries Research Program (University of Hawaii). The authors or their agencies do not necessarily approve, recommend or endorse any proprietary hardware or software mentioned in this publication. The views expressed herein are those of the authors and do not necessarily reflect the views of their agencies. For field assistance, D. W. S. thanks P. Harris and D. Uren; T. K. D. thanks V. Roantree, M. Norman, M. Lilley and P. F. O'Suilleabhain; J. M. B. thanks G. Adkison, J.-P. Botha, H. Baensch and A. Cumming. D. W. S. and N. E. H. thank A. Clauset and J. Pitchford for help with maximum-likelihood estimation and log-likelihoods, and E. P. White for manuscript comments. This research complied with all animal welfare laws of the countries or sovereign territories in which it was conducted. C. S. J. was supported by a Royal Society of Edinburgh Sabbatical Fellowship, G. C. H. by a Ray Lankester Investigatorship from the Marine Biological Association of the UK (MBA) and D. W. S. by a UK NERC-funded MBA Senior Research Fellowship.	Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434002; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Buchanan M, 2008, NATURE, V453, P714, DOI 10.1038/453714a; CLARKE MR, 1974, J MAR BIOL ASSOC UK, V54, P949, DOI 10.1017/S0025315400057672; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CORNELIUS JM, 1991, ECOLOGY, V72, P2057, DOI 10.2307/1941559; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Kashtan N, 2007, P NATL ACAD SCI USA, V104, P13711, DOI 10.1073/pnas.0611630104; Moteki M, 2001, FISHERIES SCI, V67, P1063, DOI 10.1046/j.1444-2906.2001.00362.x; POWELL TM, 1975, SCIENCE, V189, P1088, DOI 10.1126/science.189.4208.1088; Shlesinger M. F., 1986, On Growth and Form - Fractal and Non-Fractal Patterns in Physics. Proceedings of the NATO Advanced Study Institute, P279; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Travis J, 2007, SCIENCE, V318, P742, DOI 10.1126/science.318.5851.742; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	29	602	609	11	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1066	1069		10.1038/nature09116	http://dx.doi.org/10.1038/nature09116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20531470	Green Accepted			2022-12-28	WOS:000279056900050
J	Kuba, H; Oichi, Y; Ohmori, H				Kuba, Hiroshi; Oichi, Yuki; Ohmori, Harunori			Presynaptic activity regulates Na+ channel distribution at the axon initial segment	NATURE			English	Article							STEM AUDITORY NUCLEI; ACTION-POTENTIAL INITIATION; AFFERENT INFLUENCES; PYRAMIDAL NEURONS; INTRINSIC EXCITABILITY; N-MAGNOCELLULARIS; COCHLEA REMOVAL; SODIUM-CHANNELS; CHICKEN; SYSTEM	Deprivation of afferent inputs in neural circuits leads to diverse plastic changes in both pre- and postsynaptic elements that restore neural activity(1). The axon initial segment (AIS) is the site at which neural signals arise(2,3), and should be the most efficient site to regulate neural activity. However, none of the plasticity currently known involves the AIS. We report here that deprivation of auditory input in an avian brainstem auditory neuron leads to an increase in AIS length, thus augmenting the excitability of the neuron. The length of the AIS, defined by the distribution of voltage-gated Na+ channels and the AIS anchoring protein, increased by 1.7 times in seven days after auditory input deprivation. This was accompanied by an increase in the whole-cell Na+ current, membrane excitability and spontaneous firing. Our work demonstrates homeostatic regulation of the AIS, which may contribute to the maintenance of the auditory pathway after hearing loss. Furthermore, plasticity at the spike initiation site suggests a powerful pathway for refining neuronal computation in the face of strong sensory deprivation.	[Kuba, Hiroshi; Oichi, Yuki] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Ohmori, Harunori] Kyoto Univ, Grad Sch Med, Dept Physiol, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Kuba, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan.	kuba@nbiol.med.kyoto-u.ac.jp	Kuba, Hiroshi/I-7519-2014	Ohmori, Harunori/0000-0002-4319-4947	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank G. Alcaraz for providing ankyrin-G antibody. We also thank L. O. Trussell for advice and for editing the manuscript; M. N. Rasband, T. M. Ishii and R. Yamada for reading the manuscript; and K. Bender for discussions. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to H.K. and H.O.	Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BORN DE, 1991, BRAIN RES, V557, P37, DOI 10.1016/0006-8993(91)90113-A; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Kuba H, 2009, J PHYSIOL-LONDON, V587, P87, DOI 10.1113/jphysiol.2008.162651; KUBKE MF, 1998, HEARING RES, V147, P1; Lu Y, 2004, J COMP NEUROL, V470, P93, DOI 10.1002/cne.11037; Lu Y, 2007, J NEUROPHYSIOL, V97, P635, DOI 10.1152/jn.00915.2006; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SHERMAN SJ, 1984, P NATL ACAD SCI-BIOL, V81, P262, DOI 10.1073/pnas.81.1.262; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; TUCCI DL, 1985, J COMP NEUROL, V238, P371, DOI 10.1002/cne.902380402; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009	30	287	288	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1075	U136		10.1038/nature09087	http://dx.doi.org/10.1038/nature09087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543825				2022-12-28	WOS:000279056900052
J	Ameres, SL; Horwich, MD; Hung, JH; Xu, J; Ghildiyal, M; Weng, ZP; Zamore, PD				Ameres, Stefan L.; Horwich, Michael D.; Hung, Jui-Hung; Xu, Jia; Ghildiyal, Megha; Weng, Zhiping; Zamore, Phillip D.			Target RNA-Directed Trimming and Tailing of Small Silencing RNAs	SCIENCE			English	Article							PIWI-INTERACTING RNAS; DISTINCT MECHANISMS; ENDOGENOUS SIRNAS; STRUCTURAL BASIS; MESSENGER-RNA; RECOGNITION; ARGONAUTE2; MICRORNAS; 2'-O-METHYLATION; URIDYLATION	In Drosophila, microRNAs (miRNAs) typically guide Argonaute1 to repress messenger RNA (mRNA), whereas small interfering RNAs (siRNAs) guide Argonaute2 to destroy viral and transposon RNA. Unlike siRNAs, miRNAs rarely form extensive numbers of base pairs to the mRNAs they regulate. We find that extensive complementarity between a target RNA and an Argonaute1-bound miRNA triggers miRNA tailing and 3'-to-5' trimming. In flies, Argonaute2-bound small RNAs-but not those bound to Argonaute1-bear a 2'-O-methyl group at their 3' ends. This modification blocks target-directed small RNA remodeling: In flies lacking Hen1, the enzyme that adds the 2'-O-methyl group, Argonaute2-associated siRNAs are tailed and trimmed. Target complementarity also affects small RNA stability in human cells. These results provide an explanation for the partial complementarity between animal miRNAs and their targets.	[Ameres, Stefan L.; Horwich, Michael D.; Ghildiyal, Megha; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Ameres, Stefan L.; Horwich, Michael D.; Ghildiyal, Megha; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Hung, Jui-Hung; Xu, Jia] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Xu, Jia/F-7750-2012; Ghildiyal, Megha/F-7980-2014; Hung, Jui-Hung/G-2673-2012; Zamore, Phillip D/A-8941-2013; Ameres, Stefan Ludwig/B-4046-2012; Ameres, Stefan/G-3775-2010	Hung, Jui-Hung/0000-0003-2208-9213; Ameres, Stefan Ludwig/0000-0002-8248-3098; Zamore, Phillip/0000-0002-4505-9618; Xu, Jia/0000-0003-3921-018X	National Institute on Aging NRSA [F30AG030283]; EMBO [ALTF 522-2008]; Austrian Science Fund (FWF) [J2832-B09]; NIH [GM62862, GM65236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM062862, R01GM065236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030283] Funding Source: NIH RePORTER	National Institute on Aging NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EMBO(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Ma and A. Boucher for help with fly husbandry, G. Farley for technical assistance, E. Pfister for cloning of miR-16 and miR-21 reporter constructs, and members of the Zamore lab for advice, suggestions, and critical comments on the manuscript. Sequence data are available through the NCBI Short Read Archive (www.ncbi.nlm.nih.gov/sites/sra) as GSM278704 (ago2414), SRA010045 (hen1<SUP>f00810</SUP> National Institute on Aging NRSA grant F30AG030283 (M. D. H.), and HeLa cell data), and GSE18806 (Oregon R). Supported by EMBO long-term fellowship ALTF 522-2008, Austrian Science Fund (FWF) Erwin Schrodinger-Auslandsstipendium J2832-B09 (S. L. A.), and NIH grants GM62862 and GM65236 (P.D.Z.). P.D.Z. is a member of the scientific advisory board of Regulus Therapeutics.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; PELISSON A, 1951, J VIROL, V81, P2007; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	42	393	422	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1534	1539		10.1126/science.1187058	http://dx.doi.org/10.1126/science.1187058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558712	Green Accepted			2022-12-28	WOS:000278859200040
J	Elliot, JL; Person, MJ; Zuluaga, CA; Bosh, AS; Adams, ER; Brothers, TC; Gulbis, AAS; Levine, SE; Lockhart, M; Zangari, AM; Babcock, BA; DuPre, K; Pasachoff, JM; Souza, SP; Rosing, W; Secrest, N; Bright, L; Dunham, EW; Sheppard, SS; Kakkala, M; Tilleman, T; Berger, B; Briggs, JW; Jacobson, G; Valleli, P; Volz, B; Rapoport, S; Hart, R; Brucker, M; Michel, R; Mattingly, A; Zambrano-Marin, L; Meyer, AW; Wolf, J; Ryan, EV; Ryan, WH; Morzinski, K; Grigsby, B; Brimacombe, J; Ragozzine, D; Montano, HG; Gilmore, A				Elliot, J. L.; Person, M. J.; Zuluaga, C. A.; Bosh, A. S.; Adams, E. R.; Brothers, T. C.; Gulbis, A. A. S.; Levine, S. E.; Lockhart, M.; Zangari, A. M.; Babcock, B. A.; DuPre, K.; Pasachoff, J. M.; Souza, S. P.; Rosing, W.; Secrest, N.; Bright, L.; Dunham, E. W.; Sheppard, S. S.; Kakkala, M.; Tilleman, T.; Berger, B.; Briggs, J. W.; Jacobson, G.; Valleli, P.; Volz, B.; Rapoport, S.; Hart, R.; Brucker, M.; Michel, R.; Mattingly, A.; Zambrano-Marin, L.; Meyer, A. W.; Wolf, J.; Ryan, E. V.; Ryan, W. H.; Morzinski, K.; Grigsby, B.; Brimacombe, J.; Ragozzine, D.; Montano, H. G.; Gilmore, A.			Size and albedo of Kuiper belt object 55636 from a stellar occultation	NATURE			English	Article							DWARF PLANET HAUMEA; 2003 EL61; COLLISIONAL FAMILY; COLOR DIVERSITY; SATELLITES; MEMBERS	The Kuiper belt is a collection of small bodies (Kuiper belt objects, KBOs) that lie beyond the orbit of Neptune and which are believed to have formed contemporaneously with the planets. Their small size and great distance make them difficult to study. KBO 55636 (2002 TX300) is a member of the water-ice-rich Haumea KBO collisional family(1). The Haumea family are among the most highly reflective objects in the Solar System. Dynamical calculations indicate that the collision that created KBO 55636 occurred at least 1 Gyr ago(2,3). Here we report observations of a multi-chord stellar occultation by KBO 55636, which occurred on 9 October 2009 UT. We find that it has a mean radius of 143 +/- 65 km (assuming a circular solution). Allowing for possible elliptical shapes, we find a geometric albedo of 0.88(0.06)(+0.15) in the V photometric band, which establishes that KBO 55636 is smaller than previously thought and that, like its parent body, it is highly reflective. The dynamical age implies either that KBO 55636 has an active resurfacing mechanism, or that fresh water-ice in the outer Solar System can persist for gigayear timescales.	[Elliot, J. L.; Person, M. J.; Zuluaga, C. A.; Bosh, A. S.; Adams, E. R.; Brothers, T. C.; Gulbis, A. A. S.; Levine, S. E.; Lockhart, M.; Zangari, A. M.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Elliot, J. L.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Elliot, J. L.; Bright, L.; Dunham, E. W.] Lowell Observ, Flagstaff, AZ 86001 USA; [Gulbis, A. A. S.] So Africa Large Telescope & S African Astron Obse, ZA-8935 Cape Town, South Africa; [Levine, S. E.; Tilleman, T.] USNO, Flagstaff, AZ 86001 USA; [Levine, S. E.] Amer Assoc Variable Star Observers, Cambridge, MA 02138 USA; [Babcock, B. A.] Williams Coll, Dept Phys, Williamstown, MA 01267 USA; [DuPre, K.; Pasachoff, J. M.; Souza, S. P.] Williams Coll, Dept Astron, Williamstown, MA 01267 USA; [Rosing, W.] Las Cumbres Observ Global Telescope Network, Santa Barbara, CA 93117 USA; [Secrest, N.] Univ Hawaii, Hilo, HI 96720 USA; [Sheppard, S. S.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Kakkala, M.] Univ Hawaii, Dept Geol, Leeward Community Coll, Pearl City, HI 96782 USA; [Berger, B.; Briggs, J. W.; Jacobson, G.; Valleli, P.; Volz, B.] Amateur Telescope Makers Boston, Westford, MA 01886 USA; [Briggs, J. W.] Dexter Southfield Sch, Brookline, MA 02145 USA; [Rapoport, S.] Mt Stromlo & Siding Spring Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Hart, R.] Univ So Queensland, Mt Kent Observ, Toowoomba, Qld 4350, Australia; [Brucker, M.] Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA; [Michel, R.] Univ Nacl Autonoma Mexico, Inst Astron, Ensenada 22800, Baja California, Mexico; [Mattingly, A.] IBM Corp, St Leonards, NSW 2065, Australia; [Zambrano-Marin, L.] Univ Texas Brownsville, Texas Southmost Coll, Nompuewenu Observ, Brownsville, TX 78520 USA; [Meyer, A. W.] NASA, Univ Space Res Assoc, SOFIA, Moffett Field, CA 94035 USA; [Wolf, J.] NASA, Deutsch SOFIA Inst, SOFIA, Moffett Field, CA 94035 USA; [Ryan, E. V.; Ryan, W. H.] Magdalena Ridge Observ, Socorro, NM 87801 USA; [Morzinski, K.; Grigsby, B.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Brimacombe, J.] James Cook Univ, Cairns, Qld 4870, Australia; [Ragozzine, D.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Montano, H. G.] Univ Nacl Autonoma Mexico, Astron Observ, Managua, Nicaragua; [Gilmore, A.] Mt John Univ Observ, Lake Tekapo 7945, New Zealand	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Williams College; Williams College; University of Hawaii System; University Hawaii Hilo; Carnegie Institution for Science; University of Hawaii System; Australian National University; University of Southern Queensland; University of Nebraska System; University of Nebraska Lincoln; Universidad Nacional Autonoma de Mexico; International Business Machines (IBM); University of Texas System; University of Texas Rio Grande Valley; National Aeronautics & Space Administration (NASA); Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); University of California System; University of California Santa Cruz; James Cook University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Universidad Nacional Autonoma de Mexico	Elliot, JL (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	jle@mit.edu	Brucker, Melissa/B-4322-2014; Ragozzine, Darin/C-4926-2013; Souza, Steven P/T-4303-2018	Brucker, Melissa/0000-0002-2079-179X; Zambrano-Marin, Luisa Fernanda/0000-0002-6615-4040; Morzinski, Katie/0000-0002-1384-0063; Secrest, Nathan/0000-0002-4902-8077; Adams, Elisabeth/0000-0002-9131-5969; Sickafoose, Amanda/0000-0002-9468-7477	NASA; NSF	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We are grateful to W. M. Grundy for supplying H<INF>V</INF> magnitudes from his database and for discussions of water-ice surfaces in the outer Solar System; to W. B. McKinnon for discussions of the physical state of water-ice at low temperatures; to E. D. Schmidt for use of the telescope and participating in the observations at Behlen Observatory; to B. Carter for help in obtaining telescope time at Mt Kent, and to L. A. Young for assisting with the McDonald observations. We thank D. Byrne of the Visitor Information Station at the Onizuka Center for International Astronomy on Mauna Kea for use of their equipment and facilitating the observations from their site. J.W. thanks E. Gates of Lick Observatory, and E. Becklin, E. Pfueller, M. Wiedemann and M. Burgdort of SOFIA, for support of his observations. B. Sicardy provided several comments that improved the paper. Occultation research at MIT and Williams College is supported by NASA and NSF.	*ASTR, 2008, ASTR ASTR ASTR FILT; Bowell E., 1989, ASTEROIDS, VII, P524; Brown M.E., 2008, SOLAR SYSTEM NEPTUNE, P335; Brown ME, 2006, ASTROPHYS J, V639, pL43, DOI 10.1086/501524; Brown ME, 2007, NATURE, V446, P294, DOI 10.1038/nature05619; Brucker MJ, 2009, ICARUS, V201, P284, DOI 10.1016/j.icarus.2008.12.040; Elliot JL, 2003, EARTH MOON PLANETS, V92, P375, DOI 10.1023/B:MOON.0000031953.70454.50; Fraser WC, 2009, ASTROPHYS J LETT, V695, pL1, DOI 10.1088/0004-637X/695/1/L1; FRENCH RG, 1976, ASTRON J, V81, P445, DOI 10.1086/111905; Gil-Hutton R, 2002, PLANET SPACE SCI, V50, P57, DOI 10.1016/S0032-0633(01)00073-3; Grundy WM, 2005, ICARUS, V176, P184, DOI 10.1016/j.icarus.2005.01.007; Gulbis AAS, 2006, NATURE, V439, P48, DOI 10.1038/nature04276; HOBBS PV, 1974, ICE PHYSICS, P348; Licandro J, 2006, ASTRON ASTROPHYS, V445, pL35, DOI 10.1051/0004-6361:200500219; Luu J, 1996, ASTRON J, V112, P2310, DOI 10.1086/118184; NATHER RE, 1970, ASTRON J, V75, P575; Rabinowitz DL, 2008, ASTRON J, V136, P1502, DOI 10.1088/0004-6256/136/4/1502; Rabinowitz DL, 2006, ASTROPHYS J, V639, P1238, DOI 10.1086/499575; Ragozzine D, 2007, ASTRON J, V134, P2160, DOI 10.1086/522334; Ragozzine D, 2009, ASTRON J, V137, P4766, DOI 10.1088/0004-6256/137/6/4766; REITSEMA HJ, 1982, SCIENCE, V215, P289, DOI 10.1126/science.215.4530.289; Schaller EL, 2008, ASTROPHYS J LETT, V684, pL107, DOI 10.1086/592232; Schlichting HE, 2009, ASTROPHYS J, V700, P1242, DOI 10.1088/0004-637X/700/2/1242; Sheppard SS, 2003, EARTH MOON PLANETS, V92, P207, DOI 10.1023/B:MOON.0000031943.12968.46; Snodgrass C, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913031; Spencer JR, 2009, SATURN FROM CASSINI-HUYGENS, P683, DOI 10.1007/978-1-4020-9217-6_21; SPENCER JR, 1989, ICARUS, V78, P337, DOI 10.1016/0019-1035(89)90182-6; Stansberry J., 2008, SOLAR SYSTEM NEPTUNE, V161; Verbiscer AJ, 2005, ICARUS, V173, P66, DOI 10.1016/j.icarus.2004.05.001; ZULUAGA CA, 2009, 55636 20091009 OCCUL	30	69	69	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					897	900		10.1038/nature09109	http://dx.doi.org/10.1038/nature09109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559381				2022-12-28	WOS:000278804500031
J	Kantarjian, H; Shah, NP; Hochhaus, A; Cortes, J; Shah, S; Ayala, M; Moiraghi, B; Shen, ZX; Mayer, J; Pasquini, R; Nakamae, H; Huguet, F; Boque, C; Chuah, C; Bleickardt, E; Bradley-Garelik, MB; Zhu, C; Szatrowski, T; Shapiro, D; Baccarani, M				Kantarjian, Hagop; Shah, Neil P.; Hochhaus, Andreas; Cortes, Jorge; Shah, Sandip; Ayala, Manuel; Moiraghi, Beatriz; Shen, Zhixiang; Mayer, Jiri; Pasquini, Ricardo; Nakamae, Hirohisa; Huguet, Francoise; Boque, Concepcion; Chuah, Charles; Bleickardt, Eric; Bradley-Garelik, M. Brigid; Zhu, Chao; Szatrowski, Ted; Shapiro, David; Baccarani, Michele			Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; KINASE DOMAIN MUTATIONS; DURABLE CYTOGENETIC RESPONSES; PATIENTS RECEIVING IMATINIB; BCR-ABL; INTERFERON-ALPHA; FOLLOW-UP; MOLECULAR RESPONSE; RESISTANCE; SURVIVAL	Background Treatment with dasatinib, a highly potent BCR-ABL kinase inhibitor, has resulted in high rates of complete cytogenetic response and progression-free survival among patients with chronic myeloid leukemia (CML) in the chronic phase, after failure of imatinib treatment. We assessed the efficacy and safety of dasatinib, as compared with imatinib, for the first-line treatment of chronic-phase CML. Methods In a multinational study, 519 patients with newly diagnosed chronic-phase CML were randomly assigned to receive dasatinib at a dose of 100 mg once daily (259 patients) or imatinib at a dose of 400 mg once daily (260 patients). The primary end point was complete cytogenetic response by 12 months, confirmed on two consecutive assessments at least 28 days apart. Secondary end points, including major molecular response, were tested at a significance level of 0.0001 to adjust for multiple comparisons. Results After a minimum follow-up of 12 months, the rate of confirmed complete cytogenetic response was higher with dasatinib than with imatinib (77% vs. 66%, P = 0.007), as was the rate of complete cytogenetic response observed on at least one assessment (83% vs. 72%, P = 0.001). The rate of major molecular response was higher with dasatinib than with imatinib (46% vs. 28%, P<0.0001), and responses were achieved in a shorter time with dasatinib (P<0.0001). Progression to the accelerated or blastic phase of CML occurred in 5 patients who were receiving dasatinib (1.9%) and in 9 patients who were receiving imatinib (3.5%). The safety profiles of the two treatments were similar. Conclusions Dasatinib, administered once daily, as compared with imatinib, administered once daily, induced significantly higher and faster rates of complete cytogenetic response and major molecular response. Since achieving complete cytogenetic response within 12 months has been associated with better long-term, progression-free survival, dasatinib may improve the long-term outcomes among patients with newly diagnosed chronic-phase CML. (ClinicalTrials.gov number, NCT00481247.)	[Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Shah, Neil P.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Hochhaus, Andreas] Univ Klinikum Jena, Dept Hematol & Oncol, Jena, Germany; [Shah, Sandip] Hematooncol Clin, Ahmadabad, Gujarat, India; [Ayala, Manuel] Hosp Especialidades CMN La Raza, Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Moiraghi, Beatriz] Hosp Gen Agudos JM Ramos Mejia, Buenos Aires, DF, Argentina; [Shen, Zhixiang] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Mayer, Jiri] Univ Hosp Brno, Interni Hematoonkol Klin, Brno, Czech Republic; [Pasquini, Ricardo] Hosp Clin Curitiba, Curitiba, Parana, Brazil; [Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Huguet, Francoise] Hop Purpan, Dept Hematol, Toulouse, France; [Boque, Concepcion] Inst Catala Oncol, Dept Clin Hematol, Barcelona, Spain; [Chuah, Charles] Singapore Gen Hosp, Duke NUS Grad Med Sch, Singapore 0316, Singapore; [Bleickardt, Eric; Bradley-Garelik, M. Brigid; Zhu, Chao; Shapiro, David] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Szatrowski, Ted] Bristol Myers Squibb Co, Princeton, NJ USA; [Baccarani, Michele] Univ Bologna, Dept Hematol Oncol L&A Seragnoli, Bologna, Italy	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Friedrich Schiller University of Jena; Instituto Mexicano del Seguro Social; Hospital Ramos Mejia; Shanghai Jiao Tong University; University Hospital Brno; Osaka Metropolitan University; CHU de Toulouse; Catalan Institute of Oncology; National University of Singapore; Singapore General Hospital; Bristol-Myers Squibb; Bristol-Myers Squibb; University of Bologna	Kantarjian, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hkantarj@mdanderson.org	Mayer, Jiri/I-2377-2014	Cortes, Jorge/0000-0002-8636-1071; Hochhaus, Andreas/0000-0003-0626-0834	Bristol-Myers Squibb; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Bristol-Myers Squibb. Dr. Shah is a Clinical Scholar of the Leukemia and Lymphoma Society.	[Anonymous], 2007, SPRYC DAS PRESCR INF; [Anonymous], 2007, GLEEV IM MES TABL PR; [Anonymous], 2009, CHRON MYEL LEUK CLIN; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Cortes J, 2005, CLIN CANCER RES, V11, P3425, DOI 10.1158/1078-0432.CCR-04-2139; Cortes JE, 2010, J CLIN ONCOL, V28, P398, DOI 10.1200/JCO.2009.25.4920; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Deininger M, 2009, BLOOD, V114, P462; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2001, CHRONIC MYELOID LEUK, P205; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Iacobucci I, 2006, CLIN CANCER RES, V12, P3037, DOI 10.1158/1078-0432.CCR-05-2574; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paschka P, 2003, LEUKEMIA, V17, P1687, DOI 10.1038/sj.leu.2403033; Porkka K, 2010, CANCER, V116, P377, DOI 10.1002/cncr.24734; Press RD, 2006, BLOOD, V107, P4250, DOI 10.1182/blood-2005-11-4406; Quintas-Cardama A, 2009, BLOOD, V113, P6315, DOI 10.1182/blood-2008-07-166694; Roy L, 2006, BLOOD, V108, P1478, DOI 10.1182/blood-2006-02-001495; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Shah NP, 2008, J CLIN ONCOL, V26, P3204, DOI 10.1200/JCO.2007.14.9260; Shah NP, 2010, HAEMATOL-HEMATOL J, V95, P232, DOI 10.3324/haematol.2009.011452; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; White D, 2007, J CLIN ONCOL, V25, P4445, DOI 10.1200/JCO.2006.09.9499	34	1143	1204	2	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2260	2270		10.1056/NEJMoa1002315	http://dx.doi.org/10.1056/NEJMoa1002315			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20525995				2022-12-28	WOS:000278816300005
J	Bonetta, L				Bonetta, Laura			Whole-Genome Sequencing Breaks the Cost Barrier	CELL			English	Editorial Material																			0	37	38	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 11	2010	141	6					917	919		10.1016/j.cell.2010.05.034	http://dx.doi.org/10.1016/j.cell.2010.05.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550926	Bronze			2022-12-28	WOS:000278618800005
J	Newman, RD				Newman, Robert D.			Malaria control beyond 2010	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIAL; MICROSCOPY; RESISTANCE; MANAGEMENT; CHILDREN		WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Newman, RD (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	newmanr@who.int						Amin AA, 2007, J CLIN PHARM THER, V32, P429, DOI 10.1111/j.1365-2710.2007.00847.x; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2008, MAL RAP DIAGN TEST P; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Roll Back Malaria, 2010, MAL FUND RES UT 1 DE; WHO, 2010, GUID TREATM MAL, V2nd; *WHO, WORLD MAL REP 2009; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x	15	6	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 11	2010	340								c2714	10.1136/bmj.c2714	http://dx.doi.org/10.1136/bmj.c2714			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MH	20543011				2022-12-28	WOS:000278818900002
J	Tian, Y; Li, ZP; Hu, WQ; Ren, HY; Tian, E; Zhao, Y; Lu, Q; Huang, XX; Yang, PG; Li, X; Wang, XC; Kovacs, AL; Yu, L; Zhang, H				Tian, Ye; Li, Zhipeng; Hu, Wanqiu; Ren, Haiyan; Tian, E.; Zhao, Yu; Lu, Qun; Huang, Xinxin; Yang, Peiguo; Li, Xin; Wang, Xiaochen; Kovacs, Attila L.; Yu, Li; Zhang, Hong			C. elegans Screen Identifies Autophagy Genes Specific to Multicellular Organisms	CELL			English	Article							PANCREATITIS; VACUOLES	The molecular understanding of autophagy has originated almost exclusively from yeast genetic studies. Little is known about essential autophagy components specific to higher eukaryotes. Here we perform genetic screens in C. elegans and identify four metazoan-specific autophagy genes, named epg-2, -3, -4, and -5. Genetic analysis reveals that epg-2, -3, -4, and -5 define discrete genetic steps of the autophagy pathway. epg-2 encodes a coiled-coil protein that functions in specific autophagic cargo recognition. Mammalian homologs of EPG-3/VMP1, EPG-4/EI24, and EPG-5/mEPG5 are essential for starvation-induced autophagy. VMP1 regulates autophagosome formation by controlling the duration of omegasomes. EI24 and mEPG5 are required for formation of degradative autolysosomes. This study establishes C. elegans as a multicellular genetic model to delineate the autophagy pathway and provides mechanistic insights into the metazoan-specific autophagic process.	[Hu, Wanqiu; Yu, Li] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Ye; Li, Zhipeng; Ren, Haiyan; Tian, E.; Zhao, Yu; Lu, Qun; Huang, Xinxin; Yang, Peiguo; Li, Xin; Wang, Xiaochen; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Tian, Ye] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Kovacs, Attila L.] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, H-1117 Budapest, Hungary	Tsinghua University; National Institute of Biological Sciences, Beijing; Beijing Normal University; Eotvos Lorand University	Yu, L (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.	liyulab@mail.tsinghua.edu.cn; zhanghong@nibs.ac.cn	Lu, Qun/O-2978-2018; ren, haiyan/A-8907-2015	Tian, Ye/0000-0002-7675-9270; ren, haiyan/0000-0001-9995-3255; Huang, Xinxin/0000-0002-4298-4859; YANG, PEIGUO/0000-0002-2334-5664; Li, Zhipeng/0000-0001-8806-9667; Zhang, Hong/0000-0002-3342-5377	National High Technology Projects 863 [2008AA022306]; Hungarian Scientific Research Funds [OTKA K75843]	National High Technology Projects 863(National High Technology Research and Development Program of China); Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank Dr Xiaodong Wang for comments on the manuscript; Edvard Burghardt, Mariann Sarody, Fan Wu, Tao Sun, and Hui Zhang for technical assistance; Dr. Shohei Mitani for epg-5(tm3425); Dr. Gang Zhi and the NIBS antibody facility for preparing antibodies; and Dr. Isabel Hanson for editing services. This work was supported by the National High Technology Projects 863 (2008AA022306) (H.Z.) and Hungarian Scientific Research Funds OTKA K75843 (A.L.K.).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Dusetti NJ, 2002, BIOCHEM BIOPH RES CO, V290, P641, DOI 10.1006/bbrc.2001.6244; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kovacs AL, 2010, FEBS LETT, V584, P1335, DOI 10.1016/j.febslet.2010.02.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sigmond T, 2008, METHOD ENZYMOL, V451, P467, DOI 10.1016/S0076-6879(08)03228-X; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; YU L, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09076; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	24	302	320	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1042	1055		10.1016/j.cell.2010.04.034	http://dx.doi.org/10.1016/j.cell.2010.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550938	Bronze			2022-12-28	WOS:000278618800018
J	Wei, ZQ; Wang, DB; Kim, S; Kim, SY; Hu, YK; Yakes, MK; Laracuente, AR; Dai, ZT; Marder, SR; Berger, C; King, WP; de Heer, WA; Sheehan, PE; Riedo, E				Wei, Zhongqing; Wang, Debin; Kim, Suenne; Kim, Soo-Young; Hu, Yike; Yakes, Michael K.; Laracuente, Arnaldo R.; Dai, Zhenting; Marder, Seth R.; Berger, Claire; King, William P.; de Heer, Walter A.; Sheehan, Paul E.; Riedo, Elisa			Nanoscale Tunable Reduction of Graphene Oxide for Graphene Electronics	SCIENCE			English	Article							EPITAXIAL GRAPHENE; NANOLITHOGRAPHY; SHEETS; FILMS; TRANSPARENT	The reduced form of graphene oxide (GO) is an attractive alternative to graphene for producing large-scale flexible conductors and for creating devices that require an electronic gap. We report on a means to tune the topographical and electrical properties of reduced GO (rGO) with nanoscopic resolution by local thermal reduction of GO with a heated atomic force microscope tip. The rGO regions are up to four orders of magnitude more conductive than pristine GO. No sign of tip wear or sample tearing was observed. Variably conductive nanoribbons with dimensions down to 12 nanometers could be produced in oxidized epitaxial graphene films in a single step that is clean, rapid, and reliable.	[Wei, Zhongqing; Yakes, Michael K.; Laracuente, Arnaldo R.; Sheehan, Paul E.] USN, Res Lab, Div Chem, Washington, DC 20375 USA; [Wang, Debin; Kim, Suenne; Hu, Yike; Berger, Claire; de Heer, Walter A.; Riedo, Elisa] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Kim, Soo-Young; Marder, Seth R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kim, Soo-Young] Chung Ang Univ, Sch Chem Engn & Mat Sci, Seoul 156756, South Korea; [Dai, Zhenting; King, William P.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Berger, Claire] CNRS Inst Neel, F-38042 Grenoble 9, France	United States Department of Defense; United States Navy; Naval Research Laboratory; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Chung Ang University; University of Illinois System; University of Illinois Urbana-Champaign; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Sheehan, PE (corresponding author), USN, Res Lab, Div Chem, Code 6177, Washington, DC 20375 USA.	paul.sheehan@nrl.navy.mil; elisa.riedo@physics.gatech.edu	Kim, Soo Young/B-4373-2015; Sheehan, Paul E/B-4793-2010; Yakes, Michael/E-5510-2011; Riedo, Elisa/G-7233-2018; KIM, SUENNE/F-6352-2013; Wang, Debin/H-2713-2012; Marder, Seth/GRR-9990-2022	Kim, Soo Young/0000-0002-0685-7991; Sheehan, Paul E/0000-0003-2668-4124; KIM, SUENNE/0000-0002-8438-2805; Wang, Debin/0000-0001-8052-731X; King, William/0000-0001-8606-1290; Riedo, Elisa/0000-0002-2423-8801	National Science Foundation [DMR 0120967, DMR 0820382, DMR-0706031]; U.S. Department of Energy [DE-FG02-06ER46293]; Institute for Nanoscience at Naval Research Laboratory (NRL); Office of Naval Research of the United States; Defense Advanced Research Projects Agency (DARPA); Georgia Institute of Technology (Georgia Tech Research Foundation); National Research Council Research Associateship Award at Naval Research Laboratory of the United States; CAFM	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Institute for Nanoscience at Naval Research Laboratory (NRL); Office of Naval Research of the United States(Office of Naval Research); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Georgia Institute of Technology (Georgia Tech Research Foundation); National Research Council Research Associateship Award at Naval Research Laboratory of the United States; CAFM	This work has been supported by the National Science Foundation (CMDITR program DMR 0120967, Materials Research Science and Engineering Center program DMR 0820382, and DMR-0706031), U.S. Department of Energy (DE-FG02-06ER46293 and PECASE), the Institute for Nanoscience at Naval Research Laboratory (NRL), the Office of Naval Research of the United States, the Defense Advanced Research Projects Agency (DARPA) Tip-Based Nanomanufacturing program, and Georgia Institute of Technology (Georgia Tech Research Foundation, COE Cutting Edge Research Award, and COPE fellowship). This research was performed while Z.W. held a National Research Council Research Associateship Award at Naval Research Laboratory of the United States. Z.W. thanks H. Qi at NRL for providing doped silicon wafers, evaporating gold layers on mica, and taking scanning electron micrograph images of GO sheets on gold and silicon substrates. E. R. thanks T.-D. Li and M. Lucas for support with CAFM.	Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83; Eda G, 2009, J PHYS CHEM C, V113, P15768, DOI 10.1021/jp9051402; Epstein A.J., 1999, CONDUCT POLY PLAST, P1; Filleter T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086102; Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c; Kedzierski J, 2008, IEEE T ELECTRON DEV, V55, P2078, DOI 10.1109/TED.2008.926593; Mattevi C, 2009, ADV FUNCT MATER, V19, P2577, DOI 10.1002/adfm.200900166; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Nelson BA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164394; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]; PARMAN CE, 1993, PHYS REV B, V47, P12578, DOI 10.1103/PhysRevB.47.12578; Robinson JT, 2008, NANO LETT, V8, P3441, DOI 10.1021/nl8023092; Robinson JT, 2008, NANO LETT, V8, P3137, DOI 10.1021/nl8013007; Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f; Sheehan PE, 2004, APPL PHYS LETT, V85, P1589, DOI 10.1063/1.1785860; Szoszkiewicz R, 2007, NANO LETT, V7, P1064, DOI 10.1021/nl070300f; Vettiger P, 2002, IEEE T NANOTECHNOL, V1, P39, DOI 10.1109/TNANO.2002.1005425; Wang DB, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2816401; Wang DB, 2009, ADV FUNCT MATER, V19, P3696, DOI 10.1002/adfm.200901057; Wang DB, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3271178; Wu XS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026801; Yang M, 2006, J AM CHEM SOC, V128, P6774, DOI 10.1021/ja0612807	24	601	618	14	575	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1373	1376		10.1126/science.1188119	http://dx.doi.org/10.1126/science.1188119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538944	Green Submitted			2022-12-28	WOS:000278598400031
J	Blois, JL; McGuire, JL; Hadly, EA				Blois, Jessica L.; McGuire, Jenny L.; Hadly, Elizabeth A.			Small mammal diversity loss in response to late-Pleistocene climatic change	NATURE			English	Article							RADIOCARBON CALIBRATION; COMMUNITIES; FIRE	Communities have been shaped in numerous ways by past climatic change; this process continues today(1). At the end of the Pleistocene epoch about 11,700 years ago, North American communities were substantially altered by the interplay of two events. The climate shifted from the cold, arid Last Glacial Maximum to the warm, mesic Holocene interglacial, causing many mammal species to shift their geographic distributions substantially(2,3). Populations were further stressed as humans arrived on the continent(4). The resulting megafaunal extinction event, in which 70 of the roughly 220 largest mammals in North America (32%) became extinct 5, has received much attention. However, responses of small mammals to events at the end of the Pleistocene have been much less studied, despite the sensitivity of these animals to current and future environmental change. Here we examine community changes in small mammals in northern California during the last 'natural' global warming event at the Pleistocene-Holocene transition and show that even though no small mammals in the local community became extinct, species losses and gains, combined with changes in abundance, caused declines in both the evenness and richness of communities. Modern mammalian communities are thus depauperate not only as a result of megafaunal extinctions at the end of the Pleistocene but also because of diversity loss among small mammals. Our results suggest that across future landscapes there will be some unanticipated effects of global change on diversity: restructuring of small mammal communities, significant loss of richness, and perhaps the rising dominance of native 'weedy' species.	[Blois, Jessica L.; Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [McGuire, Jenny L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	Blois, JL (corresponding author), Univ Wisconsin, Ctr Climat Res, 1225 W Dayton St, Madison, WI 53706 USA.	blois@wisc.edu	McGuire, Jenny L./G-8819-2011; Blois, Jessica/G-5893-2011	McGuire, Jenny L./0000-0002-0663-6902; Blois, Jessica/0000-0003-4048-177X	National Science Foundation [EAR-0545648, EAR-0719429]; California Energy Commission; Stanford University Vice Provost for Undergraduate Education; US Forest Service	National Science Foundation(National Science Foundation (NSF)); California Energy Commission; Stanford University Vice Provost for Undergraduate Education; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	We thank numerous field assistants, A. Barnosky, C. Li, and members of the J. Williams and E. Hadly laboratories for comments that improved the manuscript. The National Science Foundation (grants EAR-0545648 and EAR-0719429 to E. A. H.), California Energy Commission's Public Interest Energy Research Environmental Area grant to J. L. B., and the Stanford University Vice Provost for Undergraduate Education supported this research. We are grateful for support from the US Forest Service.	Arnold JE, 2004, J ARCHAEOL RES, V12, P1, DOI 10.1023/B:JARE.0000016694.82226.62; Barnosky Anthony D., 2004, P341; Barnosky Anthony D., 2009, HEATSTROKE NATURE AG; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; BLOIS JL, 2009, THESIS STANFORD U; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Buchanan B, 2008, P NATL ACAD SCI USA, V105, P11651, DOI 10.1073/pnas.0803762105; Carrasco MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008331; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GRAHAM R W, 1976, Paleobiology, V2, P343; Graham RW, 1996, SCIENCE, V272, P1601; Grayson DK, 2000, J BIOGEOGR, V27, P181, DOI 10.1046/j.1365-2699.2000.00383.x; GRAYSON DK, 1973, AM ANTIQUITY, V38, P432, DOI 10.2307/279149; GRAYSON DK, 1978, AM ANTIQUITY, V43, P53, DOI 10.2307/279631; Grayson Donald K., 2000, Bulletin Utah Geological Survey, V130, P67; Hadly EA, 1999, PALAEOGEOGR PALAEOCL, V149, P389, DOI 10.1016/S0031-0182(98)00214-4; Hadly EA, 2009, P NATL ACAD SCI USA, V106, P19707, DOI 10.1073/pnas.0901648106; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Johnson CN, 1996, TRENDS ECOL EVOL, V11, P503, DOI 10.1016/S0169-5347(96)10053-7; KING JA, 1968, AM SOC MAMMALOGISTS, V2; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Myers P, 2009, GLOBAL CHANGE BIOL, V15, P1434, DOI 10.1111/j.1365-2486.2009.01846.x; *N GREENL IC COR P, 2004, NATURE, V421, P147; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NORRDAHL K, 1995, OECOLOGIA, V103, P241, DOI 10.1007/BF00329086; R Core Team, 2020, R LANG ENV STAT COMP; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Solomon S., 2007, PHYS SCI BASIS WORKI; TREGANZA AE, 1964, CAVE STUDIES, V12, P1; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Zwolak R, 2007, CAN J ZOOL, V85, P815, DOI 10.1139/Z07-065	42	167	170	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					771	U5		10.1038/nature09077	http://dx.doi.org/10.1038/nature09077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20495547				2022-12-28	WOS:000278551800043
J	Hirsch, IB; Brownlee, M				Hirsch, Irl B.; Brownlee, Michael			Beyond Hemoglobin A(1c)-Need for Additional Markers of Risk for Diabetic Microvascular Complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE VARIABILITY; INTENSIVE TREATMENT; PROGRESSION; MELLITUS		[Hirsch, Irl B.] Univ Washington, Med Ctr Roosevelt, Div Metab Endocrinol & Nutr, Sch Med, Seattle, WA 98105 USA; [Hirsch, Irl B.] Univ Washington, Diabet Care Ctr, Seattle, WA 98105 USA; [Brownlee, Michael] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hirsch, IB (corresponding author), Univ Washington, Med Ctr Roosevelt, Div Metab Endocrinol & Nutr, Sch Med, 4225 Roosevelt Way NE,Ste 101, Seattle, WA 98105 USA.	ihirsch@uw.edu						Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Cohen RA, 1999, AM J MED, V107, P45, DOI 10.1016/S0002-9343(99)00165-5; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105	10	118	123	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2291	2292		10.1001/jama.2010.785	http://dx.doi.org/10.1001/jama.2010.785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530784				2022-12-28	WOS:000278496800030
J	Renoux, C; Dell'Aniello, S; Garbe, E; Suissa, S				Renoux, Christel; Dell'Aniello, Sophie; Garbe, Edeltraut; Suissa, Samy			Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; POSTMENOPAUSAL WOMEN; VENOUS THROMBOEMBOLISM; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; EQUINE ESTROGEN; METAANALYSIS; ASSOCIATION; IMPACT	Objectives To determine the risk of stroke associated with oral and transdermal routes of administration of hormone replacement therapy. Design Population based nested case-control study. Setting About 400 general practices in the United Kingdom contributing to the General Practice Research Database. Participants Cohort of all women in the database aged 50-79 years between 1 January 1987 and 31 October 2006 who were members of a practice that fulfilled predefined quality criteria and without a diagnosis of stroke before cohort entry. For each case of stroke occurring during follow-up, up to four controls were selected from among the cohort members in the risk sets defined by the case. Exposure to hormone replacement therapy (HRT) was categorised into oestrogens only, oestrogens plus progestogen, progestogen only, and tibolone. Oestrogens were further subdivided according to the route of administration (oral v transdermal) and dose (high v low). Main outcome measures Rate ratio of stroke associated with current use of oral and transdermal HRT compared with no use. Current use was considered as a prescription whose duration included the index date. Results There were 15 710 cases of stroke matched to 59 958 controls. The rate of stroke in the cohort was 2.85 per 1000 per year. The adjusted rate ratio of stroke associated with current use of transdermal HRT was 0.95 (95% CI 0.75 to 1.20) relative to no use. The risk of stroke was not increased with use of low oestrogen dose patches (rate ratio 0.81(0.62 to 1.05)) compared with no use, whereas the risk was increased with high dose patches (rate ratio 1.89 (1.15 to 3.11)). Current users of oral HRT had a higher rate of stroke than non-users (rate ratio 1.28 (1.15 to 1.42)) with both low dose and high dose. Conclusions The use of transdermal HRT containing low doses of oestrogen does not seem to increase the risk of stroke. The presence of residual confounding, however, cannot be entirely excluded in the interpretation of this finding.	[Renoux, Christel; Dell'Aniello, Sophie; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, McGill Pharmacoepidemiol Res Unit, Montreal, PQ H3T 1E2, Canada; [Renoux, Christel; Dell'Aniello, Sophie; Suissa, Samy] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3T 1E2, Canada; [Renoux, Christel; Dell'Aniello, Sophie; Suissa, Samy] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Garbe, Edeltraut] Univ Bremen, Dept Clin Epidemiol, Bremen Inst Prevent Res & Social Med, D-28359 Bremen, Germany	McGill University; McGill University; McGill University; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, McGill Pharmacoepidemiol Res Unit, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca			Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation; Organon; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Organon; Multiple Sclerosis Society of Canada	Funding: This research was funded by grants from the Canadian Institutes of Health Research (CIHR), the Canadian Foundation for Innovation, and Organon. SS is the recipient of a distinguished investigator award from the CIHR. CR is the recipient of a postdoctoral fellowship from the Multiple Sclerosis Society of Canada	Andersohn F, 2006, STROKE, V37, P1725, DOI 10.1161/01.STR.0000226642.55207.94; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Arana A, 2006, MENOPAUSE, V13, P730, DOI 10.1097/01.gme.0000233494.28335.71; Archer DF, 2003, MENOPAUSE, V10, P516, DOI 10.1097/01.GME.0000070526.74726.8A; Bath PMW, 2005, BRIT MED J, V330, P342, DOI 10.1136/bmj.38331.655347.8F; Canonico M, 2006, J THROMB HAEMOST, V4, P1259, DOI 10.1111/j.1538-7836.2006.01933.x; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; Canonico M, 2007, CIRCULATION, V115, P840, DOI 10.1161/CIRCULATIONAHA.106.642280; Cherry N, 2002, LANCET, V360, P2001; Clarke SC, 2002, BJOG-INT J OBSTET GY, V109, P1056, DOI 10.1111/j.1471-0528.2002.01544.x; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; de Vries CS, 2006, MATURITAS, V53, P343, DOI 10.1016/j.maturitas.2005.06.004; Gutthann SP, 1997, BMJ-BRIT MED J, V314, P796, DOI 10.1136/bmj.314.7083.796; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Hemelaar M, 2008, FERTIL STERIL, V90, P642, DOI 10.1016/j.fertnstert.2007.07.1298; Hendrix SL, 2006, CIRCULATION, V113, P2425, DOI 10.1161/CIRCULATIONAHA.105.594077; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Magliano DJ, 2006, BJOG-INT J OBSTET GY, V113, P5, DOI 10.1111/j.1471-0528.2005.00797.x; Modena MG, 2005, MATURITAS, V52, P1, DOI 10.1016/j.maturitas.2005.05.003; PLACE VA, 1985, AM J OBSTET GYNECOL, V152, P1092, DOI 10.1016/0002-9378(85)90568-X; Renoux C, 2008, MATURITAS, V61, P305, DOI 10.1016/j.maturitas.2008.09.020; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Sare GM, 2008, EUR HEART J, V29, P2031, DOI 10.1093/eurheartj/ehn299; Scarabin PY, 2003, LANCET, V362, P428, DOI 10.1016/S0140-6736(03)14066-4; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; Straczek C, 2005, CIRCULATION, V112, P3495, DOI 10.1161/CIRCULATIONAHA.105.565556; Varas-Lorenzo C, 2000, CIRCULATION, V101, P2572, DOI 10.1161/01.CIR.101.22.2572; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673	32	183	185	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2010	340								c2519	10.1136/bmj.c2519	http://dx.doi.org/10.1136/bmj.c2519			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BM	20525678	hybrid			2022-12-28	WOS:000278556500005
J	Ismail, SA; Vetter, IR; Sot, B; Wittinghofer, A				Ismail, Shehab A.; Vetter, Ingrid R.; Sot, Begona; Wittinghofer, Alfred			The Structure of an Arf-ArfGAP Complex Reveals a Ca2+ Regulatory Mechanism	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEOTIDE EXCHANGE; CRYSTAL-STRUCTURE; MEMBRANE; GAP; BINDING; IDENTIFICATION; MICRODOMAINS; VESICLES; ENZYME	Arfs are small G proteins that have a key role in vesicle trafficking and cytoskeletal remodeling. Arf-GAP proteins stimulate Arf intrinsic GTP hydrolysis by a mechanism that is still unresolved. Using a fusion construct we solved the structure of the ArfGAP ASAP3 in complex with Arf6 in the transition state. This structure clarifies the ArfGAP catalytic mechanism and shows a glutamine((Arf6)) and an arginine finger((ASAP3)) as the important catalytic residues. Unexpectedly the structure shows a calcium ion, liganded by both proteins in the complex interface, stabilizing the interaction and orienting the catalytic machinery. Calcium stimulates the GAP activity of ASAPs, but not other members of the ArfGAP family. This type of regulation is unique for GAPs and any other calcium-regulated processes and hints at a crosstalk between Ca2+ and Arf signaling.	[Ismail, Shehab A.; Vetter, Ingrid R.; Sot, Begona; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Sot, Begoña/H-2882-2015	Sot, Begoña/0000-0001-8763-0651; Ismail, Shehab/0000-0002-4150-1077	Alexander Von Humboldt Stiftung; DFG [SFB 642]	Alexander Von Humboldt Stiftung(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG))	We thank Paul Randazzo for ASAP1 and AGAP1 clones; Maraget Chou for the Arf6 clone; and Michael Sporner for ARNO proteins; Wulf Blankenfeldt, Eck-hard Hoffman, and Ilme Schlichting for data collection at the Swiss Light Source, beamline X10SA, Paul Scherrer Institut, Villigen, Switzerland. We thank Ola Sabet, Raphael Gasper, and Simon Meyer for scientific discussions and Carolin Koerner for scientific discussion and expert technical support. S.A.I. is sponsored by the Alexander Von Humboldt Stiftung. A. W. thanks the DFG (SFB 642) for financial support.	Andreev J, 1999, MOL CELL BIOL, V19, P2338; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Berry H, 2002, BIOPHYS J, V83, P1891, DOI 10.1016/S0006-3495(02)73953-2; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; FRALEY R, 1980, BIOCHEMISTRY-US, V19, P6021, DOI 10.1021/bi00567a012; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOMPERTS BD, 2002, SIGNAL TRANSDUCTION; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kirberger M, 2008, J BIOL INORG CHEM, V13, P1169, DOI 10.1007/s00775-008-0402-7; Krebs J, 2007, N COMP BIOC, V41, P1; Laude AJ, 2009, FEBS J, V276, P1800, DOI 10.1111/j.1742-4658.2009.06927.x; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; McNeil BD, 2009, NEURON, V63, P419, DOI 10.1016/j.neuron.2009.08.001; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Okabe H, 2004, INT J ONCOL, V24, P43; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008; TAKAKUWA Y, 1994, J BIOL CHEM, V269, P27889; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093	43	53	56	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					812	821		10.1016/j.cell.2010.03.051	http://dx.doi.org/10.1016/j.cell.2010.03.051			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510928	Bronze			2022-12-28	WOS:000278132900016
J	Hoffman, J; Greene, B				Hoffman, Jascha; Greene, Brian			Q&A: Brian Greene on music and string theory	NATURE			English	Editorial Material									[Greene, Brian] Columbia Univ, New York, NY USA	Columbia University		jascha@jaschahoffman.com							0	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					426	426		10.1038/465426a	http://dx.doi.org/10.1038/465426a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601FM	20505712	Bronze			2022-12-28	WOS:000278043700018
J	King, AJ; Ruparelia, N; McKenna, CJ				King, Andrew J.; Ruparelia, Neil; McKenna, Charles J.			Crushing angina	LANCET			English	Editorial Material							TRAUMA; BLUNT		[King, Andrew J.; Ruparelia, Neil; McKenna, Charles J.] Royal Berkshire Hosp, Dept Cardiol, Reading RG1 5AN, Berks, England	Royal Berkshire Hospital	King, AJ (corresponding author), Royal Berkshire Hosp, Dept Cardiol, London Rd, Reading RG1 5AN, Berks, England.	andrewjohnking@gmail.com						Christensen MD, 2006, INT J CARDIOL, V108, P1, DOI 10.1016/j.ijcard.2005.04.010; LOSS DM, 1983, CATHETER CARDIO DIAG, V9, P297, DOI 10.1002/ccd.1810090309; Ryu Jae Kean, 2007, Int J Cardiol, V114, pe89; Salehian O, 2003, CAN J CARDIOL, V19, P1054	4	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1938	1938		10.1016/S0140-6736(10)60448-5	http://dx.doi.org/10.1016/S0140-6736(10)60448-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20511020				2022-12-28	WOS:000278628800034
J	Orszag, PR; Emanuel, EJ				Orszag, Peter R.; Emanuel, Ezekiel J.			Health Care Reform and Cost Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Orszag, Peter R.; Emanuel, Ezekiel J.] White House Off Management & Budget, Washington, DC USA; [Emanuel, Ezekiel J.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Orszag, PR (corresponding author), White House Off Management & Budget, Washington, DC USA.							Congressional Budget Office, 2010, COMMUNICATION   0320; Cutler D., 2010, IMPACT HLTH REFORM H; *DEP HLTH HUM SERV, FISC YEAR 2008 ANN P; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563	5	171	172	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					601	603		10.1056/NEJMp1006571	http://dx.doi.org/10.1056/NEJMp1006571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TN	20554975				2022-12-28	WOS:000280764600001
J	Behar, DM; Yunusbayev, B; Metspalu, M; Metspalu, E; Rosset, S; Parik, J; Rootsi, S; Chaubey, G; Kutuev, I; Yudkovsky, G; Khusnutdinova, EK; Balanovsky, O; Semino, O; Pereira, L; Comas, D; Gurwitz, D; Bonne-Tamir, B; Parfitt, T; Hammer, MF; Skorecki, K; Villems, R				Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Rosset, Saharon; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Yudkovsky, Guennady; Khusnutdinova, Elza K.; Balanovsky, Oleg; Semino, Ornella; Pereira, Luisa; Comas, David; Gurwitz, David; Bonne-Tamir, Batsheva; Parfitt, Tudor; Hammer, Michael F.; Skorecki, Karl; Villems, Richard			The genome-wide structure of the Jewish people	NATURE			English	Article							POPULATION STRATIFICATION; EUROPEAN AMERICANS; MIDDLE-EASTERN; ANCESTRY; INDIVIDUALS; ASSOCIATION; GENOTYPE; PATTERNS	Contemporary Jews comprise an aggregate of ethno-religious communities whose worldwide members identify with each other through various shared religious, historical and cultural traditions(1,2). Historical evidence suggests common origins in the Middle East, followed by migrations leading to the establishment of communities of Jews in Europe, Africa and Asia, in what is termed the Jewish Diaspora(3-5). This complex demographic history imposes special challenges in attempting to address the genetic structure of the Jewish people(6). Although many genetic studies have shed light on Jewish origins and on diseases prevalent among Jewish communities, including studies focusing on uniparentally and biparentally inherited markers(7-16), genome-wide patterns of variation across the vast geographic span of Jewish Diaspora communities and their respective neighbours have yet to be addressed. Here we use high-density bead arrays to genotype individuals from 14 Jewish Diaspora communities and compare these patterns of genome-wide diversity with those from 69 Old World non-Jewish populations, of which 25 have not previously been reported. These samples were carefully chosen to provide comprehensive comparisons between Jewish and non-Jewish populations in the Diaspora, as well as with non-Jewish populations from the Middle East and north Africa. Principal component and structure-like analyses identify previously unrecognized genetic substructure within the Middle East. Most Jewish samples form a remarkably tight subcluster that overlies Druze and Cypriot samples but not samples from other Levantine populations or paired Diaspora host populations. In contrast, Ethiopian Jews (Beta Israel) and Indian Jews (Bene Israel and Cochini) cluster with neighbouring autochthonous populations in Ethiopia and western India, respectively, despite a clear paternal link between the Bene Israel and the Levant. These results cast light on the variegated genetic architecture of the Middle East, and trace the origins of most Jewish Diaspora communities to the Levant.	[Behar, Doron M.; Yudkovsky, Guennady; Skorecki, Karl] Mol Med Lab, IL-31096 Haifa, Israel; [Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Villems, Richard] Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia; [Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Yunusbayev, Bayazit; Kutuev, Ildus; Khusnutdinova, Elza K.] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Rosset, Saharon] Tel Aviv Univ, Sch Math Sci, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel; [Yudkovsky, Guennady; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, IL-31096 Haifa, Israel; [Balanovsky, Oleg] Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; [Semino, Ornella] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Pereira, Luisa] IPATIMUP, P-4200465 Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4200319 Oporto, Portugal; [Comas, David] CEXS UPF PRBB, Inst Evolutionary Biol, CSIC, Barcelona 08003, Spain; [Comas, David] CIBER Epidemiol & Salud Publ, Barcelona 08003, Spain; [Gurwitz, David; Bonne-Tamir, Batsheva] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Parfitt, Tudor] Univ London Sch Oriental & African Studies, Fac Languages & Cultures, Dept Languages & Cultures Near & Middle E, London WC1H 0XG, England; [Hammer, Michael F.] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA	Rambam Health Care Campus; Estonian Biocentre; University of Tartu; University of Tartu; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Tel Aviv University; Technion Israel Institute of Technology; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; University of Pavia; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Tel Aviv University; Sackler Faculty of Medicine; University of London; University of London School Oriental & African Studies (SOAS); University of Arizona	Behar, DM (corresponding author), Mol Med Lab, Rambam Hlth Care Campus, IL-31096 Haifa, Israel.	behardm@usernet.com; skorecki@tx.technion.ac.il; rvillems@ebc.ee	Metspalu, Mait/G-8671-2015; Chaubey, Gyaneshwer/H-2753-2012; Comas, David/D-5382-2014; Chaubey, Gyaneshwer/AAC-6409-2019; Pereira, Luisa/H-3050-2011; Yunusbaev, Bayazit/T-5444-2019; Gurwitz, David/E-7642-2013; Khusnutdinova, Elza Kamilevna/A-4810-2013; Balanovsky, Oleg/G-1549-2014	Metspalu, Mait/0000-0003-3099-9161; Chaubey, Gyaneshwer/0000-0003-2899-3852; Comas, David/0000-0002-5075-0956; Chaubey, Gyaneshwer/0000-0003-2899-3852; Pereira, Luisa/0000-0002-4271-1527; Gurwitz, David/0000-0002-9363-1869; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Yunusbayev, Bayazit/0000-0002-6035-8763; SEMINO, Ornella/0000-0002-9675-9403	European Commission [205419]; European Union through a Centre of Excellence in Genomics; Swedish Collegium for Advanced Studies; Estonian Science Foundation [7858, 7445]; Arthur and Rosalinde Gilbert Foundation; American Technion Society; European Union for Marie Curie International Reintegration [CT-2007-208019]; Israeli Science Foundation [1227/09]; Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education; Fundacao para a Ciencia ea Tecnologia; Portuguese Foundation for Science and Technology	European Commission(European CommissionEuropean Commission Joint Research Centre); European Union through a Centre of Excellence in Genomics; Swedish Collegium for Advanced Studies; Estonian Science Foundation; Arthur and Rosalinde Gilbert Foundation; American Technion Society; European Union for Marie Curie International Reintegration; Israeli Science Foundation(Israel Science Foundation); Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education; Fundacao para a Ciencia ea Tecnologia(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	We thank the individuals who provided DNA samples for this study, including the National Laboratory for the Genetics of Israeli Populations; Mari Nelis, Georgi Hudjashov and Viljo Soo for conducting the autosomal genotyping; Lauri Anton for computational help. R. V. and D. M. B. thank the European Commission, Directorate-General for Research for FP7 Ecogene grant 205419. R. V. thanks the European Union, Regional Development Fund through a Centre of Excellence in Genomics grant and the Swedish Collegium for Advanced Studies for support during the initial stage of this study. E. M. and Si. R. thank the Estonian Science Foundation for grants 7858 and 7445, respectively. K. S. thanks the Arthur and Rosalinde Gilbert Foundation fund of the American Technion Society. Sa. R. thanks the European Union for Marie Curie International Reintegration grant CT-2007-208019, and the Israeli Science Foundation for grant 1227/09. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partly supported by Fundacao para a Ciencia ea Tecnologia, the Portuguese Foundation for Science and Technology.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Ben-Sasson HH, 1976, HIST JEWISH PEOPLE; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, V4; De Lange N, 1984, ATLAS JEWISH WORLD; Gao XY, 2009, HUM HERED, V68, P182, DOI 10.1159/000224638; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hourani Albert, 1991, HIST ARAB PEOPLES; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kopelman NM, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-80; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mahler Raphael, 1971, HIST MODERN JEWRY; Need AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r7; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olshen AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-14; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sergio DellaPergola, 1997, PAPERS JEWISH DEMOGR, P11; Stillman NormanA., 1979, JEWS ARAB LANDS HIST; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Weiss KM, 2009, GENOME RES, V19, P703, DOI 10.1101/gr.076539.108	30	270	275	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					238	U112		10.1038/nature09103	http://dx.doi.org/10.1038/nature09103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20531471				2022-12-28	WOS:000279580800037
J	Brown, MS; Ye, J; Goldstein, JL				Brown, Michael S.; Ye, Jin; Goldstein, Joseph L.			HDL miR-ed Down by SREBP Introns	SCIENCE			English	Editorial Material							FATTY-ACID SYNTHESIS; CHOLESTEROL; TRANSCRIPTION; LIVER		[Brown, Michael S.; Ye, Jin; Goldstein, Joseph L.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu			NHLBI NIH HHS [HL20948, P01 HL020948-34, P01 HL020948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Attie AD, 2007, TRENDS BIOCHEM SCI, V32, P172, DOI 10.1016/j.tibs.2007.02.001; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; *NIH, HL20948 NIH; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Reaven GM, 2005, CELL METAB, V1, P9, DOI 10.1016/j.cmet.2004.12.001; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247	12	39	44	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1495	1496		10.1126/science.1192409	http://dx.doi.org/10.1126/science.1192409			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558698	Green Accepted			2022-12-28	WOS:000278859200026
J	Bao, HM; Yu, SC; Tong, DQ				Bao, Huiming; Yu, Shaocai; Tong, Daniel Q.			Massive volcanic SO2 oxidation and sulphate aerosol deposition in Cenozoic North America	NATURE			English	Article							VOLCANOGENIC SULFATE; OXYGEN; SULFUR; ORIGIN; ATMOSPHERE; OLIGOCENE; ERUPTIONS; OZONE; EARTH; USA	Volcanic eruptions release a large amount of sulphur dioxide (SO2) into the atmosphere(1,2). SO2 is oxidized to sulphate and can subsequently form sulphate aerosol(3), which can affect the Earth's radiation balance, biologic productivity and high-altitude ozone concentrations, as is evident from recent volcanic eruptions(4). SO2 oxidation can occur via several different pathways that depend on its flux and the atmospheric conditions(3). An investigation into how SO2 is oxidized to sulphate-the oxidation product preserved in the rock record-can therefore shed light on past volcanic eruptions and atmospheric conditions. Here we use sulphur and triple oxygen isotope measurements of atmospheric sulphate extracted from tuffaceous deposits to investigate the specific oxidation pathways from which the sulphate was formed. We find that seven eruption-related sulphate aerosol deposition events have occurred during the mid-Cenozoic era (34 to 7 million years ago) in the northern High Plains, North America. Two extensively sampled ash beds display a similar sulphate mixing pattern that has two distinct atmospheric secondary sulphates. A three-dimensional atmospheric sulphur chemistry and transport model study reveals that the observed, isotopically discrete sulphates in sediments can be produced only in initially alkaline cloudwater that favours an ozone-dominated SO2 oxidation pathway in the troposphere. Our finding suggests that, in contrast to the weakly acidic conditions today(5), cloudwater in the northern High Plains may frequently have been alkaline during the mid-Cenozoic era. We propose that atmospheric secondary sulphate preserved in continental deposits represents an unexploited geological archive for atmospheric SO2 oxidation chemistry linked to volcanism and atmospheric conditions in the past.	[Bao, Huiming] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; [Yu, Shaocai] US EPA, Natl Exposure Res Lab, Atmospher Modeling & Anal Div E243 03, Res Triangle Pk, NC 27711 USA; [Tong, Daniel Q.] NOAA, Air Resources Lab, Silver Spring, MD 20910 USA	Louisiana State University System; Louisiana State University; United States Environmental Protection Agency; National Oceanic Atmospheric Admin (NOAA) - USA	Bao, HM (corresponding author), Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA.	bao@lsu.edu; yu.shaocai@epa.gov	Tong, Daniel Q./A-8255-2008; yu, shaocai/F-1394-2014; yu, shaocai/G-7806-2011; Bao, Huiming/C-1069-2012	Tong, Daniel Q./0000-0002-4255-4568; 	NSF [EAR-0408986]; United States Environmental Protection Agency through its Office of Research and Development	NSF(National Science Foundation (NSF)); United States Environmental Protection Agency through its Office of Research and Development(United States Environmental Protection Agency)	H. B. thanks D. Loope, H. LaGarry and J. Swinehart for guidance in the field, M. Khachaturyan, K. Jenkins, K. Howell, I. Kohl and A. J. Kaufman for technical assistance, B. Li for statistical treatment, and the National Park Service for sampling permission at Scotts Bluff National Monument (permit numbers SCBL-2000-SCI-000, BADL-2004-SCI-0012 and SCBL-2004-SCI-0005). Financial support was provided by the NSF (EAR-0408986 to H. B.). S.Y. thanks S. T. Rao, D. Mobley, K. Schere, R. Mathur, J. Pleim, J. Godowitch and S. Roselle for comments. The United States Environmental Protection Agency through its Office of Research and Development funded and managed the part of the research that is related to sulphur chemistry modelling. It has been subjected to the Agency's administrative review and approved for publication. D. Q. T. is grateful to S. Fine, D. Byun and R. Artz for discussion and acknowledges constructive internal Air Resources Laboratory comments.	Alexander B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014879; ARMSTRONG RL, 1991, J GEOPHYS RES-SOLID, V96, P13201, DOI 10.1029/91JB00412; Bao HM, 2000, NATURE, V406, P176, DOI 10.1038/35018052; Bao HM, 2005, CHEM GEOL, V214, P127, DOI 10.1016/j.chemgeo.2004.08.052; Bao HM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016869; Bao HM, 2001, EARTH PLANET SC LETT, V192, P125, DOI 10.1016/S0012-821X(01)00446-0; Bao HM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006669; Bindeman IN, 2007, GEOCHIM COSMOCHIM AC, V71, P2326, DOI 10.1016/j.gca.2007.01.026; Eder B, 2006, ATMOS ENVIRON, V40, P4811, DOI 10.1016/j.atmosenv.2005.08.045; Howell KJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026518; Jenkins KA, 2006, ATMOS ENVIRON, V40, P4528, DOI 10.1016/j.atmosenv.2006.04.010; Johnston JC, 1997, J GEOPHYS RES-ATMOS, V102, P25395, DOI 10.1029/97JD02075; Loope DB, 2005, SEDIMENTOLOGY, V52, P123, DOI 10.1111/j.1365-3091.2004.00689.x; Lyons JR, 2001, GEOPHYS RES LETT, V28, P3231, DOI 10.1029/2000GL012791; Mather TA, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006584; Morin S, 2008, SCIENCE, V322, P730, DOI 10.1126/science.1161910; *NAT ATM DEP PROGR, 2009, 2008 ANN SUMM, P15; Noda T., 1993, GEOTHERMICS, V22, P165; Robock A, 2002, SCIENCE, V295, P1242, DOI 10.1126/science.1069903; Rose WI, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006872; Savarino J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003737; Savarino J, 1999, ATMOS ENVIRON, V33, P3683, DOI 10.1016/S1352-2310(99)00122-3; Savarino J, 2000, J GEOPHYS RES-ATMOS, V105, P29079, DOI 10.1029/2000JD900456; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; Thordarson T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD002042; Wallace PJ, 2001, J VOLCANOL GEOTH RES, V108, P85, DOI 10.1016/S0377-0273(00)00279-1; Ward PL, 2009, THIN SOLID FILMS, V517, P3188, DOI 10.1016/j.tsf.2009.01.005; Wignall P, 2005, ELEMENTS, V1, P293, DOI 10.2113/gselements.1.5.293; Zhang DD, 2003, ATMOS ENVIRON, V37, P231, DOI 10.1016/S1352-2310(02)00835-X	30	31	31	5	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					909	912		10.1038/nature09100	http://dx.doi.org/10.1038/nature09100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559384				2022-12-28	WOS:000278804500034
J	Parad, RB				Parad, Richard B.			HFOV in preterms: an individual patients' data meta-analysis	LANCET			English	Editorial Material									Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Newborn Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Parad, RB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Newborn Med, Boston, MA 02115 USA.	rparad@partners.org	Parad, Richard B/AGX-7702-2022; Parad, Richard/E-8559-2010	Parad, Richard B/0000-0002-4326-0609; 				BARRINGTON KJ, 2007, COCHRANE DB SYST REV, V3; COOLS F, 2010, LANCET, DOI DOI 10.1056/S0140-6736(10)60278-4; COOLS F, 2009, BMC PEDIATR, V16, P9; Cools F, 2009, COCHRANE DB SYST REV, V3; Courtney SE, 2003, CRIT CARE, V7, P423, DOI 10.1186/cc2178; FITZHARDINGE PM, 1990, J PEDIATR-US, V117, P939; Reade MC, 2010, INTENS CARE MED, V36, P11, DOI 10.1007/s00134-009-1650-x; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K	8	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2054	2055		10.1016/S0140-6736(10)60756-8	http://dx.doi.org/10.1016/S0140-6736(10)60756-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20549868				2022-12-28	WOS:000279069300005
J	Devireddy, LR; Hart, DO; Goetz, DH; Green, MR				Devireddy, Laxminarayana R.; Hart, Daniel O.; Goetz, David H.; Green, Michael R.			A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin Production	CELL			English	Article							RNA-BINDING PROTEIN; MITOCHONDRIAL IRON; ESCHERICHIA-COLI; LABILE IRON; DEHYDROGENASE; LIPOCALIN; APOPTOSIS; ACONITASE; MITOFERRIN; INDUCTION	Intracellular iron homeostasis is critical for survival and proliferation. Lipocalin 24p3 is an iron-trafficking protein that binds iron through association with a bacterial siderophore, such as enterobactin, or a postulated mammalian siderophore. Here, we show that the iron-binding moiety of the 24p3-associated mammalian siderophore is 2,5-dihydroxybenzoic acid (2,5-DHBA), which is similar to 2,3-DHBA, the iron-binding component of enterobactin. We find that the murine enzyme responsible for 2,5-DHBA synthesis, BDH2, is the homolog of bacterial EntA, which catalyzes 2,3-DHBA production during enterobactin biosynthesis. RNA interference-mediated knockdown of BDH2 results in siderophore depletion. Mammalian cells lacking the siderophore accumulate abnormally high amounts of cytoplasmic iron, resulting in elevated levels of reactive oxygen species, whereas the mitochondria are iron deficient. Siderophore-depleted mammalian cells and zebrafish embryos fail to synthesize heme, an iron-dependent mitochondrial process. Our results reveal features of intracellular iron homeostasis that are conserved from bacteria through humans.	[Devireddy, Laxminarayana R.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Devireddy, Laxminarayana R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Hart, Daniel O.; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Program Gene Funct & Express, Sch Med, Worcester, MA 01605 USA; [Hart, Daniel O.; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Goetz, David H.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco	Devireddy, LR (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	laxminarayana.devireddy@case.edu; michael.green@umassmed.edu			National Institutes of Health (NIH) [R01 DK081395-01, R01 CA115817-04]; Case Western Reserve University; March of Dimes and American Society of Hematology; NATIONAL CANCER INSTITUTE [R01CA115817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081395] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; March of Dimes and American Society of Hematology(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Andrew Gulick, Michael Mueller, Udo Oppermann, Kostas Panto-poulos, Barry Paw, Arthur Skoultchi, David Plas, Sonia Levi, Jerry Kaplan, Maurice Burg, and David Turner for providing reagents; Andy Dancis, Heidi O'Neill, Yavuz Oktay, Stacy Dalheimer, Jon Donze, David Yao, Wei-Dong Chen, Marvin Neiman, Kiran Velpula, and Jun Liu for assistance with various experimental procedures; Jim and Barbara Evans from the University of Massachusetts Medical School Proteomics and Mass Spectrometry Facility for GC-MS analysis; and Sara Evans for editorial assistance. This work is supported by National Institutes of Health (NIH) grant R01 DK081395-01 and Case Western Reserve University start-up funds to L.R.D. and NIH grant R01 CA115817-04 to M.R.G. L.R.D. is also a recipient of career developmental awards from March of Dimes and American Society of Hematology. M.R.G. is an Investigator of the Howard Hughes Medical Institute.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Blat D, 2008, J MED CHEM, V51, P126, DOI 10.1021/jm070800l; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; FERNANDEZPOL JA, 1978, CELL, V14, P489, DOI 10.1016/0092-8674(78)90235-0; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Lukinova N, 2009, INVEST OPHTH VIS SCI, V50, P1440, DOI 10.1167/iovs.08-2545; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Powell CS, 2003, AM J PHYSIOL-LUNG C, V285, pL189, DOI 10.1152/ajplung.00253.2002; Rauen U, 2007, CHEMBIOCHEM, V8, P341, DOI 10.1002/cbic.200600311; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sundlov JA, 2006, ACTA CRYSTALLOGR D, V62, P734, DOI 10.1107/S0907444906015824; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	37	214	224	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1006	1017		10.1016/j.cell.2010.04.040	http://dx.doi.org/10.1016/j.cell.2010.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550936	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000278618800015
J	Carvajal-Vergara, X; Sevilla, A; D'Souza, SL; Ang, YS; Schaniel, C; Lee, DF; Yang, L; Kaplan, AD; Adler, ED; Rozov, R; Ge, YC; Cohen, N; Edelmann, LJ; Chang, B; Waghray, A; Su, J; Pardo, S; Lichtenbelt, KD; Tartaglia, M; Gelb, BD; Lemischka, IR				Carvajal-Vergara, Xonia; Sevilla, Ana; D'Souza, Sunita L.; Ang, Yen-Sin; Schaniel, Christoph; Lee, Dung-Fang; Yang, Lei; Kaplan, Aaron D.; Adler, Eric D.; Rozov, Roye; Ge, YongChao; Cohen, Ninette; Edelmann, Lisa J.; Chang, Betty; Waghray, Avinash; Su, Jie; Pardo, Sherly; Lichtenbelt, Klaske D.; Tartaglia, Marco; Gelb, Bruce D.; Lemischka, Ihor R.			Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome	NATURE			English	Article							SOMATIC PTPN11 MUTATIONS; SHP2 MUTATIONS; HUMAN ES; DIFFERENTIATION; HEMATOPOIESIS; EXPRESSION; LEUKEMIA	The generation of reprogrammed induced pluripotent stem cells (iPSCs) from patients with defined genetic disorders holds the promise of increased understanding of the aetiologies of complex diseases and may also facilitate the development of novel therapeutic interventions. We have generated iPSCs from patients with LEOPARD syndrome (an acronym formed from its main features; that is, lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary valve stenosis, abnormal genitalia, retardation of growth and deafness), an autosomal-dominant developmental disorder belonging to a relatively prevalent class of inherited RAS-mitogen-activated protein kinase signalling diseases, which also includes Noonan syndrome, with pleomorphic effects on several tissues and organ systems(1,2). The patient-derived cells have a mutation in the PTPN11 gene, which encodes the SHP2 phosphatase. The iPSCs have been extensively characterized and produce multiple differentiated cell lineages. A major disease phenotype in patients with LEOPARD syndrome is hypertrophic cardiomyopathy. We show that in vitro-derived cardiomyocytes from LEOPARD syndrome iPSCs are larger, have a higher degree of sarcomeric organization and preferential localization of NFATC4 in the nucleus when compared with cardiomyocytes derived from human embryonic stem cells or wild-type iPSCs derived from a healthy brother of one of the LEOPARD syndrome patients. These features correlate with a potential hypertrophic state. We also provide molecular insights into signalling pathways that may promote the disease phenotype.	[Carvajal-Vergara, Xonia; Sevilla, Ana; D'Souza, Sunita L.; Ang, Yen-Sin; Schaniel, Christoph; Lee, Dung-Fang; Yang, Lei; Rozov, Roye; Chang, Betty; Waghray, Avinash; Su, Jie; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, Dept Gene & Cell Med, New York, NY 10029 USA; [Carvajal-Vergara, Xonia] Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid 28029, Spain; [Kaplan, Aaron D.; Adler, Eric D.] Mt Sinai Sch Med, Dept Med, Cardiovasc Inst, New York, NY 10029 USA; [Ge, YongChao] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Cohen, Ninette; Edelmann, Lisa J.; Pardo, Sherly; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Pardo, Sherly; Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA; [Lichtenbelt, Klaske D.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 EA Utrecht, Netherlands; [Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Utrecht University; Utrecht University Medical Center; Istituto Superiore di Sanita (ISS); Icahn School of Medicine at Mount Sinai	Carvajal-Vergara, X (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, Dept Gene & Cell Med, New York, NY 10029 USA.		Yang, Lei/D-7462-2015; Waghray, Avinash/AAD-5292-2021; Schaniel, Christoph/P-3836-2019; Carvajal-Vergara, Xonia/ABD-1094-2021; Ge, Yongchao/AAG-9317-2021; Sevilla, Ana/N-8579-2017; CARVAJAL-VERGARA, XONIA/N-2939-2014; Schaniel, Chrisoph/C-9655-2012; Tartaglia, Marco/K-2955-2018	Waghray, Avinash/0000-0003-3242-2227; Schaniel, Christoph/0000-0002-1343-4858; Carvajal-Vergara, Xonia/0000-0002-6475-3701; Ge, Yongchao/0000-0001-6448-5703; Sevilla, Ana/0000-0002-9251-4759; CARVAJAL-VERGARA, XONIA/0000-0002-6475-3701; Tartaglia, Marco/0000-0001-7736-9672; Lee, Dung-Fang/0000-0003-2387-597X; Su, Jie/0000-0002-3071-7139	National Institutes of Health (NIH) [5R01GM078465]; New York State Department of Health (NYSTEM) [C024410, C024176, C024407]; American College of Cardiology/Pfizer; ERA; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III; New York Stem Cell Foundation; Ruth L. Kirschstein National Research Service Award (NRSA) [T32]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSTEM); American College of Cardiology/Pfizer(Pfizer); ERA; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); New York Stem Cell Foundation; Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. James, X. Niu and D. York for their technical support and laboratory management, and B. MacArthur for support in microarray analysis. We also would like to thank K. Moore and her laboratory, and S. Mulero-Navarro from B.D.G.'s laboratory for their help, and V. Fuster and A. Bernad for their support. This research was funded by grants from the National Institutes of Health (NIH) to I. R. L (5R01GM078465), the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) C024410 to I. R. L. and C.S., C024176 (HESC-SRF) to I.R.L. and S.L.D., C024407 to B D.G., American College of Cardiology/Pfizer Research Fellowship to E. D. A., and ERA-Net for research programmes on rare diseases 2009 to M. T. X. C.-V. is a recipient of a Postdoctoral Fellowship from the Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III, D.-F.L. is a New York Stem Cell Foundation Stanley and Fiona Druckenmiller Fellow and S. P. is a recipient of a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32).	Aoki H, 2000, NAT MED, V6, P183, DOI 10.1038/72287; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Edouard T, 2007, CELL MOL LIFE SCI, V64, P1585, DOI 10.1007/s00018-007-6509-0; FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; GORLIN R J, 1971, Birth Defects Original Article Series, V7, P110; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Laux D, 2008, J PEDIAT HEMATOL ONC, V30, P602, DOI 10.1097/MPH.0b013e31817588fb; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Ucar C, 2006, J PEDIAT HEMATOL ONC, V28, P123; Wu CJ, 2005, BLOOD, V106, P3639, DOI 10.1182/blood-2005-04-1376; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406	31	516	541	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					808	U12		10.1038/nature09005	http://dx.doi.org/10.1038/nature09005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535210	Green Accepted			2022-12-28	WOS:000278551800051
J	Petronis, A				Petronis, Arturas			Epigenetics as a unifying principle in the aetiology of complex traits and diseases	NATURE			English	Article							DNA METHYLATION; TWINS; ENVIRONMENT; HERITABILITY; INHERITANCE; GENETICS; CLONING; ANTICIPATION; EPIMUTATION; EXPRESSION	Epigenetic modifications of DNA and histones might be crucial for understanding the molecular basis of complex phenotypes. One reason for this is that epigenetic factors are sometimes malleable and plastic enough to react to cues from the external and internal environments. Such induced epigenetic changes can be solidified and propagated during cell division, resulting in permanent maintenance of the acquired phenotype. In addition, the finding that there is partial epigenetic stability in somatic and germline cells allows insight into the molecular mechanisms of heritability. Epigenetics can provide a new framework for the search of aetiological factors in complex traits and diseases.	Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Petronis, A (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, 250 Coll St, Toronto, ON M5T 1R8, Canada.	arturas_petronis@camh.net	Petronis, Art/AAD-4491-2019		Canadian Institutes of Health Research [199170, 186007]; US National Institutes of Health [MH074127, MH088413, DP3DK085698, HG004535]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK085698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074127, R01MH088413] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	I thank A. Wong, I. Gottesman, A. Paterson and C. Ptak for editorial suggestions, A. Schumacher for figure design, and the reviewers for their comments. Work in my laboratory has been supported by the Canadian Institutes of Health Research (grants 199170 and 186007) and the US National Institutes of Health (grants MH074127, MH088413, DP3DK085698 and HG004535). I am Tapscott Chair in Schizophrenia Studies at the University of Toronto and a senior fellow of the Ontario Mental Health Foundation.	ALBERG AJ, 2003, CHEST S1, V123, P21; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Austin Jehannine, 2005, J Genet Couns, V14, P329, DOI 10.1007/s10897-005-1622-4; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Chong S, 2007, NAT GENET, V39, P574, DOI 10.1038/ng0507-574; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; De Vries H., 1904, SPECIES VARIETIES TH; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Finch C, 2000, CHANCE DEV AGING; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; GARTNER K, 1981, NATURE, V292, P646, DOI 10.1038/292646a0; Gottesman II, 1997, SCIENCE, V276, P1522, DOI 10.1126/science.276.5318.1522; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; HARRIS JR, 1999, NURTURE ASSUMPTION W, P462; Heath A C, 1998, Twin Res, V1, P119, DOI 10.1375/136905298320566249; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Hong LE, 2008, ARCH GEN PSYCHIAT, V65, P1008, DOI 10.1001/archpsyc.65.9.1008; Jablonka E., 2007, BEHAV BRAIN SCI, V30, P365; Jablonka E, 2007, BEHAV BRAIN SCI, V30, P353, DOI 10.1017/S0140525X07002221; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jockin V, 1996, J PERS SOC PSYCHOL, V71, P288, DOI 10.1037/0022-3514.71.2.288; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kuhn, 1962, STRUCTURE SCI REVOLU, P172; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McFaul CD, 2006, GUT, V55, P252, DOI 10.1136/gut.2005.065045; Pal C, 1999, J THEOR BIOL, V200, P19, DOI 10.1006/jtbi.1999.0974; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; Petronis A, 1997, LANCET, V350, P1403, DOI 10.1016/S0140-6736(05)65184-7; Pigliucci M, 1996, HEREDITY, V77, P453, DOI 10.1038/hdy.1996.171; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; PLOMIN R, 1989, AM PSYCHOL, V44, P105, DOI 10.1037/0003-066X.44.2.105; Rhind SM, 2003, NAT BIOTECHNOL, V21, P744, DOI 10.1038/nbt0703-744; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, NATURE REV GENET, V7, P17; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Stokstad E, 1997, SCIENCE, V275, P1882, DOI 10.1126/science.275.5308.1882; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Suter CM, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573a; Suter CM, 2007, NAT GENET, V39, P575, DOI 10.1038/ng0507-575; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Timshel S, 2009, CANCER EPIDEMIOL, V33, P231, DOI 10.1016/j.canep.2009.06.007; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Turkheimer E, 2000, PSYCHOL BULL, V126, P78, DOI 10.1037/0033-2909.126.1.78; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; VOGEL F, 1997, HUMAN GENETICS PROBL, P851; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yanagimachi R, 2002, MOL CELL ENDOCRINOL, V187, P241, DOI 10.1016/S0303-7207(01)00697-9; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	77	480	497	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					721	727		10.1038/nature09230	http://dx.doi.org/10.1038/nature09230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535201				2022-12-28	WOS:000278551800034
J	Bloom, JD; Gong, LI; Baltimore, D				Bloom, Jesse D.; Gong, Lizhi Ian; Baltimore, David			Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance	SCIENCE			English	Article							NEURAMINIDASE INHIBITORS; A VIRUS; ANTIBIOTIC-RESISTANCE; PROTEIN; TRANSMISSION; REPLICATION; STABILITY; SEGMENTS; MUTANTS	The His(274)-> Tyr(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidase but had long been thought to compromise viral fitness. However, beginning in 2007-2008, viruses containing H274Y rapidly became predominant among human seasonal H1N1 isolates. We show that H274Y decreases the amount of neuraminidase that reaches the cell surface and that this defect can be counteracted by secondary mutations that also restore viral fitness. Two such mutations occurred in seasonal H1N1 shortly before the widespread appearance of H274Y. The evolution of oseltamivir resistance was therefore enabled by "permissive" mutations that allowed the virus to tolerate subsequent occurrences of H274Y. An understanding of this process may provide a basis for predicting the evolution of oseltamivir resistance in other influenza strains.	[Bloom, Jesse D.; Gong, Lizhi Ian; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Bloom, Jesse D/K-3695-2019; Bloom, Jesse D/C-6837-2013	Bloom, Jesse D/0000-0003-1267-3408	Cancer Research Institute; California Institute of Technology; NATIONAL CANCER INSTITUTE [P01CA132681] Funding Source: NIH RePORTER	Cancer Research Institute; California Institute of Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.D.B. was supported by a Beckman Institute Postdoctoral Fellowship and the Irvington Institute Fellowship Program of the Cancer Research Institute. L.I.G. was supported by a Summer Undergraduate Research Fellowship from the California Institute of Technology. Oseltamivir carboxylate was kindly provided by Roche.	Abed Y, 2004, ANTIVIR THER, V9, P577; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kramarz P, 2009, EUROSURVEILLANCE, V14; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Muramoto Y, 2006, J VIROL, V80, P2318, DOI 10.1128/JVI.80.5.2318-2325.2006; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Po ALW, 2009, EMERG INFECT DIS, V15, P1686, DOI 10.3201/eid1510.090844; Poteete AR, 1997, PROTEIN SCI, V6, P2418; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; 2010, WKLY EPIDEMIOL REC, V85, P37	32	474	495	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1272	1275		10.1126/science.1187816	http://dx.doi.org/10.1126/science.1187816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522774	Green Accepted			2022-12-28	WOS:000278318600033
J	Easter, JS; Josephson, SA; Vinton, DT; Saint, S; Edlow, JA				Easter, Joshua S.; Josephson, S. Andrew; Vinton, Deborah T.; Saint, Sanjay; Edlow, Jonathan A.			All in the Family	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; PULMONARY ARTERIOVENOUS-MALFORMATIONS; ACUTE ISCHEMIC-STROKE; CONTRAST ECHOCARDIOGRAPHY; MANIFESTATIONS; THROMBOLYSIS; ASSOCIATION		[Edlow, Jonathan A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Easter, Joshua S.] Childrens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Vinton, Deborah T.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA; [Saint, Sanjay] Univ Michigan, Sch Med, Dept Vet Affairs Hlth Serv, Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; Denver Health Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Edlow, JA (corresponding author), Beth Israel Deaconess Med Ctr, 1 Deaconess Rd,CC2, Boston, MA 02215 USA.	jedlow@bidmc.harvard.edu	Saint, Sanjay/AAF-5126-2019; Niewold, Timothy B/D-2669-2018; Edlow, Jonathan A/F-7128-2016					Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P463, DOI 10.1002/ajmg.a.31101; Brady AP, 2009, IRISH J MED SCI, V178, P135, DOI 10.1007/s11845-008-0220-5; Cottin V, 2007, RESPIRATION, V74, P361, DOI 10.1159/000103205; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Fulbright RK, 1998, AM J NEURORADIOL, V19, P477; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Lenato GM, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9400; Maher CO, 2001, STROKE, V32, P877, DOI 10.1161/01.STR.32.4.877; Nanthakumar K, 2001, AM HEART J, V141, P243, DOI 10.1067/mhj.2001.112682; Saluja S, 2000, RADIOL CLIN N AM, V38, P425, DOI 10.1016/S0033-8389(05)70172-X; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Zukotynski K, 2007, CHEST, V132, P18, DOI 10.1378/chest.06-2356	15	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2114	2120		10.1056/NEJMcps0901416	http://dx.doi.org/10.1056/NEJMcps0901416			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20519683				2022-12-28	WOS:000278242200012
J	Robinson, J				Robinson, June			Consider Tanning Motivations and Counsel Accordingly TANNING, SKIN CANCER, SEASONAL AFFECTIVE DISORDER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Robinson, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 132 E Delaware Pl,5806, Chicago, IL 60611 USA.	june-robinson@northwestern.edu						BIZZOZERO J, STATE IND REPORT 200; Cokkinides V, 2006, PEDIATRICS, V118, P853, DOI 10.1542/peds.2005-3109; Cokkinides V, 2009, CA-CANCER J CLIN, V59, P352, DOI 10.3322/caac.20037; Hillhouse J, 2005, ARCH DERMATOL, V141, P1465, DOI 10.1001/archderm.141.11.1465; Hillhouse J, 2007, ARCH DERMATOL, V143, P1530, DOI 10.1001/archderm.143.12.1530; Hillhouse J, 2010, ARCH DERMATOL, V146, P485, DOI 10.1001/archdermatol.2010.85; Kaur M, 2006, J AM ACAD DERMATOL, V54, P709, DOI 10.1016/j.jaad.2005.11.1059; Kwon HT, 2002, J AM ACAD DERMATOL, V46, P700, DOI 10.1067/mjd.2002.119560; *NAT C STAG LEG, TANN RESTR MIN STAT; van Steensel MAM, 2009, ARCH DERMATOL, V145, P211, DOI 10.1001/archdermatol.2008.564	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2074	2075		10.1001/jama.2010.674	http://dx.doi.org/10.1001/jama.2010.674			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20514665				2022-12-28	WOS:000278018200032
J	Eagle, N; Macy, M; Claxton, R				Eagle, Nathan; Macy, Michael; Claxton, Rob			Network Diversity and Economic Development	SCIENCE			English	Article							SOCIAL RESOURCES; OCCUPATIONAL-STATUS; STATUS ATTAINMENT; TIES; MOBILITY; ORGANIZATION; PATTERNS; STRENGTH; POWER; JOB	Social networks form the backbone of social and economic life. Until recently, however, data have not been available to study the social impact of a national network structure. To that end, we combined the most complete record of a national communication network with national census data on the socioeconomic well-being of communities. These data make possible a population-level investigation of the relation between the structure of social networks and access to socioeconomic opportunity. We find that the diversity of individuals' relationships is strongly correlated with the economic development of communities.	[Eagle, Nathan; Claxton, Rob] Santa Fe Inst, Santa Fe, NM 87501 USA; [Eagle, Nathan] MIT, Media Lab, Cambridge, MA 02139 USA; [Macy, Michael] Cornell Univ, Dept Sociol, Ithaca, NY 14853 USA; [Macy, Michael] Brookings Inst, Washington, DC 20036 USA; [Claxton, Rob] BT Grp Plc, Ipswich IP5 3RE, Suffolk, England	The Santa Fe Institute; Massachusetts Institute of Technology (MIT); Cornell University; Brookings Institution	Eagle, N (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	nathan@mit.edu			Santa Fe Institute; U.S. NSF [BCS-0537606]; British Telecom	Santa Fe Institute; U.S. NSF(National Science Foundation (NSF)); British Telecom	This work was supported by the Santa Fe Institute, the U.S. NSF (BCS-0537606), and British Telecom.	Aldrich H., 1986, ART SCI ENTREPRENEUR, P3; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Bian YJ, 1997, AM SOCIOL REV, V62, P366, DOI 10.2307/2657311; BRASS DJ, 1985, ACAD MANAGE J, V28, P327, DOI 10.2307/256204; BRASS DJ, 1984, ADMIN SCI QUART, V29, P518, DOI 10.2307/2392937; BRASS DJ, 1993, ACAD MANAGE J, V36, P441, DOI 10.2307/256588; BURKHARDT ME, 1990, ADMIN SCI QUART, V35, P104, DOI 10.2307/2393552; Burt R. S, 1992, STRUCTURAL HOLES; Currarini S, 2010, P NATL ACAD SCI USA, V107, P4857, DOI 10.1073/pnas.0911793107; *DEP COMM LOC GOV, 2004, IND DEPR 2004 SUMM R; DUBINI P, 1991, J BUS VENTURING, V6, P305, DOI 10.1016/0883-9026(91)90021-5; FERNANDEZ R, 1994, STANFORD GSB RES PAP, V1382, P1; FLAP HD, 1986, NETH J SOC SCI, V22, P145; Granovetter M., 1983, SOCIOL THEOR, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; LIN N, 1981, AM SOCIOL REV, V46, P393, DOI 10.2307/2095260; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; MARSDEN PV, 1988, SOC FORCES, V66, P1038, DOI 10.2307/2579435; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Office for National Statistics, 2004, SUP OUTP AR BOUND; Page SE, 2007, DIFFERENCE POWER DIV; Podolny JM, 1997, AM SOCIOL REV, V62, P673, DOI 10.2307/2657354; Seibert SE, 2001, ACAD MANAGE J, V44, P219, DOI 10.2307/3069452; Seidel MDL, 2000, ADMIN SCI QUART, V45, P1, DOI 10.2307/2666977; WEGENER B, 1991, AM SOCIOL REV, V56, P60, DOI 10.2307/2095673; [No title captured]	26	397	408	5	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1029	1031		10.1126/science.1186605	http://dx.doi.org/10.1126/science.1186605			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	598YW	20489022				2022-12-28	WOS:000277877100041
J	Wyatt, MA; Wang, WL; Roux, CM; Beasley, FC; Heinrichs, DE; Dunman, PM; Magarvey, NA				Wyatt, Morgan A.; Wang, Wenliang; Roux, Christelle M.; Beasley, Federico C.; Heinrichs, David E.; Dunman, Paul M.; Magarvey, Nathan A.			Staphylococcus aureus Nonribosomal Peptide Secondary Metabolites Regulate Virulence	SCIENCE			English	Article							NATURAL-PRODUCT; CLUMPING FACTOR; PATHOGENESIS; ANTIBIOTICS; EXPRESSION; BINDING; PROTEIN; GENES	Staphylococcus aureus is a major human pathogen that is resistant to numerous antibiotics in clinical use. We found two nonribosomal peptide secondary metabolites-the aureusimines, made by S. aureus-that are not antibiotics, but function as regulators of virulence factor expression and are necessary for productive infections. In vivo mouse models of bacteremia showed that strains of S. aureus unable to produce aureusimines were attenuated and/or cleared from major organs, including the spleen, liver, and heart. Targeting aureusimine synthesis may offer novel leads for anti-infective drugs.	[Wyatt, Morgan A.; Wang, Wenliang; Magarvey, Nathan A.] McMaster Univ, Dept Biochem & Biomed Sci, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Roux, Christelle M.; Dunman, Paul M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Beasley, Federico C.; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Beasley, Federico C.; Heinrichs, David E.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada	McMaster University; University of Nebraska System; University of Nebraska Medical Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Magarvey, NA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	magarv@mcmaster.ca	Heinrichs, David/ABD-5702-2021	Heinrichs, David/0000-0002-7217-2456	McMaster University; Canadian Institutes of Health Research [MOP-38002]; NIH [RA107380, GSE21373]	McMaster University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by generous gifts from McMaster University (N.A.M.), Canadian Institutes of Health Research (MOP-38002 to D. E. H.), and NIH (RA107380 to P.M.D.). For animal infections, all protocols were reviewed and approved by the University of Western Ontario's Animal Use Subcommittee, a subcommittee of the University Council on Animal Care. Gene microarray data have been deposited in National Center for Biotechnology Information, NIH (accession no. GSE21373). N.A.M. declares no competing financial interests but does declare patent applications related to this work (U.S. patent applications, no. 61/183,152 and no. 61/306,239).	ALVAREZ ME, 1995, J ANTIBIOT, V48, P1165, DOI 10.7164/antibiotics.48.1165; Autret N, 2003, INFECT IMMUN, V71, P4463, DOI 10.1128/IAI.71.8.4463-4471.2003; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Becker JE, 2004, GENE, V325, P35, DOI 10.1016/j.gene.2003.09.034; Byford MF, 1997, CHEM REV, V97, P2631, DOI 10.1021/cr960018l; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fujii T, 2008, J BACTERIOL, V190, P7655, DOI 10.1128/JB.01489-07; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Heying R, 2007, THROMB HAEMOSTASIS, V97, P617, DOI 10.1160/TH06-11-0640; Kopp F, 2006, J AM CHEM SOC, V128, P16478, DOI 10.1021/ja0667458; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	28	89	90	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					294	296		10.1126/science.1188888	http://dx.doi.org/10.1126/science.1188888			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	625VW	20522739				2022-12-28	WOS:000279925900032
J	Sasson, C; Keirns, CC; Smith, D; Sayre, M; Macy, M; Meurer, W; McNally, BF; Kellermann, AL; Iwashyna, TJ				Sasson, Comilla; Keirns, Carla C.; Smith, Dylan; Sayre, Michael; Macy, Michelle; Meurer, William; McNally, Bryan F.; Kellermann, Arthur L.; Iwashyna, Theodore J.		Cardiac Arrest Registry Enhance Su	Small Area Variations in Out-of-Hospital Cardiac Arrest: Does the Neighborhood Matter?	ANNALS OF INTERNAL MEDICINE			English	Article							RESUSCITATION	Background: The incidence and outcomes of out-of-hospital cardiac arrest vary widely across cities. It is unknown whether similar differences exist at the neighborhood level. Objective: To determine the extent to which neighborhoods have persistently high rates of cardiac arrest but low rates of bystander cardiopulmonary resuscitation (CPR). Design: Multilevel Poisson regression of 1108 cardiac arrests from 161 census tracts as captured by the Cardiac Arrest Registry to Enhance Survival (CARES). Setting: Fulton County, Georgia, between 1 October 2005 to 30 November 2008. Measurements: Incidence of cardiac arrest, by census tract and year and by rates of bystander CPR. Results: Adjusted rates of cardiac arrest varied across neighborhoods (interquartile range [IQR], 0.57 to 0.73 per 1000 persons; mean, 0.64 per 1000 persons [SD, 0.11]) but were stable from year to year (intraclass correlation, 0.36 [95% CI, 0.26 to 0.50]; P < 0.001). Adjusted bystander CPR rates also varied by census tract (IQR, 19% to 29%; mean, 25% [SD, 10%]). Limitation: Analysis was based on data from a single county. Conclusion: Surveillance data can identify neighborhoods with a persistently high incidence of cardiac arrest and low rates of bystander CPR. These neighborhoods are promising targets for community-based interventions.	Univ Michigan, Ann Arbor, MI 48109 USA; SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA; Ohio State Univ, Columbus, OH 43210 USA; Emory Univ, Sch Med, Atlanta, GA USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio State University; Emory University	Sasson, C (corresponding author), Robert Wood Johnson Fdn, Clin Scholars Program, 1150 W Med Ctr Dr,6312 Med Sci Bldg 1,Campus Box, Ann Arbor, MI 48109 USA.	comilla@umich.edu	Meurer, William J/A-7547-2010; Keirns, Carla/AAT-9384-2020; Sayre, Michael R/E-8383-2017; Macy, Michelle/AAV-7528-2020; McNally, Bryan/AAE-9332-2020	Meurer, William J/0000-0002-1158-5302; Sayre, Michael R/0000-0003-0322-3181; Macy, Michelle/0000-0003-4401-7384; Iwashyna, Theodore/0000-0002-4226-9310	Robert Wood Johnson Foundation; National Institutes of Health [K08 HL091249]; Centers for Disease Control and Prevention [MM-0917-05/05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Robert Wood Johnson Foundation Clinical Scholars Program, National Institutes of Health (grant K08 HL091249), and Centers for Disease Control and Prevention (grant MM-0917-05/05).	*CARD ARR REG ENH, IRB APPR MOD; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lerner EB, 2005, ACAD EMERG MED, V12, P81, DOI 10.1197/j.aem.2004.08.044; McCarthy M, 2000, Rev Environ Health, V15, P97; McNally B, 2009, ANN EMERG MED, V54, P674, DOI 10.1016/j.annemergmed.2009.03.018; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sasson C, 2008, JAMA-J AM MED ASSOC, V300, P1432, DOI 10.1001/jama.300.12.1432; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576	12	66	67	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					19	W12		10.7326/0003-4819-153-1-201007060-00255	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00255			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620GS	20516307	Green Accepted			2022-12-28	WOS:000279487700003
J	Jewkes, RK; Dunkle, K; Nduna, M; Shai, N				Jewkes, Rachel K.; Dunkle, Kristin; Nduna, Mzikazi; Shai, Nwabisa			Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study	LANCET			English	Article							STEPPING STONES; SEXUAL-BEHAVIOR; AMERICAN WOMEN; RISK; GENDER; RAKAI; TRANSMISSION; HEALTH	Background Cross-sectional studies have shown that intimate partner violence and gender inequity in relationships are associated with increased prevalence of HIV in women. Yet temporal sequence and causality have been questioned, and few HIV prevention programmes address these issues. We assessed whether intimate partner violence and relationship power inequity increase risk of incident HIV infection in South African women. Methods We did a longitudinal analysis of data from a previously published cluster-randomised controlled trial undertaken in the Eastern Cape province of South Africa in 2002-06. 1099 women aged 15-26 years who were HIV negative at baseline and had at least one additional HIV test over 2 years of follow-up were included in the analysis. Gender power equity and intimate partner violence were measured by a sexual relationship power scale and the WHO violence against women instrument, respectively. Incidence rate ratios (IRRs) of HIV acquisition at 2 years were derived from Poisson models, adjusted for study design and herpes simplex virus type 2 infection, and used to calculate population attributable fractions. Findings 128 women acquired HIV during 2076 person-years of follow-up (incidence 6.2 per 100 person-years). 51 of 325 women with low relationship power equity at baseline acquired HIV (8.5 per 100 person-years) compared with 73 of 704 women with medium or high relationship power equity (5.5 per 100 person-years); adjusted multivariable Poisson model IRR 1-51, 95% CI 1.05-2.17, p=0.027. 45 of 253 women who reported more than one episode of intimate partner violence at baseline acquired HIV (9.6 per 100 person-years) compared with 83 of 846 who reported one or no episodes (5.2 per 100 person-years); adjusted multivariable Poisson model IRR 1.51, 1.04-2-21, p=0.032. The population attributable fractions were 13.9% (95% CI 2.0-22-2) for relationship power equity and 11.9% (1.4-19.3) for intimate partner violence. Interpretation Relationship power inequity and intimate partner violence increase risk of incident HIV infection in young South African women. Policy, interventions, and programmes for HIV prevention must address both of these risk factors and allocate appropriate resources.	[Jewkes, Rachel K.; Shai, Nwabisa] MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa; [Jewkes, Rachel K.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Nduna, Mzikazi] Univ Witwatersrand, Dept Psychol, Johannesburg, South Africa; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Ctr AIDS Res, Atlanta, GA 30322 USA	University of Witwatersrand; University of Witwatersrand; Emory University; Rollins School Public Health	Jewkes, RK (corresponding author), MRC, Gender & Hlth Res Unit, Private Bag X385, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Shai, Nwabisa/0000-0003-4171-9129; Jewkes, Rachel/0000-0002-4330-6267	National Institute of Mental Health [MH 64882-01, MH 64882-04S1A1, 1R03MH085599]; South African Medical Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064882, R03MH085599] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the National Institute of Mental Health (grant numbers MH 64882-01, MH 64882-04S1A1, and 1R03MH085599) and the South African Medical Research Council. We thank all the members of the Stepping Stones study team and the National Institute for Communicable Diseases for quality control, testing, and storage of specimens; the staff who worked on the project; and members of the community advisory board and data safety and monitoring board. Carl Lombard assisted with data analysis.	Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Christofides N, 2010, AIDS CARE, V22, P279, DOI 10.1080/09540120903193617; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Doll R, 2002, PERSPECT BIOL MED, V45, P499, DOI 10.1353/pbm.2002.0067; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 1998, Violence Vict, V13, P377; Garcia-Allan C, 2000, J BIOCHEM MOL TOXIC, V14, P65, DOI 10.1002/(SICI)1099-0461(2000)14:2<65::AID-JBT1>3.0.CO;2-#; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenland S, 1998, MODERN EPIDEMIOLOGY; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Johnson SD, 2003, DRUG ALCOHOL DEPEN, V70, P169, DOI 10.1016/S0376-8716(02)00345-9; Lindsey JC, 1998, STAT MED, V17, P219, DOI 10.1002/(SICI)1097-0258(19980130)17:2<219::AID-SIM735>3.0.CO;2-O; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Nascimento, 2007, ENGAGING MEN BOYS TR; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Pulerwitz J, 2006, PROMOTING MORE GENDE; SHISANA O, 2005, S AFRICAN NATL HIV P; SOLORZANO I, 2006, POSITIVE IMPACT HIV; *SYN PROJ, 2003, MEN REPR HLTH PROGR; *UNAIDS, 2005, AIDS EP UPD 2005; *UNAIDS JOINT ACT, 2009, UNAIDS OUTC FRAM 200; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wang S. K., 2007, RAPE MEN COMMUNITY H; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wingood GM, 1998, J WOMENS HEALTH, V7, P77, DOI 10.1089/jwh.1998.7.77; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; World Health Organization, 2004, RAP HIV TESTS GUID U; World Health Organization, 2000, WHO MULTICOUNTRY STU; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	39	832	843	3	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					41	48		10.1016/S0140-6736(10)60548-X	http://dx.doi.org/10.1016/S0140-6736(10)60548-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20557928	Bronze			2022-12-28	WOS:000279841600023
J	Singmaster, D				Singmaster, David			Martin Gardner (1914-2010) OBITUARY	NATURE			English	Biographical-Item									UCL, London WC1E 6BT, England	University of London; University College London	Singmaster, D (corresponding author), UCL, London WC1E 6BT, England.	zingmast@gmail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					884	884		10.1038/465884a	http://dx.doi.org/10.1038/465884a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559379	Bronze			2022-12-28	WOS:000278804500028
J	Winickoff, JP; Gottlieb, M; Mello, MM				Winickoff, Jonathan P.; Gottlieb, Mark; Mello, Michelle M.			Regulation of Smoking in Public Housing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENVIRONMENTAL TOBACCO-SMOKE; GAS-PHASE ORGANICS; RESTRICTIONS; HOME; HOUSEHOLD; EXPOSURE; CESSATION; INFANTS		[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp Children, Dept Pediat, Boston, MA USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gottlieb, Mark] Northeastern Univ, Sch Law, Publ Hlth Advocacy Inst, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Northeastern University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu	Gottlieb, Mark A./ABI-1826-2020	Gottlieb, Mark A./0000-0001-8679-307X; Mello, Michelle/0000-0003-2877-4270	NCI NIH HHS [R01 CA127127-03, R01 CA127127, R01-CA127127] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aligne CA, 1997, ARCH PEDIAT ADOL MED, V151, P648, DOI 10.1001/archpedi.1997.02170440010002; American Society of Heating Refrigerating and Air Conditioning Engineers, 2005, ENV TOB SMOK POS DOC; [Anonymous], 2009, SURG GEN CALL ACT PR; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1199; Blackburn C, 2003, BRIT MED J, V327, P257, DOI 10.1136/bmj.327.7409.257; BUSK C, 2009, CHICAGO SUN TIM 0426, pE1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; COOPER K, 2006, WYOMING TRIBUNE 0508, pA1; *COUNC LARG PUBL H, 2004, PORTR PUBL HOUS RES; *DEP HOUS URB DEV, 2010, CURR STAT; *DEP HOUS URB DEV, 2009, HUDS FISC YEAR FY 20; *DEP HOUS URB DEV, TEN ADD SECT 8 PROJ; *DEP HOUS URB DEV, 2009, NONSM POL PUBL HOUS; *DEP HOUS URB DEV, 2010, MULT TEN CHAR SYST; Ditre JW, 2008, NICOTINE TOB RES, V10, P975, DOI 10.1080/14622200802087549; Epstein JA, 1999, TOB CONTROL, V8, P45, DOI 10.1136/tc.8.1.45; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; GARCIA C, 2008, AUGUSTA CHRONIC 0722, pA1; Gilpin E A, 1999, Nicotine Tob Res, V1, P153, DOI 10.1080/14622299050011261; Gilpin EA, 2006, NICOTINE TOB RES, V8, P661, DOI 10.1080/14622200600910801; GRONEWOLD SJ, 2007, COMMUNICATION   0801; Hecht SS, 2006, CANCER EPIDEM BIOMAR, V15, P988, DOI 10.1158/1055-9965.EPI-05-0596; Hennrikus D, 2003, TOB CONTROL, V12, P189, DOI 10.1136/tc.12.2.189; Hill SC, 2008, TOB CONTROL, V17, P32, DOI 10.1136/tc.2007.020990; Institute of Medicine Committee on Secondhand Smoke Exposure and Acute Coronary Effects, 2010, SEC SMOK EXP CARD EF; Jarvie JA, 2008, AM J PUBLIC HEALTH, V98, P2140, DOI 10.2105/AJPH.2007.130856; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; KOCH W, 2007, US TODAY        1003, pA3; Kraev TA, 2009, TOB CONTROL, V18, P438, DOI 10.1136/tc.2009.029728; LARSON J, TACOMA WEEKLY; Laws MB, 2002, TOB CONTROL, V11, pII71; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; *LIV SMOK FREE, 2009, REST SMOK DAM AP; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; MCDONALD J, 2009, SAN DIEGO UNION 0209, pA1; Mello MM, 2008, NEW ENGL J MED, V359, P192, DOI 10.1056/NEJMhle0801929; *OFF SURG GEN, 2006, HLTH CONS INV TOB SM; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Pizacani BA, 2003, PREV MED, V36, P99, DOI 10.1006/pmed.2002.1123; Pizacani BA, 2008, NICOTINE TOB RES, V10, P533, DOI 10.1080/14622200801902003; Proescholdbell R J, 2000, Nicotine Tob Res, V2, P159, DOI 10.1080/713688125; *PUBL HLTH SERV OF, 2007, CHILDR SEC SMOK EXP; SCHNEIDER P, 2009, CAPITAL TIMES   0309; Schoenmarklin S, 2005, ANAL AUTHORITY HOUSI; SCHOENMARKLIN S, 2004, INFILTRATION SECONDH; Siahpush M, 2003, NICOTINE TOB RES, V5, P597, DOI 10.1080/1462220031000118711; Singer BC, 2003, ATMOS ENVIRON, V37, P5551, DOI 10.1016/j.atmosenv.2003.07.015; Singer BC, 2002, ENVIRON SCI TECHNOL, V36, P846, DOI 10.1021/es011058w; *SMOK FREE ENV LAW, 2010, HOUS AUTH COMM WHICH; *SMOK FREE HOUS CO, 2004, MUCH DOES SEC SMOK C; Spengler JD, 1999, ENVIRON HEALTH PERSP, V107, P313, DOI 10.2307/3434423; STRANDE MF, 2007, SMOKE FREE MULTIUNIT; Szabo E, 2006, ADDICT BEHAV, V31, P2298, DOI 10.1016/j.addbeh.2006.02.025; URIE H, 2008, BOULDER DAILY C 0320; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Wakefield MA, 2000, BRIT MED J, V31, P623; WALKER SY, 2003, COMMUNICATION   0718; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Whitehead T, 2009, AM J EPIDEMIOL, V169, P1113, DOI 10.1093/aje/kwp021; Winickoff JP, 2009, PEDIATRICS, V123, pE74, DOI 10.1542/peds.2008-2184	60	60	60	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2319	2325		10.1056/NEJMhle1000941	http://dx.doi.org/10.1056/NEJMhle1000941			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20554988	Green Accepted, Bronze			2022-12-28	WOS:000278816300014
J	Farkouh, M				Farkouh, Michael			Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Med Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Farkouh, M (corresponding author), Mt Sinai Med Ctr, New York, NY 10029 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-10	10.7326/0003-4819-152-12-201006150-02010	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547892				2022-12-28	WOS:000278827700031
J	Gamble, JM; Majumdar, SR				Gamble, John-Michael; Majumdar, Sumit R.			Review: Statin use increases risk for diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gamble, John-Michael; Majumdar, Sumit R.] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Gamble, JM (corresponding author), Univ Alberta, Edmonton, AB, Canada.			Gamble, John-Michael/0000-0001-6891-8721				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12							JC6-7	10.7326/0003-4819-152-12-201006150-02007	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547901				2022-12-28	WOS:000278827700028
J	Bernard, A; Lecuyer, C; Vincent, P; Amiot, R; Bardet, N; Buffetaut, E; Cuny, G; Fourel, F; Martineau, F; Mazin, JM; Prieur, A				Bernard, Aurelien; Lecuyer, Christophe; Vincent, Peggy; Amiot, Romain; Bardet, Nathalie; Buffetaut, Eric; Cuny, Gilles; Fourel, Francois; Martineau, Francois; Mazin, Jean-Michel; Prieur, Abel			Regulation of Body Temperature by Some Mesozoic Marine Reptiles	SCIENCE			English	Article							OXYGEN ISOTOPES; BONE; EVOLUTION; FISH; ENDOTHERMY; PHOSPHATE; METABOLISM; SPEED; WATER	What the body temperature and thermoregulation processes of extinct vertebrates were are central questions for understanding their ecology and evolution. The thermophysiologic status of the great marine reptiles is still unknown, even though some studies have suggested that thermoregulation may have contributed to their exceptional evolutionary success as apex predators of Mesozoic aquatic ecosystems. We tested the thermal status of ichthyosaurs, plesiosaurs, and mosasaurs by comparing the oxygen isotope compositions of their tooth phosphate to those of coexisting fish. Data distribution reveals that these large marine reptiles were able to maintain a constant and high body temperature in oceanic environments ranging from tropical to cold temperate. Their estimated body temperatures, in the range from 35 degrees +/- 2 degrees C to 39 degrees +/- 2 degrees C, suggest high metabolic rates required for predation and fast swimming over large distances offshore.	[Bernard, Aurelien; Lecuyer, Christophe; Amiot, Romain; Fourel, Francois; Martineau, Francois; Mazin, Jean-Michel; Prieur, Abel] Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Lecuyer, Christophe] Inst Univ France, F-75005 Paris, France; [Vincent, Peggy; Bardet, Nathalie] Museum Natl Hist Nat, CNRS, UMR 5143, Dept Hist Terre, F-75231 Paris, France; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75231 Paris, France; [Cuny, Gilles] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Copenhagen	Lecuyer, C (corresponding author), Univ Lyon 1, CNRS, UMR 5125, 2 Rue Raphael Dubois, F-69622 Villeurbanne, France.	clecuyer@univ-lyonl.fr	BARDET, Nathalie/N-8670-2019; Amiot, Romain/C-8132-2012; Lecuyer, Christophe/C-8297-2012; FOUREL, Francois/G-6734-2015; Cuny, Gilles/F-8949-2017; Bardet, Nathalie/I-3805-2015; Lecuyer, Christophe/AAO-8154-2021	Cuny, Gilles/0000-0001-7680-1697; Bardet, Nathalie/0000-0001-7881-7107; Lecuyer, Christophe/0000-0001-9513-2492	CNRS; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France	The authors thank M. Sander, B. McNab, and R. Seymour for preliminary discussions of these data during the workshop dedicated to "Sauropod gigantism" that was held in Bonn, Germany, in November 2008. We are also grateful to D. Brinkman and J. Gardner (Royal Tyrrell Museum), S. Etches and J. Clarke, G. Suan, J. Lindgren (Lund University), B. Kear (La Trobe University), and A. Schulp (Maastricht University) for providing samples. L. Simon and G. Escarguel helped us in the statistical treatment of data. This study was funded by both CNRS and the Institut Universitaire de France.	Amiot R, 2007, PALAEOGEOGR PALAEOCL, V243, P412, DOI 10.1016/j.palaeo.2006.08.013; ANDERSON TF, 1994, J GEOL SOC LONDON, V151, P125, DOI 10.1144/gsjgs.151.1.0125; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Barrick RE, 1999, PALAIOS, V14, P186, DOI 10.2307/3515374; Bennett AF, 2000, EVOLUTION, V54, P1768; Benton M.J., 2005, VERTEBRATE PALAEONTO; BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974; Carlson JK, 2004, CRC MAR BIOL SER, P203; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; HEINRICH B, 1989, AM ZOOL, V29, P1157; HICKMAN CP, 2000, INTEGRATED PRINCIPLE; Kear BP, 2005, CRETACEOUS RES, V26, P769, DOI 10.1016/j.cretres.2005.04.006; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Kolodny Y, 1991, GEOCHEM SOC SPEC PUB, V3, P105; Lecuyer C, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000863; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUTCAVAGE ME, 1992, CAN J ZOOL, V70, P348, DOI 10.1139/z92-051; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; MORRISON P, 1962, BIOL BULL, V123, P154, DOI 10.2307/1539512; Motani R, 2002, PALEOBIOLOGY, V28, P251, DOI 10.1666/0094-8373(2002)028<0251:SSEOEM>2.0.CO;2; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; SEYMOUR RS, 1976, NATURE, V262, P207, DOI 10.1038/262207a0; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; Seymour RS, 2004, PLANT CELL ENVIRON, V27, P1014, DOI 10.1111/j.1365-3040.2004.01206.x; Sharp ZD, 2000, AM J SCI, V300, P222, DOI 10.2475/ajs.300.3.222; Wadley MR, 2002, GLOBAL PLANET CHANGE, V32, P89, DOI 10.1016/S0921-8181(01)00084-4; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3	32	100	109	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1379	1382		10.1126/science.1187443	http://dx.doi.org/10.1126/science.1187443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538946				2022-12-28	WOS:000278598400033
J	Scheller, S; Goenrich, M; Boecher, R; Thauer, RK; Jaun, B				Scheller, Silvan; Goenrich, Meike; Boecher, Reinhard; Thauer, Rudolf K.; Jaun, Bernhard			The key nickel enzyme of methanogenesis catalyses the anaerobic oxidation of methane	NATURE			English	Article							COENZYME-M REDUCTASE; BACTERIA; ARCHAEA; F430; FACTOR-F430; ACTIVATION; CONSORTIA; SEDIMENT; PROTEIN	Large amounts (estimates range from 70 Tg per year to 300 Tg per year) of the potent greenhouse gas methane are oxidized to carbon dioxide in marine sediments by communities of methanotrophic archaea and sulphate-reducing bacteria(1-3), and thus are prevented from escaping into the atmosphere. Indirect evidence indicates that the anaerobic oxidation of methane might proceed as the reverse of archaeal methanogenesis from carbon dioxide with the nickel-containing methyl-coenzyme M reductase (MCR) as the methane-activating enzyme(4,5). However, experiments showing that MCR can catalyse the endergonic back reaction have been lacking. Here we report that purified MCR from Methanothermobacter marburgensis converts methane into methyl-coenzyme M under equilibrium conditions with apparent V-max (maximum rate) and Km (Michaelis constant) values consistent with the observed in vivo kinetics of the anaerobic oxidation of methane with sulphate(6-8). This result supports the hypothesis of 'reverse methanogenesis'(4,9) and is paramount to understanding the still-unknown mechanism of the last step of methanogenesis. The ability of MCR to cleave the particularly strong C-H bond of methane without the involvement of highly reactive oxygen-derived intermediates is directly relevant to catalytic C-H activation, currently an area of great interest in chemistry(10-13).	[Scheller, Silvan; Jaun, Bernhard] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; [Goenrich, Meike; Boecher, Reinhard; Thauer, Rudolf K.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Jaun, B (corresponding author), ETH, Organ Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	jaun@org.chem.ethz.ch	Scheller, Silvan/M-8899-2017	Scheller, Silvan/0000-0002-0667-9224	Swiss National Science Foundation [200020-119752]; Max Planck Society; Fonds der Chemischen Industrie	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank the Swiss National Science Foundation (S.S. and B.J.; grant 200020-119752) and the Max Planck Society and the Fonds der Chemischen Industrie (M.G., R.B. and R.K.T.) for financial support.	ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; BONACKER LG, 1993, EUR J BIOCHEM, V217, P587, DOI 10.1111/j.1432-1033.1993.tb18281.x; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Chistoserdova L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-208; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Crabtree RH, 2004, J ORGANOMET CHEM, V689, P4083, DOI 10.1016/j.jorganchem.2004.07.034; Duan ZH, 2006, GEOCHIM COSMOCHIM AC, V70, P3369, DOI 10.1016/j.gca.2006.03.018; FARBER G, 1991, HELV CHIM ACTA, V74, P697, DOI 10.1002/hlca.19910740404; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2009, ENV MICROBIOL REP, V1, P370, DOI 10.1111/j.1758-2229.2009.00074.x; JAUN B, 2007, METAL IONS LIFE SCI, V0002, P00323; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; LIVINGSTON DA, 1984, HELV CHIM ACTA, V67, P334, DOI 10.1002/hlca.19840670141; Mahlert F, 2002, J BIOL INORG CHEM, V7, P101, DOI 10.1007/s007750100270; Mayr S, 2008, J AM CHEM SOC, V130, P10758, DOI 10.1021/ja802929z; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; PFALTZ A, 1982, HELV CHIM ACTA, V65, P828, DOI 10.1002/hlca.19820650320; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; ROSPERT S, 1991, FEBS LETT, V291, P371, DOI 10.1016/0014-5793(91)81323-Z; Schroder D, 2008, P NATL ACAD SCI USA, V105, P18114, DOI 10.1073/pnas.0801849105; SHILOV AE, 2000, CATAL MET C, V21, pR11; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000	32	236	244	8	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					606	U97		10.1038/nature09015	http://dx.doi.org/10.1038/nature09015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520712				2022-12-28	WOS:000278249000039
J	Schindler, DE; Hilborn, R; Chasco, B; Boatright, CP; Quinn, TP; Rogers, LA; Webster, MS				Schindler, Daniel E.; Hilborn, Ray; Chasco, Brandon; Boatright, Christopher P.; Quinn, Thomas P.; Rogers, Lauren A.; Webster, Michael S.			Population diversity and the portfolio effect in an exploited species	NATURE			English	Article							PACIFIC SALMON; FRESH-WATER; BIODIVERSITY; FISHERIES; BIOCOMPLEXITY; MANAGEMENT; NUTRIENTS; DYNAMICS	One of the most pervasive themes in ecology is that biological diversity stabilizes ecosystem processes and the services they provide to society(1-4), a concept that has become a common argument for biodiversity conservation(5). Species-rich communities are thought to produce more temporally stable ecosystem services because of the complementary or independent dynamics among species that perform similar ecosystem functions(6). Such variance dampening within communities is referred to as a portfolio effect(7) and is analogous to the effects of asset diversity on the stability of financial portfolios(8). In ecology, these arguments have focused on the effects of species diversity on ecosystem stability but have not considered the importance of biologically relevant diversity within individual species(9). Current rates of population extirpation are probably at least three orders of magnitude higher than species extinction rates(10), so there is a pressing need to clarify how population and life history diversity affect the performance of individual species in providing important ecosystem services. Here we use five decades of data from Oncorhynchus nerka (sockeye salmon) in Bristol Bay, Alaska, to provide the first quantification of portfolio effects that derive from population and life history diversity in an important and heavily exploited species. Variability in annual Bristol Bay salmon returns is 2.2 times lower than it would be if the system consisted of a single homogenous population rather than the several hundred discrete populations it currently consists of. Furthermore, if it were a single homogeneous population, such increased variability would lead to ten times more frequent fisheries closures. Portfolio effects are also evident in watershed food webs, where they stabilize and extend predator access to salmon resources. Our results demonstrate the critical importance of maintaining population diversity for stabilizing ecosystem services and securing the economies and livelihoods that depend on them. The reliability of ecosystem services will erode faster than indicated by species loss alone.	[Schindler, Daniel E.; Hilborn, Ray; Chasco, Brandon; Boatright, Christopher P.; Quinn, Thomas P.; Rogers, Lauren A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Webster, Michael S.] Gordon & Betty Moore Fdn, Palo Alto, CA 94304 USA	University of Washington; University of Washington Seattle	Schindler, DE (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	deschind@u.washington.edu	Hilborn, Ray W/D-6332-2013; Ebersole, Joseph L/A-8371-2009	Rogers, Lauren/0000-0003-3305-6441	Gordon and Betty Moore Foundation; US National Science Foundation; University of Washington; Alaska salmon processing industry; H. Mason Keeler Professorship	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF)); University of Washington(University of Washington); Alaska salmon processing industry; H. Mason Keeler Professorship	We thank the Gordon and Betty Moore Foundation, the US National Science Foundation, the University of Washington, the Alaska salmon processing industry and the H. Mason Keeler Professorship for support for this work. N. Baron, L. Neeley and S. Sethi provided feedback and comments on the manuscript, and P. Lisi and G. Holtgrieve helped prepare the figures.	Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Dixson DL, 2008, P ROY SOC B-BIOL SCI, V275, P2831, DOI 10.1098/rspb.2008.0876; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Elton C., 1958; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Helfield JM, 2006, ECOSYSTEMS, V9, P167, DOI 10.1007/s10021-004-0063-5; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Hutchinson WF, 2008, BIOL LETTERS, V4, P693, DOI 10.1098/rsbl.2008.0443; Lindley S.T., 2009, WHAT CAUSED SACRAMEN; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Olsen EM, 2008, EVOL APPL, V1, P524, DOI 10.1111/j.1752-4571.2008.00024.x; Payne LX, 2006, OIKOS, V115, P69; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rogers LA, 2008, OIKOS, V117, P1578, DOI 10.1111/j.0030-1299.2008.16758.x; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Schindler DE, 2008, FISHERIES, V33, P502, DOI 10.1577/1548-8446-33.10.502; Schindler DE, 2005, ECOLOGY, V86, P3225, DOI 10.1890/04-1730; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; WEST FW, 2006, FISHERY DATA SERIES, V647	31	973	996	20	656	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					609	612		10.1038/nature09060	http://dx.doi.org/10.1038/nature09060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520713				2022-12-28	WOS:000278249000040
J	Schmidt, AR; Hamidian, MH; Wahl, P; Meier, F; Balatsky, AV; Garrett, JD; Williams, TJ; Luke, GM; Davis, JC				Schmidt, A. R.; Hamidian, M. H.; Wahl, P.; Meier, F.; Balatsky, A. V.; Garrett, J. D.; Williams, T. J.; Luke, G. M.; Davis, J. C.			Imaging the Fano lattice to 'hidden order' transition in URu2Si2	NATURE			English	Article							QUASI-PARTICLE INTERFERENCE; FERMI-SURFACE; MAGNETIC EXCITATIONS; ELECTRONIC-STRUCTURE; HEAVY; SUPERCONDUCTIVITY; STATE; WAVE	Within a Kondo lattice, the strong hybridization between electrons localized in real space (r-space) and those delocalized in momentum-space (k-space) generates exotic electronic states called 'heavy fermions'. In URu2Si2 these effects begin at temperatures around 55 K but they are suddenly altered by an unidentified electronic phase transition at T-o=17.5 K. Whether this is conventional ordering of the k-space states, or a change in the hybridization of the r-space states at each U atom, is unknown. Here we use spectroscopic imaging scanning tunnelling microscopy (SI-STM) to image the evolution of URu2Si2 electronic structure simultaneously in r-space and k-space. Above T-o, the 'Fano lattice' electronic structure predicted for Kondo screening of a magnetic lattice is revealed. Below T-o, a partial energy gap without any associated density-wave signatures emerges from this Fano lattice. Heavy-quasiparticle interference imaging within this gap reveals its cause as the rapid splitting below T-o of a light k-space band into two new heavy fermion bands. Thus, the URu2Si2 'hidden order' state emerges directly from the Fano lattice electronic structure and exhibits characteristics, not of a conventional density wave, but of sudden alterations in both the hybridization at each U atom and the associated heavy fermion states.	[Schmidt, A. R.; Hamidian, M. H.; Wahl, P.; Meier, F.; Davis, J. C.] Cornell Univ, Atom & Solid State Phys Lab, Dept Phys, Ithaca, NY 14853 USA; [Schmidt, A. R.; Hamidian, M. H.; Davis, J. C.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Wahl, P.] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; [Balatsky, A. V.] Los Alamos Natl Lab, Div Theory, Los Alamos, NM 87545 USA; [Balatsky, A. V.] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA; [Garrett, J. D.] McMaster Univ, Brockhouse Inst Mat Res, Hamilton, ON L85 4M1, Canada; [Williams, T. J.; Luke, G. M.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Luke, G. M.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Davis, J. C.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Davis, J. C.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	Cornell University; United States Department of Energy (DOE); Brookhaven National Laboratory; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; McMaster University; McMaster University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of St Andrews	Davis, JC (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Dept Phys, Ithaca, NY 14853 USA.	jcdavis@ccmr.cornell.edu	Luke, Graeme/A-9094-2010; Williams, Travis J/A-5061-2016; Wahl, Peter/F-9337-2014	Luke, Graeme/0000-0003-4762-1173; Williams, Travis J/0000-0003-3212-2726; Wahl, Peter/0000-0002-8635-1519	US Department of Energy, Office of Basic Energy Sciences [DE-2009-BNL-PM015, DE-AC52-06NA25396]; NSERC; CIFAR; Center for Integrated Nanotechnology; LDRD; UCOP [TR01]; Humboldt Foundation; Physics and Astronomy Department at the University of British Columbia; German Academic Exchange Service; US Army Research Office	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIFAR(Canadian Institute for Advanced Research (CIFAR)); Center for Integrated Nanotechnology; LDRD; UCOP; Humboldt Foundation(Alexander von Humboldt Foundation); Physics and Astronomy Department at the University of British Columbia; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); US Army Research Office	We acknowledge and thank E. Abrahams, M. Aronson, D. Bonn, W. Buyers, A. Chantis, M. Crommie, P. Coleman, D. M. Eigler, M. Graf, A. Greene, K. Haule, C. Hooley, G. Kotliar, D.-H. Lee, A. J. Leggett, B. Maple, F. Steglich, V. Madhavan, A. P. Mackenzie, S. Sachdev, A. Schofield, T. Senthil and D. Pines for discussions and communications. These studies were supported by the US Department of Energy, Office of Basic Energy Sciences, under Award Number DE-2009-BNL-PM015. Research at McMaster University was supported by NSERC and CIFAR. Research at Los Alamos was supported in part by the Center for Integrated Nanotechnology, a US Department of Energy Office of Basic Energy Sciences user facility, under contract DE-AC52-06NA25396, by LDRD funds and by UCOP TR01. P. W. acknowledges support from the Humboldt Foundation, F. M. from the German Academic Exchange Service, and A. R. S. from the US Army Research Office. J. C. D. gratefully acknowledges the hospitality and support of the Physics and Astronomy Department at the University of British Columbia.	Affleck I, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180404; Balatsky AV, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214413; BARZYKIN V, 1995, PHYS REV LETT, V74, P4301, DOI 10.1103/PhysRevLett.74.4301; BONN DA, 1988, PHYS REV LETT, V61, P1305, DOI 10.1103/PhysRevLett.61.1305; BROHOLM C, 1991, PHYS REV B, V43, P12809, DOI 10.1103/PhysRevB.43.12809; BROHOLM C, 1987, PHYS REV LETT, V58, P1467, DOI 10.1103/PhysRevLett.58.1467; Chandra P, 2002, NATURE, V417, P831, DOI 10.1038/nature00795; Coleman P., 2007, HDB MAGNETISM ADV MA, V1, P95; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; DELATORRE AL, 1992, PHYSICA B, V179, P208, DOI 10.1016/0921-4526(92)90018-N; Denlinger JD, 2001, J ELECTRON SPECTROSC, V117, P347, DOI 10.1016/S0368-2048(01)00257-2; Dordevic SV, 2001, PHYS REV LETT, V86, P684, DOI 10.1103/PhysRevLett.86.684; ESCUDERO R, 1994, PHYS REV B, V49, P15271, DOI 10.1103/PhysRevB.49.15271; FIGGINS J, 2010, PHYS REV LE IN PRESS; FIGGINS J, 2010, DEFECTS HEAVY FERMIO; FULDE P, 1988, SOLID STATE PHYS, V41, P1; Gruner G., 1994, DENSITY WAVES SOLIDS; Hanaguri T, 2009, SCIENCE, V323, P923, DOI 10.1126/science.1166138; HARIMA G, 2010, J PHYS SOC JPN, V79; Haule K, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/57006; Haule K, 2009, NAT PHYS, V5, P796, DOI 10.1038/NPHYS1392; Hewson A C, 1993, KONDO PROBLEM HEAVY; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Ikeda H, 1998, PHYS REV LETT, V81, P3723, DOI 10.1103/PhysRevLett.81.3723; Knorr N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.096804; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Lee J, 2009, NAT PHYS, V5, P800, DOI 10.1038/NPHYS1397; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Maltseva M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.206402; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; MAPLE MB, 1986, PHYS REV LETT, V56, P185, DOI 10.1103/PhysRevLett.56.185; McElroy K, 2003, NATURE, V422, P592, DOI 10.1038/nature01496; PALSTRA TTM, 1985, PHYS REV LETT, V55, P2727, DOI 10.1103/PhysRevLett.55.2727; Rodrigo JG, 1997, PHYS REV B, V55, P14318, DOI 10.1103/PhysRevB.55.14318; Santander-Syro AF, 2009, NAT PHYS, V5, P637, DOI 10.1038/NPHYS1361; SANTINI P, 1994, PHYS REV LETT, V73, P1027, DOI 10.1103/PhysRevLett.73.1027; SCHOENES J, 1987, PHYS REV B, V35, P5375, DOI 10.1103/PhysRevB.35.5375; Schofield AJ, 1999, CONTEMP PHYS, V40, P95, DOI 10.1080/001075199181602; Steglich F, 2005, J PHYS SOC JPN, V74, P167, DOI 10.1143/JPSJ.74.167; STEGLICH F, 1995, J LOW TEMP PHYS, V99, P267, DOI 10.1007/BF00752293; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Varma CM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036405; Wang QH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020511; Wiebe CR, 2007, NAT PHYS, V3, P96, DOI 10.1038/nphys522; Wise WD, 2009, NAT PHYS, V5, P213, DOI 10.1038/NPHYS1197; Yokoyama M, 2002, PHYSICA B, V312, P498, DOI 10.1016/S0921-4526(01)01516-2	47	212	214	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					570	576		10.1038/nature09073	http://dx.doi.org/10.1038/nature09073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520706	Green Submitted			2022-12-28	WOS:000278249000032
J	Almas, I; Cappelen, AW; Sorensen, EO; Tungodden, B				Almas, Ingvild; Cappelen, Alexander W.; Sorensen, Erik O.; Tungodden, Bertil			Fairness and the Development of Inequality Acceptance	SCIENCE			English	Article							PREFERENCES; RESPONSIBILITY; ADOLESCENCE; CHILDRENS; BEHAVIOR; DICTATOR; OUTCOMES; EQUITY; AGE	Fairness considerations fundamentally affect human behavior, but our understanding of the nature and development of people's fairness preferences is limited. The dictator game has been the standard experimental design for studying fairness preferences, but it only captures a situation where there is broad agreement that fairness requires equality. In real life, people often disagree on what is fair because they disagree on whether individual achievements, luck, and efficiency considerations of what maximizes total benefits can justify inequalities. We modified the dictator game to capture these features and studied how inequality acceptance develops in adolescence. We found that as children enter adolescence, they increasingly view inequalities reflecting differences in individual achievements, but not luck, as fair, whereas efficiency considerations mainly play a role in late adolescence.	[Almas, Ingvild; Cappelen, Alexander W.; Sorensen, Erik O.; Tungodden, Bertil] Norwegian Sch Econ & Business Adm, Dept Econ, N-5045 Bergen, Norway; [Almas, Ingvild; Sorensen, Erik O.] Univ Oslo, Ctr Equal Social Org & Performance, N-0317 Oslo, Norway; [Tungodden, Bertil] Chr Michelsen Inst, N-5892 Bergen, Norway	Norwegian School of Economics (NHH); University of Oslo	Almas, I (corresponding author), Norwegian Sch Econ & Business Adm, Dept Econ, N-5045 Bergen, Norway.	ingvild.almas@nhh.no	CAPPELEN, ALEXANDER/AAY-1676-2021	Sorensen, Erik O./0000-0002-7155-4188	Centre for the Study of Mind in Nature (CSMN) at the University of Oslo; Research Council of Norway [185831]	Centre for the Study of Mind in Nature (CSMN) at the University of Oslo; Research Council of Norway(Research Council of Norway)	We are grateful to S. Bowles and W. T. Harbaugh for valuable comments; R. H. Hansen and G. Myhrvold of the school authorities in Bergen for their cooperation; L. J. Eckhoff, T. Eriksen, M. Froysok, A. Furu, C. Haugsnes, A. D. Hole, J. Hatuft, K. A. Karlstad, M. Ludvigsen, K. Risvand Mo, C. Nygard, K. E. Stokke, J. N. L. Sonsteby, I. Soreide, and E. Waerstad for research assistance. This project was supported by the Centre for the Study of Mind in Nature (CSMN) at the University of Oslo and the Research Council of Norway, grant 185831.	Andreoni J, 2002, ECONOMETRICA, V70, P737, DOI 10.1111/1468-0262.00302; Arrow Kenneth, 2000, MERITOCRACY EC INEQU; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cappelen AW, 2007, AM ECON REV, V97, P818, DOI 10.1257/aer.97.3.818; Cappelen AW, 2010, EUR ECON REV, V54, P429, DOI 10.1016/j.euroecorev.2009.08.005; Cherry TL, 2002, AM ECON REV, V92, P1218, DOI 10.1257/00028280260344740; Damon W., 1977, SOCIAL WORLD CHILD; EISENBERG N, 1995, CHILD DEV, V66, P1179, DOI 10.1111/j.1467-8624.1995.tb00930.x; Fehr E, 2002, EUR ECON REV, V46, P687, DOI 10.1016/S0014-2921(01)00208-2; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fisman R, 2007, AM ECON REV, V97, P1858, DOI 10.1257/aer.97.5.1858; Frohlich N, 2004, PUBLIC CHOICE, V119, P91, DOI 10.1023/B:PUCH.0000024169.08329.eb; Gaertner W, 2007, ECONOMICA, V74, P627, DOI 10.1111/j.1468-0335.2006.00563.x; Gilligan C., 1982, DIFFERENT VOICE; Gummerum M, 2008, CHILD DEV, V79, P562, DOI 10.1111/j.1467-8624.2008.01143.x; Harbaugh WT, 2007, J ECON PSYCHOL, V28, P127, DOI 10.1016/j.joep.2006.03.005; HOOK JG, 1979, PSYCHOL BULL, V86, P429, DOI 10.1037/0033-2909.86.3.429; Kohlberg Lawrence, 1984, PSYCHOL MORAL DEV NA, V2; Konow J, 2000, AM ECON REV, V90, P1072, DOI 10.1257/aer.90.4.1072; Mikula G, 1972, Z ENTWICKLUNGSPSYCHO, V4, P151; Montada L., 2002, JUSTICE MOTIVE EVERY; MOORE CF, 1993, PSYCHOL PERSPECTIVES, P183; Nozick Robert, 1974, ANARCHY STATE UTOPIA; Piaget J., 1965, MORAL JUDGEMENT CHIL; Rawls J., 1971, THEORY JUSTICE; Schokkaert E, 2003, SOC CHOICE WELFARE, V21, P207, DOI 10.1007/s00355-003-0257-3; Sen A., 2010, IDEA JUSTICE, DOI DOI 10.2307/J.CTVJNRV7N; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Sutter M, 2007, GAME ECON BEHAV, V59, P364, DOI 10.1016/j.geb.2006.07.006; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337	32	190	193	14	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1176	1178		10.1126/science.1187300	http://dx.doi.org/10.1126/science.1187300			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601YR	20508132	Green Submitted, Green Accepted			2022-12-28	WOS:000278104700049
J	Breitkreutz, A; Choi, H; Sharom, JR; Boucher, L; Neduva, V; Larsen, B; Lin, ZY; Breitkreutz, BJ; Stark, C; Liu, GM; Ahn, J; Dewar-Darch, D; Reguly, T; Tang, XJ; Almeida, R; Qin, ZS; Pawson, T; Gingras, AC; Nesvizhskii, AI; Tyers, M				Breitkreutz, Ashton; Choi, Hyungwon; Sharom, Jeffrey R.; Boucher, Lorrie; Neduva, Victor; Larsen, Brett; Lin, Zhen-Yuan; Breitkreutz, Bobby-Joe; Stark, Chris; Liu, Guomin; Ahn, Jessica; Dewar-Darch, Danielle; Reguly, Teresa; Tang, Xiaojing; Almeida, Ricardo; Qin, Zhaohui Steve; Pawson, Tony; Gingras, Anne-Claude; Nesvizhskii, Alexey I.; Tyers, Mike			A Global Protein Kinase and Phosphatase Interaction Network in Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; PHOSPHORYLATION; TRANSDUCTION; PROTEOMICS; FEEDBACK; MITOSIS; SIGNAL	The interactions of protein kinases and phosphatases with their regulatory subunits and substrates underpin cellular regulation. We identified a kinase and phosphatase interaction (KPI) network of 1844 interactions in budding yeast by mass spectrometric analysis of protein complexes. The KPI network contained many dense local regions of interactions that suggested new functions. Notably, the cell cycle phosphatase Cdc14 associated with multiple kinases that revealed roles for Cdc14 in mitogen-activated protein kinase signaling, the DNA damage response, and metabolism, whereas interactions of the target of rapamycin complex 1 (TORC1) uncovered new effector kinases in nitrogen and carbon metabolism. An extensive backbone of kinase-kinase interactions cross-connects the proteome and may serve to coordinate diverse cellular responses.	[Breitkreutz, Ashton; Sharom, Jeffrey R.; Boucher, Lorrie; Larsen, Brett; Lin, Zhen-Yuan; Breitkreutz, Bobby-Joe; Stark, Chris; Liu, Guomin; Ahn, Jessica; Dewar-Darch, Danielle; Reguly, Teresa; Tang, Xiaojing; Pawson, Tony; Gingras, Anne-Claude; Tyers, Mike] Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Choi, Hyungwon; Nesvizhskii, Alexey I.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Sharom, Jeffrey R.; Pawson, Tony; Gingras, Anne-Claude; Tyers, Mike] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Neduva, Victor; Almeida, Ricardo; Tyers, Mike] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Neduva, Victor; Almeida, Ricardo; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Qin, Zhaohui Steve] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Nesvizhskii, Alexey I.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Michigan System; University of Michigan; University of Toronto; University of Edinburgh; University of Edinburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gingras, AC (corresponding author), Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca; nesvi@med.umich.edu; tyers@lunenfeld.ca	Tyers, Michael/ABE-3194-2021; Qin, Zhaohui/Q-3133-2019; Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010; Pawson, Tony J/E-4578-2013; Choi, Hyungwon/S-8824-2019; Qin, Zhaohui S/E-8196-2011; Nesvizhskii, Alexey/A-5410-2012	Qin, Zhaohui/0000-0002-1583-146X; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Choi, Hyungwon/0000-0002-6687-3088; Qin, Zhaohui S/0000-0002-1583-146X; Nesvizhskii, Alexey/0000-0002-2806-7819	Canadian Institutes of Health Research [MOP-84314, MOP-57793, MOP-12246]; Ontario Research Fund [-044]; National Institutes of Health; National Center for Research Resources [R01RR024031]; National Cancer Institute of Canada; Canada Research Chairs in Functional Genomics and Bioinformatics; Functional Proteomics; Lea Reichmann Chair in Cancer Proteomics; Royal Society;  [CA-126239]; NATIONAL CANCER INSTITUTE [R01CA126239] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR024031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094231] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010929] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chairs in Functional Genomics and Bioinformatics(Canada Research Chairs); Functional Proteomics; Lea Reichmann Chair in Cancer Proteomics; Royal Society(Royal Society of London); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Raught, A. Amon, L. Harrington, J. Bader, M. Costanzo, B. Andrews, C. Boone, R. Aebersold, B. Bodenmiller, I. Sadowski, and F. Sicheri for discussions; J. P. Zhang and D. Fermin for technical support; and M. Snyder, Y. Ohsumi, S. Piatti, S. Hahn, H. Reizman, S. Biggins, T. Petes, M. P. Longhese, and D. Mao for reagents. Supported by grants from the Canadian Institutes of Health Research to A. C. G. (MOP-84314), T. P. (MOP-57793), and M. T. (MOP-12246); the Ontario Research Fund to T. P. and A. C. G. (REO#-044); the National Institutes of Health to M. T. (R01RR024031 from the National Center for Research Resources) and A.I.N. (CA-126239); a Terry Fox Foundation Research Studentship from the National Cancer Institute of Canada to J. R. S.; Federation of European Biochemical Societies and Marie Curie Fellowships to V.N.; Canada Research Chairs in Functional Genomics and Bioinformatics (to M. T.) and in Functional Proteomics (to A. C. G.); the Lea Reichmann Chair in Cancer Proteomics to A. C. G.; and a Scottish Universities Life Sciences Alliance Research Professorship and a Royal Society Wolfson Research Merit Award to M.	Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Justman QA, 2009, SCIENCE, V324, P509, DOI 10.1126/science.1169498; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Magasanik B, 2005, P NATL ACAD SCI USA, V102, P16537, DOI 10.1073/pnas.0507116102; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Reiser V, 2006, MOL BIOL CELL, V17, P3136, DOI 10.1091/mbc.E05-12-1102; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	22	495	513	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1043	1046		10.1126/science.1176495	http://dx.doi.org/10.1126/science.1176495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489023	Green Accepted			2022-12-28	WOS:000277877100045
J	Schofield, O; Ducklow, HW; Martinson, DG; Meredith, MP; Moline, MA; Fraser, WR				Schofield, Oscar; Ducklow, Hugh W.; Martinson, Douglas G.; Meredith, Michael P.; Moline, Mark A.; Fraser, William R.			How Do Polar Marine Ecosystems Respond to Rapid Climate Change?	SCIENCE			English	Review							PENINSULA CONTINENTAL-SHELF; ANTARCTIC PENINSULA; SOUTHERN-OCEAN; SEA-ICE; KRILL; VARIABILITY; SALPS; CIRCULATION; DECLINE; IMPACT	Climate change will alter marine ecosystems; however, the complexity of the food webs, combined with chronic undersampling, constrains efforts to predict their future and to optimally manage and protect marine resources. Sustained observations at the West Antarctic Peninsula show that in this region, rapid environmental change has coincided with shifts in the food web, from its base up to apex predators. New strategies will be required to gain further insight into how the marine climate system has influenced such changes and how it will do so in the future. Robotic networks, satellites, ships, and instruments mounted on animals and ice will collect data needed to improve numerical models that can then be used to study the future of polar ecosystems as climate change progresses.	[Schofield, Oscar] Rutgers State Univ, Coastal Ocean Observat Lab, Inst Marine & Coastal Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08901 USA; [Ducklow, Hugh W.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Martinson, Douglas G.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Meredith, Michael P.] British Antarctic Survey, Cambridge CB3 0ET, England; [Moline, Mark A.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA 93407 USA; [Moline, Mark A.] Calif Polytech State Univ San Luis Obispo, Ctr Coastal Marine Sci, San Luis Obispo, CA 93407 USA; [Fraser, William R.] Polar Oceans Res Grp, Sheridan, MT 59749 USA	Rutgers State University New Brunswick; Marine Biological Laboratory - Woods Hole; Columbia University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo	Schofield, O (corresponding author), Rutgers State Univ, Coastal Ocean Observat Lab, Inst Marine & Coastal Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08901 USA.	oscar@marine.rutgers.edu	Schofield, Oscar/H-4169-2018	Schofield, Oscar/0000-0003-2359-4131; Meredith, Michael/0000-0002-7342-7756	National Science Foundation's Office of Polar Programs; British Antarctic Survey; Gordon and Betty Moore Foundation; NASA; NERC [bas0100028] Funding Source: UKRI; Natural Environment Research Council [bas0100028] Funding Source: researchfish; Office of Polar Programs (OPP) [1019838, 0741351] Funding Source: National Science Foundation	National Science Foundation's Office of Polar Programs(National Science Foundation (NSF)); British Antarctic Survey; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	These efforts were only possible with funding support provided by the National Science Foundation's Office of Polar Programs, the British Antarctic Survey, the Gordon and Betty Moore Foundation, and NASA.	Anisimov OA., 2007, CLIMATE CHANGE 2007, P655; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Ballance LT, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P215; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; CLARKE A, 2009, PHILOS T R SOC LON B, V362, P149; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Costa DP, 2008, DEEP-SEA RES PT II, V55, P323, DOI 10.1016/j.dsr2.2007.11.003; DavidWard Robert., 2003, TECHNOLOGY APPL OFAU, P37; Doble MJ, 2009, COLD REG SCI TECHNOL, V56, P90, DOI 10.1016/j.coldregions.2008.11.006; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; FRAZER WR, 1996, FDN ECOLOGICAL RES W, P257; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Hakkinen S, 2004, SCIENCE, V304, P555, DOI 10.1126/science.1094917; Klinck JM, 2004, DEEP-SEA RES PT II, V51, P1925, DOI 10.1016/j.dsr2.2004.08.001; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; MCCLATCHIE S, 1983, CAN J FISH AQUAT SCI, V40, P955, DOI 10.1139/f83-122; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; NISHIKAWA J, 1995, POLAR BIOL, V15, P31; Perissinotto R, 1998, MAR BIOL, V131, P25, DOI 10.1007/s002270050292; Prezelin BB, 2004, J MAR RES, V62, P419, DOI 10.1357/0022240041446173; Quetin L.B., 1985, P372; Quetin LB, 2001, AM ZOOL, V41, P74, DOI 10.1668/0003-1569(2001)041[0074:EVAIIO]2.0.CO;2; RHODES OE, 1996, POPULATION DYNAMICS, P1; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Schofield O, 2002, IEEE J OCEANIC ENG, V27, P146, DOI 10.1109/JOE.2002.1002469; Serreze MC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016406; Skvarca P, 1999, POLAR RES, V18, P151, DOI 10.1111/j.1751-8369.1999.tb00287.x; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Smith R.C., 1995, OCEANOGRAPHY, V8, P77, DOI DOI 10.5670/OCEANOG.1995.01; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Turner J, 2006, SCIENCE, V311, P1914, DOI 10.1126/science.1121652; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Worby AP, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004254	45	235	238	6	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1520	1523		10.1126/science.1185779	http://dx.doi.org/10.1126/science.1185779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558708	Green Submitted			2022-12-28	WOS:000278859200036
J	Ahmad, M; McCallum, IJD; Mercer-Jones, M				Ahmad, Mukhtar; McCallum, Iain J. D.; Mercer-Jones, Mark			Management of faecal incontinence in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANAL-SPHINCTER; PREVALENCE		[Ahmad, Mukhtar; Mercer-Jones, Mark] Queen Elizabeth Hosp, Gateshead NE9 6SX, England; [McCallum, Iain J. D.] N Tyneside Gen Hosp, N Shields NE29 8NH, England		Mercer-Jones, M (corresponding author), Queen Elizabeth Hosp, Gateshead NE9 6SX, England.	mark.mercer-jones@ghnt.nhs.uk						Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7; Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745; BROWN SR, 2007, COCHRANE DB SYST REV, V2, P1757, DOI DOI 10.1002/14651858.CD00157.PUB2; Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x; CHEETHAM MJ, 2002, COCHRANE DB SYST REV, V3; Chelvanayagam S, 2000, Nurs Times, V96, P15; Christensen P, 2009, DIS COLON RECTUM, V52, P286, DOI 10.1007/DCR.0b013e3181979341; Collings Sarah, 2004, Br J Community Nurs, V9, P520; Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x; Collinson R, 2009, COLORECTAL DIS, V11, P77, DOI 10.1111/j.1463-1318.2008.01539.x; DEUTEKOM M, 2005, COCHRANE DB SYST REV, V3; Fader M, 2008, HEALTH TECHNOL ASSES, V12, P1; Fader M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007408; Fynes M, 1999, LANCET, V354, P983, DOI 10.1016/S0140-6736(98)11205-9; Guise JM, 2007, OBSTET GYNECOL, V109, P281, DOI 10.1097/01.AOG.0000254164.67182.78; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; KAMM MA, 1994, LANCET, V344, P730, DOI 10.1016/S0140-6736(94)92213-6; Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x; Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0; Maeda Y, 2010, COCHRANE DB SYST REV, V5; Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2; *NAT I HLTH CLIN E, 2007, CG49 NAT I HLTH CLIN; Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x; NORTON CC, 2009, COCHRANE DB SYST REV, V1; O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6; Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862; Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Thekkinkattil DK, 2009, BRIT J SURG, V96, P680, DOI 10.1002/bjs.6597; Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X; WORSOE J, 2007, DIS COLON RECTUM, V50, P1023	31	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2010	340								c2964	10.1136/bmj.c2964	http://dx.doi.org/10.1136/bmj.c2964			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551123				2022-12-28	WOS:000279051800006
J	Ziemer, DC; Kolm, P; Weintraub, WS; Vaccarino, V; Rhee, MK; Twombly, JG; Narayan, V; Koch, DD; Phillips, LS				Ziemer, David C.; Kolm, Paul; Weintraub, William S.; Vaccarino, Viola; Rhee, Mary K.; Twombly, Jennifer G.; Narayan, Venkat; Koch, David D.; Phillips, Lawrence S.			Glucose-Independent, Black-White Differences in Hemoglobin A(1c) Levels	ANNALS OF INTERNAL MEDICINE			English	Article							MEAN BLOOD-GLUCOSE; HEALTH-CARE ACCESS; GLYCEMIC CONTROL; GLYCATED HEMOGLOBIN; ETHNIC DISPARITIES; MICROVASCULAR COMPLICATIONS; DIABETIC-RETINOPATHY; BIOLOGICAL VARIATION; RACIAL DISPARITIES; HBA(1C) LEVELS	Background: A previous study of participants with prediabetes found that hemoglobin A(1c) (HbA(1c)) levels differed between black and white participants with no differences in glucose concentration. Objective: To determine whether black-white differences in HbA(1c) level are present in other populations and across the full spectrum of glycemia. Design: Cross-sectional, retrospective. Setting: Outpatient. Participants: 1581 non-Hispanic black and white participants between 18 and 87 years of age without known diabetes in the SIGT (Screening for Impaired Glucose Tolerance) study and 1967 non-Hispanic black and white participants older than 40 years without known diabetes in the NHANES III (Third National Health and Nutrition Examination Survey). Measurements: HbA(1c) levels, anthropometry, and plasma glucose levels during oral glucose tolerance testing. Results: Hemoglobin A(1c) levels were higher in black than in white participants with normal glucose tolerance (0.13 percentage point [P < 0.001] in the SIGT sample and 0.21 percentage point [P < 0.001] in the NHANES III sample), prediabetes (0.26 percentage point [P < 0.001] and 0.30 percentage point [P < 0.001], respectively), or diabetes (0.47 percentage point [P < 0.020] and 0.47 percentage point [P < 0.013], respectively) after adjustment for plasma glucose levels and other characteristics known to correlate with HbA(1c) levels. Limitation: The mechanism for the differences is unknown. Conclusion: Black persons have higher HbA(1c) levels than white persons across the full spectrum of glycemia, and the differences increase as glucose intolerance worsens. These findings could limit the use of HbA(1c) to screen for glucose intolerance, indicate the risk for complications, measure quality of care, and evaluate disparities in health.	[Ziemer, David C.] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA 30303 USA; Med Ctr, US Dept Vet Affairs, Atlanta, GA USA; Christiana Care Hlth Syst, Newark, DE USA	Emory University; US Department of Veterans Affairs; Christiana Care Health System	Ziemer, DC (corresponding author), Emory Univ, Sch Med, Div Endocrinol, 49 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.		, Viola/AAW-5600-2020		National Institutes of Health and National Center for Research Resources [DK07298, DK062668, RR017643, DK066204, RR00039]; U.S. Department of Veterans Affairs Health Services Research and Development Service [SHP 08-144, IIR 07-138]; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK062668, R18DK066204] Funding Source: NIH RePORTER	National Institutes of Health and National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health and National Center for Research Resources (awards DK07298, DK062668, RR017643, DK066204, and RR00039) and U.S. Department of Veterans Affairs Health Services Research and Development Service (awards SHP 08-144 and IIR 07-138).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; BOFILL C, 1994, METABOLISM, V43, P614, DOI 10.1016/0026-0495(94)90204-6; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; *CDCP, 2006, NHANES 3 LAB DAT FIL; Chou AF, 2007, WOMEN HEALTH ISS, V17, P150, DOI 10.1016/j.whi.2007.03.003; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; Cohen RM, 2008, DIABETES CARE, V31, P151, DOI 10.2337/dc07-1465; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; de Rekeneire N, 2003, DIABETES CARE, V26, P1986, DOI 10.2337/diacare.26.7.1986; Delamater AM, 1999, DIABETES CARE, V22, P700, DOI 10.2337/diacare.22.5.700; Dyck PJ, 2006, DIABETES CARE, V29, P2282, DOI 10.2337/dc06-0525; EBERHARDT MS, 1994, J CLIN EPIDEMIOL, V47, P1181, DOI 10.1016/0895-4356(94)90105-8; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; GOLDSTEIN DE, 1987, CLIN CHEM, V33, P2267; Gould BJ, 1997, CLIN CHIM ACTA, V260, P49, DOI 10.1016/S0009-8981(96)06508-4; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Harris MI, 2001, DIABETES CARE, V24, P454, DOI 10.2337/diacare.24.3.454; Hashimoto K, 2008, DIABETES CARE, V31, P1945, DOI 10.2337/dc08-0352; Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Hozumi M, 1998, J NUTR SCI VITAMINOL, V44, P1, DOI 10.3177/jnsv.44.1; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kilpatrick ES, 2008, DIABETOLOGIA, V51, P365, DOI 10.1007/s00125-007-0883-x; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Maney M, 2007, DIABETES CARE, V30, P245, DOI 10.2337/dc06-0771; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P982, DOI 10.1210/jc.2008-1211; MARTINA WV, 1993, CLIN CHEM, V39, P2259; McCarter RJ, 2006, DIABETES CARE, V29, P352, DOI 10.2337/diacare.29.02.06.dc05-1594; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; Nathan DM, 2007, DIABETOLOGIA, V50, P2239, DOI 10.1007/s00125-007-0803-0; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NATHAN DM, 1983, CLIN CHEM, V29, P466; Quandt SA, 2005, ETHNIC DIS, V15, P656; Rhee MK, 2008, DIABETES EDUCATOR, V34, P655, DOI 10.1177/0145721708320903; Rhee MK, 2005, J HEALTH CARE POOR U, V16, P734; Roberts WL, 2002, CLIN CHEM, V48, P383; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; SCHNEIDER RG, 1976, BLOOD, V48, P629; SIMON M, 1980, DIABETES, V29, P467, DOI 10.2337/diabetes.29.6.467; Snieder H, 2001, DIABETES, V50, P2858, DOI 10.2337/diabetes.50.12.2858; STEVENS VJ, 1981, J CLIN INVEST, V67, P361, DOI 10.1172/JCI110043; Tarim O, 1999, PEDIATR INT, V41, P357; Wang X, 2004, J ENDOCRINOL INVEST, V27, P733, DOI 10.1007/BF03347514; Weykamp CW, 1999, CLIN CHEM, V45, P438; Ziemer DC, 2008, J GEN INTERN MED, V23, P528, DOI 10.1007/s11606-008-0524-1	51	247	249	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					770	+		10.7326/0003-4819-152-12-201006150-00004	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547905				2022-12-28	WOS:000278827700002
J	Takeuchi, H; Inokuchi, K; Aoki, M; Suto, F; Tsuboi, A; Matsuda, I; Suzuki, M; Aiba, A; Serizawa, S; Yoshihara, Y; Fujisawa, H; Sakano, H				Takeuchi, Haruki; Inokuchi, Kasumi; Aoki, Mari; Suto, Fumikazu; Tsuboi, Akio; Matsuda, Ikuo; Suzuki, Misao; Aiba, Atsu; Serizawa, Shou; Yoshihara, Yoshihiro; Fujisawa, Hajime; Sakano, Hitoshi			Sequential Arrival and Graded Secretion of Sema3F by Olfactory Neuron Axons Specify Map Topography at the Bulb	CELL			English	Article							ODORANT RECEPTOR GENES; CELL-ADHESION MOLECULE; SENSORY NEURONS; ZONAL SEGREGATION; SEMAPHORIN 3F; MOUSE; EXPRESSION; GLOMERULI; SYSTEM; NEUROPILIN-2	In the mouse olfactory system, the anatomical locations of olfactory sensory neurons (OSNs) roughly correlate with their axonal projection sites along the dorsal-ventral (D-V) axis of the olfactory bulb (OB). Here we report that an axon guidance receptor, Neuropilin-2 (Nrp2), and its repulsive ligand, Sema-phorin-3F (Sema3F), are expressed by OSNs in a complementary manner that is important for establishing olfactory map topography. Sema3F is secreted by early-arriving axons of OSNs and is deposited at the anterodorsal OB to repel Nrp2-positive axons that arrive later. Sequential arrival of OSN axons as well as the graded and complementary expression of Nrp2 and Sema3F by OSNs help to form the topographic order along the D-V axis.	[Takeuchi, Haruki; Inokuchi, Kasumi; Aoki, Mari; Serizawa, Shou; Sakano, Hitoshi] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan; [Suto, Fumikazu] Natl Inst Genet, Div Dev Genet, Mishima, Shizuoka 4118540, Japan; [Suto, Fumikazu] Tohoku Univ, Div Dev Neurosci, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Tsuboi, Akio] Nara Med Univ, Lab Mol Biol Neural Syst, Nara 6348521, Japan; [Matsuda, Ikuo; Aiba, Atsu] Kobe Univ, Grad Sch Med, Div Mol Genet, Kobe, Hyogo 6500017, Japan; [Suzuki, Misao] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan; [Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; [Fujisawa, Hajime] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Nara Medical University; Kobe University; Kumamoto University; RIKEN; Nagoya University	Sakano, H (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Tsuboi, Akio/R-6793-2019; Yoshihara, Yoshihiro/N-6481-2015	Tsuboi, Akio/0000-0002-4790-4512; Yoshihara, Yoshihiro/0000-0002-0319-7166; Aoki, Mari/0000-0002-2598-9850; Aiba, Atsu/0000-0002-8192-0778; Takeuchi, Haruki/0000-0003-4911-4060	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program, Biosignaling, at the University of Tokyo	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program, Biosignaling, at the University of Tokyo(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to M. Hori and S. Takashima for Nrp2 knockin mice, Y. Hiromi for anti-PlxnA3 antibodies, and members of our laboratory for their valuable comments. This work was supported by the Mitsubishi Foundation and by the Specially Promoted Research Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. H.T. was a pre-doctoral fellow of the Japan Society for the Promotion of Science and is supported by the Global COE Program, Biosignaling, at the University of Tokyo. This paper is dedicated to the late Shou Serizawa, who was a brilliant young scientist with a lot of potential.	ASTIC L, 1987, BRAIN RES, V424, P144, DOI 10.1016/0006-8993(87)91204-2; Bailey MS, 1999, J COMP NEUROL, V415, P423; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen Y, 2006, CELL, V127, P881, DOI 10.1016/j.cell.2006.11.017; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Duggan CD, 2008, J NEUROSCI, V28, P5229, DOI 10.1523/JNEUROSCI.1134-08.2008; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Hirata T, 2006, DEVELOPMENT, V133, P1433, DOI 10.1242/dev.02329; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Prince JEA, 2009, J NEUROSCI, V29, P14211, DOI 10.1523/JNEUROSCI.3948-09.2009; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Royal SJ, 1999, J NEUROSCI, V19, P9856; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sahay A, 2003, J NEUROSCI, V23, P6671; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Treloar HB, 2003, J COMP NEUROL, V458, P389, DOI 10.1002/cne.10590; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	53	102	102	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1056	1067		10.1016/j.cell.2010.04.041	http://dx.doi.org/10.1016/j.cell.2010.04.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550939	Bronze			2022-12-28	WOS:000278618800019
J	Kim, AM; Tingen, CM; Woodruff, TK				Kim, Alison M.; Tingen, Candace M.; Woodruff, Teresa K.			Sex bias in trials and treatment must end	NATURE			English	Editorial Material							BLOOD INSTITUTE; CLINICAL-TRIALS; NATIONAL HEART; WOMEN; LUNG; GUIDELINES; ENROLLMENT; ADHERENCE; HEALTH		[Kim, Alison M.; Tingen, Candace M.; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Woodruff, Teresa K.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Kim, AM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu	Kim, Alison/D-6969-2014	Kim, Alison/0000-0001-5845-1865; Woodruff, Teresa/0000-0002-1197-3399; Tingen, Candace/0000-0003-3503-019X				Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Bristol-Gould S, 2010, WOMENS HEALTH, V6, P183, DOI [10.2217/whe.10.10, 10.2217/WHE.10.10]; Day SC, 1996, AM J MED, V100, P375, DOI 10.1016/S0002-9343(97)89510-1; Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Henrich JB, 2006, ACAD MED, V81, P476, DOI 10.1097/01.ACM.0000222268.60211.fc; Holden C, 2008, SCIENCE, V322, P219, DOI 10.1126/science.322.5899.219; Kim ESH, 2008, J AM COLL CARDIOL, V52, P672, DOI 10.1016/j.jacc.2008.05.025; Lewis V, 2010, INT J CARDIOL, V139, P204, DOI 10.1016/j.ijcard.2008.08.024; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mostertz W, 2010, JAMA-J AM MED ASSOC, V303, P535, DOI 10.1001/jama.2010.80; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	13	153	154	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					688	689		10.1038/465688a	http://dx.doi.org/10.1038/465688a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535184				2022-12-28	WOS:000278551800018
J	Skipper, M; Weiss, U; Gray, N				Skipper, Magdalena; Weiss, Ursula; Gray, Noah			PLASTICITY	NATURE			English	Editorial Material													LUO, JINGJING/AAZ-6697-2021	LUO, JINGJING/0000-0002-3222-1276; Gray, Noah/0000-0002-4672-7403					0	9	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					703	703		10.1038/465703a	http://dx.doi.org/10.1038/465703a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535198	Bronze			2022-12-28	WOS:000278551800031
J	Kahn, JM; Benson, NM; Appleby, D; Carson, SS; Iwashyna, TJ				Kahn, Jeremy M.; Benson, Nicole M.; Appleby, Dina; Carson, Shannon S.; Iwashyna, Theodore J.			Long-term Acute Care Hospital Utilization After Critical Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL VENTILATION; RACIAL VARIATION; UNITED-STATES; SEVERE SEPSIS; OUTCOMES; MEDICARE; MORTALITY; PATIENT; COSTS; EPIDEMIOLOGY	Context Long-term acute care hospitals have emerged as a novel approach for the care of patients recovering from severe acute illness, but the extent and increases in their activity at the national level are unknown. Objective To examine temporal trends in long-term acute care hospital utilization after an episode of critical illness among fee-for-service Medicare beneficiaries aged 65 years or older. Design, Setting, and Patients Retrospective cohort study using the Medicare Provider Analysis and Review files from 1997 to 2006. We included all Medicare hospitalizations involving admission to an intensive care unit of an acute care, nonfederal hospital within the continental United States. Main Outcome Measures Overall long-term acute care utilization, associated costs, and survival following transfer. Results The number of long-term acute care hospitals in the United States increased at a mean rate of 8.8% per year, from 192 in 1997 to 408 in 2006. During that time, the annual number of long-term acute care admissions after critical illness increased from 13 732 to 40 353, with annual costs increasing from $484 million to $1.325 billion. The age-standardized population incidence of long-term acute care utilization after critical illness increased from 38.1 per 100 000 in 1997 to 99.7 per 100 000 in 2006, with greater use among male individuals and black individuals in all periods. Over time, transferred patients had higher numbers of comorbidities (5.0 in 19972000 vs 5.8 in 2004-2006, P<.001) and were more likely to receive mechanical ventilation at the long-term acute care hospital (16.4% in 1997-2000 vs 29.8% in 20042006, P<.001). One-year mortality after long-term acute care hospital admission was high throughout the study period: 50.7% in 1997-2000 and 52.2% in 2004-2006. Conclusions Long-term acute care hospital utilization after critical illness is common and increasing. Survival among Medicare beneficiaries transferred to long-term acute care after critical illness is poor. JAMA. 2010; 303(22): 2253-2259	[Kahn, Jeremy M.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Kahn, Jeremy M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Carson, Shannon S.] Univ N Carolina, Sch Med, Div Pulm & Crit Care, Chapel Hill, NC USA; [Iwashyna, Theodore J.] Univ Michigan, Sch Med, Div Pulm & Crit Care, Ann Arbor, MI USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Michigan System; University of Michigan	Kahn, JM (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Pulm Allergy & Crit Care, Blockley Hall 723,423 Guardian Dr, Philadelphia, PA 19104 USA.	jmkahn@mail.med.upenn.edu		Kahn, Jeremy/0000-0001-9688-5576; Benson, Nicole/0000-0001-5361-4311; Iwashyna, Theodore/0000-0002-4226-9310	National Institutes of Health (NIH) [R01HL096651, K08HL091249]; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096651, K08HL091249] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grant R01HL096651 from the National Institutes of Health (NIH) (Dr Kahn). Dr Iwashyna is supported by NIH grant K08HL091249. This project was also funded, in part, under a grant from the Pennsylvania Department of Health, which specifically disclaims responsibility for any analyses, interpretations, or conclusions.	AIKEN LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI [DOI 10.1001/JAMA.288.16.1987, 10.1001/jama.288.16.1987]; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], CLIN CLASS SOFTW ICD; Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2007, CHEST, V131, P2, DOI 10.1378/chest.06-2513; Carson SS, 1999, AM J RESP CRIT CARE, V159, P1568, DOI 10.1164/ajrccm.159.5.9809002; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Engoren M, 2004, CHEST, V125, P220, DOI 10.1378/chest.125.1.220; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Horwitz JR, 2009, J HEALTH ECON, V28, P924, DOI 10.1016/j.jhealeco.2009.06.008; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896; Iglehart JK, 2005, NEW ENGL J MED, V352, P78, DOI 10.1056/NEJMhpr043631; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Kahn JM, 2007, CURR OPIN CRIT CARE, V13, P514, DOI 10.1097/MCC.0b013e3282efb7c9; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2010, INTENS CARE MED, V36, P8, DOI 10.1007/s00134-009-1672-4; LAUDERDALE DS, 1993, EPIDEMIOL REV, V15, P319, DOI 10.1093/oxfordjournals.epirev.a036123; Liu K, 2001, HEALTH CARE FINANC R, V23, P1; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Medicare Payment Advisory Commission, 2004, REP C NEW APPR MED; Medicare Payment Advisory Commission, 2010, REP C MED PAYM POL; Pilcher DV, 2005, THORAX, V60, P187, DOI 10.1136/thx.2004.026500; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Riley GF, 2009, MED CARE, V47, pS51, DOI 10.1097/MLR.0b013e31819c95aa; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Scheinhorn DJ, 2007, CHEST, V131, P85, DOI 10.1378/chest.06-1081; Scheinhorn DJ, 2007, CHEST, V131, P76, DOI 10.1378/chest.06-1079; Schonhofer B, 2002, INTENS CARE MED, V28, P908, DOI 10.1007/s00134-002-1287-5; Seneff MG, 2000, CRIT CARE MED, V28, P342, DOI 10.1097/00003246-200002000-00009; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Taira DA, 2003, AM HEART J, V145, P452, DOI 10.1067/mhj.2003.3; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216	41	208	213	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2253	2259		10.1001/jama.2010.761	http://dx.doi.org/10.1001/jama.2010.761			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530778	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000278496800023
J	Bennell, K; Wee, E; Coburn, S; Green, S; Harris, A; Staples, M; Forbes, A; Buchbinder, R				Bennell, Kim; Wee, Elin; Coburn, Sally; Green, Sally; Harris, Anthony; Staples, Margaret; Forbes, Andrew; Buchbinder, Rachelle			Efficacy of standardised manual therapy and home exercise programme for chronic rotator cuff disease: randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHOULDER IMPINGEMENT SYNDROME; QUALITY-OF-LIFE; SUBACROMIAL IMPINGEMENT; PHYSICAL-THERAPY; CLINICAL-TRIALS; DOUBLE-BLIND; EPIDEMIOLOGIC SURVEILLANCE; MUSCULOSKELETAL DISORDERS; COST-EFFECTIVENESS; GENERAL HEALTH	Objective To investigate the efficacy of a programme of manual therapy and exercise treatment compared with placebo treatment delivered by physiotherapists for people with chronic rotator cuff disease. Design Randomised, participant and single assessor blinded, placebo controlled trial. Setting Metropolitan region of Melbourne, Victoria, Australia. Participants 120 participants with chronic (>3 months) rotator cuff disease recruited through medical practitioners and from the community. Interventions The active treatment comprised a manual therapy and home exercise programme; the placebo treatment comprised inactive ultrasound therapy and application of an inert gel. Participants in both groups received 10 sessions of individual standardised treatment over 10 weeks. For the following 12 weeks, the active group continued the home exercise programme and the placebo group received no treatment. Main outcome measures The primary outcomes were pain and function measured by the shoulder pain and disability index, average pain on movement measured on an 11 point numerical rating scale, and participants' perceived global rating of overall change. Results 112 (93%) participants completed the 22 week trial. At 11 weeks no difference was found between groups for change in shoulder pain and disability index (3.6, 95% confidence interval -2.1 to 9.4) or change in pain (0.7, -0.1 to 1.5); both groups showed significant improvements. More participants in the active group reported a successful outcome (defined as "much better"), although the difference was not statistically significant: 42% (24/57) of active participants and 30% (18/61) of placebo participants (relative risk 1.43, 0.87 to 2.34). The active group showed a significantly greater improvement in shoulder pain and disability index than did the placebo group at 22 weeks (between group difference 7.1, 0.3 to 13.9), although no significant difference existed between groups for change in pain (0.9, -0.03 to 1.7) or for the percentage of participants reporting a successful treatment outcome (relative risk 1.39, 0.94 to 2.03). Several secondary outcomes favoured the active group, including shoulder pain and disability index function score, muscle strength, interference with activity, and quality of life. Conclusion A standardised programme of manual therapy and home exercise did not confer additional immediate benefits for pain and function compared with a realistic placebo treatment that controlled for therapists' contact in middle aged to older adults with chronic rotator cuff disease. However, greater improvements were apparent at follow-up, particularly in shoulder function and strength, suggesting that benefits with active treatment take longer to manifest.	[Bennell, Kim; Wee, Elin; Coburn, Sally] Univ Melbourne, Sch Hlth Sci, Ctr Hlth Exercise & Sports Med, Dept Physiotherapy, Parkville, Vic 3010, Australia; [Coburn, Sally] Royal Melbourne Hosp, Dept Physiotherapy, Melbourne, Vic, Australia; [Green, Sally] Monash Univ, Monash Inst Hlth Serv Res, Melbourne, Vic, Australia; [Harris, Anthony] Monash Univ, Ctr Hlth Econ, Clayton, Vic 3800, Australia; [Staples, Margaret; Buchbinder, Rachelle] Cabrini Hosp, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Staples, Margaret; Forbes, Andrew; Buchbinder, Rachelle] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Clayton, Vic 3800, Australia	University of Melbourne; Royal Melbourne Hospital; Monash University; Monash University; Cabrini Health; Monash University; Monash University	Bennell, K (corresponding author), Univ Melbourne, Sch Hlth Sci, Ctr Hlth Exercise & Sports Med, Dept Physiotherapy, Parkville, Vic 3010, Australia.	k.bennell@unimelb.edu.au	Buchbinder, Rachelle/G-2952-2011; Zmistowski, Ben/AAI-7901-2020; Bennell, Kim/C-7022-2014	Buchbinder, Rachelle/0000-0002-0597-0933; Green, Sally Elizabeth/0000-0002-9564-9050; Bennell, Kim/0000-0003-4982-5639; Harris, Anthony/0000-0003-1641-3320; Coburn, Sally/0000-0002-2233-0006; Forbes, Andrew/0000-0003-4269-914X	Australian Research Council; Australian National Health and Medical Research Council; National Health and Medical Research Council [299840]; ANZ Trustees; Department of Physiotherapy Royal Melbourne Hospital; Royal Melbourne Hospital; School of Physiotherapy, University of Melbourne	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ANZ Trustees; Department of Physiotherapy Royal Melbourne Hospital; Royal Melbourne Hospital; School of Physiotherapy, University of Melbourne(University of Melbourne)	KB is funded in part by an Australian Research Council future fellowship. RB is funded in part by an Australian National Health and Medical Research Council practitioner fellowship. This work was funded by the National Health and Medical Research Council (project grant #299840). Pilot funds were provided by ANZ Trustees, Department of Physiotherapy and Victor Hurley Grant Royal Melbourne Hospital and the School of Physiotherapy, University of Melbourne. The study sponsors had no role in the design; in the collection, analysis, and interpretation of the data; or in the writing of the article and the decision to submit it for publication.	BADLEY EM, 1992, ANN RHEUM DIS, V51, P366, DOI 10.1136/ard.51.3.366; Bang MD, 2000, J ORTHOP SPORT PHYS, V30, P126, DOI 10.2519/jospt.2000.30.3.126; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; BARTOLOZZI A, 1994, CLIN ORTHOP RELAT R, P90; Bennell K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-86; Bennell KL, 2005, ANN RHEUM DIS, V64, P906, DOI 10.1136/ard.2004.026526; Bridges-Webb C., 1992, MED J AUST S, V157, pS1; BROX JI, 1993, BMJ-BRIT MED J, V307, P899, DOI 10.1136/bmj.307.6909.899; Buchbinder R, 2007, ARTHRIT RHEUM-ARTHR, V57, P1027, DOI 10.1002/art.22892; Buchsbaum D J, 1996, Recent Results Cancer Res, V141, P9; CHARD MD, 1991, ARTHRITIS RHEUM-US, V34, P766, DOI 10.1002/art.1780340619; COBURN S, 2008, THESIS U MELBOURNE; Conroy DE, 1998, J ORTHOP SPORT PHYS, V28, P3, DOI 10.2519/jospt.1998.28.1.3; Cothran Roger Lee Jr, 2006, J Surg Orthop Adv, V15, P132; Crossley K, 2002, AM J SPORT MED, V30, P857, DOI 10.1177/03635465020300061701; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [DOI 10.3310/HTA3030, DOI 10.3310/hta3030]; Cullen DM, 2007, AUSTRALAS RADIOL, V51, P226, DOI 10.1111/j.1440-1673.2007.01685.x; Dickens VA, 2005, PHYSIOTHERAPY, V91, P159, DOI 10.1016/j.physio.2004.10.008; Ekeberg OM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3112; Faber E, 2006, J OCCUP REHABIL, V16, P7, DOI 10.1007/s10926-005-9003-2; Gartsman GM, 1998, J SHOULDER ELB SURG, V7, P228, DOI 10.1016/S1058-2746(98)90050-7; Glazier RH, 1998, CAN MED ASSOC J, V158, P1037; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Haahr JP, 2005, ANN RHEUM DIS, V64, P760, DOI 10.1136/ard.2004.021188; HAWKINS RJ, 1980, AM J SPORT MED, V8, P151, DOI 10.1177/036354658000800302; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Heald SL, 1997, PHYS THER, V77, P1079, DOI 10.1093/ptj/77.10.1079; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; James KE, 1996, STAT MED, V15, P1421; Ketola S, 2009, J BONE JOINT SURG BR, V91B, P1326, DOI 10.1302/0301-620X.91B10.22094; Krogsboll LT, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-1; Kuhn JE, 2009, J SHOULDER ELB SURG, V18, P138, DOI 10.1016/j.jse.2008.06.004; Kuijpers T, 2004, PAIN, V109, P420, DOI 10.1016/j.pain.2004.02.017; Lombardi I, 2008, ARTHRIT RHEUM-ARTHR, V59, P615, DOI 10.1002/art.23576; Ludewig PM, 2009, J ORTHOP SPORT PHYS, V39, P90, DOI 10.2519/jospt.2009.2808; Ludewig PM, 2003, OCCUP ENVIRON MED, V60, P841, DOI 10.1136/oem.60.11.841; Maitland GD, 2001, VERTEBRAL MANIPULATI; May S, 2008, AUST J PHYSIOTHER, V54, P261, DOI 10.1016/S0004-9514(08)70005-9; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Michener LA, 2003, CLIN BIOMECH, V18, P369, DOI 10.1016/S0268-0033(03)00047-0; Mintken PE, 2009, J SHOULDER ELB SURG, V18, P920, DOI 10.1016/j.jse.2008.12.015; Moosmayer S, 2007, J CLIN ULTRASOUND, V35, P20, DOI 10.1002/jcu.20286; Morton V, 2005, J EVAL CLIN PRACT, V11, P59, DOI 10.1111/j.1365-2753.2004.00505.x; Osborne RH, 2003, J CLIN EPIDEMIOL, V56, P138, DOI 10.1016/S0895-4356(02)00601-7; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; PETERS D, 1994, BRIT J GEN PRACT, V44, P25; Roach K E, 1991, Arthritis Care Res, V4, P143, DOI 10.1002/art.1790040403; Roquelaure Y, 2002, OCCUP ENVIRON MED, V59, P452, DOI 10.1136/oem.59.7.452; Roquelaure Y, 2006, ARTHRIT RHEUM-ARTHR, V55, P765, DOI 10.1002/art.22222; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Senbursa G, 2007, KNEE SURG SPORT TR A, V15, P915, DOI 10.1007/s00167-007-0288-x; Smith KL, 2000, J SHOULDER ELB SURG, V9, P395, DOI 10.1067/mse.2000.108962; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; ten Klooster PM, 2006, PAIN, V121, P151, DOI 10.1016/j.pain.2005.12.021; Thomas E, 2005, ANN RHEUM DIS, V64, P1056, DOI 10.1136/ard.2004.029959; Trampas A, 2006, PHYS THER REV, V11, P125, DOI 10.1179/108331906X99065; Walters SJ, 2001, AGE AGEING, V30, P337, DOI 10.1093/ageing/30.4.337; Walther M, 2004, J SHOULDER ELB SURG, V13, P417, DOI 10.1016/j.jse.2004.02.002; Whitfield K, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-19; WILLIAMS JW, 1995, J RHEUMATOL, V22, P727	61	114	115	2	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2010	340								c2756	10.1136/bmj.c2756	http://dx.doi.org/10.1136/bmj.c2756			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611MB	20530557	Green Published, hybrid			2022-12-28	WOS:000278818300003
J	Chen, L; Park, SM; Tumanov, AV; Hau, A; Sawada, K; Feig, C; Turner, JR; Fu, YX; Romero, IL; Lengyel, E; Peter, ME				Chen, Lina; Park, Sun-Mi; Tumanov, Alexei V.; Hau, Annika; Sawada, Kenjiro; Feig, Christine; Turner, Jerrold R.; Fu, Yang-Xin; Romero, Iris L.; Lengyel, Ernst; Peter, Marcus E.			CD95 promotes tumour growth	NATURE			English	Article							OVARIAN-CANCER; PARTIAL-HEPATECTOMY; CELLS; RECEPTOR; DEATH; PROLIFERATION; ACTIVATION; EXPRESSION; RESISTANT; MOUSE	CD95 (also called Fas and APO-1) is a prototypical death receptor that regulates tissue homeostasis mainly in the immune system through the induction of apoptosis(1-3). During cancer progression CD95 is frequently downregulated or cells are rendered apoptosis resistant(4,5), raising the possibility that loss of CD95 is part of a mechanism for tumour evasion. However, complete loss of CD95 is rarely seen in human cancers(4) and many cancer cells express large quantities of CD95 and are highly sensitive to CD95-mediated apoptosis in vitro. Furthermore, cancer patients frequently have elevated levels of the physiological ligand for CD95, CD95L(6). These data raise the possibility that CD95 could actually promote the growth of tumours through its non-apoptotic activities(7). Here we show that cancer cells in general, regardless of their CD95 apoptosis sensitivity, depend on constitutive activity of CD95, stimulated by cancer-produced CD95L, for optimal growth. Consistently, loss of CD95 in mouse models of ovarian cancer and liver cancer reduces cancer incidence as well as the size of the tumours. The tumorigenic activity of CD95 is mediated by a pathway involving JNK and Jun. These results demonstrate that CD95 has a growth-promoting role during tumorigenesis and indicate that efforts to inhibit its activity rather than to enhance it should be considered during cancer therapy.	[Chen, Lina; Park, Sun-Mi; Hau, Annika; Feig, Christine; Peter, Marcus E.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Tumanov, Alexei V.; Turner, Jerrold R.; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Sawada, Kenjiro; Romero, Iris L.; Lengyel, Ernst] Univ Chicago, Gynecol Oncol Sect, Dept Obstet & Gynecol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Peter, ME (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St, Chicago, IL 60611 USA.	m-peter@northwestern.edu	Turner, Jerrold/H-1502-2019; Lengyel, Ernst/D-9220-2014; Tumanov, Alexei/AAR-1607-2021; Hau, Annika/Q-2131-2015; Romero, Iris/N-8451-2018; Turner, Jerrold R/A-6895-2009	Lengyel, Ernst/0000-0001-8624-1507; Tumanov, Alexei/0000-0001-6042-0152; Hau, Annika/0000-0002-3388-3394; Romero, Iris/0000-0001-5849-5024; Turner, Jerrold R/0000-0003-0627-9455; Peter, Marcus Ernst/0000-0003-3216-036X; fu, yang-xin/0000-0001-8441-6617; Feig, Christine/0000-0003-1385-7049	NCI [CA112240, CA11182]; Crohn's and Colitis Foundation of America [CCFA 1661]; Burroughs Wellcome Fund; Ovarian Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA112240, R01CA095319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068271, R01DK061931, R56DK094954, P01DK067887] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ovarian Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to A. Chervonsky and D. Dinulescu for providing the CD95 loxP/loxP mice and the Kras G12D/<SUP>+</SUP>Pten<SUP>fl/fl</SUP> mice, respectively, and to S. Ahmed for help with one experiment. We are grateful to T. Li for performing the immunohistochemistry and to Y.-J. Hua for analysing the gene array data. This work was funded by grants CA112240 from the NCI and CCFA 1661 from the Crohn's and Colitis Foundation of America ( to M. E. P.) and the Burroughs Wellcome Fund, the Ovarian Cancer Research Fund and RO1 CA11182 from the NCI ( to E. L.).	Abrahams VM, 2003, CANCER RES, V63, P5573; Baldwin RL, 1999, GYNECOL ONCOL, V74, P265, DOI 10.1006/gyno.1999.5448; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Romero IL, 2009, CANCER PREV RES, V2, P792, DOI 10.1158/1940-6207.CAPR-08-0236; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551	30	288	301	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					492	496		10.1038/nature09075	http://dx.doi.org/10.1038/nature09075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505730	Green Accepted			2022-12-28	WOS:000278043700038
J	Medoff, BD; Abbott, GF; Louissaint, A				Medoff, Benjamin D.; Abbott, Gerald F.; Louissaint, Abner, Jr.			A Man with a Cough and Pain in the Left Shoulder Langerhans'-cell histiocytosis of bone and lung.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERDHEIM-CHESTER-DISEASE; DENDRITIC CELLS; PULMONARY; LESIONS; MANIFESTATIONS; CLASSIFICATION; MELIOIDOSIS; INVOLVEMENT; SARCOIDOSIS; TUMORS		[Medoff, Benjamin D.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Abbott, Gerald F.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Louissaint, Abner, Jr.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Medoff, Benjamin D.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Abbott, Gerald F.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Louissaint, Abner, Jr.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Medoff, BD (corresponding author), Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA.							Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Allen TC, 2004, ARCH PATHOL LAB MED, V128, P1428; Allen TC, 2008, ARCH PATHOL LAB MED, V132, P1171, DOI 10.1043/1543-2165(2008)132[1171:PLCHAO]2.0.CO;2; Baughman RP, 2004, CLIN CHEST MED, V25, P521, DOI 10.1016/j.ccm.2004.04.006; Bradsher R W, 1997, Semin Respir Infect, V12, P229; Chapman S W, 1997, Semin Respir Infect, V12, P219; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2007, CLIN MICROBIOL REV, V20, P533, DOI 10.1128/CMR.00018-07; Chung JH, 2005, RESPIROLOGY, V10, P389, DOI 10.1111/j.1440-1843.2005.00671.x; Delsignore J L, 1996, Iowa Orthop J, V16, P126; Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C; Gotz G, 2004, EUR J MED RES, V9, P510; Hess T, 2006, EUR J RADIOL, V58, P280, DOI 10.1016/j.ejrad.2005.11.015; Hoover KB, 2007, SKELETAL RADIOL, V36, P95, DOI 10.1007/s00256-006-0193-2; Kim W, 2007, AM J MED GENET A, V143A, P377, DOI 10.1002/ajmg.a.31600; LADISCH S, 1994, BRIT J CANCER, V70, pS41; Lederman ER, 2004, MEDICINE, V83, P300, DOI 10.1097/01.md.0000141100.30871.39; Pappas P G, 1997, Semin Respir Infect, V12, P243; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Rolland A, 2005, J IMMUNOL, V174, P3067, DOI 10.4049/jimmunol.174.5.3067; Rosier RN, 2000, NEW ENGL J MED, V342, P875, DOI 10.1056/NEJM200003233421208; Satter EK, 2008, PEDIATR DERMATOL, V25, P291, DOI 10.1111/j.1525-1470.2008.00669.x; Swerdlow SH, 2008, WHO CLASSIFICATION T; VA/NIH Acute Renal Failure Trail Network, 2009, NEW ENGL J MED, V361, P2391; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607; Vassallo R, 2004, CLIN CHEST MED, V25, P561, DOI 10.1016/j.ccm.2004.04.005; Watts HG, 1996, J BONE JOINT SURG AM, V78A, P288, DOI 10.2106/00004623-199602000-00019; Wells AU, 2007, THORAX, V62, P904, DOI 10.1136/thx.2004.031021; Wenstrup RJ, 2002, BRIT J RADIOL, V75, pA2, DOI 10.1259/bjr.75.suppl_1.750002; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wilcox A, 2000, CURR OPIN RHEUMATOL, V12, P321, DOI 10.1097/00002281-200007000-00016; WILLMAN CL, 1994, NEW ENGL J MED, V331, P154, DOI 10.1056/NEJM199407213310303; Yousem SA, 2001, AM J SURG PATHOL, V25, P630, DOI 10.1097/00000478-200105000-00010; Zuetenhorst JM, 2005, ONCOLOGIST, V10, P123, DOI 10.1634/theoncologist.10-2-123; 2000, N ENGL J MED, V342, P1620; 2008, N ENGL J MED, V359, P736	36	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					2013	2022		10.1056/NEJMcpc1002114	http://dx.doi.org/10.1056/NEJMcpc1002114			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601JI	20505181				2022-12-28	WOS:000278054000011
J	Smith, MR; Caron, JB				Smith, Martin R.; Caron, Jean-Bernard			Primitive soft-bodied cephalopods from the Cambrian	NATURE			English	Article							BURGESS SHALE; BRITISH-COLUMBIA; MOLLUSK; RADULA; ORIGIN; FOSSIL	The exquisite preservation of soft-bodied animals in Burgess Shale-type deposits provides important clues into the early evolution of body plans that emerged during the Cambrian explosion(1). Until now, such deposits have remained silent regarding the early evolution of extant molluscan lineages-in particular the cephalopods. Nautiloids, traditionally considered basal within the cephalopods, are generally depicted as evolving from a creeping Cambrian ancestor whose dorsal shell afforded protection and buoyancy(2). Although nautiloid-like shells occur from the Late Cambrian onwards, the fossil record provides little constraint on this model, or indeed on the early evolution of cephalopods. Here, we reinterpret the problematic Middle Cambrian animal Nectocaris pteryx(3,4) as a primitive (that is, stem-group), non-mineralized cephalopod, based on new material from the Burgess Shale. Together with Nectocaris, the problematic Lower Cambrian taxa Petalilium(5) and (probably) Vetustovermis(6,7) form a distinctive clade, Nectocarididae, characterized by an open axial cavity with paired gills, wide lateral fins, a single pair of long, prehensile tentacles, a pair of non-faceted eyes on short stalks, and a large, flexible anterior funnel. This clade extends the cephalopods' fossil record(2) by over 30 million years, and indicates that primitive cephalopods lacked a mineralized shell, were hyperbenthic, and were presumably carnivorous. The presence of a funnel suggests that jet propulsion evolved in cephalopods before the acquisition of a shell. The explosive diversification of mineralized cephalopods in the Ordovician may have an understated Cambrian 'fuse'.	[Smith, Martin R.; Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada; [Smith, Martin R.; Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Toronto; Royal Ontario Museum	Caron, JB (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	jcaron@rom.on.ca	Smith, Martin Ross/B-8461-2012	Smith, Martin Ross/0000-0001-5660-1727; Caron, Jean-Bernard/0000-0002-1670-5502	Natural Sciences and Engineering Research Council of Canada; University of Toronto	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Toronto(University of Toronto)	We thank S. Conway Morris, D. Fuchs, A. Lindgren, A. Scheltema, C. Schander and M. Vecchione for critically reading earlier drafts; R. Gaines for comments on preservation; J.-Y. Chen, M.-Y. Zhu and J. Paterson for images of Petalilium and Vetustovermis; and Parks Canada for research and collection permits delivered to Royal Ontario Museum teams led by D. Collins. P. Fenton assisted with collections, and S. Lackie with scanning electron microscopy. This research was undertaken as part of a PhD thesis (M.R.S.) in the Department of Ecology and Evolutionary Biology, University of Toronto. Funding was provided by Natural Sciences and Engineering Research Council of Canada Discovery Grant through J.-B. C and University of Toronto fellowships to M. R. S. This is Royal Ontario Museum Burgess Shale Research Project 27.	BEEDHAM GE, 1968, J ZOOL, V154, P443; BRIGGS DEG, 1981, PHILOS T ROY SOC B, V291, P541, DOI 10.1098/rstb.1981.0007; Butterfield NJ, 2008, J PALEONTOL, V82, P543, DOI 10.1666/07-066.1; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Chen JY, 2005, P ROY SOC B-BIOL SCI, V272, P2003, DOI 10.1098/rspb.2005.3159; Conway Morris Simon, 1997, CRUCIBLE CREATION BU; Dzik J, 2010, MALACOLOGIA, V52, P97, DOI 10.4002/040.052.0107; Fedonkin MA, 2007, GEOL SOC SPEC PUBL, V286, P157, DOI 10.1144/SP286.12; FLOWER RH, 1961, J PALEONTOL, V35, P569; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Gabbott SE, 2008, J GEOL SOC LONDON, V165, P307, DOI 10.1144/0016-76492007-023; Glaessner M.F., 1979, ALCHERINGA, V3, P21, DOI DOI 10.1080/03115517908565437; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; JOHNSON R G, 1969, Fieldiana Geology, V12, P119; LUO H., 1999, EARLY CAMBRIAN CHENG; Marin F, 1996, P NATL ACAD SCI USA, V93, P1554, DOI 10.1073/pnas.93.4.1554; Marinichev AN, 2007, RUSS J APPL CHEM+, V80, P209, DOI 10.1134/S1070427207020085; MORRIS S C, 1977, Palaeontologische Zeitschrift, V51, P271; MORRIS SC, 1976, NEUES JB GEOLOGIE PA, V12, P703; NIXON M, 1985, PALAEONTOLOGY NEONTO, P103; Shea EK, 2005, INVERTEBR BIOL, V124, P25, DOI 10.1111/j.1744-7410.2005.1241-04.x; SIMONETTA AM, 1988, B ZOOL, V55, P63; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; YOCHELSON EL, 1973, LETHAIA, V6, P275, DOI 10.1111/j.1502-3931.1973.tb01199.x	25	50	53	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					469	472		10.1038/nature09068	http://dx.doi.org/10.1038/nature09068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505727	Green Published			2022-12-28	WOS:000278043700033
J	Hamburg, MA; Collins, FS				Hamburg, Margaret A.; Collins, Francis S.			The Path to Personalized Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hamburg, Margaret A.] US FDA, Silver Spring, MD USA; [Collins, Francis S.] NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA	Hamburg, MA (corresponding author), US FDA, Silver Spring, MD USA.							Frueh FW, 2008, PHARMACOTHERAPY, V28, P992, DOI 10.1592/phco.28.8.992; HaH Services, 2008, US SYST OV GEN TEST; *NAT CANC I, OV CANC RES RES PROS; *NAT CTR BIOT, 2010, GEN TEST REG; *SECR ADV COMM GEN, 2000, ENH OV GEN TESTS REC	5	1208	1235	7	350	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					301	304		10.1056/NEJMp1006304	http://dx.doi.org/10.1056/NEJMp1006304			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628RU	20551152				2022-12-28	WOS:000280139300001
J	Wang, TJ; Zhang, F; Richards, JB; Kestenbaum, B; van Meurs, JB; Berry, D; Kiel, DP; Streeten, EA; Ohlsson, C; Koller, DL; Peltonen, L; Cooper, JD; O'Reilly, PF; Houston, DK; Glazer, NL; Vandenput, L; Peacock, M; Shi, J; Rivadeneira, F; McCarthy, MI; Anneli, P; de Boer, IH; Mangino, M; Kato, B; Smyth, DJ; Booth, SL; Jacques, PF; Burke, GL; Goodarzi, M; Cheung, CL; Wolf, M; Rice, K; Goltzman, D; Hidiroglou, N; Ladouceur, M; Wareham, NJ; Hocking, LJ; Hart, D; Arden, NK; Cooper, C; Malik, S; Fraser, WD; Hartikainen, AL; Zhai, GJ; Macdonald, HM; Forouhi, NG; Loos, RJF; Reid, DM; Hakim, A; Dennison, E; Liu, YM; Power, C; Stevens, HE; Jaana, L; Vasan, RS; Soranzo, N; Bojunga, J; Psaty, BM; Lorentzon, M; Foroud, T; Harris, TB; Hofman, A; Jonsson, JO; Cauley, JA; Uitterlinden, AG; Gibson, Q; Jarvelin, MR; Karasik, D; Siscovick, DS; Econs, MJ; Kritchevsky, SB; Florez, JC; Todd, JA; Dupuis, J; Hypponen, E; Spector, TD				Wang, Thomas J.; Zhang, Feng; Richards, J. Brent; Kestenbaum, Bryan; van Meurs, Joyce B.; Berry, Diane; Kiel, Douglas P.; Streeten, Elizabeth A.; Ohlsson, Claes; Koller, Daniel L.; Peltonen, Leena; Cooper, Jason D.; O'Reilly, Paul F.; Houston, Denise K.; Glazer, Nicole L.; Vandenput, Liesbeth; Peacock, Munro; Shi, Julia; Rivadeneira, Fernando; McCarthy, Mark I.; Anneli, Pouta; de Boer, Ian H.; Mangino, Massimo; Kato, Bernet; Smyth, Deborah J.; Booth, Sarah L.; Jacques, Paul F.; Burke, Greg L.; Goodarzi, Mark; Cheung, Ching-Lung; Wolf, Myles; Rice, Kenneth; Goltzman, David; Hidiroglou, Nick; Ladouceur, Martin; Wareham, Nicholas J.; Hocking, Lynne J.; Hart, Deborah; Arden, Nigel K.; Cooper, Cyrus; Malik, Suneil; Fraser, William D.; Hartikainen, Anna-Liisa; Zhai, Guangju; Macdonald, Helen M.; Forouhi, Nita G.; Loos, Ruth J. F.; Reid, David M.; Hakim, Alan; Dennison, Elaine; Liu, Yongmei; Power, Chris; Stevens, Helen E.; Jaana, Laitinen; Vasan, Ramachandran S.; Soranzo, Nicole; Bojunga, Joerg; Psaty, Bruce M.; Lorentzon, Mattias; Foroud, Tatiana; Harris, Tamara B.; Hofman, Albert; Jonsson, John-Olov; Cauley, Jane A.; Uitterlinden, Andre G.; Gibson, Quince; Jarvelin, Marjo-Riitta; Karasik, David; Siscovick, David S.; Econs, Michael J.; Kritchevsky, Stephen B.; Florez, Jose C.; Todd, John A.; Dupuis, Josee; Hyppoenen, Elina; Spector, Timothy D.			Common genetic determinants of vitamin D insufficiency: a genome-wide association study	LANCET			English	Article							D-BINDING PROTEIN; PLASMA-CONCENTRATIONS; D SUPPLEMENTATION; D DEFICIENCY; RISK; 25-HYDROXYVITAMIN-D; CALCIUM; CANCER; METAANALYSIS; REPLICATION	Background Vitamin D is crucial for maintenance of musculoskeletal health, and might also have a role in extraskeletal tissues. Determinants of circulating 25-hydroxyvitamin D concentrations include sun exposure and diet, but high heritability suggests that genetic factors could also play a part. We aimed to identify common genetic variants affecting vitamin D concentrations and risk of insufficiency. Methods We undertook a genome-wide association study of 25-hydroxyvitamin D concentrations in 33 996 individuals of European descent from 15 cohorts. Five epidemiological cohorts were designated as discovery cohorts (n=16 125), five as in-silico replication cohorts (n=9367), and five as de-novo replication cohorts (n=8504). 25-hydroxyvitamin D concentrations were measured by radioimmunoassay, chemiluminescent assay, ELISA, or mass spectrometry. Vitamin D insufficiency was defined as concentrations lower than 75 nmol/L or 50 nmol/L. We combined results of genome-wide analyses across cohorts using Z-score-weighted meta-analysis. Genotype scores were constructed for confirmed variants. Findings Variants at three loci reached genome-wide significance in discovery cohorts for association with 25-hydroxyvitamin D concentrations, and were confirmed in replication cohorts: 4p12 (overall p=1.9x10(-109) for rs2282679, in GC); 11q12 (p=2.1x10(-22) for rs12785878, near DHCR7); and 11p15 (p=3.3x10(-20) for rs10741657, near CYP2R1). Variants at an additional locus (20q13, CYP24A1) were genome-wide significant in the pooled sample (p=6.0x10(-10) for rs6013897). Participants with a genotype score (combining the three confirmed variants) in the highest quartile were at increased risk of having 25-hydroxyvitamin D concentrations lower than 75 nmol/L (OR 2.47, 95% CI 2.20-2.78, p=2.3x10(-48)) or lower than 50 nmol/L (1.92, 1.70-2-16, p=1.0x10(-26)) compared with those in the lowest quartile. Interpretation Variants near genes involved in cholesterol synthesis, hydroxylation, and vitamin D transport affect vitamin D status. Genetic variation at these loci identifies individuals who have substantially raised risk of vitamin D insufficiency.	[Wang, Thomas J.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Diabet Res Ctr, Diabet Unit, Boston, MA 02114 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kiel, Douglas P.; Cheung, Ching-Lung; Karasik, David] Hebrew SeniorLife, Inst Aging Res, Genet Epidemiol Program, Boston, MA USA; [Wang, Thomas J.; Florez, Jose C.] Harvard Univ, Sch Med, Boston, MA USA; [Wang, Thomas J.; Kiel, Douglas P.; Vasan, Ramachandran S.; Dupuis, Josee] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Zhang, Feng; Mangino, Massimo; Kato, Bernet; Hart, Deborah; Zhai, Guangju; Soranzo, Nicole; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Richards, J. Brent; Ladouceur, Martin] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Goltzman, David] McGill Univ, Ctr Hlth, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent; Goltzman, David; Ladouceur, Martin] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent; Ladouceur, Martin] McGill Univ, Dept Human Genet, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent; Ladouceur, Martin] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3T 1E2, Canada; [Kestenbaum, Bryan; de Boer, Ian H.] Univ Washington, Harborview Med Ctr, Kidney Res Inst, Div Nephrol, Seattle, WA 98104 USA; [Glazer, Nicole L.; Rice, Kenneth; Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Glazer, Nicole L.; Rice, Kenneth; Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98104 USA; [Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98104 USA; [van Meurs, Joyce B.; Rivadeneira, Fernando; Uitterlinden, Andre G.; Gibson, Quince] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Klin Genet, Rotterdam, Netherlands; [van Meurs, Joyce B.; Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.] NGI, Sponsored NCHA, Rotterdam, Netherlands; [Berry, Diane; Power, Chris; Hyppoenen, Elina] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Berry, Diane; Power, Chris; Hyppoenen, Elina] Ctr Paediat Epidemiol & Biostat, London, England; [Streeten, Elizabeth A.; Shi, Julia] Univ Maryland, Sch Med, Div Endocrinol, Baltimore, MD 21201 USA; [Ohlsson, Claes; Vandenput, Liesbeth; Lorentzon, Mattias] Univ Gothenburg, Inst Med, Dept Internal Med, Sahlgrenska Acad, Gothenburg, Sweden; [Jonsson, John-Olov] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Koller, Daniel L.; Peacock, Munro; Foroud, Tatiana; Econs, Michael J.] Indiana Univ, Sch Med, Indianapolis, IN USA; [Peltonen, Leena; Soranzo, Nicole] Wellcome Trust Sanger Inst, Hinxton, England; [Peltonen, Leena] Univ Helsinki, Helsinki, Finland; [Peltonen, Leena] Inst Mol Med Finland, Natl Inst Hlth & Welf, Helsinki, Finland; [Cooper, Jason D.; Smyth, Deborah J.; Stevens, Helen E.; Todd, John A.] Univ Cambridge, JDRF WT Diabet & Inflammat Lab, Cambridge, England; [O'Reilly, Paul F.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Fac Med, London, England; [Houston, Denise K.; Liu, Yongmei; Kritchevsky, Stephen B.] Wake Forest Univ, Sch Med, Sticht Ctr Aging, Winston Salem, NC 27109 USA; [Burke, Greg L.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [McCarthy, Mark I.] Univ Oxford, OCDEM, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Arden, Nigel K.; Cooper, Cyrus] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Anneli, Pouta; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Booth, Sarah L.; Jacques, Paul F.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer USDA, Boston, MA 02111 USA; [Goodarzi, Mark] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Wolf, Myles] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Cheung, Ching-Lung] ASTAR, Genome Inst Singapore Computat & Math Biol, Singapore, Singapore; [Hidiroglou, Nick] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Wareham, Nicholas J.; Forouhi, Nita G.; Loos, Ruth J. F.] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Hocking, Lynne J.; Macdonald, Helen M.; Reid, David M.] Univ Aberdeen, Div Appl Med, Bone & Musculoskeletal Res Programme, Aberdeen, Scotland; [Arden, Nigel K.; Cooper, Cyrus; Dennison, Elaine] Univ Southampton, MRC Epidemiol Resource Ctr, Southampton, Hants, England; [Malik, Suneil] Publ Hlth Agcy Canada, Off Biotechnol Genom & Populat Hlth, Toronto, ON, Canada; [Fraser, William D.] Univ Liverpool, Unit Clin Chem, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Obstet & Gynaecol, Oulu, Finland; [Jaana, Laitinen; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hakim, Alan] Whipps Cross Univ Hosp, Dept Rheumatol, London, England; [Jaana, Laitinen] Finnish Inst Occupat Hlth, Oulu, Finland; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Div Prevent Med, Boston, MA 02118 USA; [Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Bojunga, Joerg] Klinikum Johann Wolfgang Goethe Univ, Frankfurt, Germany; [Harris, Tamara B.] NIA, NIH, Bethesda, MD 20892 USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Florez, Jose C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; Framingham Heart Study; University of London; King's College London; McGill University; McGill University; McGill University; McGill University; McGill University; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of London; University College London; University System of Maryland; University of Maryland Baltimore; University of Gothenburg; University of Gothenburg; Indiana University System; Indiana University-Purdue University Indianapolis; Wellcome Trust Sanger Institute; University of Helsinki; Finland National Institute for Health & Welfare; University of Cambridge; Imperial College London; Wake Forest University; Wake Forest University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Finland National Institute for Health & Welfare; Tufts University; United States Department of Agriculture (USDA); Cedars Sinai Medical Center; University of Miami; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Health Canada; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Aberdeen; University of Southampton; Public Health Agency of Canada; University of Liverpool; University of Oulu; University of Oulu; University of Oulu; University of London; Queen Mary University London; Finnish Institute of Occupational Health; Boston University; Boston University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Spector, TD (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp Campus,1st Floor S Wing Block 4,We, London SE1 7EH, England.	tjwang@partners.org; e.hypponen@ich.ucl.ac.uk; tim.spector@kcl.ac.uk	Richards, J Brent/AAF-4225-2019; Loos, Ruth/GON-5877-2022; Vandenput, Liesbeth/AAI-4100-2021; Spector, Tim D/F-6533-2012; Cheung, Ching-Lung/C-2529-2012; Vandenput, Liesbeth/AAP-3655-2020; Hypponen, Elina/B-2596-2014; Ramachandran, Vasan/Y-2527-2019; Ohlsson, Claes/HIR-6959-2022; Ohlsson, Claes/AGP-3544-2022; Lorentzon, Mattias/W-7878-2019; Rivadeneira, Fernando/O-5385-2015; Goodarzi, Mark/AAH-7106-2021; Loos, Ruth J F/Q-2862-2016; de Boer, Ian/GYJ-3282-2022; Hakim, Alan/ABE-8520-2020; Rice, Kenneth M/A-4150-2013; Mangino, Massimo/F-5134-2011; Todd, John/A-3542-2010; McCarthy, Mark/M-3763-2015	Richards, J Brent/0000-0002-3746-9086; Vandenput, Liesbeth/0000-0002-1712-6131; Cheung, Ching-Lung/0000-0002-6233-9144; Vandenput, Liesbeth/0000-0002-1712-6131; Hypponen, Elina/0000-0003-3670-9399; Ramachandran, Vasan/0000-0001-7357-5970; Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805; Lorentzon, Mattias/0000-0003-0749-1431; Rivadeneira, Fernando/0000-0001-9435-9441; Goodarzi, Mark/0000-0001-6364-5103; Loos, Ruth J F/0000-0002-8532-5087; Rice, Kenneth M/0000-0001-5779-4495; Mangino, Massimo/0000-0002-2167-7470; van Meurs, Joyce/0000-0001-6245-2123; Todd, John/0000-0003-2740-8148; Dennison, Elaine/0000-0002-3048-4961; Wang, Thomas/0000-0003-4063-6508; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Kiel, Douglas/0000-0001-8474-0310; Cauley, Jane A/0000-0003-0752-4408; Karasik, David/0000-0002-8826-0530; Houston, Denise/0000-0002-3355-4304; Kritchevsky, Stephen/0000-0003-3336-6781; Hocking, Lynne J/0000-0002-2414-2826; McCarthy, Mark/0000-0002-4393-0510; Glazer, Nicole/0000-0002-6397-609X; O'Reilly, Paul/0000-0001-7515-0845; Soranzo, Nicole/0000-0003-1095-3852; Dupuis, Josee/0000-0003-2871-3603; smyth, deborah/0000-0002-6330-2669; Forouhi, Nita/0000-0002-5041-248X; Cooper, Cyrus/0000-0003-3510-0709	Novartis; Roche; Amgen; NIH/NHLBI [N01-HC-25195]; American Heart Association; US Department of Agriculture, Agricultural Research Service [58-1950-7-707]; National Institute of Aging [AG14759]; National Institute of Arthritis, Musculoskeletal, and Skin Diseases; National Institute on Aging [R01 AR/AG 41398]; Affymetrix Inc [N02-HL-6-4278]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center; Wellcome Trust; Arthritis Research Campaign; European Community [FP7/2007-2013, HEALTH-F2-2008-201865-GEFOS, 200800, OA /(FP7/2007-2013), HEALTH-F4-2007-201413, QLG2-CT-2002-01254]; UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Biotechnology and Biological Sciences Research Council [G20234]; National Eye Institute (NEI) via an NIH/Center for Inherited Disease Research (CIDR); Netherlands Organization of Scientific Research (NWO) [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015: RIDE2]; Netherlands Genomics Initiative/NWO [050-060-810]; European Commission [HEALTH-F2-2008-201865-GEFOS, HEALTH-F2-2008-00-TREAT-OA]; Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; MRC [G0000934, G0701863, G0600705, G0601653, MC_U106188470, G0400546, MC_UP_A100_1003] Funding Source: UKRI; Medical Research Council [MC_U106179471, G0400546, G0000934, G0400546B, MC_U106188470, G0601653, U1475000001, G0600705, MC_UP_A100_1003, MC_UP_A620_1014, G0701863] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0508-10275, PHCS/C4/4/016] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085085, N01HC085082, N01HC025195, N01HC085083, N01HC045133, N01HC085079, N01HC035129, N01HC085086, N01HC085080, N01HC015103, N01HC085081, N01HC085084, N01HC075150, N01HC055222] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750, M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL064278, R01HL087679, U01HL080295, R01HL084443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838, R01AR041398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, P30DK072488, P30DK063491, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, N01AG062103, N01AG062106, R01AG014759, P01AG018397, R01AG027002, R01AG041517, R01AG032098, R01AG029364] Funding Source: NIH RePORTER	Novartis(Novartis); Roche(Roche Holding); Amgen(Amgen); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis, Musculoskeletal, and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Affymetrix Inc; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center; Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research Campaign(Versus Arthritis); European Community(European Commission); UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Eye Institute (NEI) via an NIH/Center for Inherited Disease Research (CIDR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	TJW has served on the scientific advisory board of Diasorin. DKH has received honoraria from Abbott Nutrition. MW has received consultancy fees, honoraria, and speakers' fees from Abbott and Genzyme. DMR has acted as a consultant for Novartis, Roche, Pfizer, Amgen, Shire, Merck, and Servier, has received speakers' fees from Novartis, Roche, and Amgen, and owns stock in GlaxoSmithKline and Astra Zeneca. ML(2) has received lecture fees from Novartis and Sanofi-Aventis. All other authors declare that they have no conflicts of interest.; Framingham Heart Study The Framingham Heart Study of the National Heart, Lung and Blood Institute (NHLBI) of the US National Institutes of Health (NIH) and Boston University School of Medicine is supported by the NIH/NHLBI contract N01-HC-25195. The present study received support from the American Heart Association, the US Department of Agriculture, Agricultural Research Service (under Cooperative Agreement No 58-1950-7-707), and the National Institute of Aging (AG14759). DK was supported by a grant from the National Institute of Arthritis, Musculoskeletal, and Skin Diseases and the National Institute on Aging (R01 AR/AG 41398). The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource project. This work was partly supported by a contract with Affymetrix Inc for genotyping services (Contract No N02-HL-6-4278). A portion of this research used the Linux Cluster for Genetic Analysis, which is funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Twins UK and Chingford The study was funded by the Wellcome Trust, Arthritis Research Campaign, European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and Seventh Framework Programme grant 200800 Treat OA /(FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP.5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior investigator. The project also received support from a Biotechnology and Biological Sciences Research Council project grant. (G20234). The authors acknowledge the funding and support of the National Eye Institute (NEI) via an NIH/Center for Inherited Disease Research (CIDR) genotyping project. We thank the staff from the Genotyping Facilities at the Wellcome Trust Sanger Institute for sample preparation, quality control, and genotyping; Le Centre National de Genotypage, France, for genotyping; Duke University, NC, USA, for genotyping; and the Finnish Institute of Molecular Medicine, Finnish Genome Center, University of Helsinki. Genotyping was also done by CIDR as part of an NEI/NIH project grant. The Rotterdam Study This study was funded by the Netherlands Organization of Scientific Research (NWO) Investments (175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015: RIDE2), the Netherlands Genomics Initiative/NWO project 050-060-810, and the European Commission (HEALTH-F2-2008-201865-GEFOS, and HEALTH-F2-2008-00-TREAT-OA). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development, the Research Institute for Diseases in the Elderly, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. We thank the staff from the Rotterdam Study, and the participating general practitioners and pharmacists.	Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Becker BJ, 2007, STAT SCI, V22, P414, DOI 10.1214/07-STS243; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; HAUGHTON MA, 1992, CLIN CHEM, V38, P1796; Heaney RP, 2008, AM J CLIN NUTR, V88, p541S, DOI 10.1093/ajcn/88.2.541S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Hypponen E, 2007, J CLIN ENDOCR METAB, V92, P4615, DOI 10.1210/jc.2007-1279; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; John EM, 1999, CANCER EPIDEM BIOMAR, V8, P399; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Livshits G, 1999, ANN HUM GENET, V63, P429, DOI 10.1046/j.1469-1809.1999.6350429.x; Martinez ME, 1996, JNCI-J NATL CANCER I, V88, P1375, DOI 10.1093/jnci/88.19.1375; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Porter FD, 2002, J CLIN INVEST, V110, P715, DOI 10.1172/JCI200216386; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Rossi M, 2005, J INHERIT METAB DIS, V28, P69, DOI 10.1007/s10545-005-3676-8; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wjst M, 2007, J STEROID BIOCHEM, V103, P799, DOI 10.1016/j.jsbmb.2006.12.053; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	34	1169	1210	0	121	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					180	188		10.1016/S0140-6736(10)60588-0	http://dx.doi.org/10.1016/S0140-6736(10)60588-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20541252	Green Accepted, Green Submitted			2022-12-28	WOS:000280313100025
J	Yuan, P; Leonetti, MD; Pico, AR; Hsiung, YC; MacKinnon, R				Yuan, Peng; Leonetti, Manuel D.; Pico, Alexander R.; Hsiung, Yichun; MacKinnon, Roderick			Structure of the Human BK Channel Ca2+-Activation Apparatus at 3.0 angstrom Resolution	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; CONDUCTANCE-VOLTAGE RELATIONSHIP; DEPENDENT K+ CHANNEL; 2 RCK DOMAINS; CA2+ SENSITIVITY; LIPID-MEMBRANE; SMOOTH-MUSCLE; GATING RING; CALCIUM; MECHANISM	High-conductance voltage-and Ca2+-activated K+ (BK) channels encode negative feedback regulation of membrane voltage and Ca2+ signaling, playing a central role in numerous physiological processes. We determined the x-ray structure of the human BK Ca2+ gating apparatus at a resolution of 3.0 angstroms and deduced its tetrameric assembly by solving a 6 angstrom resolution structure of a Na+-activated homolog. Two tandem C-terminal regulator of K+ conductance (RCK) domains from each of four channel subunits form a 350-kilodalton gating ring at the intracellular membrane surface. A sequence of aspartic amino acids that is known as the Ca2+ bowl, and is located within the second of the tandem RCK domains, creates four Ca2+ binding sites on the outer perimeter of the gating ring at the "assembly interface" between RCK domains. Functionally important mutations cluster near the Ca2+ bowl, near the "flexible interface" between RCK domains, and on the surface of the gating ring that faces the voltage sensors. The structure suggests that the Ca2+ gating ring, in addition to regulating the pore directly, may also modulate the voltage sensor.	[Yuan, Peng; Leonetti, Manuel D.; Pico, Alexander R.; Hsiung, Yichun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu	Pico, Alexander/HCH-4305-2022; Yuan, Peng/A-7643-2012	Leonetti, Manuel/0000-0002-4881-405X; Pico, Alexander/0000-0001-5706-2163; Yuan, Peng/0000-0002-5660-225X	American Asthma Foundation [07-0127]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	American Asthma Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. R. Rajashankar and K. Perry at beamline 24ID-C (Advanced Photon Source, Argonne National Laboratory) and the staff at beamline X29 (National Synchrotron Light Source, Brookhaven National Laboratory) for advice at the synchrotron; members of the MacKinnon laboratory for assistance; and L. Feng and M. Whorton for comments on the manuscript. R. M. is an Investigator in the Howard Hughes Medical Institute. The research is supported by the American Asthma Foundation grant 07-0127. The x-ray crystallographic coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession code 3MT5.	Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Kim HJ, 2008, BIOPHYS J, V94, P446, DOI 10.1529/biophysj.107.108738; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee JH, 2009, BIOPHYS J, V97, P730, DOI 10.1016/j.bpj.2009.04.058; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; PICO A, 2003, THESIS ROCKEFELLER U; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239	38	217	226	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					182	186		10.1126/science.1190414	http://dx.doi.org/10.1126/science.1190414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20508092	Green Accepted			2022-12-28	WOS:000279635200039
J	Levy, JH				Levy, Jerrold H.			Antifibrinolytic therapy: new data and new concepts	LANCET			English	Editorial Material							TRANEXAMIC ACID; APROTININ		[Levy, Jerrold H.] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Levy, Jerrold H.] Emory Healthcare, Cardiothorac Anesthesiol & Crit Care, Atlanta, GA USA	Emory University; Emory University	Levy, JH (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA.	Jlevy01@emory.edu						Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chandler WL, 1996, CRIT REV ONCOL HEMAT, V24, P27, DOI 10.1016/1040-8428(96)00206-5; Dowd NP, 2002, ANESTHESIOLOGY, V97, P390, DOI 10.1097/00000542-200208000-00016; Karkouti K, 2010, ANESTH ANALG, V110, P21, DOI 10.1213/ANE.0b013e3181c0ea6d; Levy JH, 2010, ANESTH ANALG, V110, P354, DOI 10.1213/ANE.0b013e3181c84ba5; Martin K, 2008, ANESTH ANALG, V107, P1783, DOI 10.1213/ane.0b013e318184bc20; Medcalf RL, 2007, J THROMB HAEMOST, V5, P132, DOI 10.1111/j.1538-7836.2007.02464.x; PASCHE B, 1994, BLOOD, V83, P404; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Zufferey P, 2006, ANESTHESIOLOGY, V105, P1034, DOI 10.1097/00000542-200611000-00026	12	79	84	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					3	4		10.1016/S0140-6736(10)60939-7	http://dx.doi.org/10.1016/S0140-6736(10)60939-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624SR	20554318				2022-12-28	WOS:000279841600004
J	Shakur, H; Roberts, I; Bautista, R; Caballero, J; Coats, T; Dewan, Y; El-Sayed, H; Gogichaishvili, T; Gupta, S; Herrera, J; Hunt, B; Iribhogbe, P; Izurieta, M; Khamis, H; Komolafe, E; Marrero, MA; Mejia-Mantilla, J; Miranda, J; Morales, C; Olaomi, O; Dashi, F; Perel, P; Peto, R; Ramana, PV; Ravi, RR; Yutthalcasemsunt, S; Dakubo, J; Gogichaishvili, T; Golden, N; Izurieta, M; Khamis, H; Komolafe, E; Loria-Castellanos, J; Mejia-Mantilla, J; Miranda, J; Munoz, A; Mutiso, V; Olcwen, P; Ortiz, Z; Pascual, M; Ravi, R; Roslani, A; Trenkler, S; Volpi, A; Yutthakasemsunt, S; Roberts, I; Shakur, H; Perel, P; Bametson, L; Ramos, M; Cook, L; Kawahara, T; Balogun, E; Berle, M; Barrow, C; Brady, T; Rubery, C; Wayte, J; To, C; Franklin, I; Chaudhry, B; Coats, T; Deakin, C; Goodacre, S; Hunt, B; Meddings, D; Peto, R; Roberts, I; Sandercock, P; Roberts, I; Shakur, H; Coats, T; Edwards, P; Hunt, B; Ramos, M; Collins, R; Grant, A; Myburgh, J; Baxter, A				Shakur, Haleema; Roberts, Ian; Bautista, Raul; Caballero, Jose; Coats, Tim; Dewan, Yashbir; El-Sayed, Hesham; Gogichaishvili, Tamar; Gupta, Sanjay; Herrera, Jorge; Hunt, Beverley; Iribhogbe, Pius; Izurieta, Mario; Khamis, Hussein; Komolafe, Edward; Marrero, Maria-Acelia; Mejia-Mantilla, Jorge; Miranda, Jaime; Morales, Carlos; Olaomi, Oluwole; Dashi, Fatos; Perel, Pablo; Peto, Richard; Ramana, P. V.; Ravi, R. R.; Yutthalcasemsunt, Surakrant; Dakubo, Jonathan; Gogichaishvili, Tamar; Golden, Nyoman; Izurieta, Mario; Khamis, Hussein; Komolafe, Edward; Loria-Castellanos, Jorge; Mejia-Mantilla, Jorge; Miranda, Jaime; Munoz, Angeles; Mutiso, Vincent; Olcwen, Patrick; Ortiz, Zulma; Pascual, Maria; Ravi, R.; Roslani, April; Trenkler, Stefan; Volpi, Annalisa; Yutthakasemsunt, Surakrant; Roberts, Ian; Shakur, Haleema; Perel, Pablo; Bametson, Lin; Ramos, Maria; Cook, Lisa; Kawahara, Taemi; Balogun, Eni; Berle, Matthew; Barrow, Collette; Brady, Tony; Rubery, Chris; Wayte, Jackie; To, Cynthia; Franklin, Ian; Chaudhry, Brigitte; Coats, Tim; Deakin, Charles; Goodacre, Steve; Hunt, Beverley; Meddings, David; Peto, Richard; Roberts, Ian; Sandercock, Peter; Roberts, Ian; Shakur, Haleema; Coats, Tim; Edwards, Phil; Hunt, Beverley; Ramos, Maria; Collins, Rory; Grant, Adrian; Myburgh, John; Baxter, Alex		Crash 2 Trial Collaborators	Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial	LANCET			English	Article							BRAIN-INJURY; EPIDEMIOLOGY	Background Tranexamic acid can reduce bleeding in patients undergoing elective surgery. We assessed the effects of early administration of a short course of tranexamic acid on death, vascular occlusive events, and the receipt of blood transfusion in trauma patients. Methods This randomised controlled trial was undertaken in 274 hospitals in 40 countries. 20 211 adult trauma patients with, or at risk of, significant bleeding were randomly assigned within 8 h of injury to either tranexamic acid (loading dose 1 g over 10 min then infusion of 1 g over 8 h) or matching placebo. Randomisation was balanced by centre, with an allocation sequence based on a block size of eight, generated with a computer random number generator. Both participants and study staff (site investigators and trial coordinating centre staff) were masked to treatment allocation. The primary outcome was death in hospital within 4 weeks of injury, and was described with the following categories: bleeding, vascular occlusion (myocardial infarction, stroke and pulmonary embolism), multiorgan failure, head injury, and other. All analyses were by intention to treat. This study is registered as ISRCTN86750102, Clinicaltrials.gov NCT00375258, and South African Clinical Trial Register DOH-27-0607-1919. Findings 10 096 patients were allocated to tranexamic acid and 10 115 to placebo, of whom 10 060 and 10 067, respectively, were analysed. All-cause mortality was significantly reduced with tranexamic acid (1463 [14.5%] tranexamic acid group vs 1613 [16.0%] placebo group; relative risk 0.91, 95% CI 0.85-0.97; p=0.0035). The risk of death due to bleeding was significantly reduced (489 [4.9%] vs 574 [5.7%]; relative risk 0.85, 95% CI 0.76-0.96; p=0.0077). Interpretation Tranexamic acid safely reduced the risk of death in bleeding trauma patients in this study. On the basis of these results, tranexamic acid should be considered for use in bleeding trauma patients.	[Shakur, Haleema] Univ London London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Shakur, H (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England.	crash@lshtm.ac.uk	LORIA-CASTELLANOS, JORGE/J-2410-2016; Anyanwu, Stanley/W-2514-2019; Dharap, Satish/AAE-8565-2020; Mohammad, Bassim Irheim/G-3715-2019; Balogh, Zsolt/A-2002-2010; Mbuagbaw, Lawrence/D-9381-2015; Mohammad, Bassim/AAE-3715-2020; Roslani, April Camilla/B-8245-2010; Dewan, Yashbir/C-6503-2013; Collins, Rory/ABA-8487-2020; LORIA-CASTELLANOS, JORGE/N-2363-2019; Nottidge, Timothy/ACH-9894-2022; Coats, Timothy/AAW-1254-2021; Trochez, Adolfo Leon/Z-1749-2019; Miranda, J. Jaime/A-8482-2008; Volpi, Annalisa/AHH-5394-2022	LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Dharap, Satish/0000-0002-9304-9617; Balogh, Zsolt/0000-0002-0277-4822; Mbuagbaw, Lawrence/0000-0001-5855-5461; Roslani, April Camilla/0000-0003-2458-965X; Dewan, Yashbir/0000-0002-7154-1301; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Nottidge, Timothy/0000-0002-5245-8115; Coats, Timothy/0000-0003-2736-2784; Trochez, Adolfo Leon/0000-0002-3621-6036; Miranda, J. Jaime/0000-0002-4738-5468; Volpi, Annalisa/0000-0001-5337-9155; Mohammad, Bassim/0000-0001-6732-5940; /0000-0002-2342-301X; amini, afshin/0000-0001-8928-8212; Wattanakrai, Kamol/0000-0003-4383-0795; ABUBAKAR, MUHAMMAD LAWAL/0000-0002-5536-873X; RAMANA, P V/0000-0003-4654-0590; YUSUF, AYODEJI SALMAN/0000-0002-6002-8641; Kumar, Dinesh/0000-0003-3602-4023; Mankar, Dr. Sushil/0000-0002-7432-2761; Shakur-Still, Haleema/0000-0002-6511-109X; Sandercock, Peter/0000-0001-8484-0135; Hokkam, Emad/0000-0003-1532-6655; Pangi, Ashok/0000-0002-3417-3976; Goodacre, Steve/0000-0003-0803-8444; Ochoa-Parra, Marcelo/0000-0003-0432-8962; Aminu Balarabe, Muhammad/0000-0001-5607-5480; Chaudhuri, pratyush/0000-0001-9766-728X; Okwen, Patrick/0000-0002-9017-7496; RUBIANO ESCOBAR, ANDRES MARIANO/0000-0001-8931-3254; Soto, Alonso/0000-0001-8648-8032; JAMALUDDIN, SABARIAH/0000-0002-3788-7915; Caballero-Alvarado, Jose/0000-0001-8297-6901; Moradi, Ehsan/0000-0002-1403-0150; Wallis, Lee/0000-0003-2711-3139; komolafe, edward/0000-0003-1261-3501	UK NIHR Health Technology; Pfizer; BUPA Foundation; J P Moulton Charitable Foundation; National Institute for Health Research [06/303/20] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008315] Funding Source: NIH RePORTER	UK NIHR Health Technology; Pfizer(Pfizer); BUPA Foundation; J P Moulton Charitable Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding UK NIHR Health Technology Assessment programme, Pfizer, BUPA Foundation, and J P Moulton Charitable Foundation.	Baigent C, 2010, OXFORD TXB MED, P31; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; COATS T, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004896; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; Ekback G, 2000, ANESTH ANALG, V91, P1124; Ferrer P, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-29; Fiechtner BK, 2001, ANESTH ANALG, V92, P1131; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; HORROW JC, 1995, ANESTHESIOLOGY, V82, P383, DOI 10.1097/00000542-199502000-00009; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Lawson JH, 2004, SEMIN HEMATOL, V41, P55, DOI 10.1053/j.seminhematol.2003.11.012; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; *MRC CRASH TRIAL C, 2008, BMJ-BRIT MED J, V12, P12; Okamoto S, 1997, SEMIN THROMB HEMOST, V23, P493, DOI 10.1055/s-2007-996127; Peden M, 2002, INJURY CHART BOOK GR; PEREL P, 2008, EMC MED RES METHODOL, V8, P72; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shakur H, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-40; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; WYATT J, 1995, BRIT MED J, V310, P1502, DOI 10.1136/bmj.310.6993.1502	25	1774	1839	2	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					23	32		10.1016/S0140-6736(10)60835-5	http://dx.doi.org/10.1016/S0140-6736(10)60835-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624SR	20554319				2022-12-28	WOS:000279841600021
J	Dorrn, AL; Yuan, K; Barker, AJ; Schreiner, CE; Froemke, RC				Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.			Developmental sensory experience balances cortical excitation and inhibition	NATURE			English	Article							PRIMARY AUDITORY-CORTEX; VISUAL-CORTEX; SYNAPTIC DEPRESSION; RECEPTIVE-FIELDS; BARREL CORTEX; IN-VIVO; PLASTICITY; RAT; NEURONS; COMPETITION	Early in life, neural circuits are highly susceptible to outside influences. The organization of the primary auditory cortex (A1) in particular is governed by acoustic experience during the critical period, an epoch near the beginning of postnatal development throughout which cortical synapses and networks are especially plastic(1-8). This neonatal sensitivity to the pattern of sensory inputs is believed to be essential for constructing stable and adequately adapted representations of the auditory world and for the acquisition of language skills by children(5,9,10). One important principle of synaptic organization in mature brains is the balance between excitation and inhibition, which controls receptive field structure and spatiotemporal flow of neural activity(11-15), but it is unknown how and when this excitatory-inhibitory balance is initially established and calibrated. Here we use whole-cell recording to determine the processes underlying the development of synaptic receptive fields in rat A1. We find that, immediately after the onset of hearing, sensory-evoked excitatory and inhibitory responses are equally strong, although inhibition is less stimulus-selective and mismatched with excitation. However, during the third week of postnatal development, excitation and inhibition become highly correlated. Patterned sensory stimulation drives coordinated synaptic changes across receptive fields, rapidly improves excitatory-inhibitory coupling and prevents further exposure-induced modifications. Thus, the pace of cortical synaptic receptive field development is set by progressive, experience-dependent refinement of intracortical inhibition.	[Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; [Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, WM Keck Fdn Ctr Integrat Neurosci, Neurosci Grad Program,Dept Otolaryngol, San Francisco, CA 94143 USA; [Dorrn, Anja L.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; [Dorrn, Anja L.] NeuroCure Neurosci Res Ctr NWFZ, D-13125 Berlin, Germany; [Froemke, Robert C.] NYU, Sch Med, Mol Neurobiol Program, Helen & Martin Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Skirball Inst Biomol Med, Dept Otolaryngol, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University; New York University; New York University; New York University	Froemke, RC (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.	robert.froemke@med.nyu.edu	Barker, Alison/AAH-1905-2021	Barker, Alison/0000-0001-9103-9258; Dorrn, Anja L./0000-0002-4215-3609; Schreiner, Christoph/0000-0002-4571-4328; Froemke, Robert/0000-0002-1230-6811	National Institute on Deafness and Other Communication Disorders [K99/R00]; Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco; Hearing Research Inc.; John C. and Edward Coleman Fund; Jane Coffin Childs Postdoctoral Research Fellowship; Sandler Translational Research Fellowship; National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260, K99DC009635] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco(University of California System); Hearing Research Inc.; John C. and Edward Coleman Fund; Jane Coffin Childs Postdoctoral Research Fellowship; Sandler Translational Research Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. A. Atencio, T. Babcock, E. Chang, E. de Villers-Sidani, M. R. DeWeese, G. Ehret, S. Gandhi, K. Imaizumi, M. M. Merzenich, C. Niell, A.-M. Oswald, and A. Y. Tan for comments, discussions and technical assistance. This work was supported by the National Institute on Deafness and Other Communication Disorders, the Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco, Hearing Research Inc. and the John C. and Edward Coleman Fund. R. C. F. is a recipient of a National Institute on Deafness and Other Communication Disorders K99/R00 Career Award, a Jane Coffin Childs Postdoctoral Research Fellowship and a Sandler Translational Research Fellowship. A.J.B. is a recipient of a National Science Foundation Graduate Research Fellowship.	Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenet T, 2007, P NATL ACAD SCI USA, V104, P7646, DOI 10.1073/pnas.0701944104; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; SPITZER NC, 1979, ANNU REV NEUROSCI, V2, P363, DOI 10.1146/annurev.ne.02.030179.002051; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tallal P, 2002, DEV PSYCHOPATHOL, V14, P559, DOI 10.1017/S0954579402003097; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	29	196	198	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					932	U9		10.1038/nature09119	http://dx.doi.org/10.1038/nature09119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559387	Green Accepted, Green Submitted			2022-12-28	WOS:000278804500039
J	Rajaratnam, JK; Marcus, JR; Flaxman, AD; Wang, HD; Levin-Rector, A; Dwyer, L; Costa, M; Lopez, AD; Murray, CJL				Rajaratnam, Julie Knoll; Marcus, Jake R.; Flaxman, Abraham D.; Wang, Haidong; Levin-Rector, Alison; Dwyer, Laura; Costa, Megan; Lopez, Alan D.; Murray, Chnstopher J. L.			Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4	LANCET			English	Article							INFANT-MORTALITY; HEALTH; SURVIVAL; TRENDS; COVERAGE; AFRICA	Background Previous assessments have highlighted that less than a quarter of countries are on track to achieve Millennium Development Goal 4 (MDG 4), which calls for a two-thirds reduction in mortality in children younger than 5 years between 1990 and 2015. In view of policy initiatives and investments made since 2000, it is important to see if there is acceleration towards the MDG 4 target We assessed levels and trends in child mortality for 187 countries from 1970 to 2010. Methods We compiled a database of 16174 measurements of mortality in children younger than 5 years for 187 countries from 1970 to 2009, by use of data from all available sources, including vital registration systems, summary birth histories in censuses and surveys, and complete birth histories. We used Gaussian process regression to generate estimates of the probability of death between birth and age 5 years. This is the first study that uses Gaussian process regression to estimate child mortality, and this technique has better out-of-sample predictive validity than do previous methods and captures uncertainty caused by sampling and non-sampling error across data types. Neonatal, postneonatal, and childhood mortality was estimated from mortality in children younger than 5 years by use of the 1760 measurements from vital registration systems and complete birth histories that contained specific information about neonatal and postneonatal mortality. Findings Worldwide mortality in children younger than 5 years has dropped from 11.9 million deaths in 1990 to 7.7 million deaths in 2010, consisting of 3 1 million neonatal deaths, 2.3 million postneonatal deaths, and 2.3 million childhood deaths (deaths in children aged 1-4 years). 33.0% of deaths in children younger than 5 years occur in south Asia and 49.6% occur in sub-Saharan Africa, with less than 1% of deaths occurring in high-income countries. Across 21 regions of the world, rates of neonatal, postneonatal, and childhood mortality are declining. The global decline from 1990 to 2010 is 2.1% per year for neonatal mortality, 2.3% for postneonatal mortality, and 2.2% for childhood mortality. In 13 regions of the world, including all regions in sub-Saharan Africa, there is evidence of accelerating declines from 2000 to 2010 compared with 1990 to 2000. Within sub-Saharan Africa, rates of decline have increased by more than 1% in Angola, Botswana, Cameroon, Congo, Democratic Republic of the Congo, Kenya, Lesotho, Liberia, Rwanda, Senegal, Sierra Leone, Swaziland, and The Gambia. Interpretation Robust measurement of mortality in children younger than 5 years shows that accelerating declines are occurring in several low-income countries. These positive developments deserve attention and might need enhanced policy attention and resources.	[Rajaratnam, Julie Knoll; Marcus, Jake R.; Flaxman, Abraham D.; Wang, Haidong; Levin-Rector, Alison; Dwyer, Laura; Costa, Megan; Murray, Chnstopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.		Lopez, Alan/AAA-2734-2022; Levin-Rector, Alison/AAA-6756-2020; pan, tao/O-7308-2014; Lopez, Alan D/F-1487-2010	Lopez, Alan D/0000-0001-5818-6512; Dwyer-Lindgren, Laura/0000-0002-3872-6451; Costa, Megan/0000-0002-0256-477X	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation	Arnold F., 1990, ASSESSMENT QUALITY B; ARTZROUNI M, 2003, TECHN M HIV CHILD MO; Boerma JT, 2006, B WORLD HEALTH ORGAN, V84, P145, DOI 10.2471/BLT.05.025189; Brass W., 1975, LAB POPULATION STAT; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; *CTR RES EP DIS, 2009, CE DAT COMPL EM DAT; *CTR RES EP DIS, 2009, DEATHS DUE NAT DIS 1; CURTIS SL, 1995, OCCASIONAL PAPERS OR, V3; *DEP INT DEV, 2007, INT HLTH PARTN LANUC; Drevenstedt GL, 2008, P NATL ACAD SCI USA, V105, P5016, DOI 10.1073/pnas.0800221105; Garenne M, 2006, B WORLD HEALTH ORGAN, V84, P470, DOI 10.2471/BLT.05.029231; Gaskell GD, 2000, PUBLIC OPIN QUART, V64, P77, DOI 10.1086/316761; *GAVI ALL, 2010, INV IMM GAVI ALL EV; GREGSON S, 2009, IUSSP INT POP C MARR; GUILLOT M, 2009, POP ASS AM ANN M DET; HAMMOUD EI, 1965, AM J PUBLIC HEALTH N, V55, P1152, DOI 10.2105/AJPH.55.8.1152; *HARV U I HLTH MET, 2009, WHO GLOB BURD DIS ST; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P225, DOI 10.2471/BLT.05.029744; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; LESSLER JT, 1985, MILBANK FUND Q, V63, P565, DOI 10.2307/3349848; Mahy M., 2003, MEASURING CHILD MORT; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Nakiyingi JS, 2003, AIDS, V17, P1827, DOI 10.1097/00002030-200308150-00012; Ndirangu J, 2010, AIDS, V24, P593, DOI 10.1097/QAD.0b013e328335cff5; OBAID TA, 2007, UNFPA NEWS; Paciorek P, 2003, NONSTATIONARY GAUSSI; PREKER A., 1999, MEASURING COUNTRY PE; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; THOMPSON P, 1956, TELLUS, V8, P84; *UN POP DIV, 2009, WORLD POP PROPS 2008; *UNICEF, 2009, CHILD MORT DAT EST 2; *UPPS CONFL DAT PR, 2009, UCDP NONST CONFL DAT; *UPPS CONFL DAT PR, 2009, UCDP PRIO ARM CONFL; *UPPS CONFL DAT PR, 2009, UCDP NONST ACT DAT V; WARD P, 2008, S AFR J DEMOGR, V11, P39; Wiener N., 1964, EXTRAPOLATION INTERP; *WORLD BANK, 1993, WORLD DEV REP 1993 I; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9; 2007, GLOBAL HLTH COUNCIL	44	546	568	0	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2010	375	9730					1988	2008		10.1016/S0140-6736(10)60703-9	http://dx.doi.org/10.1016/S0140-6736(10)60703-9			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609WT	20546887				2022-12-28	WOS:000278689600027
J	Waddington, CS; Walker, WT; Oeser, C; Reiner, A; John, T; Wilkins, S; Casey, M; Eccleston, PE; Allen, RJ; Okike, I; Ladhani, S; Sheasby, E; Hoschler, K; Andrews, N; Waight, P; Collinson, AC; Heath, PT; Finn, A; Faust, SN; Snape, MD; Miller, E; Pollard, AJ				Waddington, Claire S.; Walker, W. T.; Oeser, C.; Reiner, A.; John, T.; Wilkins, S.; Casey, M.; Eccleston, P. E.; Allen, R. J.; Okike, I.; Ladhani, S.; Sheasby, E.; Hoschler, K.; Andrews, N.; Waight, P.; Collinson, A. C.; Heath, P. T.; Finn, A.; Faust, S. N.; Snape, M. D.; Miller, E.; Pollard, A. J.			Safety and immunogenicity of AS03(B) adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PANDEMIC INFLUENZA; YOUNG-CHILDREN; CELL-CULTURE; TRIAL; VIRUS; RECOMMENDATIONS; RESPONSES; ANTIBODY; INFANTS	Objectives To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom. Design Open label, randomised, parallel group, phase II study. Setting Five UK centres (Oxford, Southampton, Bristol, Exeter, and London). Participants Children aged 6 months to less than 13 years for whom a parent or guardian had provided written informed consent and who were able to comply with study procedures were eligible. Those with laboratory confirmed pandemic H1N1 influenza or clinically diagnosed disease meriting antiviral treatment, allergy to egg or any other vaccine components, or coagulation defects, or who were severely immunocompromised or had recently received blood products were excluded. Children were grouped by age: 6 months-<3 years (younger group) and 3-<13 years (older group). Recruitment was by media advertising and direct mailing. Recruitment visits were attended by 949 participants, of whom 943 were enrolled and 937 included in the per protocol analysis. Interventions Participants were randomised 1: 1 to receive AS03(B) (tocopherol based oil in water emulsion) adjuvanted split virion vaccine derived from egg culture or non-adjuvanted whole virion vaccine derived from cell culture. Both were given as two doses 21 days apart. Reactogenicity data were collected for one week after immunisation by diary card. Serum samples were collected at baseline and after the second dose. Main outcome measures Primary reactogenicity end points were frequency and severity of fever, tenderness, swelling, and erythema after vaccination. Immunogenicity was measured by microneutralisation and haemagglutination inhibition assays. The primary immunogenicity objective was a comparison between vaccines of the percentage of participants showing seroconversion by the microneutralisation assay (fourfold rise to a titre of >= 1:40 from before vaccination to three weeks after the second dose). Results Seroconversion rates were higher after the adjuvanted split virion vaccine than after the whole virion vaccine, most notably in the youngest children (163 of 166 participants with paired serum samples (98.2%, 95% confidence interval 94.8% to 99.6%) v 157 of 196 (80.1%, 73.8% to 85.5%), P<0.001) in children under 3 years and 226 of 228 (99.1%, 96.9% to 99.9%) v 95.9%, 92.4% to 98.1%, P=0.03) in those over 3 years). The adjuvanted split virion vaccine was more reactogenic than the whole virion vaccine, with more frequent systemic reactions and severe local reactions in children aged over 5 years after dose one (13 (7.2%, 3.9% to 12%) v 2 (1.1%, 0.1% to 3.9%), P<0.001) and dose two (15 (8.5%, 4.8% to 13.7%) v 2 (1.1%, 0.1% to 4.1%), P<0.002) and after dose two in those under 5 years (15 5.9%, 3.3% to 9.6%) v 0 (0.0%, 0% to 1.4%), P<0.001). Dose two of the adjuvanted split virion vaccine was more reactogenic than dose one, especially for fever >= 38 degrees C in those aged under 5 (24 (8.9%, 5.8% to 12.9%) v 57 (22.4%, 17.5% to 28.1%), P<0.001). Conclusions In this first direct comparison of an AS03(B) adjuvanted split virion versus whole virion non-adjuvanted H1N1 vaccine, the adjuvanted vaccine, while more reactogenic, was more immunogenic and, importantly, achieved high seroconversion rates in children aged less than 3 years. This indicates the potential for improved immunogenicity of influenza vaccines in this age group.	[Waddington, Claire S.; John, T.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Clin Team, Oxford OX3 7LJ, England; [Walker, W. T.; Faust, S. N.] Univ Southampton, Wellcome Trust Clin Res Facil, Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England; [Oeser, C.; Okike, I.; Ladhani, S.; Heath, P. T.] St Georges Vaccine Inst, London SW17 0QT, England; [Collinson, A. C.] Royal Devon & Exeter NHS Fdn Trust, Children Res Network, Exeter EX2 5DW, Devon, England; [Allen, R. J.] Univ Hosp Bristol NHS Fdn Trust, Bristol Childrens Vaccine Ctr, Res Network, Bristol BS2 8AE, Avon, England; [Finn, A.] Univ Hosp Bristol NHS Fdn Trust, Bristol Childrens Vaccine Ctr, Children Res Network, Bristol BS2 8AE, Avon, England; [Ladhani, S.; Sheasby, E.; Hoschler, K.; Andrews, N.; Waight, P.; Miller, E.] Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England	University of Oxford; University of Southampton; St Georges University London; University of Exeter; University of Bristol; University of Bristol; Health Protection Agency	Waddington, CS (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Clin Team, Oxford OX3 7LJ, England.	claire.waddington@paediatrics.ox.ac.uk	Faust, Saul/J-9779-2014	Faust, Saul/0000-0003-3410-7642; Finn, Adam/0000-0003-1756-5668; Snape, Matthew/0000-0003-0531-5426; Ladhani, Shamez/0000-0002-0856-2476; Heath, Paul/0000-0002-7540-7433	NIHR; Thames Valley; Hampshire; Isle of Wight and Western; South West and London-South East, North, Central, and East (SENCE) Local Research Networks	NIHR(National Institute for Health Research (NIHR)); Thames Valley; Hampshire; Isle of Wight and Western; South West and London-South East, North, Central, and East (SENCE) Local Research Networks	This study was funded by the NIHR Health Technology Assessment Programme and was supported by the NIHR Oxford Comprehensive Biomedical Research Centre programme (including salary support for AR, TMJ, and MDS), and the Thames Valley, Hampshire and Isle of Wight and Western (salary support for CDS) Comprehensive Local Research Networks and the Southampton Respiratory NIHR Biomedical Research Unit. None of the funders had a role in study design, data collection, data analysis, data interpretation, or writing of the report. This study was adopted by the NIHR Medicines for Children Research Network and supported by their South West and London-South East, North, Central, and East (SENCE) Local Research Networks. AJP is a Jenner Institute Investigator	[Anonymous], 2009, SUMMARY PRODUCT CHAR; Arguedas A, 2010, NEW ENGL J MED, V362, P370, DOI 10.1056/NEJMc0909988; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Chu DWS, 2009, VACCINE, V27, P7428, DOI 10.1016/j.vaccine.2009.07.102; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Department of Health, 2009, H1N1 SWIN FLU INFL P; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ellis JS, 1997, EUR J EPIDEMIOL, V13, P369, DOI 10.1023/A:1007391222905; Erlewyn-Lajeunesse M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3680; *EUR MED AG, 2007, GUID INFL VACC PREP; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Protection Agency, 2009, PAND H1N1 2009 ENGL; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly H, 2010, LANCET, V375, P6, DOI 10.1016/S0140-6736(09)62132-2; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Pollard AJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4652; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; *STRAT ADV GROUP E, 2009, REP EXTR M INFL H1N1; US Food and Drug Administration, 2007, GUID IND CLIN DAT NE; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6; 2008, CHMP RECOMMENDATIONS	32	137	140	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2010	340								c2649	10.1136/bmj.c2649	http://dx.doi.org/10.1136/bmj.c2649			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604LD	20508026	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000278279600002
J	Staels, B				Staels, Bart			Fibrates in CVD: a step towards personalised medicine	LANCET			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2 DIABETES-MELLITUS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HDL CHOLESTEROL; FENOFIBRATE; THERAPY; TRIAL; RISK		[Staels, Bart] Univ Lille Nord France, Lille, France; [Staels, Bart] INSERM, U1011, F-59045 Lille, France; [Staels, Bart] Univ Lille 2, Lille, France; [Staels, Bart] Inst Pasteur, F-59019 Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Staels, B (corresponding author), Univ Lille Nord France, Lille, France.	Bart.Staels@pasteur-lille.fr	Staels, Bart/N-9497-2016	Staels, Bart/0000-0002-3784-1503				Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2008, ARTERIOSCL THROM VAS, V28, P39, DOI 10.1161/ATVBAHA.107.148817; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Scott R, 2009, DIABETES CARE, V32, P493, DOI 10.2337/dc08-1543; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Taskinen MR, 2009, ARTERIOSCL THROM VAS, V29, P950, DOI 10.1161/ATVBAHA.108.178228; Zanchetti A, 2009, J HYPERTENS, V27, P1509, DOI 10.1097/HJH.0b013e32832e9500	14	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2010	375	9729					1847	1848		10.1016/S0140-6736(10)60758-1	http://dx.doi.org/10.1016/S0140-6736(10)60758-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20510999				2022-12-28	WOS:000278628800004
